Clustering O 0 0.0010591091122478247
of O 0 0.000611999596003443
missense O 0 0.0021022851578891277
mutations O 0 0.00013332550588529557
in O 0 0.00020052940817549825
the O 0 0.002099761040881276
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999970197677612
telangiectasia I-Disease 1 0.9999614953994751
gene O 0 0.00011755914601963013
in O 0 3.568591273506172e-05
a O 0 6.56520642223768e-05
sporadic B-Disease 0 0.011780662462115288
T I-Disease 1 0.9999988079071045
- I-Disease 1 0.9938511848449707
cell I-Disease 0 0.014901610091328621
leukaemia I-Disease 1 0.9996119141578674
. O 0 0.00042661617044359446

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.006771293468773365
A B-Disease 1 1.0
- I-Disease 1 0.999996542930603
T I-Disease 1 0.9999983310699463
) O 0 1.7099826436606236e-05
is O 0 1.6627335526209208e-06
a O 0 1.3051899259153288e-05
recessive B-Disease 0 0.0011103192809969187
multi I-Disease 1 0.9997454285621643
- I-Disease 1 0.9999988079071045
system I-Disease 1 0.9992672801017761
disorder I-Disease 1 1.0
caused O 1 0.9981104135513306
by O 0 9.11192546482198e-05
mutations O 0 3.517467848723754e-05
in O 0 4.0719107346376404e-05
the O 0 0.00012549225357361138
ATM O 0 0.0037906253710389137
gene O 0 7.371010724455118e-05
at O 0 0.0004709895874839276
11q22 O 0 0.0034613320603966713
- O 0 0.0012391482014209032
q23 O 0 0.0038971970789134502
( O 0 0.00012873075320385396
ref O 0 0.005970343481749296
. O 0 2.654848140082322e-05
3 O 0 0.0001826955412980169
) O 0 4.983705002814531e-05
. O 0 7.714139792369679e-05

The O 0 0.00033581818570382893
risk O 0 0.00029631878715008497
of O 0 0.0010854809079319239
cancer B-Disease 1 0.9999998807907104
, O 0 0.00032008884591050446
especially O 0 0.0010468066902831197
lymphoid B-Disease 1 0.9966128468513489
neoplasias I-Disease 1 0.6891159415245056
, O 0 2.7140693418914452e-05
is O 0 8.835546395857818e-06
substantially O 0 0.0002678459568414837
elevated O 0 0.008784438483417034
in O 0 0.00024546918575651944
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999988079071045
T I-Disease 1 1.0
patients O 0 9.808480535866693e-05
and O 0 1.4369958080351353e-05
has O 0 9.252426934835967e-06
long O 0 4.332767639425583e-05
been O 0 1.0836961337190587e-05
associated O 0 1.5606861779815517e-05
with O 0 4.8110166972037405e-05
chromosomal O 1 1.0
instability O 1 1.0
. O 1 0.9661465287208557

By O 0 6.918336293892935e-05
analysing O 0 0.0016916162567213178
tumour B-Disease 1 1.0
DNA O 0 0.0013227349845692515
from O 0 6.889789074193686e-05
patients O 0 2.9591332349809818e-05
with O 0 1.2542453077912796e-05
sporadic B-Disease 0 0.012617568485438824
T I-Disease 1 0.9999960660934448
- I-Disease 0 0.061716608703136444
cell I-Disease 0 0.0019667139276862144
prolymphocytic I-Disease 1 0.9995229244232178
leukaemia I-Disease 1 0.9999994039535522
( O 0 0.0026280817110091448
T B-Disease 1 0.9999927282333374
- I-Disease 1 0.7827466130256653
PLL I-Disease 1 0.9999645948410034
) O 0 4.321382220950909e-05
, O 0 3.2577456750004785e-06
a O 0 1.40576739795506e-05
rare O 0 0.0003254789626225829
clonal B-Disease 0 0.01586071401834488
malignancy I-Disease 1 0.9571878910064697
with O 0 9.430524187337141e-06
similarities O 0 0.00016774388495832682
to O 0 9.58149103098549e-05
a O 0 0.0007049116538837552
mature B-Disease 0 0.24319584667682648
T I-Disease 1 0.9999363422393799
- I-Disease 0 0.008807810954749584
cell I-Disease 0 0.0011388183338567615
leukaemia I-Disease 0 0.02168973721563816
seen O 0 0.0004150587192270905
in O 0 0.00014180036669131368
A B-Disease 1 0.9998525381088257
- I-Disease 1 0.9942213892936707
T I-Disease 1 0.9997226595878601
, O 0 8.195375812647399e-06
we O 0 9.452866720494058e-07
demonstrate O 0 7.673800610064063e-06
a O 0 3.932722393074073e-06
high O 0 2.903209133364726e-05
frequency O 0 4.361477749625919e-06
of O 0 6.654541357420385e-05
ATM O 0 0.005804991815239191
mutations O 0 0.00027290344587527215
in O 0 0.0009080111049115658
T B-Disease 1 0.9999204874038696
- I-Disease 0 0.12237883359193802
PLL I-Disease 1 0.9998512268066406
. O 0 0.00037716838414780796

In O 0 0.00011757013999158517
marked O 0 0.00033760021324269474
contrast O 0 2.9965471185278147e-05
to O 0 2.870325442927424e-05
the O 0 0.000256653584074229
ATM O 0 0.007231894414871931
mutation O 0 3.50880109181162e-05
pattern O 0 0.00016146879352163523
in O 0 0.0002653441624715924
A B-Disease 1 0.9999866485595703
- I-Disease 1 0.9992904663085938
T I-Disease 1 0.9998984336853027
, O 0 7.67018718761392e-06
the O 0 5.331622560333926e-06
most O 0 1.6976977121885284e-06
frequent O 0 2.6076575068145758e-06
nucleotide O 0 1.1727891433110926e-05
changes O 0 3.4935303574457066e-06
in O 0 1.549304579384625e-05
this O 0 2.1421848941827193e-05
leukaemia B-Disease 1 0.9468984007835388
were O 0 0.0003635001485235989
missense O 0 0.0031176526099443436
mutations O 0 0.0007717442931607366
. O 0 0.0003883066528942436

These O 0 8.062401320785284e-05
clustered O 0 0.00026426330441609025
in O 0 1.9305400201119483e-05
the O 0 3.961440597777255e-05
region O 0 0.00010006533557316288
corresponding O 0 2.5385077606188133e-05
to O 0 2.3613476514583454e-05
the O 0 7.562205428257585e-05
kinase O 0 7.160559471230954e-05
domain O 0 5.1874740165658295e-05
, O 0 3.3377880299667595e-06
which O 0 1.5365883427875815e-06
is O 0 2.302703478562762e-06
highly O 0 3.305056088720448e-05
conserved O 0 0.0001231519563589245
in O 0 7.364124758169055e-05
ATM O 0 0.004003260284662247
- O 0 0.0003159410262014717
related O 0 4.341742896940559e-05
proteins O 0 2.069797665171791e-05
in O 0 4.0650207665748894e-05
mouse O 0 6.32027949905023e-05
, O 0 4.9001482693711296e-06
yeast O 0 5.376862100092694e-05
and O 0 1.44240002555307e-05
Drosophila O 0 0.00023869321739766747
. O 0 8.66750197019428e-05

The O 0 0.0005523975705727935
resulting O 0 0.001034291461110115
amino O 0 0.0005160309956409037
- O 0 0.0011012291070073843
acid O 0 0.00010388292866991833
substitutions O 0 5.3172749176155776e-05
are O 0 2.245203859274625e-06
predicted O 0 4.735303082270548e-05
to O 0 1.4144990927889012e-05
interfere O 0 0.00017553387442603707
with O 0 4.629776594811119e-05
ATP O 1 0.928551435470581
binding O 0 0.00020156016398686916
or O 0 9.963438787963241e-05
substrate O 0 0.00020532439521048218
recognition O 0 0.00047228141920641065
. O 0 0.0005658031441271305

Two O 0 4.121282836422324e-05
of O 0 0.00020487989240791649
seventeen O 0 0.004942657425999641
mutated O 0 0.004383763764053583
T B-Disease 1 0.9643358588218689
- I-Disease 0 0.0039086309261620045
PLL I-Disease 0 0.1538342833518982
samples O 0 2.0266374122002162e-05
had O 0 9.01476050785277e-06
a O 0 3.5202720027882606e-06
previously O 0 3.465873669483699e-05
reported O 0 0.000128169049276039
A B-Disease 1 0.9928250312805176
- I-Disease 1 0.9958435893058777
T I-Disease 1 0.9999580383300781
allele O 0 0.0001412249985150993
. O 0 0.00015028197958599776

In O 0 0.00037900949246250093
contrast O 0 0.0001740966981742531
, O 0 1.8047086996375583e-05
no O 0 1.664445153437555e-05
mutations O 0 2.623363798193168e-05
were O 0 4.054698729305528e-05
detected O 0 0.00021037194528616965
in O 0 2.2848989829071797e-05
the O 0 4.884147710981779e-05
p53 O 0 3.88550033676438e-05
gene O 0 9.635075002734084e-06
, O 0 1.714040877232037e-06
suggesting O 0 1.592631815583445e-05
that O 0 3.1318204491981305e-06
this O 0 6.945530913071707e-05
tumour B-Disease 1 1.0
suppressor O 0 0.015339442528784275
is O 0 1.6318055713782087e-05
not O 0 1.3490295032170252e-06
frequently O 0 3.073777406825684e-06
altered O 0 3.142773493891582e-05
in O 0 1.774198426574003e-05
this O 0 3.801331695285626e-05
leukaemia B-Disease 1 0.9990817308425903
. O 0 0.00047624571016058326

Occasional O 0 0.0015815625665709376
missense O 0 0.003477414371445775
mutations O 0 0.0002240785543108359
in O 0 0.00029289128724485636
ATM O 0 0.005281113553792238
were O 0 4.267211625119671e-05
also O 0 7.776067832310218e-06
found O 0 7.86313830758445e-06
in O 0 8.734376024222001e-05
tumour B-Disease 1 1.0
DNA O 0 0.000948797503951937
from O 0 8.91824092832394e-05
patients O 0 2.4997678337967955e-05
with O 0 1.7009428120218217e-05
B B-Disease 1 0.9742214679718018
- I-Disease 0 0.009964203462004662
cell I-Disease 0 0.0017667128704488277
non I-Disease 0 0.005533784162253141
- I-Disease 1 0.9974979758262634
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999855756759644
( O 0 0.0008869386510923505
B B-Disease 0 0.019539853557944298
- I-Disease 0 0.0013197037624195218
NHL I-Disease 0 0.00317088863812387
) O 0 8.882248948793858e-06
and O 0 1.9156091184413526e-06
a O 0 2.411762579868082e-05
B B-Disease 0 0.0061374991200864315
- I-Disease 0 0.0017976732924580574
NHL I-Disease 0 0.02156008593738079
cell O 0 0.001204036409035325
line O 0 0.0009525728528387845
. O 0 0.00012449822679627687

The O 0 0.00017622296581976116
evidence O 0 6.975825817789882e-05
of O 0 6.060174200683832e-05
a O 0 2.0376082829898223e-05
significant O 0 4.462737706489861e-05
proportion O 0 5.728381802327931e-05
of O 0 0.00019312310905661434
loss O 0 0.005558847915381193
- O 0 0.001568678650073707
of O 0 0.0002806679403875023
- O 0 0.0006001439178362489
function O 0 2.4499186110915616e-05
mutations O 0 1.6582645912421867e-05
and O 0 2.9077698400215013e-06
a O 0 1.3069946362520568e-05
complete O 0 0.00022981195070315152
absence O 0 0.0006898566498421133
of O 0 0.00022851757239550352
the O 0 0.00026642048032954335
normal O 0 0.00015944067854434252
copy O 0 0.0001730200310703367
of O 0 0.00014181496226228774
ATM O 0 0.002331821247935295
in O 0 2.481389128661249e-05
the O 0 2.5915085643646307e-05
majority O 0 5.989312285237247e-06
of O 0 0.00017762958304956555
mutated O 0 0.011259776540100574
tumours B-Disease 1 1.0
establishes O 0 0.005602348130196333
somatic O 0 0.0014014315092936158
inactivation O 0 0.0056546879932284355
of O 0 0.00040989709668792784
this O 0 1.874073495855555e-05
gene O 0 8.72203236212954e-06
in O 0 4.537632776191458e-06
the O 0 3.817796095972881e-05
pathogenesis O 0 0.4351061284542084
of O 0 0.0008231659885495901
sporadic B-Disease 1 0.9996106028556824
T I-Disease 1 1.0
- I-Disease 1 0.9924579858779907
PLL I-Disease 1 0.9998670816421509
and O 0 2.6209554562228732e-05
suggests O 0 2.435559690638911e-05
that O 0 3.101113179582171e-06
ATM O 0 0.0010760440491139889
acts O 0 6.845824827905744e-05
as O 0 0.00012649412383325398
a O 0 0.00089439278235659
tumour B-Disease 1 1.0
suppressor O 1 0.8806157112121582
. O 0 0.0007410943508148193

As O 0 0.00015282123058568686
constitutional O 0 0.00011723549687303603
DNA O 0 0.0001874573208624497
was O 0 0.00013664216385222971
not O 0 1.3991010519021074e-06
available O 0 1.057550662153517e-06
, O 0 1.0660393172656768e-06
a O 0 1.1155131687701214e-05
putative O 0 0.0010692771757021546
hereditary O 1 0.9999880790710449
predisposition O 1 0.9999997615814209
to O 1 0.9999922513961792
T B-Disease 1 1.0
- I-Disease 1 0.9999935626983643
PLL I-Disease 1 0.9999617338180542
will O 0 9.183428119285963e-06
require O 0 1.1090986618000898e-06
further O 0 7.557734534202609e-06
investigation O 0 4.615573197952472e-05
. O 0 2.435503847664222e-05
. O 0 7.109136640792713e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.007134454790502787
kinase O 0 0.00029807694954797626
is O 0 9.046048035088461e-06
involved O 0 5.079946731711971e-06
in O 0 6.282773938437458e-06
the O 0 1.4770556845178362e-05
modulation O 0 4.072796582477167e-05
of O 0 2.9503333280445077e-05
the O 0 9.689764556242153e-05
Ca2 O 0 0.0018618114991113544
+ O 0 0.0031964322552084923
homeostasis O 0 0.011433570645749569
in O 0 0.0010164841078221798
skeletal O 1 0.9999995231628418
muscle O 1 0.9974024891853333
cells O 0 0.0047751362435519695
. O 0 0.0007106611737981439

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.0005683204508386552
, O 0 1.3195261090004351e-05
the O 0 2.2614607587456703e-05
most O 0 4.934832759317942e-05
prevalent O 1 0.5848378539085388
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.7013233304023743
adults O 0 0.0005300107295624912
, O 0 3.7607853300869465e-05
is O 0 1.8466913388692774e-05
caused O 0 0.00045759789645671844
by O 0 5.164846879779361e-05
( O 0 0.0002953037910629064
CTG O 1 0.9914385080337524
) O 0 5.2981726184953004e-05
n O 0 0.00022333094966597855
- O 0 0.00021272257436066866
repeat O 0 0.0002837413048837334
expansion O 0 0.00010120200022356585
in O 0 3.4032784697046736e-06
a O 0 1.6556116406718502e-06
gene O 0 5.96575830513757e-07
encoding O 0 1.6244408698184998e-06
a O 0 6.43778503217618e-06
protein O 0 2.8836018827860244e-05
kinase O 0 9.177203173749149e-05
( O 0 0.00014425655535887927
DM B-Disease 1 0.9999986886978149
protein O 0 0.000492850667797029
kinase O 0 0.00019429909298196435
; O 0 3.403870505280793e-05
DMPK O 1 0.8752001523971558
) O 0 2.7652715289150365e-05
and O 0 2.6201487344224006e-06
involves O 0 1.5770616300869733e-05
changes O 0 1.0780761840578634e-05
in O 0 9.086181671591476e-05
cytoarchitecture O 0 0.014543469995260239
and O 0 0.00014817759802099317
ion O 0 0.005754190031439066
homeostasis O 0 0.3948245942592621
. O 0 0.0007933982415124774

To O 0 9.893852984532714e-05
obtain O 0 4.7339261072920635e-05
clues O 0 0.0001556590577820316
to O 0 8.584312126913574e-06
the O 0 1.77450474438956e-05
normal O 0 2.1454890884342603e-05
biological O 0 3.8779671740485355e-05
role O 0 2.4826013031997718e-05
of O 0 0.0003333690401632339
DMPK O 1 0.9999926090240479
in O 0 0.0007022523786872625
cellular O 0 0.0018586647929623723
ion O 0 0.0035726383794099092
homeostasis O 0 0.007844888605177402
, O 0 1.5259254723787308e-05
we O 0 2.7884234441444278e-06
have O 0 5.190165097701538e-07
compared O 0 1.0791067325044423e-05
the O 0 6.504782504634932e-05
resting O 0 0.0032333219423890114
[ O 0 0.0010353176621720195
Ca2 O 0 0.001935220556333661
+ O 0 0.0019429298117756844
] O 0 0.0008687529480084777
i O 0 5.654229244100861e-05
, O 0 1.7493146060587605e-06
the O 0 4.946801254845923e-06
amplitude O 0 3.333359563839622e-05
and O 0 9.087231774174143e-06
shape O 0 0.00013017994933761656
of O 0 0.0002159500145353377
depolarization O 0 0.002970063593238592
- O 0 0.004384132567793131
induced O 0 0.0024709240533411503
Ca2 O 0 0.001988697797060013
+ O 0 0.0019171704770997167
transients O 0 0.0010919173946604133
, O 0 2.3689754016231745e-06
and O 0 1.0257641633870662e-06
the O 0 8.52713219501311e-06
content O 0 1.5392226487165317e-05
of O 0 0.00022970396094024181
ATP O 1 0.993605375289917
- O 0 0.004231563303619623
driven O 0 0.000568969699088484
ion O 0 0.000777433451730758
pumps O 0 0.00022951720166020095
in O 0 9.201099601341411e-05
cultured O 0 0.00327957677654922
skeletal O 1 0.995215654373169
muscle O 0 0.004907380323857069
cells O 0 0.0005024971324019134
of O 0 0.0004280109133105725
wild O 0 0.0007241283892653883
- O 0 0.0003601130156312138
type O 0 6.40025464235805e-05
and O 0 3.6743218515766785e-05
DMPK O 1 0.9998981952667236
[ O 0 0.0027815252542495728
- O 0 0.0019133951282128692
/ O 0 0.0011636529816314578
- O 0 0.0018758737714961171
] O 0 0.0023159899283200502
knockout O 0 0.05577332526445389
mice O 0 0.0025440724566578865
. O 0 0.00012617258471436799

In O 0 0.00037739030085504055
vitro O 0 0.0006208023405633867
- O 0 0.0013951953733339906
differentiated O 0 0.0010440824553370476
DMPK O 1 0.9999446868896484
[ O 0 0.00659481156617403
- O 0 0.004875748883932829
/ O 0 0.0023120995610952377
- O 0 0.0020053668413311243
] O 0 0.0014548515900969505
myotubes O 0 0.0036337915807962418
exhibit O 0 0.00021802284754812717
a O 0 5.115403109812178e-05
higher O 0 0.00010482907964615151
resting O 0 0.0020493282936513424
[ O 0 0.0007093424210324883
Ca2 O 0 0.0009972474072128534
+ O 0 0.0013810390373691916
] O 0 0.0006535344873555005
i O 0 5.513131327461451e-05
than O 0 4.468191491469042e-06
do O 0 1.0958744496747386e-05
wild O 0 0.0001588412851560861
- O 0 0.0002815204206854105
type O 0 0.00017299067985732108
myotubes O 0 0.004129671026021242
because O 0 7.0211049205681775e-06
of O 0 2.4099921574816108e-05
an O 0 1.197332858282607e-05
altered O 0 0.00015087192878127098
open O 0 4.870900374953635e-05
probability O 0 3.323979171909741e-06
of O 0 8.600122964708135e-05
voltage O 0 0.0008958810358308256
- O 0 0.0006731064640916884
dependent O 0 4.382563565741293e-05
l O 0 0.00015520953456871212
- O 0 8.569701458327472e-05
type O 0 4.0324608562514186e-05
Ca2 O 0 0.00018881275900639594
+ O 0 0.0002170492516597733
and O 0 2.3894688638392836e-05
Na O 0 0.012900067493319511
+ O 0 0.00046610881690867245
channels O 0 9.099568706005812e-05
. O 0 4.7351270040962845e-05

The O 0 0.00048575736582279205
mutant O 0 0.0008474373607896268
myotubes O 0 0.008228529244661331
exhibit O 0 0.0003483421169221401
smaller O 0 3.0303710445878096e-05
and O 0 7.774214282108005e-06
slower O 0 7.425736112054437e-05
Ca2 O 0 0.0002949810295831412
+ O 0 0.0001242893486050889
responses O 0 3.687362777782255e-06
upon O 0 4.148530206293799e-05
triggering O 0 0.00022725430608261377
by O 0 1.8732336684479378e-05
acetylcholine O 0 0.0011011247988790274
or O 0 7.809844828443602e-05
high O 0 0.0006215625326149166
external O 0 0.00038741074968129396
K O 0 0.0035115701612085104
+ O 0 0.0013396490830928087
. O 0 0.00011474983330117539

In O 0 0.0001995966158574447
addition O 0 4.32595879829023e-05
, O 0 7.191376425907947e-06
we O 0 1.9345866348885465e-06
observed O 0 3.2859493330761325e-06
that O 0 3.285816490006255e-07
these O 0 3.1716483590571443e-06
Ca2 O 0 0.0010310054058209062
+ O 0 0.003380613401532173
transients O 0 0.004737697076052427
partially O 0 0.0006419621640816331
result O 0 1.1582970728341024e-05
from O 0 5.603008503385354e-06
an O 0 1.927563062054105e-06
influx O 0 7.736314000794664e-05
of O 0 4.2957355617545545e-05
extracellular O 0 0.00028924745856784284
Ca2 O 0 0.0005584211321547627
+ O 0 0.0002357751945964992
through O 0 2.0160452550044283e-05
the O 0 4.4446103856898844e-05
l O 0 0.0001916659966809675
- O 0 8.24601884232834e-05
type O 0 3.136563827865757e-05
Ca2 O 0 0.00026488484581932425
+ O 0 0.0002976918185595423
channel O 0 0.0002833479375112802
. O 0 4.771390013047494e-05

Neither O 0 0.0003655000764410943
the O 0 5.6588247389299795e-05
content O 0 2.8132963052485138e-05
nor O 0 1.3172254512028303e-05
the O 0 5.979142770229373e-06
activity O 0 1.0539528375375085e-05
of O 0 7.793528493493795e-05
Na O 1 0.8557430505752563
+ O 0 0.0011549652554094791
/ O 0 0.00039935033419169486
K O 0 0.0007612765184603631
+ O 0 0.000356535630999133
ATPase O 0 0.00027244954253546894
and O 0 1.390795296174474e-05
sarcoplasmic O 0 0.0017310691764578223
reticulum O 0 0.001013315748423338
Ca2 O 0 0.000696128117851913
+ O 0 0.0008549331105314195
- O 0 0.0003689116274472326
ATPase O 0 9.717830835143104e-05
are O 0 5.888893497285608e-07
affected O 0 8.043412890401669e-06
by O 0 1.4095047845330555e-05
DMPK O 1 0.9980339407920837
absence O 0 0.002278387313708663
. O 0 0.00036407809238880873

In O 0 0.0002475158835295588
conclusion O 0 0.00012904635514132679
, O 0 5.889937710890081e-06
our O 0 3.2139446375367697e-06
data O 0 4.03793501391192e-06
suggest O 0 1.5380517652374692e-05
that O 0 6.284553819568828e-06
DMPK O 1 0.9249646663665771
is O 0 2.1468686099979095e-05
involved O 0 1.8153832570533268e-05
in O 0 2.2595013433601707e-05
modulating O 0 0.0002454748027957976
the O 0 1.8102246031048708e-05
initial O 0 2.188747384934686e-05
events O 0 3.564292273949832e-05
of O 0 0.00014047087461221963
excitation O 0 0.00200353330001235
- O 0 0.00627782242372632
contraction O 0 0.005768400616943836
coupling O 0 0.001164248213171959
in O 0 0.000655992014799267
skeletal O 1 0.9999938011169434
muscle O 0 0.028140857815742493
. O 0 0.0005314091104082763
. O 0 0.0003158892213832587

Constitutional O 0 0.023930728435516357
RB1 O 1 1.0
- O 0 0.01439851988106966
gene O 0 0.00010695413948269561
mutations O 0 3.91560752177611e-05
in O 0 3.0674396839458495e-05
patients O 0 4.519458889262751e-05
with O 0 1.9551785953808576e-05
isolated O 0 0.001811095280572772
unilateral B-Disease 0 0.0013210305478423834
retinoblastoma I-Disease 1 0.9999924898147583
. O 0 0.0029414654709398746

In O 0 0.00019926138338632882
most O 0 2.692864291020669e-05
patients O 0 3.189488415955566e-05
with O 0 1.0668159120541532e-05
isolated O 0 0.0010178068187087774
unilateral B-Disease 0 0.0010399766033515334
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 0.0011876056669279933
tumor B-Disease 1 0.9999990463256836
development O 0 0.00039108676719479263
is O 0 1.2268606951693073e-05
initiated O 0 6.686824053758755e-05
by O 0 3.1803201636648737e-06
somatic O 0 5.839285586262122e-05
inactivation O 0 0.0010060037020593882
of O 0 0.00010844758071471006
both O 0 1.9922425053664483e-05
alleles O 0 9.63171260082163e-06
of O 0 0.00013457622844725847
the O 0 0.0018295412883162498
RB1 O 1 0.9999998807907104
gene O 0 0.00044746490311808884
. O 0 0.000149507584865205

However O 0 6.260396912693977e-05
, O 0 3.3660267035884317e-06
some O 0 7.576624625471595e-07
of O 0 2.0189523638691753e-05
these O 0 1.2351924851827789e-05
patients O 0 7.763109897496179e-05
can O 0 2.4043769371928647e-05
transmit O 0 0.00127404707018286
retinoblastoma B-Disease 1 0.9984859824180603
predisposition O 0 0.011379736475646496
to O 0 0.0002734475419856608
their O 0 0.00028488223324529827
offspring O 0 0.0011612074449658394
. O 0 0.00014659012958873063

To O 0 3.157132232445292e-05
determine O 0 1.5034436728456058e-05
the O 0 3.854422175209038e-05
frequency O 0 2.3438522475771606e-05
and O 0 5.546299234993057e-06
nature O 0 3.4447915822966024e-05
of O 0 0.00020365809905342758
constitutional O 0 0.007050767075270414
RB1 O 1 1.0
- O 0 0.00946806836873293
gene O 0 7.572359027108178e-05
mutations O 0 1.700029861240182e-05
in O 0 2.053160460491199e-05
patients O 0 3.0308881832752377e-05
with O 0 1.451821572118206e-05
isolated O 0 0.0010910232085734606
unilateral B-Disease 0 0.0005280176410451531
retinoblastoma I-Disease 1 0.9932016730308533
, O 0 2.521329588489607e-05
we O 0 5.002678335586097e-06
analyzed O 0 1.8649878256837837e-05
DNA O 0 5.8133937272941694e-05
from O 0 6.44795800326392e-05
peripheral O 0 0.04444260150194168
blood O 0 0.0019459353061392903
and O 0 0.00023861837689764798
from O 0 0.012110809795558453
tumor B-Disease 1 1.0
tissue O 1 0.9999351501464844
. O 0 0.0009392528445459902

The O 0 7.633448694832623e-05
analysis O 0 1.2614101251529064e-05
of O 0 0.0004485134850256145
tumors B-Disease 1 1.0
from O 0 0.0006965874345041811
54 O 0 0.000784053117968142
( O 0 6.475114059867337e-05
71 O 0 0.0001900201168609783
% O 0 2.3856322513893247e-05
) O 0 8.208698091038968e-06
of O 0 5.5079133744584396e-05
76 O 0 0.0010017940076068044
informative O 0 0.00039892891072668135
patients O 0 5.360044815461151e-05
showed O 0 0.00010382846085121855
loss O 0 0.00041357107693329453
of O 0 0.0004554646147880703
constitutional O 0 0.004474378190934658
heterozygosity O 1 0.9999995231628418
( O 0 0.02516057714819908
LOH O 1 1.0
) O 0 0.0002678579476196319
at O 0 0.000975383969489485
intragenic O 0 0.012864195741713047
loci O 0 0.001568943029269576
. O 0 0.00023061662795953453

Three O 0 0.00012847813195548952
of O 0 0.00044605485163629055
13 O 0 0.006012303754687309
uninformative O 1 0.9936389327049255
patients O 0 0.0007089194259606302
had O 0 0.0005582627491094172
constitutional O 0 0.0009952180553227663
deletions O 0 0.0036134524270892143
. O 0 0.000510870129801333

For O 0 2.3541346308775246e-05
39 O 0 7.5425865361467e-05
randomly O 0 8.167769919964485e-06
selected O 0 0.0007537977071478963
tumors B-Disease 1 1.0
, O 0 0.0005452792393043637
SSCP O 1 0.9999988079071045
, O 0 0.00041742020403034985
hetero O 0 0.014852543361485004
- O 0 0.0004487042024265975
duplex O 0 0.0005269265966489911
analysis O 0 7.054233719827607e-06
, O 0 6.332817520160461e-06
sequencing O 0 4.0035312849795446e-05
, O 0 4.550971880235011e-06
and O 0 2.8314539122220594e-06
Southern O 0 5.19395834999159e-05
blot O 0 0.00010844964708667248
analysis O 0 2.5841634396783775e-06
were O 0 9.805769877857529e-06
used O 0 1.1201728739251848e-05
to O 0 2.006233080464881e-05
identify O 0 0.00013909627159591764
mutations O 0 0.00021097737771924585
. O 0 0.0003253173199482262

Mutations O 0 0.0003575975133571774
were O 0 0.00013124650286044925
detected O 0 0.00035730990930460393
in O 0 4.328955037635751e-05
21 O 0 0.00021350124734453857
( O 0 1.5287907444871962e-05
91 O 0 0.0001373690611217171
% O 0 1.7544840375194326e-05
) O 0 1.2626413990801666e-05
of O 0 0.0001798017037799582
23 O 1 0.9991637468338013
tumors B-Disease 1 1.0
with O 0 0.03861154615879059
LOH O 1 1.0
. O 0 0.0022126114927232265

In O 0 0.0003405020397622138
6 O 0 0.0005114801460877061
( O 0 2.66294209723128e-05
38 O 0 5.671720646205358e-05
% O 0 1.5580657418468036e-05
) O 0 1.8217202523374e-05
of O 0 0.00043192700832150877
16 O 1 0.9994223117828369
tumors B-Disease 1 1.0
without O 0 0.13988202810287476
LOH O 1 1.0
, O 0 7.556610944448039e-05
one O 0 1.3032023161940742e-05
mutation O 0 7.701630238443613e-06
was O 0 0.00015855726087465882
detected O 0 0.0001932736049639061
, O 0 4.310640179028269e-06
and O 0 2.687986352611915e-06
in O 0 1.5677687770221382e-05
9 O 0 0.00023425862309522927
( O 0 1.3384201338340063e-05
56 O 0 4.689761408371851e-05
% O 0 1.2099017112632282e-05
) O 0 1.4010121958563104e-05
of O 0 0.00017149775521829724
the O 0 0.04070078954100609
tumors B-Disease 1 1.0
without O 0 0.016346829012036324
LOH O 1 1.0
, O 0 3.261994424974546e-05
both O 0 3.1481165478908224e-06
mutations O 0 1.5140536561375484e-05
were O 0 5.30783217982389e-05
found O 0 5.748717376263812e-05
. O 0 0.00010601004760246724

Thus O 0 0.0002866006689146161
, O 0 5.356790097721387e-06
a O 0 3.204270342394011e-06
total O 0 9.97998176899273e-06
of O 0 3.4599524951772764e-05
45 O 0 5.19379937031772e-05
mutations O 0 2.2842936232336797e-05
were O 0 3.115238359896466e-05
identified O 0 9.803114517126232e-05
in O 0 0.00028273597126826644
tumors B-Disease 1 1.0
of O 0 0.003940376453101635
36 O 0 0.010022659786045551
patients O 0 0.0015044822357594967
. O 0 0.0006215358152985573

Thirty O 0 0.007637328933924437
- O 0 0.0004618849197868258
nine O 0 4.4817334128310904e-05
of O 0 3.331888365210034e-05
the O 0 6.65334882796742e-05
mutations O 0 6.626981485169381e-05
- O 0 0.00014357507461681962
including O 0 1.2321313079155516e-05
34 O 0 9.87383391475305e-05
small O 0 2.5021290639415383e-05
mutations O 0 3.0068838896113448e-05
, O 0 1.118622731155483e-05
2 O 0 0.00019848659576382488
large O 0 0.00016656951629556715
structural O 0 0.1358954757452011
alterations O 0 0.012141890823841095
, O 0 9.07954599824734e-05
and O 0 5.182894892641343e-05
hypermethylation O 0 0.273377388715744
in O 0 0.0013757565757259727
3 O 1 0.9060800671577454
tumors O 1 1.0
- O 0 0.0016030800761654973
were O 0 3.415475657675415e-05
not O 0 3.433639449212933e-06
detected O 0 3.036443013115786e-05
in O 0 2.748485712800175e-06
the O 0 8.460321623715572e-06
corresponding O 0 0.0001600051182322204
peripheral O 1 0.6035175323486328
blood O 0 0.01704910397529602
DNA O 0 0.007035040762275457
. O 0 0.0006903927423991263

In O 0 0.0003850719367619604
6 O 0 0.0008820585790090263
( O 0 5.156479892320931e-05
17 O 0 0.00018431174976285547
% O 0 1.9243898350396194e-05
) O 0 8.87899750523502e-06
of O 0 3.891177402692847e-05
the O 0 0.00016571786545682698
36 O 0 0.0004309009527787566
patients O 0 6.840068817837164e-05
, O 0 7.3242872531409375e-06
a O 0 2.194668741140049e-05
mutation O 0 1.7526828742120415e-05
was O 0 0.00026557670207694173
detected O 0 0.0001599418028490618
in O 0 1.7649826986598782e-05
constitutional O 0 8.067699673119932e-05
DNA O 0 0.00015700870426371694
, O 0 5.089699243399082e-06
and O 0 2.642787649165257e-06
1 O 0 7.334760448429734e-05
of O 0 6.729215965606272e-05
these O 0 2.47949683398474e-05
mutations O 0 3.527538865455426e-05
is O 0 8.627614988654386e-06
known O 0 2.3070662791724317e-05
to O 0 7.2869779614848085e-06
be O 0 5.302112640492851e-06
associated O 0 6.235052751435433e-06
with O 0 4.253051884006709e-06
reduced O 0 0.000635013566352427
expressivity O 0 0.025995340198278427
. O 0 0.0004523516690824181

The O 0 0.00024346647842321545
presence O 0 6.176647002575919e-05
of O 0 8.685903594596311e-05
a O 0 7.444404764100909e-05
constitutional O 0 0.00021773698972538114
mutation O 0 2.338534250156954e-05
was O 0 0.00010813448898261413
not O 0 1.1853632031488814e-06
associated O 0 1.8794592051563086e-06
with O 0 5.675046850228682e-07
an O 0 4.061048457515426e-06
early O 0 0.00035518978256732225
age O 0 0.0008979569538496435
at O 0 0.0015676977345719934
treatment O 0 0.001145962974987924
. O 0 0.0005367650301195681

In O 0 0.0004923353553749621
1 O 0 0.002548657823354006
patient O 0 0.0003802889259532094
, O 0 4.6114415454212576e-05
somatic O 0 0.0013416536385193467
mosaicism O 1 0.9537690877914429
was O 0 0.0015913561219349504
demonstrated O 0 0.00023620357387699187
by O 0 3.5482539715303574e-06
molecular O 0 9.891349691315554e-06
analysis O 0 9.817679256229894e-07
of O 0 3.417104744585231e-05
DNA O 0 0.00029538682429119945
and O 0 4.188257298665121e-05
RNA O 0 0.0020114148501306772
from O 0 0.00029248002101667225
peripheral O 1 0.826129674911499
blood O 0 0.011341978795826435
. O 0 0.0010140438098460436

In O 0 0.0005660208407789469
2 O 0 0.001663809409365058
patients O 0 9.054023394128308e-05
without O 0 1.977753527171444e-05
a O 0 6.568481330759823e-05
detectable O 0 0.0032298844307661057
mutation O 0 4.7529199946438894e-05
in O 0 0.00012586113007273525
peripheral O 1 0.9985997080802917
blood O 0 0.03290440887212753
, O 0 0.00025714540970511734
mosaicism O 1 0.998320996761322
was O 0 0.0008935183868743479
suggested O 0 2.8968566766707227e-05
because O 0 2.607634996820707e-06
1 O 0 3.194565579178743e-05
of O 0 3.0205816074158065e-05
the O 0 0.00012912292731925845
patients O 0 0.000713273708242923
showed O 1 0.8924493193626404
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.0004079258651472628
the O 0 0.00022598855139221996
other O 0 1.1303136489004828e-05
later O 0 0.00028727445169351995
developed O 0 0.0003812581126112491
bilateral B-Disease 0 0.2677246034145355
retinoblastoma I-Disease 1 0.9997162222862244
. O 0 0.0007708361954428256

In O 0 0.00026259434525854886
conclusion O 0 0.0001362271432299167
, O 0 6.623771241720533e-06
our O 0 3.550891051418148e-06
results O 0 3.0405810775846476e-06
emphasize O 0 1.307079401158262e-05
that O 0 1.3403030152403517e-06
the O 0 3.2993466447805986e-05
manifestation O 0 0.002784449839964509
and O 0 0.00012030934885842726
transmissibility O 0 0.029256844893097878
of O 0 0.000980129698291421
retinoblastoma B-Disease 0 0.02992013841867447
depend O 0 0.00010220664262305945
on O 0 7.450107659678906e-05
the O 0 2.791813858493697e-05
nature O 0 2.371000846324023e-05
of O 0 2.366034095757641e-05
the O 0 6.349554314510897e-05
first O 0 7.03808109392412e-05
mutation O 0 5.841789970872924e-06
, O 0 1.4122681477601873e-06
its O 0 1.7534232483740197e-06
time O 0 5.826483629789436e-06
in O 0 1.0587884389678948e-05
development O 0 3.752509655896574e-05
, O 0 1.6709661849745316e-06
and O 0 7.253402145579457e-07
the O 0 6.90028673488996e-06
number O 0 4.704838829638902e-06
and O 0 4.423633527039783e-06
types O 0 1.3644169484905433e-05
of O 0 0.00021118303993716836
cells O 0 0.0001624474098207429
that O 0 5.517983936442761e-06
are O 0 1.285171379095118e-06
affected O 0 2.888481685658917e-05
. O 0 1.5889909263933077e-05
. O 0 5.1670591346919537e-05

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999797344207764
the I-Disease 1 0.997545063495636
fifth I-Disease 1 0.7363936901092529
component I-Disease 0 0.001325890189036727
of I-Disease 0 0.0003261147649027407
complement I-Disease 0 0.0005933070788159966
in O 0 0.000395770970499143
man O 0 0.000812718877568841
. O 0 0.00011784298112615943

I O 0 0.42338722944259644
. O 0 0.0008277714368887246

Clinical O 0 0.0029756492003798485
, O 0 0.00022119229834061116
immunochemical O 0 0.01976785436272621
, O 0 3.8122660043882206e-05
and O 0 1.4375852515513543e-05
family O 0 3.0227654860937037e-05
studies O 0 6.0643942561000586e-05
. O 0 0.0001526397536508739

The O 0 0.00011479624663479626
first O 0 4.944131069350988e-05
recognized O 0 7.102183735696599e-05
human O 0 0.00010436129377922043
kindred O 0 0.008083969354629517
with O 0 0.0002787778794299811
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999966621398926
fifth I-Disease 1 0.992155909538269
component I-Disease 0 0.0009965345961973071
of I-Disease 0 0.0004183469573035836
complement I-Disease 0 0.0017528579337522388
( O 0 0.001526225940324366
C5 O 1 0.999996542930603
) O 0 6.412027141777799e-05
is O 0 1.0372498763899785e-05
described O 0 8.872858597896993e-05
. O 0 7.5331779953558e-05

The O 0 0.0010537764756008983
proband O 0 0.009863113984465599
, O 0 2.401457641099114e-05
a O 0 2.3298794985748827e-05
20 O 0 0.00034983575460501015
- O 0 0.0003697406209539622
year O 0 0.0001411864795954898
- O 0 0.0003716358041856438
old O 0 0.00018270686268806458
black O 0 5.13150189362932e-05
female O 0 5.529791451408528e-05
with O 0 0.0003019186551682651
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 1.0
age O 1 0.9999996423721313
11 O 1 0.9791656136512756
, O 0 9.877448610495776e-05
lacked O 0 0.012302964925765991
serum O 1 0.9103756546974182
hemolytic O 1 1.0
complement O 0 0.0011965340236201882
activity O 0 0.0002130258217221126
, O 0 1.5093191905179992e-05
even O 0 1.1312345122860279e-05
during O 0 0.0005422224057838321
remission O 0 0.003966670483350754
. O 0 0.0002895771758630872

C5 O 1 0.9999992847442627
was O 0 0.015826143324375153
undetectable O 0 0.019816135987639427
in O 0 6.0932627093279734e-05
her O 0 1.999501728278119e-05
serum O 0 0.0001603952405275777
by O 0 3.3784629067667993e-06
both O 0 1.805999818316195e-05
immunodiffusion O 0 0.36478862166404724
and O 0 0.0003125666407868266
hemolytic O 1 1.0
assays O 0 0.004425408318638802
. O 0 0.0019433960551396012

Other O 0 1.1387897757231258e-05
complement O 0 4.839573739445768e-05
components O 0 0.00015410277410410345
were O 0 4.54403598268982e-05
normal O 0 7.211873162304983e-05
during O 0 0.0005695264553651214
remission O 0 0.0019928300753235817
of O 0 0.0010245860321447253
lupus O 1 1.0
, O 0 0.00035013785236515105
but O 0 0.0002084195293718949
C1 O 1 0.9999998807907104
, O 0 0.0007537201745435596
C4 O 1 0.9999998807907104
, O 0 0.0003788213070947677
C2 O 1 0.9985051155090332
, O 0 8.608328062109649e-05
and O 0 9.912606765283272e-05
C3 O 1 0.999995231628418
levels O 0 0.004919129423797131
fell O 1 0.7947391867637634
during O 0 0.004265882074832916
exacerbations O 1 0.7973774075508118
. O 0 0.0005114285741001368

A O 0 0.003940150141716003
younger O 0 0.0011645256308838725
half O 0 0.0002526172320358455
- O 0 0.0009072647080756724
sister O 0 9.853807569015771e-05
, O 0 2.7658795715979068e-06
who O 0 5.2712775868712924e-06
had O 0 0.0001579806412337348
no O 0 0.0003945308562833816
underlying O 1 0.9999997615814209
disease O 1 1.0
, O 0 0.00012816146772820503
was O 0 0.0006997858872637153
also O 0 1.2731608876492828e-05
found O 0 4.3070613173767924e-06
to O 0 1.4521220691676717e-05
lack O 0 0.0011191442608833313
immunochemically O 1 0.9999806880950928
detectable O 1 0.9999783039093018
C5 O 1 0.9999998807907104
. O 0 0.0009328079759143293

By O 0 0.0007559953955933452
hemolytic O 1 1.0
assay O 0 0.0006807135650888085
, O 0 5.9997964854119346e-05
she O 0 1.7383008525939658e-05
exhibited O 0 0.00028380894218571484
1 O 0 0.00046560275950469077
- O 0 0.00017589912749826908
2 O 0 3.511123941279948e-05
% O 0 2.8258536985958926e-06
of O 0 1.4804854799876921e-05
the O 0 0.00011633459507720545
normal O 0 0.0007060646894387901
serum O 0 0.005248524714261293
C5 O 1 0.9965853691101074
level O 0 0.00037904834607616067
and O 0 7.548233952547889e-06
normal O 0 1.6845546269905753e-05
concentrations O 0 5.261443220661022e-05
of O 0 1.1078228453698102e-05
other O 0 3.4150741612393176e-06
complement O 0 5.918083115830086e-05
components O 0 0.00043915558489970863
. O 0 0.00020927021978423

C5 O 1 0.9999454021453857
levels O 0 0.0009777490049600601
of O 0 9.983353811549023e-05
other O 0 6.066567493689945e-06
family O 0 8.530238119419664e-06
members O 0 1.9413807876844658e-06
were O 0 1.5750565580674447e-05
either O 0 2.2226398868951946e-05
normal O 0 6.302729161689058e-05
or O 0 1.4384163478098344e-05
approximately O 0 0.00018983249901793897
half O 0 0.00017112681234721094
- O 0 0.0003276948700658977
normal O 0 2.2292542780633084e-05
, O 0 1.3292171843204414e-06
consistent O 0 1.0326711162633728e-05
with O 0 6.475456757470965e-06
autosomal O 0 0.002162469085305929
codominant O 1 0.9484152793884277
inheritance O 0 0.0005315494490787387
of O 0 0.0005330969579517841
the O 0 0.009783699177205563
gene O 0 0.43961283564567566
determining O 1 0.9999988079071045
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.03621187061071396

Normal O 0 0.029201531782746315
hemolytic O 1 1.0
titers O 0 0.05988609418272972
were O 0 0.0001991259487112984
restored O 0 0.0011390449944883585
to O 0 7.718512279097922e-06
both O 0 1.4944323083909694e-05
homozygous O 0 0.0033329701982438564
C5 B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
deficient I-Disease 1 1.0
( O 0 0.002407361986115575
C5D B-Disease 1 1.0
) O 0 0.00023769601830281317
sera O 0 0.0014528912724927068
by O 0 1.5380633158201817e-06
addition O 0 4.380331574793672e-06
of O 0 9.367217717226595e-05
highly O 0 0.004623810760676861
purified O 0 0.027424929663538933
human O 0 0.003668351797387004
C5 O 1 0.9999994039535522
. O 0 0.000715391302946955

In O 0 0.0004474000306800008
specific O 0 0.00025846093194559216
C5 O 1 0.9999994039535522
titrations O 0 0.019818192347884178
, O 0 4.1219904233003035e-05
however O 0 1.5504574548685923e-05
, O 0 3.3985916161327623e-06
it O 0 1.7177407016788493e-06
was O 0 5.264960782369599e-05
noted O 0 1.1437877219577786e-05
that O 0 4.597946201556624e-07
when O 0 1.432227918485296e-06
limited O 0 2.7433036393631482e-06
amounts O 0 3.4433855034876615e-05
of O 0 0.0004545117262750864
C5 O 1 0.9999823570251465
were O 0 0.0002923835418187082
assayed O 0 0.0003225028922315687
in O 0 5.997840617055772e-06
the O 0 5.818199042550987e-06
presence O 0 1.1201600500498898e-05
of O 0 3.0892981158103794e-05
low O 0 0.00035678010317496955
dilutions O 0 0.0034962657373398542
of O 0 0.0006173780420795083
either O 0 0.0028574035968631506
C5D B-Disease 1 1.0
serum O 0 0.01896572671830654
, O 0 6.0372862208168954e-05
curving O 0 0.0004788063815794885
rather O 0 7.438016837113537e-06
than O 0 4.926124802295817e-06
linear O 0 0.00012191111454740167
dose O 0 0.0007954448810778558
- O 0 0.0004127807915210724
response O 0 6.742300229234388e-06
plots O 0 4.507682388066314e-05
were O 0 1.0324712093279231e-05
consistently O 0 2.2509995687869377e-05
obtained O 0 8.965821507445071e-06
, O 0 2.646732127686846e-06
suggesting O 0 9.518247679807246e-06
some O 0 4.463927780307131e-06
inhibitory O 0 0.0005013145273551345
effect O 0 0.00042681366903707385
. O 0 0.00018437905237078667

Further O 0 6.47360720904544e-05
studies O 0 1.1775385246437509e-05
suggested O 0 1.3347465937840752e-05
that O 0 1.7620177459320985e-06
low O 0 0.00020724482601508498
dilutions O 0 0.003898916533216834
of O 0 0.0011060653487220407
C5D B-Disease 1 1.0
serum O 0 0.004485590383410454
contain O 0 0.00021286461560521275
a O 0 3.4970355045516044e-05
factor O 0 4.340823579696007e-05
( O 0 2.0241301172063686e-05
or O 0 1.0818705050041899e-05
factors O 0 2.3151549612521194e-05
) O 0 1.6233791029662825e-05
interfering O 0 2.2756572434445843e-05
at O 0 5.627220525639132e-05
some O 0 3.0781600344198523e-06
step O 0 8.126583270495757e-05
in O 0 2.6574369258014485e-05
the O 0 0.00018222650396637619
hemolytic O 1 0.9999997615814209
assay O 0 0.0007673253421671689
of O 0 0.004970733076334
C5 O 1 0.9999998807907104
, O 0 4.181492477073334e-05
rather O 0 3.8242078517214395e-06
than O 0 3.835896222881274e-06
a O 0 4.133019319851883e-05
true O 0 0.0015926765045151114
C5 O 1 0.9999988079071045
inhibitor O 0 0.004362064879387617
or O 0 0.0003929364320356399
inactivator O 0 0.02929600700736046
. O 0 0.0003638725320342928

Of O 0 0.000392641726648435
clinical O 0 0.00035647855838760734
interest O 0 8.868273289408535e-05
are O 0 3.5793248116533505e-06
( O 0 9.666542609920725e-06
a O 0 9.97952520265244e-06
) O 0 3.1960028081812197e-06
the O 0 5.609269464912359e-06
documentation O 0 0.00024461824796162546
of O 0 0.0015460822032764554
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999219179153442
vasculitis B-Disease 1 1.0
, O 1 0.8526730537414551
and O 1 0.9958345890045166
arthritis B-Disease 1 1.0
in O 0 0.2898249924182892
an O 0 0.0002595897822175175
individual O 0 0.00016202309052459896
lacking O 0 0.1070713922381401
C5 O 1 0.9999997615814209
( O 0 8.437703945674002e-05
and O 0 6.687931090709753e-06
its O 0 1.7402229786966927e-05
biologic O 0 0.0028044453356415033
functions O 0 3.664988253149204e-05
) O 0 2.297300670761615e-05
, O 0 5.533117928280262e-06
and O 0 5.901520125917159e-06
( O 0 3.609178384067491e-05
b O 0 0.0001027182224788703
) O 0 6.932402357051615e-06
a O 0 1.1833463759103324e-05
remarkable O 0 0.0005935737863183022
propensity O 0 0.0029883759561926126
to O 0 0.0010299957357347012
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.0009010560461319983
the O 0 0.0006135672447271645
proband O 0 0.009859398938715458
, O 0 6.5206945691898e-06
even O 0 2.5911103875841945e-06
during O 0 4.915383760817349e-05
periods O 0 0.00019841261382680386
of O 0 0.00014309125253930688
low O 0 0.0010922306682914495
- O 0 0.0005987697513774037
dose O 0 0.00011700164759531617
or O 0 1.0203463716607075e-05
alternate O 0 7.76571687310934e-05
- O 0 0.0006171506829559803
day O 0 0.00046063773334026337
corticosteroid O 1 0.9311302304267883
therapy O 0 0.012165042571723461
. O 0 0.0005633224500343204

Other O 0 2.375881012994796e-05
observations O 0 2.6600917408359237e-05
indicate O 0 5.146448529558256e-05
that O 0 6.0889351516379975e-06
the O 0 0.00013907173706684262
C5D B-Disease 1 0.9999988079071045
state O 0 2.81738284684252e-05
is O 0 4.758391241921345e-06
compatible O 0 1.683215486991685e-05
with O 0 1.6033047813834855e-06
normal O 0 0.0001002176504698582
coagulation O 0 0.0010323210153728724
function O 0 4.019771586172283e-05
and O 0 5.104470801597927e-06
the O 0 3.211316652595997e-05
capacity O 0 0.00017383991507813334
to O 0 2.3403457817039452e-05
mount O 0 0.0031863779295235872
a O 0 0.00022259666002355516
neutrophilic O 1 0.9998210072517395
leukocytosis O 1 0.9992514252662659
during O 1 0.9961240887641907
pyogenic B-Disease 1 0.9999978542327881
infection I-Disease 1 0.5795166492462158
. O 0 7.702996663283557e-05
. O 0 7.678515248699114e-05

Susceptibility O 1 0.9946882724761963
to O 1 0.9995681643486023
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9987841248512268
twins O 0 0.0032252913806587458
: O 0 7.1230924731935374e-06
the O 0 3.6749245282408083e-06
role O 0 1.0964556167891715e-05
of O 0 7.840154285077006e-05
genes O 0 0.00015511173114646226
, O 0 0.00010261845454806462
HLA O 1 0.9977070093154907
, O 0 4.303595778765157e-05
and O 0 1.3682646567758638e-05
the O 0 0.00012209353735670447
environment O 0 0.000167216727277264
. O 0 0.00011234213889110833

OBJECTIVE O 0 0.0025061652995646
To O 0 2.058310383290518e-05
determine O 0 8.705220352567267e-06
the O 0 1.2388389222905971e-05
relative O 0 3.0377663279068656e-05
effects O 0 0.00025635716156102717
of O 0 0.00017161374853458256
genetic O 0 0.00045211907126940787
and O 0 3.216594268451445e-05
environmental O 0 5.1107563194818795e-05
factors O 0 1.584492201800458e-05
in O 0 5.5510783568024635e-05
susceptibility O 0 0.00624714745208621
to O 1 0.9915551543235779
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999690055847168
AS B-Disease 1 1.0
) O 0 0.0004088169662281871
. O 0 9.48939923546277e-05

METHODS O 0 0.003174089826643467
Twins O 0 0.0010177759686484933
with O 0 1.4823318451817613e-05
AS B-Disease 0 0.014823952689766884
were O 0 3.370474587427452e-05
identified O 0 9.29961333895335e-06
from O 0 4.544258445093874e-06
the O 0 2.0295658032409847e-05
Royal O 0 0.0006051951204426587
National O 0 0.1115209311246872
Hospital O 1 0.9999998807907104
for O 1 0.9221563339233398
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9989645481109619
. O 0 0.00146248668897897

Clinical O 0 0.0013964814133942127
and O 0 5.457797669805586e-05
radiographic O 0 0.0017463121330365539
examinations O 0 0.0010975070763379335
were O 0 9.227591363014653e-05
performed O 0 0.0003025390033144504
to O 0 4.4981839891988784e-05
establish O 0 0.0006284488481469452
diagnoses O 0 0.009366365149617195
, O 0 0.0002224432973889634
and O 0 0.000479985581478104
disease O 1 1.0
severity O 1 0.9991421699523926
was O 0 0.008200357668101788
assessed O 0 0.00017794693121686578
using O 0 9.97958159132395e-06
a O 0 1.059160967997741e-05
combination O 0 3.150305201415904e-05
of O 0 0.00010266868048347533
validated O 0 0.0004364128108136356
scoring O 0 0.00046213087625801563
systems O 0 0.0022229361347854137
. O 0 0.0003190301649738103

HLA O 1 0.9858734607696533
typing O 0 0.0009215047466568649
for O 0 0.00018098200962413102
HLA O 1 0.9994009733200073
- O 0 0.0036227491218596697
B27 O 0 0.0033093274105340242
, O 0 5.631483145407401e-05
HLA O 0 0.16568917036056519
- O 0 0.0008146114996634424
B60 O 0 0.0011192145757377148
, O 0 1.5311998140532523e-05
and O 0 4.476248432183638e-05
HLA O 1 0.9999381303787231
- O 0 0.01106064859777689
DR1 O 1 0.9976014494895935
was O 0 0.00032620245474390686
performed O 0 5.682813571183942e-05
by O 0 4.950590209773509e-06
polymerase O 0 0.00029880134388804436
chain O 0 5.730753036914393e-05
reaction O 0 3.0599576348322444e-06
with O 0 2.5036542865564115e-06
sequence O 0 6.935484270798042e-05
- O 0 0.0002042338892351836
specific O 0 2.4341513835679507e-06
primers O 0 0.0001360170281259343
, O 0 9.864126695902087e-06
and O 0 1.2420139682944864e-05
zygosity O 0 0.0038555797655135393
was O 0 0.0002979254932142794
assessed O 0 0.00012070417869836092
using O 0 3.43082174367737e-05
microsatellite O 0 0.004790233913809061
markers O 0 0.004249652847647667
. O 0 0.0005848522414453328

Genetic O 0 0.0009967739460989833
and O 0 2.8472612029872835e-05
environmental O 0 3.13212804030627e-05
variance O 0 5.977460659778444e-06
components O 0 9.552151459502056e-05
were O 0 3.4266009606653824e-05
assessed O 0 5.165866605238989e-05
with O 0 4.312951205065474e-06
the O 0 6.094355558161624e-05
program O 0 0.00013359352305997163
Mx O 0 0.0022707043681293726
, O 0 1.6189136431421502e-06
using O 0 5.219843615122954e-07
data O 0 3.50700315721042e-06
from O 0 2.523596549508511e-06
this O 0 1.093725472856022e-06
and O 0 8.943796387939074e-07
previous O 0 6.057935479475418e-06
studies O 0 8.060982509050518e-06
of O 0 0.00010128260328201577
twins O 0 0.0006211953586898744
with O 0 4.70797203888651e-05
AS B-Disease 1 0.9999791383743286
. O 0 0.0005667182267643511

RESULTS O 0 0.0003778564860112965
Six O 0 9.473721001995727e-05
of O 0 0.00012184116349089891
8 O 0 0.0015227579278871417
monozygotic O 0 0.009171005338430405
( O 0 0.001101433183066547
MZ O 1 0.9999760389328003
) O 0 0.00026128621539101005
twin O 0 0.0010902376379817724
pairs O 0 0.00011765569797717035
were O 0 0.00018510673544369638
disease O 1 0.9987857937812805
concordant O 0 0.003629174781963229
, O 0 1.8701921362662688e-05
compared O 0 3.294608541182242e-05
with O 0 7.300123797904234e-06
4 O 0 0.0002972423390019685
of O 0 0.00025083927903324366
15 O 0 0.0006488896906375885
B27 O 0 0.0032527311705052853
- O 0 0.0004416322917677462
positive O 0 2.8285336156841367e-05
dizygotic O 0 0.007748365867882967
( O 0 0.0005620634183287621
DZ O 1 0.988892138004303
) O 0 0.00017655732517596334
twin O 0 0.0007501320214942098
pairs O 0 3.391380232642405e-05
( O 0 2.72784036496887e-05
27 O 0 0.0003480666200630367
% O 0 2.3713537302683108e-05
) O 0 1.0956779078696854e-05
and O 0 3.898283011949388e-06
4 O 0 0.0001302190648857504
of O 0 0.0004087390552740544
32 O 0 0.0037539585027843714
DZ O 1 0.9998089671134949
twin O 0 0.004658911377191544
pairs O 0 6.667988782282919e-05
overall O 0 0.00014432465832214803
( O 0 5.0677666877163574e-05
12 O 0 0.00013000975013710558
. O 0 1.3191322977945674e-05
5 O 0 5.9439524193294346e-05
% O 0 2.752114596660249e-05
) O 0 4.7003995859995484e-05
. O 0 0.00012155811418779194

Nonsignificant O 0 0.02682306058704853
increases O 0 4.997759242542088e-05
in O 0 8.364469067601021e-06
similarity O 0 1.4279400602390524e-05
with O 0 2.7231751573708607e-06
regard O 0 5.4493262723553926e-05
to O 0 3.390765778021887e-05
age O 0 0.002221931703388691
at O 1 0.9936015009880066
disease O 1 1.0
onset O 1 0.9999991655349731
and O 0 6.683547690045089e-05
all O 0 3.058582660742104e-05
of O 0 0.00023565291485283524
the O 0 0.005183040630072355
disease O 1 0.9999995231628418
severity O 0 0.002235634019598365
scores O 0 0.00027274686726741493
assessed O 0 7.426947558997199e-05
were O 0 2.0943369236192666e-05
noted O 0 5.313655856298283e-05
in O 0 0.0003727058647200465
disease O 1 0.9999998807907104
- O 0 0.10115606337785721
concordant O 0 0.4651215672492981
MZ O 1 0.9999773502349854
twins O 0 0.0008828127756714821
compared O 0 0.00011330241977702826
with O 0 8.083486318355426e-05
concordant O 1 0.9850366711616516
DZ O 1 0.9999998807907104
twins O 0 0.012906985357403755
. O 0 0.00046550380648113787

HLA O 1 0.9999932050704956
- O 0 0.010102839209139347
B27 O 0 0.002733418485149741
and O 0 1.4420505976886488e-05
B60 O 0 0.000454981200164184
were O 0 1.2566350960696582e-05
associated O 0 7.1984163696470205e-06
with O 0 6.422791557270102e-06
the O 0 0.0004272374208085239
disease O 1 0.9999997615814209
in O 0 0.0007124411640688777
probands O 1 0.977410614490509
, O 0 2.4798657250357792e-05
and O 0 3.1653119094698923e-06
the O 0 2.5764864403754473e-05
rate O 0 4.229574551573023e-05
of O 0 0.00015105173224583268
disease O 1 0.9977384805679321
concordance O 0 0.0004956299089826643
was O 0 0.0001771276001818478
significantly O 0 4.833798811887391e-05
increased O 0 4.5656714064534754e-05
among O 0 0.00021683951490558684
DZ O 1 0.9910504817962646
twin O 0 0.0010147425346076488
pairs O 0 1.5728981452411972e-05
in O 0 6.958453013794497e-06
which O 0 4.400415946292924e-06
the O 0 5.566387699218467e-05
co O 0 0.0006492101238109171
- O 0 0.00035368360113352537
twin O 0 0.00015052520029712468
was O 0 3.772405398194678e-05
positive O 0 1.0775238479254767e-06
for O 0 1.7554979194756015e-06
both O 0 2.505419251974672e-05
B27 O 0 0.007256814744323492
and O 0 0.0004467309918254614
DR1 O 1 0.9999455213546753
. O 0 0.000888920621946454

Additive O 0 0.0002314378070877865
genetic O 0 9.839451377047226e-05
effects O 0 0.00022079171321820468
were O 0 4.308909774408676e-05
estimated O 0 4.133196489419788e-05
to O 0 7.245607321237912e-06
contribute O 0 3.34084834321402e-05
97 O 0 0.00017748177924659103
% O 0 5.1450215323711745e-06
of O 0 2.212672188761644e-05
the O 0 3.8132042391225696e-05
population O 0 6.4918422140181065e-06
variance O 0 1.2988261914870236e-05
. O 0 8.221781172323972e-05

CONCLUSION O 0 0.006985880434513092
Susceptibility O 0 0.001214424497447908
to O 0 8.359443017980084e-05
AS B-Disease 1 0.5349749326705933
is O 0 1.4253863810154144e-05
largely O 0 3.465919871814549e-05
genetically O 0 8.750884262553882e-06
determined O 0 7.359434675890952e-06
, O 0 1.4255209634939092e-06
and O 0 1.1580809768929612e-06
the O 0 2.24884097406175e-05
environmental O 0 0.0001232555805472657
trigger O 0 0.00011768667900469154
for O 0 1.7727506929077208e-05
the O 0 0.0005850668530911207
disease O 1 0.9999977350234985
is O 0 7.062956865411252e-05
probably O 0 0.0003221992519684136
ubiquitous O 0 0.0010012849234044552
. O 0 6.94806149112992e-05

HLA O 1 0.999921441078186
- O 0 0.006091201677918434
B27 O 0 0.001108730211853981
accounts O 0 3.76797925127903e-06
for O 0 1.1620614941421081e-06
a O 0 4.84428392155678e-06
minority O 0 4.223872565489728e-06
of O 0 1.3216117622505408e-05
the O 0 4.513359453994781e-05
overall O 0 0.00016668836178723723
genetic O 0 0.00024206661328207701
susceptibility O 0 0.000796510954387486
to O 0 0.0003796057717408985
AS B-Disease 1 0.9999997615814209
. O 0 0.0005825350526720285

Cell O 0 0.008940278552472591
cycle O 0 0.0011720708571374416
- O 0 0.0005648173391819
dependent O 0 6.127186497906223e-05
colocalization O 0 0.003778149140998721
of O 0 0.0005099180270917714
BARD1 O 1 0.999981164932251
and O 0 0.00018863100558519363
BRCA1 O 0 0.0005789681454189122
proteins O 0 6.993599072302459e-06
in O 0 1.1569005437195301e-05
discrete O 0 6.844949530204758e-05
nuclear O 0 0.0023346717935055494
domains O 0 0.0008877794607542455
. O 0 0.00030086003243923187

Germ O 1 0.9999998807907104
- O 0 0.006126795895397663
line O 0 0.00042647222289815545
mutations O 0 1.3176297215977684e-05
of O 0 3.797726094489917e-05
the O 0 0.000377493939595297
BRCA1 O 0 0.004097005818039179
gene O 0 0.00012807143502868712
predispose O 0 0.0010227614548057318
women O 0 9.166340532829054e-06
to O 0 1.1565276508918032e-05
early O 0 0.0012379151303321123
- O 1 0.9312641620635986
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999955892562866
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.0009168656542897224
compromising O 0 0.0020526882726699114
the O 0 0.00015712433378212154
genes O 0 4.592176992446184e-05
presumptive O 0 0.0007332921959459782
function O 0 3.6472796637099236e-05
as O 0 6.923886394361034e-05
a O 0 0.0004291158402338624
tumor B-Disease 1 0.9999988079071045
suppressor O 0 0.03613952919840813
. O 0 0.0004245683958288282

Although O 0 4.2431853216839954e-05
the O 0 4.1835708543658257e-05
biochemical O 0 0.00036630325485020876
properties O 0 0.0005677748704329133
of O 0 0.002983997343108058
BRCA1 O 0 0.025187918916344643
polypeptides O 0 0.00040992291178554296
are O 0 1.7426774547857349e-06
not O 0 1.9016101759916637e-06
understood O 0 7.45131546864286e-05
, O 0 3.6751698644366115e-06
their O 0 2.7043909085477935e-06
expression O 0 5.634313856717199e-05
pattern O 0 0.00039971695514395833
and O 0 5.69263611396309e-05
subcellular O 0 0.0018583587370812893
localization O 0 0.0008772366563789546
suggest O 0 2.2282129066297784e-05
a O 0 1.0984547770931385e-05
role O 0 9.876602416625246e-05
in O 0 0.00023603228328283876
cell O 0 0.001723045133985579
- O 0 0.0010737982811406255
cycle O 0 0.000443382392404601
regulation O 0 0.0001411921257385984
. O 0 4.7017267206683755e-05

When O 0 0.0014066603034734726
resting O 0 0.012615358456969261
cells O 0 0.00020169031631667167
are O 0 6.5366334638383705e-06
induced O 0 0.00042544250027276576
to O 0 8.295248699141666e-05
proliferate O 0 0.0006279539666138589
, O 0 3.485071374598192e-06
the O 0 9.680869879957754e-06
steady O 0 0.0002351102593820542
- O 0 3.8035286706872284e-05
state O 0 2.288827090524137e-06
levels O 0 2.9372931749094278e-05
of O 0 3.3979227737290785e-05
BRCA1 O 0 0.000267964496742934
increase O 0 2.0430135919013992e-05
in O 0 7.822343468433246e-05
late O 0 0.002453792141750455
G1 O 0 0.02500169165432453
and O 0 5.242516181169776e-06
reach O 0 1.2419145605235826e-05
a O 0 5.314433565217769e-06
maximum O 0 3.0480681743938476e-05
during O 0 0.0009313728660345078
S O 0 0.010700399056077003
phase O 0 0.006136454641819
. O 0 0.00036783982068300247

Moreover O 0 0.000595258956309408
, O 0 1.4322717106551863e-05
in O 0 3.426918192417361e-05
S O 0 0.005812224932014942
phase O 0 0.006962829269468784
cells O 0 0.00035415717866271734
, O 0 1.6042014976846986e-05
BRCA1 O 0 0.0003024965990334749
polypeptides O 0 3.969359022448771e-05
are O 0 1.526813093732926e-06
hyperphosphorylated O 0 0.0005580625147558749
and O 0 5.26664416611311e-06
accumulate O 0 2.860998392861802e-05
into O 0 1.5375488146673888e-05
discrete O 0 5.991848593112081e-05
subnuclear O 0 0.011187734082341194
foci O 0 0.0062233032658696175
termed O 0 0.0040283468551933765
" O 0 0.0033501810394227505
BRCA1 O 0 0.011114227585494518
nuclear O 0 0.0262588057667017
dots O 0 0.004562127869576216
. O 0 0.00021157042647246271

" O 0 0.006629826035350561
BRCA1 O 0 0.007432708516716957
associates O 0 0.0007392547558993101
in O 0 8.224274642998353e-05
vivo O 0 0.0005210181116126478
with O 0 6.887420113343978e-06
a O 0 8.027763396967202e-05
structurally O 0 0.0026960952673107386
related O 0 0.00026638057897798717
protein O 0 0.001218364923261106
termed O 0 0.014870920218527317
BARD1 O 1 0.9999991655349731
. O 0 0.001109258970245719

Here O 0 0.0002733346773311496
we O 0 7.134629868232878e-06
show O 0 4.101483682461549e-06
that O 0 3.73034765743796e-07
the O 0 6.959641268622363e-06
steady O 0 0.00023030725424177945
- O 0 3.1352959922514856e-05
state O 0 2.698388243516092e-06
levels O 0 4.8202844482148066e-05
of O 0 0.00011491628538351506
BARD1 O 1 0.99741131067276
, O 0 3.1004485208541155e-05
unlike O 0 2.4648326871101744e-05
those O 0 9.087672879104502e-06
of O 0 0.0002555421378929168
BRCA1 O 0 0.003030139021575451
, O 0 1.5023973901406862e-05
remain O 0 4.2501949792495e-05
relatively O 0 6.486186066467781e-06
constant O 0 3.8357578887371346e-05
during O 0 0.0019991311710327864
cell O 0 0.003972124774008989
cycle O 0 0.002523470902815461
progression O 1 0.7183080315589905
. O 0 0.0006806256715208292

However O 0 0.0003688119468279183
, O 0 3.831488356809132e-05
immunostaining O 0 0.00468533905223012
revealed O 0 0.0007067284313961864
that O 0 3.370120612089522e-05
BARD1 O 1 0.9994127750396729
resides O 0 0.001262541045434773
within O 0 0.00013674305228050798
BRCA1 O 0 0.00303918425925076
nuclear O 0 0.004246123135089874
dots O 0 0.0009934395784512162
during O 0 0.0007901531644165516
S O 0 0.002879924839362502
phase O 0 0.0007666528690606356
of O 0 0.0001441652566427365
the O 0 0.00029992443160153925
cell O 0 0.0005333996377885342
cycle O 0 0.00012586293451022357
, O 0 2.7551384391699685e-06
but O 0 4.145813647937757e-07
not O 0 5.140240659784467e-07
during O 0 9.372561180498451e-05
the O 0 0.0001687629264779389
G1 O 1 0.7197301387786865
phase O 0 0.005289261229336262
. O 0 0.0003173707809764892

Nevertheless O 0 0.005608886945992708
, O 0 0.0003214653115719557
BARD1 O 1 0.9809622168540955
polypeptides O 0 0.0001835873699747026
are O 0 1.3755540066995309e-06
found O 0 2.30162777370424e-06
exclusively O 0 5.49511969438754e-06
in O 0 6.013889105815906e-06
the O 0 1.4528617612086236e-05
nuclear O 0 0.0001227411557920277
fractions O 0 1.9139208234264515e-05
of O 0 2.0281784600229003e-05
both O 0 3.8319889426929876e-05
G1 O 1 0.9693218469619751
- O 0 0.0007263950537890196
and O 0 1.9065973901888356e-05
S O 0 0.004238987807184458
- O 0 0.000578411971218884
phase O 0 0.002692354144528508
cells O 0 0.00017324966029264033
. O 0 4.759324656333774e-05

Therefore O 0 0.0003788043395616114
, O 0 6.92794201313518e-05
progression O 0 0.004534393548965454
to O 0 0.00018311446183361113
S O 0 0.007738005835562944
phase O 0 0.0011903775157406926
is O 0 7.883388207119424e-06
accompanied O 0 1.7535723600303754e-05
by O 0 5.51049879504717e-07
the O 0 4.885310318059055e-06
aggregation O 0 2.6364352379459888e-05
of O 0 0.00012538353621494025
nuclear O 0 0.014231379143893719
BARD1 O 1 0.999566376209259
polypeptides O 0 0.0004064434324391186
into O 0 0.00018570569227449596
BRCA1 O 0 0.0035909530706703663
nuclear O 0 0.008091207593679428
dots O 0 0.003273879876360297
. O 0 0.00019341499137226492

This O 0 0.00013850678806193173
cell O 0 0.000794637599028647
cycle O 0 0.0005362066440284252
- O 0 0.00024345418205484748
dependent O 0 3.173456934746355e-05
colocalization O 0 0.001945170690305531
of O 0 0.00047378340968862176
BARD1 O 1 0.9999943971633911
and O 0 0.00023537066590506583
BRCA1 O 0 0.0006781021947972476
indicates O 0 2.90141579171177e-05
a O 0 5.033805337006925e-06
role O 0 2.074407893815078e-05
for O 0 3.2305571949109435e-05
BARD1 O 1 0.9999641180038452
in O 0 0.000574038305785507
BRCA1 O 0 0.017370812594890594
- O 0 0.008113358169794083
mediated O 1 0.7500246167182922
tumor B-Disease 1 0.9999998807907104
suppression O 1 0.999876856803894
. O 0 0.001114920829422772

Ethnic O 0 0.0002444599522277713
differences O 0 0.0003124197537545115
in O 0 0.00019715815142262727
the O 0 0.0005937318783253431
HFE O 1 0.9987958669662476
codon O 0 0.0008881950052455068
282 O 0 0.001989125506952405
( O 0 0.0009582734783180058
Cys O 1 0.9999387264251709
/ O 0 0.02465200424194336
Tyr O 0 0.024116529151797295
) O 0 0.00015954181435517967
polymorphism O 0 0.00016522701480425894
. O 0 0.00018183978681918234

Recent O 0 2.9881657610530965e-05
studies O 0 3.1071108423930127e-06
have O 0 3.909889016995294e-07
shown O 0 2.740008130786009e-05
that O 0 8.845167030813172e-05
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 1.0
HH B-Disease 1 1.0
) O 0 0.0005917472881264985
is O 0 1.7043559637386352e-05
likely O 0 1.2251221960468683e-05
to O 0 3.688094466269831e-06
be O 0 9.067322025657631e-06
caused O 0 9.615997987566516e-05
by O 0 7.09904497853131e-06
homozygosity O 0 0.0016510763671249151
for O 0 1.5231657926051412e-05
a O 0 0.00010569178266450763
Cys282Tyr O 0 0.014784663915634155
mutation O 0 2.7781785320257768e-05
in O 0 2.8634851332753897e-05
the O 0 0.0001688279735390097
HFE O 1 0.9267226457595825
gene O 0 0.00011559911217773333
located O 0 0.0003671694139484316
4 O 0 0.0006040671723894775
. O 0 0.00013240787666290998

5 O 0 0.003032568609341979
Mb O 0 0.027411198243498802
telomeric O 0 0.016809390857815742
to O 0 0.0008591772639192641
HLA O 1 0.9998840093612671
- O 0 0.0030731866136193275
A O 0 0.0015544936759397388
. O 0 0.000127109931781888

Population O 0 1.4476615433522966e-05
studies O 0 4.46403009846108e-06
of O 0 1.555427661514841e-05
this O 0 5.569625955104129e-06
polymorphism O 0 1.6484447769471444e-05
are O 0 1.0283206393069122e-06
facilitated O 0 5.545057501876727e-05
by O 0 2.2180181531439302e-06
the O 0 1.0559398106124718e-05
fact O 0 9.268032044928987e-06
that O 0 1.14244699034316e-06
the O 0 3.916907007806003e-05
Cys282Tyr O 0 0.011857366189360619
mutation O 0 3.645422839326784e-05
creates O 0 8.451080066151917e-05
a O 0 6.733542977599427e-05
Rsal O 0 0.013116380199790001
restriction O 0 9.13270705495961e-05
site O 0 0.000576404039748013
. O 0 5.725002120016143e-05

We O 0 2.9293038096511737e-05
have O 0 1.6512374259036733e-06
studied O 0 4.7934954636730254e-05
the O 0 3.2936062780208886e-05
codon O 0 0.0001549154258100316
282 O 0 0.0009217883343808353
( O 0 0.0010105905821546912
Cys O 1 0.9997958540916443
/ O 0 0.020533539354801178
Tyr O 0 0.017232349142432213
) O 0 3.3876403904287145e-05
polymorphism O 0 1.0903421753027942e-05
in O 0 4.249804078426678e-06
different O 0 3.355483784162061e-07
ethnic O 0 2.350244903936982e-05
groups O 0 5.712514848710271e-06
. O 0 8.592949598096311e-05

In O 0 8.539746340829879e-05
agreement O 0 2.515874984965194e-05
with O 0 5.14315206601168e-06
previous O 0 4.681887730839662e-05
observations O 0 0.00011704584176186472
the O 0 0.0003035835106857121
Tyr O 0 0.006244998890906572
allele O 0 2.17833567148773e-05
appeared O 0 6.490846863016486e-05
to O 0 7.948226084408816e-06
be O 0 1.0193018169957213e-05
rare O 0 0.00012742338003590703
or O 0 4.99002962897066e-05
absent O 0 0.00038990683970041573
in O 0 6.285604467848316e-05
Asiatic O 0 0.0013976722257211804
( O 0 2.3548011085949838e-05
Indian O 0 3.053791442653164e-05
, O 0 8.162951417034492e-06
Chinese O 0 0.00016301345021929592
) O 0 7.813994670868851e-06
populations O 0 5.972748112981208e-06
. O 0 1.859746771515347e-05

The O 0 0.00023226744087878615
highest O 0 0.0004839447501581162
allele O 0 1.1461201211204752e-05
frequency O 0 1.3582216524810065e-05
( O 0 1.5334908312070183e-05
7 O 0 0.00010914151789620519
. O 0 5.784913810202852e-06
5 O 0 2.685319668671582e-05
% O 0 7.376826488325605e-06
) O 0 1.3679110452358145e-05
was O 0 0.0001341563620371744
found O 0 1.360943315376062e-05
in O 0 4.1563827835489064e-05
Swedes O 0 0.0018961691530421376
. O 0 0.00029385261586867273

Saamis O 0 0.029850423336029053
( O 0 0.00012460131256375462
2 O 0 0.000341486360412091
% O 0 4.123244798392989e-05
) O 0 3.0677525501232594e-05
and O 0 1.6246907762251794e-05
Mordvinians O 0 0.007807588670402765
( O 0 4.1121395042864606e-05
1 O 0 0.0002150480286218226
. O 0 9.790594958758447e-06
8 O 0 4.139622251386754e-05
% O 0 8.490625077683944e-06
) O 0 5.851257355971029e-06
had O 0 2.3868406060501002e-05
significantly O 0 3.378262044861913e-05
lower O 0 4.58144313597586e-05
frequencies O 0 6.926897640369134e-06
of O 0 3.4377426345599815e-05
the O 0 0.0003603125223889947
Tyr O 0 0.008141237311065197
allele O 0 7.002740312600508e-05
. O 0 8.155493560479954e-05

Comparisons O 0 4.3121897761011496e-05
with O 0 7.39736924515455e-06
allele O 0 5.051251719123684e-06
frequencies O 0 5.997474090690957e-06
based O 0 2.4834366740833502e-06
on O 0 3.9628084778087214e-05
prevalence O 0 0.00032885157270357013
estimates O 0 4.31049193139188e-05
of O 0 0.00034704493009485304
HH B-Disease 1 0.9999984502792358
showed O 0 0.0007345056510530412
some O 0 2.1043533706688322e-05
disagreements O 0 0.0007100492366589606
with O 0 1.4163523701427039e-05
the O 0 0.00022300094133242965
RFLP O 0 0.00259845401160419
data O 0 5.2054769184906036e-05
, O 0 5.822606453875778e-06
particularly O 0 2.3531132683274336e-05
in O 0 7.342359458561987e-05
Finns O 0 0.004603995941579342
. O 0 0.0002801613009069115

The O 0 0.00047845576773397624
newly O 0 0.004055747762322426
described O 0 0.0018168834503740072
HFE O 1 0.9997395873069763
marker O 0 0.0023070035967975855
provides O 0 1.4678888874186669e-05
a O 0 1.0030361409008037e-05
new O 0 4.997595169697888e-06
approach O 0 3.7995750972186215e-06
to O 0 3.5309976738062687e-06
the O 0 1.646154123591259e-05
screening O 0 5.507561581907794e-05
of O 0 0.0003070543461944908
HH B-Disease 1 0.9999276399612427
as O 0 8.765499660512432e-05
well O 0 9.432538718101569e-06
as O 0 3.848244432447245e-06
studies O 0 1.2866626093455125e-06
of O 0 7.715913852734957e-06
the O 0 4.491852450883016e-05
relationship O 0 8.494312351103872e-05
between O 0 0.0005942838615737855
the O 0 0.0017984331352636218
HFE O 1 0.9999996423721313
Tyr O 0 0.013692722655832767
allele O 0 1.72403160831891e-05
and O 0 3.2321470371243777e-06
different O 0 8.417596291110385e-06
disorders O 1 1.0
including O 1 0.9999947547912598
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.0005776651087217033
with O 0 3.2906955311773345e-05
a O 0 8.457520743831992e-05
missense O 0 0.0003029153449460864
mutation O 0 1.0610950994305313e-05
encoding O 0 0.00010194451169809327
Gly23 O 0 0.098122738301754
- O 0 0.0031063405331224203
- O 0 0.0007773760007694364
> O 0 0.00020020751981064677
Val O 0 0.001349350088275969
in O 0 0.00014708731032442302
neurophysin O 0 0.12076880037784576
II O 1 1.0
. O 0 0.0015285573899745941

Autosomal B-Disease 1 0.9999756813049316
dominant I-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9945740103721619
ADNDI B-Disease 1 1.0
) O 0 0.00013060617493465543
is O 0 1.2661744221986737e-05
an O 0 7.898717740317807e-05
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 0 0.028353022411465645
progressive O 1 1.0
degeneration O 1 1.0
of O 1 0.9999942779541016
the O 1 0.999992847442627
magnocellular O 1 0.9999997615814209
neurons O 0 0.0018341788090765476
of O 0 0.0005368510028347373
the O 0 0.0010096979094669223
hypothalamus O 0 0.004565645474940538
leading O 0 0.00019824279297608882
to O 0 1.969336881302297e-05
decreased O 0 0.0001568016450619325
ability O 0 7.498154900531517e-06
to O 0 7.82768074714113e-06
produce O 0 1.7341464626952074e-05
the O 0 0.00013491786376107484
hormone O 0 0.0014113709330558777
arginine O 0 0.0007248830515891314
vasopressin O 0 0.0027424527797847986
( O 0 0.00043576848111115396
AVP O 1 0.837603747844696
) O 0 0.00010615387873258442
. O 0 6.784455763408914e-05

Affected O 0 0.00024245696840807796
individuals O 0 4.865707524004392e-06
are O 0 2.363275370953488e-06
not O 0 1.1388495295250323e-05
symptomatic O 0 0.015610971488058567
at O 0 0.002740941708907485
birth O 0 0.0010423781350255013
, O 0 1.1242032087466214e-05
but O 0 2.1890189145779004e-06
usually O 0 1.2606800737557933e-05
develop O 0 0.0016763884341344237
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.9999405145645142
at O 0 0.015313484705984592
1 O 0 0.005851763300597668
- O 0 0.002208422403782606
6 O 0 0.0011618464486673474
yr O 0 0.01195593737065792
of O 0 0.00024481306900270283
age O 0 0.0026118659880012274
. O 0 0.0004883651854470372

The O 0 0.0001394250721205026
genetic O 0 0.00012255931505933404
locus O 0 0.00020418873464222997
of O 0 0.00028832152020186186
the O 0 0.0014709093375131488
disease O 1 0.9999984502792358
is O 0 5.518270336324349e-05
the O 0 0.0003814540687017143
AVP O 1 0.9998918771743774
- O 0 0.0027341763488948345
neurophysin O 0 0.027761947363615036
II O 1 1.0
( O 0 0.0011953710345551372
NPII O 1 0.9999552965164185
) O 0 6.143956125015393e-05
gene O 0 1.8863956938730553e-05
, O 0 5.211977168073645e-06
and O 0 5.386532393458765e-06
mutations O 0 6.421296711778268e-05
that O 0 2.8666574507951736e-05
cause O 0 0.0038343332707881927
ADNDI B-Disease 1 0.9999991655349731
have O 0 1.5968082152539864e-05
been O 0 9.523440894554369e-06
found O 0 1.1028926110157045e-06
in O 0 1.156946154878824e-06
both O 0 5.060105081611255e-07
the O 0 5.6639746617292985e-06
signal O 0 0.0001024604425765574
peptide O 0 3.197629121132195e-05
of O 0 3.8043956010369584e-05
the O 0 0.0002744339872151613
prepro O 1 0.996121346950531
- O 0 0.019543655216693878
AVP O 1 0.9990018010139465
- O 0 0.004758274648338556
NPII O 1 0.9888026118278503
precursor O 0 0.002102628583088517
and O 0 1.882804644992575e-05
within O 0 9.274955664295703e-05
NPII O 1 0.9999446868896484
itself O 0 0.0015373770147562027
. O 0 0.0001773792610038072

An O 0 0.00014888419536873698
affected O 0 0.0002686577499844134
girl O 0 0.0002739099145401269
who O 0 7.203470431704773e-06
presented O 0 0.0001078524292097427
at O 0 0.00031692147604189813
9 O 0 0.0004794783890247345
months O 0 6.849892815807834e-05
of O 0 0.0001482534862589091
age O 0 0.0011018809163942933
and O 0 5.366289769881405e-05
her O 0 5.620570300379768e-05
similarly O 0 0.00011577595432754606
affected O 0 0.00023872395104262978
younger O 0 0.0009046269115060568
brother O 0 0.0009280995582230389
and O 0 2.6837502446142025e-05
father O 0 0.00022147424169816077
were O 0 2.972687070723623e-05
all O 0 5.441909252112964e-06
found O 0 2.464375938870944e-06
to O 0 3.510931719574728e-06
have O 0 1.356310235678393e-06
a O 0 1.0742491213022731e-05
novel O 0 6.607079558307305e-05
missense O 0 0.00035239107091911137
mutation O 0 3.319716051919386e-05
( O 0 6.559387111337855e-05
G1758 O 0 0.005449199583381414
- O 0 0.0016327470075339079
- O 0 0.0007311991066671908
> O 0 0.0003080113383475691
T O 0 0.0005945601151324809
) O 0 1.9220451576984487e-06
encoding O 0 3.325187208247371e-06
the O 0 2.5114739401033148e-05
amino O 0 3.0264172892202623e-05
acid O 0 5.56180311832577e-05
substitution O 0 0.00026953878113999963
Gly23 O 0 0.06686676293611526
- O 0 0.0022935322485864162
- O 0 0.0006863091257400811
> O 0 0.00030403793789446354
Val O 0 0.0018759184749796987
within O 0 0.00029187413747422397
NPII O 1 0.9996771812438965
. O 0 0.0004282206646166742

The O 0 0.0005216046702116728
mutation O 0 3.890052903443575e-05
was O 0 0.0001212084389408119
confirmed O 0 1.4231222849048208e-05
by O 0 2.709796945055132e-06
restriction O 0 1.490303566242801e-05
endonuclease O 0 0.00016720556595828384
analysis O 0 1.665502531977836e-05
. O 0 7.30751853552647e-05

A O 0 0.019501151517033577
T1 O 1 0.9999116659164429
- O 0 0.0011299251345917583
weighted O 0 3.907859354512766e-05
magnetic O 0 4.7351946705020964e-05
resonance O 0 6.494760600617155e-05
imaging O 0 0.00020237821445334703
of O 0 0.00048274637083522975
the O 0 0.007353243883699179
fathers O 1 0.982740044593811
pituitary O 1 1.0
gland O 1 0.9999669790267944
demonstrates O 0 0.00603476632386446
an O 0 0.0003609664854593575
attenuated O 1 0.9889177083969116
posterior O 1 0.9932671785354614
pituitary O 1 1.0
bright O 1 0.971278190612793
spot O 0 0.011202661320567131
. O 0 0.00035441844374872744

This O 0 9.821921412367374e-05
mutation O 0 3.101655238424428e-05
may O 0 2.755907189566642e-05
be O 0 5.518615580513142e-06
valuable O 0 6.0495436628116295e-05
for O 0 4.786217687069438e-06
developing O 0 4.1082355892285705e-05
models O 0 1.4682683286082465e-05
of O 0 0.00035064213443547487
dominantly B-Disease 1 0.9999990463256836
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.0004086100962013006
as O 0 6.328004383249208e-05
the O 0 5.681431866833009e-05
early O 0 0.00013663982099387795
age O 0 0.0002159321156796068
of O 0 0.00026350701227784157
onset O 1 0.9999998807907104
of O 1 0.9849506616592407
symptoms O 1 0.9999996423721313
suggests O 0 0.0008903878624550998
that O 0 9.148865501629189e-06
this O 0 5.618697741738288e-06
mutation O 0 8.559052730561234e-06
may O 0 1.5746902136015706e-05
be O 0 4.203350272291573e-06
particularly O 0 8.899172826204449e-06
deleterious O 0 0.00020829634740948677
to O 0 6.639455386903137e-05
the O 0 0.0006905288901180029
magnocellular O 1 0.9884598255157471
neuron O 0 0.004603882785886526
. O 0 8.620863809483126e-05
. O 0 9.930393571266904e-05

Frequent O 0 0.00012903453898616135
inactivation O 0 0.00866091437637806
of O 0 0.01146200392395258
PTEN O 1 1.0
/ O 1 0.9997254014015198
MMAC1 O 1 0.9999998807907104
in O 0 0.0007315333350561559
primary O 1 0.9999903440475464
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.02711198292672634

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.004457829520106316
the O 0 0.0008479543030261993
most O 0 7.329739310080186e-05
common O 0 9.613174916012213e-05
male B-Disease 0 0.0007143508992157876
cancer I-Disease 0 0.06554502248764038
in O 0 7.366871432168409e-05
the O 0 0.00012923317262902856
Western O 0 0.00019300493295304477
world O 0 6.185877282405272e-05
, O 0 1.1865416809087037e-06
yet O 0 1.303444378208951e-06
many O 0 1.887353846541373e-07
of O 0 3.1264848985301796e-06
the O 0 1.9295737729407847e-05
major O 0 0.0001909986458485946
genetic O 0 7.907264080131426e-05
events O 0 8.681663894094527e-05
involved O 0 3.6319248465588316e-05
in O 0 4.205587538308464e-05
the O 0 0.00014734167780261487
progression O 0 0.007866390980780125
of O 0 0.00023310206597670913
this O 0 7.825447391951457e-05
often O 0 0.0002536666579544544
fatal O 1 0.999984622001648
cancer B-Disease 1 0.9999830722808838
remain O 0 0.0006784856086596847
to O 0 5.1449620514176786e-05
be O 0 5.181580490898341e-05
elucidated O 0 0.015916934236884117
. O 0 0.00017668548389337957

Numerous O 0 0.0020015111658722162
cytogenetic O 0 0.040870193392038345
and O 0 0.0002703780774027109
allelotype O 0 0.2935221791267395
studies O 0 6.71748275635764e-05
have O 0 5.192499429540476e-06
reported O 0 1.8606851881486364e-05
frequent O 0 1.5147338672250044e-05
loss O 0 0.0003059929294977337
of O 0 0.0007660919800400734
heterozygosity O 1 0.9999163150787354
on O 0 0.013483223505318165
chromosomal O 1 0.9973413348197937
arm O 0 0.06466300785541534
10q O 0 0.023228753358125687
in O 0 0.0012767305597662926
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7570695281028748

Deletion O 0 0.0019881934858858585
mapping O 0 0.0002766306570265442
studies O 0 3.772153286263347e-05
have O 0 4.931380317430012e-06
unambiguously O 0 0.0001158204540843144
identified O 0 1.0284981726726983e-05
a O 0 1.209168021887308e-05
region O 0 0.00018493719107937068
of O 0 0.000310701405396685
chromosome O 0 0.001741684041917324
10q23 O 0 0.002082168124616146
to O 0 2.0201714505674317e-05
be O 0 7.2582920438435394e-06
the O 0 1.1509658179420512e-05
minimal O 0 9.683844837127253e-05
area O 0 0.00013441976625472307
of O 0 0.00015064467152114958
loss O 0 0.00759867113083601
. O 0 0.0007143162074498832

A O 0 0.0009336859220638871
new O 0 0.0001322123280260712
tumor B-Disease 1 0.997016191482544
suppressor O 0 0.005826396867632866
gene O 0 0.0002553134399931878
, O 0 0.00013809742813464254
PTEN O 1 0.9999861717224121
/ O 0 0.07181629538536072
MMAC1 O 1 0.9999589920043945
, O 0 4.018448817078024e-05
was O 0 0.0002816887281369418
isolated O 0 0.0001669077028054744
recently O 0 2.324949855392333e-05
at O 0 3.019092582690064e-05
this O 0 1.5348103943324531e-06
region O 0 9.591216803528368e-05
of O 0 0.00014882555115036666
chromosome O 0 0.0013852291740477085
10q23 O 0 0.003178912214934826
and O 0 1.3788921023660805e-05
found O 0 3.7943314055155497e-06
to O 0 3.807511802733643e-06
be O 0 2.639316790009616e-06
inactivated O 0 5.520618287846446e-05
by O 0 8.780256735008152e-07
mutation O 0 9.363931212647003e-07
in O 0 1.771403731254395e-05
three O 0 0.0014666873030364513
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.09700015932321548
. O 0 0.000609586073551327

We O 0 8.109475311357528e-05
screened O 0 0.0012244520476087928
80 O 0 0.005961927585303783
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.00020374107407405972
microsatellite O 0 0.002496312139555812
analysis O 0 1.433333454770036e-05
and O 0 1.5859088307479396e-05
found O 0 6.063758337404579e-05
chromosome O 0 0.00045404312550090253
10q23 O 0 0.0011982140131294727
to O 0 3.542138438206166e-05
be O 0 2.0504463464021683e-05
deleted O 0 0.00020286563085392118
in O 0 2.5267214368795976e-05
23 O 0 0.00040336191887035966
cases O 0 7.031814311631024e-05
. O 0 0.00016945968673098832

We O 0 5.890224201721139e-05
then O 0 8.229947525251191e-06
proceeded O 0 3.017426024598535e-05
with O 0 3.259904133301461e-07
sequence O 0 2.7530634270078735e-06
analysis O 0 1.1104810937467846e-06
of O 0 1.5795478248037398e-05
the O 0 0.00015254270692821592
entire O 0 0.013759366236627102
PTEN O 1 0.9999982118606567
/ O 0 0.017394041642546654
MMAC1 O 1 0.9997511506080627
coding O 0 0.0016397606814280152
region O 0 0.0006209674756973982
and O 0 2.20336951315403e-05
tested O 0 4.7805348003748804e-05
for O 0 5.430845703813247e-06
homozygous O 0 4.2651696276152506e-05
deletion O 0 0.00011938413081225008
with O 0 7.243285836011637e-06
new O 0 5.475402213050984e-05
intragenic O 0 0.013223330490291119
markers O 0 0.0016043380601331592
in O 0 7.223505235742778e-05
these O 0 1.5627876564394683e-05
23 O 0 0.00021202358766458929
cases O 0 1.2124241948185954e-05
with O 0 1.563333353260532e-05
10q23 O 0 0.00450142240151763
loss O 0 0.002371332375332713
of O 0 0.002605161862447858
heterozygosity O 1 0.9999871253967285
. O 0 0.0035630573984235525

The O 0 0.00013244223373476416
identification O 0 1.4095423466642387e-05
of O 0 6.623027002206072e-05
the O 0 0.0001540772063890472
second O 0 0.0003236749325878918
mutational O 0 0.0013652392663061619
event O 0 0.00012810758198611438
in O 0 1.7275817299378105e-05
10 O 0 1.959008295671083e-05
( O 0 3.925531927961856e-06
43 O 0 4.919458297081292e-05
% O 0 0.00011398339847801253
) O 0 0.0011369797866791487
tumors B-Disease 1 1.0
establishes O 1 0.9995373487472534
PTEN O 1 1.0
/ O 0 0.30890706181526184
MMAC1 O 1 0.9995182752609253
as O 0 6.489857332780957e-05
a O 0 2.3797425455995835e-05
main O 0 0.0001257358817383647
inactivation O 0 0.0006699940422549844
target O 0 1.8943152099382132e-05
of O 0 7.651076884940267e-05
10q O 0 0.003717185463756323
loss O 0 0.001422028406523168
in O 0 0.0007552015013061464
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004124270286411047
. O 0 0.0005944051663391292

Risk O 0 0.0016388242365792394
reversals O 0 0.001163140987046063
in O 0 3.047728205274325e-05
predictive O 0 3.960850881412625e-05
testing O 0 0.00011861693201353773
for O 0 0.0010416036238893867
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.008489944972097874

The O 0 3.582182034733705e-05
first O 0 4.520592938206391e-06
predictive O 0 3.900979208992794e-06
testing O 0 1.2650181815843098e-05
for O 0 0.00014883647963870317
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0018943470204249024
HD B-Disease 1 0.9996968507766724
) O 0 2.4867758838809095e-05
was O 0 3.339567774673924e-05
based O 0 4.744103989651194e-07
on O 0 4.63385003968142e-06
analysis O 0 1.4638982293035951e-06
of O 0 5.22459922649432e-05
linked O 0 0.0013717846013605595
polymorphic O 0 0.0006617304752580822
DNA O 0 0.0008762120269238949
markers O 0 0.0008501014090143144
to O 0 4.107417043996975e-05
estimate O 0 2.950738235085737e-05
the O 0 1.9149467334500514e-05
likelihood O 0 3.4024720662273467e-05
of O 0 7.652477506780997e-05
inheriting O 0 0.0016887077363207936
the O 0 0.00012654659803956747
mutation O 0 1.1536800229805522e-05
for O 0 3.227834531571716e-05
HD B-Disease 1 0.9987591505050659
. O 0 0.00044559116940945387

Limits O 0 3.288534207968041e-05
to O 0 3.5731854950427078e-06
accuracy O 0 7.3524129220459145e-06
included O 0 8.959240403783042e-06
recombination O 0 1.0406156434328295e-05
between O 0 4.982213067705743e-05
the O 0 5.600773511105217e-05
DNA O 0 0.0003029468352906406
markers O 0 0.0005386100383475423
and O 0 1.2014046660624444e-05
the O 0 9.759880776982754e-05
mutation O 0 4.2050538468174636e-05
, O 0 1.863380748545751e-05
pedigree O 0 0.0003934692358598113
structure O 0 0.0006697438657283783
, O 0 9.907304956868757e-06
and O 0 3.210522663721349e-06
whether O 0 3.450130634519155e-06
DNA O 0 2.6881994926952757e-05
samples O 0 5.563611011893954e-06
were O 0 4.056554189446615e-06
available O 0 1.1414712162149954e-06
from O 0 6.404557552741608e-06
family O 0 1.4677209037472494e-05
members O 0 1.101641737477621e-05
. O 0 0.0001279917050851509

With O 0 9.210863936459646e-06
direct O 0 9.157245585811324e-06
tests O 0 5.140724624652648e-06
for O 0 5.107217475597281e-06
the O 0 0.00018258912314195186
HD B-Disease 1 0.977597177028656
mutation O 0 2.5298802938777953e-05
, O 0 1.8253422240377404e-06
we O 0 1.5277306602001772e-06
have O 0 4.03651540636929e-07
assessed O 0 8.546736353309825e-06
the O 0 3.1432086871063802e-06
accuracy O 0 2.120537146765855e-06
of O 0 5.7636912060843315e-06
results O 0 5.688171313522616e-06
obtained O 0 2.1557065338129178e-05
by O 0 8.6995942183421e-06
linkage O 0 0.0007328126230277121
approaches O 0 8.049840835155919e-05
when O 0 1.1486082257761154e-05
requested O 0 1.3367057363211643e-05
to O 0 8.701950719114393e-06
do O 0 7.217346137622371e-06
so O 0 2.5079511942749377e-06
by O 0 7.419798748742323e-07
the O 0 6.7176420088799205e-06
test O 0 1.002956742013339e-05
individuals O 0 5.205911747907521e-06
. O 0 8.002539834706113e-05

For O 0 6.036065678927116e-05
six O 0 5.705951843992807e-05
such O 0 4.724108293885365e-06
individuals O 0 4.06646267947508e-06
, O 0 1.057404006132856e-05
there O 0 2.066155502689071e-05
was O 0 0.0001747290079947561
significant O 0 8.868764416547492e-05
disparity O 0 0.001922344439662993
between O 0 0.00018802261911332607
the O 0 0.00012491729285102338
tests O 0 3.578508403734304e-05
. O 0 5.549098932533525e-05

Three O 0 0.00014170412032399327
went O 0 0.00017872691387310624
from O 0 1.8771286704577506e-05
a O 0 2.7209942345507443e-05
decreased O 0 0.0008653828990645707
risk O 0 5.4096028179628775e-05
to O 0 1.1702552910719533e-05
an O 0 8.313857506436761e-06
increased O 0 0.00012775503273587674
risk O 0 0.00010304374154657125
, O 0 5.744030204368755e-06
while O 0 3.800125796260545e-06
in O 0 7.26007738194312e-06
another O 0 6.40417920294567e-06
three O 0 5.853517905052286e-06
the O 0 2.4487580958520994e-05
risk O 0 9.511503594694659e-05
was O 0 0.0008116756798699498
decreased O 0 0.002311272546648979
. O 0 0.00026302156038582325

Knowledge O 0 0.0009579038014635444
of O 0 0.0003916439600288868
the O 0 0.0003707474679686129
potential O 0 0.00025705937878228724
reasons O 0 1.6903448340599425e-05
for O 0 1.4711140465806238e-06
these O 0 1.4686218037240906e-06
changes O 0 3.41886379828793e-06
in O 0 6.7664104790310375e-06
results O 0 9.522424988972489e-06
and O 0 5.426440111477859e-06
impact O 0 4.1912939195754007e-05
of O 0 4.809292295249179e-05
these O 0 2.79995656455867e-05
risk O 0 0.00015222291403915733
reversals O 0 0.001276114140637219
on O 0 0.0002325402310816571
both O 0 2.8125210519647226e-05
patients O 0 3.2292326068272814e-05
and O 0 6.5069780248450115e-06
the O 0 5.1989234634675086e-05
counseling O 0 3.859314165310934e-05
team O 0 1.5726745914435014e-05
can O 0 1.0419087175250752e-06
assist O 0 7.0538708314416e-06
in O 0 4.820885806111619e-06
the O 0 1.3861144907423295e-05
development O 0 2.261592453578487e-05
of O 0 1.888838414743077e-05
strategies O 0 3.3283828088315204e-05
for O 0 1.2819426956411917e-05
the O 0 0.00015885689936112612
prevention O 0 0.0009935427224263549
and O 0 9.877097909338772e-06
, O 0 3.856782313960139e-06
where O 0 1.3432009836833458e-05
necessary O 0 3.3921434805961326e-05
, O 0 6.331797067105072e-06
management O 0 3.4908847737824544e-05
of O 0 9.009290806716308e-05
a O 0 0.000171848718309775
risk O 0 0.00032623662264086306
reversal O 0 0.0005446849390864372
in O 0 2.1532163373194635e-05
any O 0 7.18181581760291e-06
predictive O 0 2.5778630515560508e-05
testing O 0 2.398761353106238e-05
program O 0 4.436708695720881e-05
. O 0 9.096682333620265e-06
. O 0 2.9110968171153218e-05

A O 0 0.002932626521214843
novel O 0 0.0004508434212766588
common O 0 7.356383139267564e-05
missense O 0 0.0004930525319650769
mutation O 0 4.6261797251645476e-05
G301C O 0 0.0007724587339907885
in O 0 3.9199148886837065e-05
the O 0 7.287803600775078e-05
N O 0 0.003069869475439191
- O 0 0.0009561317856423557
acetylgalactosamine O 0 0.005492792464792728
- O 0 0.0004862544883508235
6 O 0 0.0006871474906802177
- O 0 0.0009679805370979011
sulfate O 0 0.0029010421130806208
sulfatase O 0 0.02123737707734108
gene O 0 0.00010152686445508152
in O 0 0.00031002264586277306
mucopolysaccharidosis B-Disease 1 0.999832034111023
IVA I-Disease 1 0.9999997615814209
. O 0 0.001297793467529118

Mucopolysaccharidosis B-Disease 1 0.999996542930603
IVA I-Disease 1 1.0
( O 0 0.06564519554376602
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 0.00027297320775687695
is O 0 1.371436519548297e-05
an O 0 3.40738806698937e-05
autosomal B-Disease 1 0.999996542930603
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 1.0
by O 0 0.0014650820521637797
a O 0 0.0015440048882737756
genetic B-Disease 1 0.9999998807907104
defect I-Disease 1 1.0
in O 0 0.0017237926367670298
N O 0 0.050200652331113815
- O 0 0.0023017884232103825
acetylgalactosamine O 0 0.0038240766152739525
- O 0 0.0003258741635363549
6 O 0 0.0005673784180544317
- O 0 0.0014825041871517897
sulfate O 0 0.006469454150646925
sulfatase O 1 0.9098371863365173
( O 0 0.0015617068856954575
GALNS O 1 0.9999641180038452
) O 0 0.0005482021952047944
. O 0 0.00015350338071584702

In O 0 0.00017090323672164232
previous O 0 0.00011580995487747714
studies O 0 4.04010497732088e-05
, O 0 6.428067536035087e-06
we O 0 2.3329153009399306e-06
have O 0 6.375262273650151e-07
found O 0 2.095624267894891e-06
two O 0 2.5605911559978267e-06
common O 0 2.408411273790989e-05
mutations O 0 8.204871119232848e-05
in O 0 0.00019458981114439666
Caucasians O 0 0.003582158824428916
and O 0 2.9720464226556942e-05
Japanese O 0 0.0010036443127319217
, O 0 2.6960378818330355e-05
respectively O 0 0.0002577676496002823
. O 0 0.00011402001837268472

To O 0 0.00017652280803304166
characterize O 0 0.0008529216866008937
the O 0 0.000378685217583552
mutational O 0 0.004505474586039782
spectrum O 0 0.00020960031542927027
in O 0 1.9936471289838664e-05
various O 0 6.8356348492670804e-06
ethnic O 0 1.78363588929642e-05
groups O 0 2.083790604956448e-06
, O 0 4.221592917019734e-06
mutations O 0 6.6344996412226465e-06
in O 0 2.0400444554979913e-05
the O 0 0.00012535233690869063
GALNS O 1 0.9959549903869629
gene O 0 4.814954809262417e-05
in O 0 4.733912646770477e-05
Colombian O 0 0.0012779311509802938
MPS B-Disease 1 0.9999980926513672
IVA I-Disease 1 1.0
patients O 0 0.0009579983307048678
were O 0 0.0001327417412539944
investigated O 0 0.0003857784904539585
, O 0 1.4346805983223021e-05
and O 0 7.91081038187258e-06
genetic O 0 7.16067515895702e-05
backgrounds O 0 3.216367258573882e-05
were O 0 4.779591108672321e-05
extensively O 0 0.0001328258222201839
analyzed O 0 2.9138687750673853e-05
to O 0 5.402429451351054e-06
identify O 0 1.269339736609254e-05
racial O 0 7.713639206485823e-05
origin O 0 1.30783246277133e-05
, O 0 2.1452162854984635e-06
based O 0 1.1291200507912436e-06
on O 0 3.1478190066991374e-05
mitochondrial O 0 0.00021181668853387237
DNA O 0 0.00031667956500314176
( O 0 5.9800036979140714e-05
mtDNA O 0 7.199704123195261e-05
) O 0 6.476256385212764e-05
lineages O 0 0.0003443126624915749
. O 0 0.0001392706617480144

Three O 0 0.0002032460761256516
novel O 0 0.0005342720542103052
missense O 0 0.0014193874085322022
mutations O 0 0.0001935616892296821
never O 0 0.00026645121397450566
identified O 0 2.6792036806000397e-05
previously O 0 5.303955913404934e-05
in O 0 1.516730208095396e-05
other O 0 2.892398015319486e-06
populations O 0 4.60545106761856e-06
and O 0 2.702926622077939e-06
found O 0 4.252958660799777e-06
in O 0 1.5904706742730923e-05
16 O 0 9.271701128454879e-05
out O 0 4.472611180972308e-06
of O 0 4.5472741476260126e-05
19 O 0 0.0013284101150929928
Colombian O 0 0.003024822333827615
MPS B-Disease 1 0.9999203681945801
IVA I-Disease 1 1.0
unrelated O 0 0.000918633711989969
alleles O 0 1.4163781997922342e-05
account O 0 1.3179967027099337e-05
for O 0 2.1752262910013087e-05
84 O 0 0.0016848751110956073
. O 0 0.00036636926233768463

2 O 0 0.0006423174636438489
% O 0 2.0794786905753426e-05
of O 0 5.4134528909344226e-05
the O 0 6.79912482155487e-05
alleles O 0 6.8721592469955795e-06
in O 0 1.1233737495786045e-05
this O 0 3.11164171762357e-06
study O 0 1.976769090106245e-05
. O 0 4.353368058218621e-05

The O 0 0.0011594804236665368
G301C O 0 0.005239092279225588
and O 0 4.027030445286073e-05
S162F O 0 0.0014751714188605547
mutations O 0 3.0168906960170716e-05
account O 0 1.0712730727391317e-05
for O 0 2.9040231311228126e-05
68 O 0 0.0011969147017225623
. O 0 0.0004743410099763423

4 O 0 0.0012128944508731365
% O 0 8.466365397907794e-05
and O 0 5.177185084903613e-05
10 O 0 0.000442359916632995
. O 0 0.00020320869225542992

5 O 0 0.00040570698911324143
% O 0 3.066088538616896e-05
of O 0 8.543110016034916e-05
mutations O 0 0.00011921327677555382
, O 0 2.9530212486861274e-05
respectively O 0 0.00014536341768689454
, O 0 1.4905267562426161e-05
whereas O 0 2.6704339688876644e-05
the O 0 6.311613105935976e-05
remaining O 0 0.0013987028505653143
F69V O 1 0.9724005460739136
is O 0 1.0901144378294703e-05
limited O 0 4.381872713565826e-06
to O 0 6.397293418558547e-06
a O 0 1.6885996956261806e-05
single O 0 2.3801669158274308e-05
allele O 0 3.133529025944881e-05
. O 0 5.6641696573933586e-05

The O 0 0.00032084196573123336
skewed O 0 0.00020136348030064255
prevalence O 0 0.0006040181615389884
of O 0 0.00023690523812547326
G301C O 0 0.0028395496774464846
in O 0 2.6603809601510875e-05
only O 0 1.5843606888665818e-05
Colombian O 0 0.00015814974904060364
patients O 0 2.2106414689915255e-05
and O 0 7.882358659117017e-06
haplotype O 0 0.0001753034011926502
analysis O 0 5.8830496527662035e-06
by O 0 1.0762477359094191e-05
restriction O 0 4.206794619676657e-05
fragment O 0 0.00023249589139595628
length O 0 4.485594399739057e-05
polymorphisms O 0 9.024329483509064e-05
in O 0 1.8436472601024434e-05
the O 0 0.00013315642718225718
GALNS O 1 0.9952605366706848
gene O 0 3.6771401937585324e-05
suggest O 0 1.8186581655754708e-05
that O 0 4.477280072023859e-06
G301C O 0 0.0008231777464970946
originated O 0 7.988922880031168e-05
from O 0 1.4207314961822703e-05
a O 0 2.0819687051698565e-05
common O 0 3.5292348911752924e-05
ancestor O 0 0.001717461389489472
. O 0 0.00039432893390767276

Investigation O 0 0.00017236532585229725
of O 0 7.137625652831048e-05
the O 0 7.581729732919484e-05
genetic O 0 0.00010442341590533033
background O 0 4.06147119065281e-05
by O 0 6.428398137359181e-06
means O 0 3.74544870282989e-05
of O 0 8.018765220185742e-05
mtDNA O 0 8.540918497601524e-05
lineages O 0 7.702533184783533e-05
indicate O 0 1.885118763311766e-05
that O 0 2.356078539378359e-06
all O 0 5.696352218365064e-06
our O 0 3.1120933272177354e-05
patients O 0 1.856744711403735e-05
are O 0 1.5009591152193025e-06
probably O 0 6.409764318959787e-05
of O 0 5.316428359947167e-05
native O 0 0.0001177883823402226
American O 0 0.00016007591329980642
descent O 0 0.0034869518131017685

Low O 0 0.0008459766395390034
frequency O 0 4.334721961640753e-05
of O 0 0.00021705545077566057
BRCA1 O 0 0.002445456339046359
germline O 0 0.001103932736441493
mutations O 0 9.470865734328981e-06
in O 0 7.888736035965849e-06
45 O 0 9.845683962339535e-05
German O 1 0.9999998807907104
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0019988783169537783
. O 0 0.0010678601684048772

In O 0 8.324854570673779e-05
this O 0 2.8954448225704255e-06
study O 0 1.6009503269742709e-06
we O 0 7.895907856436679e-07
investigated O 0 1.8055763575830497e-05
45 O 0 5.056171721662395e-05
German O 1 0.999998927116394
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0002926420420408249
for O 0 0.0002268970711156726
germline O 0 0.0068346369080245495
mutations O 0 8.719995093997568e-05
in O 0 5.795791730633937e-05
the O 0 0.00027979505830444396
BRCA1 O 0 0.0024131909012794495
gene O 0 0.00010583327821223065
. O 0 7.161084795370698e-05

We O 0 5.855473500560038e-05
identified O 0 4.201674892101437e-05
four O 0 2.6510810130275786e-05
germline O 0 0.0017167051555588841
mutations O 0 8.106072345981374e-05
in O 0 0.00016150328156072646
three O 0 0.0009416725370101631
breast B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9946634769439697
families O 0 1.2938588952238206e-05
and O 0 8.381557563552633e-06
in O 0 0.00010430558904772624
one O 0 0.0033102440647780895
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0006439961143769324
. O 0 2.0029408915434033e-05
among O 0 5.826238975714659e-06
these O 0 2.6947445803671144e-06
were O 0 2.8705582735710777e-05
one O 0 5.655108543578535e-05
frameshift O 0 0.0031621456146240234
mutation O 0 6.60852892906405e-05
, O 0 1.73753342096461e-05
one O 0 2.526044409023598e-05
nonsense O 0 0.0008099789847619832
mutation O 0 3.8304031477309763e-05
, O 0 6.954585387575207e-06
one O 0 5.240516202320578e-06
novel O 0 9.043573663802817e-05
splice O 0 0.0008829133585095406
site O 0 0.0003631390572991222
mutation O 0 1.5380048353108577e-05
, O 0 4.481667474465212e-06
and O 0 7.331414508371381e-06
one O 0 3.4010186936939135e-05
missense O 0 0.001049695536494255
mutation O 0 0.00011604807514231652
. O 0 0.0002420287491986528

The O 0 0.0006809491314925253
missense O 0 0.0019391736714169383
mutation O 0 5.332651562639512e-05
was O 0 0.0002541735884733498
also O 0 1.1301216545689385e-05
found O 0 6.969590685912408e-06
in O 0 3.7837293348275125e-05
2 O 0 0.0008299825713038445
. O 0 0.00015689422434661537

8 O 0 0.0006861324654892087
% O 0 2.5919336621882394e-05
of O 0 3.944958370993845e-05
the O 0 5.7303212088299915e-05
general O 0 4.902131695416756e-05
population O 0 1.4688775991089642e-05
, O 0 6.608231615246041e-06
suggesting O 0 1.9737117327167653e-05
that O 0 9.68249082688999e-07
it O 0 1.632912244531326e-06
is O 0 3.6036221899848897e-06
not O 0 1.208310277434066e-05
disease O 1 0.9959796667098999
associated O 0 0.00027595547726377845
. O 0 0.00031798711279407144

The O 0 0.00014796003233641386
average O 0 4.984760016668588e-05
age O 0 0.00028482518973760307
of O 0 0.0010408764937892556
disease O 1 1.0
onset O 1 1.0
in O 0 0.0006330544129014015
those O 0 5.839329969603568e-05
families O 0 3.1501793273491785e-05
harbouring O 0 0.11882375925779343
causative O 0 0.002617497695609927
mutations O 0 0.00033501556026749313
was O 0 0.0010910211130976677
between O 0 0.0010999669320881367
32 O 0 0.0013853743439540267
. O 0 0.0002863139088731259

3 O 0 0.0011804602108895779
and O 0 5.9020148910349235e-05
37 O 0 0.000557234394364059
. O 0 0.00020787713583558798

4 O 0 0.0016571576707065105
years O 0 0.0003164166701026261
, O 0 1.1711250408552587e-05
whereas O 0 3.3390839234925807e-05
the O 0 6.736747309332713e-05
family O 0 0.0001405647926731035
harbouring O 0 0.02042875811457634
the O 0 0.000351011665770784
missense O 0 0.001032430212944746
mutation O 0 1.842416895669885e-05
had O 0 3.179012128384784e-05
an O 0 4.194225311948685e-06
average O 0 1.9210139726055786e-05
age O 0 0.0001296732370974496
of O 0 0.00023117799719329923
onset O 1 0.9998898506164551
of O 0 0.006449406500905752
51 O 0 0.009124215692281723
. O 0 0.0007002021302469075

2 O 0 0.0034782635048031807
years O 0 0.001661159680224955
. O 0 0.00035289183142594993

These O 0 2.3436019546352327e-05
findings O 0 2.904676875914447e-05
show O 0 8.324823284056038e-05
that O 0 1.2028594937874004e-05
BRCA1 O 0 0.0008439392549917102
is O 0 2.138914896931965e-05
implicated O 0 0.0003464219917077571
in O 0 2.281981142004952e-05
a O 0 8.209965017158538e-06
small O 0 2.12458962778328e-06
fraction O 0 4.2672527342801914e-05
of O 0 0.002114962786436081
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00021710533474106342
suggesting O 0 0.00010099511564476416
the O 0 3.2016352633945644e-05
involvement O 0 8.632939716335386e-05
of O 0 5.033416164224036e-05
another O 0 0.000123155492474325
susceptibility O 0 0.001043359749019146
gene O 0 0.00019709119806066155
( O 0 0.00021433627989608794
s O 0 0.002400050638243556
) O 0 0.00031519218464381993

Paternal O 1 0.5788203477859497
transmission O 1 0.9999998807907104
of O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 1.0

We O 0 5.2409613999770954e-05
report O 0 4.116040145163424e-06
a O 0 2.5078627459151903e-06
rare O 0 1.1792491022788454e-05
case O 0 9.935406524164136e-06
of O 0 0.0002526042517274618
paternally O 1 1.0
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.00941481627523899
. O 0 0.0005146288895048201

The O 0 0.0007125980919227004
proband O 0 0.010158312506973743
is O 0 1.3602283615909982e-05
a O 0 1.1125332093797624e-05
23 O 0 0.00019400290329940617
year O 0 8.256830915343016e-05
old O 0 0.0019499886548146605
, O 0 0.00045118224807083607
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.014908857643604279
who O 0 0.0021789437159895897
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999879598617554

He O 0 0.0003838858101516962
presented O 0 0.0005797739140689373
with O 0 0.000545189599506557
respiratory O 1 1.0
and O 0 0.0022544884122908115
feeding O 0 0.007630768697708845
difficulties O 1 0.9965288043022156
at O 0 0.08051152527332306
birth O 0 0.004973158240318298
. O 0 0.0003939137968700379

His O 0 0.0013470947742462158
two O 0 0.00043434739927761257
sibs O 1 0.9993634819984436
suffer O 0 0.0071777175180613995
from O 0 0.0006056095007807016
childhood O 1 0.9999998807907104
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.016212020069360733

Their O 0 0.0001407681411365047
late O 0 0.001210901653394103
father O 0 0.00022510641429107636
had O 0 2.1924179236521013e-05
the O 0 1.2593366591318045e-05
adult O 0 7.1376716732629575e-06
type O 0 7.14359775884077e-05
of O 0 0.0006594539736397564
DM B-Disease 1 1.0
, O 0 8.614436228526756e-05
with O 0 1.3036361451668199e-05
onset O 1 0.9996377229690552
around O 0 0.0009503391338512301
30 O 0 0.0005090429331175983
years O 0 0.00029386355890892446
. O 0 0.00010039336484624073

Only O 0 2.7846210286952555e-05
six O 0 1.7210077203344554e-05
other O 0 7.46277407870366e-07
cases O 0 3.2103757803270128e-06
of O 0 9.747240983415395e-05
paternal O 0 0.016914183273911476
transmission O 1 0.9999853372573853
of O 1 0.9999997615814209
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.006306229159235954
been O 0 0.0003050864615943283
reported O 0 0.0001082359958672896
recently O 0 0.00017776699678506702
. O 0 6.518798181787133e-05

We O 0 2.7238733309786767e-05
review O 0 8.014447303139605e-06
the O 0 2.0846469851676375e-05
sex O 0 3.697644206113182e-05
related O 0 5.7036133512156084e-05
effects O 0 0.0013000662438571453
on O 0 0.002234762068837881
transmission O 1 0.9991814494132996
of O 1 0.9999479055404663
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.999919056892395

Decreased O 0 0.0159453172236681
fertility O 0 0.0012964383931830525
of O 0 6.891240627737716e-05
males O 0 1.1806061593233608e-05
with O 0 1.4641853340435773e-05
adult O 0 0.0004068602283950895
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.0007941694348119199
contraction O 0 0.0033415919169783592
of O 0 0.0004491743165999651
the O 0 0.0002642507024575025
repeat O 0 0.0012903977185487747
upon O 0 0.00021118063887115568
male O 0 0.00018651914433576167
transmission O 0 0.0002787287230603397
contribute O 0 2.0300672986195423e-05
to O 0 8.77712773217354e-06
the O 0 4.031119169667363e-05
almost O 0 2.281285014760215e-05
absent O 0 7.918673509266227e-05
occurrence O 0 2.662502993189264e-05
of O 0 7.409432146232575e-05
paternal O 0 0.002390511566773057
transmission O 1 0.9999386072158813
of O 1 0.9999997615814209
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999982118606567

Also O 0 0.0001000197371467948
the O 0 0.00010061407374450937
fathers O 0 0.00011880483361892402
of O 0 6.488471262855455e-05
the O 0 0.0003484816406853497
reported O 0 0.000871105759870261
congenitally O 0 0.21103033423423767
affected O 0 0.00015960648306645453
children O 0 2.569356183812488e-05
showed O 0 0.00011681881733238697
, O 0 6.762210887245601e-06
on O 0 3.499727608868852e-05
average O 0 4.782732867170125e-05
, O 0 4.621593325282447e-05
shorter O 0 0.0013289363123476505
CTG O 1 0.9982410669326782
repeat O 0 0.0060454243794083595
lengths O 0 0.003709259442985058
and O 0 1.9216737200622447e-05
hence O 0 0.00011886502034030855
less O 0 8.455554052488878e-05
severe O 0 0.3084487020969391
clinical O 0 0.014699578285217285
symptoms O 1 0.9960903525352478
than O 0 9.08207512111403e-05
the O 0 0.00028008519439026713
mothers O 0 0.00010001659393310547
of O 0 5.657977453665808e-05
children O 0 0.00021482136799022555
with O 0 0.006783150136470795
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999994039535522

We O 0 6.0725888033630326e-05
conclude O 0 0.00022131568402983248
that O 0 4.902994987787679e-06
paternal O 0 0.0011229290394112468
transmission O 1 0.989847719669342
of O 1 0.9999903440475464
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9426014423370361
rare O 0 0.001508628367446363
and O 0 3.198428385076113e-05
preferentially O 0 3.589072366594337e-05
occurs O 0 9.109834536502603e-06
with O 0 3.585960030250135e-06
onset O 1 0.9884224534034729
of O 0 0.013798439875245094
DM B-Disease 1 1.0
past O 0 0.0032816599123179913
30 O 0 0.000378648896003142
years O 0 6.62373349769041e-05
in O 0 1.5868617992964573e-05
the O 0 5.618335853796452e-05
father O 0 0.00027950337971560657
. O 0 3.647923222160898e-05
. O 0 7.845510117476806e-05

The O 0 0.0025519474875181913
RB1 O 1 0.9999858140945435
gene O 0 9.768903692020103e-05
mutation O 0 7.736973202554509e-06
in O 0 1.0397793630545493e-05
a O 0 5.7192333770217374e-05
child O 0 0.00036069421912543476
with O 0 0.00026215234538540244
ectopic B-Disease 1 0.9999927282333374
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 1 0.750573992729187

The O 0 0.003970230929553509
RB1 O 1 0.9999922513961792
gene O 0 0.00017345481319352984
mutation O 0 1.8390448531135917e-05
was O 0 0.00019072130089625716
investigated O 0 0.00015301442181225866
in O 0 4.135211565881036e-05
a O 0 0.00010194440983468667
child O 0 0.0004502024676185101
with O 0 0.00019784134929068387
ectopic B-Disease 1 0.9993195533752441
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999713897705078
using O 0 0.00019441508629824966
DNA O 0 0.00021685005049221218
obtained O 0 3.273627589805983e-05
from O 0 2.066484375973232e-05
both O 0 1.618656278878916e-05
the O 0 0.00045512974611483514
pineal B-Disease 1 0.9999847412109375
and I-Disease 0 0.0010983491083607078
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.9999343156814575
the O 1 0.9989895224571228
patient O 0 0.009646471589803696
. O 0 0.0003384241717867553

A O 0 0.004359669517725706
nonsense O 0 0.00220324844121933
mutation O 0 3.1986568501451984e-05
in O 0 6.743245467077941e-05
exon O 0 0.0010469395201653242
17 O 0 0.0003826481115538627
( O 0 5.190690353629179e-05
codon O 0 7.301221194211394e-05
556 O 0 0.0002550273493397981
) O 0 1.0679007573344279e-05
of O 0 5.244826024863869e-05
the O 0 0.0007385759963653982
RB1 O 1 0.9999442100524902
gene O 0 0.00010357649443903938
was O 0 0.00011287334200460464
found O 0 2.3255493033502717e-06
to O 0 2.1926105091552017e-06
be O 0 5.152362064109184e-06
present O 0 2.995861359522678e-05
homozygously O 0 0.002296718303114176
in O 0 2.8380767616908997e-05
both O 0 9.26248321775347e-06
the O 0 0.00023861929366830736
retinal B-Disease 1 0.9993230104446411
and I-Disease 0 0.0005156670813448727
the I-Disease 1 0.9357998371124268
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.004710717126727104

The O 0 0.0002242616901639849
same O 0 2.2192212782101706e-05
mutation O 0 1.9725172023754567e-05
was O 0 0.0001361832401016727
present O 0 6.046239286661148e-05
heterozygously O 0 0.002750387880951166
in O 0 2.722798308241181e-05
the O 0 4.089859430678189e-05
DNA O 0 7.323102909140289e-05
from O 0 9.519028026261367e-06
the O 0 2.2075128072174266e-05
constitutional O 0 0.00013611055328510702
cells O 0 5.8003693993669e-05
of O 0 8.034770871745422e-05
the O 0 0.00025391491362825036
patient O 0 0.00013453824794851243
, O 0 1.0882426977332216e-05
proving O 0 0.0003835357492789626
it O 0 1.9286496808490483e-06
to O 0 4.078097845194861e-06
be O 0 4.800713213626295e-06
of O 0 7.227267633425072e-05
germline O 0 0.007003446575254202
origin O 0 0.00019546752446331084
. O 0 0.0003705102135427296

The O 0 0.00017253024270758033
initial O 0 8.889533637557179e-05
mutation O 0 1.8494727555662394e-05
was O 0 7.589208689751104e-05
shown O 0 2.1434663722175173e-05
to O 0 6.300143922999268e-06
have O 0 3.3680271371849813e-06
occurred O 0 0.00015278828504960984
in O 0 1.4446204659179784e-05
the O 0 7.116407505236566e-05
paternally O 0 0.0021325540728867054
derived O 0 0.0004262177972123027
RB1 O 1 0.9994475245475769
allele O 0 0.00024961636518128216
. O 0 0.00012300243542995304

The O 0 0.000540166802238673
mutation O 0 1.9003748093382455e-05
is O 0 3.163718474752386e-06
in O 0 3.060001517951605e-06
an O 0 1.7561778804520145e-06
area O 0 3.731558535946533e-05
of O 0 1.898614027595613e-05
the O 0 3.9327354897977784e-05
gene O 0 7.1441481850342825e-06
that O 0 5.506915385922184e-07
encodes O 0 4.98510462421109e-06
the O 0 1.2212296496727504e-05
protein O 0 4.9651378503767774e-05
- O 0 7.472548168152571e-05
binding O 0 5.6522230806876905e-06
region O 0 9.083426266442984e-05
known O 0 3.8516995118698105e-05
as O 0 1.924624666571617e-05
the O 0 8.604601316619664e-05
pocket O 0 0.0012069253716617823
region O 0 0.00023386586690321565
and O 0 1.302070540987188e-05
has O 0 8.7554080892005e-06
been O 0 1.7565082089276984e-05
detected O 0 6.143786595202982e-05
in O 0 3.971214027842507e-06
other O 0 1.4329342548080604e-06
cases O 0 1.2046297342749313e-05
of O 0 0.00045220443280413747
retinoblastoma B-Disease 1 0.9988914132118225
. O 0 0.00046184001257643104
. O 0 0.0002858412335626781

Low O 0 0.0006059561856091022
levels O 0 0.0001727409689920023
of O 0 0.00012433569645509124
beta O 0 0.001111525110900402
hexosaminidase O 0 0.004676186479628086
A O 0 0.0003151756536681205
in O 0 2.743012191785965e-05
healthy O 0 2.9012358936597593e-05
individuals O 0 6.147195108496817e-07
with O 0 1.856117887655273e-05
apparent O 1 0.9998761415481567
deficiency O 1 1.0
of O 1 0.9989829659461975
this O 0 0.0015952277462929487
enzyme O 0 0.0008065516012720764
. O 0 0.000249664910370484

Appreciable O 0 0.007955971173942089
beta O 0 0.003198776161298156
hexosaminidase O 0 0.01207488588988781
A O 0 0.0014848861610516906
( O 0 8.842695388011634e-05
hex O 0 0.0017044564010575414
A O 0 0.0004409184621181339
) O 0 9.504849913355429e-06
activity O 0 5.953707841399591e-06
has O 0 2.6828618047147756e-06
been O 0 1.707417868601624e-05
detected O 0 0.0003527046355884522
in O 0 0.0002441692631691694
cultured O 0 0.01804897002875805
skin O 1 0.9064564108848572
fibroblasts O 0 0.012368600815534592
and O 0 0.001919688656926155
melanoma B-Disease 1 1.0
tissue O 1 0.999991774559021
from O 0 0.00220537930727005
healthy O 0 0.0005915301735512912
individuals O 0 2.3539228095614817e-06
previously O 0 7.213427306851372e-05
reported O 0 8.655781857669353e-05
as O 0 0.0001733156095724553
having O 0 0.005279320292174816
deficiency B-Disease 1 1.0
of I-Disease 0 0.4806022346019745
hex I-Disease 1 0.9062615633010864
A I-Disease 0 0.0023295662831515074
activity O 0 5.8875506510958076e-05
indistinguishable O 0 5.5375800002366304e-05
from O 0 1.3369124189921422e-06
that O 0 1.0942288497517438e-07
of O 0 4.6182544792827684e-06
patients O 0 3.8338341255439445e-05
with O 0 0.0002463970158714801
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.007973241619765759
TSD B-Disease 1 1.0
) O 0 0.000753864471334964
. O 0 0.00020309614774305373

Identification O 0 0.00016893151041585952
and O 0 6.165095692267641e-05
quantitation O 0 0.014462905935943127
of O 0 0.0028423285111784935
hex O 0 0.019049126654863358
A O 0 0.0019334712997078896
, O 0 1.6101317669381388e-05
amounting O 0 0.0002237555308965966
to O 0 6.837779801571742e-05
3 O 0 0.0005891483742743731
. O 0 0.00016062756185419858

5 O 0 0.0010346506023779511
% O 0 0.0001771068200469017
- O 0 0.0013863734202459455
6 O 0 0.0011400198563933372
. O 0 0.00015172295388765633

9 O 0 0.0005770119605585933
% O 0 1.6037807654356584e-05
of O 0 5.683008930645883e-05
total O 0 0.0004499165224842727
beta O 0 0.0026947343721985817
hexosaminidase O 0 0.0056551070883870125
activity O 0 2.0573446818161756e-05
, O 0 1.2346756648184964e-06
has O 0 2.9785891797473596e-07
been O 0 6.947551014491182e-07
obtained O 0 8.367030204681214e-06
by O 0 2.2100510250311345e-05
cellulose O 0 0.0338699109852314
acetate O 0 0.011237871833145618
gel O 0 0.011144129559397697
electrophoresis O 0 0.0016123149544000626
, O 0 0.00016045889060478657
DEAE O 1 0.999947190284729
- O 0 0.004289543721824884
cellulose O 0 0.007451631128787994
ion O 0 0.001279431744478643
- O 0 0.0009740986279211938
exchange O 0 0.00047382470802403986
chromatography O 0 0.018857071176171303
, O 0 9.101738396566361e-05
radial O 0 0.0023629404604434967
immunodiffusion O 0 0.12194667756557465
, O 0 7.478558836737648e-05
and O 0 5.311026325216517e-05
radioimmunoassay O 0 0.03080626204609871
. O 0 0.0003452439559623599

Previous O 0 0.000333654839778319
family O 0 3.90642489946913e-05
studies O 0 1.2020888789265882e-05
suggested O 0 1.2433425581548363e-05
that O 0 6.422091018976062e-07
these O 0 7.511585522479436e-07
individuals O 0 1.9116323528578505e-06
may O 0 6.129957182565704e-05
be O 0 3.428843047004193e-05
compound O 0 0.00038299482548609376
heterozygotes O 0 0.0005062122945673764
for O 0 9.097410838876385e-06
the O 0 5.1938986871391535e-05
common O 0 8.259476453531533e-05
mutant O 0 0.0018983633490279317
TSD B-Disease 1 0.9999774694442749
gene O 0 0.00012190321285743266
and O 0 7.559197911177762e-06
a O 0 1.856395829236135e-05
rare O 0 0.0001638349931454286
( O 0 4.626135705620982e-05
allelic O 0 0.0004870825505349785
) O 0 3.26976842188742e-05
mutant O 0 0.0001910465507535264
gene O 0 6.122636114014313e-05
. O 0 8.534926018910483e-05

Thus O 0 0.0005541068967431784
, O 0 1.4103316971159074e-05
the O 0 2.5334045858471654e-05
postulated O 0 0.000306805653963238
rate O 0 3.7684570997953415e-05
mutant O 0 0.00012138611054979265
gene O 0 2.210447382822167e-05
appears O 0 2.8779015337931924e-05
to O 0 2.808872977766441e-06
code O 0 1.8716249314820743e-06
for O 0 1.43476802350051e-06
the O 0 1.5677343981224112e-05
expression O 0 1.5150242688832805e-05
of O 0 5.3559368097921833e-05
low O 0 0.00019585463451221585
amounts O 0 8.9749060862232e-05
of O 0 0.00030721366056241095
hex O 0 0.007605459075421095
A O 0 0.0031596499029546976
. O 0 0.00025169551372528076

Heterozygotes O 0 0.006808556616306305
for O 0 4.865784649155103e-05
the O 0 0.0001761340827215463
rare O 0 0.00035159310209564865
mutant O 0 0.0005819036741741002
may O 0 0.0001189231697935611
be O 0 9.19911872188095e-06
indistinguishable O 0 0.00012701869127340615
from O 0 1.5790510587976314e-05
heterozygotes O 0 0.00039998407009989023
for O 0 1.3121901247359347e-05
the O 0 0.0001994588819798082
common O 0 0.000313052732963115
TSD B-Disease 1 0.999997615814209
mutant O 0 0.0034462905023247004
. O 0 0.00040691797039471567

However O 0 0.00016265525482594967
, O 0 7.5842967817152385e-06
direct O 0 1.4155570170260035e-05
visualization O 0 0.0007982691749930382
and O 0 0.00013460278569255024
quantitation O 0 0.019508183002471924
of O 0 0.0033847882878035307
hex O 0 0.019870644435286522
A O 0 0.0007486041868105531
by O 0 5.9521812545426656e-06
the O 0 1.3201819456298836e-05
methods O 0 1.873944711405784e-05
described O 0 9.328076703241095e-05
may O 0 0.00021853648649994284
prevent O 0 0.0005600895965471864
false O 0 0.00022764140157960355
- O 0 0.0007483016815967858
positive O 0 3.9439160900656134e-05
prenatal O 0 0.0013717139372602105
diagnosis O 0 0.002385370433330536
of O 0 0.003609471721574664
TSD B-Disease 1 1.0
in O 0 0.0036753907334059477
fetuses O 0 0.002813621424138546
having O 0 6.0090667830081657e-05
the O 0 8.119409903883934e-05
incomplete O 0 0.0010887660318985581
hex B-Disease 0 0.031291183084249496
A I-Disease 1 0.8918820023536682
deficiency I-Disease 1 1.0
of O 0 0.0019295352976769209
the O 0 0.0016149391885846853
type O 0 0.0011105473386123776
described O 0 0.00020865435362793505
in O 0 4.555051418719813e-05
the O 0 6.113726703915745e-05
four O 0 5.065703226136975e-05
healthy O 0 0.0002230966347269714
individuals O 0 2.7884159862878732e-05

The O 0 0.0017362101934850216
tumor B-Disease 1 0.9999580383300781
suppressor O 0 0.01947697624564171
gene O 0 0.0008825082331895828
Smad4 O 1 0.9826105237007141
/ O 0 0.004872413352131844
Dpc4 O 0 0.010081463493406773
is O 0 1.368012817692943e-05
required O 0 4.341930889495416e-06
for O 0 1.3161291462893132e-05
gastrulation O 0 0.006902883294969797
and O 0 1.723676541587338e-05
later O 0 7.802378240739927e-05
for O 0 1.2005948519799858e-05
anterior O 0 0.00316721317358315
development O 0 0.0003097906883340329
of O 0 0.0007595482748001814
the O 0 0.0026846369728446007
mouse O 0 0.0009596618474461138
embryo O 0 0.0003977257292717695
. O 0 4.4851407437818125e-05

Mutations O 0 0.00013620169193018228
in O 0 5.120038986206055e-05
the O 0 0.0004357237776275724
SMAD4 O 1 1.0
/ O 1 0.9995538592338562
DPC4 O 1 1.0
tumor B-Disease 1 0.9999957084655762
suppressor O 0 0.002847443101927638
gene O 0 2.4372466214117594e-05
, O 0 2.053782736766152e-06
a O 0 7.311857189051807e-06
key O 0 0.00019418151350691915
signal O 0 0.00028924664366059005
transducer O 0 0.00011410606384743005
in O 0 2.2612752218265086e-05
most O 0 4.0585986425867304e-05
TGFbeta O 0 0.03469657897949219
- O 0 0.0013189536985009909
related O 0 0.00016969803255051374
pathways O 0 0.00041324575431644917
, O 0 3.0062528821872547e-06
are O 0 1.8395130041426455e-07
involved O 0 2.5955050659831613e-06
in O 0 1.4039734196558129e-05
50 O 0 8.21186913526617e-05
% O 0 7.914928573882207e-05
of O 0 0.006809007842093706
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.017196184024214745

Homozygous O 0 0.003786827903240919
Smad4 O 0 0.09378843754529953
mutant O 0 0.006953913252800703
mice O 0 0.004707954358309507
die O 0 0.003628278151154518
before O 0 0.00012487059575505555
day O 0 0.00014701232430525124
7 O 0 0.0004524842952378094
. O 0 8.849089499562979e-05

5 O 0 0.001382062560878694
of O 0 0.0009351558983325958
embryogenesis O 0 0.020036203786730766
. O 0 0.0006548163946717978

Mutant O 0 0.0016958450432866812
embryos O 0 8.253697887994349e-05
have O 0 1.904546707010013e-06
reduced O 0 2.0974133803974837e-05
size O 0 2.8042535632266663e-05
, O 0 9.987388693843968e-06
fail O 0 0.0001635460794204846
to O 0 5.186593625694513e-05
gastrulate O 0 0.00903213582932949
or O 0 5.710731784347445e-05
express O 0 6.0032816691091284e-05
a O 0 0.00010393603588454425
mesodermal O 0 0.010806350037455559
marker O 0 0.002840867731720209
, O 0 3.645669494289905e-05
and O 0 1.9616367353592068e-05
show O 0 0.0004964328254573047
abnormal O 0 0.0035678783897310495
visceral O 1 0.8867929577827454
endoderm O 1 0.9998620748519897
development O 0 0.0033810266759246588
. O 0 0.0003599654301069677

Growth B-Disease 1 0.9999990463256836
retardation I-Disease 1 1.0
of O 0 0.011489157564938068
the O 1 0.8464085459709167
Smad4 O 1 0.9999997615814209
- O 0 0.02544104866683483
deficient O 0 0.002362819155678153
embryos O 0 6.669091362709878e-06
results O 0 1.163060460385168e-06
from O 0 5.987627901049564e-06
reduced O 0 0.00019455456640571356
cell O 0 0.000622828840278089
proliferation O 0 0.0014549978077411652
rather O 0 5.162110028322786e-06
than O 0 4.89658850710839e-06
increased O 0 0.00013352233509067446
apoptosis O 0 0.002970658242702484
. O 0 0.00017945608124136925

Aggregation O 0 0.0005205782945267856
of O 0 0.000528610369656235
mutant O 0 0.006519956514239311
Smad4 O 1 0.9993847608566284
ES O 1 0.9973217844963074
cells O 0 0.0001882928190752864
with O 0 7.632344932062551e-06
wild O 0 0.00019538163905963302
- O 0 0.00027061536093242466
type O 0 0.00013853107520844787
tetraploid O 0 0.0016420024912804365
morulae O 0 0.009353507310152054
rescues O 0 0.0016644406132400036
the O 0 0.0003775457735173404
gastrulation B-Disease 1 0.9999366998672485
defect I-Disease 1 0.9985806941986084
. O 0 0.0011155157117173076

These O 0 2.891491021728143e-05
results O 0 3.201097933924757e-05
indicate O 0 5.9443893405841663e-05
that O 0 6.418064458557637e-06
Smad4 O 0 0.002948859939351678
is O 0 5.159609827387612e-06
initially O 0 6.142404799902579e-06
required O 0 7.238938337650325e-07
for O 0 1.4094882772042183e-06
the O 0 1.5767127479193732e-05
differentiation O 0 0.00010215265501756221
of O 0 0.00013352603127714247
the O 0 0.000536625855602324
visceral O 0 0.039808761328458786
endoderm O 0 0.4628078043460846
and O 0 1.5249099305947311e-05
that O 0 2.7813348424388096e-06
the O 0 0.00010724928870331496
gastrulation B-Disease 1 0.9926871061325073
defect I-Disease 0 0.011402228847146034
in O 0 9.031585796037689e-05
the O 0 0.00026741830515675247
epiblast O 1 0.7226981520652771
is O 0 2.011650758504402e-05
secondary O 0 0.0003762775450013578
and O 0 2.0686018615378998e-05
non O 0 0.0009258091449737549
- O 0 0.002556093269959092
cell O 0 0.0004950272268615663
autonomous O 0 0.0005141549627296627
. O 0 0.00014907497097738087

Rescued O 0 0.01667914353311062
embryos O 0 0.0006666674162261188
show O 0 0.0009115629945881665
severe O 1 0.8345128893852234
anterior O 1 0.998633086681366
truncations O 1 0.9993799924850464
, O 0 0.0003639431088231504
indicating O 0 0.0005997648113407195
a O 0 8.76574995345436e-05
second O 0 0.00010524032404646277
important O 0 4.8527956096222624e-05
role O 0 6.307857256615534e-05
for O 0 5.0359325541649014e-05
Smad4 O 1 0.9250071048736572
in O 0 0.0006874618702568114
anterior O 1 0.9804812073707581
patterning O 1 0.7615042328834534
during O 1 0.9987599849700928
embryogenesis O 1 0.9952114224433899
. O 0 0.0008811152074486017

Prevalence O 0 0.004528227727860212
of O 0 0.0010820069583132863
p16 O 0 0.005466598551720381
and O 0 0.0003142467758152634
CDK4 O 1 0.9999985694885254
germline O 0 0.015228914096951485
mutations O 0 0.00020797426986973733
in O 0 0.00025557357002981007
48 O 0 0.007095769979059696
melanoma B-Disease 1 1.0
- O 0 0.03234344348311424
prone O 0 0.001456078258343041
families O 0 7.807409929228015e-06
in O 0 3.4366279578534886e-05
France O 0 0.00043897394789382815
. O 0 0.00019547723059076816

The O 0 0.0004111020243726671
French O 0 0.004694647621363401
Familial B-Disease 1 0.9999997615814209
Melanoma I-Disease 1 1.0
Study O 0 0.0066876597702503204
Group O 0 0.00042310397839173675
. O 0 0.0002245008945465088

Germline O 0 0.0438656359910965
mutations O 0 0.00041515566408634186
in O 0 0.00015082606114447117
the O 0 0.00036675677984021604
p16 O 0 0.0025925522204488516
and O 0 8.970686758402735e-05
CDK4 O 1 0.9982397556304932
genes O 0 7.638785609742627e-05
have O 0 3.7130027976672864e-06
been O 0 5.198445251153316e-06
reported O 0 8.55107373354258e-06
in O 0 3.928640126105165e-06
a O 0 1.5922385500743985e-05
subset O 0 9.460721048526466e-05
of O 0 0.0015038843266665936
melanoma B-Disease 1 1.0
pedigrees O 0 0.016248099505901337
, O 0 6.962654151720926e-05
but O 0 5.508504727913532e-06
their O 0 9.717832654132508e-06
prevalence O 0 0.000499732734169811
is O 0 7.996261956577655e-06
not O 0 2.3536174467153614e-06
well O 0 1.3079173186270054e-05
known O 0 0.00013904349179938436
. O 0 0.00012501976743806154

We O 0 3.853830639855005e-05
searched O 0 4.374283889774233e-05
for O 0 3.3151309253298678e-06
such O 0 8.556196007702965e-06
germline O 0 0.004333843011409044
mutations O 0 0.00010856719018192962
in O 0 9.595497976988554e-05
48 O 0 0.0010634450009092689
French O 1 0.9867141842842102
melanoma B-Disease 1 1.0
- O 1 0.5629391670227051
prone O 0 0.001467526308260858
families O 0 1.8849034404411213e-06
selected O 0 5.620820047624875e-06
according O 0 1.6766856560934684e-06
to O 0 3.7884883568040095e-06
two O 0 4.389552032080246e-06
major O 0 9.171788406092674e-05
criteria O 0 1.3839707207807805e-05
families O 0 2.2103299670561682e-06
with O 0 1.2674130402956507e-06
at O 0 0.00010170012683374807
least O 0 7.381703198916512e-06
three O 0 5.2885284276271705e-06
affected O 0 1.3771376870863605e-05
members O 0 3.6366370750329224e-06
( O 0 1.795810203475412e-05
n O 0 0.00015817266830708832
= O 0 0.0003333108325023204
20 O 0 0.0002060280239675194
) O 0 8.777930815995205e-06
or O 0 3.5408781968726544e-06
families O 0 1.271735641239502e-06
with O 0 1.6919889276323374e-06
two O 0 1.4373069461726118e-05
affected O 0 6.429292989196256e-05
members O 0 7.683863259444479e-06
, O 0 3.940137048630277e-06
one O 0 1.3484249166140216e-06
of O 0 1.2671166587097105e-05
them O 0 7.190272299339995e-06
affected O 0 2.7796839276561514e-05
before O 0 2.98640807159245e-05
the O 0 1.8322753021493554e-05
age O 0 6.0278456658124924e-05
of O 0 5.928023892920464e-05
50 O 0 0.0001206984234158881
( O 0 2.3101352780940942e-05
n O 0 0.0001388174860039726
= O 0 0.00021935462427791208
28 O 0 0.000391385518014431
) O 0 1.2278404028620571e-05
, O 0 2.22397648030892e-06
and O 0 1.0815584801093792e-06
one O 0 1.5328181461882195e-06
additional O 0 1.3391542779572774e-05
minor O 0 0.001728908158838749
criterion O 1 0.9973706007003784
. O 0 0.0011346882674843073

Sixteen O 0 0.002419069642201066
different O 0 4.582233668770641e-05
p16 O 0 0.002965387888252735
germline O 0 0.003907285165041685
mutations O 0 9.906616469379514e-05
were O 0 5.566960680880584e-05
found O 0 1.2960744243173394e-05
in O 0 2.246725489385426e-05
21 O 0 0.00016113811579998583
families O 0 5.743077508668648e-06
, O 0 3.9986516640055925e-06
while O 0 4.675915988627821e-06
one O 0 2.008557021326851e-05
germline O 0 0.0035004415549337864
mutation O 0 6.01780011493247e-05
, O 0 3.545081926858984e-05
Arg24His O 0 0.011020381934940815
, O 0 1.8068922145175748e-05
was O 0 0.0002495435473974794
detected O 0 0.00016306384350173175
in O 0 1.6589543520240113e-05
the O 0 0.0001343988551525399
CDK4 O 1 0.9997089505195618
gene O 0 0.00022829520457889885
. O 0 9.98648683889769e-05

The O 0 0.0001418325409758836
frequency O 0 2.914293872890994e-05
of O 0 8.799383795121685e-05
p16 O 0 0.001114452606998384
gene O 0 4.27782979386393e-05
mutation O 0 3.240721298425342e-06
in O 0 4.366504981589969e-06
our O 0 5.799297923658742e-06
sample O 0 1.9432332010183018e-06
( O 0 5.791609964944655e-06
44 O 0 2.944922016467899e-05
% O 0 2.069501715595834e-05
) O 0 1.0313571692677215e-05
is O 0 2.981941861435189e-06
among O 0 4.086257376911817e-06
the O 0 1.1369993444532156e-05
highest O 0 0.00014147648471407592
rates O 0 7.5247453423799016e-06
yet O 0 3.561645371519262e-06
reported O 0 4.427926342032151e-06
and O 0 2.1756904970970936e-06
the O 0 6.557166489074007e-05
CDK4 O 1 0.9942342638969421
mutation O 0 1.1716266271832865e-05
is O 0 2.8771291908924468e-06
the O 0 1.0119059879798442e-05
second O 0 4.626965164788999e-05
mutation O 0 6.6907064137922134e-06
detected O 0 2.8960444979020394e-05
in O 0 4.2187916733382735e-06
this O 0 3.0938051622797502e-06
gene O 0 2.0116240193601698e-05
worldwide O 0 2.4826580556691624e-05
. O 0 0.000117583702376578

In O 0 0.0003182142390869558
summary O 0 0.00044807465746998787
, O 0 1.2861662071372848e-05
our O 0 8.195133887056727e-06
results O 0 5.9118401622981764e-06
show O 0 1.6123427485581487e-05
frequent O 0 6.632646091020433e-06
involvement O 0 4.555907435133122e-05
of O 0 7.542429375462234e-05
the O 0 0.00021142039622645825
p16 O 0 0.002322802320122719
gene O 0 8.984444139059633e-05
in O 0 0.00018742245447356254
familial B-Disease 1 0.9929684996604919
melanoma I-Disease 1 1.0
and O 0 0.0001892013242468238
confirm O 0 9.646645776228979e-05
the O 0 4.2737927287817e-05
role O 0 5.213509939494543e-05
of O 0 0.00011682695912895724
the O 0 0.00033581527532078326
CDK4 O 1 0.9999819993972778
gene O 0 5.976464308332652e-05
as O 0 4.006774179288186e-05
a O 0 0.00030251278076320887
melanoma B-Disease 1 0.9999992847442627
- O 0 0.010301495902240276
predisposing O 0 0.006278652232140303
gene O 0 0.00011038168304366991
. O 0 4.338369762990624e-05
. O 0 7.791128155076876e-05

Progression O 1 0.9967654943466187
of O 0 0.009977078065276146
somatic O 0 0.2776505947113037
CTG O 1 0.9999892711639404
repeat O 0 0.004635654855519533
length O 0 0.00012295530177652836
heterogeneity O 0 0.00013764675532002002
in O 0 1.0704315172915813e-05
the O 0 5.1138373237336054e-05
blood O 0 0.000951811671257019
cells O 0 0.0018722758395597339
of O 1 0.9997144341468811
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.999996542930603
. O 0 0.004706925246864557

The O 0 4.065501343575306e-05
genetic O 0 5.5811851780163124e-05
basis O 0 0.0001331984531134367
of O 1 0.9994982481002808
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999997615814209
DM B-Disease 1 1.0
) O 0 0.00036500339047051966
is O 0 1.167457321571419e-05
the O 0 1.0915103302977514e-05
expansion O 0 0.00021470464707817882
of O 0 0.00012112467811675742
an O 0 0.00012927001807838678
unstable O 1 0.6713722348213196
CTG O 1 0.9989135265350342
repeat O 0 0.0014163400046527386
in O 0 2.4408518584095873e-05
the O 0 2.3232254534377716e-05
34 O 0 0.00010912538709817454
UTR O 0 0.01544900517910719
of O 0 8.38025807752274e-05
the O 0 0.00029794566216878593
DM B-Disease 1 0.9999997615814209
protein O 0 0.00014870597806293517
kinase O 0 2.9551738407462835e-05
gene O 0 1.3765955372946337e-05
on O 0 8.492077904520556e-05
chromosome O 0 0.0005572736845351756
19 O 0 0.0012212605215609074
. O 0 0.0002450220927130431

One O 0 3.750198447960429e-05
of O 0 4.834587161894888e-05
the O 0 6.418045813916251e-05
principal O 0 0.00016627104196231812
features O 0 2.6956342480843887e-05
of O 0 0.0001258198608411476
the O 0 0.002668056869879365
DM B-Disease 1 1.0
mutation O 0 0.00015077603165991604
is O 0 7.253503099491354e-06
an O 0 2.5701249342091614e-06
extraordinarily O 0 0.00017551997734699398
high O 0 0.0001699407584965229
level O 0 0.0003524122585076839
of O 0 0.0004766705387737602
somatic O 0 0.005359149072319269
mosaicism O 1 0.9969114661216736
, O 0 5.434214472188614e-05
due O 0 0.00022208387963473797
to O 0 2.303935616509989e-05
an O 0 9.424806194147095e-06
extremely O 0 4.076561890542507e-05
high O 0 8.322083886014298e-05
degree O 0 7.81738490331918e-05
of O 0 0.00020300049800425768
somatic O 0 0.001490219496190548
instability O 0 0.0021408135071396828
both O 0 2.493168540240731e-05
within O 0 2.1431780623970553e-05
and O 0 4.1470648284303024e-06
between O 0 0.00011972729407716542
different O 0 3.0000810511410236e-05
tissues O 0 0.0009517971193417907
. O 0 0.00029276093118824065

This O 0 0.00011406363773858175
instability O 0 0.0017435611225664616
appears O 0 0.00010539036884438246
to O 0 4.487376827455591e-06
be O 0 3.131694938929286e-06
biased O 0 6.366989964590175e-06
towards O 0 2.2926347810425796e-05
further O 0 1.4028344594407827e-05
expansion O 0 0.0001970607991097495
and O 0 3.2205286970565794e-06
continuous O 0 6.758141535101458e-05
throughout O 0 1.4059444765734952e-05
the O 0 2.7282176233711652e-05
life O 0 2.7286805561743677e-05
of O 0 2.514452535251621e-05
an O 0 1.3702926480618771e-05
individual O 0 1.44573959914851e-05
, O 0 1.0678824764909223e-05
features O 0 2.481034243828617e-05
that O 0 2.0773538835783256e-06
could O 0 3.3517910651426064e-06
be O 0 1.6021050441850093e-06
associated O 0 1.5907049828456366e-06
with O 0 1.2373288882372435e-06
the O 0 9.435341053176671e-05
progressive O 0 0.0014791960129514337
nature O 0 0.00024966849014163017
of O 0 0.0009816900128498673
the O 1 0.9656959772109985
disease O 1 1.0
. O 0 0.001567317172884941

Although O 0 7.777307473588735e-05
increasing O 0 5.896529910387471e-05
measured O 0 4.2780666262842715e-05
allele O 0 1.3395781934377737e-05
size O 0 1.785455060598906e-05
between O 0 0.00019340468861628324
patients O 0 5.3924315579934046e-05
clearly O 0 6.216562906047329e-05
correlates O 0 8.334513404406607e-05
with O 0 4.86470071336953e-06
an O 0 6.600012511626119e-06
increased O 0 0.00013132698950357735
severity O 0 0.002263386035338044
of O 0 0.0012170607224106789
symptoms O 1 0.9463776350021362
and O 0 5.222446998232044e-05
an O 0 1.4151346476865001e-05
earlier O 0 0.00011971188359893858
age O 0 0.00032899927464313805
of O 0 0.0005340719362720847
onset O 1 0.999981164932251
, O 0 5.8469413488637656e-05
this O 0 5.108356617711252e-06
correlation O 0 1.3366624443733599e-05
is O 0 2.785563538054703e-06
not O 0 1.0882340575335547e-06
precise O 0 8.697172233951278e-06
and O 0 3.7229945064609637e-06
measured O 0 2.4853963623172604e-05
allele O 0 6.217998816282488e-06
length O 0 2.6313738999306224e-05
cannot O 0 9.780384971236344e-06
be O 0 1.675672251622018e-06
used O 0 2.1570883745880565e-06
as O 0 5.2422310545807704e-06
an O 0 1.7870485180537798e-06
accurate O 0 3.4334108931943774e-05
predictor O 0 0.0007133189938031137
of O 0 0.00025901474873535335
age O 0 0.0025801602751016617
of O 0 0.00592083903029561
onset O 1 1.0
. O 0 0.008562139235436916

In O 0 0.00010016500891651958
order O 0 8.61549506225856e-06
to O 0 4.01213173972792e-06
further O 0 9.521026186121162e-06
characterize O 0 8.069069008342922e-05
the O 0 5.174889520276338e-05
dynamics O 0 0.0013338194694370031
of O 0 0.007679706439375877
DM B-Disease 1 1.0
CTG O 1 1.0
repeat O 0 0.030140990391373634
somatic O 0 0.0017181031871587038
instability O 0 0.002313091419637203
, O 0 1.147362490883097e-05
we O 0 2.7495109407027485e-06
have O 0 7.317664199035789e-07
studied O 0 6.290275632636622e-05
repeat O 0 0.00035488486173562706
length O 0 2.1783147531095892e-05
changes O 0 3.079786665693973e-06
over O 0 9.722263712319545e-06
time O 0 3.943009869544767e-05
in O 0 0.0002346932451473549
111 O 1 0.9999722242355347
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0012716333149001002
with O 0 2.7575975764193572e-05
varying O 0 0.00020965746080037206
clinical O 0 0.009416049346327782
severity O 1 0.9997557997703552
and O 0 0.0021706849802285433
CTG O 1 0.9999675750732422
repeat O 0 0.0015314040938392282
size O 0 1.8376405932940543e-05
over O 0 9.03272029972868e-06
time O 0 8.569695637561381e-06
intervals O 0 9.935852176568005e-06
of O 0 3.918184665963054e-05
1 O 0 0.0007314190152101219
- O 0 0.000713044370058924
7 O 0 0.00036453671054914594
years O 0 0.0002018711675191298
. O 0 6.076932913856581e-05

We O 0 6.791161285946146e-05
have O 0 3.4231768495374126e-06
found O 0 2.9731336326221935e-06
a O 0 5.409874574979767e-06
direct O 0 2.9642393201356754e-05
progression O 0 0.004837724845856428
of O 0 0.00029878909117542207
the O 0 0.00021591564291156828
size O 0 6.43206512904726e-05
heterogeneity O 0 0.00013362296158447862
over O 0 1.9511309801600873e-05
time O 0 1.3087644219922367e-05
related O 0 1.660117595747579e-05
to O 0 2.0105500880163163e-05
initial O 0 0.0004012289282400161
CTG O 1 0.9879946112632751
repeat O 0 0.0011026920983567834
size O 0 3.026772174052894e-05
and O 0 2.2918325157661457e-06
the O 0 1.0458256838319357e-05
time O 0 8.067280759860296e-06
interval O 0 2.568670424807351e-05
and O 0 3.7762172269140137e-06
always O 0 9.280184713134076e-06
biased O 0 8.629877811472397e-06
towards O 0 4.047983748023398e-05
further O 0 3.254003604524769e-05
expansion O 0 0.0015509238000959158
. O 0 0.0002127122279489413

Attempts O 0 0.0002436847862554714
to O 0 1.2932669051224366e-05
mathematically O 0 3.960144749726169e-05
model O 0 4.554228326014709e-06
the O 0 1.7392276276950724e-05
dynamics O 0 0.00026763713685795665
have O 0 8.199801413866226e-06
proved O 0 0.0005901510594412684
only O 0 1.970578705368098e-05
partially O 0 0.00040456847636960447
successful O 0 3.5044333344558254e-05
suggesting O 0 1.3914120245317463e-05
that O 0 2.907740110913437e-07
individual O 0 2.4983208390949585e-07
specific O 0 1.8297621409146814e-06
genetic O 0 0.00025153186288662255
and O 0 0.00022493692813441157
/ O 0 0.02299722470343113
or O 0 0.0001232551148859784
environmental O 0 0.00020390001009218395
factors O 0 2.3091924958862364e-05
also O 0 8.07913784228731e-06
play O 0 2.6304629500373267e-05
a O 0 1.0782819117594045e-05
role O 0 4.886999158770777e-05
in O 0 0.0001479247584939003
somatic O 0 0.0039554559625685215
mosaicism O 1 0.9982561469078064
. O 0 0.00027619421598501503
. O 0 0.00014801816723775119

Aspartylglucosaminuria B-Disease 1 0.9999797344207764
among O 0 0.00028811319498345256
Palestinian O 0 0.0007394914864562452
Arabs O 0 0.003312012879177928
. O 0 0.0004941216320730746

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9946867227554321
AGU B-Disease 1 1.0
) O 0 0.00013602402759715915
is O 0 7.359876690316014e-06
a O 0 2.0870740627287887e-05
rare O 0 0.0006942518521100283
disorder B-Disease 1 1.0
of I-Disease 1 0.9999988079071045
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999982118606567
caused O 1 0.9735016226768494
by O 0 7.573218317702413e-05
the O 0 0.0006432348745875061
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.0003679201763588935
the I-Disease 0 0.0011103346478193998
lysosomal I-Disease 1 0.9999793767929077
enzyme I-Disease 0 0.001125409035012126
aspartylglucosaminidase I-Disease 1 0.8245065808296204
( O 0 0.0006349554751068354
AGA O 1 0.9992960691452026
) O 0 0.00014801787619944662
. O 0 0.00013090617721900344

AGU B-Disease 1 1.0
is O 0 0.00043862953316420317
inherited O 1 0.996086597442627
as O 0 0.0002767899713944644
an O 0 0.00016458169557154179
autosomal O 1 0.9999741315841675
recessive O 1 0.9999713897705078
trait O 1 0.9995477795600891
and O 0 0.0011402620002627373
occurs O 0 0.0003072734107263386
with O 0 2.030586256296374e-05
a O 0 6.272539030760527e-05
high O 0 0.00025863421615213156
frequency O 0 1.7009753719321452e-05
in O 0 1.0873649443965405e-05
Finland O 0 5.842800601385534e-05
because O 0 1.7090250139517593e-06
of O 0 1.3373763977142517e-05
a O 0 5.0602709961822256e-05
founder O 0 0.0010999558726325631
effect O 0 0.00024422910064458847
. O 0 0.00011111755156889558

While O 0 0.00011010751040885225
very O 0 1.7237949577975087e-05
few O 0 4.204496508464217e-05
patients O 0 7.321440352825448e-05
with O 0 7.396478031296283e-05
AGU B-Disease 1 1.0
have O 0 1.4639772416558117e-05
been O 0 1.1400578841858078e-05
reported O 0 1.6412039258284494e-05
from O 0 2.929192123701796e-05
non O 0 0.0005050442414358258
- O 0 0.0007116608321666718
Finnish O 0 0.002549998927861452
origin O 0 7.34788627596572e-05
, O 0 3.067041689064354e-05
we O 0 7.080774230416864e-05
diagnosed O 1 0.9998992681503296
the O 0 0.0006992006092332304
disorder O 1 1.0
in O 0 0.005154001526534557
8 O 0 0.011709087528288364
patients O 0 0.00015626550884917378
originating O 0 0.00014778110198676586
from O 0 8.278905443148687e-05
3 O 0 0.000373043236322701
unrelated O 0 8.607826748630032e-05
families O 0 2.514172820156091e-06
, O 0 1.2788858612111653e-06
all O 0 1.5234184047585586e-06
Palestinian O 0 5.684813731932081e-05
Arabs O 0 0.00018473222735337913
from O 0 2.2014770365785807e-05
the O 0 4.829882527701557e-05
region O 0 0.0002992532099597156
of O 0 0.0003058203437831253
Jerusalem O 0 0.03083052858710289
. O 0 0.0006244738469831645

The O 0 0.00028623719117604196
clinical O 0 0.0016352501697838306
diagnosis O 1 0.9997631907463074
of O 1 0.9999865293502808
AGU B-Disease 1 1.0
is O 0 0.0007089930586516857
often O 0 4.201646879664622e-05
difficult O 0 5.835922638652846e-05
, O 0 2.9131101655366365e-06
in O 0 3.5598254726210143e-06
particular O 0 4.055347289977362e-06
early O 0 7.399237074423581e-05
in O 0 1.269935273739975e-05
the O 0 1.6355728803318925e-05
course O 0 5.7161523727700114e-05
of O 0 6.656203913735226e-05
the O 0 0.000725495396181941
disease O 1 0.9999947547912598
, O 0 2.4113785912049934e-05
and O 0 3.431086270211381e-06
most O 0 5.6088897508743685e-06
of O 0 7.506208203267306e-05
the O 0 0.0002842888352461159
patients O 0 0.00014169547648634762
are O 0 1.7135689631686546e-05
diagnosed O 1 0.9795324206352234
after O 0 0.00041846741805784404
the O 0 0.00016550735745113343
age O 0 0.0003860093420371413
of O 0 0.00043526897206902504
5 O 0 0.0013353957328945398
years O 0 0.0009006461477838457
. O 0 0.00019415612041484565

However O 0 0.00021504370670299977
, O 0 1.7257227227673866e-05
since O 0 6.60783625789918e-05
these O 0 1.0847094927157741e-05
patients O 0 9.301101817982271e-05
excrete O 0 0.002846500836312771
early O 0 0.0001664306182647124
large O 0 2.271619814564474e-05
amounts O 0 2.0578472685883753e-05
of O 0 0.0001612875348655507
aspartylglucosamine O 0 0.021781427785754204
in O 0 0.00013758968270849437
urine O 0 0.00027040980057790875
, O 0 9.302195394411683e-06
biochemical O 0 7.038618059596047e-05
screening O 0 3.24568864016328e-05
is O 0 9.921005585056264e-06
easy O 0 2.512949868105352e-05
by O 0 2.1186380763538182e-05
urine O 0 0.001309872604906559
chromatography O 0 0.059657856822013855
. O 0 0.00038616740494035184
. O 0 0.0002530665951780975

Detection O 0 0.0005619570729322731
of O 0 0.00011350746353855357
heterozygous O 0 1.3724452401220333e-05
carriers O 0 8.81667438079603e-06
of O 0 3.893315079039894e-05
the O 0 0.0018131789984181523
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.0007301967125386
ATM O 0 0.00576569139957428
) O 0 1.8960789020638913e-05
gene O 0 6.109007244958775e-06
by O 0 5.556882570090238e-06
G2 O 1 0.9039283394813538
phase O 0 0.004111540038138628
chromosomal O 0 0.006338230799883604
radiosensitivity O 1 0.9894846081733704
of O 0 0.012457194738090038
peripheral O 1 1.0
blood O 1 0.9999978542327881
lymphocytes O 1 0.8388036489486694
. O 0 0.0008073358330875635

In O 0 0.004424114245921373
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 1.0
( O 0 0.0027194791473448277
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
) O 0 8.6298277892638e-05
patients O 0 2.8537038815557025e-05
, O 0 6.057878181309206e-06
mutations O 0 9.20491038414184e-06
in O 0 1.4183772691467311e-05
a O 0 2.5926430680556223e-05
single O 0 2.979509736178443e-05
gene O 0 2.8875672796857543e-05
, O 0 1.3429422324406914e-05
ATM O 0 0.0013618654338642955
, O 0 5.0085022849089e-06
result O 0 6.506630143121583e-06
in O 0 4.1702827729750425e-05
an O 0 0.0005178861320018768
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.9988597631454468
embraces O 0 0.011219893582165241
a O 0 7.016047311481088e-05
variety O 0 3.053197360713966e-05
of O 0 0.0001524527178844437
clinical O 0 0.0008083723951131105
features O 0 0.00044202792923897505
and O 0 7.36879010219127e-05
manifests O 0 0.0018594568828120828
extreme O 0 0.0017100037075579166
radiosensitivity O 1 0.7296810150146484
and O 0 4.442000135895796e-05
a O 0 4.211458872305229e-05
strong O 0 6.278044020291418e-05
pre O 0 0.004705836530774832
- O 0 0.0018828309839591384
disposition O 0 0.0012616753811016679
to O 0 0.0003903777396772057
malignancy B-Disease 1 0.9999822378158569
. O 0 0.0006271728198044002

Heterozygotes O 0 0.006755305919796228
for O 0 9.17147335712798e-05
the O 0 0.0003794062649831176
ATM O 0 0.013266724534332752
gene O 0 3.578269388526678e-05
have O 0 1.3065769053355325e-06
no O 0 2.7423357096267864e-06
clinical O 0 2.962558028229978e-05
expression O 0 5.5023643653839827e-05
of O 0 0.0007963484968058765
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999998807907104
but O 0 2.6196161343250424e-05
may O 0 8.162012818502262e-05
be O 0 5.755102029070258e-05
cancer B-Disease 0 0.0283048152923584
prone O 0 0.0008982862927950919
with O 0 5.364448043110315e-06
a O 0 4.285306204110384e-05
moderate O 0 7.944252865854651e-05
increase O 0 2.303882865817286e-05
in O 0 4.7784793423488736e-05
in O 0 6.29080313956365e-05
vitro O 0 0.000402006262447685
radiosensitivity O 0 0.01254026684910059
. O 0 0.00019266805611550808

We O 0 0.00013734286767430604
performed O 0 0.000506154028698802
a O 0 0.0001438743929611519
blind O 0 0.0021294683683663607
chromosomal O 0 0.0005775550380349159
analysis O 0 5.522713763639331e-05
on O 0 0.0010334374383091927
G2 O 1 0.9999357461929321
- O 0 0.0008489907486364245
phase O 0 0.00046886567724868655
lymphocytes O 0 7.242542051244527e-05
from O 0 7.88423767517088e-06
7 O 0 0.00022596269263885915
unrelated O 0 0.0002735088055487722
A B-Disease 1 0.9999223947525024
- I-Disease 1 0.9999648332595825
T I-Disease 1 0.9999998807907104
patients O 0 9.512864926364273e-05
, O 0 6.966188720980426e-06
13 O 0 0.00015578883176203817
obligate O 0 0.00040879688458517194
A B-Disease 1 0.9999974966049194
- I-Disease 1 0.9999934434890747
T I-Disease 1 0.9999997615814209
heterozygotes O 0 0.0029858523048460484
( O 0 2.8429501981008798e-05
parents O 0 1.8890982573793735e-06
of O 0 1.7464994016336277e-05
the O 0 0.00018776179058477283
patients O 0 0.00018721315427683294
) O 0 2.8468404707382433e-05
, O 0 5.4152324082679115e-06
and O 0 4.978942342859227e-06
14 O 0 0.00011891852773260325
normal O 0 4.89463891426567e-05
controls O 0 2.1873243895242922e-05
following O 0 7.885682862251997e-05
X O 0 0.004430011846125126
- O 0 0.0004281876317691058
irradiation O 0 7.323025783989578e-05
with O 0 4.175451522314688e-06
1 O 0 0.00025364538305439055
Gy O 0 0.0059149921871721745
in O 0 7.902952347649261e-06
order O 0 2.504260919522494e-06
to O 0 3.985940111306263e-06
evaluate O 0 4.2448366002645344e-05
this O 0 8.212471584556624e-06
cytogenetic O 0 0.001352789462544024
method O 0 1.5445482858922333e-05
as O 0 1.2535110727185383e-05
a O 0 1.2203262485854793e-05
tool O 0 6.45579639240168e-05
for O 0 9.646467333368491e-06
detection O 0 0.00017393477901350707
of O 0 0.0008068060269579291
ATM O 1 0.744208812713623
carriers O 0 0.0004990158486180007
. O 0 0.0001778828154783696

Both O 0 0.0007759505533613265
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
homozygotes O 0 0.01064104400575161
and O 0 2.501761628082022e-05
heterozygotes O 0 0.0004287602787371725
showed O 0 6.446384213631973e-05
significantly O 0 3.241568265366368e-05
increased O 0 2.0662639144575223e-05
levels O 0 0.00023745930229779333
of O 0 0.0006220235954970121
radiation O 1 0.9999879598617554
- O 0 0.09531030058860779
induced O 0 0.040403615683317184
chromatid O 0 0.03557472676038742
damage O 0 0.0015470631187781692
relative O 0 9.259569924324751e-05
to O 0 1.7158010450657457e-05
that O 0 2.7852793209603988e-06
of O 0 6.619717896683142e-05
normal O 0 0.00032431090949103236
controls O 0 0.00024382468836847693
. O 0 0.0001554257469251752

These O 0 1.1135883141832892e-05
results O 0 6.785784989915555e-06
show O 0 2.2640439055976458e-05
that O 0 2.1026248759881128e-06
the O 0 9.912475070450455e-05
G2 O 1 0.9997511506080627
- O 0 0.0017560614505782723
phase O 0 0.004024331457912922
chromosomal O 0 0.005347586236894131
radiosensitivity O 0 0.007885207422077656
assay O 0 5.7622029999038205e-05
can O 0 1.923042646012618e-06
be O 0 1.0092404636452557e-06
used O 0 9.475006663706154e-07
for O 0 5.993518357172434e-07
the O 0 1.1911030014744028e-05
detection O 0 7.257351535372436e-05
of O 0 0.0003407928452361375
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999969005584717
T I-Disease 1 0.9999997615814209
heterozygotes O 0 0.008813174441456795
. O 0 0.00028936302987858653

In O 0 0.00011750456178560853
combination O 0 3.847881453111768e-05
with O 0 8.538263500668108e-06
molecular O 0 0.0002507359895389527
genetic O 0 0.0003091145190410316
analyses O 0 8.102308493107557e-05
, O 0 9.96835751720937e-06
this O 0 2.3233460524352267e-06
test O 0 6.090422175475396e-06
may O 0 1.379744389851112e-05
be O 0 1.1275242286501452e-06
of O 0 3.7399693155748537e-06
value O 0 9.4652323241462e-06
in O 0 8.463058293273207e-06
studies O 0 8.10313576948829e-06
of O 0 5.9085581597173586e-05
familial B-Disease 0 0.005356714595109224
and I-Disease 0 0.000408255000365898
sporadic I-Disease 1 0.9998788833618164
cancers I-Disease 1 0.9999991655349731
aimed O 0 0.0020998448599129915
at O 0 0.00040583868394605815
determination O 0 4.985896157450043e-05
of O 0 2.8996815672144294e-05
the O 0 3.3647487725829706e-05
potential O 0 4.7256678953999653e-05
involvement O 0 0.0001049511120072566
of O 0 0.0003933882398996502
ATM O 1 0.9443946480751038
mutations O 0 0.0006649819551967084
in O 0 0.0010506040416657925
tumor B-Disease 1 0.9999991655349731
risk O 0 0.0007827589870430529
or O 0 8.019912638701499e-05
development O 0 0.00040022097527980804
. O 0 5.016070281271823e-05
. O 0 7.985083357198164e-05

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999991655349731
: O 0 0.00012075933773303404
identification O 0 2.4084274627966806e-05
and O 0 1.1935433576582e-05
detection O 0 0.00018760359671432525
of O 0 0.0009411670034751296
founder O 1 0.876612663269043
- O 0 0.0014729229733347893
effect O 0 5.2895851695211604e-05
mutations O 0 1.1060787983296905e-05
in O 0 1.0682389984140173e-05
the O 0 6.285688141360879e-05
ATM O 0 0.0015251203440129757
gene O 0 1.2088071343896445e-05
in O 0 8.086260095296893e-06
ethnic O 0 3.2260715670417994e-05
populations O 0 3.722417386597954e-05
. O 0 8.321472705574706e-05

To O 0 4.898888437310234e-05
facilitate O 0 8.1548401794862e-05
the O 0 2.5493520297459327e-05
evaluation O 0 3.578156611183658e-05
of O 0 0.0004972047172486782
ATM O 0 0.03991079702973366
heterozygotes O 0 0.0021240191999822855
for O 0 4.900247949990444e-05
susceptibility O 0 0.0006973764975555241
to O 0 0.00012692158634308726
other O 0 0.0001484702224843204
diseases O 1 0.9999990463256836
, O 0 1.7559772459208034e-05
such O 0 1.832376619859133e-05
as O 0 0.10687365382909775
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 4.386021464597434e-05
we O 0 9.67482446867507e-06
have O 0 1.3210546967457049e-06
attempted O 0 4.988944419892505e-05
to O 0 1.1182398338860366e-05
define O 0 4.4411190174287185e-05
the O 0 6.1595652368851e-05
most O 0 1.5428202459588647e-05
common O 0 9.08575839275727e-06
mutations O 0 1.1396263289498165e-05
and O 0 3.1661149932915578e-06
their O 0 5.334491106623318e-06
frequencies O 0 4.8578003770671785e-05
in O 0 0.0004098945646546781
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999738931655884
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.001470291754230857
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9998986721038818
T I-Disease 1 0.9999922513961792
) O 0 7.177110092015937e-05
homozygotes O 0 0.0010869508842006326
from O 0 2.646635221026372e-05
10 O 0 3.5375171137275174e-05
ethnic O 0 4.8277823225362226e-05
populations O 0 3.1448842491954565e-05
. O 0 8.045926369959489e-05

Both O 0 8.833366155158728e-05
genomic O 0 0.00025091346469707787
mutations O 0 5.779878847533837e-05
and O 0 9.986874829337467e-06
their O 0 8.031232937355526e-06
effects O 0 0.0003208588168490678
on O 0 0.00030761928064748645
cDNA O 0 0.0004964062827639282
were O 0 5.107307151774876e-05
characterized O 0 0.0002630907983984798
. O 0 0.00011880959937116131

Protein O 0 0.0016072156140580773
- O 0 0.0005565824685618281
truncation O 0 0.00029345988878048956
testing O 0 1.3233205208962318e-05
of O 0 3.573812136892229e-05
the O 0 6.244060205062851e-05
entire O 0 0.0005580148426815867
ATM O 0 0.0025288648903369904
cDNA O 0 0.00022312258079182357
detected O 0 5.572554073296487e-05
92 O 0 9.676109038991854e-05
( O 0 1.2486896594054997e-05
66 O 0 0.00012655962200369686
% O 0 3.312158150947653e-05
) O 0 4.5969438360771164e-05
truncating O 0 0.0009221002692356706
mutations O 0 2.3508726371801458e-05
in O 0 1.8830289263860323e-05
140 O 0 6.484153709607199e-05
mutant O 0 0.00010180462413700297
alleles O 0 1.758789221639745e-05
screened O 0 0.0004677164542954415
. O 0 0.00010122700041392818

The O 0 0.001092387712560594
haplotyping O 0 0.019202962517738342
of O 0 0.000612183939665556
patients O 0 0.0001626495213713497
with O 0 2.057340861938428e-05
identical O 0 0.00010952978482237086
mutations O 0 6.615060556214303e-05
indicates O 0 0.00010166035644942895
that O 0 2.741870275713154e-06
almost O 0 6.620967269554967e-06
all O 0 1.640873620090133e-06
of O 0 1.0528518942010123e-05
these O 0 4.035105575894704e-06
represent O 0 1.86363668035483e-05
common O 0 2.767957266769372e-05
ancestry O 0 5.126967516844161e-05
and O 0 1.2694958968495484e-05
that O 0 6.671088613074971e-06
very O 0 2.2904274374013767e-05
few O 0 0.00011987910693278536
spontaneously O 0 0.0020608471240848303
recurring O 0 0.0058058807626366615
ATM O 1 0.5587842464447021
mutations O 0 0.0005396290798671544
exist O 0 0.0006194081506691873
. O 0 0.00040096716838888824

Assays O 0 0.0001344021875411272
requiring O 0 2.4341246898984537e-05
minimal O 0 9.01672538020648e-05
amounts O 0 5.190651063458063e-05
of O 0 0.00010206542356172577
genomic O 0 0.00017696822760626674
DNA O 0 0.00023627342307008803
were O 0 2.0058580048498698e-05
designed O 0 3.0166953365551308e-05
to O 0 6.79564709571423e-06
allow O 0 5.335844434739556e-06
rapid O 0 0.0001770841918187216
screening O 0 1.004760451905895e-05
for O 0 2.747073494901997e-06
common O 0 9.353255336463917e-06
ethnic O 0 0.00015130139945540577
mutations O 0 0.0004666269232984632
. O 0 0.0004714028036687523

These O 0 6.3341147324536e-05
rapid O 0 0.0013844839995726943
assays O 0 9.593357390258461e-05
detected O 0 0.0002558026753831655
mutations O 0 1.2081859495083336e-05
in O 0 8.523149517714046e-06
76 O 0 0.00013641591067425907
% O 0 1.1665736565191764e-05
of O 0 0.0001123864931287244
Costa O 0 0.0006829739431850612
Rican O 0 0.000834393547847867
patients O 0 0.00011543147411430255
( O 0 4.188680759398267e-05
3 O 0 0.0002356295590288937
) O 0 1.5481748050660826e-05
, O 0 2.2805995740782237e-06
50 O 0 6.365259650920052e-06
% O 0 3.0889436857250985e-06
of O 0 4.773269029101357e-05
Norwegian O 0 0.0013756380649283528
patients O 0 0.00018692795129027218
( O 0 5.715084989788011e-05
1 O 0 0.00032006719266064465
) O 0 1.643630093894899e-05
, O 0 2.8653876142925583e-06
25 O 0 2.3668530047871172e-05
% O 0 7.566201020381413e-06
of O 0 0.0001534966577310115
Polish O 1 0.9995230436325073
patients O 0 0.0019832008983939886
( O 0 0.00026079118833877146
4 O 0 0.0007706580800004303
) O 0 2.245797986688558e-05
, O 0 3.038169779756572e-06
and O 0 2.1528012439375743e-06
14 O 0 4.265788084012456e-05
% O 0 9.498262443230487e-06
of O 0 7.562666723970324e-05
Italian O 0 0.0032363939099013805
patients O 0 0.0006407244363799691
( O 0 0.00017811005818657577
1 O 0 0.0009913321118801832
) O 0 1.9790100850514136e-05
, O 0 2.2581975827051792e-06
as O 0 3.6212679788150126e-06
well O 0 1.7117213246820029e-06
as O 0 5.491138381330529e-06
in O 0 1.955734296643641e-05
patients O 0 4.575429920805618e-05
of O 0 0.00040754632209427655
Amish O 0 0.007054145913571119
/ O 0 0.0036135041154921055
Mennonite O 0 0.0017642570892348886
and O 0 2.1532780010602437e-05
Irish O 0 0.0004238202527631074
English O 0 0.00030900727142579854
backgrounds O 0 0.0002938954858109355
. O 0 0.0003037039132323116

Additional O 0 9.055231930688024e-05
mutations O 0 6.395720993168652e-05
were O 0 2.120833596563898e-05
observed O 0 2.502921415725723e-05
in O 0 2.4074835891951807e-05
Japanese O 0 0.0006818017573095858
, O 0 2.504760050214827e-05
Utah O 0 0.0008351402939297259
Mormon O 0 0.00027755528572015464
, O 0 3.930975253751967e-06
and O 0 2.715633399930084e-06
African O 0 5.2772411436308175e-05
American O 0 0.00011226224160054699
patients O 0 0.00023895781487226486
. O 0 0.00026665860787034035

These O 0 1.572481050970964e-05
assays O 0 9.870413123280741e-06
should O 0 1.878436023616814e-06
facilitate O 0 1.3030817171966191e-05
screening O 0 9.759644854057115e-06
for O 0 2.140449214493856e-05
A B-Disease 1 0.9998034834861755
- I-Disease 1 0.9972363710403442
T I-Disease 1 0.999914288520813
heterozygotes O 0 0.001379896653816104
in O 0 1.487736062699696e-05
the O 0 1.5021710169094149e-05
populations O 0 5.113085080665769e-06
studied O 0 9.357174712931737e-05
. O 0 1.7882106476463377e-05
. O 0 6.01133651798591e-05

The O 0 0.0006000528810545802
von B-Disease 1 0.9998857975006104
Hippel I-Disease 1 0.9999998807907104
- I-Disease 1 0.999987006187439
Lindau I-Disease 1 1.0
tumor I-Disease 1 0.9999963045120239
suppressor O 0 0.003940623719245195
gene O 0 1.2251981388544664e-05
is O 0 9.950472303899005e-07
required O 0 2.8699193990178173e-06
for O 0 9.853098163148388e-06
cell O 0 0.0003244284598622471
cycle O 0 0.00016484555089846253
exit O 0 0.0002972176589537412
upon O 0 0.00016643253911752254
serum O 0 0.0017560229171067476
withdrawal O 0 0.0012190069537609816
. O 0 0.00031585883698426187

The O 0 0.00012894673272967339
inactivation O 0 0.0017629325157031417
of O 0 0.00013156249769963324
the O 0 0.0002350963477510959
von B-Disease 1 0.9999538660049438
Hippel I-Disease 1 0.9999995231628418
- I-Disease 1 0.99981290102005
Lindau I-Disease 1 0.9999997615814209
( I-Disease 0 0.0021590280812233686
VHL I-Disease 1 1.0
) I-Disease 0 0.0017958173993974924
tumor I-Disease 1 0.999990701675415
suppressor O 0 0.017431944608688354
gene O 0 0.00021609193936455995
predisposes O 0 0.001499132253229618
affected O 0 2.9267850550240837e-05
individuals O 0 9.010462918013218e-07
to O 0 9.65820345300017e-06
the O 0 0.0003877455019392073
human O 1 0.9999992847442627
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.0001386357325827703
is O 0 1.8071265003527515e-05
associated O 0 9.291971764469054e-06
with O 0 1.1937072486034594e-05
sporadic B-Disease 1 0.9999994039535522
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999997615814209
RCC B-Disease 1 1.0
) O 0 0.0028943936340510845
and O 0 0.0005481384578160942
brain B-Disease 1 0.9999982118606567
hemangioblastomas I-Disease 1 0.9999889135360718
. O 0 0.000978183699771762

VHL O 1 0.9999874830245972
- O 0 0.003373529762029648
negative O 0 0.00015664368402212858
786 O 0 0.010351769626140594
- O 0 0.003128182142972946
0 O 0 0.0011700449977070093
RCC B-Disease 1 0.9999996423721313
cells O 0 0.00022561651712749153
are O 0 8.441108548140619e-06
tumorigenic O 0 0.004609572701156139
in O 0 0.00019830517703667283
nude O 0 0.0037591620348393917
mice O 0 0.00022560749494004995
which O 0 3.5032858249905985e-06
is O 0 4.8597066779620945e-06
suppressed O 0 0.00017243123147636652
by O 0 1.6975795915641356e-06
the O 0 2.4194334400817752e-05
reintroduction O 0 0.0007964691612869501
of O 0 0.0006212078151293099
VHL B-Disease 1 0.9999997615814209
. O 0 0.0009300981182605028

Remarkably O 0 0.0048394282348454
, O 0 2.2533105948241428e-05
this O 0 4.959596935805166e-06
occurs O 0 1.7436219422961585e-05
without O 0 6.298888365563471e-06
affecting O 0 3.532322443788871e-05
the O 0 3.099954847129993e-05
growth O 0 0.00010461268539074808
rate O 0 3.622747681220062e-05
and O 0 1.206767228723038e-05
cell O 0 0.0001943414972629398
cycle O 0 0.00010650734475348145
profile O 0 2.303065593878273e-05
of O 0 4.6555484004784375e-05
these O 0 3.688107608468272e-05
cells O 0 9.660205978434533e-05
in O 0 3.45168991771061e-05
culture O 0 0.00021395077055785805
. O 0 7.231390191009268e-05

The O 0 0.0007964979740791023
786 O 0 0.012209444306790829
- O 0 0.0011225620983168483
0 O 0 0.00011154782987432554
cell O 0 0.0002725779195316136
line O 0 0.00016606031567789614
, O 0 7.760466360196006e-06
like O 0 7.110278602340259e-06
many O 0 2.8778191335732117e-05
cancer B-Disease 1 0.9998063445091248
cells O 0 0.00030010490445420146
, O 0 1.1921030818484724e-05
fails O 0 5.483752829604782e-05
to O 0 6.685941571049625e-06
exit O 0 0.00020154651429038495
the O 0 0.00013520740321837366
cell O 0 0.00019299995619803667
cycle O 0 0.0001221300772158429
upon O 0 0.00019040204642806202
serum O 0 0.0016059275949373841
withdrawal O 0 0.0008335264865309
. O 0 0.0002461727417539805

Here O 0 0.0005848003784194589
, O 0 6.2818635342409834e-06
it O 0 7.052626642689575e-07
is O 0 5.724407969864842e-07
shown O 0 3.1060294531926047e-06
that O 0 8.901794785742823e-07
reintroduction O 0 0.00011674276174744591
of O 0 3.339497925480828e-05
the O 0 9.734775085235015e-05
wild O 0 0.0004663152212742716
- O 0 0.0009022515150718391
type O 0 0.0005510952323675156
VHL B-Disease 1 0.9996298551559448
gene O 0 8.350009738933295e-05
restores O 0 0.000112255169369746
the O 0 1.5534087651758455e-05
ability O 0 1.9387058273423463e-05
of O 0 0.000579559535253793
VHL O 1 1.0
- O 1 0.966289758682251
negative O 0 0.001603524899110198
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9985528588294983
cells O 0 5.657664223690517e-05
to O 0 9.341274562757462e-06
exit O 0 0.00021627660316880792
the O 0 0.00010271449718857184
cell O 0 0.0003056783461943269
cycle O 0 0.0001838348835008219
and O 0 2.9928687581559643e-05
enter O 0 0.0009282782557420433
G0 O 1 0.9991563558578491
/ O 0 0.002720816759392619
quiescence O 0 0.006421652156859636
in O 0 0.00021681883663404733
low O 0 0.0010770777007564902
serum O 0 0.001882469980046153
. O 0 0.00010682256106520072

Both O 0 0.0011598339769989252
VHL O 1 0.9999982118606567
- O 0 0.003045501187443733
positive O 0 4.3295749492244795e-05
and O 0 0.00013829641102347523
VHL O 1 0.9999992847442627
- O 0 0.004266282543540001
negative O 0 0.00034844811307266355
RCC B-Disease 1 0.9999984502792358
cells O 0 0.0002560564607847482
exit O 0 0.00023333886929322034
the O 0 9.635723836254328e-05
cell O 0 0.000259062391705811
cycle O 0 0.00010242245480185375
by O 0 8.14851500763325e-06
contact O 0 8.33758240332827e-05
inhibition O 0 0.0005940678529441357
. O 0 0.00039392843609675765

The O 0 0.0008910482283681631
cyclin O 0 0.006666881497949362
- O 0 0.0005983772571198642
dependent O 0 4.96524189657066e-05
kinase O 0 0.00012417692050803453
inhibitor O 0 0.00040463689947500825
, O 0 2.6352363420301117e-05
p27 O 0 0.0025259375106543303
, O 0 1.4199053111951798e-05
accumulates O 0 0.00024166003277059644
upon O 0 6.0274025599937886e-05
serum O 0 0.0005024600541219115
withdrawal O 0 0.00012632909056264907
, O 0 4.1078446884057485e-06
only O 0 1.2088690937162028e-06
in O 0 3.860141987388488e-06
the O 0 1.7689832020550966e-05
presence O 0 3.716426363098435e-05
of O 0 0.0005285217193886638
VHL B-Disease 1 0.999991774559021
, O 0 2.878604209399782e-05
as O 0 7.106170869519701e-06
a O 0 4.6301220208988525e-06
result O 0 4.6336908781086095e-06
of O 0 1.9400633391342126e-05
the O 0 3.757200465770438e-05
stabilization O 0 0.000478647300042212
of O 0 0.0002591866650618613
the O 0 0.0006684847176074982
protein O 0 0.000482601928524673
. O 0 0.00013700015551876277

We O 0 3.981961344834417e-05
propose O 0 1.898469236039091e-05
that O 0 7.728594937361777e-07
the O 0 1.0765053957584314e-05
loss O 0 0.00027378747472539544
of O 0 0.0005184299661777914
wild O 0 0.00250039529055357
- O 0 0.0030021867714822292
type O 0 0.0007508947746828198
VHL B-Disease 1 0.9997873902320862
gene O 0 2.2791538867750205e-05
results O 0 3.2375548926211195e-06
in O 0 1.9912208699679468e-06
a O 0 3.8183802644198295e-06
specific O 0 6.379978458426194e-06
cellular O 0 0.0008454399066977203
defect O 0 0.03813206031918526
in O 0 0.0005130348727107048
serum O 0 0.006308873649686575
- O 0 0.0007320891018025577
dependent O 0 1.8170461771660484e-05
growth O 0 2.0208417481626384e-05
control O 0 1.9759228962357156e-05
, O 0 1.8588192460811115e-06
which O 0 3.5502341688697925e-06
may O 0 7.474508311133832e-05
initiate O 0 0.0009342288831248879
tumor B-Disease 1 0.9999908208847046
formation O 1 0.6133632659912109
. O 0 0.0011188420467078686

This O 0 7.679855480091646e-05
is O 0 2.3329808755079284e-05
corrected O 0 0.00031601451337337494
by O 0 2.233790382888401e-06
the O 0 1.1429001460783184e-05
reintroduction O 0 0.00023250762023963034
of O 0 9.6256953838747e-05
wild O 0 0.0009151554550044239
- O 0 0.003287923289462924
type O 0 0.002976304152980447
VHL B-Disease 1 1.0
, O 0 0.00046348790056072176
implicating O 1 0.9969379901885986
VHL B-Disease 1 0.9999961853027344
as O 0 0.000159688395797275
the O 0 0.0001094722465495579
first O 0 0.0004919844795949757
tumor B-Disease 1 0.9968737363815308
suppressor O 0 0.0015967481303960085
involved O 0 3.091296457569115e-05
in O 0 1.5974113921402022e-05
the O 0 4.49629696959164e-05
regulation O 0 5.4175536206457764e-05
of O 0 0.00013325117470230907
cell O 0 0.0009842728031799197
cycle O 0 0.00027132502873428166
exit O 0 0.0003754786739591509
, O 0 6.702137852698797e-06
which O 0 1.6010571926017292e-06
is O 0 1.486219616708695e-06
consistent O 0 4.9183609007741325e-06
with O 0 9.243080967280548e-07
its O 0 1.7980226402869448e-05
gatekeeper O 0 0.0012748725712299347
function O 0 5.5687822168692946e-05
in O 0 0.00010853220010176301
the O 0 0.0007486077956855297
kidney O 1 0.9999997615814209
. O 0 0.0003356904489919543
. O 0 0.00024771987227723

Piebaldism B-Disease 1 1.0
with O 0 0.004791962448507547
deafness B-Disease 1 1.0
: O 0 0.0012341892579570413
molecular O 0 0.0001949173747561872
evidence O 0 9.074301487999037e-05
for O 0 1.862075259850826e-05
an O 0 5.7610544899944216e-05
expanded O 1 0.9996944665908813
syndrome O 1 1.0
. O 0 0.002164298202842474

In O 0 0.00013486488023772836
a O 0 6.777166709071025e-05
South O 0 0.0006475570844486356
African O 0 0.00014401851512957364
girl O 0 0.00012135138240410015
of O 0 5.042948396294378e-05
Xhosa O 0 0.017561590299010277
stock O 0 0.0006533203413709998
with O 0 3.4929060348076746e-05
severe O 1 0.9999995231628418
piebaldism B-Disease 1 1.0
and O 1 0.9996422529220581
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.9999927282333374
identified O 0 0.001072194892913103
a O 0 9.309948654845357e-05
novel O 0 0.0001615065266378224
missense O 0 0.00018990927492268384
substitution O 0 5.454571873997338e-05
at O 0 0.0001599254901520908
a O 0 1.7838961866800673e-05
highly O 0 6.282704998739064e-05
conserved O 0 0.00015500646259170026
residue O 0 9.878767741611227e-05
in O 0 6.538691195601132e-06
the O 0 1.676314241194632e-05
intracellular O 0 3.658842251752503e-05
kinase O 0 1.6286930986098014e-05
domain O 0 2.1985673811286688e-05
of O 0 9.79526448645629e-05
the O 0 0.0007947861449792981
KIT O 1 0.9391912221908569
proto O 0 0.023085884749889374
- O 0 0.0029145274311304092
oncogene O 0 0.008219647221267223
, O 0 6.13098600297235e-05
R796G O 0 0.0023684122134000063
. O 0 0.00014286002260632813

Though O 0 0.0011576737742871046
auditory B-Disease 0 0.2280837446451187
anomalies I-Disease 0 0.36892399191856384
have O 0 2.596037302282639e-05
been O 0 3.4975793823832646e-05
observed O 0 4.440039992914535e-05
in O 0 5.93538825341966e-05
mice O 0 0.00024072319502010942
with O 0 1.4564089724444784e-05
dominant O 0 0.001325193326920271
white O 0 0.0007511040894314647
spotting O 0 0.006978229619562626
( O 0 0.0007556198397651315
W O 1 0.9955379962921143
) O 0 3.385783202247694e-05
due O 0 0.0002117141120834276
to O 0 9.96083690552041e-05
KIT O 1 0.999817430973053
mutations O 0 0.0008970414637587965
, O 0 0.00033826916478574276
deafness B-Disease 1 1.0
is O 0 0.00017017230857163668
not O 0 1.0963197382807266e-05
typical O 0 5.4740456107538193e-05
in O 0 4.596443977789022e-05
human O 0 0.0001437967730453238
piebaldism B-Disease 0 0.03195112571120262
. O 0 0.00020490352471824735

Thus O 0 0.000277129583992064
, O 0 7.761917004245333e-06
the O 0 2.6299740056856535e-05
occurrence O 0 0.0006522175972349942
of O 0 0.13055793941020966
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.9944496154785156
this O 0 0.0002761131327133626
patient O 0 8.50791548145935e-05
extends O 0 2.794418833218515e-05
considerably O 0 2.111896719725337e-05
the O 0 5.664066520694178e-06
phenotypic O 0 6.572718120878562e-05
range O 0 5.4670439567416906e-05
of O 0 0.00029949896270409226
piebaldism B-Disease 0 0.019834257662296295
due O 0 0.0010347521165385842
to O 0 0.0002456234360579401
KIT O 0 0.02567308023571968
gene O 0 0.00010310261131962761
mutation O 0 1.7014393961289898e-05
in O 0 3.0145094569888897e-05
humans O 0 7.071098661981523e-05
and O 0 1.2570126273203641e-05
tightens O 0 7.079666829667985e-05
the O 0 5.3711337386630476e-06
clinical O 0 2.361466977163218e-05
similarity O 0 0.000140079646371305
between O 0 0.0010359451407566667
piebaldism B-Disease 1 0.5807734727859497
and O 0 8.631564924144186e-06
the O 0 7.39356801204849e-06
various O 0 6.845877123851096e-06
forms O 0 0.00013789819786325097
of O 1 0.999997615814209
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.004741651937365532
. O 0 0.0008223185432143509

Cycloheximide O 0 0.04090350493788719
facilitates O 0 0.00022452852863352746
the O 0 2.6480087399249896e-05
identification O 0 7.848094355722424e-06
of O 0 9.751220204634592e-05
aberrant O 0 0.0009960999013856053
transcripts O 0 0.0027360464446246624
resulting O 0 0.0003056398709304631
from O 0 9.48023734963499e-05
a O 0 6.653183663729578e-05
novel O 0 0.0003600571071729064
splice O 0 0.002606448018923402
- O 0 0.0006928684306330979
site O 0 0.0002788547135423869
mutation O 0 1.1018970326404087e-05
in O 0 4.5684242650168017e-05
COL17A1 O 1 0.9822322130203247
in O 0 3.69279550795909e-05
a O 0 2.333788688702043e-05
patient O 0 4.089001231477596e-05
with O 0 2.354426214878913e-05
generalized O 1 0.9999079704284668
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.07199864089488983

Patients O 0 0.0005601365701295435
with O 0 0.000128903950098902
generalized O 1 0.9999998807907104
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.00027706456603482366
show O 0 0.000276531238341704
decreased O 0 0.0007841835613362491
expression O 0 5.271874397294596e-05
of O 0 0.0003465432091616094
type O 0 0.43046480417251587
XVII O 1 1.0
collagen O 1 0.9970065951347351
, O 0 5.0155438657384366e-05
a O 0 4.8472778871655464e-05
transmembrane O 0 0.0015014137607067823
hemidesmosomal O 0 0.0023366729728877544
protein O 0 3.837781332549639e-05
encoded O 0 2.2881569748278707e-05
by O 0 3.920026938430965e-05
COL17A1 O 1 0.9926167130470276
. O 0 0.00027421381673775613

This O 0 3.790746268350631e-05
report O 0 1.0046205716207623e-05
documents O 0 3.0951836379244924e-05
a O 0 2.1116953575983644e-05
novel O 0 0.0003953776613343507
splice O 0 0.005489951465278864
- O 0 0.0010136092314496636
site O 0 0.0003243414976168424
mutation O 0 1.057880035659764e-05
in O 0 5.251187030808069e-05
COL17A1 O 1 0.9915055632591248
in O 0 4.712356167146936e-05
a O 0 2.749722079897765e-05
patient O 0 3.164725785609335e-05
with O 0 1.9036686353501864e-05
generalized O 1 0.9998821020126343
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0007255409727804363
and O 0 4.456001261132769e-05
applies O 0 1.706214970909059e-05
a O 0 1.221934326167684e-05
new O 0 5.870949280506466e-06
methodology O 0 1.5317284123739228e-05
to O 0 5.381901701184688e-06
define O 0 4.065617758897133e-05
and O 0 1.1290077964076772e-05
characterize O 0 0.00027986016357317567
the O 0 0.00010934621968772262
resulting O 0 0.00023073011834640056
mRNA O 0 0.0007534289034083486
splice O 0 0.0010059457272291183
variants O 0 0.000283230998320505
. O 0 0.00013723656593356282

Mutational O 0 0.00343448668718338
analysis O 0 2.282096647832077e-05
of O 0 0.0002520328853279352
COL17A1 O 1 0.9999080896377563
identified O 0 0.00013347268395591527
a O 0 3.8475842302432284e-05
maternally O 0 0.0009678928763605654
inherited O 1 0.9276427030563354
G O 0 0.4077235162258148
- O 0 0.0028509488329291344
to O 0 0.00016290298663079739
- O 0 0.0030465037561953068
T O 0 0.0056439414620399475
transversion O 0 0.001818265882320702
at O 0 0.00010696627577999607
the O 0 3.317285518278368e-05
- O 0 7.405102951452136e-05
1 O 0 5.930285624344833e-05
position O 0 3.336155350552872e-05
of O 0 0.00011902425467269495
exon O 0 0.0014441808452829719
32 O 0 0.00040501897456124425
. O 0 0.00018400023691356182

This O 0 5.3057468903716654e-05
acceptor O 0 3.957905573770404e-05
splice O 0 0.002961604855954647
- O 0 0.0007060236530378461
site O 0 0.00023331285046879202
mutation O 0 3.885763362632133e-06
led O 0 1.8482613086234778e-05
to O 0 6.76476520311553e-06
the O 0 7.256839307956398e-05
formation O 0 0.0009653308079577982
of O 0 0.0004256440734025091
aberrant O 0 0.0012392610078677535
transcripts O 0 0.001410416211001575
present O 0 0.00014864701370242983
at O 0 0.00038159298128448427
extremely O 0 9.947091893991455e-05
low O 0 0.0003580981574486941
levels O 0 0.00046299179666675627
. O 0 8.27627009130083e-05

Based O 0 3.9681246562395245e-05
on O 0 6.564035720657557e-05
our O 0 8.403038918913808e-06
recent O 0 3.718257630680455e-06
finding O 0 9.219125786330551e-06
that O 0 2.6746129151433706e-06
cycloheximide O 0 0.006500995252281427
stabilized O 0 0.007132891099900007
mutant O 0 0.0015221490757539868
COL17A1 O 1 0.9957003593444824
transcripts O 0 0.0026004789397120476
in O 0 0.00010892639693338424
keratinocytes O 0 0.0004929598653689027
homozygous O 0 2.8156502594356425e-05
for O 0 1.0422325431136414e-05
a O 0 7.792265387251973e-05
frameshift O 0 0.001856009243056178
mutation O 0 2.036450314335525e-05
, O 0 3.967723841924453e-06
the O 0 2.4405071599176154e-05
effects O 0 0.00023131647321861237
of O 0 0.00023572752252221107
the O 0 0.0006541109178215265
splice O 0 0.005692968610674143
- O 0 0.000512518163304776
site O 0 0.00013976488844491541
mutation O 0 1.7472104900662089e-06
on O 0 1.2485384104365949e-05
splicing O 0 6.157949974294752e-05
of O 0 9.086771024158224e-05
COL17A1 O 1 0.9944896697998047
transcripts O 0 0.0008021635585464537
were O 0 1.3942440091341268e-05
determined O 0 8.585164323449135e-06
using O 0 2.5995207124651643e-06
reverse O 0 0.0001346731442026794
transcriptase O 0 0.00025808560894802213
polymerase O 0 0.000291119038593024
chain O 0 4.327948045101948e-05
reaction O 0 2.544925109759788e-06
of O 0 2.250329816888552e-05
total O 0 0.00010531632142374292
RNA O 0 0.0009174835286103189
from O 0 2.40318950091023e-05
keratinocytes O 0 0.00015692129090894014
incubated O 0 0.0001216571472468786
for O 0 1.958141865543439e-06
2 O 0 0.00021713141177315265
. O 0 8.679842721903697e-05

5 O 0 0.0014449250884354115
h O 0 0.0005677341250702739
in O 0 2.5308068870799616e-05
the O 0 3.364719668752514e-05
presence O 0 5.0763854233082384e-05
or O 0 2.0647115889005363e-05
absence O 0 0.0002210238599218428
of O 0 0.00023296674771700054
10 O 0 0.0009696576744318008
microg O 0 0.030013641342520714
cycloheximide O 0 0.018286725506186485
per O 0 0.00021747846039943397
ml O 0 0.003765982575714588
. O 0 0.00020922673866152763

Using O 0 4.051042560604401e-05
this O 0 6.8238391577324364e-06
approach O 0 6.98534040566301e-06
, O 0 3.0417065772780916e-06
an O 0 3.6551800803863443e-06
abnormally O 0 0.0010297509143128991
spliced O 0 0.0015006839530542493
transcript O 0 0.0010368820512667298
was O 0 0.0001732770906528458
identified O 0 6.9213042479532305e-06
that O 0 3.48842263520055e-07
contains O 0 2.4546020540583413e-06
an O 0 1.1633788972176262e-06
extra O 0 1.4135903256828897e-05
264 O 0 0.00016043777577579021
bases O 0 4.315830665291287e-05
upstream O 0 0.00024212153221014887
from O 0 2.8342306904960424e-05
exon O 0 0.0002207586949225515
32 O 0 3.982325870310888e-05
, O 0 6.134894647402689e-06
resulting O 0 4.902753425994888e-05
in O 0 4.446976527106017e-05
a O 0 0.00016681794659234583
premature O 0 0.00207494106143713
termination O 0 0.0008007994038052857
codon O 0 0.0006023426540195942
27 O 0 0.001614285632967949
bp O 0 0.0007959403446875513
downstream O 0 0.0005056534428149462
from O 0 2.8680051400442608e-05
the O 0 0.00016274990048259497
cryptic O 0 0.0029951659962534904
splice O 0 0.004554612562060356
site O 0 0.0028925114311277866
. O 0 0.00030320516088977456

Three O 0 5.579290518653579e-05
other O 0 7.530230504926294e-06
splice O 0 0.0003386732132639736
variants O 0 6.152057903818786e-05
, O 0 5.1542738219723105e-06
including O 0 2.395835281276959e-06
one O 0 4.118537617614493e-06
derived O 0 8.743450962356292e-06
from O 0 1.852788045653142e-05
the O 0 8.73557582963258e-05
skipping O 0 0.0002697516465559602
of O 0 0.0001276505645364523
exon O 0 0.0007881381316110492
32 O 0 0.00010594505147309974
, O 0 6.372402367560426e-06
were O 0 1.7475838831160218e-05
also O 0 1.4818076124356594e-05
identified O 0 8.218605944421142e-05
. O 0 0.00014812476001679897

These O 0 1.9168524886481464e-05
results O 0 1.4987182112236042e-05
indicate O 0 7.382532930932939e-05
the O 0 5.734667502110824e-05
usefulness O 0 0.0005194185068830848
of O 0 0.0003383672737982124
cycloheximide O 0 0.18540167808532715
treatment O 0 0.00048244878416880965
in O 0 4.5659675379283726e-05
evaluating O 0 5.64379442948848e-05
the O 0 7.754031685180962e-05
abnormal O 0 0.00016862766642589122
processing O 0 0.00012304198753554374
of O 0 0.0001673104998189956
mRNA O 0 0.000400470569729805
due O 0 0.0002365263062529266
to O 0 3.449025098234415e-05
splice O 0 0.0011404129909351468
- O 0 0.00030605774372816086
site O 0 0.00015468841593246907
mutations O 0 1.9592531316448003e-05
, O 0 5.85876796321827e-06
because O 0 1.3350699191505555e-05
( O 0 7.174242637120187e-05
i O 0 0.0004440519551280886
) O 0 7.56134104449302e-05
aberrant O 0 0.0004278935957700014
splicing O 0 0.00024125442723743618
often O 0 7.394611202471424e-06
generates O 0 1.8036300389212556e-05
a O 0 4.299333522794768e-05
premature O 0 0.0010413308627903461
termination O 0 0.00045070124906487763
codon O 0 0.0001383349153911695
, O 0 1.2873160812887363e-05
( O 0 2.7760806915466674e-05
ii O 1 0.9984858632087708
) O 0 8.517428796039894e-05
transcripts O 0 0.0006915293051861227
with O 0 3.8075140764703974e-05
premature O 0 0.002506180899217725
termination O 0 0.001513147377409041
codons O 0 0.0009247608250007033
can O 0 1.8224378436570987e-05
occur O 0 3.798417674261145e-05
at O 0 0.0003375186352059245
low O 0 0.0003020179574377835
or O 0 8.153315866366029e-05
undetectable O 0 0.005088686477392912
levels O 0 0.0002444783749524504
due O 0 0.0001777639554347843
to O 0 3.856201874441467e-05
nonsense O 0 0.0005634776898659766
- O 0 0.00022542709484696388
mediated O 0 0.00024302955716848373
mRNA O 0 0.0003906588244717568
decay O 0 0.0008140637073665857
, O 0 5.582623089139815e-06
and O 0 4.722910034615779e-06
( O 0 4.9012855015462264e-05
iii O 0 0.04885236918926239
) O 0 4.2349343857495114e-05
the O 0 2.3663067622692324e-05
levels O 0 4.7909357817843556e-05
of O 0 1.8789245586958714e-05
these O 0 4.1342354961670935e-06
transcripts O 0 0.00015144659846555442
can O 0 1.0467580295880907e-06
be O 0 1.0214903340965975e-06
increased O 0 8.051409167819656e-06
by O 0 1.1400655239413027e-05
cycloheximide O 0 0.005499939434230328
. O 0 0.00015547749353572726

A O 0 0.003812957787886262
deletion O 0 0.0031998164486140013
mutation O 0 0.00013548744027502835
in O 0 0.00019013919518329203
COL17A1 O 1 0.9906147718429565
in O 0 4.6090150135569274e-05
five O 0 1.9498251276672818e-05
Austrian O 0 0.00018699531210586429
families O 0 5.2551599765138235e-06
with O 0 1.6426507500000298e-05
generalized O 1 0.9999284744262695
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 0 0.002622199011966586
propagation O 0 0.0008064316934905946
of O 0 0.00037675024941563606
an O 0 0.0001568346779095009
ancestral O 0 0.011049064807593822
allele O 0 0.00021091500821057707
. O 0 0.00010259262489853427

Patients O 0 0.0005078715621493757
with O 0 7.039422052912414e-05
generalized O 1 0.9999994039535522
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.000309670198475942
a O 0 4.8665315262041986e-05
usually O 0 1.1790230018959846e-05
nonlethal O 0 0.0005680523463524878
form O 0 0.00010200859105680138
of O 0 0.024328825995326042
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.0001270905340788886
have O 0 1.107800653699087e-05
generalized O 0 0.0006240252405405045
blistering B-Disease 1 0.9913257956504822
, O 0 0.13048729300498962
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.027737116441130638
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 1 0.6088526844978333
and O 1 0.9890120029449463
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.9993461966514587

Skin B-Disease 1 0.9999924898147583
fragility I-Disease 1 0.9997088313102722
in O 0 0.00036164585617370903
most O 0 2.6552253984846175e-05
cases O 0 1.1346487553964835e-05
is O 0 5.659245289280079e-06
due O 0 6.114228744991124e-05
to O 0 6.991078407736495e-06
mutations O 0 6.514851065730909e-06
in O 0 3.266662133682985e-06
the O 0 6.024473805155139e-06
gene O 0 5.235925073066028e-06
encoding O 0 3.675040352391079e-05
type O 0 0.002046937355771661
XVII O 1 1.0
collagen O 1 0.9999984502792358
( O 0 0.003916740883141756
COL17A1 O 1 0.9999996423721313
) O 0 0.00045731174759566784
. O 0 0.00013059396587777883

Recently O 0 0.0008698671008460224
, O 0 1.2616736967174802e-05
we O 0 5.139464974490693e-06
reported O 0 7.771152922941837e-06
five O 0 4.3167619878659025e-06
Austrian O 0 0.0001564887206768617
families O 0 5.175651040190132e-06
with O 0 3.024818579433486e-05
generalized O 1 0.9999761581420898
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.0006684379186481237
share O 0 0.00011189065116923302
the O 0 0.00019391522801015526
same O 0 0.00029710205853916705
COL17A1 O 1 0.9999977350234985
mutation O 0 0.0002623230975586921
. O 0 0.00013616352225653827

Affected O 0 0.00029529843595810235
individuals O 0 4.29616920882836e-06
in O 0 1.599974166310858e-05
three O 0 7.87780481914524e-06
families O 0 1.7460862409279798e-06
are O 0 8.067074190876156e-07
homozygous O 0 1.4186330190568697e-05
for O 0 1.7155884052044712e-05
4003delTC O 0 0.0035625796299427748
, O 0 2.374485666223336e-05
whereas O 0 3.553587885107845e-05
those O 0 6.1507053032983094e-06
in O 0 2.3436890842276625e-05
two O 0 1.085301391867688e-05
others O 0 1.1605084182519931e-05
are O 0 4.0105555854097474e-06
compound O 0 0.0008383128442801535
heterozygotes O 0 0.0041076443158090115
. O 0 0.00032666584593243897

To O 0 0.00010558580834185705
determine O 0 5.855975905433297e-05
if O 0 6.1353043747658376e-06
the O 0 1.657831307966262e-05
occurrence O 0 4.170378451817669e-05
of O 0 9.221688378602266e-05
4003delTC O 0 0.003263915190473199
in O 0 4.621787593350746e-05
these O 0 9.60679699346656e-06
unrelated O 0 0.00011739491310436279
families O 0 1.6007907106541097e-05
signifies O 0 0.0009496802813373506
propagation O 0 0.00019554320897441357
of O 0 0.00015265998081304133
an O 0 8.027074363781139e-05
ancestral O 0 0.008203607052564621
allele O 0 0.000136472619487904
or O 0 9.5563598733861e-05
a O 0 0.0002331325231352821
mutational O 0 0.015465834178030491
hot O 0 0.0021867621690034866
spot O 0 0.0003571482957340777
, O 0 6.182533070386853e-06
haplotypes O 0 4.043092121719383e-05
were O 0 5.864715603820514e-06
determined O 0 9.808295544644352e-06
for O 0 5.105215677758679e-06
polymorphisms O 0 0.00011509392788866535
both O 0 1.3764406503469218e-05
within O 0 7.651295163668692e-05
and O 0 0.00013302835577633232
flanking O 1 0.998160183429718
COL17A1 O 1 1.0
. O 0 0.0014509748434647918

Five O 0 0.0006284125265665352
intragenic O 0 0.008059117943048477
polymorphisms O 0 0.000225811279960908
were O 0 1.5502711903536692e-05
chosen O 0 1.2564038115669973e-05
based O 0 2.1723483314417535e-06
on O 0 6.139574543340132e-05
their O 0 3.0092995075392537e-05
informativeness O 0 0.016706153750419617
. O 0 0.00040860421722754836

One O 0 6.139246397651732e-05
of O 0 5.715368388337083e-05
these O 0 1.624780816200655e-05
, O 0 7.906804967205971e-06
not O 0 2.3876784780441085e-06
previously O 0 4.480797360884026e-05
reported O 0 5.568681444856338e-05
, O 0 1.0076083526655566e-05
was O 0 0.0006712448666803539
2988 O 0 0.006161345634609461
A O 0 0.0014617068227380514
or O 0 0.00012831993808504194
C O 0 0.0012402416905388236
that O 0 5.22841583006084e-06
introduces O 0 2.1578787709586322e-05
a O 0 4.043144599563675e-06
new O 0 2.617134668980725e-06
restriction O 0 8.361709660675842e-06
site O 0 0.00012167536624474451
for O 0 2.666029286046978e-05
Eco0109 O 0 0.007812502793967724
I O 0 0.010076350532472134
. O 0 0.00029753943090327084

All O 0 5.83390356041491e-05
the O 0 9.425637836102396e-05
4003delTC O 0 0.001692092278972268
alleles O 0 1.7454303815611638e-05
showed O 0 4.554877523332834e-05
the O 0 2.5713170543895103e-05
same O 0 8.452321708318777e-06
haplotype O 0 7.580833334941417e-05
for O 0 5.6244502957270015e-06
these O 0 8.571321814088151e-06
five O 0 5.0008096877718344e-05
polymorphic O 0 0.0004347091889940202
markers O 0 0.0037828402128070593
. O 0 0.0004915560130029917

Fourteen O 0 0.00491721648722887
microsatellite O 0 0.008047924377024174
polymorphisms O 0 0.0003665332624223083
were O 0 1.933742532855831e-05
selected O 0 1.0368216862843838e-05
based O 0 2.7350122309144353e-06
on O 0 3.605968595365994e-05
their O 0 1.333559430349851e-05
high O 0 0.0004191861080471426
heterozygosity O 0 0.005281641613692045
and O 0 1.3570188457379118e-05
their O 0 5.408961442299187e-06
location O 0 0.00010408560774521902
within O 0 3.983423448516987e-05
10q23 O 0 0.0034428040962666273
- O 0 0.0014045634306967258
q25 O 0 0.0056208036839962006
near O 0 0.008449182845652103
COL17A1 O 1 0.9998331069946289
. O 0 0.0005070270854048431

Three O 0 5.4564810852753e-05
families O 0 7.091588486218825e-06
shared O 0 0.0001639501570025459
microsatellite O 0 0.011185716837644577
polymorphisms O 0 0.0018363967537879944
covering O 0 0.0019203961128368974
at O 0 0.001564321923069656
most O 0 0.00012751515896525234
19 O 0 0.0016379195731133223
cM O 0 0.0023407279513776302
, O 0 1.7715659851091914e-05
whereas O 0 2.5676466975710355e-05
the O 0 3.6695069866254926e-05
others O 0 1.0604365343169775e-05
shared O 0 1.9029786926694214e-05
smaller O 0 1.0639424544933718e-05
regions O 0 1.8062686649500392e-05
consistent O 0 4.338295184425078e-05
with O 0 1.3020134247199167e-05
cross O 0 0.0004312420205678791
- O 0 0.0002771644212771207
over O 0 2.882515764213167e-05
events O 0 3.182045111316256e-05
during O 0 0.00022116930631455034
passage O 0 8.426471322309226e-05
of O 0 1.593032902746927e-05
this O 0 2.8969418508495437e-06
mutation O 0 2.0922891508234898e-06
through O 0 4.018419531348627e-06
several O 0 1.4912092410668265e-05
generations O 0 0.00047184363938868046
. O 0 0.000110665823740419

These O 0 3.676073902170174e-05
results O 0 4.2195995774818584e-05
indicate O 0 0.0001554193877382204
that O 0 1.3700077943212818e-05
4003delTC O 0 0.0018999469466507435
occurs O 0 2.7555761334951967e-05
on O 0 2.8310378183959983e-05
a O 0 1.6017100278986618e-05
single O 0 2.1244082745397463e-05
ancestral O 0 0.0006313803023658693
allele O 0 3.304141864646226e-05
. O 0 2.571425102360081e-05
. O 0 5.06925061927177e-05

The O 0 0.000992562505416572
haptoglobin O 0 0.024386480450630188
- O 0 0.0009455361869186163
gene O 0 1.5593546777381562e-05
deletion O 0 0.0001048586709657684
responsible O 0 8.304254879476503e-05
for O 0 0.00010723251762101427
anhaptoglobinemia B-Disease 1 0.9970105886459351
. O 0 0.0007694187224842608

We O 0 5.477783633978106e-05
have O 0 1.8252237623528345e-06
found O 0 2.537361524446169e-06
an O 0 2.42958026319684e-06
allelic O 0 0.00029495288617908955
deletion O 0 0.0005776475882157683
of O 0 0.0005933201173320413
the O 0 0.0016766070621088147
haptoglobin O 0 0.29935839772224426
( O 0 0.00027251316350884736
Hp O 0 0.0003072833933401853
) O 0 9.897851668938529e-06
gene O 0 4.134420578338904e-06
from O 0 4.385351076052757e-06
an O 0 2.76612240668328e-06
individual O 0 4.083877229277277e-06
with O 0 3.232640665373765e-05
anhaptoglobinemia B-Disease 1 0.9934265613555908
. O 0 0.000742935691960156

The O 0 0.0010287566110491753
Hp O 0 0.0012330590980127454
gene O 0 6.0304788348730654e-05
cluster O 0 0.00022128023556433618
consists O 0 3.747292066691443e-05
of O 0 7.077216287143528e-05
coding O 0 0.0005726164090447128
regions O 0 0.0001139299274655059
of O 0 0.00020467409922275692
the O 0 0.00041538066579960287
alpha O 0 0.0008320092456415296
chain O 0 5.065157529315911e-05
and O 0 3.981733698310563e-06
beta O 0 0.00012985625653527677
chain O 0 2.0121113266213797e-05
of O 0 2.0179608327453025e-05
the O 0 0.0001940795045811683
haptoglobin O 0 0.01357343140989542
gene O 0 0.00014986727910581976
( O 0 6.680750811938196e-05
Hp O 0 0.00020970367768313736
) O 0 7.263360203069169e-06
and O 0 1.5175687622104306e-06
of O 0 2.5092549549299292e-05
the O 0 0.0001802243059501052
alpha O 0 0.0006797430687583983
chain O 0 5.915222209296189e-05
and O 0 3.746412630789564e-06
beta O 0 0.00014501439000014216
chain O 0 1.8366630683885887e-05
of O 0 9.467850759392604e-06
the O 0 9.707475692266598e-05
haptoglobin O 0 0.007347356528043747
- O 0 0.0004444758815225214
related O 0 8.016715582925826e-05
gene O 0 8.623248140793294e-05
( O 0 9.539462917018682e-05
Hpr O 0 0.007286683190613985
) O 0 4.2152962123509496e-05
, O 0 6.5895719671971165e-06
in O 0 1.5096532479219604e-05
tandem O 0 0.0005202119937166572
from O 0 3.805440792348236e-05
the O 0 0.00018550817912910134
5 O 0 0.0005450609605759382
side O 0 0.0005394917097873986
. O 0 0.00025433115661144257

Southern O 0 0.0013112617889419198
blot O 0 0.0008444943814538419
and O 0 2.977887743327301e-05
PCR O 0 0.00012650883581954986
analyses O 0 1.5793297279742546e-05
have O 0 8.359552907677426e-07
indicated O 0 6.17375417277799e-06
that O 0 3.1710058578937605e-07
the O 0 3.8346379369613715e-06
individual O 0 9.435556194148376e-07
with O 0 2.875231302823522e-06
anhaptoglobinemia B-Disease 0 0.0036226145457476377
was O 0 0.000384857936296612
homozygous O 0 1.5097655705176294e-05
for O 0 3.3531562166899676e-06
the O 0 5.3698990086559206e-05
gene O 0 4.5286997192306444e-05
deletion O 0 0.00017809070413932204
and O 0 5.930078259552829e-06
that O 0 1.4777029946344555e-06
the O 0 2.21046429942362e-05
gene O 0 2.2074305888963863e-05
deletion O 0 9.823457367019728e-05
was O 0 0.000192846535355784
included O 0 1.656154745433014e-05
at O 0 0.00010118492355104536
least O 0 8.480080396111589e-06
from O 0 1.3207725714892149e-05
the O 0 5.687199518433772e-05
promoter O 0 0.002446052385494113
region O 0 0.0005376457120291889
of O 0 0.00035501393722370267
Hp O 0 0.001034865970723331
to O 0 0.00012137406883994117
Hpr O 0 0.006824077572673559
alpha O 0 0.00013002414198126644
but O 0 9.060414640771342e-07
not O 0 4.040174133024266e-07
to O 0 6.128766472102143e-06
Hpr O 0 0.0038485717959702015
beta O 0 0.0012882787268608809
( O 0 0.00022947433171793818
Hpdel O 0 0.026294812560081482
) O 0 0.00019953935407102108
. O 0 0.00012956175487488508

In O 0 0.00017776564345695078
addition O 0 3.298805313534103e-05
, O 0 8.027673175092787e-06
we O 0 3.4726963349385187e-06
found O 0 1.8964576611324446e-06
seven O 0 7.64619471738115e-06
individuals O 0 1.2163535529907676e-06
with O 0 9.873407179838978e-06
hypohaptoglobinemia B-Disease 0 0.016388054937124252
in O 0 0.00010439295874675736
three O 0 3.089091842412017e-05
families O 0 4.900078238279093e-06
, O 0 4.0857394196791574e-06
and O 0 3.0071273613430094e-06
the O 0 4.47606980742421e-05
genotypes O 0 0.00034765939926728606
of O 0 0.00012530716776382178
six O 0 9.66659135883674e-05
of O 0 5.2227558626327664e-05
the O 0 4.833973798668012e-05
seven O 0 2.3203090677270666e-05
individuals O 0 8.469715453429671e-07
were O 0 1.1275284123257734e-05
found O 0 5.478782895806944e-06
to O 0 1.3777234926237725e-05
be O 0 7.937073678476736e-05
Hp2 O 1 0.9737405180931091
/ O 0 0.01277444139122963
Hpdel O 1 0.7851542830467224
. O 0 0.0006410105852410197

The O 0 0.0007025395170785487
phenotypes O 0 0.000852416327688843
and O 0 3.4494198189349845e-05
genotypes O 0 0.0005073927459307015
in O 0 4.117453136132099e-05
one O 0 9.625156053516548e-06
of O 0 3.070728780585341e-05
these O 0 5.029712156101596e-06
three O 0 7.401843049592571e-06
families O 0 2.144735390174901e-06
showed O 0 4.509208520175889e-05
the O 0 3.067167563131079e-05
father O 0 8.865923155099154e-05
to O 0 9.36576907406561e-06
be O 0 3.492216637823731e-05
hypohaptoglobinemic B-Disease 0 0.005121760535985231
( O 0 0.00022873534180689603
Hp2 O 0 0.02723962813615799
) O 0 9.443920134799555e-05
and O 0 6.595471495529637e-05
Hp2 O 1 0.7540159821510315
/ O 0 0.004899097140878439
Hpdel O 0 0.020388277247548103
, O 0 1.3115845831634942e-05
the O 0 2.569066964497324e-05
mother O 0 1.8775976059259847e-05
to O 0 5.090771537652472e-06
be O 0 1.6431051335530356e-05
Hp2 O 0 0.008509363047778606
- O 0 0.0004240064008627087
1 O 0 0.00020252278773114085
and O 0 4.613412238541059e-05
Hp1 O 0 0.08688751608133316
/ O 0 0.0022057825699448586
Hp2 O 0 0.011608407832682133
, O 0 1.3133921129337978e-05
one O 0 2.2018534764356446e-06
of O 0 1.564741432957817e-05
the O 0 2.8911408662679605e-05
two O 0 5.876259820070118e-06
children O 0 3.445126367296325e-06
to O 0 4.643440661311615e-06
be O 0 1.8838534742826596e-05
hypohaptoglobinemic B-Disease 0 0.006201424170285463
( O 0 0.0001574732013978064
Hp2 O 0 0.021734479814767838
) O 0 6.717789801768959e-05
and O 0 4.24723002652172e-05
Hp2 O 1 0.9783123731613159
/ O 0 0.007010679692029953
Hpdel O 0 0.06405363231897354
, O 0 3.064036354771815e-05
and O 0 6.677161309198709e-06
the O 0 2.428457810310647e-05
other O 0 6.275085524976021e-06
child O 0 4.345648630987853e-05
to O 0 1.3911493624618743e-05
be O 0 3.457422644714825e-05
Hp1 O 0 0.013821078464388847
and O 0 0.00010115115583175793
Hp1 O 1 0.9991768002510071
/ O 0 0.009877417236566544
Hpdel O 0 0.22773951292037964
, O 0 2.542580659792293e-05
showing O 0 0.00011633947724476457
an O 0 2.0108760509174317e-05
anomalous O 0 0.0024154968559741974
inheritance O 0 0.002058872953057289
of O 0 0.0035178731195628643
Hp O 0 0.016316985711455345
phenotypes O 0 0.001490964787080884
in O 0 0.00010693282820284367
the O 0 0.0001534789480501786
child O 0 0.00024541205493733287
with O 0 5.412575410446152e-05
Hp1 O 1 0.9938103556632996
. O 0 0.000813030987046659

The O 0 0.0032403110526502132
Hp2 O 1 0.9994348883628845
/ O 0 0.021277237683534622
Hpdel O 0 0.03463452681899071
individuals O 0 2.7036845494876616e-05
had O 0 0.00012921926099807024
an O 0 1.4672380530100781e-05
extremely O 0 7.228680624393746e-05
low O 0 8.430643356405199e-05
level O 0 0.00021599986939691007
of O 0 0.0001299660070799291
Hp O 0 0.0003351391642354429
( O 0 1.9821945898002014e-05
mean O 0 4.958764111506753e-05
+ O 0 0.0003152472199872136
/ O 0 0.000295531062874943
- O 0 0.00025757678668014705
SD O 0 0.005346114747226238
= O 0 9.790119656827301e-05
0 O 0 1.2186374988232274e-05
. O 0 8.185135811800137e-06
049 O 0 0.0005191860254853964
+ O 0 0.00012908810458611697
/ O 0 0.00014731976261828095
- O 0 8.833719766698778e-05
0 O 0 1.8703900423133746e-05
. O 0 1.0331853445677552e-05
043 O 0 0.002702510915696621
mg O 0 0.0015257971826940775
/ O 0 0.0005350257270038128
ml O 0 0.0005408087163232267
; O 0 9.337721166957635e-06
n O 0 0.00011429673031670973
= O 0 0.00026470559532754123
6 O 0 0.00021828098397236317
) O 0 7.715604624536354e-06
, O 0 1.0878438843064941e-06
compared O 0 4.053607881360222e-06
with O 0 1.5045475265651476e-06
the O 0 2.8633377951337025e-05
level O 0 0.0003083650954067707
( O 0 1.604588578629773e-05
1 O 0 5.7738579926081e-05
. O 0 4.232908850099193e-06
64 O 0 4.0128004911821336e-05
+ O 0 0.00019359655561856925
/ O 0 0.000162926284247078
- O 0 0.0001326535566477105
1 O 0 0.0001016389433061704
. O 0 1.3411337931756862e-05
07 O 0 0.0018084731418639421
mg O 0 0.0023926207795739174
/ O 0 0.000880205596331507
ml O 0 0.0004966168780811131
) O 0 8.404400432482362e-06
obtained O 0 1.4869119695504196e-05
from O 0 5.1407540013315156e-05
52 O 0 0.0005408141296356916
healthy O 0 0.0003432511002756655
volunteers O 0 0.00013222065172158182
having O 0 0.00013977408525533974
phenotype O 0 0.00038615192170254886
Hp2 O 0 0.01900910586118698
, O 0 3.613466105889529e-05
whereas O 0 6.977881275815889e-05
the O 0 0.00017890799790620804
serum O 0 0.0018870580242946744
Hp O 0 0.00028007745277136564
level O 0 0.00010809016384882852
of O 0 3.7818030250491574e-05
an O 0 3.943787305615842e-06
individual O 0 3.9089563870220445e-06
with O 0 1.2413071090122685e-05
Hp1 O 1 0.9894683957099915
/ O 0 0.005660337395966053
Hpdel O 0 0.0509631372988224
was O 0 0.0014089554315432906
0 O 0 0.0001658776745898649
. O 0 0.00010031621786765754

50 O 0 0.001452229218557477
mg O 0 0.007460975553840399
/ O 0 0.0032393764704465866
ml O 0 0.0012491000816226006
, O 0 1.0050986929854844e-05
which O 0 3.9311739783443045e-06
was O 0 9.94235961115919e-05
approximately O 0 3.103265044046566e-05
half O 0 1.0466059393365867e-05
the O 0 1.1089665349572897e-05
level O 0 0.00010470910638105124
of O 0 9.699434303911403e-05
Hp O 0 0.00036270986311137676
in O 0 6.0527232562890276e-05
control O 0 0.00033431235351599753
sera O 0 0.003980671986937523
from O 0 3.227545312256552e-05
the O 0 0.0001123577676480636
Hp1 O 0 0.012415900826454163
phenotype O 0 7.869952241890132e-05
( O 0 1.6649149984004907e-05
1 O 0 0.00013367673091124743
. O 0 1.0675871635612566e-05
26 O 0 0.00019379713921807706
+ O 0 0.0002502993738744408
/ O 0 0.00015856877143960446
- O 0 6.91571767674759e-05
0 O 0 8.2714532254613e-06
. O 0 4.027328031952493e-06
33 O 0 9.130973921855912e-05
mg O 0 0.001287979306653142
/ O 0 0.0006064041517674923
ml O 0 0.0005704600480385125
; O 0 7.695514796068892e-06
n O 0 0.00011107793397968635
= O 0 0.0003068196529056877
9 O 0 0.00030162057373672724
) O 0 1.1009401532646734e-05
, O 0 1.583873427080107e-06
showing O 0 1.7159060007543303e-05
a O 0 3.9499653212260455e-05
gene O 0 0.00019979351782239974
- O 0 0.0008107225876301527
dosage O 0 0.0005283710779622197
effect O 0 0.0003195281606167555
. O 0 0.0001969387085409835

The O 0 0.00016998565115500242
other O 0 6.599458629352739e-06
allele O 0 1.6867457816260867e-05
( O 0 5.821710510645062e-05
Hp2 O 0 0.006512054242193699
) O 0 9.532891454000492e-06
of O 0 1.6104528185678646e-05
individuals O 0 6.540461981785484e-06
with O 0 0.00010013856081059203
Hp2 O 1 0.9999977350234985
/ O 0 0.13896910846233368
Hpdel O 1 0.8399784564971924
was O 0 0.0005926481098867953
found O 0 5.979142770229373e-06
to O 0 3.804063453571871e-06
have O 0 1.9119897842756473e-06
, O 0 1.7804532035370357e-06
in O 0 5.2770014917769e-06
all O 0 6.775353995180922e-06
exons O 0 0.00037103224894963205
, O 0 7.768485374981537e-06
no O 0 9.960536772268824e-06
mutation O 0 4.633832759282086e-06
, O 0 2.423357727820985e-06
by O 0 4.498345788306324e-06
DNA O 0 0.00024994785781018436
sequencing O 0 0.00040313880890607834
. O 0 0.00016728289483580738

On O 0 0.0002366553235333413
the O 0 1.5263054592651315e-05
basis O 0 5.7583242778491694e-06
of O 0 2.2487272872240283e-05
the O 0 3.8438800402218476e-05
present O 0 3.9292866858886555e-05
study O 0 1.3435097571345977e-05
, O 0 4.452100256457925e-06
the O 0 2.2454252757597715e-05
mechanism O 0 0.00020440573280211538
of O 0 0.00031771743670105934
anhaptoglobinemia B-Disease 0 0.035532254725694656
and O 0 4.1189330659108236e-05
the O 0 0.00012514571426436305
mechanism O 0 0.0005011135363020003
of O 0 0.0002884683199226856
anomalous O 0 0.005855920724570751
inheritance O 0 0.0019992419984191656
of O 0 0.001977779669687152
Hp O 0 0.00711517408490181
phenotypes O 0 0.0007262313738465309
were O 0 0.0001330770755885169
well O 0 6.512814434245229e-05
explained O 0 0.00024701657821424305
. O 0 0.00010788596409838647

However O 0 8.2556733104866e-05
, O 0 4.254346094967332e-06
the O 0 9.193400728690904e-06
mechanism O 0 0.00010684263543225825
of O 0 0.00019466310914140195
hypohaptoglobinemia B-Disease 1 0.9960975050926208
remains O 0 0.015381783246994019
unknown O 0 0.002571129472926259

ATM O 0 0.04278143495321274
mutations O 0 0.0002858071820810437
and O 0 9.293786570196971e-05
phenotypes O 0 0.001988273812457919
in O 0 0.005022494122385979
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 0.9999997615814209
families O 0 0.00011745628580683842
in O 0 4.706567051471211e-05
the O 0 6.596722960239276e-05
British O 0 5.893303386983462e-05
Isles O 0 0.00027404495631344616
: O 0 1.120946581067983e-05
expression O 0 1.3575353477790486e-05
of O 0 0.00010660510451998562
mutant O 0 0.000870239338837564
ATM O 0 0.004068394657224417
and O 0 6.098686753830407e-06
the O 0 1.0951273907267023e-05
risk O 0 3.6649711546488106e-05
of O 0 0.0009935416746884584
leukemia B-Disease 1 1.0
, O 1 0.9999929666519165
lymphoma B-Disease 1 1.0
, O 1 0.9995631575584412
and O 1 0.9998937845230103
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.005108200944960117

We O 0 3.6574085243046284e-05
report O 0 2.75275124295149e-06
the O 0 5.221609171712771e-06
spectrum O 0 6.501353345811367e-05
of O 0 0.00012347695883363485
59 O 0 0.0022394731640815735
ATM O 0 0.01477719284594059
mutations O 0 7.271066715475172e-05
observed O 0 8.559133129892871e-05
in O 0 0.00039727427065372467
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999973773956299
telangiectasia I-Disease 1 1.0
( O 0 0.002390687819570303
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999998807907104
) O 0 6.696299533359706e-05
patients O 0 1.635200169403106e-05
in O 0 7.975896551215556e-06
the O 0 3.814797310042195e-05
British O 0 0.0001406453811796382
Isles O 0 0.0012303341645747423
. O 0 0.00020788605615962297

Of O 0 0.0016800288576632738
51 O 0 0.004762810654938221
ATM O 0 0.07250615209341049
mutations O 0 0.00015944008191581815
identified O 0 5.1143251766916364e-05
in O 0 1.8367645679973066e-05
families O 0 4.010678367194487e-06
native O 0 1.3368867257668171e-05
to O 0 6.283750735747162e-06
the O 0 3.468694194452837e-05
British O 0 5.562778824241832e-05
Isles O 0 0.000269109703367576
, O 0 1.1774128324759658e-05
11 O 0 0.00015987854567356408
were O 0 0.0001254621020052582
founder O 0 0.0015678618801757693
mutations O 0 5.768624032498337e-05
, O 0 1.084646373783471e-05
and O 0 1.0763164937088732e-05
2 O 0 0.00023958312522154301
of O 0 8.238717418862507e-05
these O 0 2.0022573153255507e-05
11 O 0 0.00023170233180280775
conferred O 0 0.0002459039387758821
a O 0 1.6545996913919225e-05
milder O 0 2.58038653555559e-05
clinical O 0 2.6770863769343123e-05
phenotype O 0 1.0988527719746344e-05
with O 0 1.2334105576883303e-06
respect O 0 2.784950629575178e-05
to O 0 0.0001465810346417129
both O 0 0.00292301457375288
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9996640682220459
cellular O 1 0.9996638298034668
features O 0 0.0030475202947854996
. O 0 0.00044852247810922563

We O 0 5.4479027312481776e-05
report O 0 7.174886832217453e-06
, O 0 1.3275955552671803e-06
in O 0 4.603132765623741e-06
two O 0 1.352717572444817e-05
A B-Disease 1 0.9673057794570923
- I-Disease 0 0.22157806158065796
T I-Disease 1 0.9985098242759705
families O 0 1.2209618034830783e-05
, O 0 4.075360720889876e-06
an O 0 7.860536243242677e-06
ATM O 0 0.0042567127384245396
mutation O 0 5.39853899681475e-05
( O 0 7.952150190249085e-05
7271T O 0 0.004993340466171503
- O 0 0.0013084461679682136
- O 0 0.0006426986656151712
> O 0 0.0004543663817457855
G O 0 0.0010712019866332412
) O 0 1.0536885383771732e-05
that O 0 1.616768940948532e-06
may O 0 1.1760123015847057e-05
be O 0 1.564708895784861e-06
associated O 0 1.1199230129932403e-06
with O 0 2.667109129106393e-07
an O 0 2.3733962279948173e-06
increased O 0 0.00010628667951095849
risk O 0 0.000387794483685866
of O 0 0.00479758670553565
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999765157699585
in O 0 0.00023543689167127013
both O 0 5.954385414952412e-05
homozygotes O 0 0.003027457743883133
and O 0 3.6711306165670976e-05
heterozygotes O 0 0.001452303840778768
( O 0 7.553880277555436e-05
relative O 0 0.00020652740204241127
risk O 0 0.00016774180403444916
12 O 0 0.0001599895622348413
. O 0 1.1185993571416475e-05
7 O 0 0.00010581441893009469
; O 0 1.0123442734766286e-05
P O 0 0.0018088879296556115
= O 0 0.0004899096093140543
. O 0 4.363880361779593e-05
0025 O 0 0.008494643494486809
) O 0 9.993353160098195e-06
, O 0 1.5445220924448222e-06
although O 0 1.4065609548197244e-06
there O 0 3.3637995784374652e-06
is O 0 2.491758777978248e-06
a O 0 1.326296023762552e-05
less O 0 0.00010912912694038823
severe O 1 0.9972648620605469
A B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999934434890747
phenotype O 0 5.0497525080572814e-05
in O 0 3.847539574053371e-06
terms O 0 2.527867081880686e-06
of O 0 1.3060962373856455e-05
the O 0 4.847143645747565e-05
degree O 0 0.0008072197088040411
of O 1 0.8173786401748657
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9998800754547119

This O 0 4.9496979045215994e-05
mutation O 0 4.7067776904441416e-05
( O 0 7.11359825800173e-05
7271T O 0 0.004419253207743168
- O 0 0.0014326988020911813
- O 0 0.0006689385045319796
> O 0 0.0004999669035896659
G O 0 0.0013738514389842749
) O 0 8.457917829218786e-06
also O 0 2.111681851602043e-06
allows O 0 7.789701044202957e-07
expression O 0 7.6134874689159915e-06
of O 0 3.6025037843501195e-05
full O 0 0.0001901652867672965
- O 0 0.0006040362641215324
length O 0 8.325148519361392e-05
ATM O 0 0.0017239484004676342
protein O 0 2.635344208101742e-05
at O 0 5.524230800801888e-05
a O 0 6.244491032703081e-06
level O 0 5.483271525008604e-05
comparable O 0 7.662577263545245e-05
with O 0 2.7229466468270402e-06
that O 0 3.7447907743626274e-06
in O 0 4.077405537827872e-05
unaffected O 0 0.0003857258998323232
individuals O 0 9.191016033582855e-06
. O 0 0.00013709136692341417

In O 0 0.00013443078205455095
addition O 0 1.8657277905731462e-05
, O 0 3.2358911994379014e-06
we O 0 9.570206884745858e-07
have O 0 3.8824859416308755e-07
studied O 0 8.201406308216974e-05
18 O 0 0.0008044009446166456
A B-Disease 1 0.9999947547912598
- I-Disease 1 0.9999881982803345
T I-Disease 1 0.9999998807907104
patients O 0 6.539469177369028e-05
, O 0 3.41971804118657e-06
in O 0 6.8811632445431314e-06
15 O 0 2.509785736037884e-05
families O 0 1.677341288086609e-06
, O 0 2.223834371761768e-06
who O 0 8.57060331327375e-06
developed O 1 0.5822644233703613
leukemia B-Disease 1 1.0
, O 1 0.99982088804245
lymphoma B-Disease 1 1.0
, O 1 0.9976187348365784
preleukemic O 1 1.0
T O 1 1.0
- O 1 0.9999749660491943
cell O 1 0.5548309087753296
proliferation O 1 0.9998577833175659
, O 0 9.468681673752144e-05
or O 0 0.23486533761024475
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.004658969584852457
mostly O 0 0.0005075378576293588
in O 0 0.0005336964386515319
childhood O 1 0.8573408722877502
. O 0 0.0006962866755202413

A O 0 0.002555879531428218
wide O 0 0.0005591854569502175
variety O 0 7.514129538321868e-05
of O 0 0.0007057290058583021
ATM O 1 0.5624942779541016
mutation O 0 7.210277544800192e-05
types O 0 4.509217251325026e-05
, O 0 1.5320509191951714e-05
including O 0 2.746886275417637e-05
missense O 0 0.001106986659578979
mutations O 0 0.00025804087636061013
and O 0 8.274659921880811e-05
in O 0 0.0006054415134713054
- O 0 0.004251586273312569
frame O 0 0.001556473784148693
deletions O 0 0.0003699220542330295
, O 0 8.95114408194786e-06
were O 0 1.5207710021059029e-05
seen O 0 7.139429362723604e-05
in O 0 2.674636743904557e-05
these O 0 2.2824406187282875e-05
patients O 0 0.00019036231969948858
. O 0 0.00022662097762804478

We O 0 3.2994441426126286e-05
also O 0 2.233008672192227e-06
show O 0 4.321614142099861e-06
that O 0 2.5309063289569167e-07
25 O 0 8.081904525170103e-06
% O 0 1.631785153222154e-06
of O 0 1.509330832050182e-05
all O 0 0.00010405424836790189
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999979734420776
T I-Disease 1 0.9999998807907104
patients O 0 9.986724762711674e-05
carried O 0 8.111824718071148e-05
in O 0 0.00012832178617827594
- O 0 0.001588820363394916
frame O 0 0.0012591471895575523
deletions O 0 0.0005738019244745374
or O 0 0.00011155485117342323
missense O 0 0.0016739489510655403
mutations O 0 0.00015100507880561054
, O 0 1.347999022982549e-05
many O 0 3.6876442663924536e-06
of O 0 5.611230153590441e-05
which O 0 2.080631020362489e-05
were O 0 1.8760047169052996e-05
also O 0 3.995689439761918e-06
associated O 0 3.298171577625908e-06
with O 0 1.5975630276443553e-06
expression O 0 1.992483885260299e-05
of O 0 0.00027554697589948773
mutant O 0 0.0026310784742236137
ATM O 0 0.06066754832863808
protein O 0 0.0007820380269549787
. O 0 0.0001387293596053496

The O 0 0.0005100906710140407
DMPK O 1 0.9999873638153076
gene O 0 0.00021224768715910614
of O 0 0.0007025067461654544
severely O 1 1.0
affected O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999842643737793
is O 0 0.0011064874706789851
hypermethylated O 1 0.9965864419937134
proximal O 0 0.23982717096805573
to O 0 5.4651576647302136e-05
the O 0 8.505611185682938e-05
largely O 0 0.00013763231982011348
expanded O 0 0.0005041672266088426
CTG O 1 0.9684072732925415
repeat O 0 0.002982790581882
. O 0 0.00017043472325894982

Using O 0 0.00018764278502203524
methylation O 0 0.0006173306028358638
- O 0 0.0014524200232699513
sensitive O 0 0.00023961601254995912
restriction O 0 2.0109660908929072e-05
enzymes O 0 1.7840033251559362e-05
, O 0 3.28772034663416e-06
we O 0 3.6574886053131195e-06
characterized O 0 2.8058213501935825e-05
the O 0 4.354900374892168e-05
methylation O 0 5.537954712053761e-05
pattern O 0 0.00015338942466769367
on O 0 0.0001299611758440733
the O 0 7.0959358708933e-05
5 O 0 9.563216008245945e-05
side O 0 5.024716301704757e-05
of O 0 8.527799946023151e-05
the O 0 0.0006375653902068734
CTG O 1 0.9985602498054504
repeat O 0 0.0011264989152550697
in O 0 3.8462818338302895e-05
the O 0 0.0001072414088412188
DMPK O 0 0.42706310749053955
gene O 0 2.836196290445514e-05
of O 0 3.0901410354999825e-05
normal O 0 4.521303708315827e-05
individuals O 0 1.4986990208853967e-06
and O 0 5.420027264335658e-06
of O 0 0.00019544738461263478
patients O 0 0.0025743821170181036
affected O 0 0.20446261763572693
with O 1 0.9592986106872559
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.000780937378294766
showing O 0 0.0015746873104944825
expansions O 0 0.0029396829195320606
of O 0 0.0003592292487155646
the O 0 0.00034533513826318085
repetitive O 0 0.0025059848558157682
sequence O 0 0.0003297183138784021
. O 0 0.0001727151102386415

The O 0 0.00026237161364406347
gene O 0 4.2926072637783363e-05
segment O 0 6.0700760514009744e-05
analyzed O 0 1.5477155102416873e-05
corresponds O 0 1.4830007785349153e-05
to O 0 5.855260042153532e-06
the O 0 4.401562182465568e-05
genomic O 0 0.00042065020534209907
SacI O 0 0.07786927372217178
- O 0 0.0015271446900442243
HindIII O 0 0.004519676323980093
fragment O 0 0.0001959792571142316
carrying O 0 2.912504533014726e-05
exons O 0 0.00034812671947292984
11 O 0 0.0005040366086177528
- O 0 0.0007932932348921895
15 O 0 0.00036690125125460327
. O 0 0.00012731176684610546

There O 0 9.388419857714325e-05
is O 0 1.1478025044198148e-05
constitutive O 0 0.00026587158208712935
methylation O 0 9.362511627841741e-05
in O 0 0.00013083427620586008
intron O 0 0.0060754516161978245
12 O 0 0.00038193329237401485
at O 0 0.00017075274081435055
restriction O 0 1.1465902389318217e-05
sites O 0 2.5555764295859262e-05
of O 0 8.723680366529152e-05
SacII O 0 0.019176160916686058
and O 0 0.00011018083023373038
HhaI O 0 0.008445115759968758
, O 0 1.709402204141952e-05
localized O 0 0.00011371697473805398
1 O 0 0.0001556725474074483
, O 0 5.606691956927534e-06
159 O 0 3.7342822906794026e-05
- O 0 9.250638686353341e-05
1 O 0 9.609654807718471e-05
, O 0 6.025416041666176e-06
232 O 0 7.160586392274126e-05
bp O 0 0.00026656402042135596
upstream O 0 0.00022228808666113764
of O 0 7.005223596934229e-05
the O 0 0.0005343509837985039
CTG O 1 0.9991055130958557
repeat O 0 0.00231210608035326
, O 0 1.5838410035939887e-05
whereas O 0 2.1993453628965653e-05
most O 0 7.818079211574513e-06
, O 0 3.2732793897594092e-06
if O 0 1.4881910601616255e-06
not O 0 7.874415359765408e-07
all O 0 1.448632588108012e-06
, O 0 1.5175080534390872e-06
of O 0 8.178425559890456e-06
the O 0 1.677219188422896e-05
other O 0 2.6724815143097658e-06
sites O 0 5.1688079111045226e-05
of O 0 0.0002404664846835658
SacII O 1 0.8595372438430786
, O 0 0.000155709232785739
HhaI O 0 0.011938116513192654
, O 0 2.2259911929722875e-05
and O 0 1.208229787152959e-05
HpaII O 0 0.003746856702491641
in O 0 3.2841431675478816e-05
this O 0 4.728819021693198e-06
region O 0 0.00018656985776033252
are O 0 5.594562026089989e-06
unmethylated O 0 0.00115723826456815
, O 0 9.628194675315171e-06
in O 0 1.437456376152113e-05
normal O 0 4.63694341306109e-05
individuals O 0 1.76479250058037e-06
and O 0 7.641419870196842e-06
most O 0 1.473170232202392e-05
of O 0 0.000144607198308222
the O 0 0.0006412528455257416
patients O 0 0.0005859427619725466
. O 0 0.00022331796935759485

In O 0 9.130686521530151e-05
a O 0 1.885850724647753e-05
number O 0 1.262170644622529e-05
of O 0 0.0002594935358501971
young O 0 0.0016980115324258804
and O 0 0.0003315610811114311
severely O 1 0.5736990571022034
affected O 0 0.0002647331275511533
patients O 0 0.00015799058019183576
, O 0 1.1883810657309368e-05
however O 0 1.4848573300696444e-05
, O 0 3.6688668387796497e-06
complete O 0 0.0001046434190357104
methylation O 0 4.605948197422549e-05
of O 0 6.86594721628353e-05
these O 0 2.1238329281914048e-05
restriction O 0 2.4814649805193767e-05
sites O 0 5.087192039354704e-05
was O 0 0.00014970301708672196
found O 0 4.62406751466915e-06
in O 0 6.638759714405751e-06
the O 0 4.654136864701286e-05
mutated O 0 9.651559230405837e-05
allele O 0 2.4868682885426097e-05
. O 0 6.0036993090761825e-05

In O 0 9.600596968084574e-05
most O 0 1.2670708201767411e-05
of O 0 3.846674371743575e-05
these O 0 1.5946685380185954e-05
patients O 0 3.5941651731263846e-05
, O 0 5.4482602536154445e-06
the O 0 1.7026273781084456e-05
onset O 1 0.9833588004112244
of O 0 0.0007689166232012212
the O 1 0.9999059438705444
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9972182512283325

Preliminary O 0 0.0003822924627456814
in O 0 0.0005580959841609001
vivo O 0 0.007776620797812939
footprinting O 0 0.016546059399843216
data O 0 3.329100218252279e-05
gave O 0 2.149302054021973e-05
evidence O 0 3.2299656595569104e-05
for O 0 2.350975773879327e-05
protein O 0 0.0002858744701370597
- O 0 0.0004924878594465554
DNA O 0 0.00011898182856384665
contact O 0 1.615136170585174e-05
in O 0 1.5720073861302808e-05
normal O 0 6.203086377354339e-05
genes O 0 1.4240414202504326e-05
at O 0 8.49262869451195e-05
an O 0 1.4909077435731888e-05
Sp1 O 0 0.005269558168947697
consensus O 0 0.0001257985131815076
binding O 0 2.100029269058723e-05
site O 0 0.0003997694584541023
upstream O 0 0.00042593225953169167
of O 0 7.315954280784354e-05
the O 0 0.0005831901216879487
CTG O 1 0.992651641368866
repeat O 0 0.0012824776349589229
and O 0 5.433425485534826e-06
for O 0 2.194093667640118e-06
a O 0 5.989814781059977e-06
significant O 0 3.18610473186709e-05
reduction O 0 0.00011058027303079143
of O 0 4.125183477299288e-05
this O 0 6.118225428508595e-06
interaction O 0 1.672411963227205e-05
in O 0 1.64643679454457e-05
cells O 0 1.093154241971206e-05
with O 0 9.186881584355433e-07
a O 0 6.038092033122666e-05
hypermethylated O 0 0.3402365446090698
DMPK O 1 0.999936580657959
gene O 0 0.00038560290704481304
. O 0 5.770412099082023e-05
. O 0 7.536871271440759e-05

The O 0 0.004626304842531681
hemochromatosis B-Disease 1 1.0
gene O 0 0.00039464145083911717
product O 0 6.834070518380031e-05
complexes O 0 0.0004073457093909383
with O 0 9.821605090110097e-06
the O 0 0.00017701533215586096
transferrin O 0 0.0039001614786684513
receptor O 0 8.004120172699913e-05
and O 0 9.724895789986476e-06
lowers O 0 4.496828114497475e-05
its O 0 2.116044242939097e-06
affinity O 0 6.200104053277755e-06
for O 0 1.2041473382851109e-05
ligand O 0 0.00029678555438295007
binding O 0 8.297796011902392e-05
. O 0 0.00021314651530701667

We O 0 0.0001308965584030375
recently O 0 7.752560486551374e-05
reported O 0 1.914236599986907e-05
the O 0 1.3303546438692138e-05
positional O 0 0.0003940512251574546
cloning O 0 5.103548028273508e-05
of O 0 1.5367349988082424e-05
a O 0 1.564654849062208e-05
candidate O 0 2.0246785425115377e-05
gene O 0 5.463448178488761e-05
for O 0 0.0003335842629894614
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 0.00822317786514759

The O 0 0.00023089032038114965
gene O 0 4.166593498666771e-05
product O 0 1.6450743714813143e-05
, O 0 3.0047394830035046e-06
a O 0 3.777661504500429e-06
member O 0 5.5948712542885914e-06
of O 0 2.519623376429081e-05
the O 0 0.00014627331984229386
major O 0 0.00938712153583765
histocompatibility O 1 1.0
complex O 1 0.9999446868896484
class O 0 0.003892551176249981
I O 0 0.019653933122754097
- O 0 0.0005334210000000894
like O 0 9.675295586930588e-06
family O 0 7.750140866846777e-06
, O 0 3.480281975498656e-06
was O 0 8.238725422415882e-05
found O 0 4.085957243660232e-06
to O 0 4.820914000447374e-06
have O 0 2.840972229023464e-06
a O 0 2.446666439936962e-05
mutation O 0 3.0307322958833538e-05
, O 0 4.947489287587814e-05
Cys O 1 0.7343336343765259
- O 0 0.0021656393073499203
282 O 0 0.001758922473527491
- O 0 0.0013226732844486833
- O 0 0.0008276354055851698
> O 0 0.0006647310801781714
Tyr O 0 0.005649869330227375
( O 0 6.802989810239524e-05
C282Y O 0 0.0014591368380934
) O 0 1.2010003047180362e-05
, O 0 1.8078412722388748e-06
in O 0 4.94846199217136e-06
85 O 0 4.9275629862677306e-05
% O 0 2.0495117496466264e-05
of O 0 0.00022663480194751173
patient O 0 0.0008453509653918445
chromosomes O 0 0.0009744280832819641
. O 0 0.00031112501164898276

This O 0 7.66601151553914e-05
mutation O 0 2.789791142276954e-05
eliminates O 0 6.41747101326473e-05
the O 0 1.689962846285198e-05
ability O 0 1.4390379874384962e-05
of O 0 0.0001377469307044521
HFE O 1 0.9914020895957947
to O 0 4.707590414909646e-05
associate O 0 5.378318746807054e-05
with O 0 1.0826795914908871e-05
beta2 O 1 0.7450753450393677
- O 0 0.004048512317240238
microglobulin O 0 0.05006014555692673
( O 0 0.0002077776734950021
beta2m O 0 0.018522370606660843
) O 0 0.0001198753307107836
and O 0 4.896081372862682e-05
prevents O 0 0.00047866645036265254
cell O 0 0.002434154972434044
- O 0 0.0016135144978761673
surface O 0 0.0008569565252400935
expression O 0 0.00014278404705692083
. O 0 0.00013486617535818368

A O 0 0.0020375330932438374
second O 0 0.0002755064924713224
mutation O 0 8.446359061053954e-06
that O 0 9.487339411862195e-07
has O 0 2.5918145638570422e-06
no O 0 4.207979145576246e-06
effect O 0 3.897446003975347e-05
on O 0 0.00038562959525734186
beta2m O 0 0.032134734094142914
association O 0 0.0003861009608954191
, O 0 9.04825865291059e-05
H63D O 1 0.996241569519043
, O 0 3.0189514291123487e-05
was O 0 0.00017152214422821999
found O 0 6.612499873881461e-06
in O 0 7.885636478022207e-06
eight O 0 2.7628331736195832e-05
out O 0 4.4750563574780244e-06
of O 0 3.17359299515374e-05
nine O 0 0.00027391279581934214
patients O 0 4.920594074064866e-05
heterozygous O 0 6.877593932586024e-06
for O 0 5.711920948670013e-06
the O 0 0.00016438972670584917
C282Y O 0 0.00481026666238904
mutant O 0 0.0006382575375027955
. O 0 0.0001738227001624182

In O 0 0.00012493121903389692
this O 0 9.318674528913107e-06
report O 0 1.2244436220498756e-05
, O 0 2.2891283606440993e-06
we O 0 1.895895138659398e-06
demonstrate O 0 4.375472781248391e-05
in O 0 6.59389334032312e-05
cultured O 0 0.001177710248157382
293 O 0 0.002647601766511798
cells O 0 0.0006272020982578397
overexpressing O 0 0.01702597737312317
wild O 0 0.00047205996816046536
- O 0 0.0003318036033306271
type O 0 0.0001138966836151667
or O 0 7.700578862568364e-05
mutant O 0 0.0009888577042147517
HFE O 1 0.968158483505249
proteins O 0 2.4414104700554162e-05
that O 0 1.6380031411245e-06
both O 0 2.347705958527513e-06
the O 0 2.8759563065250404e-05
wild O 0 0.0002429489541100338
- O 0 0.0003149411058984697
type O 0 0.00019041093764826655
and O 0 0.00014171318616718054
H63D O 1 0.9999979734420776
HFE O 1 0.9997169375419617
proteins O 0 0.00014067476149648428
form O 0 5.613531902781688e-05
stable O 0 0.0007376893190667033
complexes O 0 0.0003395485400687903
with O 0 8.063680979830679e-06
the O 0 0.00011996465764241293
transferrin O 0 0.009561607614159584
receptor O 0 0.0006499802693724632
( O 0 0.00018023634038399905
TfR O 0 0.024517042562365532
) O 0 0.0001054979584296234
. O 0 7.287698826985434e-05

The O 0 0.001376245985738933
C282Y O 0 0.005833198316395283
mutation O 0 6.108203524490818e-05
nearly O 0 9.18807927519083e-05
completely O 0 0.00028994405874982476
prevents O 0 2.0256848074495792e-05
the O 0 1.6834112102515064e-05
association O 0 1.5790375982760452e-05
of O 0 4.738907955470495e-05
the O 0 0.0001726001937640831
mutant O 0 0.0013548277784138918
HFE O 1 0.9938495755195618
protein O 0 0.00017154161469079554
with O 0 1.779164631443564e-05
the O 0 0.0005697152810171247
TfR O 1 0.991741418838501
. O 0 0.000644007115624845

Studies O 0 0.00030714718741364777
on O 0 0.0006672865129075944
cell O 0 0.0009384084260091186
- O 0 0.00031669341842643917
associated O 0 2.6478521249373443e-05
transferrin O 0 0.0012326485011726618
at O 0 0.00019693380454555154
37 O 0 7.011259003775194e-05
degrees O 0 5.2300871175248176e-05
C O 0 0.00053064787061885
suggest O 0 2.162342752853874e-05
that O 0 2.4892081000871258e-06
the O 0 7.575847121188417e-05
overexpressed O 0 0.005858458112925291
wild O 0 0.00044137073564343154
- O 0 0.0006270018639042974
type O 0 0.0004240834095980972
HFE O 1 0.9831932783126831
protein O 0 0.00016578059876337647
decreases O 0 4.953290772391483e-05
the O 0 2.3355252778856084e-05
affinity O 0 1.5029377209430095e-05
of O 0 8.466526924166828e-05
the O 0 0.000533261161763221
TfR O 0 0.07402999699115753
for O 0 0.00027637151652015746
transferrin O 0 0.029384352266788483
. O 0 0.00039261195342987776

The O 0 0.0033533878158777952
overexpressed O 0 0.46659982204437256
H63D O 1 0.999675989151001
protein O 0 0.00011329723201924935
does O 0 1.6933448705458432e-06
not O 0 4.698023019500397e-07
have O 0 1.7849335165465163e-07
this O 0 6.23477546923823e-07
effect O 0 1.2711918316199444e-05
, O 0 1.6238088846876053e-06
providing O 0 2.418887561361771e-06
the O 0 4.497385361901252e-06
first O 0 6.532806764880661e-06
direct O 0 1.9239082575950306e-06
evidence O 0 1.1698066373355687e-05
for O 0 2.590519670775393e-06
a O 0 1.1798182640632149e-05
functional O 0 0.0001230157067766413
consequence O 0 0.00037789883208461106
of O 0 0.000535178289283067
the O 0 0.0025337226688861847
H63D O 1 0.9999997615814209
mutation O 0 0.00033763417741283774
. O 0 0.00018129029194824398

Addition O 0 0.00020713677804451436
of O 0 0.0009064637706615031
soluble O 0 0.06345687806606293
wild O 0 0.001297420240007341
- O 0 0.003734142519533634
type O 0 0.002993473317474127
HFE O 1 1.0
/ O 0 0.3497079610824585
beta2m O 0 0.49403664469718933
heterodimers O 0 0.019566141068935394
to O 0 0.00035635297535918653
cultured O 0 0.001940730377100408
cells O 0 0.00011298005119897425
also O 0 9.09672598936595e-06
decreased O 0 0.00025170965818688273
the O 0 2.7233438231633045e-05
apparent O 0 0.00015074366820044816
affinity O 0 3.4026797948172316e-05
of O 0 0.00015125496429391205
the O 0 0.0003826669417321682
TfR O 0 0.011980567127466202
for O 0 1.1196057130291592e-05
its O 0 2.402969403192401e-05
ligand O 0 0.00013052549911662936
under O 0 0.00021137001749593765
steady O 0 0.0015879960265010595
- O 0 0.0001688197662588209
state O 0 6.033069439581595e-06
conditions O 0 3.783762076636776e-05
, O 0 2.898605544032762e-06
both O 0 3.0510091164615005e-06
in O 0 4.092442395631224e-05
293 O 0 0.000971352681517601
cells O 0 0.00011570818605832756
and O 0 2.44799921347294e-05
in O 0 0.00030887266620993614
HeLa O 1 0.5657176971435547
cells O 0 0.00022758757404517382
. O 0 5.721229899791069e-05

Furthermore O 0 0.0006897038547322154
, O 0 1.4070496035856195e-05
at O 0 0.00010406734509160742
4 O 0 0.0001287243649130687
degrees O 0 6.962341285543516e-05
C O 0 0.000462069408968091
, O 0 3.7737474940513493e-06
the O 0 1.4313391147879884e-05
added O 0 0.00010089317947858945
soluble O 0 0.000595311401411891
complex O 0 0.0013921897625550628
of O 0 0.002397867850959301
HFE O 1 1.0
/ O 1 0.9553400874137878
beta2m O 0 0.06457728147506714
inhibited O 0 0.0005225299973972142
binding O 0 9.621577191865072e-06
of O 0 0.00015283259563148022
transferrin O 0 0.015343253500759602
to O 0 0.0006133356946520507
HeLa O 1 0.9925925135612488
cell O 0 0.0010202806442975998
TfR O 0 0.006016266066581011
in O 0 2.7216716262046248e-05
a O 0 4.968211578670889e-05
concentration O 0 0.010287844575941563
- O 0 0.001114125712774694
dependent O 0 4.878599429503083e-05
manner O 0 3.437677150941454e-05
. O 0 6.702126847812906e-05

Scatchard O 0 0.0020963288843631744
plots O 0 0.00016444051288999617
of O 0 5.3091378504177555e-05
these O 0 7.440215540555073e-06
data O 0 1.8317037756787613e-05
indicate O 0 5.254167626844719e-05
that O 0 3.301831839053193e-06
the O 0 3.4405758924549446e-05
added O 0 9.29184679989703e-05
heterodimer O 0 0.0005743782385252416
substantially O 0 6.59642755636014e-05
reduced O 0 1.806537329684943e-05
the O 0 1.3166602002456784e-05
affinity O 0 1.989333759411238e-05
of O 0 0.0002086714666802436
TfR O 0 0.33886080980300903
for O 0 0.00028190395096316934
transferrin O 0 0.03230256959795952
. O 0 0.00044753740075975657

These O 0 1.639608308323659e-05
results O 0 1.0893869330175221e-05
establish O 0 2.785372817015741e-05
a O 0 2.1738056602771394e-05
molecular O 0 0.00018522290338296443
link O 0 0.0021908883936703205
between O 0 0.007432722952216864
HFE O 1 0.9999988079071045
and O 0 4.0082646592054516e-05
a O 0 4.738446659757756e-05
key O 0 0.0005196633865125477
protein O 0 6.213612505234778e-05
involved O 0 6.638593913521618e-05
in O 0 0.0002699147444218397
iron O 1 0.9999556541442871
transport O 0 0.0016501679783686996
, O 0 7.549445581389591e-05
the O 0 0.0002241875190520659
TfR O 0 0.27559250593185425
, O 0 2.4328226572833955e-05
and O 0 5.255931682768278e-06
raise O 0 1.3955463145975955e-05
the O 0 1.3272146134113427e-05
possibility O 0 2.9269946026033722e-05
that O 0 1.2787186278728768e-06
alterations O 0 0.0002741824137046933
in O 0 2.4892315195756964e-05
this O 0 9.676383342593908e-06
regulatory O 0 0.0001626127923373133
mechanism O 0 0.0003619425115175545
may O 0 5.54749058210291e-05
play O 0 2.7098876671516337e-05
a O 0 5.150578999746358e-06
role O 0 1.5337043805629946e-05
in O 0 1.1293265743006486e-05
the O 0 7.975685730343685e-05
pathogenesis O 1 0.9999997615814209
of O 1 0.9995324611663818
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999998807907104
. O 0 0.009514221921563148

Genomic O 0 0.0002928561589214951
organization O 0 1.5257449376804288e-05
of O 0 0.00010908835974987596
the O 0 0.0011586743639782071
UBE3A O 1 0.9999998807907104
/ O 1 0.6035193800926208
E6 O 1 0.9999115467071533
- O 0 0.004261856898665428
AP O 0 0.0018551826942712069
gene O 0 1.4305517652246635e-05
and O 0 4.090008133061929e-06
related O 0 9.475654223933816e-05
pseudogenes O 0 0.002603695262223482
. O 0 0.00032662719604559243

The O 0 0.0010809529339894652
UBE3A O 0 0.32841581106185913
gene O 0 9.480553853791207e-05
encodes O 0 4.304469985072501e-05
the O 0 0.00010429106623632833
E6 O 1 0.709797739982605
- O 0 0.003156940219923854
AP O 0 0.003923893440514803
ubiquitin O 0 0.0009844247251749039
- O 0 0.00040368831832893193
protein O 0 3.392686994629912e-05
ligase O 0 0.00014918418310116976
and O 0 4.272365913493559e-06
has O 0 2.4609728370705852e-06
recently O 0 4.4443791011872236e-06
been O 0 8.837930067784328e-07
shown O 0 1.6960584616754204e-06
to O 0 1.1519169902385329e-06
be O 0 4.544570401776582e-06
mutated O 0 0.00017983344150707126
in O 0 0.013760033994913101
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999878406524658
who O 0 0.000944117025937885
lack O 0 0.19316904246807098
15q11 O 1 0.9947037100791931
- O 0 0.01180314365774393
q13 O 0 0.003176288679242134
deletions O 0 0.000369238288840279
or O 0 8.62170199980028e-05
chromosome O 0 0.0010846508666872978
15 O 0 0.0013043624348938465
paternal O 0 0.010506877675652504
uniparental B-Disease 1 0.9999985694885254
disomy I-Disease 1 0.9999275207519531
. O 0 0.002015742240473628

Previous O 0 0.0027879157569259405
UBE3A O 0 0.3103718161582947
cDNA O 0 0.00036221882328391075
analysis O 0 3.842915248242207e-06
has O 0 1.460777070860786e-06
shown O 0 5.720648914575577e-06
a O 0 6.689277142868377e-06
coding O 0 0.0001486118562752381
region O 0 0.00021395036310423166
of O 0 0.00013515169848687947
approximately O 0 0.000899623439181596
2 O 0 0.0016709547489881516
. O 0 0.0002518164983484894

6 O 0 0.002495452528819442
kb O 0 0.004321272484958172
and O 0 1.786321990948636e-05
a O 0 4.4637079554377124e-05
3 O 0 0.0003419562999624759
- O 0 0.0006772561464458704
untranslated O 0 0.009296349249780178
region O 0 0.0008894423954188824
( O 0 0.00017296065925620496
UTR O 0 0.21061131358146667
) O 0 5.118540866533294e-05
of O 0 9.401060378877446e-05
< O 0 0.002413656795397401
50 O 0 0.00026783806970342994
bp O 0 0.0003401109133847058
, O 0 3.608601900850772e-06
whereas O 0 4.241904662194429e-06
Northern O 0 6.853886134194909e-06
analysis O 0 8.326103966282972e-07
has O 0 1.497024982199946e-06
indicated O 0 8.382573469134513e-06
mRNA O 0 2.1124264094396494e-05
sizes O 0 2.8971519441256532e-06
of O 0 2.335650242457632e-05
5 O 0 0.00028643652331084013
- O 0 0.0004142418911214918
8 O 0 0.0003498270525597036
kb O 0 0.005041501950472593
. O 0 0.000229569966904819

We O 0 2.7638556275633164e-05
have O 0 4.7643169409639086e-07
analyzed O 0 4.219081347400788e-06
additional O 0 3.4972706544067478e-06
cDNA O 0 0.00040223149699158967
clones O 0 0.00032285487395711243
and O 0 1.2129560218454571e-06
provide O 0 1.2306118151172996e-06
evidence O 0 5.7065631153818686e-06
for O 0 1.6594354974586167e-06
an O 0 2.3747522845951607e-06
additional O 0 1.953570063051302e-05
0 O 0 0.00019679528486449271
. O 0 0.0001576474605826661

5 O 0 0.0007821829058229923
kb O 0 0.002863975940272212
of O 0 0.0004123984545003623
5 O 0 0.0017408146522939205
- O 0 0.0019411479588598013
UTR O 0 0.02998085878789425
and O 0 1.3046758795098867e-05
> O 0 4.818266461370513e-05
2 O 0 7.010978151811287e-05
kb O 0 0.0007454127771779895
of O 0 0.00017915279022417963
3 O 0 0.002362185390666127
- O 0 0.007741525303572416
UTR O 1 0.9828599095344543
. O 0 0.00028312168433330953

We O 0 2.2010341126588173e-05
have O 0 9.150236905952625e-07
established O 0 1.7081849364330992e-05
the O 0 1.2447684639482759e-05
genomic O 0 3.989266406279057e-05
organization O 0 1.8030985302175395e-05
of O 0 0.00021731121523771435
UBE3A O 1 0.9780594110488892
and O 0 1.3931620742368978e-05
the O 0 1.1898133379872888e-05
sequence O 0 1.7990603737416677e-05
of O 0 0.00021059751452412456
intron O 0 0.07421059161424637
- O 0 0.006251029670238495
exon O 0 0.0015142534393817186
borders O 0 9.401643183082342e-05
. O 0 6.613710866076872e-05

We O 0 8.726284431759268e-05
have O 0 2.6375553261459572e-06
also O 0 3.2297928100888385e-06
mapped O 0 1.7632144590606913e-05
two O 0 2.834290626196889e-06
highly O 0 4.075679316883907e-05
homologous O 0 0.00010932266741292551
processed O 0 0.00014137360267341137
pseudogenes O 0 0.0007671531056985259
, O 0 3.648149504442699e-05
UBE3AP1 O 1 0.9981768131256104
and O 0 8.176066330634058e-05
UBE3AP2 O 1 0.9993187189102173
, O 0 1.9346631233929656e-05
to O 0 1.068935034709284e-05
chromosomes O 0 4.51221494586207e-05
2 O 0 0.0001255551032954827
and O 0 1.1235859346925281e-05
21 O 0 0.00022668948804493994
, O 0 1.1730307051038835e-05
respectively O 0 5.3943644161336124e-05
, O 0 4.684650775743648e-06
and O 0 2.025543153649778e-06
determined O 0 1.0752105481515173e-05
their O 0 3.6216270018485375e-06
genomic O 0 0.00010814769484568387
organization O 0 5.808201967738569e-05
. O 0 0.00011702206393238157

These O 0 2.606011366879102e-05
results O 0 7.622939392604167e-06
will O 0 1.6187004803214222e-06
form O 0 8.130143100970599e-07
the O 0 3.5228983961133054e-06
basis O 0 2.5322513010905823e-06
for O 0 1.5154442962739267e-06
studies O 0 6.424059392884374e-06
of O 0 4.431997876963578e-05
mutation O 0 3.462989116087556e-05
and O 0 4.1059600334847346e-05
imprinting O 0 0.0032767504453659058
of O 0 0.010262511670589447
UBE3A O 1 0.9999998807907104
. O 0 0.002507802564650774

Mutation O 0 0.0004239916452206671
spectrum O 0 0.0007669188198633492
and O 0 7.979740621522069e-05
genotype O 0 0.0007346932543441653
- O 0 0.000583726679906249
phenotype O 0 2.2419482775148936e-05
analyses O 0 1.8484992324374616e-05
in O 0 0.0001435223821317777
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0006710734451189637
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0001411521661793813
two O 0 0.00035888521233573556
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9783012270927429
germline O 1 1.0
PTEN O 1 1.0
mutation O 0 0.0023857029154896736
. O 0 0.0006441464647650719

The O 0 0.00750928046181798
tumour B-Disease 1 1.0
suppressor O 1 0.9982694387435913
gene O 0 0.0020252957474440336
PTEN O 0 0.3709522783756256
, O 0 9.155664884019643e-06
which O 0 1.9181118204869563e-06
maps O 0 2.4555394702474587e-05
to O 0 5.0547445425763726e-05
10q23 O 0 0.005535162054002285
. O 0 0.00016733459779061377

3 O 0 0.0005880138487555087
and O 0 1.0584290976112243e-05
encodes O 0 1.0888053111557383e-05
a O 0 9.520372259430587e-06
403 O 0 2.9604316296172328e-05
amino O 0 1.8078902940033004e-05
acid O 0 2.3080630853655748e-05
dual O 0 4.755658301291987e-05
specificity O 0 0.0001218327961396426
phosphatase O 0 0.0026077141519635916
( O 0 0.00010475692397449166
protein O 0 0.00016687522293068469
tyrosine O 0 0.00015789583267178386
phosphatase O 0 0.0016505637904629111
; O 0 3.4093511203536764e-05
PTPase O 0 0.0068291788920760155
) O 0 2.1994372218614444e-05
, O 0 3.1796043913345784e-06
was O 0 4.49579929409083e-05
shown O 0 2.3219648937811144e-05
recently O 0 2.2926042220206e-05
to O 0 2.8743290840793634e-06
play O 0 1.622634408704471e-05
a O 0 6.227754965948407e-06
broad O 0 2.9177670512581244e-05
role O 0 9.012281225295737e-05
in O 0 0.00020638290152419358
human O 0 0.0009404487209394574
malignancy B-Disease 1 0.9999991655349731
. O 0 0.0008366178371943533

Somatic O 0 0.06609533727169037
PTEN O 1 0.9997852444648743
deletions O 0 0.0011857404606416821
and O 0 2.8897271477035247e-05
mutations O 0 2.3569289623992518e-05
were O 0 2.144999962183647e-05
observed O 0 3.307897350168787e-05
in O 0 4.451503627933562e-05
sporadic B-Disease 0 0.0064990948885679245
breast I-Disease 1 0.9999802112579346
, I-Disease 0 0.0003163075016345829
brain I-Disease 1 0.9999998807907104
, I-Disease 0 0.001345618162304163
prostate I-Disease 1 1.0
and I-Disease 1 1.0
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.0010773609392344952
and O 0 1.533849172119517e-05
in O 0 1.8769496819004416e-05
several O 0 3.106687290710397e-05
primary O 0 0.0008828220306895673
tumours B-Disease 1 1.0
such O 0 6.429060158552602e-05
as O 1 0.9999659061431885
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9999996423721313

In O 0 0.00019819724548142403
addition O 0 0.0001057072076946497
, O 0 7.728387572569773e-05
PTEN O 1 0.9599590301513672
was O 0 0.000360268575605005
identified O 0 1.889524719445035e-05
as O 0 4.566662937577348e-06
the O 0 1.0268986443406902e-05
susceptibility O 0 5.9202666307101026e-05
gene O 0 6.328018116619205e-06
for O 0 6.1263644965947606e-06
two O 0 0.00021526814089156687
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.7300469875335693
CD B-Disease 1 0.9999995231628418
; O 0 0.00042638363083824515
MIM O 1 0.9997115731239319
158350 O 0 0.0037756520323455334
) O 0 1.9599314327933826e-05
and O 0 1.4871941857563797e-05
Bannayan B-Disease 1 0.7724151015281677
- I-Disease 0 0.008345137350261211
Zonana I-Disease 1 0.9987360835075378
( I-Disease 0 0.00044890810386277735
BZS I-Disease 1 0.9987127780914307
) I-Disease 0 0.00013882886560168117
or I-Disease 0 0.000105343344330322
Ruvalcaba I-Disease 0 0.21300002932548523
- I-Disease 0 0.0038719684816896915
Riley I-Disease 0 0.0053808423690497875
- I-Disease 0 0.038487836718559265
Smith I-Disease 1 0.9716192483901978
syndrome I-Disease 1 1.0
( O 0 0.018933027982711792
MIM O 1 1.0
153480 O 1 0.984900712966919
) O 0 0.0003001429431606084
. O 0 0.00011888451990671456

Constitutive O 0 0.006433263421058655
DNA O 0 0.0010643075220286846
from O 0 0.0002137831470463425
37 O 0 0.0006464299513027072
CD B-Disease 0 0.005301794037222862
families O 0 5.73217221244704e-06
and O 0 6.486396614491241e-06
seven O 0 0.000144749297760427
BZS B-Disease 1 0.9841259717941284
families O 0 8.516689376847353e-06
was O 0 0.00013586612476501614
screened O 0 0.0002429836749797687
for O 0 0.000103741382190492
germline O 1 0.7552976608276367
PTEN O 1 0.9999374151229858
mutations O 0 0.0017824756214395165
. O 0 0.0006595042650587857

PTEN O 1 0.972213625907898
mutations O 0 0.00011033096234314144
were O 0 3.877730341628194e-05
identified O 0 2.1202105926931836e-05
in O 0 1.5102090401342139e-05
30 O 0 7.92235805420205e-05
of O 0 0.00010122506500920281
37 O 0 0.000280905922409147
( O 0 3.7335521483328193e-05
81 O 0 0.0003280036908108741
% O 0 5.2112238336121663e-05
) O 0 4.1990671888925135e-05
CD B-Disease 0 0.0027100606821477413
families O 0 7.406319582514698e-06
, O 0 4.882739631284494e-06
including O 0 1.2044723916915245e-05
missense O 0 0.000511300575453788
and O 0 7.46159057598561e-05
nonsense O 0 0.0021477879490703344
point O 0 0.0015857001999393106
mutations O 0 0.00018469277711119503
, O 0 3.0577426514355466e-05
deletions O 0 0.0002094772207783535
, O 0 2.3585658709635027e-05
insertions O 0 0.00025047408416867256
, O 0 1.1619946235441603e-05
a O 0 4.8931084165815264e-05
deletion O 0 0.002351209754124284
/ O 0 0.004977955482900143
insertion O 0 0.0012023160234093666
and O 0 0.0001439920160919428
splice O 0 0.003453311510384083
site O 0 0.00251719169318676
mutations O 0 0.00035834897425957024
. O 0 0.00019494375737849623

These O 0 5.931427585892379e-05
mutations O 0 5.746651004301384e-05
were O 0 3.957701846957207e-05
scattered O 0 5.654321284964681e-05
over O 0 2.4063863747869618e-05
the O 0 8.478410745738074e-05
entire O 0 0.00047865574015304446
length O 0 0.00014070414181333035
of O 0 0.0004654690274037421
PTEN O 1 0.9575505256652832
, O 0 1.4316176930151414e-05
with O 0 1.3662050832863315e-06
the O 0 1.6007355952751823e-05
exception O 0 1.4385013855644502e-05
of O 0 2.8153846869827248e-05
the O 0 5.2916690037818626e-05
first O 0 7.047611143207178e-05
, O 0 7.858999197196681e-06
fourth O 0 0.00010754228424048051
and O 0 6.095930530136684e-06
last O 0 0.00015947202336974442
exons O 0 0.001554256770759821
. O 0 0.0001482605584897101

A O 0 0.007692134473472834
hot O 0 0.0030541166197508574
spot O 0 0.0006976848817430437
for O 0 8.153914677677676e-05
PTEN O 0 0.05195314809679985
mutation O 0 2.5157480195048265e-05
in O 0 5.361123112379573e-05
CD B-Disease 0 0.006641698069870472
was O 0 0.00027616447187028825
identified O 0 1.4227762221707962e-05
in O 0 1.5585383152938448e-05
exon O 0 0.00016301173309329897
5 O 0 1.748354043229483e-05
that O 0 5.53769268663018e-07
contains O 0 7.71288341638865e-06
the O 0 3.805756932706572e-05
PTPase O 0 0.013408509083092213
core O 0 0.001160836429335177
motif O 0 0.00021193384600337595
, O 0 1.6604311667833827e-06
with O 0 9.03417685549357e-07
13 O 0 6.9950103352312e-05
of O 0 9.905898332362995e-05
30 O 0 0.0002815832558553666
( O 0 2.1878540792386048e-05
43 O 0 8.925404108595103e-05
% O 0 4.18420931964647e-05
) O 0 5.173907265998423e-05
CD B-Disease 0 0.004666121210902929
mutations O 0 3.4159806091338396e-05
identified O 0 1.649131991143804e-05
in O 0 1.8155253201257437e-05
this O 0 1.589818566571921e-05
exon O 0 0.000924757681787014
. O 0 6.285532435867935e-05

Seven O 0 0.0002601172309368849
of O 0 0.00021815302898176014
30 O 0 0.0004290795768611133
( O 0 4.21540426032152e-05
23 O 0 0.0002882720436900854
% O 0 2.1630996343446895e-05
) O 0 6.826768185419496e-06
were O 0 1.1272735719103366e-05
within O 0 1.3065671737422235e-05
the O 0 6.021084118401632e-05
core O 0 0.0020907639991492033
motif O 0 0.0003778242680709809
, O 0 3.0107487418717938e-06
the O 0 7.865268344176002e-06
majority O 0 3.481360863588634e-06
( O 0 9.092397704080213e-06
five O 0 9.090993444260675e-06
of O 0 3.675783227663487e-05
seven O 0 8.802899537840858e-05
) O 0 1.0462416867085267e-05
of O 0 3.118691893178038e-05
which O 0 2.6140687623410486e-05
were O 0 0.00013419947936199605
missense O 0 0.0013466564705595374
mutations O 0 0.00027703604428097606
, O 0 3.938357986044139e-05
possibly O 0 0.00031677947845309973
pointing O 0 0.000235052895732224
to O 0 1.1545759662112687e-05
the O 0 2.2556778276339173e-05
functional O 0 5.720760964322835e-05
significance O 0 0.000158745315275155
of O 0 0.00014768855180591345
this O 0 4.686752436100505e-05
region O 0 0.001171208219602704
. O 0 0.0001629146427148953

Germline O 1 0.992203950881958
PTEN O 1 0.9960075616836548
mutations O 0 0.00011142058065161109
were O 0 3.3555359550518915e-05
identified O 0 1.0583836228761356e-05
in O 0 5.9445510487421416e-06
four O 0 3.886355898430338e-06
of O 0 3.795934026129544e-05
seven O 0 0.00011998363333987072
( O 0 3.0810897442279384e-05
57 O 0 0.0001881416974356398
% O 0 9.175899322144687e-05
) O 0 0.00017103740538004786
BZS B-Disease 1 0.9732515811920166
families O 0 3.492589894449338e-05
studied O 0 0.0007227761088870466
. O 0 0.0003286487772129476

Interestingly O 0 0.0020224566105753183
, O 0 2.0719740859931335e-05
none O 0 3.8066933484515175e-05
of O 0 3.1472634873352945e-05
these O 0 2.0821533325943165e-05
mutations O 0 9.617978503229097e-05
was O 0 0.000489908445160836
observed O 0 3.8780410250183195e-05
in O 0 2.8833901524194516e-05
the O 0 0.00014628337521571666
PTPase O 1 0.8370904326438904
core O 0 0.014985248446464539
motif O 0 0.0024578364100307226
. O 0 0.0002499597903806716

It O 0 4.399489262141287e-05
is O 0 6.042391760274768e-06
also O 0 3.662850076580071e-06
worthy O 0 7.958165224408731e-05
of O 0 4.9737340305000544e-05
note O 0 4.960802834830247e-05
that O 0 3.4820086511899717e-06
a O 0 2.136823059117887e-05
single O 0 4.3698513763956726e-05
nonsense O 0 0.0006120530306361616
point O 0 0.0003055189736187458
mutation O 0 2.6744988645077683e-05
, O 0 1.3906851563660894e-05
R233X O 0 0.001138782361522317
, O 0 1.2498333489929792e-05
was O 0 0.00012459429854061455
observed O 0 2.5415985874133185e-05
in O 0 2.0776966266566887e-05
the O 0 9.570742258802056e-05
germline O 0 0.0022793347015976906
DNA O 0 0.0002504614822100848
from O 0 4.8363210225943476e-05
two O 0 3.614534580265172e-05
unrelated O 0 0.0005706402589567006
CD B-Disease 0 0.009297904558479786
families O 0 1.7046453649527393e-05
and O 0 2.40683166339295e-05
one O 0 0.00011042043479392305
BZS B-Disease 1 0.9998871088027954
family O 0 0.0003895710106007755
. O 0 0.00016888914979062974

Genotype O 0 0.004803782794624567
- O 0 0.0015595052391290665
phenotype O 0 2.7109552320325747e-05
studies O 0 2.829990535246907e-06
were O 0 3.839882083411794e-06
not O 0 1.0666188927643816e-06
performed O 0 4.7938156058080494e-05
on O 0 2.8567423214553855e-05
this O 0 2.2562151116289897e-06
small O 0 4.272732894605724e-06
group O 0 3.581609462344204e-06
of O 0 0.00021966666099615395
BZS B-Disease 1 0.9999898672103882
families O 0 0.00012095535930711776
. O 0 0.0001648880133870989

However O 0 0.0002897213271353394
, O 0 3.622561052907258e-05
genotype O 0 0.0002844094706233591
- O 0 0.0003791922063101083
phenotype O 0 2.466901787556708e-05
analysis O 0 7.699411980865989e-06
inthe O 0 0.0016585743287578225
group O 0 1.7779739209800027e-05
of O 0 0.00031373422825708985
CD B-Disease 1 0.797581672668457
families O 0 3.683475006255321e-05
revealed O 0 0.0002221654140157625
two O 0 5.626955498883035e-06
possible O 0 1.5174505278992001e-05
associations O 0 7.071322215779219e-06
worthy O 0 0.0002431050961604342
of O 0 0.0001918192283483222
follow O 0 0.0001823733764467761
- O 0 0.00030319186043925583
up O 0 2.6148341930820607e-05
in O 0 6.722685611748602e-06
independent O 0 3.3602148050704272e-06
analyses O 0 2.974104972963687e-05
. O 0 7.49220562283881e-05

The O 0 0.0002527333563193679
first O 0 7.728461059741676e-05
was O 0 0.00021464875317178667
an O 0 5.13117856826284e-06
association O 0 2.1177291273488663e-05
noted O 0 2.2158630599733442e-05
in O 0 7.369063951045973e-06
the O 0 1.6692982171662152e-05
group O 0 4.631340743799228e-06
of O 0 7.145669223973528e-05
CD B-Disease 0 0.4342148005962372
families O 0 4.855994484387338e-05
with O 0 0.00035786404623650014
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.003669179743155837

A O 0 0.0010759972501546144
correlation O 0 6.346146255964413e-05
was O 0 0.0002271193516207859
observed O 0 1.4479210221907124e-05
between O 0 3.099615059909411e-05
the O 0 4.924829045194201e-05
presence O 0 0.0001305367040913552
/ O 0 0.0006316755898296833
absence O 0 0.0003882402088493109
of O 0 0.00040947808884084225
a O 0 0.0009256599587388337
PTEN O 1 0.9991046786308289
mutation O 0 2.1214362277532928e-05
and O 0 3.5239536373410374e-06
the O 0 2.0911700630676933e-05
type O 0 0.00017019096412695944
of O 0 0.0006573509308509529
breast O 1 0.9999662637710571
involvement O 1 0.8444023728370667
( O 0 0.0016462603816762567
unaffected O 0 0.010855101980268955
versus O 0 0.017090875655412674
benign O 1 0.9998835325241089
versus O 1 0.9998531341552734
malignant O 1 1.0
) O 0 0.002530579222366214
. O 0 0.0005505171720869839

Specifically O 0 0.00016661050904076546
and O 0 1.2100803360226564e-05
more O 0 2.3968498226167867e-06
directly O 0 1.7236106941709295e-05
, O 0 4.743077170132892e-06
an O 0 4.1820549085969105e-06
association O 0 3.7820518627995625e-05
was O 0 0.00019807161879725754
also O 0 5.561155376199167e-06
observed O 0 4.828726105188252e-06
between O 0 1.6739850252633914e-05
the O 0 9.327700354333501e-06
presence O 0 1.1250119314354379e-05
of O 0 3.692883183248341e-05
a O 0 0.00048808366409502923
PTEN O 1 0.9999998807907104
mutation O 0 0.0006377908866852522
and O 0 0.0026815233286470175
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.5162224769592285

Secondly O 0 0.00388540280982852
, O 0 2.1911782823735848e-05
there O 0 9.897285963234026e-06
appeared O 0 7.374694541795179e-05
to O 0 8.857279681251384e-06
be O 0 9.516505087958649e-06
an O 0 9.014183888211846e-06
interdependent O 0 0.0011919911485165358
association O 0 6.769809988327324e-05
between O 0 0.0004661670536734164
mutations O 0 0.00025132286828011274
upstream O 0 0.0012104437919333577
and O 0 7.303313395823352e-06
within O 0 1.718794919725042e-05
the O 0 0.00015385185542982072
PTPase O 1 0.8132645487785339
core O 0 0.004711759276688099
motif O 0 0.000580635154619813
, O 0 7.738028216408566e-06
the O 0 2.2868414816912264e-05
core O 0 0.0007915745372883976
motif O 0 0.00016076180327218026
containing O 0 3.4082037018379197e-05
the O 0 1.2356978913885541e-05
majority O 0 4.420867298904341e-06
of O 0 8.611907833255827e-05
missense O 0 0.0018018486443907022
mutations O 0 0.00018385570729151368
, O 0 1.531920861452818e-05
and O 0 4.685950898419833e-06
the O 0 3.1211020541377366e-05
involvement O 0 9.917921124724671e-05
of O 0 0.0001277594274142757
all O 0 4.983010876458138e-05
major O 0 0.4431421160697937
organ O 1 1.0
systems O 1 0.9998185038566589
( O 0 0.0005038708331994712
central O 0 0.011813482269644737
nervous O 0 0.1823461949825287
system O 0 0.0025405113119632006
, O 0 0.0006504369666799903
thyroid O 1 1.0
, O 1 0.999277651309967
breast O 1 1.0
, O 1 0.9974517226219177
skin O 1 1.0
and O 1 0.9999834299087524
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.997294008731842
. O 0 0.001987871713936329

However O 0 0.00016996425983961672
, O 0 5.901317308598664e-06
these O 0 8.698745546098507e-07
observations O 0 8.215699381253216e-06
would O 0 3.4602398955030367e-06
need O 0 4.644175987777999e-06
to O 0 3.236625616409583e-06
be O 0 3.2716973237256752e-06
confirmed O 0 4.0801360228215344e-06
by O 0 8.401928539569781e-07
studying O 0 8.39489348436473e-06
a O 0 4.2619849409675226e-06
larger O 0 8.069911928032525e-06
number O 0 6.521788691316033e-06
of O 0 0.00016453731223009527
CD B-Disease 0 0.030682435259222984
families O 0 7.816318975528702e-05
. O 0 0.00012186602543806657

Molecular O 1 0.9914968609809875
defects O 1 0.9999961853027344
leading O 0 0.0011931650806218386
to O 0 5.4569343774346635e-05
human O 0 0.0001194923315779306
complement B-Disease 0 0.019903434440493584
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0005865906132385135
an O 0 2.9380666092038155e-05
African O 0 0.00018337722576688975
- O 0 0.00018608818936627358
American O 0 2.2260741388890892e-05
family O 0 2.6084182536578737e-05
. O 0 4.391830589156598e-05

Complement B-Disease 0 0.017773596569895744
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.5052130222320557
C6D B-Disease 1 0.9999998807907104
) O 0 0.0003987205564044416
was O 0 0.00148761214222759
diagnosed O 0 0.014639765955507755
in O 0 0.00010708731861086562
a O 0 7.952954183565453e-05
16 O 0 0.0005396634805947542
- O 0 0.00030892950599081814
year O 0 6.681661034235731e-05
- O 0 9.700544615043327e-05
old O 0 0.000109991138742771
African O 0 6.009307617205195e-05
- O 0 9.632003639126197e-05
American O 0 8.583854651078582e-06
male O 0 4.675823947764002e-05
with O 0 0.00013937508629169315
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.006088151130825281

The O 0 0.00089797138934955
patients O 0 0.0001973112375708297
father O 0 0.00029507384169846773
and O 0 1.6051259080995806e-05
two O 0 3.2546769944019616e-05
brothers O 0 0.0013260386185720563
also O 0 9.764312562765554e-05
had O 0 0.0010688630864024162
C6D B-Disease 1 0.9999830722808838
, O 0 2.9099228413542733e-05
but O 0 1.7248602262043278e-06
gave O 0 8.066711416176986e-06
no O 0 7.517084668506868e-06
history O 0 0.00028391179512254894
of O 0 0.0016062984941527247
meningitis B-Disease 1 1.0
or O 0 0.0007825758657418191
other O 0 0.0003794780350290239
neisserial B-Disease 1 0.9999998807907104
infection I-Disease 1 0.9999123811721802
. O 0 0.0007770938100293279

By O 0 5.45464972674381e-05
using O 0 2.3812770450604148e-05
exon O 0 0.0003489490773063153
- O 0 3.2806157832965255e-05
specific O 0 7.527879688495887e-07
polymerase O 0 0.00011984791490249336
chain O 0 6.77548669045791e-05
reaction O 0 1.528418761154171e-05
( O 0 5.471446274896152e-05
PCR O 0 0.0003701532550621778
) O 0 5.117433101986535e-05
/ O 0 0.00040959561010822654
single O 0 7.03424884704873e-05
- O 0 0.00040872112731449306
strand O 0 7.718399865552783e-05
conformation O 0 1.0969995855703019e-05
polymorphism O 0 4.117312528251205e-06
as O 0 3.2884604479477275e-06
a O 0 3.5098905755148735e-06
screening O 0 7.60710008762544e-06
step O 0 2.6515488571021706e-05
and O 0 2.257614141853992e-06
nucleotide O 0 7.296588137251092e-06
sequencing O 0 1.4202221791492775e-05
of O 0 2.557514380896464e-05
target O 0 3.848284904961474e-05
exons O 0 0.00031799348653294146
, O 0 5.803834483231185e-06
we O 0 1.4228288591766614e-06
determined O 0 5.122035872773267e-06
that O 0 1.1647043720586225e-06
the O 0 3.0090353902778588e-05
proband O 0 0.0029793139547109604
was O 0 0.00015458991401828825
a O 0 2.4455908715026453e-05
compound O 0 0.00029794397414661944
heterozygote O 0 0.00035358115565031767
for O 0 1.9668179447762668e-05
two O 0 0.00013915861200075597
C6 O 1 0.9999997615814209
gene O 0 0.0003329792816657573
mutations O 0 0.00014505258877761662
. O 0 0.0001946128177223727

The O 0 0.0002900930994655937
first O 0 0.00012963566405232996
, O 0 1.2779220924130641e-05
1195delC O 0 0.0006944239721633494
located O 0 0.00016363157192245126
in O 0 7.013064168859273e-05
exon O 0 0.0007330819498747587
7 O 0 0.00021622839267365634
, O 0 5.4430456657428294e-06
is O 0 1.6469142565256334e-06
a O 0 7.083247965056216e-06
novel O 0 4.9814243539003655e-05
mutation O 0 3.711151293828152e-06
, O 0 1.7224734847332002e-06
while O 0 2.3585000690218294e-06
the O 0 1.6654468709020875e-05
second O 0 8.845722913974896e-05
, O 0 1.239795074070571e-05
1936delG O 0 0.0007769989897496998
in O 0 7.185910362750292e-05
exon O 0 0.0007109071011655033
12 O 0 0.00013029668480157852
, O 0 6.336768819892313e-06
has O 0 2.735043381107971e-06
been O 0 6.9002403506601695e-06
described O 0 2.4876344468793832e-05
before O 0 7.624687714269385e-05
to O 0 4.1323728510178626e-05
cause O 0 0.0009612211724743247
C6D B-Disease 1 0.9998204112052917
in O 0 0.00010631880286382511
an O 0 2.2033022105460986e-05
unrelated O 0 0.0003622424555942416
African O 0 0.00043917339644394815
- O 0 0.0005718631437048316
American O 0 2.9332342819543555e-05
individual O 0 1.5968538718880154e-05
. O 0 0.00010934330202871934

Both O 0 9.107294317800552e-05
mutations O 0 0.00013104417303111404
result O 0 0.00012490383232943714
in O 0 0.00036579984589479864
premature O 0 0.004260566551238298
termination O 0 0.0022333506494760513
codons O 0 0.003448918228968978
and O 0 0.0007786162896081805
C6 O 1 0.999971866607666
null O 0 0.000987192615866661
alleles O 0 0.00010583348193904385
. O 0 0.00014714790449943393

Allele O 0 0.00018234243907500058
- O 0 0.00012788240564987063
specific O 0 1.390253601130098e-06
PCR O 0 5.784378663520329e-05
indicated O 0 1.228307701239828e-05
that O 0 4.2755513618430996e-07
the O 0 1.4299078429758083e-05
probands O 0 0.002293898956850171
two O 0 1.450242598366458e-05
brothers O 0 0.00041021607466973364
also O 0 4.988758882973343e-05
inherited O 1 0.7436652779579163
the O 0 0.0009440301219001412
1195delC O 0 0.008279366418719292
mutation O 0 3.4852768294513226e-05
from O 0 3.3180513128172606e-05
their O 0 1.7447298887418583e-05
heterozygous O 0 4.552224345388822e-05
mother O 0 4.563399124890566e-05
and O 0 5.954258995188866e-06
the O 0 7.253627700265497e-05
1936delG O 0 0.002828949363902211
mutation O 0 1.4462112631008495e-05
from O 0 2.2117439584690146e-05
their O 0 1.692409387032967e-05
homozygous O 0 0.00040307114250026643
father O 0 0.0007135106716305017
. O 0 7.291542715393007e-05
. O 0 0.0001222699211211875

PAX6 O 1 0.9934784173965454
mutations O 0 0.00036239446490071714
reviewed O 0 0.0006167402025312185
. O 0 0.00022589851869270205

Mutations O 0 0.0007464567315764725
in O 0 0.0004585346905514598
PAX6 O 1 0.9795776009559631
are O 0 1.0986589586536866e-05
responsible O 0 4.6864395699230954e-05
for O 0 5.810069342260249e-05
human O 0 0.000843956891912967
aniridia B-Disease 1 0.9999997615814209
and O 0 3.168594048474915e-05
have O 0 2.0736686110467417e-06
also O 0 1.8394970311419456e-06
been O 0 3.2917237149376888e-06
found O 0 1.959699829967576e-06
in O 0 5.845289706485346e-06
patients O 0 1.925564356497489e-05
with O 0 2.0441362721612677e-05
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 0.009338092058897018
with O 1 0.9999998807907104
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999998807907104
with O 1 0.9999995231628418
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.0013387256767600775
and O 0 0.00011274673306616023
with O 0 0.000498997513204813
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.046474356204271317

No O 0 0.00016815366689115763
locus O 0 0.0001112353420467116
other O 0 4.0290760807693005e-06
than O 0 1.1247265319980215e-05
chromosome O 0 0.0005772722070105374
11p13 O 0 0.0012192298891022801
has O 0 1.2258992683200631e-05
been O 0 3.1165749533101916e-05
implicated O 0 0.0008116949466057122
in O 0 0.00036716979229822755
aniridia B-Disease 1 0.9999998807907104
, O 0 0.00015606865053996444
and O 0 5.50435324839782e-05
PAX6 O 1 0.9981789588928223
is O 0 3.218739220756106e-05
clearly O 0 3.018416100530885e-05
the O 0 3.250256850151345e-05
major O 0 0.000262322835624218
, O 0 5.225001132203033e-06
if O 0 1.7157286720248521e-06
not O 0 8.349115319106204e-07
only O 0 1.4333511444419855e-06
, O 0 2.8216634291311493e-06
gene O 0 1.274974874831969e-05
responsible O 0 8.425708074355498e-05
. O 0 0.000302048196317628

Twenty O 0 0.00431216461583972
- O 0 0.00030741491355001926
eight O 0 3.0453866202151403e-05
percent O 0 1.3332555681699887e-05
of O 0 3.380182170076296e-05
identified O 0 0.0001468990813009441
PAX6 O 0 0.44818300008773804
mutations O 0 0.00012620579218491912
are O 0 9.915225746226497e-06
C O 0 0.004839315544813871
- O 0 0.0030776862986385822
T O 0 0.002184750745072961
changes O 0 9.289827175962273e-06
at O 0 0.00023067643633112311
CpG O 0 0.0019855827558785677
dinucleotides O 0 0.0037003413308411837
, O 0 8.651415555505082e-06
20 O 0 4.3989773985231295e-05
% O 0 1.139767664426472e-05
are O 0 2.2766880647395737e-06
splicing O 0 0.0002414852351648733
errors O 0 0.0007470811833627522
, O 0 2.3857935957494192e-05
and O 0 3.996585292043164e-06
more O 0 2.1498428850463824e-06
than O 0 3.7499048630706966e-06
30 O 0 6.324155401671305e-05
% O 0 1.3382925317273475e-05
are O 0 4.068921953148674e-06
deletion O 0 0.000476600369438529
or O 0 0.0001525562402093783
insertion O 0 0.0010165665298700333
events O 0 0.0012812170898541808
. O 0 0.0005675347056239843

There O 0 0.0001362666516797617
is O 0 1.931560291268397e-05
a O 0 4.233755680616014e-05
noticeably O 0 0.002024717628955841
elevated O 0 0.005452245473861694
level O 0 0.00039682499482296407
of O 0 0.00012612785212695599
mutation O 0 1.1735946827684529e-05
in O 0 1.465251170884585e-05
the O 0 3.5473240131977946e-05
paired O 0 2.7795858841273002e-05
domain O 0 2.4250190108432434e-05
compared O 0 1.3247637980384752e-05
with O 0 2.09328709388501e-06
the O 0 5.284730650600977e-05
rest O 0 0.00017606039182282984
of O 0 6.115219730418175e-05
the O 0 0.0002771578438114375
gene O 0 0.00021248622215352952
. O 0 0.00014243077021092176

Increased O 0 0.0004455030430108309
mutation O 0 2.3545115254819393e-05
in O 0 1.7522666894365102e-05
the O 0 4.910324059892446e-05
homeodomain O 0 0.0008266954100690782
is O 0 3.791408971665078e-06
accounted O 0 1.1825872206827626e-05
for O 0 1.4424730352402548e-06
by O 0 4.243389412295073e-06
the O 0 0.00018813634233083576
hypermutable O 0 0.017421657219529152
CpG O 0 0.0052929953671991825
dinucleotide O 0 0.0031206300482153893
in O 0 0.00018929548969026655
codon O 0 0.0001756426936481148
240 O 0 0.00021214694424998015
. O 0 8.85305562405847e-05

Very O 0 6.492542888736352e-05
nearly O 0 5.3375708375824615e-05
all O 0 9.402416253578849e-06
mutations O 0 3.0363446057890542e-05
appear O 0 9.489254443906248e-05
to O 0 5.3284016757970676e-05
cause O 0 0.000313268305035308
loss O 0 0.0006983221974223852
of O 0 0.0003752480261027813
function O 0 0.00017906057473737746
of O 0 0.00039543979801237583
the O 0 0.0003369627520442009
mutant O 0 0.0003323113778606057
allele O 0 1.3019215657550376e-05
, O 0 1.5207881460810313e-06
and O 0 5.699606049347494e-07
more O 0 4.2381057596685423e-07
than O 0 1.360937176286825e-06
80 O 0 2.8254222343093716e-05
% O 0 1.1354607522662263e-05
of O 0 0.00014846822887193412
exonic O 0 0.014387873001396656
substitutions O 0 0.0003529273089952767
result O 0 9.797189704841003e-05
in O 0 0.00014122553693596274
nonsense O 0 0.002232494531199336
codons O 0 0.0016471617855131626
. O 0 0.00032220722641795874

In O 0 0.00017719466995913535
a O 0 5.5917225836310536e-05
gene O 0 1.3913178918301128e-05
with O 0 2.745627853073529e-06
such O 0 7.40769064577762e-06
extraordinarily O 0 0.0006732905167154968
high O 0 0.0002012438781093806
sequence O 0 1.9738999981200323e-05
conservation O 0 7.550177542725578e-06
throughout O 0 3.2513426049263217e-06
evolution O 0 2.9016788175795227e-05
, O 0 2.226973265351262e-06
there O 0 5.16813452122733e-06
are O 0 3.3955082017200766e-06
presumed O 0 0.0013649427564814687
undiscovered O 1 0.9811449646949768
missense O 0 0.0037667572032660246
mutations O 0 0.00022101457579992712
, O 0 1.3823917470290326e-05
these O 0 4.858751708525233e-06
are O 0 3.0388480354304193e-06
hypothesized O 0 0.0001553709153085947
to O 0 1.6865671568666585e-05
exist O 0 4.7905381507007405e-05
in O 0 3.968030432588421e-05
as O 0 6.461333396146074e-05
- O 0 0.00025613143225200474
yet O 0 3.7979469198035076e-05
unidentified O 0 0.00014782084326725453
phenotypes O 0 9.152950224233791e-05
. O 0 1.9463233911665156e-05
. O 0 7.33111664885655e-05

Genetic O 0 0.0015671103028580546
heterogeneity O 0 0.00238055014051497
and O 0 8.849992445902899e-05
penetrance O 0 0.001450867741368711
analysis O 0 8.869874363881536e-06
of O 0 9.939014125848189e-05
the O 0 0.0008445707499049604
BRCA1 O 0 0.0038646480534225702
and O 0 6.518138980027288e-05
BRCA2 O 0 0.0016049003461375833
genes O 0 0.00010771233792183921
in O 0 0.0003465410554781556
breast B-Disease 1 0.9999978542327881
cancer I-Disease 1 0.9998819828033447
families O 0 0.00015628190885763615
. O 0 0.00041496497578918934

The O 1 0.9959003329277039
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999948740005493
Consortium O 0 0.0038282531313598156
. O 0 0.000372014386812225

The O 0 9.414606756763533e-05
contribution O 0 0.00016669997421558946
of O 0 0.0005174268153496087
BRCA1 O 0 0.004764040466398001
and O 0 0.00015100334712769836
BRCA2 O 0 0.015210561454296112
to O 0 0.002806314267218113
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.999862551689148
assessed O 0 0.0008798936614766717
by O 0 5.216469071456231e-05
linkage O 0 0.0006777526577934623
and O 0 1.356727625534404e-05
mutation O 0 4.177155915385811e-06
analysis O 0 2.5396686851308914e-06
in O 0 2.177824717364274e-05
237 O 0 0.00014614559768233448
families O 0 3.537071052051033e-06
, O 0 1.1249561566728516e-06
each O 0 1.2310538011206518e-07
with O 0 7.158034804888302e-07
at O 0 4.9999951443169266e-05
least O 0 4.147077106608776e-06
four O 0 5.139033419254702e-06
cases O 0 1.054642598319333e-05
of O 0 0.0009343872661702335
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999785423278809
, O 0 1.4581043615180533e-05
collected O 0 1.297898870689096e-05
by O 0 9.304591003456153e-06
the O 0 0.0016342448070645332
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999914169311523
Consortium O 0 0.0037338249385356903
. O 0 0.0003113160782959312

Families O 0 3.7260113458614796e-05
were O 0 2.363862222409807e-05
included O 0 2.3329028408625163e-05
without O 0 1.5327670553233474e-05
regard O 0 4.7409150283783674e-05
to O 0 1.4571132851415314e-05
the O 0 7.125411502784118e-05
occurrence O 0 0.0007131401798687875
of O 0 0.00991219561547041
ovarian B-Disease 1 1.0
or I-Disease 1 0.7944042086601257
other I-Disease 0 0.011558602564036846
cancers I-Disease 1 1.0
. O 0 0.002957954304292798

Overall O 0 0.0031780691351741552
, O 0 0.0003504668129608035
disease O 1 0.9999758005142212
was O 0 0.005031043663620949
linked O 0 0.002168472856283188
to O 0 0.00014151292270980775
BRCA1 O 0 0.0006757909432053566
in O 0 1.349833473796025e-05
an O 0 2.8136612399976e-06
estimated O 0 5.133709419169463e-05
52 O 0 6.060503801563755e-05
% O 0 7.687843208259437e-06
of O 0 4.05880346079357e-05
families O 0 1.4071959412831347e-05
, O 0 1.4889355952618644e-05
to O 0 4.6226647100411355e-05
BRCA2 O 0 0.00125952810049057
in O 0 4.7990841267164797e-05
32 O 0 0.00010350225056754425
% O 0 1.6428748494945467e-05
of O 0 5.6639808462932706e-05
families O 0 1.2300813068577554e-05
, O 0 5.497106030816212e-06
and O 0 1.871525000751717e-06
to O 0 6.260960162762785e-06
neither O 0 3.8328034861478955e-05
gene O 0 8.868267286743503e-06
in O 0 9.649254934629425e-06
16 O 0 9.374455839861184e-05
% O 0 9.105552635446656e-06
( O 0 8.927810085879173e-06
95 O 0 6.0113761719549075e-05
% O 0 1.5456769688171335e-05
confidence O 0 0.0003106264630332589
interval O 0 0.0005983379087410867
[ O 0 0.004207846242934465
CI O 1 0.9996483325958252
] O 0 0.0008913130732253194
6 O 0 0.0002462507109157741
% O 0 3.6612647818401456e-05
- O 0 0.00016842197510413826
28 O 0 0.00017563501023687422
% O 0 2.4024515369092114e-05
) O 0 1.4209889741323423e-05
, O 0 5.9016101658926345e-06
suggesting O 0 3.882880992023274e-05
other O 0 1.6611991668469273e-05
predisposition O 0 0.011889507062733173
genes O 0 0.0011726844822987914
. O 0 0.0007240090635605156

The O 0 0.00013737243716605008
majority O 0 1.5068470929691102e-05
( O 0 1.5902811355772428e-05
81 O 0 0.00013428817328531295
% O 0 1.2689451068581548e-05
) O 0 7.1430108619097155e-06
of O 0 6.216509063960984e-05
the O 0 0.4439491033554077
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.311777881113812e-05
were O 0 7.706757605774328e-05
due O 0 0.00048116789548657835
to O 0 0.00010239998664474115
BRCA1 O 0 0.0010290095815435052
, O 0 6.594249498448335e-06
with O 0 1.8546738829172682e-06
most O 0 1.4756941709492821e-05
others O 0 1.363700175716076e-05
( O 0 2.7329648219165392e-05
14 O 0 0.00026989338221028447
% O 0 5.5966247600736097e-05
) O 0 4.289930438972078e-05
due O 0 0.000608081987593323
to O 0 0.0005038974923081696
BRCA2 O 0 0.014123388566076756
. O 0 0.0005803842796012759

Conversely O 0 0.0008772517903707922
, O 0 6.418762040993897e-06
the O 0 7.192487373686163e-06
majority O 0 1.95461552721099e-06
of O 0 1.345494638371747e-05
families O 0 5.040103133069351e-06
with O 0 9.769590178621002e-06
male B-Disease 0 0.0005301953642629087
and I-Disease 0 0.00021818524692207575
female I-Disease 0 0.2170526534318924
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999762773513794
were O 0 0.00026588147738948464
due O 0 0.0019928300753235817
to O 0 0.0003846521722152829
BRCA2 O 0 0.00272097229026258
( O 0 5.693125058314763e-05
76 O 0 0.000664802675601095
% O 0 0.00011323847866151482
) O 0 0.00010368935181759298
. O 0 0.00014882328105159104

The O 0 0.00028683821437880397
largest O 0 0.0003862644371110946
proportion O 0 7.422862108796835e-05
( O 0 1.920550494105555e-05
67 O 0 0.00011452628677943721
% O 0 1.9914883523597382e-05
) O 0 1.0052424840978347e-05
of O 0 3.213779564248398e-05
families O 0 9.830629096541088e-06
due O 0 0.00020074332132935524
to O 0 3.162073699058965e-05
other O 0 9.189176125801168e-06
genes O 0 2.7059648346039467e-05
was O 0 0.0001155988938990049
found O 0 5.024591246183263e-06
in O 0 4.080743110534968e-06
families O 0 1.026670474857383e-06
with O 0 1.714459472168528e-06
four O 0 1.7768719771993347e-05
or O 0 1.2033885468554217e-05
five O 0 2.7580315872910433e-05
cases O 0 2.3559536202810705e-05
of O 0 0.0006670525181107223
female O 1 0.9976669549942017
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
only O 0 0.0004979199729859829
. O 0 0.0004940543440170586

These O 0 3.488941001705825e-05
estimates O 0 1.678493026702199e-05
were O 0 1.1268930393271148e-05
not O 0 4.151318989897845e-06
substantially O 0 0.00012197624164400622
affected O 0 1.1133971383969765e-05
either O 0 6.284745722950902e-06
by O 0 2.5067413389479043e-06
changing O 0 1.1952609384024981e-05
the O 0 2.36538216995541e-05
assumed O 0 0.0003505996719468385
penetrance O 0 0.0022441851906478405
model O 0 1.8585587895358913e-05
for O 0 3.249857036280446e-05
BRCA1 O 0 0.0006590840057469904
or O 0 1.2109427188988775e-05
by O 0 4.3396084947744384e-06
including O 0 1.1868600267916918e-05
or O 0 6.989696703385562e-05
excluding O 0 0.0009009093046188354
BRCA1 O 0 0.004733678884804249
mutation O 0 4.3571097194217145e-05
data O 0 9.118991874856874e-05
. O 0 0.00010578727233223617

Among O 0 6.226733239600435e-05
those O 0 7.0246815084828995e-06
families O 0 1.1504082067403942e-05
with O 0 5.5872558732517064e-05
disease O 1 0.9999996423721313
due O 1 0.5906529426574707
to O 0 0.0008057929808273911
BRCA1 O 0 0.0021404121071100235
that O 0 5.969069206912536e-06
were O 0 1.6694209989509545e-05
tested O 0 1.5674713722546585e-05
by O 0 1.1489328244351782e-06
one O 0 1.497151970397681e-06
of O 0 1.0909941920544952e-05
the O 0 3.059936352656223e-05
standard O 0 3.0405519282794558e-05
screening O 0 1.176164823846193e-05
methods O 0 1.0470282177266199e-05
, O 0 5.318043804436456e-06
mutations O 0 1.84365071618231e-05
were O 0 3.264157203375362e-05
detected O 0 0.00015314885240513831
in O 0 1.6155934645212255e-05
the O 0 2.2138647182146087e-05
coding O 0 0.0001587041188031435
sequence O 0 6.46834378130734e-05
or O 0 2.0510075046331622e-05
splice O 0 0.0002058515092357993
sites O 0 2.559866516094189e-05
in O 0 4.05631044486654e-06
an O 0 1.9903779957530787e-06
estimated O 0 3.970615944126621e-05
63 O 0 0.00010474534064996988
% O 0 1.0657623533916194e-05
( O 0 1.373089435219299e-05
95 O 0 0.0001548352447571233
% O 0 0.00011720164184225723
CI O 1 0.9747803807258606
51 O 0 0.0005134205566719174
% O 0 8.530556806363165e-05
- O 0 0.00041511564631946385
77 O 0 0.0002913883945439011
% O 0 6.52145390631631e-05
) O 0 7.336719136219472e-05
. O 0 0.00012171865091659129

The O 0 0.0001899521885206923
estimated O 0 0.00015912752132862806
sensitivity O 0 7.316777919186279e-05
was O 0 0.00018893305968958884
identical O 0 4.75362821816816e-06
for O 0 1.5838476201679441e-06
direct O 0 7.655804438400082e-06
sequencing O 0 6.846842734375969e-05
and O 0 7.620402357133571e-06
other O 0 6.464134457928594e-06
techniques O 0 0.00034587999107316136
. O 0 0.0002813597093336284

The O 0 0.0007339846924878657
penetrance O 0 0.010484473779797554
of O 0 0.0010571355232968926
BRCA2 O 0 0.006503022275865078
was O 0 0.0006097237346693873
estimated O 0 9.40246827667579e-05
by O 0 6.36991671854048e-06
maximizing O 0 0.0001408076350344345
the O 0 0.00013192520418670028
LOD O 1 0.843620240688324
score O 0 0.0005032751359976828
in O 0 0.00028612068854272366
BRCA2 O 0 0.00630124332383275
- O 0 0.0004893073346465826
mutation O 0 4.389572950458387e-06
families O 0 1.085645635612309e-06
, O 0 1.4412217979042907e-06
over O 0 6.017526629875647e-06
all O 0 5.818132194690406e-06
possible O 0 4.726622501038946e-05
penetrance O 0 0.002944638952612877
functions O 0 0.00018099926819559187
. O 0 0.00022920929768588394

The O 0 9.065461927093565e-05
estimated O 0 0.00010627380106598139
cumulative O 0 0.0003930006641894579
risk O 0 0.00022871918918099254
of O 0 0.000892536889296025
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999501705169678
reached O 0 0.002603240543976426
28 O 0 0.0005652843392454088
% O 0 1.3824840607412625e-05
( O 0 1.1885465937666595e-05
95 O 0 0.0001185296569019556
% O 0 6.642660446232185e-05
CI O 1 0.9920713305473328
9 O 0 0.0005453639896586537
% O 0 2.9125325454515405e-05
- O 0 0.00010747789201559499
44 O 0 1.7246204151888378e-05
% O 0 6.141684025351424e-06
) O 0 3.798926400122582e-06
by O 0 2.4891248813219136e-06
age O 0 0.00011291500413790345
50 O 0 5.334787056199275e-05
years O 0 5.178122955840081e-05
and O 0 3.433239953665179e-06
84 O 0 0.00010662511340342462
% O 0 1.713624624244403e-05
( O 0 2.228533776360564e-05
95 O 0 0.0001824133942136541
% O 0 8.573183004045859e-05
CI O 1 0.9722915887832642
43 O 0 0.00029647277551703155
% O 0 4.3771004129666835e-05
- O 0 0.00019098572374787182
95 O 0 7.971229206304997e-05
% O 0 1.16251776489662e-05
) O 0 3.6076039577892516e-06
by O 0 3.3121159503934905e-06
age O 0 0.0002156623813789338
70 O 0 0.0002166301419492811
years O 0 0.0005119050038047135
. O 0 0.00019812639220617712

The O 0 0.001063053379766643
corresponding O 1 0.9999905824661255
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9995511174201965
were O 0 0.0005976573447696865
0 O 0 0.0004351296229287982
. O 0 0.00019974226597696543

4 O 0 0.0007625020225532353
% O 0 5.20676258020103e-05
( O 0 3.268693035352044e-05
95 O 0 0.0002758936898317188
% O 0 0.00013332004891708493
CI O 1 0.5642660856246948
0 O 0 6.19681813986972e-05
% O 0 2.386094092798885e-05
- O 0 9.522448090137914e-05
1 O 0 6.565913645317778e-05
% O 0 8.719661309442017e-06
) O 0 3.120869450867758e-06
by O 0 2.254558921777061e-06
age O 0 9.798796236282215e-05
50 O 0 4.747547791339457e-05
years O 0 6.686396955046803e-05
and O 0 8.481002623739187e-06
27 O 0 0.0001843511126935482
% O 0 1.5375208022305742e-05
( O 0 1.8605005607241765e-05
95 O 0 0.00017873235628940165
% O 0 9.920257434714586e-05
CI O 0 0.4909485876560211
0 O 0 6.604798545595258e-05
% O 0 2.512861101422459e-05
- O 0 0.00012670682917814702
47 O 0 4.038105544168502e-05
% O 0 9.90281841950491e-06
) O 0 6.282240974542219e-06
by O 0 4.467931375984335e-06
age O 0 0.00022150992299430072
70 O 0 0.0003851346846204251
years O 0 0.0006658967467956245
. O 0 0.00020448175200726837

The O 0 0.0005838663782924414
lifetime O 0 0.00213978486135602
risk O 0 0.0014710543910041451
of O 0 0.07625814527273178
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
appears O 0 0.00048383057583123446
similar O 0 6.604433110624086e-06
to O 0 1.4305845070339274e-05
the O 0 9.133856656262651e-05
risk O 0 0.0001472057483624667
in O 0 0.0001314588007517159
BRCA1 O 0 0.0026009525172412395
carriers O 0 5.444536873255856e-05
, O 0 5.2819555094174575e-06
but O 0 1.2275911558390362e-06
there O 0 3.6022959193360293e-06
was O 0 6.409054913092405e-05
some O 0 2.1725390979554504e-06
suggestion O 0 2.3424134269589558e-05
of O 0 5.9218367823632434e-05
a O 0 9.478998981649056e-05
lower O 0 0.0008076771046034992
risk O 0 0.0002131796209141612
in O 0 0.00012117492588004097
BRCA2 O 0 0.002759487833827734
carriers O 0 8.560030983062461e-05
< O 0 0.0005561731522902846
50 O 0 5.4007839935366064e-05
years O 0 7.670903869438916e-05
of O 0 0.0001616089721210301
age O 0 0.0022358980495482683
. O 0 0.0006390229682438076

Eye B-Disease 1 0.9999897480010986
movement I-Disease 0 0.01613204926252365
abnormalities I-Disease 1 0.9973304271697998
correlate O 0 0.0004137795476708561
with O 0 5.3512143495026976e-05
genotype O 0 0.0004638195678126067
in O 0 0.0004943758249282837
autosomal O 1 0.9999097585678101
dominant O 1 0.9999998807907104
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 0.005999943241477013

We O 0 0.00033684438676573336
compared O 0 0.0009095108252950013
horizontal O 0 0.007095783017575741
eye O 0 0.102080337703228
movements O 0 0.000764276715926826
( O 0 0.0003014038084074855
visually O 0 0.0018559094751253724
guided O 0 0.002045420464128256
saccades O 0 0.04328343644738197
, O 0 9.154470171779394e-05
antisaccades O 0 0.0037207347340881824
, O 0 1.7420512449461967e-05
and O 0 1.2114162927900907e-05
smooth O 0 0.000535291968844831
pursuit O 0 0.0007592877373099327
) O 0 1.7200478396262042e-05
in O 0 1.8576743968878873e-05
control O 0 6.92383327987045e-05
subjects O 0 0.00022048313985578716
( O 0 5.0616708904271945e-05
n O 0 0.00025132333394140005
= O 0 0.00035999546525999904
14 O 0 0.0002449959283694625
) O 0 1.5505020201089792e-05
and O 0 5.162454726814758e-06
patients O 0 5.986834366922267e-06
with O 0 1.365535581498989e-06
three O 0 1.2727832654491067e-05
forms O 0 8.606160554336384e-05
of O 0 0.005722357425838709
autosomal O 1 0.9999996423721313
dominant O 1 0.9999998807907104
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999998807907104
I I-Disease 1 1.0
spinocerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.8758910298347473
1 I-Disease 0 0.0008822670206427574
and I-Disease 0 3.711995668709278e-05
2 I-Disease 0 0.0003416312683839351
( O 0 0.00011371405707905069
SCA1 B-Disease 0 0.2796189486980438
, O 0 1.3832120203005616e-05
n O 0 6.284549453994259e-05
= O 0 0.00010918596672127023
11 O 0 0.00013533291348721832
; O 0 9.605614650354255e-06
SCA2 B-Disease 0 0.017456376925110817
, O 0 1.0073873454530258e-05
n O 0 3.364109943504445e-05
= O 0 6.978920282563195e-05
10 O 0 2.502794814063236e-05
) O 0 7.79142737883376e-06
and O 0 2.2986132535152137e-05
SCA3 B-Disease 1 1.0
/ O 0 0.004256950691342354
Machado B-Disease 0 0.005330194719135761
- I-Disease 0 0.0018138885498046875
Joseph I-Disease 1 0.9935564398765564
disease I-Disease 1 0.9999998807907104
( O 0 0.0010765402112156153
MJD B-Disease 1 1.0
) O 0 0.0001328212529188022
( O 0 2.630069138831459e-05
n O 0 0.00013730251521337777
= O 0 0.0003725843853317201
16 O 0 0.0004046043613925576
) O 0 5.87177237321157e-05
. O 0 8.162573067238554e-05

In O 0 0.001944629941135645
SCA1 B-Disease 1 0.9997599720954895
, O 0 4.456902388483286e-05
saccade O 0 0.00023620763386134058
amplitude O 0 0.00010394972196081653
was O 0 0.00017107054009102285
significantly O 0 2.418123222014401e-05
increased O 0 1.098520715459017e-05
, O 0 2.8435852073016576e-06
resulting O 0 4.896692917100154e-05
in O 0 7.736416591797024e-05
hypermetria B-Disease 0 0.013713402673602104
. O 0 0.000314118224196136

The O 0 0.00048808319843374193
smooth O 0 0.0023416089825332165
pursuit O 0 0.001189020462334156
gain O 0 0.0006992184789851308
was O 0 0.0018123163608834147
decreased O 0 0.005576883442699909
. O 0 0.0002768340636976063

In O 0 0.0024298515636473894
SCA2 B-Disease 1 0.999749481678009
, O 0 6.972560368012637e-05
saccade O 0 0.0004653121577575803
velocity O 0 9.081997268367559e-05
was O 0 0.0006050262018106878
markedly O 0 0.0014807779807597399
decreased O 0 0.0021251309663057327
. O 0 0.0001537357020424679

The O 0 0.0002503194264136255
percentage O 0 0.00020883350225631148
of O 0 0.00017281557666137815
errors O 0 0.002807765966281295
in O 0 0.0004278379201423377
antisaccades O 0 0.042039740830659866
was O 0 0.000568932038731873
greatly O 0 0.000131387758301571
increased O 0 1.796305332391057e-05
and O 0 3.8885214053152595e-06
was O 0 5.780986975878477e-05
significantly O 0 1.098963912227191e-05
correlated O 0 7.480312888219487e-06
with O 0 1.726133859847323e-06
age O 0 0.0006994171417318285
at O 1 0.9331128597259521
disease O 1 1.0
onset O 1 1.0
. O 0 0.004921352490782738

In O 0 0.00017659334116615355
addition O 0 3.9387108699884266e-05
, O 0 3.9973056118469685e-06
a O 0 5.5163950491987634e-06
correlation O 0 1.4287818885350134e-05
between O 0 0.000275706232059747
smooth O 0 0.0030126268975436687
pursuit O 0 0.0010519891511648893
gain O 0 0.0002464407298248261
and O 0 6.971372386033181e-06
the O 0 1.3563809261540882e-05
number O 0 9.886860425467603e-06
of O 0 0.00028438103618100286
trinucleotide O 1 0.9998636245727539
repeats O 0 0.0025413227267563343
was O 0 0.000992775778286159
found O 0 5.992568549118005e-05
. O 0 9.637488255975768e-05

In O 0 0.00555391376838088
SCA3 B-Disease 1 1.0
, O 0 0.0009465609909966588
gaze B-Disease 0 0.024990351870656013
- I-Disease 0 0.006108032073825598
evoked I-Disease 0 0.00514895748347044
nystagmus I-Disease 0 0.005370023660361767
was O 0 0.0006120320176705718
often O 0 9.08409583644243e-06
present O 0 3.829669003607705e-05
as O 0 7.569463195977733e-05
was O 0 0.001207082881592214
saccade O 0 0.004992193542420864
hypometria O 0 0.01275826245546341
and O 0 6.58228964312002e-05
smooth O 0 0.000922400678973645
pursuit O 0 0.0006139506585896015
gain O 0 0.0004495138127822429
was O 0 0.0013288294430822134
markedly O 0 0.0017244613263756037
decreased O 0 0.0021042758598923683
. O 0 0.0001448716502636671

Three O 0 0.00013311604561749846
major O 0 0.0002860031381715089
criteria O 0 0.00010702494182623923
, O 0 2.2682863345835358e-05
saccade O 0 0.0005828272551298141
amplitude O 0 0.00017587530601304024
, O 0 2.4192904675146565e-05
saccade O 0 0.00046985334483906627
velocity O 0 6.683215906377882e-05
, O 0 6.271956863201922e-06
and O 0 3.2986688438541023e-06
presence O 0 4.05817263526842e-05
of O 0 0.0006540598697029054
gaze B-Disease 0 0.1724947988986969
- I-Disease 0 0.011329520493745804
evoked I-Disease 0 0.00575746176764369
nystagmus I-Disease 0 0.00424705445766449
, O 0 1.7843640307546593e-05
permitted O 0 1.5337658624048345e-05
the O 0 1.5250816431944259e-05
correct O 0 4.3475305574247614e-05
assignment O 0 2.6297784643247724e-05
of O 0 4.2269773985026404e-05
90 O 0 8.365311077795923e-05
% O 0 1.9294540834380314e-05
of O 0 0.00010692946671042591
the O 0 0.0007641219417564571
SCA1 B-Disease 1 0.9982512593269348
, O 0 1.4937883861421142e-05
90 O 0 2.4272074369946495e-05
% O 0 5.6853350542951375e-06
of O 0 5.888887244509533e-05
the O 0 0.0006613295990973711
SCA2 B-Disease 1 0.9998418092727661
, O 0 1.6610503735137172e-05
and O 0 4.156698651058832e-06
93 O 0 9.307045547757298e-05
% O 0 9.168080396193545e-06
of O 0 6.914253754075617e-05
the O 0 0.00036545147304423153
patients O 0 0.0001953548053279519
with O 0 9.595022856956348e-05
SCA3 B-Disease 1 1.0
to O 0 8.78314531291835e-05
their O 0 1.6644466086290777e-05
genetically O 0 3.400953937671147e-05
confirmed O 0 1.6418271115981042e-05
patient O 0 3.202707375749014e-05
group O 0 4.019856987724779e-06
and O 0 3.4183160551037872e-06
, O 0 8.450347195321228e-06
therefore O 0 2.551750367274508e-05
, O 0 1.1648859072010964e-05
may O 0 6.28148191026412e-05
help O 0 0.00010584841948002577
orient O 0 0.010224532335996628
diagnoses O 0 0.0029133514035493135
of O 0 0.005667432211339474
SCA1 B-Disease 1 1.0
, O 0 0.0008125485619530082
SCA2 B-Disease 1 0.9999943971633911
, O 0 5.9156172937946394e-05
and O 0 3.527013905113563e-05
SCA3 B-Disease 1 1.0
at O 0 0.0003886896010953933
early O 0 7.207555609056726e-05
clinical O 0 6.662770465482026e-05
stages O 0 0.0011288782116025686
of O 0 0.000648131943307817
the O 0 0.053668100386857986
diseases O 1 1.0
. O 0 0.00035703121102415025
. O 0 0.00021257292246446013

Genetic O 0 8.420793164987117e-05
basis O 0 1.4931330952094868e-05
and O 0 7.589839242427843e-06
molecular O 0 0.00011799657659139484
mechanism O 0 0.0037335341330617666
for O 1 0.9146602749824524
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999998807907104

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 0.3287910223007202
more O 0 0.0001491140719735995
than O 0 6.092681724112481e-05
300 O 0 0.00013972425949759781
, O 0 1.3571806448453572e-05
000 O 0 0.0005265987711027265
sudden O 0 0.00091550376964733
deaths O 0 6.632583244936541e-05
each O 0 1.7211368685821071e-06
year O 0 2.0890331143164076e-05
in O 0 2.3177639377536252e-05
the O 0 0.00012201206118334085
USA O 0 0.0011801626533269882
alone O 0 0.0002337209734832868
. O 0 5.31170007889159e-05

In O 0 0.00010841490438906476
approximately O 0 0.0002632325340528041
5 O 0 0.00033033406361937523
- O 0 0.00019535311730578542
12 O 0 3.796136661549099e-05
% O 0 5.794466233055573e-06
of O 0 2.5358654966112226e-05
these O 0 7.130915946618188e-06
cases O 0 1.3869316717318725e-05
, O 0 8.238012014771812e-06
there O 0 1.0809608284034766e-05
are O 0 3.266674411861459e-06
no O 0 8.546295430278406e-05
demonstrable O 1 0.9998792409896851
cardiac O 1 1.0
or O 1 0.9932206869125366
non O 1 0.9999998807907104
- O 1 1.0
cardiac O 1 1.0
causes O 0 0.0008141009020619094
to O 0 5.3067535191075876e-05
account O 0 1.549653461552225e-05
for O 0 4.274477305443725e-06
the O 0 1.95587235793937e-05
episode O 0 0.00010633827332640067
, O 0 1.6194215959330904e-06
which O 0 3.016005223344109e-07
is O 0 3.46381142435348e-07
therefore O 0 1.2560195727928658e-06
classified O 0 6.631735595874488e-05
as O 0 0.0006231901934370399
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.0014099273830652237
. O 0 0.00030284866807051003

A O 0 0.00045157031854614615
distinct O 0 3.17893318424467e-05
group O 0 3.0219123800634407e-05
of O 0 0.001254190574400127
IVF B-Disease 1 1.0
patients O 0 0.00025992808514274657
has O 0 1.2765992323693354e-05
been O 0 1.0582554750726558e-05
found O 0 2.0586264781741193e-06
to O 0 2.0241720903868554e-06
present O 0 9.17681882128818e-06
with O 0 3.4514107483119005e-06
a O 0 0.00010040236520580947
characteristic O 0 0.003094304585829377
electrocardiographic O 1 0.9999651908874512
pattern O 0 0.013882527127861977
. O 0 0.0007712212973274291

Because O 0 0.0001237801625393331
of O 0 0.00010415689757792279
the O 0 6.365626904880628e-05
small O 0 8.357037586392835e-06
size O 0 6.103288797021378e-06
of O 0 2.374037285335362e-05
most O 0 2.7875677915289998e-05
pedigrees O 0 0.00040465156780555844
and O 0 7.220279258035589e-06
the O 0 6.254321488086134e-05
high O 0 0.0007754508405923843
incidence O 0 0.0019172918982803822
of O 0 0.0011887997388839722
sudden B-Disease 1 0.5962459444999695
death I-Disease 0 0.0029607589822262526
, O 0 1.5056146366987377e-05
however O 0 6.50401216262253e-06
, O 0 1.7242090279978584e-06
molecular O 0 1.2713202522718348e-05
genetic O 0 5.1996277761645615e-05
studies O 0 4.7808498493395746e-05
of O 0 0.0013502538204193115
IVF B-Disease 1 0.9999992847442627
have O 0 1.8592005289974622e-05
not O 0 2.1904138520767447e-06
yet O 0 1.1105752491857857e-05
been O 0 9.516114914731588e-06
done O 0 4.3532683775993064e-05
. O 0 7.590396126033738e-05

Because O 0 0.0091018071398139
IVF B-Disease 1 1.0
causes O 1 0.9999990463256836
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999997615814209
, O 0 8.656772115500644e-05
we O 0 1.039874587149825e-05
investigated O 0 7.99038534751162e-05
whether O 0 3.724874841282144e-05
malfunction O 1 0.679252028465271
of O 0 0.0003451279771979898
ion O 0 0.0019340115832164884
channels O 0 0.00037366501055657864
could O 0 8.439096563961357e-05
cause O 0 0.0002179640141548589
the O 0 0.0001351207756670192
disorder O 1 0.9972572922706604
by O 0 5.251261973171495e-05
studying O 0 0.00015623928629793227
mutations O 0 1.4435421689995565e-05
in O 0 1.8721566448220983e-05
the O 0 0.00012187891115900129
cardiac O 0 0.48706212639808655
sodium O 0 0.000873428420163691
channel O 0 0.0012590453261509538
gene O 0 0.00027371878968551755
SCN5A O 1 0.9910675883293152
. O 0 0.0003520700556691736

We O 0 6.84615079080686e-05
have O 0 3.7121496916370234e-06
now O 0 7.459404514520429e-06
identified O 0 5.9244202930131e-06
a O 0 1.795668140402995e-05
missense O 0 0.0004174516361672431
mutation O 0 2.700682307477109e-05
, O 0 1.8715210899244994e-05
a O 0 8.524043369106948e-05
splice O 0 0.0063980682753026485
- O 0 0.002401247387751937
donor O 0 7.26735161151737e-05
mutation O 0 9.540258361084852e-06
, O 0 4.9174273044627625e-06
and O 0 5.360213890526211e-06
a O 0 4.374988566269167e-05
frameshift O 0 0.0011936300434172153
mutation O 0 1.3222697816672735e-05
in O 0 7.119893780327402e-06
the O 0 2.0639792637666687e-05
coding O 0 0.00011957361130043864
region O 0 0.0002650248061399907
of O 0 0.00033755498589016497
SCN5A O 1 0.9998188614845276
in O 0 0.0002499881375115365
three O 0 0.0001862939534476027
IVF B-Disease 1 0.958568811416626
families O 0 2.9544946301029995e-05
. O 0 0.00010511094296816736

We O 0 5.35299041075632e-05
show O 0 2.7201329430681653e-05
that O 0 1.644771600695094e-06
sodium O 0 1.641156995901838e-05
channels O 0 1.100406916521024e-05
with O 0 1.8285113583260681e-06
the O 0 8.09480989119038e-05
missense O 0 0.0010820713359862566
mutation O 0 7.771161472192034e-05
recover O 0 0.001677200896665454
from O 0 0.0001349062949884683
inactivation O 0 0.006038047838956118
more O 0 3.197497790097259e-05
rapidly O 0 0.0004994095652364194
than O 0 4.8388592404080555e-06
normal O 0 1.659197914705146e-05
and O 0 1.4843583358015167e-06
that O 0 1.128667804550787e-06
the O 0 5.270220572128892e-05
frameshift O 0 0.0014635329134762287
mutation O 0 1.6428106391686015e-05
causes O 0 2.3667829736950807e-05
the O 0 5.790244904346764e-05
sodium O 0 7.059496419969946e-05
channel O 0 3.2991829357342795e-05
to O 0 9.608124855731148e-06
be O 0 9.03269483387703e-06
non O 0 0.00024268454581033438
- O 0 0.0004183635173831135
functional O 0 0.0002063390420516953
. O 0 0.00011605204781517386

Our O 0 0.0001317775750067085
results O 0 1.7806907635531388e-05
indicate O 0 2.1720275981351733e-05
that O 0 2.011434844462201e-06
mutations O 0 2.6091000108863227e-05
in O 0 0.0001032028449117206
cardiac O 1 0.9814630746841431
ion O 0 0.0036863565910607576
- O 0 0.0018800514517351985
channel O 0 8.237924339482561e-05
genes O 0 2.0873626453976613e-06
contribute O 0 3.014497906406177e-06
to O 0 2.864846692318679e-06
the O 0 2.194568151026033e-05
risk O 0 4.321118467487395e-05
of O 0 0.00016878306632861495
developing O 0 0.0026503303088247776
IVF B-Disease 1 0.9999877214431763
. O 0 0.00013426631630863994
. O 0 8.29544587759301e-05

Molecular O 0 0.0009460921864956617
heterogeneity O 0 0.002579362830147147
in O 0 0.0009540524333715439
mucopolysaccharidosis B-Disease 1 0.9990054965019226
IVA I-Disease 1 0.9999701976776123
in O 0 0.0001579524832777679
Australia O 0 1.9975654140580446e-05
and O 0 3.954641670134151e-06
Northern O 0 2.4443039364996366e-05
Ireland O 0 6.73446775181219e-05
: O 0 1.4368985830515157e-05
nine O 0 4.357841316959821e-05
novel O 0 7.687614561291412e-05
mutations O 0 2.923962165368721e-05
including O 0 3.42902603733819e-05
T312S O 0 0.004177630878984928
, O 0 2.9914874176029116e-05
a O 0 2.5585241019143723e-05
common O 0 1.5634168448741548e-05
allele O 0 1.1303416613372974e-05
that O 0 3.589337211451493e-06
confers O 0 0.00024559744633734226
a O 0 0.0001398919557686895
mild O 0 0.001467847265303135
phenotype O 0 0.001025121659040451
. O 0 0.00028047908563166857

Mucopolysaccharidosis B-Disease 1 0.9999984502792358
IVA I-Disease 1 1.0
( O 0 0.02284778654575348
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
) O 0 0.00018859827832784504
is O 0 9.861258149612695e-06
an O 0 2.0869743821094744e-05
autosomal B-Disease 1 0.9999897480010986
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 1.0
by O 0 0.0007340899319387972
a O 0 0.0013472684659063816
genetic B-Disease 1 0.9999998807907104
defect I-Disease 1 1.0
in O 0 0.0020855970215052366
N O 0 0.050480879843235016
- O 0 0.0022904560901224613
acetylgalactosamine O 0 0.00702357804402709
- O 0 0.00046373868826776743
6 O 0 0.0005503959255293012
- O 0 0.0012528878869488835
sulfate O 0 0.006584436632692814
sulfatase O 1 0.6820634007453918
( O 0 0.001185271772556007
GALNS O 1 0.9999574422836304
) O 0 0.00028243311680853367
. O 0 0.000126308121252805

Previous O 0 0.00020312501874286681
studies O 0 2.0832538211834617e-05
of O 0 0.00011853768955916166
patients O 0 6.553983985213563e-05
from O 0 3.0371551474672742e-05
a O 0 3.7235960917314515e-05
British O 0 0.0001429415278835222
- O 0 0.00027838264941237867
Irish O 0 7.747808558633551e-05
population O 0 2.5254623778891983e-06
showed O 0 1.9866303773596883e-05
that O 0 1.1977596159340465e-06
the O 0 2.7274450985714793e-05
I113F O 0 0.0014595321845263243
mutation O 0 7.496610123780556e-06
is O 0 2.2987255761108827e-06
the O 0 6.595356808247743e-06
most O 0 2.7755665996664902e-06
common O 0 3.9770507100911345e-06
single O 0 1.5591762348776683e-05
mutation O 0 2.4763678084127605e-05
among O 0 8.274431456811726e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.016597094014286995
and O 0 8.946868911152706e-05
produces O 0 0.00015745428390800953
a O 0 0.00020128110190853477
severe O 1 0.9948821067810059
clinical O 0 0.023432698100805283
phenotype O 0 0.003058734117075801
. O 0 0.0006355457589961588

We O 0 8.624957990832627e-05
studied O 0 0.00021714260219596326
mutations O 0 3.3078529668273404e-05
in O 0 2.6697567591327243e-05
the O 0 0.00011696171713992953
GALNS O 1 0.5959934592247009
gene O 0 2.372455310251098e-05
from O 0 1.2785487342625856e-05
23 O 0 0.0001903192896861583
additional O 0 0.00010463523358339444
MPS B-Disease 1 0.9999545812606812
IVA I-Disease 1 1.0
patients O 0 0.001021451666019857
( O 0 6.311708420980722e-05
15 O 0 0.00012174546282039955
from O 0 2.7880940251634456e-05
Australia O 0 1.2814270121452864e-05
, O 0 2.153398781956639e-06
8 O 0 2.2923484721104614e-05
from O 0 7.675382221350446e-06
Northern O 0 4.032418655697256e-05
Ireland O 0 4.132467438466847e-05
) O 0 7.172609002736863e-06
, O 0 6.499726055153587e-07
with O 0 3.525576630636351e-07
various O 0 1.7791018763091415e-05
clinical O 0 0.00428083585575223
phenotypes O 0 0.26485317945480347
( O 0 0.0013837959850206971
severe O 1 0.9967747330665588
, O 0 0.00021224364172667265
16 O 0 0.000593697652220726
cases O 0 4.186647856840864e-05
; O 0 1.5532221368630417e-05
intermediate O 0 0.0005902366247028112
, O 0 1.845064980443567e-05
4 O 0 0.00013104054960422218
cases O 0 1.4653853213530965e-05
; O 0 7.086018285917817e-06
mild O 0 0.0001628561003599316
, O 0 2.5922030545189045e-05
3 O 0 0.0001789760572137311
cases O 0 4.2207102524116635e-05
) O 0 9.225180110661313e-05
. O 0 0.00010847458179341629

We O 0 5.117183900438249e-05
found O 0 8.07765081844991e-06
two O 0 1.8121115772373741e-06
common O 0 5.264726041787071e-06
mutations O 0 1.2991358744329773e-05
that O 0 2.200824610554264e-06
together O 0 1.1617165000643581e-05
accounted O 0 7.659880793653429e-05
for O 0 9.743220289237797e-06
32 O 0 6.002709051244892e-05
% O 0 1.0851161277969368e-05
of O 0 5.350724313757382e-05
the O 0 0.00015452624938916415
44 O 0 0.0002326555404579267
unrelated O 0 0.0001487017289036885
alleles O 0 1.5112606888578739e-05
in O 0 3.1952542485669255e-05
these O 0 3.540399484336376e-05
patients O 0 0.000290232797851786
. O 0 0.0002847363939508796

One O 0 0.00010333598038414493
is O 0 1.713982601359021e-05
the O 0 5.852760295965709e-05
T312S O 0 0.001864963211119175
mutation O 0 1.2565188626467716e-05
, O 0 3.2293614822265226e-06
a O 0 9.911501365422737e-06
novel O 0 0.00010263793228659779
mutation O 0 1.2816702110285405e-05
found O 0 5.333168246579589e-06
exclusively O 0 3.1009512895252556e-05
in O 0 2.9093649573042057e-05
milder O 0 0.0003288456646259874
patients O 0 0.0002223915362264961
. O 0 0.00023037136998027563

The O 0 0.0002248683013021946
other O 0 5.135540504852543e-06
is O 0 3.2406842365162447e-06
the O 0 1.2763752238242887e-05
previously O 0 5.914505891269073e-05
described O 0 0.00014150618517305702
I113F O 0 0.0014973910292610526
that O 0 7.852841008570977e-06
produces O 0 4.618518505594693e-05
a O 0 0.00011853926116600633
severe O 1 0.6818702816963196
phenotype O 0 0.0017335854936391115
. O 0 0.0005016524810343981

The O 0 0.0008109566988423467
I113F O 0 0.0032130079343914986
and O 0 2.087938082695473e-05
T312S O 0 0.0005548584740608931
mutations O 0 2.0125949959037825e-05
accounted O 0 7.120182272046804e-05
for O 0 1.6349536963389255e-05
8 O 0 0.0003480777086224407
( O 0 2.4423303329967894e-05
18 O 0 0.00014239830488804728
% O 0 1.991649878618773e-05
) O 0 1.1494904356368352e-05
and O 0 6.573291102540679e-06
6 O 0 0.00017364625819027424
( O 0 1.911228901008144e-05
14 O 0 7.840707985451445e-05
% O 0 7.950348845042754e-06
) O 0 3.232110202588956e-06
of O 0 2.355239303142298e-05
44 O 0 0.00014742191706318408
unrelated O 0 0.0002028563612839207
alleles O 0 1.4701921827509068e-05
, O 0 1.950135629158467e-05
respectively O 0 0.00034740244154818356
. O 0 0.00025137700140476227

The O 0 0.0003732356708496809
relatively O 0 0.00019637876539491117
high O 0 0.0007702701259404421
residual O 0 0.010198593139648438
GALNS O 1 0.9999253749847412
activity O 0 0.0002889051684178412
seen O 0 0.00018598532187752426
when O 0 8.94989807420643e-06
the O 0 1.4850754268991295e-05
T312S O 0 0.0003212269803043455
mutant O 0 7.760267180856317e-05
cDNA O 0 0.0002472606720402837
is O 0 1.8259415810462087e-05
overexpressed O 0 0.001006796141155064
in O 0 2.6076420908793807e-05
mutant O 0 0.00028949935222044587
cells O 0 2.8357500923448242e-05
provides O 0 1.5714831533841789e-06
an O 0 6.803142014177865e-07
explanation O 0 5.70134670851985e-06
for O 0 3.7564009289781097e-06
the O 0 7.872662536101416e-05
mild O 0 0.00044014531886205077
phenotype O 0 0.00015114019333850592
in O 0 3.964277857448906e-05
patients O 0 3.0460863854386844e-05
with O 0 3.99722921429202e-06
this O 0 2.3787146346876398e-05
mutation O 0 6.122279592091218e-05
. O 0 0.00015263960813172162

The O 0 0.0001837971794884652
distribution O 0 1.873401561169885e-05
and O 0 5.382148174248869e-06
relative O 0 2.992158078995999e-05
frequencies O 0 1.5091263776412234e-05
of O 0 7.867220847401768e-05
the O 0 0.00022988798446021974
I113F O 0 0.0032095080241560936
and O 0 2.1497571651707403e-05
T312S O 0 0.0009126811055466533
mutations O 0 2.4673396183061413e-05
in O 0 1.1878316399815958e-05
Australia O 0 1.0856843800866045e-05
corresponded O 0 3.349183680256829e-05
to O 0 5.251898073765915e-06
those O 0 3.5561201912059914e-06
observed O 0 1.6110931028379127e-05
in O 0 2.385686821071431e-05
Northern O 0 8.054969657678157e-05
Ireland O 0 4.7120189265115187e-05
and O 0 3.4346678603469627e-06
are O 0 3.877061658386083e-07
unique O 0 5.913875156693393e-06
to O 0 4.520071342994925e-06
these O 0 2.1033408756920835e-06
two O 0 3.172020569763845e-06
populations O 0 4.1712564780027606e-06
, O 0 1.6921146652748575e-06
suggesting O 0 7.469869615306379e-06
that O 0 4.823921244678786e-07
both O 0 4.851242010772694e-06
mutations O 0 2.182119533244986e-05
were O 0 3.531285256030969e-05
probably O 0 4.8303845687769353e-05
introduced O 0 5.457131464936538e-06
to O 0 2.102378175550257e-06
Australia O 0 2.6822860945685534e-06
by O 0 6.934610610187519e-07
Irish O 0 6.393605872290209e-05
migrants O 0 1.8342858311370946e-05
during O 0 0.0001705050963209942
the O 0 5.3500712965615094e-05
19th O 0 0.0010934663005173206
century O 0 0.002197480062022805
. O 0 0.00018705935508478433

Haplotype O 0 0.0008891161996871233
analysis O 0 1.1434933185228147e-05
using O 0 2.2334741515805945e-05
6 O 0 0.0008852926548570395
RFLPs O 0 0.003795374883338809
provides O 0 2.663710574779543e-06
additional O 0 2.125749006154365e-06
data O 0 4.732455181510886e-06
that O 0 6.361869964166544e-07
the O 0 2.356450022489298e-05
I113F O 0 0.0007194441859610379
mutation O 0 9.671899533714168e-06
originated O 0 4.8077879910124466e-05
from O 0 1.0698407095333096e-05
a O 0 1.973943471966777e-05
common O 0 4.593079211190343e-05
ancestor O 0 0.00252444576472044
. O 0 0.0007370544481091201

The O 0 0.00033917854307219386
other O 0 1.7708160157781094e-05
9 O 0 0.00048696226440370083
novel O 0 0.00012087972572771832
mutations O 0 3.686441050376743e-05
identified O 0 1.7271780961891636e-05
in O 0 1.6419633539044298e-05
these O 0 8.063742825470399e-06
23 O 0 0.0005737845203839242
patients O 0 3.976948210038245e-05
were O 0 1.6787234926596284e-05
each O 0 1.3140609098627465e-06
limited O 0 5.829457222716883e-06
to O 0 1.0541801202634815e-05
a O 0 2.8882172045996413e-05
single O 0 2.6874924515141174e-05
family O 0 3.4049939131364226e-05
. O 0 7.193005876615644e-05

These O 0 1.892247746582143e-05
data O 0 1.265409173356602e-05
provide O 0 5.953674190095626e-06
further O 0 1.2590100595843978e-05
evidence O 0 3.845823084702715e-05
for O 0 9.337214578408748e-06
extensive O 0 0.00046145141823217273
allelic O 0 0.002636479213833809
heterogeneity O 0 0.00456592533737421
in O 0 0.001785829896107316
MPS B-Disease 1 0.9998910427093506
IVA I-Disease 1 1.0
in O 0 0.0006764968857169151
British O 0 0.0005905601428821683
- O 0 0.0012628319673240185
Irish O 0 0.00044661283027380705
patients O 0 2.6777348466566764e-05
and O 0 2.763928250715253e-06
provide O 0 4.572078978526406e-06
evidence O 0 3.655350883491337e-05
for O 0 1.796062133507803e-05
their O 0 3.495468263281509e-05
transmission O 0 0.00030431803315877914
to O 0 9.67011055763578e-06
Australia O 0 5.4111951612867415e-06
by O 0 2.0579116153385257e-06
British O 0 5.296480594552122e-05
- O 0 0.0002135403046850115
Irish O 0 0.0003627302357926965
migrants O 0 8.088759932434186e-05
. O 0 3.2325664506061e-05
. O 0 5.276259980746545e-05

Identification O 0 6.228703568922356e-05
of O 0 0.0004538765933830291
constitutional O 0 0.007715609390288591
WT1 O 1 0.9999998807907104
mutations O 0 0.0003538586897775531
, O 0 1.9474447981338017e-05
in O 0 2.9766610168735497e-05
patients O 0 5.771370342699811e-05
with O 0 6.373607902787626e-05
isolated O 1 0.9998849630355835
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0005538043333217502
and O 0 1.5603720385115594e-05
analysis O 0 7.129508048819844e-06
of O 0 0.000286572496406734
genotype O 0 0.002823082497343421
/ O 0 0.0036534119863063097
phenotype O 0 5.342964504961856e-05
correlations O 0 6.58946082694456e-05
by O 0 4.471293323149439e-06
use O 0 5.131751095177606e-06
of O 0 7.383075717370957e-05
a O 0 0.00015453567903023213
computerized O 0 0.0015064073959365487
mutation O 0 3.920610106433742e-05
database O 0 5.919391696806997e-05
. O 0 0.00011251302203163505

Constitutional O 0 0.0005094676744192839
mutations O 0 5.023787161917426e-05
of O 0 0.00021544347691815346
the O 0 0.0013451247941702604
WT1 O 1 0.9990154504776001
gene O 0 5.072397834737785e-05
, O 0 3.054642320421408e-06
encoding O 0 2.3702301405137405e-05
a O 0 0.0002162937307730317
zinc O 1 0.9962863922119141
- O 0 0.0017046574503183365
finger O 0 0.0005103445146232843
transcription O 0 0.00048551338841207325
factor O 0 6.557498272741213e-05
involved O 0 6.54544637654908e-05
in O 0 0.0006642902735620737
renal O 1 1.0
and O 0 0.46074405312538147
gonadal O 1 1.0
development O 0 0.03143112733960152
, O 0 2.982397927553393e-05
are O 0 6.027331664881785e-07
found O 0 1.340161134066875e-06
in O 0 2.0838540422118967e-06
most O 0 3.1416052479471546e-06
patients O 0 9.045453225553501e-06
with O 0 1.797837467165664e-05
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9978166818618774
DDS B-Disease 1 1.0
) O 0 0.00044461232027970254
, O 0 5.422003960120492e-05
or O 0 0.0002871835313271731
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999983310699463
DMS B-Disease 1 1.0
) O 0 0.00012814582441933453
associated O 0 1.5590943803545088e-05
with O 0 1.4429007933358662e-05
pseudohermaphroditism B-Disease 1 1.0
and O 0 0.0004790184029843658
/ O 1 0.9771337509155273
or O 0 0.009700346738100052
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.05491001158952713
WT B-Disease 1 1.0
) O 0 0.0004060755600221455
. O 0 0.00015165572403930128

Most O 0 0.00016224679711740464
mutations O 0 0.00035525314160622656
in O 0 0.0009001155267469585
DDS B-Disease 1 1.0
patients O 0 0.0020789573900401592
lie O 0 0.0031538731418550014
in O 0 0.00021548313088715076
exon O 0 0.000826110364869237
8 O 0 0.00027253577718511224
or O 0 2.9727805667789653e-05
exon O 0 0.00030816937214694917
9 O 0 0.00020963267888873816
, O 0 1.3601607861346565e-05
encoding O 0 0.00016332977975253016
zinc O 1 0.6538002490997314
finger O 0 0.005611450877040625
2 O 0 0.004256936721503735
or O 0 0.0009248885326087475
zinc O 1 0.9947280287742615
finger O 0 0.0032103059347718954
3 O 0 0.0003304632264189422
, O 0 1.529982364445459e-05
respectively O 0 3.6323992389952764e-05
, O 0 3.8050429793656804e-06
with O 0 2.8776560156984488e-06
a O 0 6.40856014797464e-05
hot O 0 0.0011667462531477213
spot O 0 0.000673099362757057
( O 0 5.491822230396792e-05
R394W O 0 0.0013767435448244214
) O 0 2.9619057386298664e-05
in O 0 6.397337710950524e-05
exon O 0 0.0014483692357316613
9 O 0 0.0013137470232322812
. O 0 0.00018452908261679113

We O 0 2.1260257199173793e-05
analyzed O 0 1.2111251635360532e-05
a O 0 2.157273229386192e-06
series O 0 6.1165796978457365e-06
of O 0 3.555343937478028e-05
24 O 0 0.0004779791343025863
patients O 0 5.024055644753389e-05
, O 0 4.8458041419507936e-06
10 O 0 2.0214471078361385e-05
with O 0 1.3430639228317887e-05
isolated B-Disease 0 0.012264475226402283
DMS I-Disease 1 1.0
( O 0 0.004560824483633041
IDMS B-Disease 1 0.9999979734420776
) O 0 0.00014579290291294456
, O 0 9.794181096367538e-06
10 O 0 2.896055593737401e-05
with O 0 1.777363650035113e-05
DDS B-Disease 1 1.0
, O 0 3.0018840334378183e-05
and O 0 7.1535087045049295e-06
4 O 0 0.00028373103123158216
with O 0 0.0001130466625909321
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9766879677772522
/ O 1 0.9999994039535522
or O 1 0.997882068157196
WT B-Disease 1 1.0
. O 0 0.002095888601616025

We O 0 0.00018888439808506519
report O 0 9.086684440262616e-05
WT1 O 0 0.04318152740597725
heterozygous O 0 4.3128766264999285e-05
mutations O 0 3.955057400162332e-05
in O 0 6.481173477368429e-05
16 O 0 0.0007939489441923797
patients O 0 8.062408596742898e-05
, O 0 1.1830586117866915e-05
4 O 0 0.00011587535846047103
of O 0 0.00010284661402693018
whom O 0 0.00019600408268161118
presented O 0 0.0012477765558287501
with O 0 0.0006312425248324871
IDMS B-Disease 1 1.0
. O 0 0.002076762495562434

One O 0 0.0003026621707249433
male O 0 0.0001837765157688409
and O 0 1.8449929484631866e-05
two O 0 6.510983075713739e-05
female O 0 0.0020958399400115013
IDMS B-Disease 1 1.0
patients O 0 0.0010210400214418769
with O 0 0.000422753015300259
WT1 O 1 1.0
mutations O 0 0.028217270970344543
underwent O 1 1.0
normal O 1 0.9940207600593567
puberty O 1 0.9995625615119934
. O 0 0.00042830395977944136

Two O 0 0.00012311121099628508
mutations O 0 0.00019132856687065214
associated O 0 8.852498285705224e-05
with O 0 0.00011057573283324018
IDMS B-Disease 1 0.9999988079071045
are O 0 6.123659659351688e-06
different O 0 1.0766456171040772e-06
from O 0 1.2820845768146683e-05
those O 0 1.138783227361273e-05
described O 0 0.0002115954557666555
in O 0 0.0011765945237129927
DDS B-Disease 1 1.0
patients O 0 0.004112342372536659
. O 0 0.00060038932133466

No O 0 0.003150255884975195
WT1 O 1 0.9954018592834473
mutations O 0 0.00014930812176316977
were O 0 8.388044807361439e-05
detected O 0 0.00018552869732957333
in O 0 1.3920836863690056e-05
the O 0 4.098499994142912e-05
six O 0 0.00016101310029625893
other O 0 9.728595614433289e-05
IDMS B-Disease 1 1.0
patients O 0 0.0005542870494537055
, O 0 2.5320669010397978e-05
suggesting O 0 5.4107174946693704e-05
genetic O 0 7.169072341639549e-05
heterogeneity O 0 0.0005402120877988636
of O 0 0.0017139576375484467
this O 0 0.002107143634930253
disease O 1 1.0
. O 0 0.000967366446275264

We O 0 0.0001080135116353631
analyzed O 0 0.0003797925601247698
genotype O 0 0.0008658127044327557
/ O 0 0.001823323662392795
phenotype O 0 0.00017105862207245082
correlations O 0 0.00027551886159926653
, O 0 9.325751307187602e-06
on O 0 2.212764957221225e-05
the O 0 8.516193702234887e-06
basis O 0 6.385986580426106e-06
of O 0 2.526605749153532e-05
the O 0 7.092695886967704e-05
constitution O 0 4.6239918447099626e-05
of O 0 8.406471170019358e-05
a O 0 0.00021427292085718364
WT1 O 1 0.9219210147857666
mutation O 0 7.369942068180535e-06
database O 0 1.3692110769625288e-05
of O 0 0.0001086640331777744
84 O 0 0.012914752587676048
germ O 1 1.0
- O 0 0.014466523192822933
line O 0 0.0004873426223639399
mutations O 0 1.3532517186831683e-05
, O 0 1.8599417899167747e-06
to O 0 2.4589082840975607e-06
compare O 0 1.8006532627623528e-05
the O 0 2.1962243408779614e-05
distribution O 0 1.158988834504271e-05
and O 0 5.4899915085115936e-06
type O 0 6.412564835045487e-05
of O 0 0.00020637994748540223
mutations O 0 0.00019353952666278929
, O 0 8.295863153762184e-06
according O 0 2.4174878490157425e-06
to O 0 5.484261691890424e-06
the O 0 3.787876994465478e-05
different O 0 1.2601681191881653e-05
symptoms O 0 0.008384198881685734
. O 0 0.0007466242532245815

This O 0 5.253175550024025e-05
demonstrated O 0 0.000464223645394668
( O 0 4.343552791397087e-05
1 O 0 0.0001964323309948668
) O 0 9.110677638091147e-06
the O 0 1.0989973816322163e-05
association O 0 1.067098492057994e-05
between O 0 7.085015386110172e-05
mutations O 0 3.535652285791002e-05
in O 0 4.542263923212886e-05
exons O 0 0.0003722254768945277
8 O 0 0.00019048468675464392
and O 0 1.3471713828039356e-05
9 O 0 0.0005668543744832277
and O 0 5.261609112494625e-05
DMS B-Disease 1 0.9998120665550232
; O 0 3.650126382126473e-05
( O 0 4.3667605496011674e-05
2 O 0 0.0003339969553053379
) O 0 2.4196689992095344e-05
among O 0 2.1507867131731473e-05
patients O 0 7.24065030226484e-05
with O 0 9.996929293265566e-05
DMS B-Disease 1 0.9999979734420776
, O 0 4.223351788823493e-05
a O 0 1.221124784933636e-05
higher O 0 1.2267038982827216e-05
frequency O 0 8.447350410278887e-06
of O 0 5.887494990020059e-05
exon O 0 0.0004388607922010124
8 O 0 0.00012712676834780723
mutations O 0 1.1510019248817116e-05
among O 0 8.867040378390811e-06
46 O 0 0.00014109873154666275
, O 0 5.7430679589742795e-05
XY O 1 0.9662058353424072
patients O 0 8.233408152591437e-05
with O 0 1.1929560969292652e-05
female O 0 0.0001603671262273565
phenotype O 0 3.093431223533116e-05
than O 0 4.028572675451869e-06
among O 0 1.7245940398424864e-05
46 O 0 0.0003454292891547084
, O 0 0.00013561890227720141
XY O 1 0.9987106323242188
patients O 0 0.00011695903958752751
with O 0 2.022449734795373e-05
sexual O 0 0.0006289638695307076
ambiguity O 0 0.007837877608835697
or O 0 0.0013786184135824442
male O 0 0.0008290747064165771
phenotype O 0 0.00017397853662259877
; O 0 9.842814506555442e-06
and O 0 2.0042249161633663e-05
( O 0 4.644160799216479e-05
3 O 0 0.00017332470451947302
) O 0 3.571417437342461e-06
statistically O 0 1.8185743329013349e-06
significant O 0 7.165273018472362e-06
evidence O 0 2.1433088477351703e-05
that O 0 3.608726046877564e-06
mutations O 0 1.0604284398141317e-05
in O 0 4.7847766836639494e-05
exons O 0 0.000407153507694602
8 O 0 0.00028498462052084506
and O 0 1.7126279999502003e-05
9 O 0 0.00023333175340667367
preferentially O 0 2.2768857888877392e-05
affect O 0 2.6747158699436113e-05
amino O 0 1.0146504791919142e-05
acids O 0 2.3763245735608507e-06
with O 0 3.952893052883155e-07
different O 0 4.5526462599809747e-07
functions O 0 1.5415187590406276e-05
. O 0 3.823224687948823e-05
. O 0 7.955465844133869e-05

The O 0 0.001331574865616858
185delAG O 0 0.02439705841243267
BRCA1 O 0 0.00422308873385191
mutation O 0 3.212783849448897e-05
originated O 0 9.871555084828287e-05
before O 0 2.58792242675554e-05
the O 0 1.005709509627195e-05
dispersion O 0 5.2575058361981064e-05
of O 0 8.459731179755181e-05
Jews O 0 0.0012819621479138732
in O 0 0.0001488455745857209
the O 0 0.00012117307051084936
diaspora O 0 0.00010903031943598762
and O 0 5.1789147619274445e-06
is O 0 3.215409833501326e-06
not O 0 1.037118522617675e-06
limited O 0 4.172784429101739e-06
to O 0 3.605741585488431e-05
Ashkenazim O 0 0.013442153111100197
. O 0 0.0005062171840108931

The O 0 0.0008771865395829082
185delAG O 0 0.0056434632278978825
mutation O 0 5.470517135108821e-05
in O 0 7.180608372436836e-05
BRCA1 O 0 0.0013031294802203774
is O 0 1.3505107745004352e-05
detected O 0 8.103544678306207e-05
in O 0 6.9611810431524646e-06
Ashkenazi O 0 8.494069334119558e-05
Jews O 0 0.00011981683201156557
both O 0 1.7955893781618215e-05
in O 0 0.00026510845054872334
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0025349301286041737
in O 0 0.0001144468187703751
the O 0 5.19250170327723e-05
general O 0 2.850320379366167e-05
population O 0 1.718652310955804e-05
. O 0 3.590103005990386e-05

All O 0 0.00016362860333174467
tested O 0 0.00023758022871334106
Ashkenazi O 0 0.00029292760882526636
mutation O 0 1.4985810594225768e-05
carriers O 0 1.146494014392374e-05
share O 0 5.315153430274222e-06
the O 0 1.782622348400764e-05
same O 0 1.3828822375216987e-05
allelic O 0 0.00038507647695951164
pattern O 0 0.0003506107022985816
at O 0 0.0005439704982563853
the O 0 0.00020031919120810926
BRCA1 O 0 0.002222297480329871
locus O 0 0.00084348936798051
. O 0 0.000163783595780842

Our O 0 8.914694626582786e-05
previous O 0 3.313908746349625e-05
study O 0 9.407376637682319e-06
showed O 0 2.3665956177865155e-05
that O 0 9.515601959719788e-07
this O 0 1.946011252584867e-06
Ashkenazi O 0 0.00017312398995272815
mutation O 0 1.4430795999942347e-05
also O 0 6.0976508393650874e-06
occurs O 0 1.114633687393507e-05
in O 0 1.2089985830243677e-05
Iraqi O 0 0.0002615798148326576
Jews O 0 0.00023227209749165922
with O 0 6.870272045489401e-06
a O 0 2.4634671717649326e-05
similar O 0 2.6687765057431534e-05
allelic O 0 0.005058618262410164
pattern O 0 0.0032126354053616524
. O 0 0.0006922457250766456

We O 0 7.273029041243717e-05
extended O 0 4.4001269998261705e-05
our O 0 8.83691154740518e-06
analysis O 0 1.8815466091837152e-06
to O 0 5.29567932971986e-06
other O 0 8.968489964900073e-06
non O 0 0.00032609052141197026
- O 0 0.0002752917062025517
Ashkenazi O 0 8.200146839953959e-05
subsets O 0 3.790363189182244e-05
354 O 0 7.006205851212144e-05
of O 0 4.5684155338676646e-05
Moroccan O 0 0.0003841939615085721
origin O 0 2.839433182089124e-05
, O 0 1.9962879377999343e-05
200 O 0 8.276365406345576e-05
Yemenites O 0 0.002976704854518175
and O 0 1.381113634124631e-05
150 O 0 6.636074249399826e-05
Iranian O 0 0.0003526222426444292
Jews O 0 0.0008548733312636614
. O 0 0.0002273334248457104

Heteroduplex O 0 0.0068882224150002
analysis O 0 6.542034043377498e-06
complemented O 0 2.047944872174412e-05
by O 0 7.249066129588755e-07
direct O 0 3.4404902180540375e-06
DNA O 0 7.223602005979046e-05
sequencing O 0 6.942359323147684e-05
of O 0 0.00014465187268797308
abnormally O 0 0.0016721513820812106
migrating O 0 8.739825716475025e-05
bands O 0 0.00011544896551640704
were O 0 4.1490999137749895e-05
employed O 0 0.00026721032918430865
. O 0 0.0001432778954040259

Four O 0 9.55445648287423e-05
of O 0 0.00011476876534288749
Moroccan O 0 0.0005272431881166995
origin O 0 4.3944364733761176e-05
( O 0 3.417750122025609e-05
1 O 0 0.00017482282419223338
. O 0 7.635089787072502e-06
1 O 0 7.118375651771203e-05
% O 0 1.073490329872584e-05
) O 0 7.340740921790712e-06
and O 0 4.091658411198296e-06
none O 0 3.315969661343843e-05
of O 0 6.11519644735381e-05
the O 0 0.00031681667314842343
Yemenites O 0 0.03550378233194351
or O 0 6.305380520643666e-05
Iranians O 0 0.0004787545476574451
was O 0 0.00018153888231609017
a O 0 1.0450669833517168e-05
carrier O 0 1.806754335120786e-05
of O 0 2.4561530153732747e-05
the O 0 0.00015272843302227557
185delAG O 0 0.006129240617156029
mutation O 0 7.976408232934773e-05
. O 0 8.114935917546973e-05

BRCA1 O 0 0.027750244364142418
allelic O 0 0.0045564379543066025
patterns O 0 0.00027812799089588225
were O 0 4.270615681889467e-05
determined O 0 1.8986864233738743e-05
for O 0 3.11823623633245e-06
four O 0 8.366431757167447e-06
of O 0 1.8777980585582554e-05
these O 0 5.009467713534832e-06
individuals O 0 1.56633461756428e-06
and O 0 3.3349178920616396e-06
for O 0 9.817699719860684e-06
12 O 0 0.0001540792582090944
additional O 0 6.506017234642059e-05
non O 0 0.0008953920914791524
- O 0 0.0005749390693381429
Ashkenazi O 0 0.00022239662939682603
185delAG O 0 0.0007667277241125703
mutation O 0 5.6537214732088614e-06
carriers O 0 8.594806786277331e-06
who O 0 1.476962734159315e-05
had O 0 0.06583907455205917
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9972334504127502

Six O 0 0.0015289228176698089
non O 0 0.0027610822580754757
- O 0 0.0008929328178055584
Ashkenazi O 0 0.00017993772053159773
individuals O 0 2.619911356305238e-06
shared O 0 4.593123230733909e-05
the O 0 7.663256110390648e-05
common O 0 5.6399210734525695e-05
Ashkenazi O 0 0.0008007657597772777
haplotype O 0 0.0015895918477326632
, O 0 4.268424891051836e-05
four O 0 3.157282844767906e-05
had O 0 9.279989899368957e-05
a O 0 2.7365922505850904e-05
closely O 0 4.988583532394841e-05
related O 0 0.00010701778955990449
pattern O 0 0.0004934405442327261
, O 0 2.245232644781936e-05
and O 0 7.565825853816932e-06
the O 0 8.432741742581129e-05
rest O 0 0.00033255352173000574
( O 0 3.981379995821044e-05
n O 0 0.00020816095639020205
= O 0 0.0003789593174587935
6 O 0 0.00028963215299881995
) O 0 6.757891696906881e-06
displayed O 0 9.595452138455585e-05
a O 0 4.1787538066273555e-05
distinct O 0 0.00023773679276928306
BRCA1 O 0 0.009171386249363422
allelic O 0 0.009042052552103996
pattern O 0 0.0043719797395169735
. O 0 0.0009787617018446326

We O 0 7.416783773805946e-05
conclude O 0 0.00021913196542300284
that O 0 3.144719812553376e-06
the O 0 6.27074550720863e-05
185delAG O 0 0.009204760193824768
BRCA1 O 0 0.002435361733660102
mutation O 0 1.983690344786737e-05
occurs O 0 8.492042070429306e-06
in O 0 7.614591140736593e-06
some O 0 9.347878403787035e-06
non O 0 0.0005540319252759218
- O 0 0.0004350271774455905
Ashkenazi O 0 9.675878391135484e-05
populations O 0 3.7732220334874e-06
at O 0 2.4168921299860813e-05
rates O 0 4.401784281071741e-06
comparable O 0 9.203831723425537e-06
with O 0 7.288182359843631e-07
that O 0 1.9867406990670133e-06
of O 0 0.00021009751071687788
Ashkenazim O 1 0.6336390376091003
. O 0 0.0010209059109911323

The O 0 0.00010685811139410362
majority O 0 9.094531378650572e-06
of O 0 0.00011478814121801406
Jewish O 0 0.0005727449315600097
185delAG O 0 0.011607772670686245
mutation O 0 5.6776083511067554e-05
carriers O 0 2.207297984568868e-05
have O 0 1.3039790474067559e-06
a O 0 1.275876275030896e-05
common O 0 1.800466088752728e-05
allelic O 0 0.0015646315878257155
pattern O 0 0.0009820172563195229
, O 0 5.1642458856804296e-05
supporting O 0 0.00013777938147541136
the O 0 0.0003805741434916854
founder O 0 0.0038170856423676014
effect O 0 0.0002072138013318181
notion O 0 0.00015239122149068862
, O 0 7.541347258666065e-06
but O 0 2.447019824103336e-06
dating O 0 0.00015995674766600132
the O 0 1.866927595983725e-05
mutations O 0 9.709699043014552e-06
origin O 0 2.8873048449895578e-06
to O 0 3.736553935596021e-06
an O 0 4.06584194934112e-06
earlier O 0 3.65761443390511e-05
date O 0 0.00011923146666958928
than O 0 2.2037925191398244e-06
currently O 0 9.725730706122704e-06
estimated O 0 0.00015194242587313056
. O 0 0.00012160345067968592

However O 0 0.0002767971018329263
, O 0 9.321413017460145e-06
the O 0 1.022038941300707e-05
different O 0 1.7492644701633253e-06
allelic O 0 0.00047221482964232564
pattern O 0 0.0004548649303615093
at O 0 0.001337535330094397
the O 0 0.0007658139220438898
BRCA1 O 0 0.002644828287884593
locus O 0 0.00016790373774711043
even O 0 1.047557634592522e-05
in O 0 4.08812093155575e-06
some O 0 2.054247033811407e-06
Jewish O 0 5.735432932851836e-05
mutation O 0 2.5381446903338656e-05
carriers O 0 2.9919183361926116e-05
, O 0 4.003466983704129e-06
might O 0 4.211375198792666e-06
suggest O 0 4.130262823309749e-06
that O 0 5.882056939299218e-07
the O 0 9.010462235892192e-06
mutation O 0 5.515259090316249e-06
arose O 0 0.00010500455391593277
independently O 0 1.9293878722237423e-05
. O 0 1.4005046978127211e-05
. O 0 4.9988793762167916e-05

Crystal O 1 0.6376590728759766
structure O 0 0.004830935969948769
of O 0 0.003688111901283264
the O 1 0.9985029697418213
hemochromatosis B-Disease 1 1.0
protein O 1 0.9996738433837891
HFE O 1 0.9999970197677612
and O 0 9.591591515345499e-05
characterization O 0 0.0001558449730509892
of O 0 6.60477380733937e-05
its O 0 4.548180368146859e-05
interaction O 0 3.924744305550121e-05
with O 0 1.9553724996512756e-05
transferrin O 0 0.005322853568941355
receptor O 0 0.0004077587218489498
. O 0 8.205168705899268e-05

HFE O 1 0.9996628761291504
is O 0 0.0003218008205294609
an O 0 9.332730405731127e-05
MHC O 1 0.9651736617088318
- O 0 0.0027172183617949486
related O 0 0.00011420664668548852
protein O 0 1.771841198205948e-05
that O 0 6.560781571351981e-07
is O 0 6.981664455452119e-07
mutated O 0 3.749182724277489e-06
in O 0 4.192593678453704e-06
the O 0 0.00026550228358246386
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 1.0

HFE O 1 0.9775893092155457
binds O 0 0.00046521396143361926
to O 0 7.544723484897986e-05
transferrin O 0 0.005121104884892702
receptor O 0 0.0004378524317871779
( O 0 0.0001454266457585618
TfR O 0 0.0156016880646348
) O 0 2.0564268197631463e-05
and O 0 4.2107249100808986e-06
reduces O 0 1.5069706932990812e-05
its O 0 5.982347829558421e-06
affinity O 0 2.9122185878804885e-05
for O 0 9.828292240854353e-05
iron O 1 0.9999793767929077
- O 0 0.0028692095074802637
loaded O 0 0.0005041033145971596
transferrin O 0 0.0034870710223913193
, O 0 9.423211304238066e-05
implicating O 1 0.5638298988342285
HFE O 1 0.9999998807907104
in O 0 0.02876000478863716
iron O 1 1.0
metabolism O 1 0.9917780160903931
. O 0 0.0007495571626350284

The O 0 0.0006631267024204135
2 O 0 0.0016313889063894749
. O 0 0.00020750485418830067

6 O 0 0.006468976382166147
A O 0 0.0059868525713682175
crystal O 1 0.9903504252433777
structure O 0 0.1268056482076645
of O 0 0.0080190384760499
HFE O 1 0.9999994039535522
reveals O 0 0.0007333194953389466
the O 0 2.5539415219100192e-05
locations O 0 2.9286640710779466e-05
of O 0 0.0007122048991732299
hemochromatosis B-Disease 1 1.0
mutations O 0 0.0042838407680392265
and O 0 0.0002448562881909311
a O 0 0.0005536734825000167
patch O 1 0.9999521970748901
of O 0 0.0036584327463060617
histidines O 1 0.9898825287818909
that O 0 1.1660241398203652e-05
could O 0 7.38555490897852e-06
be O 0 1.5518378404522082e-06
involved O 0 8.05808485893067e-06
in O 0 6.267469143494964e-05
pH O 0 0.0050634900107979774
- O 0 0.001281678443774581
dependent O 0 7.45794823160395e-05
interactions O 0 7.429838296957314e-05
. O 0 0.00010874126019189134

We O 0 6.460359873017296e-05
also O 0 8.195329428417608e-06
demonstrate O 0 0.00012820889241993427
that O 0 4.106308915652335e-05
soluble O 0 0.022869886830449104
TfR O 1 0.996350884437561
and O 0 0.0004646570305339992
HFE O 1 0.9996558427810669
bind O 0 0.00048344035167247057
tightly O 0 0.0002251727564726025
at O 0 7.711823127465323e-05
the O 0 2.8350064894766547e-05
basic O 0 0.0001882202923297882
pH O 0 0.001097696484066546
of O 0 0.000277810002444312
the O 0 0.001093695405870676
cell O 0 0.0015901187434792519
surface O 0 0.0004810497921425849
, O 0 8.043313755479176e-06
but O 0 1.3104241816108697e-06
not O 0 7.120764848878025e-07
at O 0 4.8992340452969074e-05
the O 0 3.989003744209185e-05
acidic O 0 0.0006682232487946749
pH O 0 0.0018031062791123986
of O 0 0.001116172643378377
intracellular O 0 0.01362820528447628
vesicles O 0 0.10624322295188904
. O 0 0.0014131866628304124

TfR O 1 0.9988571405410767
HFE O 1 0.9963178634643555
stoichiometry O 0 0.004467221908271313
( O 0 0.0002027492446359247
2 O 0 0.00039785110857337713
1 O 0 0.00032909397850744426
) O 0 1.5807911040610634e-05
differs O 0 1.954291292349808e-05
from O 0 3.709748125402257e-05
TfR O 0 0.014665555208921432
transferrin O 0 0.0032600359991192818
stoichiometry O 0 0.0004838008899241686
( O 0 5.807736670249142e-05
2 O 0 0.0003129695251118392
2 O 0 0.0003858772397506982
) O 0 2.382169805059675e-05
, O 0 4.296341558074346e-06
implying O 0 2.834038605215028e-05
a O 0 4.173863089818042e-06
different O 0 5.291063303047849e-07
mode O 0 0.0001117419233196415
of O 0 7.043223013170063e-05
binding O 0 4.699413329944946e-05
for O 0 0.00015953103138599545
HFE O 1 0.9999821186065674
and O 0 0.0002752085274551064
transferrin O 0 0.011758778244256973
to O 0 0.00031513904104940593
TfR O 0 0.10362682491540909
, O 0 1.4570229723176453e-05
consistent O 0 1.8010910935117863e-05
with O 0 3.21797438118665e-06
our O 0 5.272105408948846e-05
demonstration O 0 0.0008220607414841652
that O 0 3.531005859258585e-05
HFE O 1 0.9994139671325684
, O 0 0.00012786593288183212
transferrin O 0 0.006775091867893934
, O 0 3.191992800566368e-05
and O 0 2.2163490939419717e-05
TfR O 0 0.015369858592748642
form O 0 0.00014348009426612407
a O 0 0.00026492803590372205
ternary O 0 0.02269146963953972
complex O 1 0.9204737544059753
. O 0 0.0007149013108573854

Identification O 0 7.79194597271271e-05
of O 0 0.00018246937543153763
three O 0 9.050364315044135e-05
novel O 0 0.00022180622909218073
mutations O 0 4.097034252481535e-05
and O 0 5.845072337251622e-06
a O 0 1.473681641073199e-05
high O 0 0.000105110346339643
frequency O 0 1.3944767488283105e-05
of O 0 4.328868453740142e-05
the O 0 0.0001621464325580746
Arg778Leu O 0 0.006734930444508791
mutation O 0 8.283239367301576e-06
in O 0 1.406232695444487e-05
Korean O 0 0.02278580516576767
patients O 0 3.1103456421988085e-05
with O 0 2.861383109120652e-05
Wilson B-Disease 1 0.9999487400054932
disease I-Disease 1 1.0
. O 0 0.0011300640180706978

Four O 0 0.0006004344904795289
mutations O 0 0.0005429998273029923
- O 0 0.00156655244063586
- O 0 0.0006153924041427672
R778L O 0 0.0009916145354509354
, O 0 1.5215659004752524e-05
A874V O 0 0.0007797954021953046
, O 0 1.5934645489323884e-05
L1083F O 0 0.0008522823336534202
, O 0 1.2008342309854925e-05
and O 0 1.3955504073237535e-05
2304delC O 0 0.002321593463420868
- O 0 0.0004939250065945089
- O 0 0.00018126869690604508
in O 0 2.471795778546948e-05
the O 0 0.00013019907055422664
copper O 0 0.019741544499993324
- O 0 0.00032550038304179907
transporting O 0 0.0002708794199861586
enzyme O 0 3.3469135814812034e-05
, O 0 1.8982320398208685e-05
P O 0 0.0029378999024629593
- O 0 0.0005399541696533561
type O 0 0.00019756518304347992
ATPase O 0 0.0013702516444027424
( O 0 0.00027577110449783504
ATP7B O 1 0.9886271357536316
) O 0 1.9742747099371627e-05
, O 0 1.1066022125305608e-06
were O 0 3.1452357234229567e-06
identified O 0 5.6055209824990015e-06
in O 0 1.4768303117307369e-05
Korean O 1 0.9390583038330078
Patients O 0 0.00017949118046090007
with O 0 7.045461097732186e-05
Wilson B-Disease 1 0.9999837875366211
disease I-Disease 1 1.0
. O 0 0.0019421549513936043

Arg778Leu O 0 0.11533191800117493
, O 0 2.846465758921113e-05
the O 0 2.032258089457173e-05
most O 0 6.2682252064405475e-06
frequently O 0 1.176489058707375e-05
reported O 0 1.1473449376353528e-05
mutation O 0 2.175889676436782e-06
of O 0 2.120445242326241e-05
this O 0 1.171744861494517e-05
enzyme O 0 3.3673455618554726e-05
, O 0 7.67363962950185e-06
was O 0 0.0001134377671405673
found O 0 4.215699391352246e-06
in O 0 5.10301060785423e-06
six O 0 1.2970092029718217e-05
of O 0 4.742045348393731e-05
eight O 0 0.0003252410388085991
unrelated O 0 0.00047370229731313884
patients O 0 0.00010119804210262373
studied O 0 0.00034560836502350867
, O 0 8.27598250907613e-06
an O 0 3.611387001001276e-06
allele O 0 4.8685064939490985e-06
frequency O 0 1.1825240108009893e-05
of O 0 0.00015018628619145602
37 O 0 0.000981091521680355
. O 0 0.0003428278723731637

5 O 0 0.0007894494920037687
% O 0 7.30236351955682e-05
, O 0 1.0687261237762868e-05
which O 0 5.228600002737949e-06
is O 0 3.975318122684257e-06
considerably O 0 3.390435813344084e-05
higher O 0 7.726053809165023e-06
than O 0 9.761047294887248e-07
those O 0 1.8150951746065402e-06
in O 0 9.67043342825491e-06
other O 0 7.622001703566639e-06
Asian O 0 0.00017744592332746834
populations O 0 1.938463537953794e-05
. O 0 3.211322837159969e-05

The O 0 0.00027093986864201725
novel O 0 0.0001734189281705767
single O 0 2.2878690288052894e-05
nucleotide O 0 0.00010067039693240076
deletion O 0 0.00037962498026899993
, O 0 3.0072622394072823e-05
2304delC O 0 0.0019508758559823036
, O 0 1.6095713363029063e-05
was O 0 0.00021270554861985147
found O 0 1.907252226374112e-05
in O 0 2.3180358766694553e-05
one O 0 3.166086753481068e-05
patient O 0 0.0001918535854201764
. O 0 0.00018225639360025525

Since O 0 0.0002174233231926337
a O 0 1.638470530451741e-05
mutation O 0 6.221000148798339e-06
at O 0 0.00012270233128219843
cDNA O 0 0.000328625290421769
nucleotide O 0 0.0003545857034623623
2302 O 0 0.01870565116405487
( O 0 7.005864608800039e-05
2302insC O 0 0.0026083108969032764
) O 0 3.273983747931197e-05
had O 0 3.534388088155538e-05
been O 0 1.651260936341714e-05
previously O 0 6.33441741229035e-05
described O 0 3.204036329407245e-05
, O 0 2.893292048611329e-06
this O 0 9.503431783741689e-07
region O 0 5.317041723174043e-05
of O 0 5.563484592130408e-05
the O 0 0.0006778977112844586
ATP7B O 1 0.9999990463256836
gene O 0 0.00023402668011840433
may O 0 8.183086174540222e-05
be O 0 1.112294467020547e-05
susceptible O 0 9.297696669818833e-05
to O 0 2.7930602300330065e-05
gene O 0 0.00033510656794533134
rearrangements O 1 0.9990811347961426
causing O 1 0.9999992847442627
Wilson B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
. O 0 0.0015973998233675957

Disruption O 0 0.008079960942268372
of O 0 0.0005567907937802374
splicing O 0 0.0005588911008089781
regulated O 0 4.965772313880734e-05
by O 0 3.915813977073412e-06
a O 0 4.201418414595537e-05
CUG O 1 0.9965881109237671
- O 0 0.0006133263232186437
binding O 0 2.5722785721882246e-05
protein O 0 0.0004046238027513027
in O 0 0.002769668120890856
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.01776694506406784

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.0012855679960921407
is O 0 4.127426655031741e-05
caused O 0 0.0002161859010811895
by O 0 1.0457030839461368e-05
a O 0 9.857538680080324e-05
CTG O 0 0.17701484262943268
expansion O 0 0.0005470862379297614
in O 0 2.052829586318694e-05
the O 0 3.363308132975362e-05
3 O 0 9.430457430426031e-05
untranslated O 0 0.0038443219382315874
region O 0 0.0002901246480178088
of O 0 0.00011593668750720099
the O 0 0.0009842662839218974
DM B-Disease 1 1.0
gene O 0 0.0007811438990756869
. O 0 0.0002044610882876441

One O 0 4.5845059503335506e-05
model O 0 1.5237208572216332e-05
of O 0 0.0008108500624075532
DM B-Disease 1 1.0
pathogenesis O 1 1.0
suggests O 0 0.00022286403691396117
that O 0 5.828239409311209e-06
RNAs O 0 0.00015276222256943583
from O 0 5.365901415643748e-06
the O 0 7.4777312875085045e-06
expanded O 0 2.620653140184004e-05
allele O 0 1.9082444850937463e-06
create O 0 5.327109192876378e-06
a O 0 1.2739830708596855e-05
gain O 0 0.00024857776588760316
- O 0 0.0003441759617999196
of O 0 9.597968892194331e-05
- O 0 0.0003406211908441037
function O 0 2.3551066988147795e-05
mutation O 0 2.6134855488635367e-06
by O 0 1.0823706588780624e-06
the O 0 2.082967694150284e-05
inappropriate O 0 6.306299474090338e-05
binding O 0 5.828779194416711e-06
of O 0 6.592051067855209e-05
proteins O 0 2.049660361080896e-05
to O 0 4.513979365583509e-05
the O 0 0.00044029386481270194
CUG O 1 0.9999405145645142
repeats O 0 0.0035575765650719404
. O 0 0.0001711787044769153

Data O 0 8.748163963900879e-05
presented O 0 0.00010180878598475829
here O 0 3.0204200811567716e-05
indicate O 0 1.3746303011430427e-05
that O 0 4.108434268346173e-07
the O 0 1.1246461326663848e-05
conserved O 0 0.00025558765628375113
heterogeneous O 0 0.0015812456840649247
nuclear O 0 0.024635659530758858
ribonucleoprotein O 1 0.9873633980751038
, O 0 8.4251856605988e-05
CUG O 1 0.6764070987701416
- O 0 0.00023886877170298249
binding O 0 6.802987627452239e-06
protein O 0 5.685920041287318e-05
( O 0 7.958932110341266e-05
CUG O 1 0.9994261264801025
- O 0 0.0031008771620690823
BP O 0 0.004272583406418562
) O 0 1.5311778042814694e-05
, O 0 3.896346697729314e-06
may O 0 3.745659705600701e-05
mediate O 0 0.0003192696312908083
the O 0 0.00028147155535407364
trans O 0 0.0035597779788076878
- O 0 0.0004975775955244899
dominant O 0 0.00017274294805247337
effect O 0 2.5322868168586865e-05
of O 0 5.833525210618973e-05
the O 0 0.00024630659027025104
RNA O 0 0.0036679962649941444
. O 0 9.911925735650584e-05

CUG O 1 0.999995231628418
- O 0 0.020929398015141487
BP O 0 0.006349989678710699
was O 0 0.00012996366422157735
found O 0 1.5020244745755917e-06
to O 0 8.913101510188426e-07
bind O 0 3.6241494854039047e-06
to O 0 3.5119901440339163e-06
the O 0 3.641007060650736e-05
human O 0 0.0003126712399534881
cardiac O 1 1.0
troponin O 1 1.0
T O 1 0.9999891519546509
( O 0 0.000441393640358001
cTNT O 0 0.01292857713997364
) O 0 3.639000715338625e-05
pre O 0 0.001469687675125897
- O 0 0.0007797972648404539
messenger O 0 0.00018757353245746344
RNA O 0 0.00024729958386160433
and O 0 3.630029596024542e-06
regulate O 0 1.158257327915635e-05
its O 0 4.1743087422219105e-06
alternative O 0 1.5773744962643832e-05
splicing O 0 0.00024089630460366607
. O 0 7.850553083699197e-05

Splicing O 0 0.0005243786727078259
of O 0 0.0005776887992396951
cTNT O 0 0.25098779797554016
was O 0 0.005501395091414452
disrupted O 0 0.1521104872226715
in O 0 0.0017377017065882683
DM B-Disease 1 1.0
striated O 1 0.9992778897285461
muscle O 0 0.009592889808118343
and O 0 9.439003770239651e-05
in O 0 0.00011335624003550038
normal O 0 0.0002777879999484867
cells O 0 3.1915940780891106e-05
expressing O 0 1.6692378267180175e-05
transcripts O 0 0.00026835512835532427
that O 0 6.7429236878524534e-06
contain O 0 0.0007816256256774068
CUG O 1 0.9991088509559631
repeats O 0 0.0031457669101655483
. O 0 0.00026138112298212945

Altered O 0 0.0008196243434213102
expression O 0 3.606852260418236e-05
of O 0 0.00010123066749656573
genes O 0 6.8531786382664e-05
regulated O 0 0.0001609592291060835
posttranscriptionally O 0 0.0033060340210795403
by O 0 7.754631224088371e-05
CUG O 1 0.9999924898147583
- O 0 0.007027792278677225
BP O 0 0.0027827927842736244
therefore O 0 7.955043656693306e-06
may O 0 1.4169645510264672e-05
contribute O 0 4.574356717057526e-05
to O 0 0.0004598782688844949
DM B-Disease 1 1.0
pathogenesis O 1 1.0
. O 0 0.00027303199749439955
. O 0 0.00013047322863712907

Identification O 0 0.0001124426707974635
of O 0 0.0002904686552938074
a O 0 0.00019788039207924157
novel O 0 0.0007001720368862152
nonsense O 0 0.0013810949167236686
mutation O 0 1.8540144083090127e-05
and O 0 3.597040176828159e-06
a O 0 1.6176440112758428e-05
missense O 0 0.00014733422722201794
substitution O 0 3.228684363421053e-05
in O 0 4.3804830056615174e-05
the O 0 0.00018441634892951697
vasopressin O 0 0.002519784029573202
- O 0 0.0012321872636675835
neurophysin O 0 0.009465175680816174
II O 1 0.9999996423721313
gene O 0 2.7013957151211798e-05
in O 0 5.269468147162115e-06
two O 0 9.458349268243182e-07
Spanish O 0 3.1233888876158744e-05
kindreds O 0 0.00041797265294007957
with O 0 1.840327422542032e-05
familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.17405351996421814

Familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999568462371826
FNDI B-Disease 1 1.0
) O 0 0.00019662683189380914
is O 0 7.89793466537958e-06
an O 0 1.54970221046824e-05
autosomal B-Disease 1 0.9999780654907227
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.999250590801239
deficiency O 1 1.0
in O 0 0.04834846034646034
the O 0 0.23278699815273285
antidiuretic O 1 0.9904910326004028
hormone O 0 0.011003639549016953
arginine O 0 0.0021804857533425093
vasopressin O 0 0.004971582442522049
( O 0 0.0003046992642339319
AVP O 0 0.01675875298678875
) O 0 5.604269972536713e-06
encoded O 0 2.084494326481945e-06
by O 0 1.8828875454346417e-06
the O 0 5.217035868554376e-05
AVP O 1 0.6284419894218445
- O 0 0.0021317603532224894
neurophysin O 0 0.02857780270278454
II O 1 1.0
( O 0 0.0036665727384388447
AVP O 1 0.9997825026512146
- O 0 0.003505456494167447
NPII O 1 0.9693629145622253
) O 0 2.265994407935068e-05
gene O 0 1.9373546820133924e-05
on O 0 0.0001310165534960106
chromosome O 0 0.0016596373170614243
20p13 O 0 0.007181558292359114
. O 0 0.00042174875852651894

In O 0 0.00015204824740067124
this O 0 7.3342325777048245e-06
study O 0 8.565863936382812e-06
, O 0 2.273082372994395e-06
we O 0 1.0762103102024412e-06
analyzed O 0 4.862052264797967e-06
two O 0 8.335955499205738e-07
families O 0 9.570097745381645e-07
with O 0 1.2659378626267426e-05
FNDI B-Disease 1 0.9999998807907104
using O 0 5.7054945500567555e-05
direct O 0 8.230997627833858e-05
automated O 0 0.0016918062465265393
fluorescent O 0 0.00015956205606926233
, O 0 9.09170375962276e-06
solid O 0 0.0002076885139103979
phase O 0 0.0013679710682481527
, O 0 1.784050982678309e-05
single O 0 1.1758979781006929e-05
- O 0 4.2598734580678865e-05
stranded O 0 1.9130011423840187e-05
DNA O 0 7.447641564795049e-06
sequencing O 0 6.509820650535403e-06
of O 0 2.970816603919957e-05
PCR O 0 0.0009275298216380179
- O 0 0.0030747121199965477
amplified O 0 0.0031392539385706186
AVP O 1 0.746918797492981
- O 0 0.003358978545293212
NPII O 1 0.9208334684371948
DNA O 0 0.0009353163186460733
. O 0 0.0001339220762019977

In O 0 0.00015820705448277295
one O 0 7.728101991233416e-06
of O 0 2.5517454560031183e-05
the O 0 5.4828480642754585e-05
families O 0 6.2276071730593685e-06
, O 0 4.006889412266901e-06
affected O 0 1.0669876246538479e-05
individuals O 0 1.4948949456083938e-06
presented O 0 0.0001229785120813176
a O 0 7.75082444306463e-05
novel O 0 0.00016148541180882603
nonsense O 0 0.00048194199916906655
mutation O 0 9.91974684438901e-06
in O 0 2.626074456202332e-05
exon O 0 0.00027564153424464166
3 O 0 5.639576556859538e-05
of O 0 3.121976988040842e-05
the O 0 7.37920418032445e-05
gene O 0 1.704864735074807e-05
, O 0 2.0339732600405114e-06
consisting O 0 5.98967790210736e-06
in O 0 8.538312613382004e-06
a O 0 2.721718374232296e-05
G O 0 0.001048759906552732
to O 0 9.509645315119997e-05
T O 0 0.0050101871602237225
transition O 0 0.0011409258004277945
at O 0 0.0008258333546109498
nucleotide O 0 0.00046322838170453906
2101 O 0 0.006251814309507608
, O 0 5.621377567877062e-06
which O 0 1.6854261275511817e-06
produces O 0 3.5634632240544306e-06
a O 0 5.85386396778631e-06
stop O 0 3.860270953737199e-05
signal O 0 0.0001898023037938401
in O 0 2.8942444259882905e-05
codon O 0 6.91539462422952e-05
82 O 0 0.0003982442431151867
( O 0 0.00022937063477002084
Glu O 0 0.09434163570404053
) O 0 9.625906386645511e-05
of O 0 0.0008766199462115765
NPII O 1 0.9999842643737793
. O 0 0.0008239225135184824

The O 0 0.002357988618314266
premature O 0 0.004465568345040083
termination O 0 0.0008987700566649437
eliminates O 0 0.0003708511940203607
part O 0 8.219060691772029e-05
of O 0 0.00011375862959539518
the O 0 0.00026315776631236076
C O 0 0.004617119673639536
- O 0 0.0005468706367537379
terminal O 0 0.0006614990415982902
domain O 0 6.823411240475252e-05
of O 0 0.0002171394880861044
NPII O 1 0.9995309114456177
, O 0 1.3719951311941259e-05
including O 0 4.282670488464646e-06
a O 0 4.643328793463297e-05
cysteine O 0 0.00010628434392856434
residue O 0 0.0003227625275030732
in O 0 3.281044337200001e-05
position O 0 3.495731652947143e-05
85 O 0 6.893357203807682e-05
, O 0 2.4658336315042106e-06
which O 0 1.947309101524297e-06
could O 0 6.089655016694451e-06
be O 0 1.946144948306028e-06
involved O 0 6.193167337187333e-06
in O 0 1.805757165129762e-05
the O 0 7.252882642205805e-05
correct O 0 0.0005506568122655153
folding O 0 0.0035996141377836466
of O 0 0.0008229369996115565
the O 0 0.002385541796684265
prohormone O 1 0.9998602867126465
. O 0 0.0012346543371677399

In O 0 0.00021865985763724893
the O 0 7.859669858589768e-05
second O 0 0.0001309645886067301
family O 0 9.732225407788064e-06
, O 0 2.722671524679754e-06
a O 0 9.115961802308448e-06
G279A O 0 0.0007489666459150612
substitution O 0 4.9043850594898686e-05
at O 0 0.00029524159617722034
position O 0 8.685191278345883e-05
- O 0 0.00010389501403551549
1 O 0 3.557942181942053e-05
of O 0 1.5582143532810733e-05
the O 0 5.485321889864281e-05
signal O 0 0.0005821649683639407
peptide O 0 0.00042500265408307314
was O 0 0.0002055509976344183
observed O 0 1.2009006240987219e-05
in O 0 5.981920367048588e-06
all O 0 3.929502327082446e-06
affected O 0 2.7484742531669326e-05
individuals O 0 8.306123163492884e-06
. O 0 0.0001471111609134823

This O 0 8.337247709278017e-05
missense O 0 0.0006315774517133832
mutation O 0 3.0869774491293356e-05
, O 0 8.28055362944724e-06
which O 0 1.6224921637331136e-05
replaces O 0 0.0018243168015033007
Ala O 0 0.010293511673808098
with O 0 6.281392415985465e-05
Thr O 1 0.9989091157913208
, O 0 3.689159348141402e-05
is O 0 6.963378382351948e-06
frequent O 0 1.570779932080768e-05
among O 0 0.00030062548466958106
FNDI B-Disease 1 1.0
patients O 0 0.000480347138363868
and O 0 2.7698453777702525e-05
is O 0 1.554846494400408e-05
thought O 0 1.9668030290631577e-05
to O 0 4.693903520092135e-06
reduce O 0 2.9058266591164283e-05
the O 0 3.5028297133976594e-05
efficiency O 0 6.905951158842072e-05
of O 0 6.33670060778968e-05
cleavage O 0 0.0009075016714632511
by O 0 4.1624356526881456e-05
signal O 0 0.0020576214883476496
peptidases O 0 0.008138100616633892
. O 0 7.716008985880762e-05
. O 0 7.231334166135639e-05

Genetic O 0 0.00039814019692130387
heterogeneity O 0 0.0009441443835385144
of O 0 0.014442081563174725
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 9.033308742800727e-05
due O 0 0.0007043555960990489
to O 0 0.00021935628319624811
TWIST O 1 0.7755353450775146
and O 0 0.0003531499532982707
FGFR O 1 0.9999990463256836
mutations O 0 0.0005865691346116364
. O 0 0.0002527441829442978

Thirty O 0 0.02022884599864483
- O 0 0.0020735955331474543
two O 0 1.7223013855982572e-05
unrelated O 0 8.323966176249087e-05
patients O 0 8.53790515975561e-06
with O 0 1.7358569266434642e-06
features O 0 5.159918509889394e-05
of O 0 0.0031358981505036354
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.162298086564988e-05
a O 0 7.732744415989146e-05
common O 0 0.00018230851856060326
autosomal B-Disease 1 0.999921441078186
dominant I-Disease 1 0.9999970197677612
condition I-Disease 1 1.0
of O 1 1.0
craniosynostosis B-Disease 1 1.0
and O 1 1.0
limb B-Disease 1 1.0
anomalies I-Disease 1 1.0
, O 0 0.0001509215944679454
were O 0 4.665664164349437e-05
screened O 0 7.201069820439443e-05
for O 0 6.530383870995138e-06
mutations O 0 2.1098834622534923e-05
in O 0 9.29946982068941e-05
TWIST O 0 0.009235957637429237
, O 0 0.00011407842976041138
FGFR2 O 1 0.9998522996902466
, O 0 6.117570592323318e-05
and O 0 6.84739206917584e-05
FGFR3 O 1 0.9999916553497314
. O 0 0.0007467117393389344

Nine O 0 0.0011535986559465528
novel O 0 0.00017875758931040764
and O 0 1.5017928490124177e-05
three O 0 3.38529898726847e-05
recurrent O 0 0.015966761857271194
TWIST O 0 0.3801506459712982
mutations O 0 0.00018830789485946298
were O 0 5.088671969133429e-05
found O 0 1.3845950888935477e-05
in O 0 2.0778590624104254e-05
12 O 0 0.0001954164617927745
families O 0 2.07202356250491e-05
. O 0 9.69608809100464e-05

Seven O 0 0.0002063522260868922
families O 0 6.4769019445520826e-06
were O 0 1.1459201232355554e-05
found O 0 3.1356339604826644e-06
to O 0 5.532052455237135e-06
have O 0 6.258262601477327e-06
the O 0 0.0002708784013520926
FGFR3 O 1 0.9999792575836182
P250R O 0 0.008901483379304409
mutation O 0 3.7588524719467387e-05
, O 0 6.283984930632869e-06
and O 0 3.566002760635456e-06
one O 0 4.031208845844958e-06
individual O 0 1.5100732753126067e-06
was O 0 9.339210373582318e-05
found O 0 5.20968160344637e-06
to O 0 2.257635742353159e-06
have O 0 1.8640828329807846e-06
an O 0 1.151466403825907e-05
FGFR2 O 1 0.9998674392700195
VV269 O 0 0.01391016598790884
- O 0 0.0010383836925029755
270 O 0 0.0002484000870026648
deletion O 0 0.0012588511453941464
. O 0 0.0002316835307283327

To O 0 0.0001409997494192794
date O 0 0.00046645328984595835
, O 0 7.704744348302484e-06
our O 0 5.961446731816977e-06
detection O 0 2.06136883207364e-05
rate O 0 1.306530975853093e-05
for O 0 1.2696058547589928e-05
TWIST O 0 0.0031753559596836567
or O 0 0.000135877140564844
FGFR O 1 0.9966375827789307
mutations O 0 4.911293217446655e-05
is O 0 6.58821454635472e-06
68 O 0 3.856025432469323e-05
% O 0 8.66974369273521e-06
in O 0 3.8294572732411325e-05
our O 0 0.0003753423225134611
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0011266061337664723
, O 0 2.9825345336575992e-05
including O 0 1.5158393580350094e-05
our O 0 5.721699562855065e-05
five O 0 5.7031891628867015e-05
patients O 0 3.6596236896002665e-05
elsewhere O 0 3.61485181201715e-05
reported O 0 3.617386391852051e-05
with O 0 1.6187505025300197e-05
TWIST O 0 0.015176506713032722
mutations O 0 0.0004035613383166492
. O 0 0.00030404169228859246

More O 0 1.4956356608308852e-05
than O 0 3.758913180718082e-06
35 O 0 3.3148629881907254e-05
different O 0 6.12859048487735e-06
TWIST O 0 0.0016965775284916162
mutations O 0 2.2197122234501876e-05
are O 0 1.4200392115526483e-06
now O 0 1.073973544407636e-05
known O 0 1.5599480320815928e-05
in O 0 8.998647899716161e-06
the O 0 2.979873534059152e-05
literature O 0 0.00014586006000172347
. O 0 7.853309216443449e-05

The O 0 0.00033975651604123414
most O 0 2.1562000256380998e-05
common O 0 8.830356819089502e-06
phenotypic O 0 0.00033113081008195877
features O 0 0.0001862094213720411
, O 0 1.2248535313119646e-05
present O 0 2.5436962459934875e-05
in O 0 1.4418691534956452e-05
more O 0 2.3716902433079667e-06
than O 0 1.7993065739574376e-06
a O 0 6.285105428105453e-06
third O 0 2.556090839789249e-05
of O 0 2.998876698256936e-05
our O 0 4.628342139767483e-05
patients O 0 3.7206500564934686e-05
with O 0 1.4027769793756306e-05
TWIST O 0 0.02788555808365345
mutations O 0 0.00016402240726165473
, O 0 2.8094704248360358e-05
are O 0 1.1710814760590438e-05
coronal B-Disease 0 0.0740349069237709
synostosis I-Disease 1 0.9943729639053345
, O 0 0.0001606499426998198
brachycephaly B-Disease 1 0.6531992554664612
, O 0 0.00015095784328877926
low B-Disease 0 0.011313918977975845
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 0.09221102297306061
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 1 0.8567758202552795
ptosis B-Disease 1 1.0
, O 0 0.0006010969518683851
hypertelorism B-Disease 1 0.9995276927947998
, O 0 0.00014024402480572462
broad B-Disease 0 0.0016575254267081618
great I-Disease 1 0.9999850988388062
toes I-Disease 1 0.9993612170219421
, O 0 9.511158714303747e-05
and O 0 7.683466537855566e-05
clinodactyly B-Disease 0 0.09283982962369919
. O 0 0.0006421488360501826

Significant O 0 0.0029192205984145403
intra O 0 0.2883329391479492
- O 0 0.002863192930817604
and O 0 3.879669020534493e-05
interfamilial O 0 0.003679571906104684
phenotypic O 0 0.000485955155454576
variability O 0 0.0008079793187789619
is O 0 1.1941534467041492e-05
present O 0 1.981100285775028e-05
for O 0 1.9137145500280894e-05
either O 0 0.00016957898333203048
TWIST O 0 0.013751914724707603
mutations O 0 0.0003986595256719738
or O 0 0.0004622603883035481
FGFR O 1 0.9999979734420776
mutations O 0 0.0009732758044265211
. O 0 0.000430308427894488

The O 0 0.00024112724349834025
overlap O 0 7.681532588321716e-05
in O 0 3.050027953577228e-05
clinical O 0 0.00013033596042077988
features O 0 7.864393410272896e-05
and O 0 1.276526199944783e-05
the O 0 4.8251957196043804e-05
presence O 0 6.618291081395e-05
, O 0 5.774199507868616e-06
in O 0 4.423443897394463e-06
the O 0 7.953549356898293e-06
same O 0 3.607614416978322e-06
genes O 0 6.878873591631418e-06
, O 0 1.2490260132835829e-06
of O 0 6.417880740627879e-06
mutations O 0 5.875480837858049e-06
for O 0 5.818249064759584e-06
more O 0 4.866561539529357e-06
than O 0 8.97416248335503e-06
one O 0 2.22129856410902e-05
craniosynostotic B-Disease 0 0.00794722605496645
condition I-Disease 0 0.0011066830484196544
- O 0 0.0002579442225396633
such O 0 3.911234671249986e-06
as O 0 0.00011503029963932931
Saethre B-Disease 1 0.9782325029373169
- I-Disease 0 0.0033851920161396265
Chotzen I-Disease 0 0.011472458019852638
, I-Disease 0 2.6605939638102427e-05
Crouzon I-Disease 0 0.00656700786203146
, I-Disease 0 5.860131568624638e-05
and I-Disease 0 0.00011533298675203696
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 0 0.003939957823604345
support O 0 5.294511356623843e-05
the O 0 0.00011289390386082232
hypothesis O 0 5.604417674476281e-05
that O 0 1.5897903722361661e-06
TWIST O 0 0.0006940150051377714
and O 0 1.0526751793804578e-05
FGFRs O 0 0.002375918673351407
are O 0 8.260639674517734e-07
components O 0 1.2307349606999196e-05
of O 0 2.527131073293276e-05
the O 0 6.0101265262346715e-05
same O 0 2.962786857096944e-05
molecular O 0 0.00013230464537627995
pathway O 0 0.00017543384456075728
involved O 0 1.512740163889248e-05
in O 0 1.8125807400792837e-05
the O 0 8.53400633786805e-05
modulation O 0 0.0012029048521071672
of O 0 0.007702627219259739
craniofacial O 1 1.0
and O 1 0.9904285669326782
limb O 1 0.9999998807907104
development O 0 0.006953057367354631
in O 0 0.0005027498700655997
humans O 0 0.0003442676679696888
. O 0 2.634909651533235e-05
. O 0 3.959536843467504e-05

Mutation O 0 3.396629836061038e-05
analysis O 0 7.246146651596064e-06
of O 0 0.0004569004231598228
UBE3A O 1 1.0
in O 1 1.0
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999983310699463
. O 0 0.0064216735772788525

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997619986534119
AS B-Disease 1 1.0
) O 0 0.00016445682558696717
is O 0 1.1325731065880973e-05
caused O 0 0.00012065964983776212
by O 0 1.7396689145243727e-05
chromosome O 0 0.0012210196582600474
15q11 O 0 0.008583943359553814
- O 0 0.0019308892078697681
q13 O 0 0.0016668440075591207
deletions O 0 0.00013046152889728546
of O 0 6.0246682551223785e-05
maternal O 0 0.0003204989479854703
origin O 0 3.2287058274960145e-05
, O 0 8.755191629461478e-06
by O 0 7.734015525784343e-06
paternal O 0 0.002126136561855674
uniparental B-Disease 1 0.9999996423721313
disomy I-Disease 1 0.9999997615814209
( O 0 0.018459821119904518
UPD B-Disease 1 1.0
) O 0 0.00024610047694295645
15 O 0 0.00018278334755450487
, O 0 1.12957859528251e-05
by O 0 2.822535316227004e-05
imprinting O 0 0.07357995957136154
defects O 1 0.9999798536300659
, O 0 0.00011340100172674283
and O 0 1.4273315173340961e-05
by O 0 9.821361345530022e-06
mutations O 0 1.7973403373616748e-05
in O 0 5.13235354446806e-05
the O 0 0.0005125200841575861
UBE3A O 1 0.9999380111694336
gene O 0 0.0004055266035720706
. O 0 0.00012986255751457065

UBE3A O 1 0.5196539163589478
encodes O 0 0.00019939707999583334
a O 0 5.7885055866790935e-05
ubiquitin O 0 0.0007989906007423997
- O 0 0.00031810838845558465
protein O 0 2.506270175217651e-05
ligase O 0 0.00018214675947092474
and O 0 1.212017195939552e-05
shows O 0 0.00035787190427072346
brain O 1 0.9850180745124817
- O 0 0.0011156471446156502
specific O 0 2.430404128972441e-05
imprinting O 0 0.0025681816041469574
. O 0 0.00032298476435244083

Here O 0 0.000395659328205511
we O 0 2.2891916160006076e-05
describe O 0 0.0002579786232672632
UBE3A O 1 0.9784172177314758
coding O 0 0.004740499891340733
- O 0 0.0016314976383000612
region O 0 0.0003739513922482729
mutations O 0 7.146744610508904e-05
detected O 0 8.352303848369047e-05
by O 0 8.928108400141355e-06
SSCP O 0 0.01760471798479557
analysis O 0 9.646237231208943e-06
in O 0 3.399235720280558e-05
13 O 0 0.00046498895972035825
AS B-Disease 0 0.24510984122753143
individuals O 0 1.2671795957430732e-05
or O 0 6.199253402883187e-05
families O 0 3.862178709823638e-05
. O 0 0.0002333455631742254

Two O 0 4.830877514905296e-05
identical O 0 4.552962491288781e-05
de O 0 0.001340776216238737
novo O 0 0.0016797753050923347
5 O 0 0.0012005696771666408
- O 0 0.001141459564678371
bp O 0 0.00040325740701518953
duplications O 0 0.0007108518620952964
in O 0 4.9254955229116604e-05
exon O 0 0.0005046961596235633
16 O 0 0.00015632034046575427
were O 0 5.871263419976458e-05
found O 0 5.7974946685135365e-05
. O 0 0.0001256113755516708

Among O 0 7.581360841868445e-05
the O 0 2.9530325264204293e-05
other O 0 2.9285220080055296e-06
11 O 0 8.04176161182113e-05
unique O 0 3.5709399526240304e-05
mutations O 0 3.865008329739794e-05
, O 0 1.2195141607662663e-05
8 O 0 0.00018450831703376025
were O 0 4.506590630626306e-05
small O 0 2.5822473617154174e-05
deletions O 0 0.00022877109586261213
or O 0 4.7508445277344435e-05
insertions O 0 0.000650803791359067
predicted O 0 0.0003412730584386736
to O 0 8.226306090364233e-05
cause O 0 0.0009362806449644268
frameshifts O 0 0.02091815508902073
, O 0 3.235990516259335e-05
1 O 0 0.00015625641390215605
was O 0 0.00018469418864697218
a O 0 1.2954268640896771e-05
mutation O 0 2.5464303234912222e-06
to O 0 5.8451892073208e-06
a O 0 3.182117870892398e-05
stop O 0 0.00019485995289869606
codon O 0 9.8406795586925e-05
, O 0 8.256392902694643e-06
1 O 0 9.57055963226594e-05
was O 0 0.00017506987205706537
a O 0 3.6300236388342455e-05
missense O 0 0.000283649074845016
mutation O 0 1.3354812836041674e-05
, O 0 4.4529706428875215e-06
and O 0 6.702911377942655e-06
1 O 0 0.0003878989373333752
was O 0 0.0007180004031397402
predicted O 0 0.00019419130694586784
to O 0 4.0365350287174806e-05
cause O 0 0.00020604355086106807
insertion O 0 0.00031257292721420527
of O 0 0.0006325014983303845
an O 0 0.0002689491375349462
isoleucine O 0 0.010463347658514977
in O 0 0.00011761509085772559
the O 0 0.00016937698819674551
hect O 0 0.003550369292497635
domain O 0 9.179155313177034e-05
of O 0 9.524791676085442e-05
the O 0 0.0004498258640524
UBE3A O 1 0.9969106316566467
protein O 0 0.00014610089419875294
, O 0 2.4436899366264697e-06
which O 0 1.0135314596482203e-06
functions O 0 5.473310011439025e-06
in O 0 6.106025102781132e-05
E2 O 0 0.02124284952878952
binding O 0 3.530820686137304e-05
and O 0 2.495163971616421e-05
ubiquitin O 0 0.00041742558823898435
transfer O 0 0.0006256069173105061
. O 0 0.00038742960896342993

Eight O 0 0.00032971735345199704
of O 0 0.00014027839642949402
the O 0 0.00015150164836086333
cases O 0 3.473709512036294e-05
were O 0 6.757368100807071e-05
familial O 0 0.000850966083817184
, O 0 7.006646774243563e-05
and O 0 2.2603268007515e-05
five O 0 6.31900766165927e-05
were O 0 0.00010132125316886231
sporadic O 0 0.0022057383321225643
. O 0 0.00044827692909166217

In O 0 0.00034110163687728345
two O 0 6.123634375398979e-05
familial O 0 0.0014517508680000901
cases O 0 0.00016564787074457854
and O 0 7.318446296267211e-05
one O 0 6.087117799324915e-05
sporadic O 0 0.0009067739592865109
case O 0 0.00017706122889649123
, O 0 5.644236080115661e-05
mosaicism O 0 0.03350261598825455
for O 0 0.0003072854015044868
UBE3A O 1 0.9999873638153076
mutations O 0 0.00043036910938099027
was O 0 0.000643609557300806
detected O 0 0.0002608585637062788
in O 0 1.1637157513177954e-05
the O 0 2.903876520576887e-05
mother O 0 1.895737113954965e-05
of O 0 3.0689847335452214e-05
three O 0 9.885553299682215e-05
AS B-Disease 1 0.999840497970581
sons O 0 0.0029205111786723137
, O 0 1.154427354776999e-05
in O 0 1.5197475477179978e-05
the O 0 6.864454917376861e-05
maternal O 0 0.00044432483264245093
grandfather O 0 0.0009136511944234371
of O 0 0.00016013422282412648
two O 0 6.42638115095906e-05
AS B-Disease 1 0.9997240900993347
first O 0 0.0006151027046144009
cousins O 0 0.0002977789845317602
, O 0 5.8106134019908495e-06
and O 0 3.007838586199796e-06
in O 0 1.3963331184640992e-05
the O 0 5.060594412498176e-05
mother O 0 3.921473762602545e-05
of O 0 3.5867487895302474e-05
an O 0 6.521317118313164e-05
AS B-Disease 1 0.9999994039535522
daughter O 0 0.0039042020216584206
. O 0 0.0003421110741328448

The O 0 0.00010382192704128101
frequencies O 0 1.0229985491605476e-05
with O 0 1.6722032114557805e-06
which O 0 3.0050287023186684e-06
we O 0 3.9439751162717585e-06
detected O 0 3.4789434721460566e-05
mutations O 0 8.730869922146667e-06
were O 0 1.8886114048655145e-05
5 O 0 0.00010218811803497374
( O 0 1.9043585780309513e-05
14 O 0 0.00010605310671962798
% O 0 1.4630113582825288e-05
) O 0 6.173789188324008e-06
of O 0 3.37926103384234e-05
35 O 0 9.989135287469253e-05
in O 0 2.5383867978234775e-05
sporadic O 0 0.00019126434926874936
cases O 0 1.8346550859860145e-05
and O 0 9.747682270244695e-06
8 O 0 0.00011529451148817316
( O 0 1.314146356889978e-05
80 O 0 6.333003693725914e-05
% O 0 1.238698314409703e-05
) O 0 5.962640443613054e-06
of O 0 4.465990059543401e-05
10 O 0 0.00015393242938444018
in O 0 5.7692017435329035e-05
familial O 0 0.0009294017218053341
cases O 0 0.00030434736981987953
. O 0 0.00020080493413843215
. O 0 0.00021223716612439603

The O 0 0.008305752649903297
hemochromatosis B-Disease 1 1.0
845 O 1 0.9899011850357056
G O 0 0.3758782148361206
- O 0 0.0038274892140179873
- O 0 0.0004341029853094369
> O 0 5.7875950005836785e-05
A O 0 9.079779556486756e-05
and O 0 3.5619241316453554e-06
187 O 0 3.3924861781997606e-05
C O 0 0.000589628703892231
- O 0 0.0003759394458029419
- O 0 0.00027804262936115265
> O 0 0.00024838256649672985
G O 0 0.0012355466606095433
mutations O 0 2.929993934230879e-05
: O 0 1.8405642549623735e-05
prevalence O 0 0.00039493388612754643
in O 0 0.00011638164869509637
non O 0 0.0016621540999040008
- O 0 0.0018680841894820333
Caucasian O 0 0.00098371971398592
populations O 0 3.095806823694147e-05
. O 0 2.846455026883632e-05

Hemochromatosis B-Disease 1 1.0
, O 0 0.00023141705605667084
the O 0 0.02629675529897213
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 0.0006248578429222107
leads O 0 0.000691377732437104
, O 0 2.7206959202885628e-05
if O 0 4.562955291476101e-05
untreated O 1 0.9986853003501892
, O 0 2.768646299955435e-05
to O 0 0.00024590370594523847
progressive O 1 0.999998927116394
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.00640504714101553
premature B-Disease 1 0.9951313734054565
death I-Disease 0 0.11645731329917908
. O 0 0.0008431394235230982

The O 0 0.00909028947353363
hemochromatosis B-Disease 1 1.0
gene O 0 0.015382952988147736
, O 0 0.0005939758266322315
HFE O 1 0.9999924898147583
, O 0 5.132167279953137e-05
recently O 0 6.2146908021532e-05
has O 0 3.3152005016745534e-06
been O 0 6.0689285419357475e-06
identified O 0 1.3840142855769955e-05
, O 0 2.8843930977018317e-06
and O 0 2.1408363863884006e-06
characterization O 0 4.3311647459631786e-05
of O 0 5.7190369261661544e-05
this O 0 3.620419738581404e-05
gene O 0 3.199090133421123e-05
has O 0 3.177385451635928e-06
shown O 0 6.671069968433585e-06
that O 0 6.199508675308607e-07
it O 0 3.178878102971794e-07
contains O 0 1.2736849157590768e-06
two O 0 4.619663229732396e-07
mutations O 0 2.0841484911215957e-06
that O 0 5.830980285281839e-07
result O 0 1.0547150850470643e-05
in O 0 4.933440141030587e-05
amino O 0 5.822948514833115e-05
acid O 0 6.722045509377494e-05
substitutions O 0 0.0001108540382119827
- O 0 0.0002934307558462024
cDNA O 0 0.00010465469677001238
nucleotides O 0 5.982199581922032e-05
845 O 0 0.0005300824414007366
G O 0 0.001006933394819498
- O 0 0.0002706004015635699
- O 0 0.0001638131361687556
> O 0 6.553790444741026e-05
A O 0 0.00020273511472623795
( O 0 3.29953218169976e-05
C282Y O 0 0.0005863254773430526
) O 0 5.517878889804706e-06
and O 0 2.3369411792373285e-06
187 O 0 3.352030398673378e-05
C O 0 0.0005247148801572621
- O 0 0.0002738117182161659
- O 0 0.00023232880630530417
> O 0 0.0003262341197114438
G O 0 0.0024426765739917755
( O 0 0.000327391957398504
H63D O 1 0.9992027878761292
) O 0 0.0002459590323269367
. O 0 0.00014446138811763376

Although O 0 0.008310400880873203
hemochromatosis B-Disease 1 1.0
is O 0 0.00039862972334958613
common O 0 7.236729288706556e-05
in O 0 0.0001680975838098675
Caucasians O 0 0.004741746932268143
, O 0 4.3390729842940345e-05
affecting O 0 0.00016565796977374703
> O 0 0.00046525048674084246
= O 0 0.00024072434462141246
1 O 0 0.00029984352295286953
/ O 0 0.00012338317173998803
300 O 0 1.9617358702817e-05
individuals O 0 9.076959486264968e-07
of O 0 3.628508056863211e-05
northern O 0 0.00010805809870362282
European O 0 3.174343510181643e-05
origin O 0 1.96353648789227e-05
, O 0 5.818109912070213e-06
it O 0 1.0127587302122265e-06
has O 0 1.1028652124878136e-06
not O 0 4.6667648234688386e-07
been O 0 2.3674758722336264e-06
recognized O 0 8.009312296053395e-06
in O 0 6.713767561450368e-06
other O 0 2.318003453183337e-06
populations O 0 1.4711949916090816e-05
. O 0 4.014036676380783e-05

The O 0 0.00012460583820939064
present O 0 3.398833723622374e-05
study O 0 1.6292866348521784e-05
used O 0 3.2901338272495195e-05
PCR O 0 0.00023103652347344905
and O 0 1.7755102817318402e-05
restriction O 0 5.500785482581705e-05
- O 0 0.00018605537479743361
enzyme O 0 1.6278856492135674e-05
digestion O 0 5.308358231559396e-05
to O 0 2.452902890581754e-06
analyze O 0 9.0079020083067e-06
the O 0 6.497180038422812e-06
frequency O 0 3.1674860565544805e-06
of O 0 1.7216891137650236e-05
the O 0 0.0001754749973770231
845 O 0 0.00402700062841177
G O 0 0.0038384937215596437
- O 0 0.00043780094711109996
- O 0 0.00014531658962368965
> O 0 3.692348036565818e-05
A O 0 7.387209188891575e-05
and O 0 6.823110652476316e-06
187 O 0 4.162630284554325e-05
C O 0 0.0004811757244169712
- O 0 0.0002715362061280757
- O 0 0.00017708064115140587
> O 0 0.00019497016910463572
G O 0 0.0007409912650473416
mutations O 0 5.4235704737948254e-05
in O 0 0.00011998168338323012
HLA O 0 0.3622872531414032
- O 0 0.0008853875333443284
typed O 0 4.5596971176564693e-05
samples O 0 1.4932854355720337e-05
from O 0 2.4365213903365657e-05
non O 0 0.000646146247163415
- O 0 0.000875015975907445
Caucasian O 0 0.0007234690710902214
populations O 0 9.344981663161889e-06
, O 0 2.278847432535258e-06
comprising O 0 1.2142872037657071e-05
Australian O 0 7.364813063759357e-05
Aboriginal O 0 0.00025185177219100296
, O 0 9.665077413956169e-06
Chinese O 0 0.0001953978353412822
, O 0 8.371683179575484e-06
and O 0 1.1595659088925458e-05
Pacific O 0 0.0005699265748262405
Islanders O 0 0.0005602000746876001
. O 0 0.00010643038694979623

Results O 0 4.992081085219979e-05
showed O 0 6.485415360657498e-05
that O 0 2.3635730030946434e-06
the O 0 5.2999814215581864e-05
845 O 0 0.00396112073212862
G O 0 0.008253077045083046
- O 0 0.0017400706419721246
- O 0 0.0005837139906361699
> O 0 0.0001970444427570328
A O 0 0.00018107626237906516
mutation O 0 1.5877247278694995e-05
was O 0 6.656470941379666e-05
present O 0 1.2921560482936911e-05
in O 0 9.048861102201045e-06
these O 0 1.3302735624165507e-06
populations O 0 2.68553162641183e-06
( O 0 2.921765599239734e-06
allele O 0 7.225737022054091e-07
frequency O 0 3.4855236208386486e-06
0 O 0 6.9405255089805e-06
. O 0 2.242646587546915e-06
32 O 0 1.8533501133788377e-05
% O 0 1.541629171697423e-05
) O 0 1.6005373254301958e-05
, O 0 8.566215001337696e-06
and O 0 1.0729969289968722e-05
, O 0 1.1612369235081133e-05
furthermore O 0 7.046461541904137e-05
, O 0 8.937367965700105e-06
it O 0 4.051910764246713e-06
was O 0 0.00011452967737568542
always O 0 1.1767325304390397e-05
seen O 0 1.949369652720634e-05
in O 0 3.5035197925026296e-06
conjunction O 0 5.729780241381377e-05
with O 0 5.5711727327434346e-05
HLA O 1 0.9999892711639404
haplotypes O 0 0.004560120869427919
common O 0 0.000128146682982333
in O 0 0.0002348749985685572
Caucasians O 0 0.002213421044871211
, O 0 1.6956111721810885e-05
suggesting O 0 4.8226564103970304e-05
that O 0 6.083606876927661e-06
845 O 0 0.0022663644049316645
G O 0 0.007192770019173622
- O 0 0.001779170474037528
- O 0 0.0005200999439693987
> O 0 0.00015054384130053222
A O 0 0.00016847322694957256
may O 0 2.8309621484368108e-05
have O 0 8.54533993788209e-07
been O 0 3.4026002140308265e-06
introduced O 0 2.3596137452841504e-06
into O 0 1.7028086176651414e-06
these O 0 3.1574745662510395e-07
populations O 0 9.83141489996342e-07
by O 0 2.0483821572270244e-06
Caucasian O 0 0.0007814881973899901
admixture O 0 0.0015132076805457473
. O 0 0.0008674386190250516

187 O 0 0.001013173721730709
C O 0 0.0030467442702502012
- O 0 0.0008907952578738332
- O 0 0.0004098320787306875
> O 0 0.00027740554651245475
G O 0 0.0005844109109602869
was O 0 9.4011498731561e-05
present O 0 2.687699998205062e-05
at O 0 4.3053489207522944e-05
an O 0 2.256537982248119e-06
allele O 0 1.7993924075199175e-06
frequency O 0 8.568738849135116e-06
of O 0 0.0001145237692981027
2 O 0 0.0021489167120307684
. O 0 0.00038756499998271465

68 O 0 0.0011627287603914738
% O 0 3.8910253351787105e-05
in O 0 2.2632495529251173e-05
the O 0 2.4154611310223117e-05
two O 0 3.394096665942925e-06
populations O 0 2.3535051241196925e-06
analyzed O 0 1.937236447702162e-05
( O 0 7.610800821566954e-06
Australian O 0 4.025302769150585e-05
Aboriginal O 0 0.00015183612413238734
and O 0 1.9633362171589397e-05
Chinese O 0 0.0009321864927187562
) O 0 6.678004865534604e-05
. O 0 7.605967402923852e-05

In O 0 0.00019908990361727774
the O 0 7.883029320510104e-05
Australian O 0 9.076309652300552e-05
Aboriginal O 0 7.798674050718546e-05
samples O 0 9.669502105680294e-06
, O 0 4.329860530560836e-06
187 O 0 5.054870052845217e-05
C O 0 0.0008786424878053367
- O 0 0.0005516211967915297
- O 0 0.00035943035618402064
> O 0 0.00021541431488003582
G O 0 0.000543005473446101
was O 0 8.006920688785613e-05
found O 0 1.9845970200549345e-06
to O 0 1.143723579843936e-06
be O 0 2.4333342025784077e-06
associated O 0 9.040244549396448e-06
with O 0 3.751167969312519e-05
HLA O 1 0.9999996423721313
haplotypes O 0 0.00558935571461916
common O 0 0.00019505048112478107
in O 0 0.00037754111690446734
Caucasians O 0 0.00564801087602973
, O 0 2.4492204829584807e-05
suggesting O 0 4.656848977901973e-05
that O 0 1.1456974107204587e-06
it O 0 1.2983107353647938e-06
was O 0 3.1623181712348014e-05
introduced O 0 4.868274572800146e-06
by O 0 9.403898957316414e-07
recent O 0 8.616735613031778e-06
admixture O 0 0.0004059052444063127
. O 0 0.00023659532598685473

In O 0 8.154108945745975e-05
the O 0 3.288700827397406e-05
Chinese O 0 0.00011836994235636666
samples O 0 4.313568297220627e-06
analyzed O 0 1.3727988516620826e-05
, O 0 2.5686620119813597e-06
187 O 0 2.3975217118277214e-05
C O 0 0.0007177458610385656
- O 0 0.0005327332764863968
- O 0 0.0004207337915431708
> O 0 0.0003534340357873589
G O 0 0.001037284848280251
was O 0 0.00024725738330744207
present O 0 3.6685902159661055e-05
in O 0 2.7045200113207102e-05
association O 0 1.940329821081832e-05
with O 0 3.0110445550235454e-06
a O 0 2.517593566153664e-05
wide O 0 0.00016173228505067527
variety O 0 6.750091415597126e-05
of O 0 0.0017535631777718663
HLA O 1 0.9999998807907104
haplotypes O 0 0.00745392357930541
, O 0 4.12172703363467e-05
showing O 0 0.00010365791240474209
this O 0 5.182205313758459e-06
mutation O 0 3.104368033746141e-06
to O 0 2.4230757844634354e-06
be O 0 3.488846004984225e-06
widespread O 0 3.395289240870625e-05
and O 0 1.0232952263322659e-05
likely O 0 2.053074240393471e-05
to O 0 1.591848376847338e-05
predate O 0 0.0009233762975782156
the O 0 1.3129762919561472e-05
more O 0 1.7960662717086961e-06
genetically O 0 1.2508648069342598e-05
restricted O 0 1.3627965927298646e-05
845 O 0 0.0014011666644364595
G O 0 0.004802734591066837
- O 0 0.0012597530148923397
- O 0 0.0006176648894324899
> O 0 0.00021523077157326043
A O 0 0.00037480887840501964
mutation O 0 3.7318932299967855e-05
. O 0 3.851806104648858e-05

Genotype O 0 0.005762516055256128
- O 0 0.001111751887947321
phenotype O 0 3.965763971791603e-05
correlations O 0 0.00020967547607142478
in O 0 0.000566353730391711
attenuated B-Disease 1 0.9999029636383057
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.004524072166532278

Germ O 1 1.0
- O 0 0.006426807958632708
line O 0 0.00035447569098323584
mutations O 0 1.537802381790243e-05
of O 0 7.389533857349306e-05
the O 0 0.0007495121681131423
tumor B-Disease 1 0.9999994039535522
suppressor O 0 0.02326238714158535
APC O 0 0.0028409678488969803
are O 0 2.0972297534171958e-06
implicated O 0 0.00023904988483991474
in O 0 0.0003613467270042747
attenuated B-Disease 1 0.9998399019241333
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9997687935829163
AAPC B-Disease 1 1.0
) O 0 0.00015725682897027582
, O 0 4.949925369146513e-06
a O 0 3.778126256293035e-06
variant O 0 0.00011899748642463237
of O 0 0.0010748514905571938
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.0015833985526114702
. O 0 0.00038291089003905654

AAPC B-Disease 1 0.9999995231628418
is O 0 8.415686897933483e-05
recognized O 0 3.0370161766768433e-05
by O 0 1.9155925201630453e-06
the O 0 9.5737814262975e-06
occurrence O 0 5.413783583207987e-05
of O 0 0.0003027326019946486
< O 0 0.0794660747051239
100 O 0 0.004033741541206837
colonic B-Disease 1 0.9999862909317017
adenomas I-Disease 1 0.9864444136619568
and O 0 1.3973509339848533e-05
a O 0 1.1436426575528458e-05
later O 0 0.0002776032197289169
onset O 1 0.9999997615814209
of O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.02003379911184311
age O 0 0.004417918622493744
> O 0 0.0010196792427450418
40 O 0 0.00015754529158584774
years O 0 0.0002687099913600832
) O 0 4.733813329949044e-05
. O 0 6.716849020449445e-05

The O 0 0.0002561727014835924
aim O 0 0.00019072386203333735
of O 0 2.8570368158398196e-05
this O 0 4.5126716941013e-06
study O 0 5.385330950957723e-06
was O 0 7.469920092262328e-05
to O 0 1.1246032045164611e-05
assess O 0 0.00020908813166897744
genotype O 0 0.0006273072795011103
- O 0 0.0004943597596138716
phenotype O 0 7.302377343876287e-05
correlations O 0 0.0003353178035467863
in O 0 0.0006644563982263207
AAPC B-Disease 1 1.0
families O 0 0.00021513843967113644
. O 0 0.00020647207566071302

By O 0 8.113705553114414e-05
protein O 0 0.00018195425218436867
- O 0 0.00032499092048965394
truncation O 0 0.0003762567648664117
test O 0 5.913682252867147e-05
( O 0 6.289513839874417e-05
PTT O 0 0.0009963258635252714
) O 0 4.294514383218484e-06
assay O 0 2.850895043593482e-06
, O 0 8.171371632670343e-07
the O 0 5.1643751248775516e-06
entire O 0 9.553518611937761e-05
coding O 0 0.00017184675380121917
region O 0 0.00015724422701168805
of O 0 9.170547127723694e-05
the O 0 0.00042857800144702196
APC B-Disease 0 0.005265120416879654
gene O 0 3.130371987936087e-05
was O 0 9.173528815153986e-05
screened O 0 4.0120274206856266e-05
in O 0 5.32295507582603e-06
affected O 0 7.671730600122828e-06
individuals O 0 2.3072404928825563e-06
from O 0 0.00015708657156210393
11 O 1 0.991081178188324
AAPC B-Disease 1 1.0
kindreds O 0 0.029395736753940582
, O 0 2.6431516744196415e-05
and O 0 2.6300754143449012e-06
their O 0 3.0029116260266164e-06
phenotypic O 0 0.0002817693748511374
differences O 0 0.0002902864944189787
were O 0 0.00036391534376889467
examined O 0 0.001958897104486823
. O 0 0.00036537781124934554

Five O 0 0.0009015789837576449
novel O 0 0.003605416277423501
germ O 1 0.9999985694885254
- O 0 0.009800090454518795
line O 0 0.002135771093890071
APC B-Disease 0 0.003925565164536238
mutations O 0 3.926960562239401e-05
were O 0 3.116292646154761e-05
identified O 0 5.1148716011084616e-05
in O 0 7.421609188895673e-05
seven O 0 0.0004736208647955209
kindreds O 0 0.008723737671971321
. O 0 0.0004410924739204347

Mutations O 0 0.0002840636589098722
were O 0 9.458970453124493e-05
located O 0 0.00011433065083110705
in O 0 7.303069196495926e-06
three O 0 1.8495023823561496e-06
different O 0 1.8347930108575383e-07
regions O 0 4.900096882920479e-06
of O 0 3.512754847179167e-05
the O 0 0.00041622595745138824
APC B-Disease 0 0.004793412517756224
gene O 0 4.430045373737812e-05
( O 0 1.2607017197296955e-05
1 O 0 0.00012020488793496042
) O 0 6.1569612626044545e-06
at O 0 3.511776958475821e-05
the O 0 2.1960693629807793e-05
5 O 0 7.172518962761387e-05
end O 0 0.0003638905182015151
spanning O 0 0.002512615406885743
exons O 0 0.0007462760549969971
4 O 0 0.00018623621144797653
and O 0 1.3145222510502208e-05
5 O 0 8.144209277816117e-05
, O 0 6.6951679400517605e-06
( O 0 9.103885531658307e-06
2 O 0 0.00010388272494310513
) O 0 8.267707016784698e-06
within O 0 1.891001193143893e-05
exon O 0 0.00032177011598832905
9 O 0 0.0001916100736707449
, O 0 6.3721831793372985e-06
and O 0 3.5528657917893725e-06
( O 0 1.194016840599943e-05
3 O 0 0.0001052056104526855
) O 0 9.020539437187836e-06
at O 0 6.45339023321867e-05
the O 0 5.455560312839225e-05
3 O 0 0.0002482438285369426
distal O 0 0.00251278979703784
end O 0 0.001292464672587812
of O 0 0.0003415161627344787
the O 0 0.0005348146660253406
gene O 0 0.00024115254927892238
. O 0 0.00013543384557124227

Variability O 0 0.0007384133641608059
in O 0 2.4901481083361432e-05
the O 0 2.523677540011704e-05
number O 0 7.525322871515527e-05
of O 0 0.30173543095588684
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9987326264381409
most O 0 9.775390208233148e-05
apparent O 0 0.00016663641144987196
in O 0 9.151404810836539e-06
individuals O 0 7.051032753224717e-07
with O 0 3.903435299434932e-06
mutations O 0 2.6460647859494202e-05
in O 0 9.542537009110674e-05
region O 0 0.0014339410699903965
1 O 0 0.0019437085138633847
, O 0 4.930862269247882e-05
and O 0 9.764591959537938e-05
upper O 1 0.9986961483955383
- O 1 0.9993576407432556
gastrointestinal O 1 0.9998878240585327
manifestations O 0 0.24255900084972382
were O 0 0.0005143843591213226
more O 0 4.422822894412093e-05
severe O 0 0.0038075896445661783
in O 0 0.00019513066217768937
them O 0 5.697285814676434e-05
. O 0 0.0001495930046075955

In O 0 9.37148870434612e-05
individuals O 0 4.220357368467376e-06
with O 0 8.35976425150875e-06
mutations O 0 4.672556678997353e-05
in O 0 7.389442180283368e-05
either O 0 5.245801730779931e-05
region O 0 0.0005086675519123673
2 O 0 0.0003828499175142497
or O 0 3.9043763536028564e-05
region O 0 0.00026456883642822504
3 O 0 0.00013462822244036943
, O 0 3.375882897671545e-06
the O 0 6.3221846176020335e-06
average O 0 7.287297194125131e-06
number O 0 1.4463781553786248e-05
of O 0 0.0003809745248872787
adenomas B-Disease 1 0.9881716370582581
tended O 0 0.0005312455468811095
to O 0 3.90571694879327e-05
be O 0 1.7773669242160395e-05
lower O 0 4.427182284416631e-05
than O 0 9.681982646725373e-07
those O 0 1.421661067979585e-06
in O 0 3.0577405141229974e-06
individuals O 0 5.060925900579605e-07
with O 0 2.5723563794599613e-06
mutations O 0 3.3528489439049736e-05
in O 0 7.475121674360707e-05
region O 0 0.0006460105068981647
1 O 0 0.00045723270159214735
, O 0 8.102077117655426e-06
although O 0 6.437637694034493e-06
age O 0 0.00016866497753653675
at O 0 0.0004883642541244626
diagnosis O 0 0.001940735848620534
was O 0 0.000917967816349119
similar O 0 8.067530870903283e-05
. O 0 0.00037840873119421303

In O 0 0.0009366290178149939
all O 0 0.0009692051098681986
AAPC B-Disease 1 1.0
kindreds O 0 0.00647207535803318
, O 0 9.388609214511234e-06
a O 0 1.0911876415775623e-05
predominance O 0 0.0012584037613123655
of O 0 0.001959054032340646
right O 1 0.9999679327011108
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 1.0
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 0.011590871028602123
was O 0 0.0026839859783649445
observed O 0 0.00025156259653158486
. O 0 9.642903023632243e-05

No O 0 0.005834020674228668
desmoid B-Disease 1 0.9999985694885254
tumors I-Disease 1 1.0
were O 0 0.0004742980236187577
found O 0 5.5261905799852684e-05
in O 0 5.29883400304243e-05
these O 0 3.57224780600518e-05
kindreds O 0 0.005272496026009321
. O 0 0.0002249735698569566

Our O 0 0.00012182419595774263
data O 0 3.2634659874020144e-05
suggest O 0 1.9915358279831707e-05
that O 0 3.0490716653730487e-06
, O 0 1.4660143278888427e-05
in O 0 0.00021166203077882528
AAPC B-Disease 1 0.9999998807907104
families O 0 3.198751437594183e-05
, O 0 4.318334504205268e-06
the O 0 5.874041107745143e-06
location O 0 5.957986650173552e-05
of O 0 0.00012773809430655092
the O 0 0.0011696004075929523
APC B-Disease 1 0.9538569450378418
mutation O 0 0.00017083743296097964
may O 0 0.00024472488439641893
partially O 0 0.0006290480378083885
predict O 0 4.2675128497648984e-05
specific O 0 2.7277915251033846e-06
phenotypic O 0 0.0005234624841250479
expression O 0 0.0008634378318674862
. O 0 0.0005111790378578007

This O 0 2.8549828130053356e-05
should O 0 5.5964774219319224e-06
help O 0 5.16913496539928e-06
in O 0 3.912988177035004e-06
the O 0 9.925368431140669e-06
design O 0 3.8640282582491636e-05
of O 0 4.890608033747412e-05
tailored O 0 0.00010165774438064545
clinical O 0 0.0004157102666795254
- O 0 0.0011789010604843497
management O 0 0.00019226051517762244
protocols O 0 0.0004312296805437654
in O 0 2.7018029868486337e-05
this O 0 6.645751909672981e-06
subset O 0 9.702931856736541e-05
of O 0 0.0007295925752259791
FAP B-Disease 1 0.9999958276748657
patients O 0 0.0007742078159935772
. O 0 8.92501266207546e-05
. O 0 8.890491153579205e-05

Wilms B-Disease 1 1.0
' I-Disease 1 0.9783580303192139
tumor I-Disease 1 0.9995903372764587
1 O 0 0.0009423192241229117
and O 0 5.592458546743728e-05
Dax O 1 0.9993736147880554
- O 0 0.0006175745511427522
1 O 0 0.00014728282985743135
modulate O 0 0.0001525953848613426
the O 0 4.766814163303934e-05
orphan O 0 0.0006502739852294326
nuclear O 0 0.0009449436329305172
receptor O 0 0.0002846663410309702
SF O 1 0.9289610981941223
- O 0 0.00013320719881448895
1 O 0 4.637239544535987e-05
in O 0 1.5212916878226679e-05
sex O 0 2.142358607670758e-05
- O 0 4.092169183422811e-05
specific O 0 1.7230617004315718e-06
gene O 0 2.327776383026503e-05
expression O 0 7.057476614136249e-05
. O 0 0.0001352750841761008

Products O 0 0.00031970092095434666
of O 0 0.0003920935560017824
steroidogenic O 0 0.03620755299925804
factor O 0 0.00027808002778328955
1 O 0 0.0007114892941899598
( O 0 0.00014429357543122023
SF O 1 0.9923566579818726
- O 0 0.000274140591500327
1 O 0 0.00011533727956702933
) O 0 1.5318477380787954e-05
and O 0 2.6067469661938958e-05
Wilms B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999881982803345
1 O 0 0.004763609264045954
( O 0 0.0005626158090308309
WT1 O 1 0.9662767648696899
) O 0 2.8134065360063687e-05
genes O 0 5.281018729874631e-06
are O 0 3.3829076073743636e-07
essential O 0 1.1865136912092566e-05
for O 0 8.106830136966892e-06
mammalian O 0 0.0007211718475446105
gonadogenesis O 0 0.004139822442084551
prior O 0 0.00022665035794489086
to O 0 4.729494685307145e-05
sexual O 0 0.00021453172666952014
differentiation O 0 0.0038183950819075108
. O 0 0.0010318034328520298

In O 0 0.00032269235816784203
males O 0 0.00011139189882669598
, O 0 0.00012050155055476353
SF O 1 0.9999912977218628
- O 0 0.0011590775102376938
1 O 0 0.00020071555627509952
participates O 0 3.473815741017461e-05
in O 0 7.931748768896796e-06
sexual O 0 1.699185486359056e-05
development O 0 2.8927266612299718e-05
by O 0 3.8361999941116665e-06
regulating O 0 4.682767394115217e-05
expression O 0 1.2880590475106146e-05
of O 0 8.290614641737193e-05
the O 0 0.000779118447098881
polypeptide O 1 0.93283611536026
hormone O 0 0.07280007749795914
Mullerian O 1 0.9999339580535889
inhibiting O 0 0.00640434306114912
substance O 0 0.007196513004601002
( O 0 0.0016798354918137193
MIS O 1 0.9999958276748657
) O 0 0.00031776679679751396
. O 0 9.439571294933558e-05

Here O 0 0.00039051377098076046
, O 0 8.21380308480002e-06
we O 0 3.709131078721839e-06
show O 0 2.368962304899469e-05
that O 0 1.2911385056213476e-05
WT1 O 1 0.9995437264442444
- O 0 0.009541397914290428
KTS O 1 0.985921323299408
isoforms O 0 3.7133722798898816e-05
associate O 0 6.0333608416840434e-05
and O 0 1.0168154403800145e-05
synergize O 0 0.005254034418612719
with O 0 8.27826006570831e-05
SF O 1 0.9999994039535522
- O 0 0.0014474795898422599
1 O 0 0.0002579210849944502
to O 0 5.514519216376357e-05
promote O 0 0.001539877732284367
MIS O 1 0.9998688697814941
expression O 0 0.00038879370549693704
. O 0 0.00017743880744092166

In O 0 0.00048606633208692074
contrast O 0 0.00048416396020911634
, O 0 0.0002979175478685647
WT1 O 1 0.9994584918022156
missense O 0 0.003027434926480055
mutations O 0 0.00010797065624501556
, O 0 6.5134345277328975e-06
associated O 0 6.935920737305423e-06
with O 0 6.94143864166108e-06
male B-Disease 0 0.000842684821691364
pseudohermaphroditism I-Disease 1 1.0
in O 0 0.0026300421450287104
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.00015160191105678678
fail O 0 0.0004436125745996833
to O 0 6.155380106065422e-05
synergize O 0 0.022460948675870895
with O 0 0.0002924476284533739
SF O 1 1.0
- O 0 0.005861608311533928
1 O 0 0.000985794118605554
. O 0 0.00011302208440611139

Additionally O 0 0.00039528062916360795
, O 0 1.1452983926574234e-05
the O 0 4.700265344581567e-05
X O 0 0.009502475149929523
- O 0 0.002348716836422682
linked O 0 0.000695733237080276
, O 0 1.3279286577017047e-05
candidate O 0 3.869201100314967e-05
dosage O 0 0.0006340743857435882
- O 0 0.0007251249044202268
sensitive O 0 0.0003048704529646784
sex O 0 5.665158460033126e-05
- O 0 0.00016073820006567985
reversal O 0 0.0001548362779431045
gene O 0 4.575940693030134e-05
, O 0 1.8880748029914685e-05
Dax O 1 0.7757479548454285
- O 0 0.0004832491686102003
1 O 0 0.00017643245519138873
, O 0 6.569223387487e-06
antagonizes O 0 0.0003396451356820762
synergy O 0 0.0007857882883399725
between O 0 0.0019972515292465687
SF O 1 1.0
- O 0 0.0019446616061031818
1 O 0 0.0004949154099449515
and O 0 3.800091872108169e-05
WT1 O 0 0.3942635953426361
, O 0 7.774629921186715e-06
most O 0 2.4311332254001172e-06
likely O 0 2.7467356176202884e-06
through O 0 1.0223948265775107e-06
a O 0 1.4190670754032908e-06
direct O 0 2.5008716875163373e-06
interaction O 0 1.3834811397828162e-05
with O 0 5.487451562657952e-05
SF O 1 0.9999995231628418
- O 0 0.004427514038980007
1 O 0 0.0010444396175444126
. O 0 0.00011955159425269812

We O 0 7.25055142538622e-05
propose O 0 6.825394666520879e-05
that O 0 1.633708416193258e-05
WT1 O 1 0.7066952586174011
and O 0 0.00011415176413720474
Dax O 1 0.9999125003814697
- O 0 0.0011922307312488556
1 O 0 0.00035604852018877864
functionally O 0 0.0003204311360605061
oppose O 0 6.005217983329203e-06
each O 0 3.26008432693925e-07
other O 0 1.170809468931111e-06
in O 0 3.960246976930648e-05
testis O 0 0.004078802186995745
development O 0 9.158068132819608e-05
by O 0 1.788643749023322e-05
modulating O 0 0.006270116660743952
SF O 1 0.9999988079071045
- O 0 0.0030825654976069927
1 O 0 0.0009203482186421752
- O 0 0.0006459489814005792
mediated O 0 0.0006457940908148885
transactivation O 0 0.00526444660499692
. O 0 5.89669834880624e-05
. O 0 7.84938529250212e-05

A O 0 0.0011496043298393488
mouse O 0 5.198328653932549e-05
model O 0 8.312161298817955e-06
for O 0 6.830578058725223e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999997615814209
- O 1 0.9999940395355225
centre O 1 0.8132094740867615
mutations O 0 0.0003611920983530581
. O 0 0.00022524554515257478

Imprinting O 0 0.0031284126453101635
in O 0 0.0001491439325036481
the O 0 0.0002714896108955145
15q11 O 0 0.005294410977512598
- O 0 0.000666304025799036
q13 O 0 0.0006000797729939222
region O 0 5.717188469134271e-05
involves O 0 1.3203845810494386e-05
an O 0 1.0529603059694637e-05
imprinting O 0 0.0021393857896327972
centre O 0 0.009446118958294392
( O 0 0.0005900093237869442
IC O 1 0.6863490343093872
) O 0 5.102516297483817e-05
, O 0 3.4581812542455737e-06
mapping O 0 1.6214558854699135e-05
in O 0 1.0208281310042366e-05
part O 0 1.9208986486773938e-05
to O 0 1.1319262739561964e-05
the O 0 9.401266288477927e-05
promoter O 0 0.0022923145443201065
and O 0 1.6620548194623552e-05
first O 0 0.00015649454144295305
exon O 0 0.0009400855051353574
of O 0 0.0005217369762249291
SNRPN O 1 0.9999978542327881
. O 0 0.0009997707093134522

Deletion O 0 0.0029587268363684416
of O 0 0.0008760723285377026
this O 0 0.00043052894761785865
IC O 1 0.9981885552406311
abolishes O 0 0.005974804516881704
local O 0 0.00012349628377705812
paternally O 0 0.0009361410629935563
derived O 0 4.0554488805355504e-05
gene O 0 1.920473550853785e-05
expression O 0 6.215840585355181e-06
and O 0 1.2132602478232002e-06
results O 0 9.42801489145495e-06
in O 0 0.0002631565148476511
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
PWS B-Disease 1 1.0
) O 0 0.004045575391501188
. O 0 0.000502672977745533

We O 0 4.965265907230787e-05
have O 0 1.7528012676848448e-06
created O 0 1.983997026400175e-05
two O 0 4.612184511643136e-06
deletion O 0 0.0002894985373131931
mutations O 0 0.00010131912858923897
in O 0 0.00015819859982002527
mice O 0 0.00044586905278265476
to O 0 9.153578866971657e-05
understand O 0 0.0026149661280214787
PWS B-Disease 1 1.0
and O 0 7.872955757193267e-05
the O 0 0.00010918888438027352
mechanism O 0 0.00020762457279488444
of O 0 0.00012107132351957262
this O 0 0.00010881189518840984
IC O 1 0.993740975856781
. O 0 0.0005894663627259433

Mice O 0 0.030162932351231575
harbouring O 0 0.1150994673371315
an O 0 0.0001364645577268675
intragenic O 0 0.049840763211250305
deletion O 0 0.0025644588749855757
in O 0 0.00039366577402688563
Snrpn O 0 0.2169843167066574
are O 0 2.2738870029570535e-05
phenotypically O 0 0.0020410469733178616
normal O 0 0.00012130024697398767
, O 0 7.192898920038715e-06
suggesting O 0 1.9855035134241916e-05
that O 0 1.944534687936539e-06
mutations O 0 1.5661596989957616e-05
of O 0 0.0002769087441265583
SNRPN O 1 0.9999438524246216
are O 0 4.024670943181263e-06
not O 0 1.1857633808176615e-06
sufficient O 0 3.200765058863908e-05
to O 0 7.645125879207626e-05
induce O 0 0.04125729575753212
PWS B-Disease 1 1.0
. O 0 0.002938084537163377

Mice O 0 0.0011886826250702143
with O 0 6.34941761745722e-06
a O 0 1.9048346075578593e-05
larger O 0 3.732185359694995e-05
deletion O 0 0.00021121770259924233
involving O 0 0.0001101638117688708
both O 0 5.9554247854975984e-05
Snrpn O 1 0.924903154373169
and O 0 7.884803926572204e-05
the O 0 0.0007638409151695669
putative O 1 0.9986037611961365
PWS O 1 1.0
- O 1 0.9980802536010742
IC O 1 0.9914290308952332
lack O 0 0.0002681781188584864
expression O 0 1.9898367099813186e-05
of O 0 6.243368989089504e-05
the O 0 0.0001816682197386399
imprinted O 0 0.0012059990549460053
genes O 0 0.00011596443800954148
Zfp127 O 0 0.011849976144731045
( O 0 0.00010259976261295378
mouse O 0 0.00010398303129477426
homologue O 0 0.00019519522902555764
of O 0 0.00016478267207276076
ZNF127 O 1 0.9999985694885254
) O 0 0.00028322183061391115
, O 0 0.00010784420010168105
Ndn O 0 0.018752003088593483
and O 0 7.093851309036836e-05
Ipw O 0 0.007313837762922049
, O 0 2.1369249225244857e-05
and O 0 7.825090506230481e-06
manifest O 0 0.0006473504472523928
several O 0 6.934135308256373e-05
phenotypes O 0 0.0007651238702237606
common O 0 0.0002771652361843735
to O 0 0.021611999720335007
PWS B-Disease 1 1.0
infants O 1 0.9999954700469971
. O 0 0.0014497780939564109

These O 0 1.9668179447762668e-05
data O 0 1.9656779841170646e-05
demonstrate O 0 4.510417056735605e-05
that O 0 1.1671684205794008e-06
both O 0 1.598341555109073e-06
the O 0 8.420293852395844e-06
position O 0 2.4810484319459647e-05
of O 0 5.608640640275553e-05
the O 0 0.0003564178477972746
IC O 0 0.08092948794364929
and O 0 1.8381240806775168e-05
its O 0 8.440963938483037e-06
role O 0 1.9295737729407847e-05
in O 0 8.57531267683953e-06
the O 0 7.721744623268023e-06
coordinate O 0 8.082544809440151e-06
expression O 0 1.2018332199659199e-05
of O 0 3.924220072804019e-05
genes O 0 2.1759602532256395e-05
is O 0 5.8948771766154096e-06
conserved O 0 0.00012740649981424212
between O 0 0.0002473295317031443
mouse O 0 0.00014400093641597778
and O 0 7.802357686159667e-06
human O 0 2.3316973965847865e-05
, O 0 5.607627372228308e-06
and O 0 3.147666348013445e-06
indicate O 0 4.4879863708047196e-05
that O 0 4.0156419345294125e-06
the O 0 7.802422624081373e-05
mouse O 0 5.573318412643857e-05
is O 0 2.1294438283803174e-06
a O 0 3.777931851800531e-06
suitable O 0 2.001207394641824e-05
model O 0 5.982405127724633e-06
system O 0 1.1525496120157186e-05
in O 0 4.07827656090376e-06
which O 0 1.6256155959126772e-06
to O 0 2.2556450858246535e-06
investigate O 0 1.6467100067529827e-05
the O 0 2.9859415008104406e-05
molecular O 0 0.0001081720256479457
mechanisms O 0 0.00014300899056252092
of O 0 0.0003124942595604807
imprinting O 0 0.001686501083895564
in O 0 9.185774979414418e-05
this O 0 1.0169561392103788e-05
region O 0 8.975086529972032e-05
of O 0 3.983944043284282e-05
the O 0 7.30470273992978e-05
genome O 0 0.00018018287664745003
. O 0 2.1582078261417337e-05
. O 0 5.3994503105059266e-05

Mutations O 0 0.00012806862650904804
of O 0 0.00014267624646890908
the O 0 0.00042303744703531265
ATM O 0 0.015593722462654114
gene O 0 7.325728074647486e-05
detected O 0 0.0002024027198785916
in O 0 5.5417327530449256e-05
Japanese O 1 0.8452858328819275
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.0005864598206244409
: O 0 2.663772647792939e-05
possible O 0 2.8062706405762583e-05
preponderance O 0 0.0014721411280333996
of O 0 0.00011816908954642713
the O 0 0.00019881216576322913
two O 0 7.467170507879928e-05
founder O 0 0.00243070675060153
mutations O 0 0.0001814831339288503
4612del165 O 0 0.0026757046580314636
and O 0 9.171631245408207e-05
7883del5 O 0 0.0057922364212572575
. O 0 0.0002643202606122941

The O 0 0.0012348402524366975
ATM O 0 0.018194530159235
( O 0 0.0004118082288186997
A O 1 0.9998650550842285
- O 1 0.9863681197166443
T O 1 0.9996757507324219
, O 0 1.4428938811761327e-05
mutated O 0 2.6428291675983928e-05
) O 0 5.274480827210937e-06
gene O 0 6.958897756703664e-06
on O 0 5.921119372942485e-05
human O 0 0.00012105446512578055
chromosome O 0 0.0014846206177026033
11q22 O 0 0.01101671438664198
. O 0 0.0004426678060553968

3 O 0 0.0007587423315271735
has O 0 1.9520801288308576e-05
recently O 0 1.8293842003913596e-05
been O 0 2.8449983346945373e-06
identified O 0 3.4889158087025862e-06
as O 0 2.5793131044338224e-06
the O 0 5.891612090636045e-06
gene O 0 4.990784418623662e-06
responsible O 0 5.3818603191757575e-06
for O 0 3.105007635895163e-06
the O 0 9.84409634838812e-05
human O 0 0.000932012393604964
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9566167593002319
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999998807907104
) O 0 0.0001255059032700956
. O 0 7.963927782839164e-05

In O 0 7.764266047161072e-05
order O 0 9.570093425281812e-06
to O 0 3.9335891415248625e-06
define O 0 3.7586949474643916e-05
the O 0 4.199615796096623e-05
types O 0 0.00015648947737645358
of O 0 0.004683502484112978
disease O 1 1.0
- O 1 0.9996287822723389
causing O 0 0.017902573570609093
ATM O 0 0.010814514011144638
mutations O 0 4.565105336951092e-05
in O 0 6.013045276631601e-05
Japanese O 0 0.0033699150662869215
A B-Disease 1 0.9999953508377075
- I-Disease 1 0.9999444484710693
T I-Disease 1 0.9999972581863403
patients O 0 6.926779315108433e-05
as O 0 1.8511755115468986e-05
well O 0 7.444119091815082e-06
as O 0 5.685307769454084e-06
to O 0 5.263290404400323e-06
look O 0 6.677008514088811e-06
for O 0 2.725310878304299e-06
possible O 0 3.2402793294750154e-05
mutational O 0 0.005331888794898987
hotspots O 0 0.0020360357593744993
, O 0 1.7130707419710234e-05
reverse O 0 0.00019813206745311618
- O 0 0.0002601283777039498
transcribed O 0 0.0002881335385609418
RNA O 0 0.00018755189375951886
derived O 0 5.747860996052623e-06
from O 0 6.4287664827133995e-06
ten O 0 0.00012138633610447869
patients O 0 1.8036351320915855e-05
belonging O 0 3.1546551326755434e-05
to O 0 1.5416524547617882e-05
eight O 0 0.0001654713851166889
unrelated O 0 0.0003274412592872977
Japanese O 0 0.004909548442810774
A B-Disease 1 0.9999972581863403
- I-Disease 1 0.9985148310661316
T I-Disease 1 0.9997803568840027
families O 0 4.3044456106144935e-06
was O 0 4.942943269270472e-05
analyzed O 0 1.6543093806831166e-05
for O 0 2.6897148472926347e-06
mutations O 0 1.4182717677613255e-05
by O 0 4.331380296207499e-06
the O 0 3.2259576983051375e-05
restriction O 0 1.660068483033683e-05
endonuclease O 0 0.00010310821380699053
fingerprinting O 0 9.642497752793133e-05
method O 0 3.1568553822580725e-05
. O 0 0.00010001754708355293

As O 0 0.0001285020262002945
has O 0 9.538621270621661e-06
been O 0 6.51108121019206e-06
reported O 0 6.824919637438143e-06
by O 0 1.392580998071935e-06
others O 0 4.000196440756554e-06
, O 0 2.781586999844876e-06
mutations O 0 4.2586325434967875e-06
that O 0 3.1430047329195077e-06
lead O 0 0.00021868135081604123
to O 0 0.00022673855710309
exon O 0 0.004903718363493681
skipping O 0 0.0020992294885218143
or O 0 0.00013494078302755952
premature O 0 0.0010772522073239088
protein O 0 0.00014803398516960442
truncation O 0 0.0008325258968397975
were O 0 9.28743538679555e-05
also O 0 1.1992102372460067e-05
predominant O 0 0.00017374695744365454
in O 0 3.204983295290731e-05
our O 0 5.272739508654922e-05
mutants O 0 0.0006575242732651532
. O 0 9.563708590576425e-05

Six O 0 9.737338405102491e-05
different O 0 2.0194192984490655e-06
mutations O 0 1.645312840992119e-05
were O 0 3.129202013951726e-05
identified O 0 3.6735051253344864e-05
on O 0 8.74809775268659e-05
12 O 0 0.00011624588660197333
of O 0 8.330722630489618e-05
the O 0 0.00016696802049409598
16 O 0 0.0006360620027408004
alleles O 0 6.535928696393967e-05
examined O 0 0.0007067809929139912
. O 0 0.00025038194144144654

Four O 0 0.00022841518511995673
were O 0 8.790210267761722e-05
deletions O 0 0.0001672961370786652
involving O 0 0.00012854431406594813
a O 0 0.00011709094542311504
loss O 0 0.0009748653974384069
of O 0 0.0006303020054474473
a O 0 0.0004317991842981428
single O 0 0.0003004802274517715
exon O 0 0.0012704385444521904
exon O 0 0.0006742820842191577
7 O 0 0.0003171992429997772
, O 0 2.2114843886811286e-05
exon O 0 0.00031226850114762783
16 O 0 0.00019078096374869347
, O 0 2.662655242602341e-05
exon O 0 0.0006636561593040824
33 O 0 0.00025488855317234993
or O 0 0.00012434032396413386
exon O 0 0.0015876685502007604
35 O 0 0.00041359811439178884
. O 0 0.0001639639085624367

The O 0 0.00038232855149544775
others O 0 3.840516728814691e-05
were O 0 3.70190609828569e-05
minute O 0 0.00010643465066095814
deletions O 0 0.0002974546514451504
, O 0 2.6525931389187463e-05
4649delA O 0 0.0014763281214982271
in O 0 0.00012116038124077022
exon O 0 0.000828757241833955
33 O 0 0.00017956561350729316
and O 0 1.6045152733568102e-05
7883del5 O 0 0.0008967462345026433
in O 0 0.00011398078640922904
exon O 0 0.0011229512747377157
55 O 0 0.00026841016369871795
. O 0 0.00014903134433552623

The O 0 0.0006748252781108022
mutations O 0 0.0003149933472741395
4612del165 O 0 0.0016267976025119424
and O 0 2.88230694422964e-05
7883del5 O 0 0.0009078921866603196
were O 0 2.7426563974586315e-05
found O 0 5.193975084694102e-06
in O 0 6.921627573319711e-06
more O 0 1.1751565125450725e-06
than O 0 1.7564592553753755e-06
two O 0 3.7860213524254505e-06
unrelated O 0 4.0138951590051875e-05
families O 0 2.4621676857350394e-06
; O 0 1.5621889133399236e-06
44 O 0 3.4580261853989214e-05
% O 0 2.5803718017414212e-05
( O 0 6.44863466732204e-05
7 O 0 0.00046642308006994426
of O 0 0.00039298340561799705
16 O 0 0.0007594252238050103
) O 0 1.1949850886594504e-05
of O 0 1.9068011170020327e-05
the O 0 4.0115683077601716e-05
mutant O 0 5.757692997576669e-05
alleles O 0 8.163153324858285e-06
had O 0 1.5250931937771384e-05
one O 0 2.510703097868827e-06
of O 0 1.9382730897632428e-05
the O 0 7.561153324786574e-05
two O 0 3.821660720859654e-05
mutations O 0 0.00016802593017928302
. O 0 0.0001899860508274287

The O 0 0.0011594705283641815
4612del165 O 0 0.0031151019502431154
mutations O 0 3.481974272290245e-05
in O 0 7.739416105323471e-06
three O 0 1.8878699847846292e-06
different O 0 2.1790535242871556e-07
families O 0 7.566421800220269e-07
were O 0 5.01999829793931e-06
all O 0 2.3440882159775356e-06
ascribed O 0 0.00015049763896968216
to O 0 1.4221142009773757e-05
the O 0 7.820128666935489e-05
same O 0 0.00014331520651467144
T O 0 0.017373988404870033
- O 0 0.0008588432101532817
- O 0 0.00026825949316844344
> O 0 5.820344449602999e-05
A O 0 6.494847184512764e-05
substitution O 0 1.7654623661655933e-05
at O 0 8.333639561897144e-05
the O 0 3.085647040279582e-05
splice O 0 0.0003741542750503868
donor O 0 2.0768920876435004e-05
site O 0 0.00017876543279271573
in O 0 7.149110024329275e-05
intron O 0 0.007740389090031385
33 O 0 0.001228075590915978
. O 0 0.00028553346055559814

Microsatellite O 0 0.03683670610189438
genotyping O 0 0.003864692058414221
around O 0 0.00029006737167946994
the O 0 0.00030584511114284396
ATM O 0 0.007249162532389164
locus O 0 0.00019301025895401835
also O 0 1.123232414101949e-05
indicated O 0 1.1687417099892627e-05
that O 0 7.404091775242705e-07
a O 0 8.249993697972968e-06
common O 0 1.0970330549753271e-05
haplotype O 0 0.0004420511540956795
was O 0 0.00029696215642616153
shared O 0 1.7639544239500538e-05
by O 0 1.4639651908510132e-06
the O 0 1.3443633179122116e-05
mutant O 0 5.033709021518007e-05
alleles O 0 4.251579866831889e-06
in O 0 1.0629820280882996e-05
both O 0 1.4032987564860377e-05
mutations O 0 0.0001569308660691604
. O 0 0.0002649227390065789

This O 0 2.526234857214149e-05
suggests O 0 1.7383323211106472e-05
that O 0 5.184757583265309e-07
these O 0 1.2060340850439388e-06
two O 0 1.797126060409937e-05
founder O 0 0.001459563267417252
mutations O 0 0.0001096602063626051
may O 0 0.00011013440234819427
be O 0 9.759784006746486e-06
predominant O 0 8.334116864716634e-05
among O 0 1.4111456948739942e-05
Japanese O 0 0.00032979538082145154
ATM O 0 0.00241926871240139
mutant O 0 0.00018406675371807069
alleles O 0 2.9917813662905246e-05
. O 0 6.696791388094425e-05

W474C O 0 0.014780573546886444
amino O 0 0.00043574019218795
acid O 0 0.0002102584403473884
substitution O 0 0.00010937603656202555
affects O 0 9.296632197219878e-05
early O 0 7.395978173008189e-05
processing O 0 4.117237403988838e-05
of O 0 2.9124685170245357e-05
the O 0 5.6068874982884154e-05
alpha O 0 7.823619671398774e-05
- O 0 1.1602427548496053e-05
subunit O 0 1.2247681979715708e-06
of O 0 9.92860623227898e-06
beta O 0 0.0004159584059379995
- O 0 0.0002872890036087483
hexosaminidase O 0 0.001374725834466517
A O 0 9.207402035826817e-05
and O 0 2.0857330582657596e-06
is O 0 1.1688504173434922e-06
associated O 0 3.94104654333205e-06
with O 0 1.3180294445191976e-05
subacute O 1 0.999994158744812
G B-Disease 1 0.9999734163284302
( I-Disease 0 0.004674921743571758
M2 I-Disease 1 0.9999998807907104
) I-Disease 0 0.0004803549381904304
gangliosidosis I-Disease 0 0.015073944814503193
. O 0 0.0003172891156282276

Mutations O 0 0.00035361203481443226
in O 0 0.0001731566881062463
the O 0 0.0008465366554446518
HEXA O 1 0.9533337950706482
gene O 0 4.142335455981083e-05
, O 0 2.2106019059719983e-06
encoding O 0 3.4088852771674283e-06
the O 0 2.0837564079556614e-05
alpha O 0 7.232548523461446e-05
- O 0 1.6605181372142397e-05
subunit O 0 1.4678838624604396e-06
of O 0 1.144452289736364e-05
beta O 0 0.00038333694101311266
- O 0 0.00032404696685262024
hexosaminidase O 0 0.0017888150177896023
A O 0 0.00047870841808617115
( O 0 6.67548956698738e-05
Hex O 0 0.002207930665463209
A O 0 0.0005023518460802734
) O 0 2.0385647076182067e-05
, O 0 1.9072766690442222e-06
that O 0 1.128934854932595e-06
abolish O 0 0.00021322698739822954
Hex O 0 0.0007448742398992181
A O 0 9.20583916013129e-05
enzyme O 0 2.0612096705008298e-05
activity O 0 6.750754255335778e-05
cause O 1 0.9734223484992981
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.002031050156801939
TSD B-Disease 1 0.9999998807907104
) O 0 0.00027343869442120194
, O 0 1.9666398657136597e-05
the O 0 0.00013800422311760485
fatal O 1 0.9595987796783447
infantile B-Disease 1 0.9475234746932983
form I-Disease 0 0.0003090997925028205
of I-Disease 1 0.7523118853569031
G I-Disease 1 0.999998927116394
( I-Disease 0 0.004270235076546669
M2 I-Disease 1 0.9999966621398926
) I-Disease 0 0.00015552580589428544
gangliosidosis I-Disease 0 0.003580652642995119
, I-Disease 0 1.0909234333666973e-05
Type I-Disease 0 0.00016206804139073938
1 I-Disease 0 0.0011587804183363914
. O 0 0.00022384025214705616

Less O 0 0.0018473565578460693
severe O 1 0.9979661703109741
, O 0 0.0005076220841147006
subacute O 1 0.9999973773956299
( O 0 0.0023234121035784483
juvenile O 1 0.999997615814209
- O 1 0.8353257179260254
onset O 1 0.9999998807907104
) O 0 0.0003298003866802901
and O 0 0.0001583921111887321
chronic O 1 1.0
( O 0 0.0024289442226290703
adult O 0 0.0018895585089921951
- O 0 0.008509893901646137
onset O 1 0.9995893836021423
) O 0 5.341277937986888e-05
variants O 0 3.5821853089146316e-05
are O 0 1.0896235380641883e-06
characterized O 0 1.1689903658407275e-05
by O 0 2.1418370579340262e-06
a O 0 1.0683123036869802e-05
broad O 0 6.61848098388873e-05
spectrum O 0 0.00034814063110388815
of O 0 0.0003824355371762067
clinical O 0 0.014260917901992798
manifestations O 1 0.9963796734809875
and O 0 0.00012245640391483903
are O 0 4.762136541103246e-06
associated O 0 6.377435965987388e-06
with O 0 5.465157300932333e-06
residual O 0 0.004369823727756739
levels O 0 0.002243478549644351
of O 0 0.000976663432084024
Hex O 0 0.010110042989253998
A O 0 0.0011315785814076662
enzyme O 0 3.3705193345667794e-05
activity O 0 5.655108543578535e-05
. O 0 4.569434895529412e-05

We O 0 7.912158616818488e-05
identified O 0 4.111084854230285e-05
a O 0 7.151121826609597e-05
1422 O 0 0.4379332363605499
G O 0 0.014573810622096062
- O 0 0.00224031088873744
- O 0 0.0004746115009766072
> O 0 0.0001613428903510794
C O 0 0.0004872567078564316
( O 0 3.6611774703487754e-05
amino O 0 4.7377787268487737e-05
acid O 0 0.00016471892013214529
W474C O 0 0.0010174188064411283
) O 0 7.825016837159637e-06
substitution O 0 4.279755103198113e-06
in O 0 4.534985237114597e-06
the O 0 8.467442057735752e-06
first O 0 1.2206591236463282e-05
position O 0 1.598241760802921e-05
of O 0 6.211988511495292e-05
exon O 0 0.0007599055534228683
13 O 0 0.00040982308564707637
of O 0 0.0006720141973346472
HEXA O 1 0.9994645714759827
of O 0 0.0004805041535291821
a O 0 0.0002816380001604557
non O 0 0.0016241990961134434
- O 0 0.001123376190662384
Jewish O 0 0.0001817120355553925
proband O 0 0.006691157817840576
who O 0 3.771297269850038e-05
manifested O 0 0.0009492993704043329
a O 0 9.567229426465929e-05
subacute O 0 0.2822760343551636
variant O 0 0.0010489339474588633
of O 0 0.005104382988065481
G B-Disease 1 0.9999438524246216
( I-Disease 0 0.0030120641458779573
M2 I-Disease 1 0.9999984502792358
) I-Disease 0 0.0004943543463014066
gangliosidosis I-Disease 0 0.010285018011927605
. O 0 0.00020307076920289546

On O 0 0.0005314270965754986
the O 0 0.00013562885578721762
second O 0 0.0005253964918665588
maternally O 0 0.0025289186742156744
inherited O 0 0.02394222468137741
allele O 0 4.611410622601397e-05
, O 0 3.6616834222513717e-06
we O 0 2.1477608243003488e-06
identified O 0 4.4374673962011e-06
the O 0 2.5577583073754795e-05
common O 0 0.0003995376464445144
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999793767929077
causing O 1 0.9674404859542847
4 O 0 0.0042296587489545345
- O 0 0.0015008291229605675
bp O 0 0.0002442139375489205
insertion O 0 9.212450822815299e-05
, O 0 2.646516622917261e-05
+ O 0 0.0017574612284079194
TATC O 1 0.9997870326042175
1278 O 0 0.0917118713259697
, O 0 2.8271608243812807e-05
in O 0 5.389516809373163e-05
exon O 0 0.0010610193712636828
11 O 0 0.0007910836720839143
. O 0 0.0001506578701082617

Pulse O 0 0.016034895554184914
- O 0 0.0006455624243244529
chase O 0 6.905075133545324e-05
analysis O 0 8.882832958079234e-07
using O 0 1.4162578736431897e-05
proband O 0 0.00897052139043808
fibroblasts O 0 0.0007068456034176052
revealed O 0 0.0003742302651517093
that O 0 3.3489025099697756e-06
the O 0 3.715196726261638e-05
W474C O 0 0.0014647807693108916
- O 0 0.00017474032938480377
containing O 0 5.633136970573105e-05
alpha O 0 0.00018002971773967147
- O 0 6.275733903748915e-05
subunit O 0 1.1597495358728338e-05
precursor O 0 0.00035374853177927434
was O 0 0.00015506484487559646
normally O 0 1.0250395462207962e-05
synthesized O 0 6.39516074443236e-05
, O 0 2.4618952920718584e-06
but O 0 8.16922920421348e-07
not O 0 1.1050128705392126e-06
phosphorylated O 0 6.194997695274651e-05
or O 0 2.1485111574293114e-05
secreted O 0 5.7401382946409285e-05
, O 0 5.4523816288565286e-06
and O 0 5.169307314645266e-06
the O 0 8.134180825436488e-05
mature O 0 0.0010839371243491769
lysosomal O 0 0.017893420532345772
alpha O 0 0.001016234396956861
- O 0 0.0001277778355870396
subunit O 0 7.515723609685665e-06
was O 0 3.9609643863514066e-05
not O 0 4.077700850757537e-06
detected O 0 0.0002148895728169009
. O 0 4.890705531579442e-05

When O 0 0.00014210303197614849
the O 0 7.231610652524978e-05
W474C O 0 0.0016018792521208525
- O 0 0.00014374495367519557
containing O 0 4.517394700087607e-05
alpha O 0 0.00017455514171160758
- O 0 7.079849456204101e-05
subunit O 0 2.028772360063158e-05
was O 0 0.00026023382088169456
transiently O 0 0.0013202168047428131
co O 0 0.00018107453070115298
- O 0 3.4239616070408374e-05
expressed O 0 2.4012015273910947e-06
with O 0 7.161271469158237e-07
the O 0 2.0651763406931423e-05
beta O 0 0.00013757905981037766
- O 0 3.137428575428203e-05
subunit O 0 1.803226496122079e-06
to O 0 2.7154601411893964e-06
produce O 0 1.118806358135771e-05
Hex O 0 0.0007630566251464188
A O 0 0.0004344503104221076
( O 0 5.3031872084829956e-05
alphabeta O 0 0.003092400263994932
) O 0 3.393800216144882e-05
in O 0 0.00016593432519584894
COS O 1 0.9972283244132996
- O 0 0.0024716281332075596
7 O 0 0.0006436512339860201
cells O 0 3.387314427527599e-05
, O 0 1.7259167179872748e-06
the O 0 1.4232091416488402e-05
mature O 0 0.0001279277930734679
alpha O 0 9.378407412441447e-05
- O 0 3.066468343604356e-05
subunit O 0 5.619850071525434e-06
was O 0 2.9508197258110158e-05
present O 0 1.1203545000171289e-05
, O 0 2.169210119973286e-06
but O 0 5.601671091426397e-07
its O 0 1.244448412762722e-06
level O 0 8.946596062742174e-05
was O 0 0.00014431598538067192
much O 0 1.4265599929785822e-05
lower O 0 3.237718192394823e-05
than O 0 7.937114219203067e-07
that O 0 4.0534348499932094e-07
from O 0 8.861173228069674e-06
normal O 0 4.648587491828948e-05
alpha O 0 0.00012680437066592276
- O 0 8.354517194675282e-05
subunit O 0 1.853777575888671e-05
transfections O 0 0.0007285104948095977
, O 0 2.172839458580711e-06
although O 0 1.243129304384638e-06
higher O 0 6.063403816369828e-06
than O 0 1.2824459645344177e-06
in O 0 1.030764451570576e-05
those O 0 1.3550390576710925e-05
cells O 0 4.932009687763639e-05
transfected O 0 0.0003207297413609922
with O 0 7.603101721542771e-07
an O 0 3.313837851237622e-06
alpha O 0 0.00022155934129841626
- O 0 6.74235780024901e-05
subunit O 0 1.0395264325779863e-05
associated O 0 1.0927549737971276e-05
with O 0 4.040948988404125e-05
infantile O 1 0.9999929666519165
TSD B-Disease 1 1.0
. O 0 0.002988366177305579

Furthermore O 0 0.0005788385751657188
, O 0 1.0245040357403923e-05
the O 0 2.2615296984440647e-05
precursor O 0 0.0007043528603389859
level O 0 0.00021659443154931068
of O 0 9.240906365448609e-05
the O 0 0.00017778122855816036
W474C O 0 0.001990498509258032
alpha O 0 0.00022439176973421127
- O 0 4.1579802200431004e-05
subunit O 0 6.3120633058133535e-06
was O 0 3.238314457121305e-05
found O 0 1.6052786122600082e-06
to O 0 3.091604867222486e-06
accumulate O 0 4.142813486396335e-05
in O 0 5.688523742719553e-06
comparison O 0 7.065437330311397e-06
to O 0 4.9518653213453945e-06
the O 0 2.1271451259963214e-05
normal O 0 3.657167690107599e-05
alpha O 0 6.1020313296467066e-05
- O 0 2.879152998502832e-05
subunit O 0 5.162213255971437e-06
precursor O 0 0.0004069338901899755
levels O 0 0.0002445665013510734
. O 0 3.943009869544767e-05

We O 0 4.645157605409622e-05
conclude O 0 0.000161387215484865
that O 0 3.677876748042763e-06
the O 0 7.406224904116243e-05
1422 O 1 0.867018461227417
G O 0 0.016386590898036957
- O 0 0.0023719547316432
- O 0 0.0007974617765285075
> O 0 0.0003015851543750614
C O 0 0.00043664753320626915
mutation O 0 2.589702035038499e-06
is O 0 8.861324545250682e-07
the O 0 7.3575474743847735e-06
cause O 0 6.618468614760786e-05
of O 0 0.0003353251959197223
Hex B-Disease 1 0.9801268577575684
A I-Disease 1 0.99991774559021
enzyme I-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
in O 0 0.0008423284161835909
the O 0 0.0006943981279619038
proband O 0 0.038942355662584305
. O 0 0.000263124646153301

The O 0 0.0004862929636146873
resulting O 0 0.0004053165903314948
W474C O 0 0.0022328533232212067
substitution O 0 0.00020277127623558044
clearly O 0 0.00015580338367726654
interferes O 0 8.769061241764575e-05
with O 0 5.961514489172259e-06
alpha O 0 0.00016374893311876804
- O 0 6.986963853705674e-05
subunit O 0 8.14747363619972e-06
processing O 0 3.696213025250472e-05
, O 0 2.946043423435185e-06
but O 0 9.21076093618467e-07
because O 0 1.2638862472158507e-06
the O 0 7.670040758966934e-06
base O 0 6.211656727828085e-05
substitution O 0 0.00013251953350845724
falls O 0 0.002270492259413004
at O 0 0.0001550682500237599
the O 0 1.9023656932404265e-05
first O 0 2.6104464268428273e-05
position O 0 3.3714324672473595e-05
of O 0 0.00013840169413015246
exon O 0 0.0014452608302235603
13 O 0 0.0005066369194537401
, O 0 3.063671101699583e-05
aberrant O 0 0.00026698800502344966
splicing O 0 0.0001638768590055406
may O 0 6.132541602710262e-05
also O 0 7.155616913223639e-06
contribute O 0 4.928277121507563e-05
to O 0 9.210957796312869e-05
Hex B-Disease 0 0.07313517481088638
A I-Disease 0 0.28048911690711975
deficiency I-Disease 1 0.9999997615814209
in O 0 0.0001834508584579453
this O 0 3.862443918478675e-05
proband O 0 0.007072553504258394
. O 0 5.695628351531923e-05
. O 0 4.2693529394455254e-05

Two O 0 3.346785524627194e-05
frequent O 0 2.678337477846071e-05
missense O 0 0.0004974491312168539
mutations O 0 0.000559828826226294
in O 0 0.4343891739845276
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.6769447326660156

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0022914011497050524
an O 0 0.28094345331192017
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9999966621398926
early O 1 1.0
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9999520778656006

A O 0 0.001374168205074966
century O 0 0.0006409250781871378
after O 0 4.569434895529412e-05
its O 0 3.036043835891178e-06
recognition O 0 3.321533222333528e-05
as O 0 8.219405572162941e-05
a O 0 0.0004404764622449875
syndrome O 1 1.0
by O 0 0.00010736838885350153
Vaughan O 0 0.003701684530824423
Pendred O 0 0.3656467795372009
, O 0 2.226609103672672e-05
the O 0 0.00011992370127700269
disease O 1 0.9999984502792358
gene O 0 0.00040781471761874855
( O 0 0.0004632606287486851
PDS O 1 0.9999629259109497
) O 0 4.97069995617494e-05
was O 0 0.0001690212666289881
mapped O 0 9.084535122383386e-05
to O 0 5.612680615740828e-05
chromosome O 0 0.0021639768965542316
7q22 O 0 0.01636936329305172
- O 0 0.005514883436262608
q31 O 0 0.007424622308462858
. O 0 0.00022166922281030566

1 O 0 0.0014332971768453717
and O 0 3.1582225346937776e-05
, O 0 9.958760529116262e-06
recently O 0 4.059364437125623e-05
, O 0 1.3554788438341348e-06
found O 0 8.570975751354126e-07
to O 0 1.948111275851261e-06
encode O 0 1.5265455658663996e-05
a O 0 5.860282544745132e-05
putative O 0 0.003005508566275239
sulfate O 0 0.027656937018036842
transporter O 0 0.11491024494171143
. O 0 0.0012218980118632317

We O 0 6.476293492596596e-05
performed O 0 7.274319796124473e-05
mutation O 0 2.2084777810960077e-06
analysis O 0 5.087526346869709e-07
of O 0 1.584635720064398e-05
the O 0 0.00038466264959424734
PDS B-Disease 1 0.9999555349349976
gene O 0 0.00010723200830398127
in O 0 4.435113805811852e-05
patients O 0 3.862340599880554e-05
from O 0 5.394009713199921e-05
14 O 0 0.0008465193095616996
Pendred B-Disease 0 0.006800603587180376
families O 0 8.1548505477258e-06
originating O 0 3.12122683681082e-05
from O 0 9.180714187095873e-06
seven O 0 2.3541571863461286e-05
countries O 0 1.1642802064670832e-06
and O 0 3.8122350360936252e-06
identified O 0 1.3480748748406768e-05
all O 0 1.2050455552525818e-05
mutations O 0 0.00016875907022040337
. O 0 0.0002024602290475741

The O 0 0.00043279517558403313
mutations O 0 7.603145786561072e-05
include O 0 3.422345616854727e-05
three O 0 7.088814163580537e-05
single O 0 6.708513683406636e-05
base O 0 0.00022563287348020822
deletions O 0 0.00026647557388059795
, O 0 9.637823495722841e-06
one O 0 9.654262612457387e-06
splice O 0 0.0008872129255905747
site O 0 0.000563472043722868
mutation O 0 1.9941473510698415e-05
and O 0 1.3644741557072848e-05
10 O 0 0.0002643747138790786
missense O 0 0.0015922337770462036
mutations O 0 0.00043720289249904454
. O 0 0.0004318889114074409

One O 0 0.00020507414592429996
missense O 0 0.0011457140790298581
mutation O 0 8.962872379925102e-05
( O 0 0.00017236944404430687
L236P O 0 0.004369813017547131
) O 0 5.481666812556796e-05
was O 0 0.00018337162327952683
found O 0 6.014658083586255e-06
in O 0 5.207615231483942e-06
a O 0 8.759609954722691e-06
homozygous O 0 1.825730942073278e-05
state O 0 3.6242324767954415e-06
in O 0 1.2160439837316517e-05
two O 0 1.4336219464894384e-05
consanguineous O 0 0.00187978136818856
families O 0 9.98426548903808e-06
and O 0 7.157152595027583e-06
in O 0 1.4628439203079324e-05
a O 0 2.066498200292699e-05
heterozygous O 0 4.796187567990273e-06
state O 0 1.992147872442729e-06
in O 0 5.1349966270208824e-06
five O 0 3.97571966459509e-06
additional O 0 1.4169617315928917e-05
non O 0 0.0008960322011262178
- O 0 0.0017833986785262823
consanguineous O 0 0.00537920743227005
families O 0 3.103143535554409e-05
. O 0 6.974941061343998e-05

Another O 0 0.0003775346267502755
missense O 0 0.002042206935584545
mutation O 0 9.444567695027217e-05
( O 0 0.0001402961788699031
T416P O 0 0.003153745550662279
) O 0 3.4074109862558544e-05
was O 0 0.00022156759223435074
found O 0 7.854339855839498e-06
in O 0 1.0471840141690336e-05
a O 0 1.3584808584710117e-05
homozygous O 0 2.19748562813038e-05
state O 0 4.539779638434993e-06
in O 0 1.292608430958353e-05
one O 0 1.075942964234855e-05
family O 0 1.2047595191688742e-05
and O 0 2.3697798496868927e-06
in O 0 1.35705895445426e-05
a O 0 1.5441801224369556e-05
heterozygous O 0 6.5974704739346635e-06
state O 0 3.060147264477564e-06
in O 0 9.006175787362736e-06
four O 0 1.2653258636419196e-05
families O 0 1.4534714864566922e-05
. O 0 6.482039316324517e-05

Pendred B-Disease 1 0.9707494378089905
patients O 0 0.0004154466441832483
in O 0 8.928622264647856e-05
three O 0 0.00012971677642781287
non O 0 0.001485705142840743
- O 0 0.0017778092296794057
consanguineous O 0 0.0014825161779299378
families O 0 2.738167495408561e-06
were O 0 3.656836270238273e-06
shown O 0 6.796023171773413e-06
to O 0 1.3095123904349748e-05
be O 0 2.853527075785678e-05
compound O 0 0.00047212030040100217
heterozygotes O 0 0.0009787010494619608
for O 0 7.001090853009373e-05
L236P O 0 0.004685330204665661
and O 0 0.000124810598208569
T416P O 0 0.007038189098238945
. O 0 0.0002369043359067291

In O 0 0.00012089332449249923
total O 0 9.451794176129624e-05
, O 0 1.4478257980954368e-05
one O 0 4.276728304830613e-06
or O 0 2.3768934624968097e-06
both O 0 2.2031179014447844e-06
of O 0 3.985122384619899e-05
these O 0 1.2723912732326426e-05
mutations O 0 3.504647611407563e-05
were O 0 3.0477105610771105e-05
found O 0 1.0965131878037937e-05
in O 0 1.0416899385745637e-05
nine O 0 4.137231007916853e-05
of O 0 4.739341966342181e-05
the O 0 0.00010145457781618461
14 O 0 0.00019639788661152124
families O 0 8.020105269679334e-06
analyzed O 0 0.00021791229664813727
. O 0 0.0001075575637514703

The O 0 9.615063027013093e-05
identification O 0 1.4092413039179519e-05
of O 0 7.283440208993852e-05
two O 0 4.7129222366493195e-05
frequent O 0 0.0003241857048124075
PDS B-Disease 1 0.9997581839561462
mutations O 0 4.7294815885834396e-05
will O 0 4.151643224759027e-06
facilitate O 0 1.4546265447279438e-05
the O 0 1.95324591913959e-05
molecular O 0 0.00016009027604013681
diagnosis O 1 0.9450579881668091
of O 1 0.9999977350234985
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9993329644203186

Insertional O 0 0.029550498351454735
mutation O 0 4.235007145325653e-05
by O 0 1.237810283782892e-05
transposable O 0 0.004031122196465731
element O 0 0.0008535364177078009
, O 0 0.00013081307406537235
L1 O 0 0.22593849897384644
, O 0 1.6096113540697843e-05
in O 0 2.1396759620984085e-05
the O 0 0.00021903839660808444
DMD B-Disease 1 0.9999996423721313
gene O 0 4.478528717299923e-05
results O 0 1.523636638012249e-05
in O 0 8.957439422374591e-05
X B-Disease 1 0.999896764755249
- I-Disease 1 0.9999251365661621
linked I-Disease 1 0.9999479055404663
dilated I-Disease 1 0.9999984502792358
cardiomyopathy I-Disease 1 1.0
. O 0 0.007534326054155827

X B-Disease 1 0.9999864101409912
- I-Disease 1 0.9999860525131226
linked I-Disease 1 0.9999964237213135
dilated I-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
( O 1 0.9961723685264587
XLDCM B-Disease 1 1.0
) O 0 0.00010267925244988874
is O 0 3.684533112391364e-06
a O 0 7.117103905329714e-06
clinical O 0 9.110509563470259e-05
phenotype O 0 0.00015658632037229836
of O 0 0.00031456537544727325
dystrophinopathy B-Disease 1 0.99720299243927
which O 0 3.426797047723085e-05
is O 0 7.04482181390631e-06
characterized O 0 3.0059320124564692e-05
by O 0 1.4047905096958857e-05
preferential O 0 0.001888907398097217
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9987913966178894
without O 0 0.00022155194892548025
any O 0 4.8717647587182e-05
overt O 0 0.000428576982812956
clinical O 0 0.10165313631296158
signs O 1 0.9999725818634033
of O 1 1.0
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9999991655349731

To O 0 8.282009366666898e-05
date O 0 0.00021126281353645027
, O 0 2.8695224045804935e-06
several O 0 1.478677177146892e-06
mutations O 0 8.127360160870012e-06
in O 0 8.006310963537544e-05
the O 1 0.9967087507247925
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999305009841919
, O 0 0.00898148026317358
DMD O 1 1.0
, O 0 4.8673533456167206e-05
have O 0 1.3620915524370503e-06
been O 0 2.9774464564980008e-06
identified O 0 9.918990144797135e-06
in O 0 1.289602823817404e-05
patients O 0 6.178703188197687e-05
with O 0 4.161828474025242e-05
XLDCM B-Disease 1 1.0
, O 0 6.522783951368183e-05
but O 0 2.4218027192546288e-06
a O 0 4.9880291044246405e-06
pathogenic O 0 2.694192335184198e-05
correlation O 0 7.569694389530923e-06
of O 0 3.026232479896862e-05
these O 0 2.703738573472947e-05
cardiospecific O 0 0.07391244173049927
mutations O 0 0.0003121185000054538
in O 0 0.00048380065709352493
DMD O 1 1.0
with O 0 0.00010642571578500792
the O 0 0.0010389419039711356
XLDCM B-Disease 1 0.9999973773956299
phenotype O 0 0.00013242026034276932
has O 0 8.326935130753554e-06
remained O 0 0.00017720834875945002
to O 0 9.108158337767236e-06
be O 0 2.4325583581230603e-05
elucidated O 0 0.010022466070950031
. O 0 0.00027390653849579394

We O 0 8.190151856979355e-05
report O 0 8.087170499493368e-06
here O 0 5.083630185254151e-06
the O 0 3.068751084356336e-06
identification O 0 1.6947827816693462e-06
of O 0 1.4871885468892287e-05
a O 0 2.850902092177421e-05
unique O 0 6.948777445359156e-05
de O 0 0.0032661468721926212
novo O 0 0.004266595002263784
L1 O 0 0.03724271059036255
insertion O 0 0.00034412735840305686
in O 0 6.895474507473409e-05
the O 0 0.0002506284217815846
muscle O 0 0.0009421212016604841
exon O 0 0.0015410572523251176
1 O 0 0.0008927996968850493
in O 0 0.0004337819991633296
DMD O 1 0.9999998807907104
in O 0 0.00031223040423355997
three O 0 0.00022937545145396143
XLDCM B-Disease 1 0.9999521970748901
patients O 0 0.0001082940143533051
from O 0 3.269023363827728e-05
two O 0 1.8709626601776108e-05
unrelated O 0 0.00025531151914037764
Japanese O 0 0.0007193296332843602
families O 0 3.10052273562178e-05
. O 0 0.00011384978279238567

The O 0 0.0005369661375880241
insertion O 0 0.0008009521407075226
was O 0 0.0007230282062664628
a O 0 8.402447565458715e-05
5 O 0 0.000292488926788792
- O 0 0.00014746087254025042
truncated O 0 8.7619227997493e-05
form O 0 9.229285751644056e-06
of O 0 9.958244481822476e-05
human O 0 0.00026017677737399936
L1 O 0 0.09546156227588654
inversely O 0 0.0003743214183486998
integrated O 0 0.0001472088333684951
in O 0 1.8458356862538494e-05
the O 0 4.5611453970195726e-05
5 O 0 0.00018645408272277564
- O 0 0.00022958814224693924
untranslated O 0 0.0024928925558924675
region O 0 0.0001384810166200623
in O 0 2.563230555097107e-05
the O 0 0.0001155789359472692
muscle O 0 0.0005124346353113651
exon O 0 0.000526471238117665
1 O 0 0.00015882586012594402
, O 0 2.6258599064021837e-06
which O 0 9.354791927762562e-07
affected O 0 3.497007128316909e-06
the O 0 1.003390207188204e-05
transcription O 0 0.00021588683011941612
or O 0 1.3693259461433627e-05
the O 0 4.019388143206015e-05
stability O 0 0.0005575313116423786
of O 0 0.0001465053210267797
the O 0 0.00047523173270747066
muscle O 0 0.0011169075733050704
form O 0 0.0001551479654153809
of O 0 0.001860621734522283
dystrophin O 0 0.10629141330718994
transcripts O 0 0.0026570013724267483
but O 0 2.7560531634662766e-06
not O 0 2.572140544998547e-07
that O 0 1.2303308949412894e-07
of O 0 1.939399226102978e-05
the O 0 0.0006058560102246702
brain O 1 0.9999990463256836
or O 0 0.006067503243684769
Purkinje O 1 0.9999866485595703
cell O 0 0.002774635097011924
form O 0 0.00013771082740277052
, O 0 4.027507020509802e-05
probably O 0 5.30126562807709e-05
due O 0 5.358235284802504e-05
to O 0 2.634172005855362e-06
its O 0 4.3050981730630156e-06
unique O 0 8.449743290839251e-06
site O 0 0.0001024501834763214
of O 0 5.8128058299189433e-05
integration O 0 0.0007646555313840508
. O 0 0.0004467271501198411

We O 0 8.96505152923055e-05
speculate O 0 7.953493332024664e-05
that O 0 7.394064596155658e-07
this O 0 8.627199576949351e-07
insertion O 0 3.389214180060662e-05
of O 0 7.019085751380771e-05
an O 0 6.337081140372902e-05
L1 O 0 0.3212820887565613
sequence O 0 0.0006880491273477674
in O 0 0.0009700226946733892
DMD O 1 1.0
is O 0 3.215082688257098e-05
responsible O 0 1.4005501725478098e-05
for O 0 1.7964226799449534e-06
some O 0 1.944082214322407e-06
of O 0 1.748494105413556e-05
the O 0 1.9595501726143993e-05
population O 0 2.628262336656917e-06
of O 0 2.3753780624247156e-05
Japanese O 0 0.000876119825989008
patients O 0 7.639528485015035e-05
with O 0 4.415932562551461e-05
XLDCM B-Disease 1 0.9999996423721313
. O 0 0.0002454558270983398
. O 0 0.0001818015007302165

Severe O 1 0.9989917874336243
early O 1 0.9992432594299316
- O 1 0.9999996423721313
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999977350234985
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 1.0
red O 1 1.0
hair O 1 0.9999864101409912
pigmentation O 1 0.9999436140060425
caused O 1 0.9998898506164551
by O 0 0.0007475102902390063
POMC O 1 0.9999996423721313
mutations O 0 0.0004496280162129551
in O 0 0.0002250107063446194
humans O 0 0.0006041353335604072
. O 0 0.00017320754704996943

Sequential O 0 0.0011628728825598955
cleavage O 0 0.001063418691046536
of O 0 0.00024026779283303767
the O 0 0.00037372225779108703
precursor O 0 0.003610229818150401
protein O 0 0.00023520666582044214
pre O 0 0.0027803510893136263
- O 0 0.0018645810196176171
pro O 0 0.00408164644613862
- O 0 0.0021727215498685837
opiomelanocortin O 0 0.012717317789793015
( O 0 0.000438056857092306
POMC O 1 0.5997421741485596
) O 0 1.6591946405242197e-05
generates O 0 9.465962648391724e-06
the O 0 5.153987876838073e-05
melanocortin O 0 0.02138444408774376
peptides O 0 0.0005230290698818862
adrenocorticotrophin O 0 0.03011467680335045
( O 0 0.0011402876116335392
ACTH O 0 0.48069584369659424
) O 0 0.00015924575563985854
, O 0 8.399467333219945e-05
melanocyte O 0 0.11395925283432007
- O 0 0.005665441509336233
stimulating O 0 0.007983596995472908
hormones O 0 0.00205264356918633
( O 0 0.00034257679362781346
MSH O 1 0.9875276684761047
) O 0 6.194767775014043e-05
alpha O 0 0.0001192057752632536
, O 0 3.4599459013406886e-06
beta O 0 5.561866419157013e-05
and O 0 2.3436546143784653e-06
gamma O 0 1.9897570382454433e-05
as O 0 5.359774149837904e-06
well O 0 2.384606432315195e-06
as O 0 3.855727300106082e-06
the O 0 2.1396494048531167e-05
opioid O 0 0.0008946675225161016
- O 0 0.0004759334842674434
receptor O 0 8.2525955804158e-05
ligand O 0 0.0004662316641770303
beta O 0 0.003140098648145795
- O 0 0.0022908453829586506
endorphin O 0 0.0065652537159621716
. O 0 4.9532627599546686e-05

While O 0 9.083027543965727e-05
a O 0 1.3650219443661626e-05
few O 0 1.3642816156789195e-05
cases O 0 6.384135758707998e-06
of O 0 0.00045639247400686145
isolated O 1 0.9999995231628418
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 2.9911881938460283e-05
been O 0 3.606236714404076e-05
reported O 0 5.583937672781758e-05
( O 0 0.0001926800177898258
OMIM O 1 0.9996935129165649
201400 O 0 0.015815511345863342
) O 0 6.558267341461033e-05
, O 0 1.1865545275213663e-05
an O 0 7.1605114499107e-05
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.9999998807907104
has O 0 0.00015630008419975638
not O 0 6.831920018157689e-06
been O 0 1.3063341611996293e-05
described O 0 2.4563967599533498e-05
so O 0 8.160024663084187e-06
far O 0 3.514537456794642e-05
. O 0 4.150319000473246e-05

Recent O 0 0.0001910201390273869
studies O 0 4.3271968024782836e-05
in O 0 2.9204478778410703e-05
animal O 0 2.3018645151751116e-05
models O 0 7.027006631687982e-06
elucidated O 0 0.0005521472776308656
a O 0 1.0846660188690294e-05
central O 0 4.075147080584429e-05
role O 0 4.250170968589373e-05
of O 0 0.0003380834823474288
alpha O 0 0.009306402876973152
- O 0 0.006112896837294102
MSH O 1 0.9488245248794556
in O 0 1.838250318542123e-05
the O 0 1.44064042615355e-05
regulation O 0 1.5710869774920866e-05
of O 0 1.3212827070674393e-05
food O 0 1.7567308532306924e-05
intake O 0 1.3396895155892707e-05
by O 0 5.546805255107756e-07
activation O 0 1.4556979294866323e-05
of O 0 8.579815767006949e-05
the O 0 0.0005641806637868285
brain O 1 0.9803012013435364
melanocortin O 1 0.9956117272377014
- O 0 0.0011148115154355764
4 O 0 0.000231645317398943
- O 0 0.00018978781008627266
receptor O 0 5.032014814787544e-05
( O 0 8.8053013314493e-05
MC4 O 0 0.4510764181613922
- O 0 0.0010629664175212383
R O 0 0.0008207036298699677
; O 0 8.30755743663758e-06
refs O 0 0.0005912476917728782
3 O 0 0.0001827272353693843
- O 0 0.0001760237937560305
5 O 0 4.3812433432321995e-05
) O 0 2.11313204090402e-06
and O 0 7.837151088097016e-07
the O 0 1.2615485502465162e-05
linkage O 0 0.000489748374093324
of O 0 0.00025607869611121714
human O 0 0.0010166018037125468
obesity B-Disease 1 0.9999996423721313
to O 0 0.0003759872925002128
chromosome O 0 0.000559389591217041
2 O 0 0.00024176696024369448
in O 0 3.568972533685155e-05
close O 0 6.370132905431092e-05
proximity O 0 9.614457667339593e-05
to O 0 2.8416572604328394e-05
the O 0 0.0004467373655643314
POMC O 1 0.9832971096038818
locus O 0 0.0004526507400441915
, O 0 7.655701665498782e-06
led O 0 2.4004708393476903e-05
to O 0 3.856583589367801e-06
the O 0 1.53846249304479e-05
proposal O 0 5.634720309899421e-06
of O 0 1.089342276827665e-05
an O 0 8.962034371506888e-06
association O 0 5.089929618407041e-05
of O 0 0.0010199366370216012
POMC O 1 1.0
with O 0 0.00022745200840290636
human O 0 0.16206544637680054
obesity B-Disease 1 1.0
. O 0 0.0014919120585545897

The O 0 8.314722799696028e-05
dual O 0 7.779042789479718e-05
role O 0 9.781356493476778e-05
of O 0 0.0005973060033284128
alpha O 0 0.02107498049736023
- O 0 0.017707353457808495
MSH O 1 0.9997404217720032
in O 0 0.00010722239676397294
regulating O 0 0.0005119728157296777
food O 0 0.0001393506390741095
intake O 0 0.0005098354304209352
and O 0 8.343149238498881e-05
influencing O 0 0.0033600081223994493
hair O 0 0.008276057429611683
pigmentation O 0 0.008972360752522945
predicts O 0 0.0003914636909030378
that O 0 2.572528046584921e-06
the O 0 1.7313670468865894e-05
phenotype O 0 1.3625405699713156e-05
associated O 0 5.127597432874609e-06
with O 0 5.650605544360587e-06
a O 0 0.0002879643870983273
defect O 1 0.9998282194137573
in O 0 0.0014836284099146724
POMC O 1 0.9999996423721313
function O 0 0.00012702001549769193
would O 0 3.3692020224407315e-05
include O 0 0.00015540544700343162
obesity B-Disease 1 1.0
, O 0 8.553413499612361e-05
alteration O 0 0.05699745565652847
in O 0 0.005504891742020845
pigmentation O 1 0.9999998807907104
and O 1 0.9999873638153076
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.004629931412637234

The O 0 0.0004277849511709064
observation O 0 0.0005322567303664982
of O 0 0.0002704312209971249
these O 0 7.754290709272027e-05
symptoms O 0 0.005875364877283573
in O 0 0.0003018466813955456
two O 0 8.222635369747877e-05
probands O 0 0.004446407314389944
prompted O 0 6.026673145242967e-05
us O 0 7.856227057345677e-06
to O 0 1.562245529385109e-06
search O 0 3.885107616952155e-06
for O 0 1.7045862250597565e-06
mutations O 0 1.7103873688029125e-05
within O 0 5.697383312508464e-05
their O 0 0.00017899638623930514
POMC O 1 0.9999731779098511
genes O 0 0.00046977648162283003
. O 0 0.00017896463396027684

Patient O 0 0.0009942690376192331
1 O 0 0.0008019243250600994
was O 0 0.00045090532512404025
found O 0 8.342060027644038e-06
to O 0 5.040386440668954e-06
be O 0 4.744439138448797e-06
a O 0 1.5003527551016305e-05
compound O 0 0.0001876059250207618
heterozygote O 0 0.00017171489889733493
for O 0 3.8494777072628494e-06
two O 0 5.333311037247768e-06
mutations O 0 1.509775665908819e-05
in O 0 7.232810457935557e-05
exon O 0 0.0008067906019277871
3 O 0 0.00032754993299022317
( O 0 8.962402353063226e-05
G7013T O 0 0.0016223120037466288
, O 0 3.176984318997711e-05
C7133delta O 0 0.004537837114185095
) O 0 1.4104742149356753e-05
which O 0 1.991528733924497e-06
interfere O 0 5.966383469058201e-06
with O 0 6.104576755205926e-07
appropriate O 0 8.339100531884469e-06
synthesis O 0 0.0002846365387085825
of O 0 0.0018304467666894197
ACTH O 1 0.9981582760810852
and O 0 0.00039251858834177256
alpha O 0 0.008976579643785954
- O 0 0.008075937628746033
MSH O 1 0.9987074136734009
. O 0 0.00019056643941439688

Patient O 0 0.000942699087318033
2 O 0 0.0006485929479822516
was O 0 0.0003735085192602128
homozygous O 0 1.4080980690778233e-05
for O 0 2.7264311484032078e-06
a O 0 1.2193908332847059e-05
mutation O 0 6.258208941289922e-06
in O 0 3.063942858716473e-05
exon O 0 0.00036735410685651004
2 O 0 0.0003136257000733167
( O 0 7.60594557505101e-05
C3804A O 0 0.002395179821178317
) O 0 4.139622251386754e-05
which O 0 2.9325909054023214e-05
abolishes O 0 0.009437582455575466
POMC O 1 0.9998588562011719
translation O 0 0.0019057047320529819
. O 0 0.00034625257831066847

These O 0 1.6911688362597488e-05
findings O 0 8.680697646923363e-06
represent O 0 4.439491021912545e-06
the O 0 1.0353384823247325e-05
first O 0 6.556705557159148e-06
examples O 0 9.045271326613147e-06
of O 0 3.874632602673955e-05
a O 0 0.0003041002491954714
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 0.00179798633325845
the O 0 0.002554294653236866
POMC O 1 0.9999974966049194
gene O 0 4.342202373663895e-05
and O 0 2.5472854758845642e-06
define O 0 2.1923699023318477e-05
a O 0 3.804595326073468e-05
new O 0 0.00043548562098294497
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9999868869781494
in O 0 0.0446380190551281
early O 1 0.9999886751174927
- O 1 0.9999997615814209
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999542236328125
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999996423721313
red O 1 1.0
hair O 1 0.9991004467010498
pigmentation O 1 0.9656602144241333
. O 0 0.00028085315716452897
. O 0 0.00016206603322643787

A O 0 0.0007419399335049093
European O 0 3.937944711651653e-05
multicenter O 0 0.0018849828047677875
study O 0 3.841476427624002e-05
of O 0 0.0024284301325678825
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.0004846111114602536
classification O 0 0.0002771707659121603
of O 0 0.0004137497453484684
105 O 0 0.0013414070708677173
mutations O 0 4.549676668830216e-05
and O 0 3.4050349313474726e-06
a O 0 5.872080691915471e-06
general O 0 1.8566437574918382e-05
system O 0 4.94481973873917e-05
for O 0 8.250945938925724e-06
genotype O 0 0.00011919303506147116
- O 0 9.457438136450946e-05
based O 0 3.6451199321163585e-06
prediction O 0 8.112181239994243e-05
of O 0 0.000264987931586802
metabolic O 1 0.9998999834060669
phenotype O 0 0.003334221662953496
. O 0 0.0006429853965528309

Phenylketonuria B-Disease 1 0.9999997615814209
( O 0 0.025471894070506096
PKU B-Disease 1 1.0
) O 0 0.0002976588730234653
and O 0 5.896332731936127e-05
mild B-Disease 1 0.8006156086921692
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9999023675918579
MHP B-Disease 1 1.0
) O 0 0.00042199325980618596
are O 0 2.932378265541047e-05
allelic B-Disease 1 0.5947030186653137
disorders I-Disease 1 1.0
caused O 1 0.9996410608291626
by O 0 0.00010684039443731308
mutations O 0 3.353271313244477e-05
in O 0 1.1414993423386477e-05
the O 0 1.634531326999422e-05
gene O 0 8.369161150767468e-06
encoding O 0 3.8552534533664584e-05
phenylalanine O 0 0.001623755320906639
hydroxylase O 0 0.018147435039281845
( O 0 0.003246407490223646
PAH O 1 1.0
) O 0 0.0005635456182062626
. O 0 0.0001336021814495325

Previous O 0 0.0001424453075742349
studies O 0 1.3083637895761058e-05
have O 0 1.6592375686741434e-06
suggested O 0 6.556943390023662e-06
that O 0 4.0863173467187153e-07
the O 0 6.340299023577245e-06
highly O 0 5.843536200700328e-05
variable O 0 3.641597504611127e-05
metabolic O 1 0.9964638352394104
phenotypes O 1 0.5556001663208008
of O 1 1.0
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9997761845588684
with O 1 0.9983254075050354
PAH O 1 1.0
genotypes O 1 0.9985532164573669
. O 0 0.0010034091537818313

We O 0 7.307434134418145e-05
identified O 0 3.2987361919367686e-05
both O 0 1.4791673493164126e-05
causative O 0 0.0011951648630201817
mutations O 0 0.0001734455581754446
in O 0 0.00020840780052822083
686 O 0 0.01267471443861723
patients O 0 0.00010694598313421011
from O 0 4.54705732408911e-05
seven O 0 0.00013300729915499687
European O 0 6.066742571420036e-05
centers O 0 0.00018392760830465704
. O 0 9.290269372286275e-05

On O 0 0.00024543452309444547
the O 0 1.1061051736760419e-05
basis O 0 6.6078282543458045e-06
of O 0 1.344037718808977e-05
the O 0 1.8372831618762575e-05
phenotypic O 0 0.0001144135239883326
characteristics O 0 0.0001971370802493766
of O 0 0.0006069624796509743
297 O 0 0.010631735436618328
functionally O 0 0.409477561712265
hemizygous O 1 0.9563489556312561
patients O 0 0.00016834332200232893
, O 0 1.1110573723271955e-05
105 O 0 7.515118340961635e-05
of O 0 5.338782648323104e-05
the O 0 7.965477561810985e-05
mutations O 0 2.2997777705313638e-05
were O 0 9.90388525679009e-06
assigned O 0 1.9599165170802735e-05
to O 0 1.4432585885515437e-05
one O 0 7.0155761022761e-06
of O 0 3.742214175872505e-05
four O 0 3.5824894439429045e-05
arbitrary O 0 1.7640235455473885e-05
phenotype O 0 0.00011851055751321837
categories O 0 0.00022056511079426855
. O 0 0.0002460561227053404

We O 0 0.0001002469944069162
proposed O 0 4.8188961955020204e-05
and O 0 1.3822230357618537e-05
tested O 0 5.966885146335699e-05
a O 0 9.119005881075282e-06
simple O 0 9.467805284657516e-06
model O 0 3.6243154681869783e-06
for O 0 2.645339236551081e-06
correlation O 0 2.5538782210787758e-05
between O 0 0.00024314381880685687
genotype O 0 0.00019213624182157218
and O 0 1.029811301123118e-05
phenotypic O 0 0.0004241842543706298
outcome O 0 0.0014835888287052512
. O 0 0.0005657338770106435

The O 0 0.00031436601420864463
observed O 0 9.148239041678607e-05
phenotype O 0 0.00010521724470891058
matched O 0 6.829875201219693e-05
the O 0 3.328462116769515e-05
predicted O 0 0.00019156148482579738
phenotype O 0 1.7627722627366893e-05
in O 0 1.3561804735218175e-05
79 O 0 0.0001040918577928096
% O 0 1.6749047063058242e-05
of O 0 5.2581523050321266e-05
the O 0 0.0001653120998525992
cases O 0 4.4447715481510386e-05
, O 0 8.827813871903345e-06
and O 0 2.7966766538156662e-06
in O 0 8.313096259371378e-06
only O 0 5.822506409458583e-06
5 O 0 4.41779411630705e-05
of O 0 5.5234722822206095e-05
184 O 0 0.000651529582682997
patients O 0 9.284052066504955e-05
was O 0 0.0003926437930203974
the O 0 3.947239019908011e-05
observed O 0 2.734070221777074e-05
phenotype O 0 1.230197540280642e-05
more O 0 7.311294893952436e-07
than O 0 8.510118050253368e-07
one O 0 3.201545723641175e-06
category O 0 9.134776519204024e-06
away O 0 9.823010259424336e-06
from O 0 2.0919560483889654e-06
that O 0 1.4177414868754568e-06
expected O 0 8.988558693090454e-05
. O 0 0.00010617818043101579

Among O 0 7.898913463577628e-05
the O 0 3.288509469712153e-05
seven O 0 3.5958659282187e-05
contributing O 0 0.00010018192551797256
centers O 0 2.833057806128636e-05
, O 0 2.3521902221546043e-06
the O 0 7.301189270947361e-06
proportion O 0 2.9558052119682543e-05
of O 0 0.00010546838166192174
patients O 0 0.00011563384759938344
for O 0 3.5826669773086905e-05
whom O 0 0.0003001095028594136
the O 0 0.00014661515888292342
observed O 0 0.00013923694496043026
phenotype O 0 8.48349736770615e-05
did O 0 2.3802507712389342e-05
not O 0 1.3396231679507764e-06
match O 0 1.4256393114919774e-05
the O 0 1.2107418115192559e-05
predicted O 0 3.964073766837828e-05
phenotype O 0 1.138717016146984e-05
was O 0 8.008066652109846e-05
4 O 0 6.260367081267759e-05
% O 0 1.647552016947884e-05
- O 0 0.00016204964776989073
23 O 0 0.00022573400929104537
% O 0 3.7977293686708435e-05
( O 0 0.00013185702846385539
P O 0 0.008769520558416843
< O 0 0.0038133689668029547
. O 0 0.0001121901223086752
0001 O 0 0.035869818180799484
) O 0 2.5986704713432118e-05
, O 0 4.2885685616056435e-06
suggesting O 0 1.2551787222037092e-05
that O 0 7.204901066870661e-07
differences O 0 1.8764807464322075e-05
in O 0 9.830226190388203e-06
methods O 0 1.0330710210837424e-05
used O 0 2.4466989998472854e-05
for O 0 3.64936058758758e-05
mutation O 0 9.674992179498076e-05
detection O 0 0.000944558356422931
or O 0 0.00012077362043783069
phenotype O 0 0.0002188350772485137
classification O 0 0.00030636077281087637
may O 0 0.0001134357153205201
account O 0 1.137287836172618e-05
for O 0 4.367858764453558e-06
a O 0 1.1002327482856344e-05
considerable O 0 7.446158269885927e-05
proportion O 0 0.00016876727750059217
of O 0 0.00048215684364549816
genotype O 0 0.0037365402095019817
- O 0 0.00568107794970274
phenotype O 0 0.0003401047724764794
inconsistencies O 0 0.003664427436888218
. O 0 0.00027867822791449726

Our O 0 6.818558176746592e-05
data O 0 1.481849994888762e-05
indicate O 0 3.223918974981643e-05
that O 0 7.942134288896341e-06
the O 0 0.0008997507393360138
PAH O 1 1.0
- O 0 0.005125501658767462
mutation O 0 7.839065801817924e-06
genotype O 0 1.3753802704741247e-05
is O 0 9.668106031313073e-07
the O 0 4.811773578694556e-06
main O 0 9.545367356622592e-05
determinant O 0 0.00041504527325741947
of O 0 0.000338466779794544
metabolic O 1 0.9992883801460266
phenotype O 0 0.00022406785865314305
in O 0 5.3755757107865065e-05
most O 0 2.7247981051914394e-05
patients O 0 0.0015195878222584724
with O 1 0.9992666840553284
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9401427507400513

In O 0 7.503561209887266e-05
the O 0 2.132722693204414e-05
present O 0 1.7934367861016653e-05
study O 0 6.410216428776039e-06
, O 0 1.3469764326146105e-06
the O 0 4.914234523312189e-06
classification O 0 0.00013170008605811745
of O 0 0.0006625799578614533
105 O 1 0.9944581985473633
PAH O 1 1.0
mutations O 0 0.0005511261988431215
may O 0 6.799682887503877e-05
allow O 0 4.360504590295022e-06
the O 0 7.67835445003584e-06
prediction O 0 3.179263512720354e-05
of O 0 1.859145595517475e-05
the O 0 0.00014749659749213606
biochemical O 0 0.0011172142112627625
phenotype O 0 0.0002067368186544627
in O 0 0.00011041580000892282
> O 0 0.00044903584057465196
10 O 0 9.982021583709866e-05
, O 0 7.4783156378543936e-06
000 O 0 0.0003467864589765668
genotypes O 0 0.0004429141408763826
, O 0 5.440783297672169e-06
which O 0 2.8627653136936715e-06
may O 0 1.1824630746559706e-05
be O 0 1.3273651120471186e-06
useful O 0 1.3438137784760329e-06
for O 0 9.61847263170057e-07
the O 0 1.3706833669857588e-05
management O 0 0.00012191529822302982
of O 0 0.0004755584232043475
hyperphenylalaninemia B-Disease 1 1.0
in O 0 0.0023028641007840633
newborns O 0 0.004992970731109381
. O 0 0.0002970185305457562

Somatic O 0 0.0039840200915932655
instability O 0 0.006270211655646563
of O 0 0.001122243469581008
the O 0 0.005901381839066744
CTG O 1 0.9999955892562866
repeat O 0 0.0026308305095881224
in O 0 7.492506119888276e-05
mice O 0 0.00014150497736409307
transgenic O 0 9.21787359402515e-05
for O 0 8.344789421244059e-06
the O 0 0.0023993272334337234
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9981805086135864
is O 0 0.00033143311156891286
age O 0 0.0006489441730082035
dependent O 0 4.727704435936175e-05
but O 0 1.261119336959382e-06
not O 0 5.056993472862814e-07
correlated O 0 6.766733349650167e-06
to O 0 1.4276431556936586e-06
the O 0 1.1032103429897688e-05
relative O 0 5.406333366408944e-05
intertissue O 0 0.0034940571058541536
transcription O 0 0.0016308623598888516
levels O 0 0.0013392356922850013
and O 0 0.00013522982771974057
proliferative O 1 0.9999597072601318
capacities O 0 0.027821902185678482
. O 0 0.0005298730684444308

A O 0 0.011513318866491318
( O 0 0.0012246130499988794
CTG O 1 0.9865663647651672
) O 0 0.00012824607256334275
nexpansion O 0 0.0012488883221521974
in O 0 2.1264129827613942e-05
the O 0 4.1928764403564855e-05
3 O 0 0.0003037212591152638
- O 0 0.0004296538245398551
untranslated O 0 0.006521254312247038
region O 0 0.0009440972353331745
( O 0 0.00013303026207722723
UTR O 0 0.04747404530644417
) O 0 1.035463901644107e-05
of O 0 1.5559853636659682e-05
the O 0 0.00016429193783551455
DM O 1 0.9999998807907104
protein O 0 0.0002818394568748772
kinase O 0 5.177323328098282e-05
gene O 0 4.612602788256481e-05
( O 0 4.93410334456712e-05
DMPK O 1 0.8712510466575623
) O 0 1.3894787116441876e-05
is O 0 1.8954540337290382e-06
responsible O 0 1.3635609320772346e-05
for O 0 0.00016084614617284387
causing O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.0022877193987369537
. O 0 0.0003674287290778011

Major O 0 0.014596343971788883
instability O 0 0.028711160644888878
, O 0 2.5158222342724912e-05
with O 0 3.008148496519425e-06
very O 0 5.406289801612729e-06
large O 0 2.4026807295740582e-05
expansions O 0 0.0005932098720222712
between O 0 0.0002064504224108532
generations O 0 0.0001999225205508992
and O 0 6.6005541157210246e-06
high O 0 9.5507682999596e-05
levels O 0 0.00017857873172033578
of O 0 0.0002823981049004942
somatic O 0 0.003408854827284813
mosaicism O 1 0.9889125823974609
, O 0 3.725244096131064e-05
is O 0 7.488207302230876e-06
observed O 0 3.7880650779698044e-05
in O 0 5.924186189076863e-05
patients O 0 0.0001538644719403237
. O 0 0.00017281723557971418

There O 0 0.00011887862638104707
is O 0 8.273615094367415e-06
a O 0 8.671265277371276e-06
good O 0 1.5380222976091318e-05
correlation O 0 1.219465320900781e-05
between O 0 0.00021111500973347574
repeat O 0 0.0014215396950021386
size O 0 7.562472455902025e-05
( O 0 1.446094029233791e-05
at O 0 7.145989366108552e-05
least O 0 7.5157158789807e-06
in O 0 3.8346348446793854e-05
leucocytes O 0 0.00744118494912982
) O 0 2.5451736291870475e-05
, O 0 3.7988793337717652e-06
clinical O 0 9.769461757969111e-05
severity O 0 0.0010122088715434074
and O 0 8.423144754488021e-05
age O 0 0.0014303765492513776
of O 0 0.005123767536133528
onset O 1 1.0
. O 0 0.0057955714873969555

The O 0 0.0022301417775452137
trinucleotide O 1 0.9999974966049194
repeat O 0 0.009855815209448338
instability O 0 0.0075643653981387615
mechanisms O 0 0.0004536135820671916
involved O 0 8.562970469938591e-05
in O 0 0.0009317903313785791
DM B-Disease 1 1.0
and O 0 0.00011349836131557822
other O 0 3.7548899854300544e-05
human O 0 0.0022176122292876244
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 0.00010549513535806909
unknown O 0 0.0020198712591081858
. O 0 0.0002388879074715078

We O 0 8.775184687692672e-05
studied O 0 0.0004575352359097451
somatic O 0 0.00062340940348804
instability O 0 0.0015118637820705771
by O 0 3.759462197194807e-05
measuring O 0 0.0034418979194015265
the O 0 0.001273521687835455
CTG O 1 0.9996626377105713
repeat O 0 0.002113558351993561
length O 0 7.41606272640638e-05
at O 0 5.961316855973564e-05
several O 0 5.789549959445139e-06
ages O 0 9.380276605952531e-05
in O 0 1.9335508113726974e-05
various O 0 5.8356334193376824e-05
tissues O 0 0.0004126626008655876
of O 0 0.000433236884418875
transgenic O 0 0.008215122856199741
mice O 0 0.0004364404594525695
carrying O 0 3.8806931115686893e-05
a O 0 6.798846152378246e-05
( O 0 0.00024127168580889702
CTG O 1 0.9957925081253052
) O 0 0.00012199948832858354
55expansion O 0 0.0038964508567005396
surrounded O 0 0.0006282407557591796
by O 0 3.1603831303073093e-06
45 O 0 2.2782065570936538e-05
kb O 0 0.0010902470676228404
of O 0 0.00023597398831043392
the O 0 0.0008078268729150295
human O 0 0.0019791072700172663
DM B-Disease 1 1.0
region O 0 0.0027924480382353067
, O 0 1.5937775970087387e-05
using O 0 8.296947271446697e-06
small O 0 5.304714431986213e-05
- O 0 0.0006059073493815958
pool O 0 0.000588951981626451
PCR O 0 0.0003688792639877647
. O 0 5.618486102321185e-05

These O 0 0.0001563766854815185
mice O 0 0.00024020344426389784
have O 0 1.3143703654350247e-06
been O 0 3.5040543480135966e-06
shown O 0 8.404785148741212e-06
to O 0 9.098574082599953e-06
reproduce O 0 9.124767530011013e-05
the O 0 2.8019625460729003e-05
intergenerational O 0 0.000380855577532202
and O 0 2.3640785002498887e-05
somatic O 0 0.0004103138926438987
instability O 0 0.001629766309633851
of O 0 0.0005415680352598429
the O 0 0.0013883343199267983
55 O 0 0.0037487405352294445
CTG O 1 0.9995825886726379
repeat O 0 0.0016283130971714854
suggesting O 0 6.063884939067066e-05
that O 0 1.1374072528269608e-06
surrounding O 0 5.784219320048578e-05
sequences O 0 1.204417185363127e-05
and O 0 3.7639781567122554e-06
the O 0 3.20068902510684e-05
chromatin O 0 0.0005509497714228928
environment O 0 1.988484109460842e-05
are O 0 4.861904017161578e-07
involved O 0 8.016021638468374e-06
in O 0 0.00011958432878600433
instability O 1 0.9778748154640198
mechanisms O 0 0.012679369188845158
. O 0 0.0005477449740283191

As O 0 0.00014838020433671772
observed O 0 2.7645832233247347e-05
in O 0 5.772305485152174e-06
some O 0 1.6633663335596793e-06
of O 0 3.839721830445342e-05
the O 0 0.0004065672983415425
tissues O 0 0.0030994287226349115
of O 0 0.014607005752623081
DM B-Disease 1 1.0
patients O 0 0.010066205635666847
, O 0 4.138027725275606e-05
there O 0 1.2266150406503584e-05
is O 0 5.436913852463476e-06
a O 0 1.1241453648835886e-05
tendency O 0 4.063722008140758e-05
for O 0 1.7943224520422518e-05
repeat O 0 0.0011740749469026923
length O 0 0.00015208535478450358
and O 0 4.2427524022059515e-05
somatic O 0 0.0007372426334768534
mosaicism O 0 0.01502291765064001
to O 0 3.939533780794591e-05
increase O 0 1.7101523553719744e-05
with O 0 3.6517621992970817e-06
the O 0 7.177267252700403e-05
age O 0 0.00022894676658324897
of O 0 0.00020624777243938297
the O 0 0.0005560705903917551
mouse O 0 0.0008558720583096147
. O 0 9.067051723832265e-05

Furthermore O 0 0.0015582117484882474
, O 0 2.2470489057013765e-05
we O 0 5.457402039610315e-06
observed O 0 7.458785603375873e-06
no O 0 3.4854836030717706e-06
correlation O 0 6.5838685259222984e-06
between O 0 7.334662950597703e-05
the O 0 0.0001663573202677071
somatic O 0 0.0005296755698509514
mutation O 0 3.801258935709484e-05
rate O 0 0.00013789675722364336
and O 0 0.00012496756971813738
tissue O 1 0.9645397663116455
proliferation O 1 0.9999788999557495
capacity O 0 0.02706637606024742
. O 0 0.00040172666194848716

The O 0 0.0009198503685183823
somatic O 0 0.0012478253338485956
mutation O 0 3.014762478414923e-05
rates O 0 2.3283933842321858e-05
in O 0 8.559853085898794e-06
different O 0 2.208069190601236e-06
tissues O 0 7.933834422146901e-05
were O 0 1.7897460566018708e-05
also O 0 4.56757697975263e-06
not O 0 1.0572985047474504e-06
correlated O 0 8.160856850736309e-06
to O 0 3.4736006000457564e-06
the O 0 2.9416492907330394e-05
relative O 0 0.0002503528376109898
inter O 0 0.37070873379707336
- O 0 0.008433219976723194
tissue O 0 0.0004258661065250635
difference O 0 3.7364588933996856e-05
in O 0 1.2015833817713428e-05
transcriptional O 0 5.3305309847928584e-05
levels O 0 3.82804028049577e-05
of O 0 9.149633115157485e-06
the O 0 1.5701209122198634e-05
three O 0 1.2057986168656498e-05
genes O 0 2.5366272893734276e-05
( O 0 7.846497464925051e-05
DMAHP O 1 0.9952285289764404
, O 0 0.00010120402293978259
DMPK O 1 0.9137701988220215
and O 0 4.3473275582073256e-05
59 O 0 0.0003075101994909346
) O 0 4.5750766730634496e-05
surrounding O 0 0.0004867551033385098
the O 0 0.00015644857194274664
repeat O 0 0.002532387850806117
. O 0 8.346141112269834e-05
. O 0 8.067245653364807e-05

A O 0 0.0034098592586815357
novel O 0 0.0007025249069556594
missense O 0 0.0010949381394311786
mutation O 0 6.18931808276102e-05
in O 0 9.150734695140272e-05
patients O 0 0.00016989184950944036
from O 0 0.00022880054893903434
a O 0 0.0006643364322371781
retinoblastoma B-Disease 1 0.9980872273445129
pedigree O 0 0.0023877909407019615
showing O 0 0.00030626790248788893
only O 0 2.5422556063858792e-05
mild O 0 0.00019461540796328336
expression O 0 5.09986057295464e-05
of O 0 0.0003251300659030676
the O 0 0.0035141403786838055
tumor B-Disease 1 0.9999998807907104
phenotype O 0 0.0009762583649717271
. O 0 0.00025841433671303093

We O 0 0.00010906203533522785
have O 0 5.273972419672646e-06
used O 0 1.700475695542991e-05
single O 0 3.63323742931243e-05
strand O 0 9.559669706504792e-05
conformation O 0 1.013122709991876e-05
polymorphism O 0 2.1823402676091064e-06
analysis O 0 3.4006239957307116e-07
to O 0 2.3514814984082477e-06
study O 0 5.162966772331856e-06
the O 0 3.0445155061897822e-05
27 O 0 0.00042155239498242736
exons O 0 0.0006047235219739377
of O 0 0.0002763230004347861
the O 0 0.00169611896853894
RB1 O 1 0.9999672174453735
gene O 0 7.358313450822607e-05
in O 0 1.590478132129647e-05
individuals O 0 2.088879909933894e-06
from O 0 4.42508899141103e-05
a O 0 7.051871943986043e-05
family O 0 7.634866778971627e-05
showing O 0 0.0002698586613405496
mild O 0 0.000539831758942455
expression O 0 0.00013587622379418463
of O 0 0.0006015509134158492
the O 0 0.002762972144410014
retinoblastoma B-Disease 1 0.9997848868370056
phenotype O 0 0.0014543383149430156
. O 0 0.0003937545989174396

In O 0 0.00012875629181507975
this O 0 7.4737099566846155e-06
family O 0 1.4188914065016434e-05
affected O 0 1.0060490239993669e-05
individuals O 0 3.447325070737861e-06
developed O 0 0.0012425149325281382
unilateral B-Disease 0 0.08593561500310898
tumors I-Disease 1 1.0
and O 0 0.00040902275941334665
, O 0 2.619203951326199e-05
as O 0 1.5778830857016146e-05
a O 0 8.526498277205974e-06
result O 0 1.4622637536376715e-05
of O 0 0.00012654006422962993
linkage O 0 0.0017064022831618786
analysis O 0 3.385282616363838e-05
, O 0 2.9268017897265963e-05
unaffected O 0 0.0004752199456561357
mutation O 0 1.6162361134774983e-05
carriers O 0 9.591436537448317e-06
were O 0 6.684207619400695e-06
also O 0 4.7022458602441475e-06
identified O 0 1.1384032404748723e-05
within O 0 1.5479694411624223e-05
the O 0 0.00010143242980120704
pedigree O 0 0.00156144960783422
. O 0 0.00021553266560658813

A O 0 0.0022504718508571386
single O 0 7.820367318345234e-05
band O 0 0.0003980362380389124
shift O 0 0.00013289130583871156
using O 0 3.70305024262052e-05
SSCP O 1 0.7328096032142639
was O 0 0.0004401348123792559
identified O 0 3.1185489206109196e-05
in O 0 2.455050162097905e-05
exon O 0 0.0002949588233605027
21 O 0 0.00011723885836545378
which O 0 3.968272267229622e-06
resulted O 0 9.456022235099226e-05
in O 0 1.944838913914282e-05
a O 0 3.489616574370302e-05
missense O 0 0.0002957955002784729
mutation O 0 1.3473487342707813e-05
converting O 0 0.00032406492391601205
a O 0 0.00042042508721351624
cys O 1 0.9895568490028381
- O 0 0.005415979772806168
- O 0 0.0012505464255809784
> O 0 0.00032422805088572204
arg O 0 0.00015308331057894975
at O 0 0.00011742481729015708
nucleotide O 0 4.7972454922273755e-05
position O 0 4.8298916226485744e-05
28 O 0 0.00030705786775797606
in O 0 5.794763637823053e-05
the O 0 0.00021426985040307045
exon O 0 0.003181928303092718
. O 0 0.00013907928951084614

The O 0 0.0005999957793392241
mutation O 0 9.407787001691759e-05
destroyed O 0 0.0033629140816628933
an O 0 3.698977525345981e-05
NdeI O 0 0.012545522302389145
restriction O 0 9.4254755822476e-05
enzyme O 0 7.757204730296507e-05
site O 0 0.0006812833598814905
. O 0 9.372730710310861e-05

Analysis O 0 2.3910530217108317e-05
of O 0 7.067908882163465e-05
all O 0 2.694307841011323e-05
family O 0 1.5067178537719883e-05
members O 0 2.8314943847362883e-06
demonstrated O 0 6.753760681021959e-05
that O 0 2.0854981812590268e-06
the O 0 4.019165498903021e-05
missense O 0 0.0011246148496866226
mutation O 0 0.00010397550067864358
co O 0 0.00077840342419222
- O 0 0.0004889865522272885
segregated O 0 0.00022690593323204666
with O 0 1.1225310117879417e-05
patients O 0 0.0002917622623499483
with O 0 0.001437522005289793
tumors B-Disease 1 1.0
or O 0 0.022775450721383095
who O 0 0.00023039928055368364
, O 0 2.4441571440547705e-05
as O 0 1.8521202946431004e-05
a O 0 1.3963731362309773e-05
result O 0 2.4075272449408658e-05
of O 0 0.00012709744623862207
linkage O 0 0.0008621762972325087
analysis O 0 9.75252714852104e-06
had O 0 4.9803886213339865e-05
been O 0 2.4408191166003235e-05
predicted O 0 3.2422143704025075e-05
to O 0 5.033421075495426e-06
carry O 0 1.228464680025354e-05
the O 0 6.562571070389822e-05
predisposing O 0 0.002733977511525154
mutation O 0 9.461487934459001e-05
. O 0 0.00015113933477550745

These O 0 2.6359928597230464e-05
observations O 0 3.139712134725414e-05
point O 0 6.783710705349222e-05
to O 0 3.771822548515047e-06
another O 0 7.347611699515255e-06
region O 0 7.351951353484765e-05
of O 0 6.545134237967432e-05
the O 0 0.0007863160572014749
RB1 O 1 0.9999960660934448
gene O 0 8.688156231073663e-05
where O 0 3.754227509489283e-05
mutations O 0 6.495620255009271e-06
only O 0 1.9713772871909896e-06
modify O 0 1.012413758871844e-05
the O 0 1.1144690688524861e-05
function O 0 1.25250135170063e-05
of O 0 7.31712716515176e-05
the O 0 0.00017430668231099844
gene O 0 6.267534627113491e-05
and O 0 8.22228321339935e-06
raise O 0 2.0488219888648018e-05
important O 0 1.5113904737518169e-05
questions O 0 4.310344593250193e-06
for O 0 2.25898793360102e-06
genetic O 0 6.0205900808796287e-05
counseling O 0 5.9508838603505865e-05
in O 0 3.3069823984988034e-05
families O 0 4.730582077172585e-06
with O 0 3.7479671846085694e-06
these O 0 2.0521521946648136e-05
distinctive O 0 0.0004692533111665398
phenotypes O 0 0.0013099168427288532
. O 0 0.00014398254279512912
. O 0 0.00014759112673345953

Maternal B-Disease 0 0.02245756983757019
disomy I-Disease 1 0.9999589920043945
and O 0 0.047454833984375
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.01483688224107027
with O 0 0.00039444532012566924
gamete O 0 0.41730955243110657
complementation O 0 0.04837954416871071
in O 0 0.0001188279566122219
a O 0 4.3105326767545193e-05
case O 0 3.3193300623679534e-05
of O 0 0.00013959921489004046
familial O 0 0.01235532108694315
translocation O 0 0.04898304492235184
( O 0 0.000441935466369614
3 O 0 0.0007221292471513152
; O 0 1.44718105730135e-05
15 O 0 0.00011839918443001807
) O 0 2.6598279873724096e-05
( O 0 3.505115455482155e-05
p25 O 0 0.0023700206074863672
; O 0 1.1240221283514984e-05
q11 O 0 0.0007970089791342616
. O 0 1.8561513570602983e-05
2 O 0 0.0002521355345379561
) O 0 5.800778671982698e-05
. O 0 9.496260463492945e-05

Maternal B-Disease 1 0.968169093132019
uniparental I-Disease 1 0.9999996423721313
disomy I-Disease 1 0.9999991655349731
( I-Disease 0 0.017463769763708115
UPD I-Disease 1 1.0
) I-Disease 0 0.00020119726832490414
for I-Disease 0 4.461282514967024e-05
chromosome I-Disease 0 0.0003927307843696326
15 I-Disease 0 0.0001164226996479556
is O 0 6.296216270129662e-06
responsible O 0 7.178987289080396e-06
for O 0 1.8806460957421223e-06
an O 0 3.250809186283732e-06
estimated O 0 5.148844138602726e-05
30 O 0 2.4387574740103446e-05
% O 0 1.2608596762220259e-06
of O 0 6.955911430850392e-06
cases O 0 1.5527097275480628e-05
of O 0 0.00323472055606544
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999998807907104
PWS B-Disease 1 1.0
) O 0 0.003983698319643736
. O 0 0.0004567167197819799

We O 0 0.00010558852955000475
report O 0 1.213813629874494e-05
on O 0 1.6713882359908894e-05
an O 0 1.9806075215456076e-06
unusual O 0 1.2864938071288634e-05
case O 0 2.3644461180083454e-05
of O 0 0.0001944809191627428
maternal B-Disease 0 0.00467674108222127
disomy I-Disease 1 0.9836606383323669
15 I-Disease 0 0.0028069959953427315
in O 0 0.0010052109137177467
PWS B-Disease 1 1.0
that O 0 1.5197330867522396e-05
is O 0 2.9435216220008442e-06
most O 0 9.410744041815633e-07
consistent O 0 5.500152838067152e-06
with O 0 1.8585338921184302e-06
adjacent O 0 0.0006730782333761454
- O 0 0.0003959743771702051
1 O 0 0.00023833822342567146
segregation O 0 0.0006101928884163499
of O 0 6.227813719306141e-05
a O 0 5.6567907449789345e-05
paternal O 0 0.0006239796639420092
t O 0 0.0005034190835431218
( O 0 3.3942076697712764e-05
3 O 0 0.00010188590385951102
; O 0 6.241728442546446e-06
15 O 0 9.624924859963357e-05
) O 0 2.4472965378663503e-05
( O 0 4.442339195520617e-05
p25 O 0 0.002404505154117942
; O 0 1.0745145118562505e-05
q11 O 0 0.0005272175185382366
. O 0 7.386985089397058e-06
2 O 0 4.59889488411136e-05
) O 0 2.114845983669511e-06
with O 0 7.245182018777996e-07
simultaneous O 0 5.3465624660020694e-05
maternal O 0 0.0015801633708178997
meiotic O 0 0.36027202010154724
nondisjunction O 1 0.8790860176086426
for O 0 0.00040654343320056796
chromosome O 0 0.0028876648284494877
15 O 0 0.0013633702183142304
. O 0 0.0004509208374656737

The O 0 0.000586291600484401
patient O 0 0.00045757429325021803
( O 0 0.00015527095820289105
J O 0 0.016124017536640167
. O 0 6.707983266096562e-05
B O 0 0.0007341186283156276
. O 0 7.857763193896972e-06
) O 0 2.353431000301498e-06
, O 0 1.1110847708550864e-06
a O 0 8.668718692206312e-06
17 O 0 0.00035481146187521517
- O 0 0.0004907870315946639
year O 0 0.0001871633721748367
- O 0 0.0005042595439590514
old O 0 0.0003292078908998519
white O 0 0.00010238748654955998
male O 0 0.00010565400589257479
with O 0 0.00010366997594246641
PWS B-Disease 1 1.0
, O 0 0.0002319038612768054
was O 0 0.0004960841033607721
found O 0 9.409718586539384e-06
to O 0 6.084430879127467e-06
have O 0 3.119580696875346e-06
47 O 0 5.08822085976135e-05
chromosomes O 0 1.6374613551306538e-05
with O 0 3.6474636999628274e-06
a O 0 8.382767555303872e-05
supernumerary O 0 0.018079232424497604
, O 0 0.00012309876910876483
paternal O 0 0.002499713795259595
der O 1 0.999833345413208
( O 0 0.0003679651999846101
15 O 0 0.0003126122464891523
) O 0 1.1609290595515631e-05
consisting O 0 2.229817800980527e-05
of O 0 0.00010167247819481418
the O 0 0.00028413059771992266
short O 0 0.0005806188564747572
arm O 0 0.0006866290350444615
and O 0 2.005257374548819e-05
the O 0 0.00024800674873404205
proximal O 1 0.9998900890350342
long O 0 0.005375422537326813
arm O 0 0.0011628185166046023
of O 0 0.0007797657162882388
chromosome O 0 0.0032026630360633135
15 O 0 0.0009250075090676546
, O 0 7.203350105555728e-05
and O 0 9.692963067209348e-05
distal O 1 0.9999973773956299
chromosome O 1 0.9999485015869141
arm O 1 0.9999101161956787
3p O 1 0.9999957084655762
. O 0 0.0025533277075737715

The O 0 0.0011130361817777157
t O 0 0.0009550365502946079
( O 0 3.533043491188437e-05
3 O 0 0.00015089221415109932
; O 0 6.3171460169542115e-06
15 O 0 7.291731162695214e-05
) O 0 1.1601078767853323e-05
was O 0 6.167589890537784e-05
present O 0 1.2791707376891281e-05
in O 0 9.093038897844963e-06
the O 0 1.2417806829034816e-05
balanced O 0 8.457902367808856e-06
state O 0 1.9456067548162537e-06
in O 0 6.28441648586886e-06
the O 0 4.739938594866544e-05
patients O 0 7.673668733332306e-05
father O 0 0.00025684869615361094
and O 0 2.1523335817619227e-05
a O 0 0.00019868691742885858
sister O 0 0.001325902296230197
. O 0 0.00021975756681058556

Fluorescent O 0 0.0010627591982483864
in O 0 8.434438495896757e-05
situ O 0 0.00212979968637228
hybridization O 0 8.695139513292816e-06
analysis O 0 1.5675391296099406e-06
demonstrated O 0 7.391253166133538e-05
that O 0 3.8887733353476506e-06
the O 0 0.00019146544218529016
PWS B-Disease 1 1.0
critical O 0 0.0008950351038947701
region O 0 0.00040769067709334195
resided O 0 0.0006976795848459005
on O 0 5.7797631598077714e-05
the O 0 2.1133713744347915e-05
derivative O 0 0.0001402825437253341
chromosome O 0 0.00024622390628792346
3 O 0 0.0001475632598157972
and O 0 6.182886863825843e-06
that O 0 2.102155576721998e-06
there O 0 1.0236104571959004e-05
was O 0 0.00014380102220457047
no O 0 1.576610520714894e-05
deletion O 0 0.00022253788483794779
of O 0 0.0005122263683006167
the O 0 0.004606333095580339
PWS B-Disease 1 1.0
region O 0 0.005531509406864643
on O 0 0.00043045615893788636
the O 0 0.00012719625374302268
normal O 0 0.00010740260040620342
pair O 0 3.302926052128896e-05
of O 0 7.591655594296753e-05
15s O 0 0.00368095631711185
present O 0 0.00035817016032524407
in O 0 0.0005617914139293134
J O 1 0.9975962042808533
. O 0 0.0007037816103547812

B O 0 0.060740500688552856
. O 0 0.000779788417275995

Methylation O 0 7.970735168782994e-05
analysis O 0 1.0648073839547578e-05
at O 0 0.0002259833854623139
exon O 0 0.0003044565091840923
alpha O 0 4.4338536099530756e-05
of O 0 1.6080248315120116e-05
the O 0 2.172821041313e-05
small O 0 4.883197834715247e-05
nuclear O 0 0.0036066945176571608
ribonucleoprotein O 0 0.030665695667266846
- O 0 0.0003587574465200305
associated O 0 2.1109039153088816e-05
polypeptide O 0 0.0005396450287662446
N O 0 0.002766476245597005
( O 0 0.0002779318601824343
SNRPN O 1 0.9995998740196228
) O 0 7.361688767559826e-05
gene O 0 2.3919947125250474e-05
showed O 0 4.397819429868832e-05
a O 0 2.059015241684392e-05
pattern O 0 0.00010800566815305501
characteristic O 0 4.580857421387918e-05
of O 0 9.419833804713562e-05
only O 0 2.3856322513893247e-05
the O 0 0.00011290423572063446
maternal O 0 0.000706150138285011
chromosome O 0 0.000477589521324262
15 O 0 0.00037971424171701074
in O 0 0.0003474272962193936
J O 1 0.9679507613182068
. O 0 0.000498890527524054

B O 0 0.0603097602725029
. O 0 0.0007928197737783194

Maternal B-Disease 0 0.012744840234518051
disomy I-Disease 0 0.020426969975233078
was O 0 0.0004569964949041605
confirmed O 0 1.644814074097667e-05
by O 0 3.5110190310660983e-06
polymerase O 0 0.0002717485767789185
chain O 0 3.264857878093608e-05
reaction O 0 2.288979885634035e-06
analysis O 0 2.7981946004729252e-06
of O 0 8.014714694581926e-05
microsatellite O 0 0.0035460800863802433
repeats O 0 0.0008346756803803146
at O 0 0.0002855821803677827
the O 0 0.0001300291041843593
gamma O 0 0.0004177463997621089
- O 0 0.0004302597953937948
aminobutyric O 0 0.0012901328736916184
acid O 0 5.1384948164923117e-05
receptor O 0 4.2073683289345354e-05
beta3 O 0 0.0012231592554599047
subunit O 0 4.706705658463761e-05
( O 0 6.926726928213611e-05
GABRB3 O 1 0.7065280079841614
) O 0 8.397721103392541e-05
locus O 0 0.0002894601202569902
. O 0 0.0001124426707974635

A O 0 0.006513164844363928
niece O 0 0.004689378663897514
( O 0 0.00013709894847124815
B O 0 0.001453230855986476
. O 0 2.2342963347909972e-05
B O 0 0.0003288791631348431
. O 0 3.341227284181514e-06
) O 0 1.0584708434180357e-06
with O 0 8.323904694407247e-07
45 O 0 3.1461113394470885e-05
chromosomes O 0 2.986325489473529e-05
and O 0 2.8976603516639443e-06
the O 0 1.9905655790353194e-05
derivative O 0 5.977781256660819e-05
3 O 0 9.598216274753213e-05
but O 0 3.4077279451594222e-06
without O 0 5.373296062316513e-06
the O 0 0.00010829773236764595
der O 1 0.9942487478256226
( O 0 0.0002800715737976134
15 O 0 0.0004740178701467812
) O 0 4.94580963277258e-05
demonstrated O 0 0.00011002555402228609
a O 0 3.6526300391415134e-05
phenotype O 0 4.2896361264865845e-05
consistent O 0 1.3258419130579568e-05
with O 0 1.0754388313216623e-06
that O 0 1.1685160643537529e-06
reported O 0 1.1404949873394798e-05
for O 0 1.0840434697456658e-05
haploinsufficiency O 0 0.005191056989133358
of O 0 0.0011247466318309307
distal O 1 0.9963505268096924
3 O 0 0.24391049146652222
p O 0 0.008090450428426266
. O 0 0.00042933059739880264

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 0.00047445655218325555
with O 0 3.8302678149193525e-05
unbalanced O 0 0.003819311037659645
segregation O 0 0.020774057134985924
of O 0 0.001769447815604508
non O 1 0.9265261888504028
- O 0 0.4262407124042511
Robertsonian O 1 0.5142897963523865
translocations O 0 0.000636034703347832
has O 0 7.0457017500302754e-06
been O 0 8.483494639222044e-06
reported O 0 1.024670109472936e-05
previously O 0 1.4708401067764498e-05
but O 0 1.2509177622632706e-06
has O 0 1.7257750641874736e-06
not O 0 7.564826773887035e-07
, O 0 9.864623962130281e-07
to O 0 2.560383563832147e-06
our O 0 1.0094463505083695e-05
knowledge O 0 6.0976508393650874e-05
, O 0 6.578972715942655e-06
been O 0 7.461382665496785e-06
observed O 0 5.3430244406627025e-06
in O 0 7.329164873226546e-06
a O 0 1.758256257744506e-05
case O 0 9.105835488298908e-05
of O 0 0.0016548437997698784
PWS B-Disease 1 1.0
. O 0 0.00418042903766036

Furthermore O 0 0.0024913065135478973
, O 0 2.8943959478056058e-05
our O 0 1.1852020179503597e-05
findings O 0 5.602078999800142e-06
are O 0 5.485634915203264e-07
best O 0 6.58207909509656e-06
interpreted O 0 1.2714839613181539e-05
as O 0 1.3824339475831948e-05
true O 0 0.00016308606427628547
gamete O 0 0.0034605907276272774
complementation O 0 0.006520765833556652
resulting O 0 0.0007984441472217441
in O 0 0.0008283427450805902
maternal B-Disease 1 0.9954381585121155
UPD I-Disease 1 1.0
15 I-Disease 0 0.029967425391077995
and O 0 0.0031711433548480272
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9902915358543396
- I-Disease 1 0.9996596574783325
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
type I-Disease 0 0.0020398420747369528
2 I-Disease 0 0.008212178945541382
and O 0 0.0004411397676449269
Stuve B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Wiedemann I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
: O 0 0.00010408193338662386
a O 0 3.559424658305943e-05
case O 0 2.9283541152835824e-05
for O 0 1.2128265552746598e-05
" O 0 0.0004173901106696576
lumping O 0 0.0016372933750972152
" O 0 0.000980838667601347
. O 0 0.00013365494669415057

Recent O 0 9.675693581812084e-05
studies O 0 2.9179505872889422e-05
demonstrated O 0 0.0001470160932512954
the O 0 2.55374179687351e-05
existence O 0 0.00015012056974228472
of O 0 4.1069546568905935e-05
a O 0 4.651474955608137e-05
genetically O 0 5.3925243264529854e-05
distinct O 0 1.1239159903198015e-05
, O 0 5.295119080983568e-06
usually O 0 4.249103312758962e-06
lethal O 0 1.2345211871434003e-05
form O 0 2.0699462766060606e-06
of O 0 2.9865846954635344e-05
the O 0 0.00022620888194069266
Schwartz B-Disease 1 0.8943886756896973
- I-Disease 1 0.9997690320014954
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.008342900313436985
SJS B-Disease 1 1.0
) O 0 0.00022675302170682698
of O 0 0.0016799611039459705
myotonia B-Disease 1 1.0
and O 1 0.9736959934234619
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.000779025605879724
which O 0 8.067115413723513e-05
we O 0 4.979647565050982e-05
called O 0 0.00030971423257142305
SJS B-Disease 1 0.9999743700027466
type I-Disease 0 0.0008606734336353838
2 I-Disease 0 0.001631915452890098
. O 0 0.0001611925254110247

This O 0 0.0004735116090159863
disorder O 1 0.9999998807907104
is O 0 0.00034421219606883824
reminiscent O 0 0.010621247813105583
of O 0 0.0004148447187617421
another O 0 0.00015358917880803347
rare O 0 0.00030476434039883316
condition O 0 0.0005162538145668805
, O 0 1.064746447809739e-05
the O 0 0.00019567487470339984
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.08023393154144287
SWS B-Disease 1 0.9999990463256836
) O 0 8.626356429886073e-05
, O 0 3.272630237916019e-06
which O 0 1.2475830999392201e-06
comprises O 0 5.8242476370651275e-05
campomelia B-Disease 0 0.0045662978664040565
at O 0 0.0006903183530084789
birth O 0 0.0012586064403876662
with O 0 0.0005358126945793629
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999666213989258
contractures B-Disease 1 1.0
, O 0 0.0006914284313097596
and O 0 0.00012828691978938878
early B-Disease 0 0.0029886185657233
death I-Disease 0 0.004313106648623943
. O 0 0.0002723557990975678

To O 0 2.9807888495270163e-05
test O 0 4.689187790063443e-06
for O 0 2.335802719244384e-06
possible O 0 3.877164635923691e-05
nosologic O 0 0.00382744031958282
identity O 0 8.571008947910741e-05
between O 0 0.0005300685297697783
these O 0 0.000247080868575722
disorders O 1 1.0
, O 0 0.000215930471313186
we O 0 3.492502946755849e-05
reviewed O 0 3.985954390373081e-05
the O 0 1.7751055565895513e-05
literature O 0 1.5253143828886095e-05
and O 0 1.2968430382898077e-06
obtained O 0 5.130811587150674e-06
a O 0 9.219687854056247e-06
follow O 0 8.710253496246878e-06
- O 0 6.562245835084468e-05
up O 0 8.857110515236855e-06
of O 0 1.2063484064128716e-05
the O 0 1.80108781933086e-05
only O 0 5.4139309213496745e-06
two O 0 1.2873725609097164e-05
surviving O 0 0.0026176772080361843
patients O 0 9.263598622055724e-05
, O 0 1.0666642992873676e-05
one O 0 9.991123079089448e-06
with O 0 3.943603951483965e-05
SJS B-Disease 1 0.9999939203262329
type I-Disease 0 0.0011293224524706602
2 I-Disease 0 0.001172029646113515
at O 0 0.0004896906903013587
age O 0 0.00023233634419739246
10 O 0 4.8527679609833285e-05
years O 0 5.0870465202024207e-05
and O 0 3.4496306398068555e-06
another O 0 1.659061854297761e-05
with O 0 3.0930506909498945e-05
SWS B-Disease 1 0.9981583952903748
at O 0 0.0014617500128224492
age O 0 0.001295371912419796
7 O 0 0.0018239814089611173
years O 0 0.0012140393955633044
. O 0 0.00024872025824151933

Patients O 0 0.0003026189224328846
reported O 0 4.987080319551751e-05
as O 0 2.116654832207132e-05
having O 0 0.0001008227773127146
either O 0 0.0008063663262873888
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.006029220297932625
SWS B-Disease 1 0.9999456405639648
presented O 0 0.0001864915684564039
a O 0 2.5659133825683966e-05
combination O 0 2.2827018256066367e-05
of O 0 6.745611608494073e-05
a O 0 0.00017323036445304751
severe O 1 0.9996448755264282
, O 0 0.00016150205919984728
prenatal O 1 0.999942421913147
- O 1 0.9999998807907104
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
with O 1 1.0
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999837875366211
feeding O 1 0.9991133809089661
difficulties O 1 0.999862551689148
, O 0 9.086095087695867e-05
tendency O 0 0.0003422624431550503
to O 0 0.0005065777222625911
hyperthermia B-Disease 1 0.9999675750732422
, O 0 5.6120759836630896e-05
and O 0 1.603415330464486e-05
frequent O 0 7.852425187593326e-05
death O 0 0.0008745939121581614
in O 0 0.0002163001336157322
infancy O 0 0.004075903911143541
) O 0 4.245875061315019e-06
with O 0 3.827634031949856e-07
a O 0 9.279635378334206e-06
distinct O 0 0.00013164847041480243
campomelic B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.7232275009155273

The O 0 0.00011256647121626884
similarity O 0 8.759224147070199e-05
of O 0 0.00010531301086302847
the O 0 0.00020323369244579226
clinical O 0 0.00039700089837424457
and O 0 4.786496720043942e-05
radiographic O 0 0.003282374469563365
findings O 0 0.00024162388581316918
is O 0 2.018003215198405e-05
so O 0 6.378189482347807e-06
extensive O 0 6.452455272665247e-05
that O 0 1.0586923963273875e-05
these O 0 3.2620224374113604e-05
disorders O 1 0.9999992847442627
appear O 0 0.001357268774881959
to O 0 0.00013805029448121786
be O 0 3.422002919251099e-05
a O 0 3.19927312375512e-05
single O 0 2.557207153586205e-05
entity O 0 0.0001613588974578306
. O 0 0.00031744642183184624

The O 0 0.0004775997658725828
follow O 0 0.00012309184239711612
- O 0 0.0003285820712335408
up O 0 3.330560866743326e-05
observation O 0 9.303585102315992e-05
of O 0 4.484046439756639e-05
an O 0 1.322122261626646e-05
identical O 0 2.784971729852259e-05
and O 0 6.4804912653926294e-06
unique O 0 5.061680349172093e-05
pattern O 0 0.00109471392352134
of O 1 0.54692542552948
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.0036940143909305334
the O 0 0.0007559910300187767
two O 0 5.7913941418519244e-05
patients O 0 5.9612888435367495e-05
( O 0 2.461032272549346e-05
one O 0 1.5027098015707452e-05
with O 0 2.7891233912669122e-05
SJS B-Disease 1 0.999972939491272
type I-Disease 0 0.000584155844990164
2 I-Disease 0 0.000497127475682646
, O 0 9.70924611465307e-06
one O 0 6.122124432295095e-06
with O 0 3.576167728169821e-05
SWS B-Disease 1 0.999929666519165
) O 0 0.0002605851332191378
surviving O 0 0.0059600090608000755
beyond O 0 0.0019482129719108343
infancy O 0 0.004023459739983082
adds O 0 4.498578346101567e-05
to O 0 6.339294941426488e-06
the O 0 2.3080916434992105e-05
evidence O 0 3.549713073880412e-05
in O 0 1.7068919987650588e-05
favor O 0 1.5853522199904546e-05
of O 0 8.768893894739449e-05
identity O 0 0.00034696634975261986
. O 0 0.0004392031114548445

The O 0 0.0002490591141395271
hypothesis O 0 8.407224959228188e-05
that O 0 1.7546195522299968e-05
SWS B-Disease 1 0.9944802522659302
and O 0 0.0003275930357631296
SJS B-Disease 1 0.9999825954437256
type I-Disease 0 0.00048260169569402933
2 I-Disease 0 0.0002242704649688676
are O 0 1.6488738765474409e-06
the O 0 2.092566319333855e-05
same O 0 6.261661474127322e-05
disorder O 1 0.9999827146530151
should O 0 0.00010399473103461787
be O 0 2.584383219073061e-05
testable O 0 5.795548713649623e-05
by O 0 2.4667672278155806e-06
molecular O 0 3.9721762732369825e-05
methods O 0 5.198943108553067e-05
. O 0 9.256904013454914e-05
. O 0 0.00014298976748250425

A O 0 0.001247516949661076
mouse O 0 3.3319040085189044e-05
model O 0 3.3185312986461213e-06
of O 0 1.8865035599446855e-05
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999996423721313
defects O 1 1.0
in O 1 0.996726393699646
hemostasis O 1 1.0
and O 1 0.9893761873245239
thrombosis B-Disease 1 1.0
. O 0 0.009980602189898491

von B-Disease 1 0.9996798038482666
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.502933919429779
( I-Disease 0 0.08726198226213455
vWf I-Disease 1 1.0
) I-Disease 1 0.9999719858169556
deficiency I-Disease 1 1.0
causes O 1 0.9999985694885254
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9988351464271545
humans O 0 0.008130508475005627
. O 0 0.0002757984912022948

We O 0 5.532581781153567e-05
generated O 0 2.384854269621428e-05
a O 0 1.592079206602648e-05
mouse O 0 1.5521944078500383e-05
model O 0 8.544500360585516e-07
for O 0 9.175271316053113e-07
this O 0 5.775190857093548e-06
disease O 0 0.0010632373159751296
by O 0 3.895596364600351e-06
using O 0 1.2593774954439141e-05
gene O 0 4.7819758037803695e-05
targeting O 0 6.644129462074488e-05
. O 0 0.000132530287373811

vWf B-Disease 1 0.9992961883544922
- I-Disease 1 0.9920244216918945
deficient I-Disease 1 0.966624915599823
mice O 0 0.0003979201428592205
appeared O 0 0.00011929275933653116
normal O 0 6.970870890654624e-05
at O 0 0.00017553656653035432
birth O 0 0.00016716698883101344
; O 0 1.8680514131119708e-06
they O 0 1.115988766287046e-06
were O 0 2.405822124273982e-05
viable O 0 0.00022618255752604455
and O 0 2.9794842703267932e-05
fertile O 0 0.0037382161244750023
. O 0 0.0003165023517794907

Neither O 0 0.0037727761082351208
vWf O 0 0.037152864038944244
nor O 0 0.0017392683075740933
vWf O 0 0.024676939472556114
propolypeptide O 0 0.04112527519464493
( O 0 0.0003092946426477283
von B-Disease 1 0.9850489497184753
Willebrand I-Disease 1 0.9999998807907104
antigen O 0 0.026963962242007256
II O 1 1.0
) O 0 0.00028352983645163476
were O 0 7.83929499448277e-05
detectable O 0 0.0010072393342852592
in O 0 4.479878771235235e-05
plasma O 0 0.000447456375695765
, O 0 2.8348145860945806e-05
platelets O 0 0.0006727864383719862
, O 0 2.6983449060935527e-05
or O 0 6.597534957109019e-05
endothelial O 0 0.002186377299949527
cells O 0 7.68003155826591e-05
of O 0 6.445517647080123e-05
the O 0 0.00014683802146464586
homozygous O 0 0.00029017386259511113
mutant O 0 0.00105924136005342
mice O 0 0.0011736751766875386
. O 0 8.717036689631641e-05

The O 0 0.0007740437285974622
mutant O 0 0.00625239172950387
mice O 0 0.008006186224520206
exhibited O 0 0.20534169673919678
defects O 1 0.9999979734420776
in O 0 0.001890060375444591
hemostasis O 1 0.9979861974716187
with O 0 7.204910070868209e-05
a O 0 0.0003891416999977082
highly O 1 0.7309632897377014
prolonged O 1 0.9999998807907104
bleeding O 1 1.0
time O 0 0.002134752692654729
and O 0 0.00033177260775119066
spontaneous O 0 0.005499981343746185
bleeding O 1 0.9997109770774841
events O 0 0.0003370780614204705
in O 0 5.2791037887800485e-05
approximately O 0 8.15859020804055e-05
10 O 0 5.63157991564367e-05
% O 0 1.5523130059591495e-05
of O 0 0.00029047945281490684
neonates O 0 0.012049158103764057
. O 0 0.00034821245935745537

As O 0 0.00011265839566476643
in O 0 3.9961621951078996e-05
the O 0 0.00011813529272330925
human O 0 0.00037530972622334957
disease O 1 0.9992150068283081
, O 0 2.05374581128126e-05
the O 0 6.456190749304369e-05
factor O 0 0.0002688104286789894
VIII O 1 0.9960753321647644
level O 0 0.0013377945870161057
in O 0 8.413119212491438e-05
these O 0 1.675888961472083e-05
mice O 0 0.00021911674411967397
was O 0 0.00012582751514855772
reduced O 0 2.376538213866297e-05
strongly O 0 4.776395144290291e-06
as O 0 6.482277967734262e-06
a O 0 6.1409641602949705e-06
result O 0 1.2193001566629391e-05
of O 0 4.6257693611551076e-05
the O 0 7.051368447719142e-05
lack O 0 0.00022985094983596355
of O 0 0.00016341560694854707
protection O 0 0.00044631597120314837
provided O 0 0.00017849648429546505
by O 0 6.399406265700236e-05
vWf O 0 0.0151742622256279
. O 0 0.0002919392427429557

Defective O 1 0.9999991655349731
thrombosis B-Disease 1 0.9999998807907104
in O 0 0.0027181038167327642
mutant O 0 0.008557719178497791
mice O 0 0.0016224973369389772
was O 0 0.00039612012915313244
also O 0 1.1121491297672037e-05
evident O 0 0.00011322336649755016
in O 0 5.700221208826406e-06
an O 0 1.8468587086317712e-06
in O 0 1.927390621858649e-05
vivo O 0 0.0005915180663578212
model O 0 6.356176163535565e-05
of O 0 0.003693175734952092
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 1 0.5546648502349854

In O 0 6.331276381388307e-05
this O 0 5.024931851949077e-06
model O 0 7.514117896789685e-06
, O 0 4.604682544595562e-06
the O 0 4.857925887336023e-05
exteriorized O 0 0.011188915930688381
mesentery O 0 0.009773846715688705
was O 0 0.0016954110469669104
superfused O 0 0.008250873535871506
with O 0 0.00016424214118160307
ferric O 1 0.9999998807907104
chloride O 1 0.9974690675735474
and O 0 0.0002890236210078001
the O 0 0.0008710937690921128
accumulation O 0 0.3321049213409424
of O 0 0.0019663656130433083
fluorescently O 1 0.9800127148628235
labeled O 0 0.003554675495252013
platelets O 0 0.0024065282195806503
was O 0 0.00033967741183005273
observed O 0 3.36059856635984e-05
by O 0 1.1214352525712457e-05
intravital O 0 0.004713892936706543
microscopy O 0 0.0004811157996300608
. O 0 0.00022432010155171156

We O 0 0.00010653151548467577
conclude O 0 0.00023665442131459713
that O 0 2.2269223336479627e-06
these O 0 4.715484465123154e-06
mice O 0 9.001707803690806e-05
very O 0 4.596096459863475e-06
closely O 0 4.863122012466192e-05
mimic O 0 0.004550420679152012
severe O 1 0.9991983771324158
human O 1 0.9789925217628479
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0010128262219950557
will O 0 5.796477125841193e-05
be O 0 5.937332844041521e-06
very O 0 1.1557397101569222e-06
useful O 0 1.8223227016278543e-06
for O 0 1.2661072332775802e-06
investigating O 0 1.1956588423345238e-05
the O 0 2.5953913791454397e-05
role O 0 8.233432163251564e-05
of O 0 0.0002837510546669364
vWf O 0 0.011627495288848877
in O 0 0.00015861699648667127
normal O 0 0.00042454813956283033
physiology O 0 0.0009951237589120865
and O 0 3.621572977863252e-05
in O 0 0.0002189838996855542
disease O 1 0.999833345413208
models O 0 0.00012975487334188074
. O 0 9.512229735264555e-05
. O 0 0.00010637986270012334

Oral O 1 0.998715877532959
contraceptives O 0 0.02538054995238781
and O 0 2.497694549674634e-05
the O 0 0.00010952058801194653
risk O 0 0.0005337676266208291
of O 1 0.9987121820449829
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999996423721313

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999996423721313
Study O 0 0.003401679452508688
Group O 0 0.00014602219744119793
. O 0 0.00014698272570967674

BACKGROUND O 0 0.008816441521048546
Women O 0 6.589285476366058e-05
with O 0 8.121626706270035e-06
mutations O 0 4.5011485781287774e-05
in O 0 5.798490019515157e-05
either O 0 9.078403672901914e-05
the O 0 0.0002839864755515009
BRCA1 O 0 0.0021727941930294037
or O 0 6.687136192340404e-05
the O 0 0.0001718025450827554
BRCA2 O 0 0.0014849853469058871
gene O 0 8.693970812601037e-06
have O 0 5.711130484087334e-07
a O 0 3.531994479999412e-06
high O 0 0.00011363026715116575
lifetime O 0 0.0003327942395117134
risk O 0 0.0006785669829696417
of O 1 0.9998865127563477
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9900187253952026

Oral O 1 0.9999853372573853
contraceptives O 1 0.9999932050704956
protect O 1 0.9988481998443604
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.002728232881054282
general O 0 0.0002629609080031514
, O 0 1.61419520736672e-05
but O 0 1.2029498748233891e-06
it O 0 5.005218213227636e-07
is O 0 4.907388415631431e-07
not O 0 4.875755053035391e-07
known O 0 5.918524038861506e-06
whether O 0 2.149578449461842e-06
they O 0 1.185649239232589e-06
also O 0 2.7649407456920017e-06
protect O 0 2.990851498907432e-05
against O 0 9.56336225499399e-05
hereditary B-Disease 1 0.9999973773956299
forms I-Disease 1 0.9999934434890747
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999744892120361

METHODS O 0 0.000722046010196209
We O 0 2.5138675482594408e-05
enrolled O 0 0.00015481916489079595
207 O 0 0.0001806568179745227
women O 0 1.8971823010360822e-05
with O 0 0.00010164843843085691
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9997523427009583
161 O 0 0.004693782888352871
of O 0 0.0014517826493829489
their O 0 0.00018912085215561092
sisters O 0 0.0006146912346594036
as O 0 2.1667705368599854e-05
controls O 0 1.9241841073380783e-05
in O 0 1.1392025953682605e-05
a O 0 2.569723619672004e-05
case O 0 5.2761592087335885e-05
- O 0 0.00021950481459498405
control O 0 7.136386557249352e-05
study O 0 2.6999228794011287e-05
. O 0 7.175672362791374e-05

All O 0 0.00014344904047902673
the O 0 0.00012889904610347003
patients O 0 6.660610233666375e-05
carried O 0 3.0179124223650433e-05
a O 0 2.200708695454523e-05
pathogenic O 0 8.277525193989277e-05
mutation O 0 8.552117833460215e-06
in O 0 1.3267437680042349e-05
either O 0 9.041151497513056e-05
BRCA1 O 0 0.0010849636746570468
( O 0 4.972871101927012e-05
179 O 0 0.00014129746705293655
women O 0 3.813007424469106e-05
) O 0 2.166452213714365e-05
or O 0 5.939249967923388e-05
BRCA2 O 0 0.0030285492539405823
( O 0 0.0001712786324787885
28 O 0 0.0019150848966091871
women O 0 0.00015074237307999283
) O 0 9.490810771239921e-05
. O 0 0.00014356194878928363

The O 0 0.0005601269658654928
control O 0 0.0005869197775609791
women O 0 2.5638173610786907e-05
were O 0 2.0359144400572404e-05
enrolled O 0 0.00011496055958559737
regardless O 0 2.907869748014491e-05
of O 0 5.247727676760405e-05
whether O 0 2.408967338851653e-05
or O 0 2.0978353859391063e-05
not O 0 4.79359005112201e-06
they O 0 3.5145096717315027e-06
had O 0 5.024831261835061e-05
either O 0 5.15792598889675e-05
mutation O 0 9.914535621646792e-05
. O 0 0.00024231575662270188

Lifetime O 0 0.0012718415819108486
histories O 0 0.0008246662910096347
of O 0 0.003291215980425477
oral O 1 0.9999696016311646
- O 1 0.8248559236526489
contraceptive O 0 0.0006004556780681014
use O 0 4.107049335289048e-06
were O 0 9.669372957432643e-06
obtained O 0 1.2216653885843698e-05
by O 0 4.642767635232303e-06
interview O 0 6.668631249340251e-05
or O 0 3.2986561109282775e-06
by O 0 1.4036357924851472e-06
written O 0 2.547397116359207e-06
questionnaire O 0 8.356456419278402e-06
and O 0 2.490979568392504e-06
were O 0 1.4273451597546227e-05
compared O 0 9.335987851954997e-05
between O 0 0.001000268035568297
patients O 0 0.0004793085972778499
and O 0 0.00011129189078928903
control O 0 0.000937177159357816
women O 0 6.0374248278094456e-05
, O 0 7.752712917863391e-06
after O 0 4.6266301069408655e-05
adjustment O 0 0.0001711517688818276
for O 0 9.693424544821028e-06
year O 0 5.3111431043362245e-05
of O 0 0.00016547390259802341
birth O 0 0.0012480203295126557
and O 0 9.485409100307152e-05
parity O 0 0.007672591600567102
. O 0 0.00048831821186468

RESULTS O 0 0.00043649913277477026
The O 0 8.033843187149614e-05
adjusted O 0 0.0001509575522504747
odds O 0 0.0004902719520032406
ratio O 0 0.0006406981265172362
for O 0 0.0023213839158415794
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.0005206880159676075
with O 0 9.068791769095697e-06
any O 0 1.3905525520385709e-05
past O 0 3.646483310149051e-05
use O 0 4.106329015485244e-06
of O 0 0.00011812176671810448
oral O 1 0.5461331009864807
contraceptives O 0 0.06983055174350739
was O 0 0.0031177890487015247
0 O 0 0.0003374025400262326
. O 0 0.00014073564670979977

5 O 0 0.0006852399092167616
( O 0 3.878780989907682e-05
95 O 0 9.891522495308891e-05
percent O 0 3.262535756221041e-05
confidence O 0 0.00011208876094315201
interval O 0 7.3343122494407e-05
, O 0 4.141350018471712e-06
0 O 0 4.655545581044862e-06
. O 0 1.3387725630309433e-06
3 O 0 8.405314474657644e-06
to O 0 5.153674010216491e-06
0 O 0 1.204916861752281e-05
. O 0 7.177001862146426e-06
8 O 0 0.00013748541823588312
) O 0 3.080375972785987e-05
. O 0 5.59193613298703e-05

The O 0 0.00047804907080717385
risk O 0 0.00023853876336943358
decreased O 0 0.00036420117248781025
with O 0 3.4531092296674615e-06
increasing O 0 2.0394996681716293e-05
duration O 0 0.00012858746049460024
of O 0 5.8196954341838136e-05
use O 0 2.363176827202551e-05
( O 0 5.877038711332716e-05
P O 0 0.0010670764604583383
for O 0 1.5929599612718448e-05
trend O 0 0.00010586215648800135
, O 0 7.3908959166146815e-06
< O 0 0.0002081569837173447
0 O 0 2.8159563953522593e-05
. O 0 1.3034596122452058e-05
001 O 0 0.0011504469439387321
) O 0 7.090074177540373e-06
; O 0 8.339700912074477e-07
use O 0 1.3837853884979268e-06
for O 0 5.193494871491566e-06
six O 0 6.083682455937378e-05
or O 0 1.208902813232271e-05
more O 0 3.161773065585294e-06
years O 0 4.8702870117267594e-05
was O 0 0.00013088145351503044
associated O 0 4.5562919694930315e-06
with O 0 9.272401371163141e-07
a O 0 1.58452385221608e-05
60 O 0 7.111827289918438e-05
percent O 0 6.121941260062158e-05
reduction O 0 0.00032457816996611655
in O 0 0.00031576878973282874
risk O 0 0.0005847705760970712
. O 0 0.00026874817558564246

Oral O 1 0.9990506768226624
- O 0 0.03176462650299072
contraceptive O 0 0.0013136719353497028
use O 0 5.3329364163801074e-05
protected O 0 0.1240529790520668
against O 1 0.9999372959136963
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.00018794664356391877
for O 0 3.6815221392316744e-05
carriers O 0 4.4578799133887514e-05
of O 0 6.594516162294894e-05
the O 0 0.0003486067580524832
BRCA1 O 0 0.002665931126102805
mutation O 0 2.9419859856716357e-05
( O 0 2.5349610950797796e-05
odds O 0 0.00039039988769218326
ratio O 0 6.044723340892233e-05
, O 0 3.031524556718068e-06
0 O 0 5.386316843214445e-06
. O 0 2.1714392914873315e-06
5 O 0 9.320150638814084e-06
; O 0 5.537640390684828e-07
95 O 0 1.5569961760775186e-05
percent O 0 1.0196206858381629e-05
confidence O 0 7.942593947518617e-05
interval O 0 3.5662713344208896e-05
, O 0 2.468118054821389e-06
0 O 0 3.0799160413153004e-06
. O 0 1.0501886436031782e-06
3 O 0 9.463986316404771e-06
to O 0 3.7790020996908424e-06
0 O 0 8.942629392549861e-06
. O 0 5.200939085625578e-06
9 O 0 6.885472976136953e-05
) O 0 2.8632896373892436e-06
and O 0 8.640463988740521e-07
for O 0 2.326616595382802e-06
carriers O 0 1.0841137736861128e-05
of O 0 3.923093754565343e-05
the O 0 0.0003990664263255894
BRCA2 O 0 0.003996709827333689
mutation O 0 3.450393705861643e-05
( O 0 3.888313949573785e-05
odds O 0 0.0005091967759653926
ratio O 0 6.761365511920303e-05
, O 0 3.3764013096515555e-06
0 O 0 7.006443411228247e-06
. O 0 2.3187310489447555e-06
4 O 0 1.3790471712127328e-05
; O 0 7.338279601754039e-07
95 O 0 2.4984330593724735e-05
percent O 0 1.8191058188676834e-05
confidence O 0 0.00011971633648499846
interval O 0 7.795380224706605e-05
, O 0 4.266490577720106e-06
0 O 0 6.117028988228412e-06
. O 0 1.627911615287303e-06
2 O 0 1.0788340659928508e-05
to O 0 4.467560302146012e-06
1 O 0 9.337074152426794e-05
. O 0 8.417507160629611e-06
1 O 0 0.00017077715892810374
) O 0 2.2892527340445668e-05
. O 0 5.3829160606255755e-05

CONCLUSIONS O 0 0.014114263467490673
Oral O 1 0.9980179071426392
- O 0 0.015857277438044548
contraceptive O 0 0.0004145351704210043
use O 0 9.450123798160348e-06
may O 0 2.401013443886768e-05
reduce O 0 2.5002183974720538e-05
the O 0 5.231937757343985e-05
risk O 0 0.0003831438662018627
of O 1 0.9871482253074646
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.003367304103448987
women O 0 3.675068001030013e-05
with O 0 3.4003360269707628e-06
pathogenic O 0 7.64267606427893e-05
mutations O 0 2.0041752577526495e-05
in O 0 2.2393262042896822e-05
the O 0 0.00011456659558461979
BRCA1 O 0 0.0024810326285660267
or O 0 0.0002240682952105999
BRCA2 O 0 0.00921729113906622
gene O 0 0.0011868705041706562

A O 0 0.0018166083609685302
Japanese O 0 0.0011279892642050982
family O 0 8.468077430734411e-05
with O 0 3.495835335343145e-05
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.0001644383155507967
a O 0 0.0005141485598869622
codon O 0 0.0006606032256968319
291 O 0 0.00036758778151124716
deletion O 0 0.00038896725163795054
: O 0 1.183180484076729e-05
a O 0 1.0923184163402766e-05
clinical O 0 0.00017073516210075468
, O 0 4.524590622168034e-05
biochemical O 0 0.001308416249230504
, O 0 0.00012458182754926383
pathological O 1 0.8863587975502014
, O 0 8.571924263378605e-05
and O 0 3.053677937714383e-05
genetic O 0 0.0005325703532435
report O 0 0.00014939274115022272
. O 0 0.0002154504763893783

We O 0 3.411386933294125e-05
report O 0 2.479848717484856e-06
a O 0 2.1147370716789737e-06
Japanese O 0 5.6625660363351926e-05
family O 0 1.999187225010246e-05
with O 0 0.00010008117533288896
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.999987006187439
ALD B-Disease 1 1.0
) O 0 0.0004202872223686427
with O 0 1.6361267626052722e-05
a O 0 2.862035580619704e-05
three O 0 1.9223958588554524e-05
base O 0 7.518307393183932e-05
pair O 0 9.994423453463241e-05
deletion O 0 0.0006823978037573397
( O 0 0.00020602348376996815
delGAG O 0 0.010606410913169384
291 O 0 0.0004567585128825158
) O 0 2.322944055777043e-05
in O 0 5.115574094816111e-05
the O 0 0.001182852778583765
ALD B-Disease 1 1.0
gene O 0 0.001733884448185563
. O 0 0.00044335596612654626

A O 0 0.0007737250998616219
variety O 0 4.848479511565529e-05
of O 0 0.00013512824079953134
phenotypes O 0 0.00045752761070616543
were O 0 4.016582897747867e-05
observed O 0 2.6537469238974154e-05
within O 0 1.3604410014522728e-05
this O 0 5.770945790573023e-06
family O 0 7.455232844222337e-05
. O 0 0.00011314630683045834

While O 0 7.664017175557092e-05
the O 0 0.00014350459969136864
proband O 0 0.02135729230940342
( O 0 0.00015731682651676238
patient O 0 0.00013404306082520634
1 O 0 0.000497068278491497
) O 0 3.3648801036179066e-05
was O 0 0.0002602355380076915
classified O 0 0.00014052032202016562
as O 0 1.9341263396199793e-05
having O 0 3.770251350942999e-05
a O 0 2.1475545509019867e-05
rare O 0 0.00014838558854535222
intermediate O 0 0.0008372686570510268
type O 0 0.00017289123206865042
of O 0 0.0006035990081727505
adult O 0 0.0010452530113980174
cerebral O 1 0.9999281167984009
and O 0 0.002360367914661765
cerebello O 1 1.0
- O 1 0.9999967813491821
brain O 1 0.9999896287918091
stem O 0 0.0035897574853152037
forms O 0 0.00012206699466332793
, O 0 2.0863972167717293e-05
his O 0 9.132776904152706e-05
younger O 0 0.000674604088999331
brother O 0 0.0007705296156927943
( O 0 5.925994264543988e-05
patient O 0 8.134367089951411e-05
2 O 0 0.00039256797754205763
) O 0 3.2372860005125403e-05
and O 0 1.5580375475110486e-05
nephew O 0 0.002129195723682642
( O 0 9.878287528408691e-05
patient O 0 0.00010551686864346266
3 O 0 0.00021491209918167442
) O 0 2.5789006031118333e-05
had O 0 0.00011551658826647326
a O 0 0.00040453547262586653
childhood O 1 0.9999992847442627
ALD B-Disease 1 1.0
type O 1 0.9947073459625244
. O 0 0.0022607839200645685

Another O 0 0.0014380320208147168
nephew O 0 0.01275989692658186
( O 0 0.0002591348020359874
patient O 0 0.0002303327200934291
4 O 0 0.0005384975811466575
) O 0 2.4778184524620883e-05
of O 0 9.649984713178128e-05
patient O 0 0.00021295757323969156
1 O 0 0.0006522801122628152
was O 0 0.0005355747998692095
classified O 0 0.00017468217993155122
as O 0 2.3043750843498856e-05
having O 0 3.195034878444858e-05
an O 0 1.5512518075411208e-05
adolescent O 0 0.0025617622304707766
form O 0 0.0004853316058870405
. O 0 0.0007735803374089301

The O 0 0.0003922133764717728
tau O 0 0.0013554292963817716
level O 0 0.00014778348850086331
in O 0 2.8425083655747585e-05
the O 0 0.00012310300371609628
cerebrospinal O 0 0.015166361816227436
fluid O 0 0.006934552453458309
( O 0 0.001636954490095377
CSF O 1 0.9999929666519165
) O 0 0.00017921497055795044
in O 0 7.263042061822489e-05
patient O 0 7.259759877342731e-05
1 O 0 0.00017668213695287704
was O 0 0.00019088613044004887
as O 0 8.748505933908746e-06
high O 0 2.089389818138443e-05
as O 0 1.385795371788845e-06
that O 0 2.709761020014412e-07
of O 0 1.2008982594124973e-05
patients O 0 9.920115553541109e-05
with O 0 0.0005924786673858762
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0023360312916338444
AD B-Disease 0 0.2395971119403839
) O 0 0.00026052078464999795
. O 0 0.0001100837835110724

His O 0 0.0049616023898124695
brain O 1 0.9982030391693115
magnetic O 0 0.004410442430526018
resonance O 0 0.0023126713931560516
image O 0 0.0020262105390429497
( O 0 0.0005023918347433209
MRI O 1 0.6360455751419067
) O 0 0.00023186321777757257
showed O 0 0.0005659002345055342
abnormalities B-Disease 0 0.015880852937698364
in I-Disease 0 0.0001435776794096455
the I-Disease 0 0.00034601151128299534
bilateral I-Disease 1 0.9998070597648621
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9913058876991272
and O 0 0.002108234679326415
brain O 1 1.0
stem O 1 0.9970989227294922
, O 0 2.3892138415249065e-05
but O 0 1.3387253829932888e-06
not O 0 1.1420527243899414e-06
in O 0 2.257082815049216e-05
the O 0 0.00027952337404713035
cerebral O 1 0.9103525876998901
white O 0 0.0005573767703026533
matter O 0 0.00017918543017003685
, O 0 7.99482859292766e-06
where O 0 1.9814573533949442e-05
marked O 0 0.0003582210629247129
reductions O 0 0.00037616404006257653
of O 0 0.0002456890360917896
the O 0 0.0019370110239833593
cerebral O 1 0.9999451637268066
blood O 0 0.270244836807251
flow O 0 0.012423181906342506
and O 0 0.00036771412123925984
oxygen O 0 0.001076537766493857
metabolism O 0 0.0002636343997437507
were O 0 1.844442158471793e-05
clearly O 0 3.6316996556706727e-05
demonstrated O 0 0.00011367208207957447
by O 0 1.5144695680646691e-05
positron O 0 0.0009483773028478026
emission O 0 0.00016269109619315714
tomography O 0 0.00020462764950934798
( O 0 0.0002293688739882782
PET O 0 0.003361042821779847
) O 0 0.00010168635344598442
. O 0 0.00010257785470457748

In O 0 0.000446262420155108
patients O 0 0.0002018315135501325
2 O 0 0.000398121599573642
and O 0 1.643685027374886e-05
3 O 0 0.00013940484495833516
, O 0 4.160145181231201e-06
the O 0 1.130530199588975e-05
autopsy O 0 8.775143214734271e-05
findings O 0 2.9969301976962015e-05
showed O 0 0.00047424566582776606
massive O 1 0.9953272342681885
demyelination B-Disease 1 1.0
of I-Disease 1 0.9894137382507324
the I-Disease 1 0.9982000589370728
cerebral I-Disease 1 0.999995231628418
white I-Disease 0 0.0014297073939815164
matter I-Disease 0 0.00015159598842728883
with O 0 6.123093498899834e-06
sparing O 0 0.00012216760660521686
of O 0 0.00029709527734667063
the O 0 0.0031232195906341076
U O 1 1.0
- O 1 0.8833158612251282
fibers O 0 0.0012186599196866155
, O 0 5.018973752157763e-06
compatible O 0 1.228571363753872e-05
with O 0 5.479977289724047e-07
the O 0 1.064845946530113e-05
findings O 0 2.8112097425037064e-05
of O 0 0.0006412198999896646
childhood O 1 1.0
ALD B-Disease 1 1.0
. O 0 0.014186402782797813

Oleic O 0 0.0496223084628582
and O 0 0.0008260757895186543
erucic O 1 0.9884968996047974
acids O 0 0.000705389422364533
( O 0 0.0002183082397095859
Lorenzos O 0 0.026993591338396072
Oil O 0 0.0007218946702778339
) O 0 3.6524377264868235e-06
were O 0 2.3763609533489216e-06
administered O 0 8.002562935871538e-06
to O 0 9.510744348517619e-06
patients O 0 4.87151337438263e-05
1 O 0 0.0003068881342187524
and O 0 2.7682079235091805e-05
4 O 0 0.00023419520584866405
, O 0 5.17633725394262e-06
but O 0 1.5412598486364004e-06
sufficient O 0 2.4824781576171517e-05
effectiveness O 0 5.1348011766094714e-05
was O 0 0.00011842830281239003
not O 0 2.4770290565356845e-06
obtained O 0 4.036927566630766e-05
. O 0 9.519979357719421e-05

The O 0 0.00026785361114889383
findings O 0 2.8776708859368227e-05
in O 0 1.5205911950033624e-05
this O 0 2.741336629696889e-06
family O 0 9.09838308871258e-06
suggest O 0 1.3162170034775045e-05
that O 0 4.742882993014064e-06
delGAG291 O 0 0.0007878989563323557
is O 0 7.434136932715774e-06
part O 0 2.7726149710360914e-05
of O 0 9.139379835687578e-05
the O 0 0.00023950774630066007
cause O 0 0.0005968268378637731
of O 0 0.0012153780553489923
Japanese O 1 0.999817430973053
ALD B-Disease 1 1.0
with O 0 6.647633563261479e-05
phenotypic O 0 0.0022923669312149286
variations O 0 0.0032376707531511784
. O 0 0.0009028401109389961

Moreover O 0 0.001138031017035246
, O 0 1.0616357030812651e-05
although O 0 5.524692369363038e-06
the O 0 8.845174306770787e-06
scale O 0 0.00011578611156437546
of O 0 5.025914288125932e-05
the O 0 5.64576439501252e-05
study O 0 1.1339348930050619e-05
is O 0 2.373151801293716e-06
limited O 0 2.673722974577686e-06
, O 0 1.6215279856623965e-06
there O 0 2.890671794375521e-06
is O 0 1.6967719602689613e-06
a O 0 8.400595106650144e-06
possibility O 0 8.547485776944086e-05
that O 0 1.6273455912596546e-05
PET O 0 0.0018955481937155128
can O 0 1.984426489798352e-05
detect O 0 0.0010223701829090714
an O 0 0.00011480817920528352
insidious B-Disease 1 0.9122580885887146
lesion I-Disease 1 0.9931809306144714
which O 0 5.378769856179133e-05
is O 0 2.114016388077289e-05
undetectable O 0 0.0006251002778299153
by O 0 4.246247499395395e-06
computed O 0 5.178227002033964e-05
tomogram O 0 0.011638806201517582
( O 0 0.0002847307187039405
CT O 1 0.5433560013771057
) O 0 8.521922427462414e-05
or O 0 3.4154265449615195e-05
MRI O 0 0.002810682402923703
analysis O 0 1.5630739653715864e-05
, O 0 6.186561677168356e-06
and O 0 2.5332778932352085e-06
that O 0 5.392785169533454e-07
the O 0 1.0252898391627241e-05
higher O 0 1.2959396372025367e-05
level O 0 0.00011877132055815309
of O 0 5.690953912562691e-05
tau O 0 0.000444618723122403
reflects O 0 9.323919584858231e-06
the O 0 3.223195562895853e-06
process O 0 1.0639688298397232e-05
of O 0 0.0002980561985168606
neuronal B-Disease 1 0.9996078610420227
degeneration I-Disease 1 1.0
in O 1 0.9999983310699463
ALD B-Disease 1 1.0
. O 0 0.009711461141705513

Lorenzos O 1 0.6819797158241272
Oil O 0 0.0014069295721128583
should O 0 3.2219111290032743e-06
be O 0 4.1765005676097644e-07
given O 0 6.794583669034182e-07
in O 0 1.9545148006727686e-06
the O 0 5.979473371553468e-06
early O 0 0.0001084865871234797
stage O 0 0.0007476623286493123
. O 0 4.64192962681409e-05
. O 0 7.245940651046112e-05

Nonsense O 0 0.005922113545238972
mutation O 0 6.986223888816312e-05
in O 0 7.325532351387665e-05
exon O 0 0.0005934691289439797
4 O 0 9.572613635100424e-05
of O 0 6.332169868983328e-05
human O 0 0.0001046247489284724
complement O 0 0.001021475880406797
C9 O 1 0.9998635053634644
gene O 0 4.296177939977497e-05
is O 0 3.0426638204517076e-06
the O 0 6.906205271661747e-06
major O 0 8.50145224831067e-05
cause O 0 6.567529635503888e-05
of O 0 0.00019135010370519012
Japanese O 1 0.9968550205230713
complement B-Disease 1 0.9999260902404785
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0028670683968812227

Deficiency B-Disease 1 1.0
of I-Disease 0 0.002576143480837345
the I-Disease 0 0.0010758860735222697
ninth I-Disease 0 0.0032561474945396185
component I-Disease 0 0.00013579010555986315
of I-Disease 0 7.155433559091762e-05
human I-Disease 0 7.859437755541876e-05
complement I-Disease 0 0.0006388798356056213
( O 0 0.0007738862768746912
C9 O 1 0.9999041557312012
) O 0 3.0387198421522044e-05
is O 0 2.1891733013035264e-06
the O 0 6.176209808472777e-06
most O 0 9.71299596130848e-06
common O 0 0.00020084247807972133
complement B-Disease 1 0.9999983310699463
deficiency I-Disease 1 1.0
in O 0 0.004282559733837843
Japan O 0 0.002628141548484564
but O 0 8.054841600824147e-06
is O 0 1.3968226539873285e-06
rare O 0 9.579169272910804e-06
in O 0 7.252755949593848e-06
other O 0 1.3740108215642977e-06
countries O 0 4.066470410180045e-06
. O 0 6.897802086314186e-05

We O 0 3.3458953112130985e-05
studied O 0 4.675079617300071e-05
the O 0 1.4054766324989032e-05
molecular O 0 4.6076704165898263e-05
basis O 0 8.480133692501113e-05
of O 0 0.007647715974599123
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0006261050002649426
four O 0 0.00032966837170533836
Japanese O 1 0.9944702386856079
C9 B-Disease 1 1.0
- I-Disease 1 0.9997469782829285
deficient I-Disease 1 0.9943029880523682
patients O 0 5.765461901319213e-05
who O 0 1.8003887817030773e-05
had O 0 0.0003919173323083669
suffered O 1 1.0
from O 1 0.999997615814209
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.004240739159286022

Direct O 0 7.258250843733549e-05
sequencing O 0 0.00017150888743344694
of O 0 0.0005608391365967691
amplified O 0 0.005460305139422417
C9 O 0 0.34157413244247437
cDNA O 0 0.0004646984743885696
and O 0 1.1549063856364228e-05
DNA O 0 8.908704330679029e-05
revealed O 0 0.0001212539937114343
a O 0 2.1361302060540766e-05
nonsense O 0 0.0002431403408991173
substitution O 0 0.00015729355800431222
( O 0 0.00027513637905940413
CGA O 0 0.014544960111379623
- O 0 0.0008254800923168659
- O 0 0.00045452683116309345
> O 0 0.0003101805050391704
TGA O 0 0.0030476448591798544
) O 0 1.1937539056816604e-05
at O 0 7.450086559401825e-05
codon O 0 2.0504307030932978e-05
95 O 0 3.926605131709948e-05
in O 0 2.8279266189201735e-05
exon O 0 0.0001806223881430924
4 O 0 7.213001663330942e-05
in O 0 2.10994385270169e-05
the O 0 7.314210961339995e-05
four O 0 0.0004086735425516963
C9 B-Disease 1 0.9999995231628418
- I-Disease 0 0.020373385399580002
deficient I-Disease 0 0.007273298688232899
individuals O 0 1.3495967323251534e-05
. O 0 0.0001370441896142438

An O 0 6.372416100930423e-05
allele O 0 2.6563904611975886e-05
- O 0 6.994103023316711e-05
specific O 0 1.7555967133375816e-06
polymerase O 0 0.0003671127196867019
chain O 0 0.00012224521196912974
reaction O 0 1.6823714759084396e-05
system O 0 0.00011248780356254429
designed O 0 8.075858931988478e-05
to O 0 2.689753455342725e-05
detect O 0 0.00022526744578499347
exclusively O 0 3.2064261176856235e-05
only O 0 3.4488869005144807e-06
one O 0 2.051285036941408e-06
of O 0 8.006128155102488e-06
the O 0 3.93355694541242e-05
normal O 0 5.2843424782622606e-05
and O 0 4.272993464837782e-06
mutant O 0 4.540271402220242e-05
alleles O 0 4.647870810003951e-06
indicated O 0 7.800980711181182e-06
that O 0 6.105369152464846e-07
all O 0 1.733597059683234e-06
the O 0 1.5309033187804744e-05
four O 0 1.0683204891392961e-05
patients O 0 1.326748952124035e-05
were O 0 1.1651571185211651e-05
homozygous O 0 9.601063538866583e-06
for O 0 4.70581744593801e-06
the O 0 6.40686193946749e-05
mutation O 0 2.046695226454176e-05
in O 0 6.06053217779845e-05
exon O 0 0.0004392408300191164
4 O 0 0.0001168241651612334
and O 0 2.633890517245163e-06
that O 0 5.48396599242551e-07
the O 0 9.588171451468952e-06
parents O 0 1.5237133084156085e-06
of O 0 1.4715051293023862e-05
patient O 0 6.253510218812153e-05
2 O 0 0.00029615528183057904
were O 0 4.5726123062195256e-05
heterozygous O 0 2.6383746444480494e-05
. O 0 5.799429345643148e-05

The O 0 0.000446455116616562
common O 0 8.231578976847231e-05
mutation O 0 2.147736813640222e-05
at O 0 0.00021431846835184842
codon O 0 9.197643521474674e-05
95 O 0 0.00013017871242482215
in O 0 4.688724220613949e-05
exon O 0 0.00042713500442914665
4 O 0 9.899137512547895e-05
might O 0 4.021095719508594e-06
be O 0 9.584729241396417e-07
responsible O 0 2.6097472982655745e-06
for O 0 3.3128742416010937e-06
most O 0 4.553965845843777e-05
Japanese O 1 0.999657154083252
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0005184613983146846
. O 0 0.00025110921706072986

BRCA1 O 0 0.0018127330113202333
required O 0 1.7148620827356353e-05
for O 0 4.1436585888732225e-05
transcription O 0 0.03459548205137253
- O 0 0.0055885836482048035
coupled O 0 0.0012009220663458109
repair O 0 0.008104901760816574
of O 0 0.0010397270089015365
oxidative O 0 0.041981544345617294
DNA O 0 0.07442625612020493
damage O 1 0.9988580942153931
. O 0 0.0011686544166877866

The O 0 0.005294627510011196
breast B-Disease 1 1.0
and I-Disease 1 0.9999977350234985
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999998807907104
gene O 0 0.003927219193428755
BRCA1 O 0 0.003966080956161022
encodes O 0 0.0002161582960980013
a O 0 0.0002271836856380105
zinc O 0 0.10310381650924683
finger O 0 0.0011491774348542094
protein O 0 6.27244298812002e-05
of O 0 8.200701995519921e-05
unknown O 0 0.0004484874370973557
function O 0 0.00016958998457994312
. O 0 0.00017651439702603966

Association O 0 0.000292029173579067
of O 0 0.00023024006804917008
the O 0 0.00042888414463959634
BRCA1 O 0 0.0005589573993347585
protein O 0 1.185530982183991e-05
with O 0 1.0821466958077508e-06
the O 0 9.531205432722345e-05
DNA O 0 0.0013826695503666997
repair O 0 0.039639610797166824
protein O 0 0.0012120461324229836
Rad51 O 0 0.01149526797235012
and O 0 1.3674572073796298e-05
changes O 0 7.318415100598941e-06
in O 0 6.973400104470784e-06
the O 0 1.35296531880158e-05
phosphorylation O 0 7.419199846481206e-06
and O 0 4.6448935790976975e-06
cellular O 0 4.275871833669953e-05
localization O 0 0.00017682669567875564
of O 0 4.359765807748772e-05
the O 0 0.0001004638324957341
protein O 0 5.5226402764674276e-05
after O 0 0.0001273763773497194
exposure O 0 0.00031475769355893135
to O 0 6.219112401595339e-05
DNA O 0 0.0017677373252809048
- O 0 0.0011217565042898059
damaging O 0 0.00027428724570199847
agents O 0 1.0949237548629753e-05
are O 0 3.6615261933548027e-07
consistent O 0 3.930656930606347e-06
with O 0 1.0305413979949662e-06
a O 0 1.2376119229884353e-05
role O 0 6.69440341880545e-05
for O 0 6.120470789028332e-05
BRCA1 O 0 0.00209543714299798
in O 0 0.0002071774797514081
DNA O 0 0.002932831412181258
repair O 1 0.8817199468612671
. O 0 0.0007094830507412553

Here O 0 0.0004679659614339471
, O 0 4.3906279643124435e-06
it O 0 4.7420508053619415e-07
is O 0 6.166083039715886e-07
shown O 0 6.1617074607056566e-06
that O 0 4.261346475686878e-06
mouse O 0 0.0002166369667975232
embryonic O 0 0.0016198146622627974
stem O 0 0.0029638248961418867
cells O 0 0.0006329295574687421
deficient B-Disease 0 0.005662791896611452
in I-Disease 0 9.465016046306118e-05
BRCA1 I-Disease 0 0.001128785195760429
are O 0 6.796502930228598e-06
defective O 0 0.00045123687596060336
in O 0 2.4356153517146595e-05
the O 0 2.3145943487179466e-05
ability O 0 3.2204457056650426e-06
to O 0 3.503673497107229e-06
carry O 0 5.761882675869856e-06
out O 0 8.577160770073533e-06
transcription O 0 0.0011838749051094055
- O 0 0.0006520622409880161
coupled O 0 0.0004872515855822712
repair O 0 0.004812334664165974
of O 0 0.0009050164953805506
oxidative O 0 0.01330860611051321
DNA O 0 0.014919827692210674
damage O 1 0.9805537462234497
, O 0 7.185067079262808e-05
and O 0 1.5035283468023408e-05
are O 0 9.518520528217778e-06
hypersensitive O 0 0.0022528974805027246
to O 0 0.0002936820965260267
ionizing O 1 0.9963681697845459
radiation O 1 0.8094650506973267
and O 0 0.00017339277837891132
hydrogen O 0 0.0005006936844438314
peroxide O 0 0.0006216733600012958
. O 0 0.00016326125478371978

These O 0 2.1182238924666308e-05
results O 0 1.9961869838880375e-05
suggest O 0 3.452262899372727e-05
that O 0 1.237469223269727e-05
BRCA1 O 0 0.0008594015962444246
participates O 0 8.957328100223094e-05
, O 0 7.37704431230668e-06
directly O 0 1.159636758529814e-05
or O 0 8.105655069812201e-06
indirectly O 0 7.528587593697011e-05
, O 0 6.908194336574525e-06
in O 0 3.6622357583837584e-05
transcription O 0 0.004126354586333036
- O 0 0.002425426384434104
coupled O 0 0.0006887878989800811
repair O 0 0.006047066301107407
of O 0 0.001001646975055337
oxidative O 0 0.017710283398628235
DNA O 0 0.02621673047542572
damage O 1 0.9916986227035522
. O 0 0.00033948002965189517
. O 0 0.00018055747204925865

Truncation O 0 0.004799932241439819
mutations O 0 0.00018201759667135775
in O 0 3.866029510390945e-05
the O 0 0.0001259156415471807
transactivation O 0 0.0038812526036053896
region O 0 0.000615334021858871
of O 0 0.0005979597335681319
PAX6 O 1 0.9999262094497681
result O 0 0.0002905705478042364
in O 0 0.0001493672316428274
dominant O 0 0.0009112560655921698
- O 0 0.00039348515565507114
negative O 0 2.175491681555286e-05
mutants O 0 0.0003241866361349821
. O 0 8.709175745025277e-05

PAX6 O 0 0.33649376034736633
is O 0 2.297824357810896e-05
a O 0 1.0901519090111833e-05
transcription O 0 0.00012552864791359752
factor O 0 9.986379154725e-06
with O 0 1.2015431138934218e-06
two O 0 8.835217158775777e-06
DNA O 0 0.0002793851017486304
- O 0 0.0002387344284215942
binding O 0 1.805426654755138e-05
domains O 0 0.00022802830790169537
( O 0 0.00012351346958894283
paired O 0 0.00026751417317427695
box O 0 0.0007940865471027792
and O 0 2.518273140594829e-05
homeobox O 0 0.003141531953588128
) O 0 1.9583827452152036e-05
and O 0 4.863364665652625e-06
a O 0 5.31719924765639e-05
proline O 0 0.0019595136400312185
- O 0 0.0009639164200052619
serine O 0 0.0003523535851854831
- O 0 0.0006117494776844978
threonine O 0 0.0003234463219996542
( O 0 0.00018479673599358648
PST O 1 0.994959831237793
) O 0 0.00017505082360003144
- O 0 0.0006199018098413944
rich O 0 9.159918408840895e-05
transactivation O 0 0.0022950167767703533
domain O 0 0.0006010494544170797
. O 0 0.0002183228061767295

PAX6 O 1 0.9999985694885254
regulates O 0 0.01193157210946083
eye O 0 0.00918147899210453
development O 0 0.0003996441373601556
in O 0 7.406662916764617e-05
animals O 0 3.317114897072315e-05
ranging O 0 0.00012788655294571072
from O 0 0.00013907345419283956
jellyfish O 0 4.6681114326929674e-05
to O 0 1.1433688996476121e-05
Drosophila O 0 3.8014331948943436e-05
to O 0 1.6548552594031207e-05
humans O 0 0.0002021913242060691
. O 0 6.742975529050454e-05

Heterozygous O 0 0.0001229426561621949
mutations O 0 4.774507397087291e-05
in O 0 3.08014678012114e-05
the O 0 9.331128967460245e-05
human O 0 0.00016519076598342508
PAX6 O 1 0.9984379410743713
gene O 0 4.607630762620829e-05
result O 0 1.2819671610486694e-05
in O 0 6.5109757088066544e-06
various O 0 7.222537533380091e-06
phenotypes O 0 0.00015536515275016427
, O 0 8.84920791577315e-06
including O 0 2.422203942842316e-05
aniridia B-Disease 1 1.0
, O 0 0.0017408618004992604
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 0.0006564169307239354
autosomal B-Disease 1 0.9995378255844116
dominant I-Disease 1 0.9999958276748657
keratitis I-Disease 1 1.0
, O 0 0.0018841486889868975
and O 0 0.0017519379034638405
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.999992847442627

It O 0 2.3506394427386113e-05
is O 0 8.124461601255462e-06
believed O 0 2.071760900435038e-05
that O 0 8.132764151014271e-07
the O 0 9.751345714903437e-06
mutated O 0 3.2678264688001946e-05
allele O 0 7.323162662942195e-06
of O 0 0.00012004451855318621
PAX6 O 1 0.960027813911438
produces O 0 8.107734902296215e-05
an O 0 1.2777794836438261e-05
inactive O 0 0.0007544984109699726
protein O 0 0.00016788355424068868
and O 0 5.5932800023583695e-05
aniridia B-Disease 1 0.9999755620956421
is O 0 7.463290967280045e-05
caused O 0 0.00035720979212783277
due O 0 0.0003571822016965598
to O 0 8.84019973454997e-05
genetic O 0 0.0013284290907904506
haploinsufficiency O 1 0.9856582283973694
. O 0 0.0007024414953775704

However O 0 0.00014565812307409942
, O 0 7.5668576755560935e-06
several O 0 6.223278887773631e-06
truncation O 0 0.00042464022408239543
mutations O 0 4.823755443794653e-05
have O 0 3.1363215384772047e-06
been O 0 8.821216397336684e-06
found O 0 3.7527920540014748e-06
to O 0 3.6522776554193115e-06
occur O 0 6.823468083894113e-06
in O 0 1.3545635738410056e-05
the O 0 7.489320705644786e-05
C O 0 0.0024942958261817694
- O 0 0.0006103499908931553
terminal O 0 0.0010633618803694844
half O 0 3.353850115672685e-05
of O 0 0.00011375038593541831
PAX6 O 1 0.972834050655365
in O 0 0.00022623258701059967
patients O 0 0.00013936776667833328
with O 0 4.598478335537948e-05
Aniridia B-Disease 1 0.9999998807907104
resulting O 0 0.0010131843155249953
in O 0 0.00014448838192038238
mutant O 0 0.00016448723908979446
proteins O 0 7.737586201983504e-06
that O 0 5.127066629029287e-07
retain O 0 2.4400394977419637e-05
the O 0 4.159634045208804e-05
DNA O 0 0.000458101014373824
- O 0 0.00019727510516531765
binding O 0 7.89373279985739e-06
domains O 0 4.824643474421464e-05
but O 0 3.513732053761487e-06
have O 0 1.1626058267211192e-06
lost O 0 7.666852616239339e-05
most O 0 3.2132211345015094e-06
of O 0 1.5764091585879214e-05
the O 0 7.829671812942252e-05
transactivation O 0 0.00817403569817543
domain O 0 0.0010150616290047765
. O 0 0.00025536990142427385

It O 0 3.588473191484809e-05
is O 0 4.404366791277425e-06
not O 0 7.135222972465272e-07
clear O 0 4.957587407261599e-06
whether O 0 5.091490038466873e-06
such O 0 5.1444371820252854e-06
mutants O 0 0.0006454726681113243
really O 0 0.0001647696626605466
behave O 0 4.528445060714148e-05
as O 0 2.9720265956711955e-05
loss O 0 0.0007368739461526275
- O 0 0.0006855736719444394
of O 0 0.00020132237114012241
- O 0 0.000501389498822391
function O 0 2.4695147658349015e-05
mutants O 0 0.00012962848995812237
as O 0 9.9903800219181e-06
predicted O 0 7.204456051113084e-05
by O 0 8.934785910241771e-06
haploinsufficiency O 0 0.004880155436694622
. O 0 0.0001728722854750231

Contrary O 0 0.00021339663362596184
to O 0 2.025804678851273e-05
this O 0 7.706412361585535e-06
theory O 0 7.819919846951962e-05
, O 0 3.3497140066174325e-06
our O 0 3.401214826226351e-06
data O 0 4.651391918741865e-06
showed O 0 1.1794425518019125e-05
that O 0 5.508287017619296e-07
these O 0 1.6303260963468347e-06
mutants O 0 9.006171603687108e-05
are O 0 2.664302428456722e-06
dominant O 0 0.00027434766525402665
- O 0 0.00014964534784667194
negative O 0 5.332833097781986e-06
in O 0 2.524731826269999e-05
transient O 0 0.0003500589227769524
transfection O 0 0.000937174423597753
assays O 0 1.775593227648642e-05
when O 0 8.260873983090278e-06
they O 0 9.82414121608599e-07
are O 0 5.735205377277452e-07
coexpressed O 0 0.0007929534767754376
with O 0 1.5044220162963029e-05
wild O 0 0.0005574947572313249
- O 0 0.002573490608483553
type O 0 0.0015017156256362796
PAX6 O 1 0.9998877048492432
. O 0 0.0007681970600970089

We O 0 6.989543180679902e-05
found O 0 1.157096994575113e-05
that O 0 1.4012430256116204e-06
the O 0 3.901164745911956e-05
dominant O 0 0.000912616727873683
- O 0 0.00044615499791689217
negative O 0 1.374897692585364e-05
effects O 0 0.0001575070054968819
result O 0 2.6948166123474948e-05
from O 0 1.6910218619159423e-05
the O 0 3.2993968488881364e-05
enhanced O 0 0.00017545056471135467
DNA O 0 8.229209925048053e-05
binding O 0 4.64849608761142e-06
ability O 0 5.811533355881693e-06
of O 0 4.202387935947627e-05
these O 0 3.0437025998253375e-05
mutants O 0 0.000847577874083072
. O 0 0.00011930059554288164

Kinetic O 0 0.0009104246273636818
studies O 0 3.7285884900484234e-05
of O 0 0.00014620092406403273
binding O 0 8.145777246681973e-05
and O 0 5.3510255384026095e-05
dissociation O 0 0.000332930707372725
revealed O 0 0.0002930656191892922
that O 0 1.5703207054684754e-06
various O 0 5.997611424390925e-06
truncation O 0 0.0005911627085879445
mutants O 0 0.0003086162614636123
have O 0 5.0541329983389005e-06
3 O 0 0.00012738924124278128
- O 0 0.00023894573678262532
5 O 0 0.00012808546307496727
- O 0 0.00010593525803415105
fold O 0 2.8259126338525675e-05
higher O 0 5.176124886929756e-06
affinity O 0 3.2996504160109907e-06
to O 0 3.690993708005408e-06
various O 0 1.8035303583019413e-05
DNA O 0 0.00039407340227626264
- O 0 0.0001446917449356988
binding O 0 2.361763563385466e-06
sites O 0 9.946640602720436e-06
when O 0 2.2290851120487787e-06
compared O 0 4.891860498901224e-06
with O 0 2.3750105810904643e-06
the O 0 0.00013029681576881558
wild O 0 0.0006738812080584466
- O 0 0.001680649584159255
type O 0 0.0013394105480983853
PAX6 O 1 0.9995850920677185
. O 0 0.0008518252288922668

These O 0 1.982423236768227e-05
results O 0 9.347824743599631e-06
provide O 0 4.825858923140913e-06
a O 0 6.975395081099123e-06
new O 0 6.941239917068742e-06
insight O 0 3.672920138342306e-05
into O 0 7.685651326028164e-06
the O 0 7.527358320658095e-06
role O 0 2.646794200700242e-05
of O 0 9.472925739828497e-05
mutant O 0 0.002126244828104973
PAX6 O 1 0.99997878074646
in O 0 0.0008119231788441539
causing O 0 0.15252405405044556
aniridia B-Disease 1 0.9999997615814209
. O 0 0.00021322903921827674
. O 0 0.00012927765783388168

Reversal O 0 0.012714659795165062
of O 1 0.9804690480232239
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9982175230979919
excellent O 1 0.8903915882110596
neuropsychologic O 1 0.9929916858673096
outcome O 0 0.00045072438661009073
in O 0 7.219282997539267e-05
very B-Disease 0 2.235656211269088e-05
- I-Disease 0 0.00028495799051597714
long I-Disease 0 0.00023871871235314757
- I-Disease 0 0.0004216030356474221
chain I-Disease 0 0.00018411746714264154
acyl I-Disease 0 0.00026545446598902345
- I-Disease 0 0.0006329652387648821
coenzyme I-Disease 0 0.00018002850993070751
A I-Disease 0 0.008968528360128403
dehydrogenase I-Disease 1 0.9996451139450073
deficiency I-Disease 1 1.0
. O 0 0.0019719733390957117

Very B-Disease 0 0.00047334685223177075
- I-Disease 0 0.0013100678334012628
long I-Disease 0 0.00037248601438477635
- I-Disease 0 0.0005504216533154249
chain I-Disease 0 0.0001077100750990212
acyl I-Disease 0 0.00012568963575176895
- I-Disease 0 0.00012079791486030445
coenzyme I-Disease 0 7.790513336658478e-06
A I-Disease 0 0.0002028934977715835
dehydrogenase I-Disease 0 0.0005887546576559544
( I-Disease 0 0.0008621696615591645
VLCAD I-Disease 1 1.0
) I-Disease 0 0.005366000812500715
deficiency I-Disease 1 0.9999997615814209
is O 0 7.751290104351938e-05
a O 0 0.00022221500694286078
disorder O 1 1.0
of O 1 0.9999920129776001
fatty O 1 0.9999998807907104
acid O 0 0.1483749896287918
beta O 0 0.0025247579906135798
oxidation O 0 0.00012854690430685878
that O 0 5.434239028545562e-06
reportedly O 0 5.7227145589422435e-05
has O 0 2.945234427897958e-06
high O 0 4.0402705053566024e-05
rates O 0 1.4785327039135154e-05
of O 0 6.779396790079772e-05
morbidity O 0 0.0021947319619357586
and O 0 9.492132812738419e-05
mortality O 0 0.001616683672182262
. O 0 0.00016746149049140513

We O 0 5.961749411653727e-05
describe O 0 4.2085801396751776e-05
the O 0 2.1741725504398346e-05
outcome O 0 3.858482159557752e-05
of O 0 5.44720132893417e-05
a O 0 7.344713230850175e-05
5 O 0 0.00042055174708366394
- O 0 0.0004749631625600159
year O 0 0.00011597914999583736
- O 0 0.0003521348407957703
old O 0 0.0003708936274051666
girl O 0 0.0004229967016726732
with O 0 0.00035403500078246
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0010072325821965933
was O 0 0.0017354302108287811
first O 0 9.80940749286674e-05
seen O 0 7.001143967499956e-05
at O 0 4.79301052109804e-05
5 O 0 1.616525878489483e-05
months O 0 5.497656729858136e-06
of O 0 1.1426179298723582e-05
age O 0 0.0003129205433651805
with O 0 0.0003331294865347445
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 0 0.0038713288959115744
and O 0 0.0013651171466335654
hypotonia B-Disease 1 0.999987006187439
. O 0 0.002066213171929121

Biochemical O 0 0.007006299216300249
studies O 0 0.0012354518985375762
indicated O 1 0.9999972581863403
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999680519104004
by O 0 0.00013714628585148603
a O 0 0.00010929899872280657
stable O 0 0.000590949784964323
yet O 0 5.4908538004383445e-05
inactive O 0 0.0004829951503779739
enzyme O 0 7.823672058293596e-05
. O 0 7.844462379580364e-05

Molecular O 0 0.0004522149683907628
genetic O 0 0.00011189172073500231
analysis O 0 1.3757069609710015e-05
of O 0 0.0003201367799192667
her O 0 0.0007475237944163382
VLCAD O 1 0.9999995231628418
gene O 0 0.0002679335593711585
revealed O 0 0.000625080312602222
a O 0 0.00010365169146098197
T1372C O 0 0.0031604308169335127
( O 0 0.00015171023551374674
F458L O 0 0.0032738149166107178
) O 0 8.881009853212163e-05
missense O 0 0.0005283421487547457
mutation O 0 2.5088960683206096e-05
and O 0 2.146997576346621e-05
a O 0 0.0004519814101513475
1668 O 1 0.9999878406524658
ACAG O 1 0.9999998807907104
1669 O 1 0.9980173110961914
splice O 0 0.008898249827325344
site O 0 0.0020951309707015753
mutation O 0 7.952135638333857e-05
. O 0 8.86276102392003e-05

After O 0 0.0001749677467159927
initial O 0 6.787969323340803e-05
treatment O 0 0.0002632096875458956
with O 0 8.928008901420981e-05
intravenous O 1 0.9713580012321472
glucose O 1 0.7763578295707703
and O 0 0.000736880989279598
carnitine O 1 0.996833860874176
, O 0 3.1833744287723675e-05
the O 0 3.9026086597004905e-05
patient O 0 3.5582943382905796e-05
has O 0 6.279665285546798e-06
thrived O 0 0.0003883930912707001
on O 0 2.7723663151846267e-05
a O 0 2.275336009915918e-05
low O 0 0.00038213576772250235
- O 0 0.0007224713335745037
fat O 0 0.00032306238426826894
diet O 0 2.923507781815715e-05
supplemented O 0 1.5082846402947325e-05
with O 0 2.0927482182742096e-06
medium O 0 0.00017497474618721753
- O 0 0.0005930158658884466
chain O 0 0.00020284397760406137
triglyceride O 0 0.001251607551239431
oil O 0 0.0010413815034553409
and O 0 8.630650700069964e-05
carnitine O 0 0.010523385368287563
and O 0 0.00010259654663968831
avoidance O 0 0.0026965364813804626
of O 0 0.002892854157835245
fasting O 0 0.009183813817799091
. O 0 0.000878293882124126

Her O 0 0.013722939416766167
ventricular O 1 0.9999996423721313
hypertrophy O 1 0.9999973773956299
resolved O 0 0.012540851719677448
significantly O 0 0.0001466850662836805
over O 0 4.008562973467633e-05
1 O 0 0.00022241761325858533
year O 0 8.363141387235373e-05
, O 0 1.1373962479410693e-05
and O 0 3.219144491595216e-05
cognitively O 0 0.005644841119647026
, O 0 1.7692715118755586e-05
she O 0 8.643870387459174e-06
is O 0 1.8157790009354358e-06
in O 0 3.896662292390829e-06
the O 0 1.3342425518203527e-05
superior O 0 0.00014951941557228565
range O 0 7.191339682321995e-05
for O 0 4.02988116547931e-05
age O 0 0.0019743714947253466
. O 0 0.00043262692634016275

Clinical O 0 0.00041153919300995767
recognition O 0 0.001972314901649952
of O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.0011590863578021526
important O 0 0.00024576892610639334
because O 0 4.683860424847808e-06
it O 0 7.201960556812992e-07
is O 0 3.6978534012632736e-07
one O 0 3.8090263387857703e-07
of O 0 4.813223767996533e-06
the O 0 4.390960020828061e-05
few O 0 0.0002117322728736326
directly O 0 0.0006500224699266255
treatable O 1 1.0
causes O 0 0.012484695762395859
of O 1 0.9999408721923828
cardiomyopathy B-Disease 1 1.0
in O 1 0.9999570846557617
children O 0 0.002445910358801484
. O 0 0.00014158284466248006
. O 0 0.00011053789785364643

Cloning O 0 0.0005139050772413611
of O 0 7.241037383209914e-05
a O 0 5.089307887828909e-05
novel O 0 7.143080438254401e-05
member O 0 1.3567316273110919e-05
of O 0 4.697123949881643e-05
the O 0 0.00010297723201802
low O 0 0.0005326810060068965
- O 0 0.0002402295358479023
density O 0 3.476439815131016e-05
lipoprotein O 0 0.001033123000524938
receptor O 0 0.00021954646217636764
family O 0 0.00010494099842617288
. O 0 9.141916234511882e-05

A O 0 0.0007824849453754723
gene O 0 1.60859854076989e-05
encoding O 0 8.611214980192017e-06
a O 0 2.038560705841519e-05
novel O 0 0.00017220435256604105
transmembrane O 0 0.0007508847629651427
protein O 0 4.6470675442833453e-05
was O 0 5.9525413234950975e-05
identified O 0 2.2221468043426285e-06
by O 0 2.2272590172178752e-07
DNA O 0 3.3563460419827607e-06
sequence O 0 1.4512460211335565e-06
analysis O 0 4.046498247589625e-07
within O 0 2.7401135866966797e-06
the O 0 3.504116102703847e-05
insulin B-Disease 0 0.0019857699517160654
- I-Disease 0 0.004537178203463554
dependent I-Disease 0 0.0007844312931410968
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.7120333313941956
IDDM B-Disease 1 1.0
) O 0 0.0002037210506387055
locus O 0 0.0006859101704321802
IDDM4 O 1 0.987963080406189
on O 0 0.0009886891348287463
chromosome O 0 0.0032084910199046135
11q13 O 0 0.006889650598168373
. O 0 0.00037406012415885925

Based O 0 2.4364237106055953e-05
on O 0 8.292930579045787e-05
its O 0 3.791852941503748e-05
chromosomal O 0 0.0006473855464719236
position O 0 0.0001893991429824382
, O 0 1.2066141607647296e-05
this O 0 3.463032726358506e-06
gene O 0 1.1447960787336342e-05
is O 0 1.802772771952732e-06
a O 0 2.5895612907334e-06
candidate O 0 1.8975340481119929e-06
for O 0 1.3472924820234766e-06
conferring O 0 0.0003056489222217351
susceptibility O 0 0.0029141507111489773
to O 0 0.0015078525757417083
diabetes B-Disease 1 1.0
. O 0 0.004239044152200222

The O 0 0.0004077884368598461
gene O 0 0.00013850664254277945
, O 0 1.630956285225693e-05
termed O 0 0.0003503806365188211
low O 0 0.00039256649324670434
- O 0 0.00015898160927463323
density O 0 1.3706820936931763e-05
lipoprotein O 0 0.00014899609959684312
receptor O 0 1.7936796211870387e-05
related O 0 5.4186642955755815e-05
protein O 0 4.9643145757727325e-05
5 O 0 0.00012241680815350264
( O 0 8.235458517447114e-05
LRP5 O 0 0.07119408994913101
) O 0 1.7172220395877957e-05
, O 0 1.6543426681892015e-06
encodes O 0 2.8054730591975385e-06
a O 0 5.254743882687762e-06
protein O 0 2.6606752726365812e-05
of O 0 0.0002186132041970268
1615 O 0 0.02335127629339695
amino O 0 0.00022044275829102844
acids O 0 1.4945320799597539e-05
that O 0 1.6542859384571784e-06
contains O 0 2.3342650820268318e-05
conserved O 0 0.00018792584887705743
modules O 0 0.00014273312990553677
which O 0 2.3562943169963546e-06
are O 0 4.47905591727249e-07
characteristic O 0 1.4773909242649097e-05
of O 0 6.789885082980618e-05
the O 0 0.00024218964972533286
low O 0 0.0009123976342380047
- O 0 0.00039486761670559645
density O 0 8.768559200689197e-05
lipoprotein O 0 0.004387666005641222
( O 0 0.0005708065000362694
LDL O 0 0.06387361139059067
) O 0 8.999467536341399e-05
receptor O 0 8.870490273693576e-05
family O 0 4.148886364419013e-05
. O 0 4.970628651790321e-05

These O 0 9.519961167825386e-05
modules O 0 0.0005049790488556027
include O 0 3.404958260944113e-05
a O 0 4.416774754645303e-05
putative O 0 0.0006280724774114788
signal O 0 0.0003422723966650665
peptide O 0 0.00012526975478976965
for O 0 7.944869139464572e-06
protein O 0 3.8113277696538717e-05
export O 0 7.968061254359782e-05
, O 0 4.753238954435801e-06
four O 0 1.599057395651471e-05
epidermal O 0 0.002317943377420306
growth O 0 0.0002133197122020647
factor O 0 0.00014635953994002193
( O 0 0.00015274996985681355
EGF O 0 0.04959870129823685
) O 0 2.9827679099980742e-05
repeats O 0 6.852525257272646e-05
with O 0 3.4560316635179333e-06
associated O 0 2.635075361467898e-05
spacer O 0 0.001028254977427423
domains O 0 0.0004726692277472466
, O 0 3.996188388555311e-05
three O 0 0.00011520066618686542
LDL O 1 0.9765864610671997
- O 0 0.0021491479128599167
receptor O 0 0.00018300309602636844
( O 0 0.00010888382530538365
LDLR O 1 0.8517991304397583
) O 0 2.784820389933884e-05
repeats O 0 9.876451076706871e-05
, O 0 3.6697379073302727e-06
a O 0 9.807210517465137e-06
single O 0 4.6447545173577964e-05
transmembrane O 0 0.0017201571026816964
spanning O 0 0.011006358079612255
domain O 0 0.0009277414646930993
, O 0 3.994672078988515e-05
and O 0 1.0974348697345704e-05
a O 0 5.0300091970711946e-05
cytoplasmic O 0 0.0003928100340999663
domain O 0 0.000685403065290302
. O 0 0.00019806480850093067

The O 0 0.00013204084825702012
encoded O 0 3.0486991818179376e-05
protein O 0 2.0709054297185503e-05
has O 0 1.0686441100915545e-06
a O 0 1.960363533726195e-06
unique O 0 5.849477474839659e-06
organization O 0 7.896323040768038e-06
of O 0 0.00018442848522681743
EGF O 1 0.9999548196792603
and O 0 0.0004550970043055713
LDLR O 1 0.9999885559082031
repeats O 0 0.001312562613748014
; O 0 8.086237357929349e-06
therefore O 0 1.8244410966872238e-05
, O 0 2.2544112653122284e-05
LRP5 O 1 0.8562757968902588
likely O 0 3.7906418583588675e-05
represents O 0 6.9552484092128e-06
a O 0 4.134830760449404e-06
new O 0 2.807566261253669e-06
category O 0 1.2142442756157834e-05
of O 0 5.261764090391807e-05
the O 0 0.0006704098777845502
LDLR O 1 0.9999955892562866
family O 0 0.0003756657533813268
. O 0 0.00017499395471531898

Both O 0 0.00015697530761826783
human O 0 0.0002757642650976777
and O 0 0.0001595448557054624
mouse O 0 0.0020146758761256933
LRP5 O 1 0.9999929666519165
cDNAs O 0 0.013581504113972187
have O 0 5.254638381302357e-06
been O 0 1.1102331882284489e-05
isolated O 0 2.4797898731776513e-05
and O 0 1.6796448107925244e-06
the O 0 1.1750561498047318e-05
encoded O 0 3.424118403927423e-05
mature O 0 0.00011244566849200055
proteins O 0 3.9101901165849995e-06
are O 0 6.68736788611568e-07
95 O 0 3.2112031476572156e-05
% O 0 1.3727018085774034e-05
identical O 0 2.324198248970788e-05
, O 0 8.168447493517306e-06
indicating O 0 7.481939246645197e-05
a O 0 2.1416823074105196e-05
high O 0 0.00014131254283711314
degree O 0 0.0001122511166613549
of O 0 0.00022717849060427397
evolutionary O 0 0.0003442750312387943
conservation O 0 0.0001322374155279249
. O 0 2.2065489247324876e-05
. O 0 4.193732456769794e-05

The O 0 0.0014753169380128384
APC B-Disease 0 0.008197635412216187
variants O 0 0.00026888554566539824
I1307K O 0 0.0013680141419172287
and O 0 1.3560072147811297e-05
E1317Q O 0 0.00031288713216781616
are O 0 1.7984676787818898e-06
associated O 0 6.691678572678939e-05
with O 1 0.9332599639892578
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.813224732875824
but O 0 5.226428038440645e-05
not O 0 4.3535028453334235e-06
always O 0 4.287966930860421e-06
with O 0 7.29945838884305e-07
a O 0 1.5595702279824764e-05
family O 0 3.704547634697519e-05
history O 0 0.0007450456032529473
. O 0 0.00021048269991297275

Classical O 1 0.9959291815757751
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999998927116394
FAP B-Disease 1 1.0
) O 0 0.00018848251784220338
is O 0 9.061071068572346e-06
a O 0 3.562535493983887e-05
high O 0 0.0033129812218248844
- O 0 0.19169756770133972
penetrance O 1 0.9902896285057068
autosomal B-Disease 1 0.9995689988136292
dominant I-Disease 1 0.9999797344207764
disease I-Disease 1 1.0
that O 0 8.727949170861393e-05
predisposes O 0 0.03701768070459366
to O 0 7.350500527536497e-05
hundreds O 0 0.00012945517664775252
or O 0 3.1181476515484974e-05
thousands O 0 0.00082252302672714
of O 1 0.9999781847000122
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 0.001619225717149675
that O 0 2.1468029444804415e-05
results O 0 3.0652845453005284e-05
from O 0 4.664360676542856e-05
truncating O 0 0.0009082729229703546
mutations O 0 2.5530844141030684e-05
in O 0 3.537962766131386e-05
the O 0 0.0003023368481080979
APC B-Disease 0 0.009902985766530037
gene O 0 0.0001606836449354887
. O 0 0.00010513641609577462

A O 0 0.0010181473335251212
variant O 0 0.0005054989014752209
of O 0 0.0011868206784129143
FAP B-Disease 1 0.9999884366989136
is O 0 0.0005004904232919216
attenuated B-Disease 1 0.9883072972297668
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999457597732544
, O 0 5.509268885361962e-05
which O 0 4.5558876990980934e-06
results O 0 2.991461951751262e-05
from O 0 0.00020562452846206725
germ O 1 0.9999992847442627
- O 0 0.0020315381698310375
line O 0 0.00018785848806146532
mutations O 0 7.4503268479020335e-06
in O 0 5.992363185214344e-06
the O 0 2.0922789190080948e-05
5 O 0 4.434340007719584e-05
and O 0 2.7821386083815014e-06
3 O 0 2.9104307031957433e-05
regions O 0 1.3653656424139626e-05
of O 0 5.44596987310797e-05
the O 0 0.000558197614736855
APC B-Disease 0 0.009530332870781422
gene O 0 0.00018339681264478713
. O 0 0.00012610149860847741

Attenuated B-Disease 1 0.9999995231628418
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.001720873056910932
have O 0 2.6099110982613638e-05
" O 0 0.00042812922038137913
multiple O 0 0.0020404700189828873
" O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.0010099809151142836
typically O 0 2.2908601749804802e-05
fewer O 0 1.8334638298256323e-05
than O 0 3.8100179153843783e-06
100 O 0 5.5555217841174453e-05
) O 0 9.321403922513127e-06
without O 0 6.0685001699312124e-06
the O 0 5.8370143960928544e-05
florid O 0 0.003874290268868208
phenotype O 0 0.00016008401871658862
of O 0 0.00043097633169963956
classical O 0 0.1780620515346527
FAP B-Disease 1 0.9999206066131592
. O 0 0.0012502928730100393

Another O 0 0.0002131444780388847
group O 0 1.4969512449169997e-05
of O 0 0.00019329167844261974
patients O 0 0.00036657784949056804
with O 0 0.00011439235822763294
multiple O 1 0.9832234978675842
adenomas B-Disease 1 1.0
has O 0 0.0003050800587516278
no O 0 6.978095188969746e-05
mutations O 0 3.25046457874123e-05
in O 0 4.099887519259937e-05
the O 0 0.00035479117650538683
APC B-Disease 0 0.00811739545315504
gene O 0 7.575702329631895e-05
, O 0 9.101073374040425e-06
and O 0 3.853227553918259e-06
their O 0 7.010105491644936e-06
phenotype O 0 8.307446842081845e-05
probably O 0 8.500763215124607e-05
results O 0 6.693188879580703e-06
from O 0 1.0681992534955498e-05
variation O 0 3.686293348437175e-05
at O 0 0.0003278583171777427
a O 0 5.838138531544246e-05
locus O 0 0.00028633710462599993
, O 0 2.4266082618851215e-05
or O 0 3.0569910450140014e-05
loci O 0 0.00020329240942373872
, O 0 1.1679171620926354e-05
elsewhere O 0 1.641980452404823e-05
in O 0 9.02995543583529e-06
the O 0 4.901565989712253e-05
genome O 0 0.00017774038133211434
. O 0 6.75623377901502e-05

Recently O 0 0.0007344902842305601
, O 0 1.13753512778203e-05
however O 0 5.975944532110589e-06
, O 0 1.9330266241013305e-06
a O 0 6.3442421378567815e-06
missense O 0 0.00019411910034250468
variant O 0 0.0003357954556122422
of O 0 0.0018921069568023086
APC B-Disease 1 0.9967854022979736
( O 0 0.0005558996926993132
I1307K O 0 0.005838064476847649
) O 0 3.598486728151329e-05
was O 0 8.866835560183972e-05
described O 0 1.2224716556374915e-05
that O 0 4.4229281570551393e-07
confers O 0 1.3918765944254119e-05
an O 0 1.6967653664323734e-06
increased O 0 0.00011180331057403237
risk O 0 0.0023588791955262423
of O 1 0.9999994039535522
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.013802534900605679
including O 0 0.00037835666444152594
multiple O 0 0.14999790489673615
adenomas B-Disease 1 1.0
, O 0 0.0002890872419811785
in O 0 0.0005015592905692756
Ashkenazim O 1 0.9200782179832458
. O 0 0.0007885521627031267

We O 0 4.588744559441693e-05
have O 0 1.6802679283500765e-06
studied O 0 3.2176005333894864e-05
a O 0 6.507703801617026e-06
set O 0 1.3933241461927537e-05
of O 0 1.3129461876815185e-05
164 O 0 0.00019876933947671205
patients O 0 4.759701187140308e-05
with O 0 6.080254752305336e-05
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 0.9999576807022095
carcinoma I-Disease 1 1.0
and O 0 0.0015499308938160539
analyzed O 0 0.0022476045414805412
codons O 0 0.0032604311127215624
1263 O 0 0.07861639559268951
- O 0 0.004809368867427111
1377 O 0 0.0389939583837986
( O 0 0.0001567509607411921
exon O 0 0.0010809863451868296
15G O 0 0.0005924588767811656
) O 0 3.198731974407565e-06
of O 0 9.556485565553885e-06
the O 0 0.000136393922730349
APC B-Disease 0 0.0033744308166205883
gene O 0 4.3255506170680746e-05
for O 0 9.798683458939195e-05
germ O 1 0.9999991655349731
- O 0 0.003039879258722067
line O 0 0.0007708222838118672
variants O 0 0.00017446462879888713
. O 0 0.00015367928426712751

Three O 0 0.000235745741520077
patients O 0 5.492482159752399e-05
with O 0 7.72839666751679e-06
the O 0 0.0001610482722753659
I1307K O 0 0.0030701695941388607
allele O 0 2.552332080085762e-05
were O 0 2.706008672248572e-05
detected O 0 0.00013658210809808224
, O 0 1.4810791526542744e-06
each O 0 5.034218588662043e-07
of O 0 3.817454125965014e-05
Ashkenazi O 0 0.0012020990252494812
descent O 0 0.003025337355211377
. O 0 0.0007648140308447182

Four O 0 0.00037106461240909994
patients O 0 0.00015253821038641036
had O 0 0.0002599694998934865
a O 0 0.0006882458692416549
germ O 1 1.0
- O 0 0.009114188142120838
line O 0 0.0011413672473281622
E1317Q O 0 0.001385518116876483
missense O 0 0.0002567725023254752
variant O 0 0.0002492983767297119
of O 0 0.0005509783513844013
APC O 0 0.00983264110982418
that O 0 9.33007504499983e-06
was O 0 0.00018378140521235764
not O 0 2.5876158815663075e-06
present O 0 2.0357902030809782e-05
in O 0 2.9380049454630353e-05
controls O 0 4.4743454054696485e-05
; O 0 3.990792720287573e-06
one O 0 4.019645984953968e-06
of O 0 3.1523610232397914e-05
these O 0 9.815706107474398e-06
individuals O 0 4.953220923198387e-06
had O 0 8.133544906741008e-05
an O 0 1.2202261132188141e-05
unusually O 0 8.819226059131324e-05
large O 0 2.3365637389360927e-05
number O 0 1.831429653975647e-05
of O 0 0.00038947895518504083
metaplastic B-Disease 1 0.9963306784629822
polyps I-Disease 0 0.01805347576737404
of I-Disease 0 0.0006189567502588034
the I-Disease 0 0.0015891008079051971
colorectum I-Disease 1 0.9990859031677246
. O 0 0.0007929244311526418

There O 0 6.730724271619692e-05
is O 0 3.874565663863905e-06
increasing O 0 5.387082183005987e-06
evidence O 0 1.142581913882168e-05
that O 0 8.496526788803749e-07
there O 0 1.5558814993710257e-05
exist O 0 0.00028891756664961576
germ O 1 0.9996875524520874
- O 0 0.0005324172670952976
line O 0 7.962280506035313e-05
variants O 0 1.8561479009804316e-05
of O 0 5.068849350209348e-05
the O 0 0.00017768565157894045
APC B-Disease 0 0.004707288928329945
gene O 0 3.0075721952016465e-05
that O 0 2.5026040475495392e-06
predispose O 0 0.00012932883691973984
to O 0 4.925570920022437e-06
the O 0 1.1981858733633999e-05
development O 0 3.610321437008679e-05
of O 0 0.00033436782541684806
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.0051626344211399555
but O 0 2.1121664758538827e-05
without O 0 1.4131588613963686e-05
the O 0 9.882782615022734e-05
florid O 0 0.005955183412879705
phenotype O 0 0.00016554270405322313
of O 0 0.0004991007153876126
classical O 0 0.1593785583972931
FAP B-Disease 1 0.999729573726654
, O 0 2.616425626911223e-05
and O 0 2.1737118913733866e-06
possibly O 0 1.3124279576004483e-05
with O 0 1.6236185729212593e-06
importance O 0 0.0028749776538461447
for O 1 0.9996956586837769
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.5651829242706299
in O 0 8.502027776557952e-05
the O 0 3.3420525141991675e-05
general O 0 2.9394814191618934e-05
population O 0 8.710145266377367e-06
. O 0 1.1429197911638767e-05
. O 0 4.682914732256904e-05

Genomic O 0 0.00015125467325560749
structure O 0 0.00015670029097236693
of O 0 9.71837725955993e-05
the O 0 0.13008669018745422
human O 1 1.0
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.001565230661071837
gene O 0 0.0003595902235247195
. O 0 0.00014614296378567815

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 0 0.0007662978605367243
is O 0 3.846696199616417e-05
caused O 0 9.487544593866915e-05
by O 0 3.533790504661738e-06
mutations O 0 6.840917194494978e-06
in O 0 6.786567610106431e-06
a O 0 8.889748642104678e-06
gene O 0 6.073299573472468e-06
which O 0 4.0779809751256835e-06
encodes O 0 3.80701276299078e-05
an O 0 5.5663342209300026e-05
intestinal O 1 1.0
anion O 1 0.982721745967865
transporter O 1 0.9994619488716125
. O 0 0.001572656910866499

We O 0 6.775029032723978e-05
report O 0 6.1624245972780045e-06
here O 0 4.850709956372157e-06
the O 0 2.80246763395553e-06
complete O 0 4.366127905086614e-05
genomic O 0 5.358536873245612e-05
organization O 0 6.498748007288668e-06
of O 0 3.9556718547828496e-05
the O 0 0.0002005967398872599
human O 0 0.0004169355961494148
CLD B-Disease 1 0.9999971389770508
gene O 0 9.558356396155432e-05
which O 0 1.7379776181769557e-05
spans O 0 0.0013885879889130592
approximately O 0 0.00018709983851294965
39kb O 0 0.0057479701936244965
, O 0 1.118982345360564e-05
and O 0 4.6900017878215294e-06
comprises O 0 0.00014194050163496286
21 O 0 0.0013945583486929536
exons O 0 0.0029006507247686386
. O 0 0.0002268460375489667

All O 0 0.0004060434002894908
exon O 0 0.004474025685340166
/ O 0 0.0011723388452082872
intron O 0 0.0023466218262910843
boundaries O 0 1.1461223039077595e-05
conform O 0 1.671515747148078e-05
to O 0 1.01073419500608e-05
the O 0 0.00023341808991972357
GT O 0 0.02984023466706276
/ O 0 0.007264510728418827
AG O 1 0.9994146823883057
rule O 0 0.002286938251927495
. O 0 0.0005717765307053924

An O 0 7.272662514878903e-06
analysis O 0 3.9118162931117695e-06
of O 0 6.596402090508491e-05
the O 0 0.00029528012964874506
putative O 0 0.0011606308398768306
promoter O 0 0.0026034624315798283
region O 0 0.00025518666370771825
sequence O 0 4.4761804019799456e-05
shows O 0 6.174391455715522e-05
a O 0 0.0001480908686062321
putative O 0 0.005316575989127159
TATA O 1 0.9908691644668579
box O 0 0.001517970347777009
and O 0 1.2468605746107642e-05
predicts O 0 6.585378287127241e-05
multiple O 0 2.1640631530317478e-05
transcription O 0 0.0011648574145510793
factor O 0 0.00013371727254707366
binding O 0 2.2395741325453855e-05
sites O 0 0.00015185408119577914
. O 0 9.744193812366575e-05

The O 0 0.0002731848508119583
genomic O 0 0.00036277109757065773
structure O 0 0.0005998993874527514
was O 0 0.00021743036631960422
determined O 0 1.5221363355522044e-05
using O 0 4.043368335260311e-06
DNA O 0 3.3462241844972596e-05
from O 0 3.891277629008982e-06
several O 0 3.606076916184975e-06
sources O 0 1.307722686760826e-05
including O 0 1.0071328688354697e-05
multiple O 0 0.00014393284800462425
large O 0 0.0014676367864012718
- O 0 0.006211647763848305
insert O 0 0.0011631431989371777
libaries O 0 0.0015789746539667249
and O 0 3.459893378021661e-06
genomic O 0 2.0163373847026378e-05
DNA O 0 0.0001321555901085958
from O 0 0.00014097285747993737
Finnish O 1 0.9999483823776245
CLD B-Disease 1 1.0
patients O 0 0.0010608596494421363
and O 0 0.00010399928578408435
controls O 0 0.0007470619748346508
. O 0 0.0004368577210698277

Exon O 0 0.018284251913428307
- O 0 0.0005054247449152172
specific O 0 5.701422651327448e-06
primers O 0 0.0001382919290335849
developed O 0 3.6732672015205026e-05
in O 0 5.9445114857226145e-06
this O 0 8.615984370408114e-07
study O 0 1.5948882037264411e-06
will O 0 1.107200773731165e-06
facilitate O 0 1.3204085007600952e-05
mutation O 0 1.1136943385281484e-06
screening O 0 3.544131459420896e-06
studies O 0 2.930849632321042e-06
of O 0 3.228274727007374e-05
patients O 0 8.512086787959561e-05
with O 0 4.79963309771847e-05
the O 0 0.005076045170426369
disease O 1 1.0
. O 0 0.0015467788325622678

Genomic O 0 0.00014719100727234036
sequencing O 0 7.13049594196491e-05
of O 0 0.00015268431161530316
a O 0 0.0007925825193524361
BAC O 1 0.9999984502792358
clone O 1 0.5835816264152527
H O 1 0.9999984502792358
_ O 0 0.00034436711575835943
RG364P16 O 0 0.0009190381970256567
revealed O 0 0.00010652156197465956
the O 0 9.421093636774458e-06
presence O 0 7.558477136626607e-06
of O 0 2.8611211746465415e-05
another O 0 4.728831845568493e-05
, O 0 8.252755833382253e-06
highly O 0 4.381117469165474e-05
homologous O 0 0.00010483786900294945
gene O 0 2.9990969778737053e-05
3 O 0 9.533760021440685e-05
of O 0 0.00016043608775362372
the O 0 0.0011727577075362206
CLD B-Disease 1 0.9999864101409912
gene O 0 0.0001005476078717038
, O 0 2.801137043206836e-06
with O 0 4.877480819232005e-07
a O 0 5.41433382750256e-06
similar O 0 5.506975867319852e-06
genomic O 0 9.439139103051275e-05
structure O 0 0.00038990165921859443
, O 0 5.145477643964114e-06
recently O 0 9.04818716662703e-06
identified O 0 2.707306975935353e-06
as O 0 5.42472207598621e-06
the O 0 0.0002624011249281466
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.024042608216404915
( O 0 0.0024713906459510326
PDS B-Disease 1 0.9999990463256836
) O 0 0.0002712419955059886
. O 0 6.254804611671716e-05
. O 0 9.699767542770132e-05

The O 0 0.0020755226723849773
APCI1307K O 1 0.9999957084655762
allele O 0 0.00040901187458075583
and O 0 0.00013782709720544517
cancer B-Disease 1 0.9988376498222351
risk O 0 0.0002977823605760932
in O 0 6.982514605624601e-05
a O 0 4.437394454726018e-05
community O 0 1.9288892872282304e-05
- O 0 3.243534956709482e-05
based O 0 4.2334480099270877e-07
study O 0 1.914067752295523e-06
of O 0 2.668875822564587e-05
Ashkenazi O 0 0.0006519315065816045
Jews O 0 0.004660265054553747
. O 0 0.0008342054206877947

Mutations O 0 0.0007430199184454978
in O 0 0.0003479795122984797
APC O 0 0.0062732757069170475
are O 0 5.979194156680023e-06
classically O 0 0.00029889281722716987
associated O 0 2.657100048963912e-05
with O 0 8.143029117491096e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 0 0.00026101808180101216
, O 0 8.284731848107185e-06
a O 0 2.6230009098071605e-05
highly O 0 0.024854004383087158
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9999995231628418
multiple O 1 1.0
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.007257415913045406
, O 0 0.00010050945274997503
without O 0 7.616716902703047e-05
surgical O 0 0.01664474979043007
intervention O 0 0.0004481791111174971
, O 0 6.86233579472173e-06
the O 0 1.3464881703839637e-05
development O 0 0.0001264121092390269
of O 1 0.9977896213531494
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999969005584717
CRC B-Disease 1 0.9999991655349731
) O 0 0.00034924258943647146
. O 0 0.00011144491872983053

APC B-Disease 0 0.015269485302269459
is O 0 6.328547169687226e-05
a O 0 0.0004119480145163834
tumour O 1 1.0
- O 1 0.9696769118309021
suppressor O 0 0.0035604648292064667
gene O 0 3.846556501230225e-05
, O 0 4.4544444790517446e-06
and O 0 8.36725394037785e-06
somatic O 0 0.0004927006084471941
loss O 0 0.018410921096801758
occurs O 0 0.0010759476572275162
in O 0 0.00208763824775815
tumours B-Disease 1 1.0
. O 0 0.002896345453336835

The O 0 0.0028652751352638006
germline O 0 0.08246162533760071
T O 0 0.05968499183654785
- O 0 0.0005115608801133931
to O 0 3.965647192671895e-05
- O 0 0.00021625272347591817
A O 0 0.0002812119200825691
transversion O 0 0.0017772745341062546
responsible O 0 2.372371636738535e-05
for O 0 8.529669685231056e-06
the O 0 0.00037567486288025975
APC O 0 0.00791980605572462
I1307K O 0 0.0019790655933320522
allele O 0 1.514926043455489e-05
converts O 0 1.5021251783764455e-05
the O 0 3.515690332278609e-05
wild O 0 6.68856519041583e-05
- O 0 2.103350379911717e-05
type O 0 2.821636599037447e-06
sequence O 0 2.7198245788895292e-06
to O 0 5.323097411746858e-06
a O 0 0.00010420279431855306
homopolymer O 1 0.9999291896820068
tract O 1 0.9999983310699463
( O 0 0.002723868004977703
A8 O 1 0.9997159838676453
) O 0 6.540735193993896e-05
that O 0 4.982656719221268e-06
is O 0 2.722590579651296e-05
genetically O 0 0.00028383571770973504
unstable O 0 0.003792467759922147
and O 0 9.041978773893788e-05
prone O 0 0.001786162261851132
to O 0 0.00017984630540013313
somatic O 0 0.0025228625163435936
mutation O 0 0.0002808973367791623
. O 0 0.0003949402889702469

The O 0 0.0008878074586391449
I1307K O 0 0.0035139769315719604
allele O 0 4.839273606194183e-05
was O 0 0.00016437451995443553
found O 0 1.647250246605836e-05
in O 0 4.6653705794597045e-05
6 O 0 0.0012497617863118649
. O 0 0.000275254191365093

1 O 0 0.0009061097516678274
% O 0 7.893703150330111e-05
of O 0 0.0002860429813154042
unselected O 1 0.6029535531997681
Ashkenazi O 0 0.0023576205130666494
Jews O 0 0.0019183132098987699
and O 0 8.034686470637098e-05
higher O 0 0.00015090459783095866
proportions O 0 0.0003466373891569674
of O 0 0.00017546696471981704
Ashkenazim O 0 0.007953104563057423
with O 0 6.009611388435587e-05
family O 0 8.938828250393271e-05
or O 0 4.398880628286861e-05
personal O 0 0.0004011128330603242
histories O 0 0.0033275315072387457
of O 1 0.9933104515075684
CRC B-Disease 1 0.9999998807907104
( O 0 0.0019336628029122949
ref O 0 0.12667877972126007
. O 0 6.096279321354814e-05
2 O 0 0.0003422980080358684
) O 0 6.411867070710286e-05
. O 0 6.771799235139042e-05

To O 0 3.278548683738336e-05
evaluate O 0 3.778367681661621e-05
the O 0 1.4718545571668074e-05
role O 0 2.8896112780785188e-05
of O 0 0.00015877165424171835
I1307K O 0 0.006196536123752594
in O 0 0.00034494753344915807
cancer B-Disease 1 0.8417730927467346
, O 0 3.3352549507981166e-05
we O 0 3.866936458507553e-05
genotyped O 0 0.006324424874037504
5 O 0 0.0006016475381329656
, O 0 5.699404937331565e-05
081 O 0 0.008809425868093967
Ashkenazi O 0 0.000560277549084276
volunteers O 0 0.00014219817239791155
in O 0 1.5609050024067983e-05
a O 0 1.470716597395949e-05
community O 0 9.248589776689187e-06
survey O 0 3.171850403305143e-05
. O 0 9.198020416079089e-05

Risk O 0 0.0010951238218694925
of O 0 0.0018877419643104076
developing O 1 0.9999958276748657
colorectal B-Disease 1 1.0
, I-Disease 1 0.5469632744789124
breast I-Disease 1 0.9999818801879883
and I-Disease 0 6.965264037717134e-05
other I-Disease 0 4.876738239545375e-05
cancers I-Disease 1 0.9971336126327515
were O 0 0.00012713174510281533
compared O 0 0.00016752028022892773
between O 0 0.0011529932962730527
genotyped O 0 0.2746179401874542
I1307K O 0 0.005865594372153282
carriers O 0 5.9683876315830275e-05
and O 0 1.119653825298883e-05
non O 0 0.00026019959477707744
- O 0 0.0002450052706990391
carriers O 0 7.769144758640323e-06
and O 0 5.650631464959588e-07
their O 0 9.932838338500005e-07
first O 0 2.8998776542721316e-05
- O 0 0.00010033909347839653
degree O 0 7.490920688724145e-05
relatives O 0 0.00011374148743925616
. O 0 6.55560361337848e-05

Sperm O 0 0.00014833803288638592
DNA O 0 3.511247632559389e-05
analysis O 0 1.5603724250468076e-06
in O 0 1.4955002370697912e-05
a O 0 0.00024360441602766514
Friedreich B-Disease 1 0.9999990463256836
ataxia I-Disease 1 0.9999996423721313
premutation O 1 0.999993085861206
carrier O 0 0.0018228603294119239
suggests O 0 0.0001765803899616003
both O 0 3.857179399346933e-05
meiotic O 0 0.006656295619904995
and O 0 4.9486407078802586e-05
mitotic O 0 0.000619846920017153
expansion O 0 0.0009069847874343395
in O 0 9.153989958576858e-05
the O 0 0.00032038777135312557
FRDA B-Disease 1 0.9996490478515625
gene O 0 0.00029261334566399455
. O 0 0.00011992152576567605

Friedreich B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999995231628418
is O 0 0.0009087666985578835
usually O 0 9.3038150225766e-05
caused O 0 0.00037872634129598737
by O 0 6.555524123541545e-06
an O 0 3.980424480687361e-06
expansion O 0 0.000500816386193037
of O 0 0.00023191671061795205
a O 0 0.00046660072985105217
GAA O 0 0.04781785234808922
trinucleotide O 1 0.928492546081543
repeat O 0 0.0016357079148292542
in O 0 8.198942668968812e-05
intron O 0 0.0024003135040402412
1 O 0 0.00021645653760060668
of O 0 0.00012321396206971258
the O 0 0.0005943257128819823
FRDA B-Disease 1 0.9999749660491943
gene O 0 0.0003330608597025275
. O 0 0.00010940108040813357

Occasionally O 0 0.0003479388833511621
, O 0 7.5332327469368465e-06
a O 0 1.131789122155169e-05
fully O 0 0.00010590274177957326
expanded O 0 4.434449874679558e-05
allele O 0 3.44373347616056e-06
has O 0 9.935121170201455e-07
been O 0 3.157329047098756e-06
found O 0 2.313979393875343e-06
to O 0 6.290249984886032e-06
arise O 0 6.988036329858005e-05
from O 0 1.9284092559246346e-05
a O 0 4.1698374843690544e-05
premutation O 0 0.004933805204927921
of O 0 0.00040241042734123766
100 O 0 0.0007446956587955356
or O 0 0.0001141334796557203
less O 0 0.00025174999609589577
triplet O 0 0.008980072103440762
repeats O 0 0.004240848124027252
. O 0 0.00043050124077126384

We O 0 6.73293907311745e-05
have O 0 2.442264076307765e-06
examined O 0 3.554964132490568e-05
the O 0 1.9147713828715496e-05
sperm O 0 1.4941131667001173e-05
DNA O 0 1.687646727077663e-05
of O 0 2.0825526007683948e-05
a O 0 0.00011658357107080519
premutation O 0 0.013730963692069054
carrier O 0 0.0005731351557187736
. O 0 0.0001646575256017968

This O 0 5.613516259472817e-05
mans O 0 0.0009131604456342757
leucocyte O 0 0.004657815210521221
DNA O 0 0.00020651596423704177
showed O 0 9.895880793919787e-05
one O 0 1.1211187484150287e-05
normal O 0 3.467440546955913e-05
allele O 0 4.14976693718927e-06
and O 0 1.546143039377057e-06
one O 0 1.3921813888373435e-06
allele O 0 1.2061032066412736e-06
of O 0 1.929778045450803e-05
approximately O 0 0.0002559659187681973
100 O 0 0.0003583117504604161
repeats O 0 0.0009041280136443675
. O 0 0.00012943615729454905

His O 0 0.0014979216502979398
sperm O 0 0.00018495728727430105
showed O 0 4.992524191038683e-05
an O 0 2.3586867428093683e-06
expanded O 0 7.302976155187935e-05
allele O 0 1.2708197573374491e-05
in O 0 1.650584272283595e-05
a O 0 4.63364995084703e-05
tight O 0 0.00044755428098142147
range O 0 5.793161108158529e-05
centering O 0 0.00027784815756604075
on O 0 4.1975261410698295e-05
a O 0 7.050380190776195e-06
size O 0 8.642239663458895e-06
of O 0 3.728947922354564e-05
approximately O 0 0.00030075511313043535
320 O 0 0.0013826702488586307
trinucleotide O 1 0.9876552224159241
repeats O 0 0.0022993574384599924
. O 0 0.00028813464450649917

His O 0 0.001605490455403924
affected O 0 0.0010225663427263498
son O 0 0.004140239208936691
has O 0 4.311026350478642e-05
repeat O 0 0.0007724483730271459
sizes O 0 6.86734274495393e-05
of O 0 0.00032170844497159123
1040 O 0 0.009546603076159954
and O 0 0.0002138304553227499
540 O 0 0.003416366409510374
. O 0 0.0004294798127375543

These O 0 3.363680298207328e-05
data O 0 3.9663733332417905e-05
suggest O 0 2.1815119907842018e-05
that O 0 3.0653318390250206e-06
expansion O 0 0.0003078463487327099
occurs O 0 1.836144656408578e-05
in O 0 8.46939565235516e-06
two O 0 3.898576778738061e-06
stages O 0 0.00030108331702649593
, O 0 5.803468866361072e-06
the O 0 1.0234063665848225e-05
first O 0 2.716874223551713e-05
during O 0 0.00033915459061972797
meiosis O 0 0.0005964052397757769
followed O 0 5.809542562928982e-05
by O 0 4.6827881305944175e-06
a O 0 1.053694541042205e-05
second O 0 0.00016289117047563195
mitotic O 0 0.0010963587556034327
expansion O 0 0.002469912637025118
. O 0 0.00027440651319921017

We O 0 5.604743637377396e-05
also O 0 5.647874331771163e-06
show O 0 1.1303276551188901e-05
that O 0 7.36725382921577e-07
in O 0 2.9021568934695097e-06
all O 0 2.234293106084806e-06
informative O 0 3.63883409590926e-05
carrier O 0 6.746120197931305e-05
father O 0 6.824776210123673e-05
to O 0 1.5774347048136406e-05
affected O 0 9.647023398429155e-05
child O 0 0.00019071857968810946
transmissions O 0 0.0003809334884863347
, O 0 2.91463288704108e-06
with O 0 9.165380561171332e-07
the O 0 1.690522003627848e-05
notable O 0 7.307246414711699e-05
exception O 0 4.827630255022086e-05
of O 0 0.0001254591188626364
the O 0 0.0004278061678633094
premutation O 0 0.021552221849560738
carrier O 0 0.00017456112254876643
, O 0 6.995313469815301e-06
the O 0 1.879046430985909e-05
expansion O 0 0.00036192251718603075
size O 0 7.140157686080784e-05
decreases O 0 0.00018126005306839943
. O 0 2.623096042952966e-05
. O 0 5.415781924966723e-05

The O 0 0.00043765033478848636
R496H O 0 0.0022464788053184748
mutation O 0 1.4777038813917898e-05
of O 0 0.00014885494601912796
arylsulfatase O 1 0.847414493560791
A O 0 0.0026038452051579952
does O 0 2.888415656343568e-05
not O 0 2.545639654272236e-05
cause O 0 0.010215927846729755
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.003816694486886263

Deficiency B-Disease 1 1.0
of I-Disease 0 0.3533468246459961
arylsulfatase I-Disease 1 0.9999990463256836
A I-Disease 1 0.9978610873222351
( O 0 0.0015369787579402328
ARSA O 1 0.9999891519546509
) O 0 9.486902126809582e-05
enzyme O 0 5.519307524082251e-05
activity O 0 0.0001495469332439825
causes O 0 0.007410350721329451
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.8542299270629883
MLD B-Disease 1 1.0
) O 0 0.0007863190839998424
. O 0 0.0001332445681327954

A O 0 0.0005123309092596173
number O 0 4.069667193107307e-05
of O 0 0.0005207703798078001
ARSA O 1 0.9999773502349854
gene O 0 0.00034234728082083166
mutations O 0 8.212699322029948e-05
responsible O 0 0.00014197421842254698
for O 0 0.0003609898849390447
MLD B-Disease 1 1.0
have O 0 4.390947287902236e-05
been O 0 5.137436164659448e-05
identified O 0 7.711860234849155e-05
. O 0 7.217020174721256e-05

Recently O 0 0.00044596256338991225
, O 0 1.0188004125666339e-05
the O 0 3.429130447329953e-05
R496H O 0 0.0014200229197740555
mutation O 0 1.1569192793103866e-05
of O 0 0.0002016074286075309
ARSA O 1 0.9999463558197021
was O 0 0.0007349891820922494
proposed O 0 2.0442981622181833e-05
to O 0 3.2822379125718726e-06
be O 0 3.068446858378593e-06
a O 0 1.0342174391553272e-05
cause O 0 0.00016802673053462058
of O 0 0.00202089617960155
MLD B-Disease 1 1.0
( O 0 0.0019266549497842789
Draghia O 0 0.28478533029556274
et O 0 0.0073891193605959415
al O 0 0.0016661070985719562
. O 0 1.885275196400471e-05
, O 0 1.0297455446561798e-05
1997 O 0 0.00022152384917717427
) O 0 7.179033855209127e-05
. O 0 8.897853695088997e-05

We O 0 5.155261533218436e-05
have O 0 3.4251036140631186e-06
investigated O 0 0.00012342986883595586
the O 0 9.535151184536517e-05
R496H O 0 0.0030012878123670816
mutation O 0 2.071608651021961e-05
and O 0 7.133888175303582e-06
found O 0 5.835041065438418e-06
this O 0 3.6955020732420962e-06
mutation O 0 1.1786216418840922e-05
at O 0 8.370538125745952e-05
a O 0 1.2896778571303003e-05
relatively O 0 1.3537047379941214e-05
high O 0 3.43007268384099e-05
frequency O 0 4.841480404138565e-06
in O 0 3.245803100071498e-06
an O 0 1.6356241303583374e-06
African O 0 1.6173724361578934e-05
American O 0 5.779471393907443e-06
population O 0 3.448903498792788e-06
( O 0 6.896846116433153e-06
f O 0 4.297915438655764e-05
= O 0 9.166882955469191e-05
0 O 0 1.955657899088692e-05
. O 0 9.337997653346974e-06
09 O 0 0.00032768642995506525
, O 0 4.900559815723682e-06
n O 0 4.4723914470523596e-05
= O 0 0.00015722817624919116
61 O 0 0.00019734959641937166
subjects O 0 0.00051457853987813
) O 0 0.00010499934433028102
. O 0 0.00013535405742004514

The O 0 0.0023775603622198105
ARSA O 1 0.9994229078292847
enzyme O 0 9.103213960770518e-05
activity O 0 1.640659502299968e-05
in O 0 1.4137532161839772e-05
subjects O 0 5.821749073220417e-05
with O 0 5.294573838909855e-06
and O 0 1.1070930668211076e-05
without O 0 2.072329880320467e-05
the O 0 0.00012439698912203312
R496H O 0 0.002872045850381255
mutation O 0 1.8871371139539406e-05
was O 0 0.0001371925900457427
determined O 0 2.143198435078375e-05
and O 0 3.845258106593974e-06
found O 0 5.309671905706637e-06
to O 0 9.55052746576257e-06
be O 0 2.364881402172614e-05
normal O 0 0.00013997657515574247
. O 0 0.00010574703628662974

It O 0 3.081976683461107e-05
is O 0 5.542159669857938e-06
therefore O 0 4.474394700082485e-06
concluded O 0 3.0362374673131853e-05
that O 0 5.620469778477855e-07
the O 0 1.8960627130581997e-05
R496H O 0 0.0015993675915524364
mutation O 0 3.0653631256427616e-05
of O 0 0.0003274016489740461
ARSA O 1 0.9999797344207764
does O 0 4.135743802180514e-05
not O 0 3.417416564843734e-06
negatively O 0 1.601374060555827e-05
influence O 0 2.2607211576541886e-05
the O 0 1.8714266843744554e-05
activity O 0 2.639587728481274e-05
of O 0 0.00019431169494055212
ARSA O 1 0.9996134638786316
and O 0 3.692922109621577e-05
is O 0 6.489044153568102e-06
not O 0 1.9972308109572623e-06
a O 0 3.7878122384427115e-05
cause O 0 0.0007969133439473808
of O 0 0.01000910997390747
MLD B-Disease 1 1.0

Down O 0 0.008727466687560081
- O 0 0.00044337433064356446
regulation O 0 3.519753227010369e-05
of O 0 4.8561105359112844e-05
transmembrane O 0 0.006741629447788
carbonic O 1 0.9322230219841003
anhydrases O 1 0.9999856948852539
in O 1 0.9909734129905701
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 0 0.006184532307088375
by O 0 6.67400672682561e-05
wild O 0 0.0003004269383382052
- O 0 0.0002927187888417393
type O 0 0.00018800004909280688
von B-Disease 1 0.9985439777374268
Hippel I-Disease 1 0.9999939203262329
- I-Disease 1 0.9960188269615173
Lindau I-Disease 1 0.9999430179595947
transgenes O 0 0.039580777287483215
. O 0 0.000466207682620734

To O 0 0.00010537117486819625
discover O 0 9.54235511017032e-05
genes O 0 6.566636329807807e-06
involved O 0 1.1923930287593976e-05
in O 0 7.318858115468174e-05
von B-Disease 1 0.9973269701004028
Hippel I-Disease 1 0.9999951124191284
- I-Disease 1 0.9995367527008057
Lindau I-Disease 1 0.9999995231628418
( O 0 0.0017063047271221876
VHL B-Disease 1 0.9999996423721313
) O 0 0.00033451226772740483
- O 0 0.0009098580339923501
mediated O 0 0.0009293543989770114
carcinogenesis O 1 0.980190098285675
, O 0 1.6485924788867123e-05
we O 0 1.7011700037983246e-05
used O 0 0.0022247752640396357
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.9967778325080872
stably O 1 0.5000984072685242
transfected O 0 0.005086369346827269
with O 0 1.9103759768768214e-05
wild O 0 0.00030415362562052906
- O 0 0.0014458869118243456
type O 0 0.0019294086378067732
VHL O 1 0.9999998807907104
- O 0 0.005843242164701223
expressing O 0 0.00048651895485818386
transgenes O 0 0.010369566269218922
. O 0 0.00033374043414369226

Large O 0 0.0010616927174851298
- O 0 0.000877981714438647
scale O 0 0.0006112942355684936
RNA O 0 0.0011494314530864358
differential O 0 0.00013655280054081231
display O 0 0.0002467503654770553
technology O 0 0.00026412730221636593
applied O 0 1.345576765743317e-05
to O 0 1.2768061424139887e-05
these O 0 1.2951983080711216e-05
cell O 0 0.00017387440311722457
lines O 0 3.5097618820145726e-05
identified O 0 4.84731572214514e-06
several O 0 2.4536188902857248e-06
differentially O 0 0.00014657992869615555
expressed O 0 1.6589765436947346e-05
genes O 0 7.991215170477517e-06
, O 0 1.333272166448296e-06
including O 0 1.6669998785801e-06
an O 0 1.4254216694098432e-05
alpha O 0 0.002023190027102828
carbonic O 0 0.01922747865319252
anhydrase O 0 0.024927686899900436
gene O 0 0.00018377721426077187
, O 0 3.624264718382619e-05
termed O 0 0.0018798814853653312
CA12 O 1 0.9999490976333618
. O 0 0.0006676630582660437

The O 0 0.0003988024836871773
deduced O 0 0.0003327044832985848
protein O 0 2.2872995032230392e-05
sequence O 0 1.2983557098777965e-05
was O 0 7.383533375104889e-05
classified O 0 3.804900188697502e-05
as O 0 7.484858542738948e-06
a O 0 1.5846690075704828e-05
one O 0 2.8994491003686562e-05
- O 0 0.0007596307550556958
pass O 0 0.0008323562215082347
transmembrane O 0 0.0073742675594985485
CA O 0 0.010478015057742596
possessing O 0 0.0005011793109588325
an O 0 4.873572106589563e-05
apparently O 0 0.0003301803953945637
intact O 0 0.0005765546229667962
catalytic O 0 7.911788998171687e-05
domain O 0 9.531305840937421e-05
in O 0 3.069783269893378e-05
the O 0 0.00017334353469777852
extracellular O 0 0.004937519319355488
CA O 1 0.998660683631897
module O 0 0.020267752930521965
. O 0 0.0001882931828731671

Reintroduced O 0 0.007146320305764675
wild O 0 0.0010924937669187784
- O 0 0.002028749091550708
type O 0 0.0015037073753774166
VHL B-Disease 1 0.9999411106109619
strongly O 0 7.92520004324615e-05
inhibited O 0 0.00010706812463467941
the O 0 1.704034184513148e-05
overexpression O 0 7.340833690250292e-05
of O 0 5.889876410947181e-05
the O 0 0.0001818774180719629
CA12 O 1 0.9980746507644653
gene O 0 1.1537295904417988e-05
in O 0 4.1155144572257996e-06
the O 0 4.17737610405311e-05
parental O 0 0.0008802668889984488
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.999854564666748
. O 0 0.0012618490727618337

Similar O 0 1.8458060367265716e-05
results O 0 1.0561653652985115e-05
were O 0 8.72686541697476e-06
obtained O 0 2.7385764042264782e-05
with O 0 3.206065593985841e-05
CA9 O 1 0.9997794032096863
, O 0 3.9499278500443324e-05
encoding O 0 4.94185442221351e-05
another O 0 0.00027766352286562324
transmembrane O 0 0.011697825975716114
CA O 0 0.0037501223850995302
with O 0 6.0533157011377625e-06
an O 0 1.725900438032113e-05
intact O 0 0.002180222189053893
catalytic O 0 0.0006455378606915474
domain O 0 0.0007849860703572631
. O 0 0.00027994182892143726

Although O 0 3.182855652994476e-05
both O 0 5.805567525385413e-06
domains O 0 0.00011268106027273461
of O 0 0.0002500935224816203
the O 0 0.0012538906885311007
VHL B-Disease 1 0.9999881982803345
protein O 0 0.00016257897368632257
contribute O 0 2.9014323445153423e-05
to O 0 1.2968694136361592e-05
regulation O 0 6.979412137297913e-05
of O 0 0.0002052466879831627
CA12 O 1 0.9999239444732666
expression O 0 0.0001538531796541065
, O 0 7.772383469273336e-06
the O 0 2.505225893401075e-05
elongin O 0 0.0015732011524960399
binding O 0 1.9869999960064888e-05
domain O 0 0.0001252640358870849
alone O 0 0.00012281036470085382
could O 0 4.189623359707184e-05
effectively O 0 0.0005076610250398517
regulate O 0 0.0013474570587277412
CA9 O 1 0.999976634979248
expression O 0 0.0008135014213621616
. O 0 0.0003230660513509065

We O 0 0.000172550804563798
mapped O 0 0.000850079522933811
CA12 O 1 0.9980461597442627
and O 0 0.00028683137497864664
CA9 O 1 0.9998303651809692
loci O 0 0.0007092066807672381
to O 0 0.00015581156185362488
chromosome O 0 0.0015254716854542494
bands O 0 0.002424030564725399
15q22 O 0 0.008012013509869576
and O 0 0.00014845406985841691
17q21 O 0 0.0062344493344426155
. O 0 0.0002598567516542971

2 O 0 0.001389741781167686
respectively O 0 0.00030757879721932113
, O 0 1.8708913557929918e-05
regions O 0 0.00012075840641045943
prone O 0 0.0008725092047825456
to O 0 5.150612196302973e-05
amplification O 0 0.0004844033101107925
in O 0 6.493397813756019e-05
some O 0 7.914136222098023e-05
human O 0 0.0011782700894400477
cancers B-Disease 1 0.9999842643737793
. O 0 0.0007992396713234484

Additional O 0 0.00010219524119747803
experiments O 0 0.00014222502068150789
are O 0 9.563638059262303e-07
needed O 0 9.847922228800599e-06
to O 0 4.01597935706377e-06
define O 0 2.246080657641869e-05
the O 0 2.683021011762321e-05
role O 0 0.00013860163744539022
of O 0 0.001017619390040636
CA O 1 0.9998940229415894
IX O 1 0.999998927116394
and O 0 0.0007024267106316984
CA O 0 0.2866469919681549
XII O 1 0.9999791383743286
enzymes O 0 6.934829434612766e-05
in O 0 1.550908746139612e-05
the O 0 2.8650312742684036e-05
regulation O 0 3.101486436207779e-05
of O 0 5.041649637860246e-05
pH O 0 0.0011275499127805233
in O 0 7.138442015275359e-05
the O 0 0.00014233913680072874
extracellular O 0 0.0014655677368864417
microenvironment O 0 0.002053657313808799
and O 0 4.635291134036379e-06
its O 0 5.4378624554374255e-06
potential O 0 5.6391516409348696e-05
impact O 0 0.00016818543372210115
on O 0 0.0006920637679286301
cancer B-Disease 1 0.9999257326126099
cell O 0 0.0030031863134354353
growth O 0 0.0011000926606357098
. O 0 0.00020577457325998694

A O 0 0.0008460342651233077
gene O 0 1.667793003434781e-05
encoding O 0 1.87807745533064e-05
a O 0 4.370493479655124e-05
transmembrane O 0 0.0013424206990748644
protein O 0 4.9772639613365754e-05
is O 0 2.8032693535351427e-06
mutated O 0 6.525111075461609e-06
in O 0 3.0266801331890747e-06
patients O 0 3.125483272015117e-05
with O 0 0.00014075470971874893
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.005061163101345301
. O 0 0.000657348136883229

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999995231628418
WFS B-Disease 1 1.0
; O 0 0.003957519773393869
OMIM O 1 0.9999998807907104
222300 O 0 0.469643771648407
) O 0 4.8204223276115954e-05
is O 0 5.742075245507294e-06
an O 0 2.553975718910806e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9999997615814209
by O 1 0.893893837928772
young O 1 0.9997711777687073
- O 1 0.9999490976333618
onset O 1 1.0
non O 1 0.9999783039093018
- O 1 0.9998648166656494
immune O 1 0.8207986354827881
insulin B-Disease 0 0.02884071320295334
- I-Disease 1 0.6011217832565308
dependent I-Disease 0 0.0016105290269479156
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999997615814209
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9991378784179688

Linkage O 0 0.004175572656095028
to O 0 8.920052641769871e-05
markers O 0 0.002244834555312991
on O 0 0.0013810667442157865
chromosome O 0 0.003912555519491434
4p O 1 0.6909236311912537
was O 0 0.001051199622452259
confirmed O 0 8.763393998378888e-05
in O 0 2.2555466784979217e-05
five O 0 2.4728236894588917e-05
families O 0 1.0688299880712293e-05
. O 0 6.809818296460435e-05

On O 0 0.00013057977776043117
the O 0 1.4777715477976017e-05
basis O 0 1.3070607565168757e-05
of O 0 0.00018862525757867843
meiotic O 1 0.9999488592147827
recombinants O 1 0.9999998807907104
and O 0 0.006044550333172083
disease O 1 1.0
- O 0 0.09979970753192902
associated O 0 0.0002504681469872594
haplotypes O 0 0.0009575292351655662
, O 0 2.5597519197617657e-05
the O 0 0.00023162126308307052
WFS B-Disease 1 0.9999960660934448
gene O 0 8.707159577170387e-05
was O 0 0.00017148630286101252
localized O 0 0.0001736778940539807
to O 0 3.898657814715989e-05
a O 0 0.00032188487239181995
BAC O 1 0.9998875856399536
/ O 0 0.00552356755360961
P1 O 0 0.09560874104499817
contig O 0 0.005735459737479687
of O 0 9.91774068097584e-05
less O 0 2.432377186778467e-05
than O 0 7.755508704576641e-06
250 O 0 0.00012294943735469133
kb O 0 0.008570813573896885
. O 0 0.00028558328631334007

Mutations O 0 0.00026921569951809943
in O 0 3.7371744838310406e-05
a O 0 3.347848542034626e-05
novel O 0 0.0001314838882535696
gene O 0 6.968272646190599e-05
( O 0 0.00011285719665465876
WFS1 O 1 0.6456830501556396
) O 0 1.8388605894870125e-05
encoding O 0 1.769376285665203e-05
a O 0 4.485359022510238e-05
putative O 0 0.0011370107531547546
transmembrane O 0 0.0015177737222984433
protein O 0 6.88654399709776e-05
were O 0 2.6726454962044954e-05
found O 0 4.7327262109320145e-06
in O 0 6.394262072717538e-06
all O 0 4.157447619945742e-06
affected O 0 2.2381753296940587e-05
individuals O 0 3.7161696582188597e-06
in O 0 9.96370508801192e-05
six O 0 0.0012119803577661514
WFS B-Disease 1 0.9999932050704956
families O 0 2.2831152818980627e-05
, O 0 5.373147359932773e-06
and O 0 2.808414819810423e-06
these O 0 2.5697891032905318e-06
mutations O 0 2.125577702827286e-05
were O 0 2.057974779745564e-05
associated O 0 2.9776407245662995e-05
with O 0 2.0262143152649514e-05
the O 0 0.005608817562460899
disease O 1 1.0
phenotype O 0 0.0024743995163589716
. O 0 0.0005625865305773914

WFS1 O 1 0.9992745518684387
appears O 0 0.00024786917492747307
to O 0 5.13698569193366e-06
function O 0 8.858765795594081e-06
in O 0 1.8406344679533504e-05
survival O 0 0.00035177296376787126
of O 0 0.00015123101184144616
islet O 0 0.01204944122582674
beta O 0 0.0061026387847959995
- O 0 0.0019084076629951596
cells O 0 8.032288315007463e-05
and O 0 1.2735956261167303e-05
neurons O 0 0.0002107324980897829
. O 0 4.1890361899277195e-05
. O 0 0.00010315956023987383

Stable O 0 0.00285299401730299
interaction O 0 3.075682252529077e-05
between O 0 7.046434620860964e-05
the O 0 4.5960932766320184e-05
products O 0 1.9541439542081207e-05
of O 0 6.402452709153295e-05
the O 0 0.00039813757757656276
BRCA1 O 0 0.002930914517492056
and O 0 8.234044071286917e-05
BRCA2 O 0 0.010980871506035328
tumor B-Disease 1 0.9969058632850647
suppressor O 0 0.0023124930448830128
genes O 0 1.842822712205816e-05
in O 0 2.9871285732951947e-05
mitotic O 0 0.0006351812044158578
and O 0 0.00012062110909027979
meiotic O 1 0.734905481338501
cells O 0 0.002509104087948799
. O 0 0.0003884300822392106

BRCA1 O 0 0.026356570422649384
and O 0 0.0002943435974884778
BRCA2 O 0 0.001895531197078526
account O 0 7.873771210142877e-06
for O 0 3.792605866692611e-06
most O 0 3.671376134661841e-06
cases O 0 4.564463779388461e-06
of O 0 5.288218380883336e-05
familial O 0 0.0035112700425088406
, O 0 0.00012090877135051414
early O 1 0.8122479915618896
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 0 0.0040703583508729935
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0006672537419945002
encode O 0 0.0001568794104969129
products O 0 2.615507401060313e-05
that O 0 1.1949061899940716e-06
each O 0 6.997295827204653e-07
interact O 0 8.905386494006962e-06
with O 0 1.212263396155322e-05
hRAD51 O 0 0.008048244751989841
. O 0 0.00033484725281596184

Results O 0 4.327431815909222e-05
presented O 0 7.899365300545469e-05
here O 0 2.7230684281676076e-05
show O 0 5.1668768719537184e-05
that O 0 1.0615708561090287e-05
BRCA1 O 0 0.0011345315724611282
and O 0 4.941896622767672e-05
BRCA2 O 0 0.0023693093098700047
coexist O 0 0.0003169492701999843
in O 0 1.2746150787279475e-05
a O 0 2.668409979378339e-05
biochemical O 0 0.0007275216048583388
complex O 0 0.012286445125937462
and O 0 0.00015169083781074733
colocalize O 0 0.0991431474685669
in O 0 0.00032355799339711666
subnuclear O 0 0.060291726142168045
foci O 0 0.00808299146592617
in O 0 0.0003355132066644728
somatic O 0 0.0008834161562845111
cells O 0 0.00013578569632954895
and O 0 4.667833763960516e-06
on O 0 2.8591979571501724e-05
the O 0 1.6081321518868208e-05
axial O 0 3.1382543966174126e-05
elements O 0 2.863293957489077e-05
of O 0 0.00021781132090836763
developing O 0 0.0015312975738197565
synaptonemal O 1 0.7886231541633606
complexes O 0 0.011530975811183453
. O 0 0.0003849210625048727

Like O 0 0.001480540377087891
BRCA1 O 0 0.00874919630587101
and O 0 0.00040801826980896294
RAD51 O 1 0.9999822378158569
, O 0 0.0002110196219291538
BRCA2 O 0 0.0018965174676850438
relocates O 0 0.0007804519264027476
to O 0 0.00015292414173018187
PCNA O 0 0.4255187511444092
+ O 0 0.0005515676457434893
replication O 0 8.576829714002088e-05
sites O 0 9.094028428080492e-06
following O 0 1.1566390639927704e-05
exposure O 0 0.00019566966511774808
of O 0 0.00024354866764042526
S O 0 0.03277813270688057
phase O 0 0.010146887972950935
cells O 0 0.00025207013823091984
to O 0 8.532004721928388e-05
hydroxyurea O 0 0.014663529582321644
or O 0 0.0007788864313624799
UV O 1 0.987798810005188
irradiation O 0 0.002688753418624401
. O 0 0.00018024613382294774

Thus O 0 0.0012484220787882805
, O 0 0.00014721810293849558
BRCA1 O 0 0.0020347977988421917
and O 0 7.373280823230743e-05
BRCA2 O 0 0.0009739622473716736
participate O 0 3.648333949968219e-05
, O 0 4.96766824653605e-06
together O 0 6.485876838269178e-06
, O 0 2.7984908683720278e-06
in O 0 1.0354165169701446e-05
a O 0 6.477769784396514e-05
pathway O 0 0.0008349290583282709
( O 0 7.05372222000733e-05
s O 0 0.0003502398612909019
) O 0 9.451133337279316e-06
associated O 0 3.913715772796422e-06
with O 0 6.262730494199786e-07
the O 0 2.5934392397175543e-05
activation O 0 0.00010060304339276627
of O 0 0.0005711306002922356
double O 0 0.0018151046242564917
- O 0 0.004331999458372593
strand O 0 0.0004030986165162176
break O 0 0.0003444930480327457
repair O 0 0.005169292911887169
and O 0 8.088404865702614e-05
/ O 0 0.0012076739221811295
or O 0 0.00012348567543085665
homologous O 0 0.0009682041709311306
recombination O 0 0.0006849257624708116
. O 0 0.0003526669752318412

Dysfunction O 1 0.9999951124191284
of O 0 0.00527525506913662
this O 0 0.0006187519757077098
pathway O 0 0.0053473785519599915
may O 0 0.00014155246026348323
be O 0 4.811796770809451e-06
a O 0 3.227101842639968e-06
general O 0 1.3596992175735068e-05
phenomenon O 0 3.126571755274199e-05
in O 0 4.410688688949449e-06
the O 0 5.338063601811882e-06
majority O 0 1.0795922662509838e-06
of O 0 7.147582891775528e-06
cases O 0 1.6391126337111928e-05
of O 0 0.0012636790052056313
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.021571293473243713
. O 0 0.0007004905492067337

A O 0 0.003429997945204377
novel O 0 0.0008572913939133286
Arg362Ser O 0 0.009606576524674892
mutation O 0 1.2842468095186632e-05
in O 0 7.775526682962663e-06
the O 0 4.271629950380884e-05
sterol O 0 0.0006979649187996984
27 O 0 0.001098213018849492
- O 0 0.0011296301381662488
hydroxylase O 0 0.0009972270345315337
gene O 0 0.00012703541142400354
( O 0 0.00015371269546449184
CYP27 O 1 0.9609713554382324
) O 0 3.6469282349571586e-05
: O 0 2.952636350528337e-06
its O 0 2.7020244033337804e-06
effects O 0 9.528089867671952e-05
on O 0 0.00015366668230853975
pre O 0 0.0018818062962964177
- O 0 0.00043510820250958204
mRNA O 0 9.519897139398381e-05
splicing O 0 4.001053821411915e-05
and O 0 2.5468725652899593e-06
enzyme O 0 1.4353291589941364e-05
activity O 0 5.1452221669023857e-05
. O 0 9.14406991796568e-05

A O 0 0.001942206872627139
novel O 0 0.00042000706889666617
C O 0 0.0005648217047564685
to O 0 1.596479160070885e-05
A O 0 0.00020657190179917961
mutation O 0 5.158886779099703e-06
in O 0 5.705757757823449e-06
the O 0 2.8736449166899547e-05
sterol O 0 0.00045302894432097673
27 O 0 0.000630610273219645
- O 0 0.0006726825376972556
hydroxylase O 0 0.0007911114953458309
gene O 0 0.00011018125951522961
( O 0 0.00010866952652577311
CYP27 O 1 0.962759256362915
) O 0 4.2047289753099903e-05
was O 0 9.14628617465496e-05
identified O 0 9.97341612674063e-06
by O 0 3.516477590892464e-06
sequencing O 0 0.00013592431787401438
amplified O 0 0.0012131109833717346
CYP27 O 1 0.6304160952568054
gene O 0 4.014618389192037e-05
products O 0 9.241228326573037e-06
from O 0 1.0584149094938766e-05
a O 0 1.380068169964943e-05
patient O 0 3.390312849660404e-05
with O 0 2.5003137125167996e-05
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 0.09578558802604675
CTX B-Disease 1 1.0
) O 0 0.0005737101309932768
. O 0 0.00021143390040379018

The O 0 0.0002612605458125472
mutation O 0 2.733731162152253e-05
changed O 0 6.623494118684903e-05
the O 0 5.569653512793593e-05
adrenodoxin O 0 0.004053602926433086
cofactor O 0 0.00032613525399938226
binding O 0 2.547257099649869e-05
residue O 0 0.0004039659397676587
362Arg O 0 0.0018429093761369586
to O 0 7.217364327516407e-05
362Ser O 0 0.00832014437764883
( O 0 0.0007262901635840535
CGT O 1 0.9987517595291138
362Arg O 0 0.011384442448616028
to O 0 0.0006872024387121201
AGT O 1 1.0
362Ser O 0 0.05651018023490906
) O 0 0.00010770616790978238
, O 0 5.242810857453151e-06
and O 0 3.548494305505301e-06
was O 0 0.0002611375239212066
responsible O 0 0.0002384996332693845
for O 0 0.00041133977356366813
deficiency O 1 1.0
in O 0 0.0011871113674715161
the O 0 0.0013829105300828815
sterol O 0 0.003593465778976679
27 O 0 0.002256987150758505
- O 0 0.0011320108314976096
hydroxylase O 0 0.0004638104874175042
activity O 0 1.1625288607319817e-05
, O 0 1.6861705489645828e-06
as O 0 1.737006186885992e-06
confirmed O 0 3.841519628622336e-06
by O 0 7.712264391557255e-07
expression O 0 3.753418468477321e-06
of O 0 2.3316641090787016e-05
mutant O 0 0.00020827274420298636
cDNA O 0 0.0006503774784505367
into O 0 0.00021467986516654491
COS O 1 0.9803259372711182
- O 0 0.001044503296725452
1 O 0 0.0005775088211521506
cells O 0 9.747576405061409e-05
. O 0 3.5949909943155944e-05

Quantitative O 0 0.00010581269452814013
analysis O 0 6.819213467679219e-06
showed O 0 3.92161964555271e-05
that O 0 1.5161207329583704e-06
the O 0 1.0986957022396382e-05
expression O 0 1.4796865798416547e-05
of O 0 0.00017593722441233695
CYP27 O 1 0.9983192086219788
gene O 0 7.948737766128033e-05
mRNA O 0 0.0001071214210242033
in O 0 7.3835058174154256e-06
the O 0 1.4673905752715655e-05
patient O 0 1.4337846550915856e-05
represented O 0 1.1552875548659358e-05
52 O 0 0.00038742960896342993
. O 0 0.00016375658742617816

5 O 0 0.0005849748849868774
% O 0 4.094866380910389e-05
of O 0 9.546759974909946e-05
the O 0 0.00030110738589428365
normal O 0 0.00044727721251547337
level O 0 0.0013762323651462793
. O 0 0.0002016962826019153

As O 0 0.00014316551096271724
the O 0 7.459854532498866e-05
mutation O 0 2.4707491320441477e-05
occurred O 0 0.00037315490772016346
at O 0 0.00012000812421320006
the O 0 3.336359077366069e-05
penultimate O 0 0.0008697618031874299
nucleotide O 0 5.604219768429175e-05
of O 0 0.00010202279372606426
exon O 0 0.0011538459220901132
6 O 0 0.0006678816862404346
( O 0 5.372285158955492e-05
- O 0 0.0001295539696002379
2 O 0 6.158115138532594e-05
position O 0 2.2856400391901843e-05
of O 0 6.864140596007928e-05
exon O 0 0.0008050568867474794
6 O 0 0.0008526649908162653
- O 0 0.000888714799657464
intron O 0 0.003302820725366473
6 O 0 0.0004504177486523986
splice O 0 0.0004914023447781801
site O 0 0.0001637027453398332
) O 0 5.444260750664398e-06
of O 0 1.370688642055029e-05
the O 0 6.19351485511288e-05
gene O 0 4.45035366283264e-05
, O 0 4.519718004303286e-06
we O 0 5.525782853510464e-06
hypothesized O 0 5.017821240471676e-05
that O 0 1.132749162024993e-06
the O 0 3.513026240398176e-05
mutation O 0 1.761374187481124e-05
may O 0 8.980881830211729e-05
partially O 0 0.0003561551566235721
affect O 0 8.332368452101946e-06
the O 0 1.4656675375590567e-05
normal O 0 2.9658738640137017e-05
splicing O 0 4.413339411257766e-05
efficiency O 0 4.134288610657677e-05
in O 0 3.8068748835939914e-05
exon O 0 0.000640744052361697
6 O 0 0.0003095923166256398
and O 0 1.0047729119833093e-05
cause O 0 7.412980630761012e-05
alternative O 0 3.822269354714081e-05
splicing O 0 0.00015541196626145393
elsewhere O 0 2.348757152503822e-05
, O 0 1.6589717688475503e-06
which O 0 9.600208841220592e-07
resulted O 0 6.013509846525267e-05
in O 0 2.689435495994985e-05
decreased O 0 0.0009777051163837314
transcript O 0 0.0007111184531822801
in O 0 3.1474435672862455e-05
the O 0 7.466330862371251e-05
patient O 0 0.0001736576814437285
. O 0 0.00010933975863736123

Transfection O 0 0.013158128596842289
of O 0 0.0015110033564269543
constructed O 1 0.9979069232940674
minigenes O 1 0.5584249496459961
, O 0 2.1664047380909324e-05
with O 0 6.418223620130448e-06
or O 0 2.1866777387913316e-05
without O 0 2.979146120196674e-05
the O 0 9.437599510420114e-05
mutation O 0 2.318097722309176e-05
, O 0 1.2263132703083102e-05
into O 0 0.00013282518193591386
COS O 1 0.9988569021224976
- O 0 0.00208930391818285
1 O 0 0.00038366284570656717
cells O 0 1.621966111997608e-05
confirmed O 0 1.9051788058277452e-06
that O 0 2.663362579369277e-07
the O 0 8.203860488720238e-06
mutant O 0 0.0001687653420958668
minigene O 0 0.0037665837444365025
was O 0 0.00024083911557681859
responsible O 0 2.478054739185609e-05
for O 0 6.174213012855034e-06
a O 0 3.4531851270003244e-05
mRNA O 0 9.921497257892042e-05
species O 0 5.357396162253281e-07
alternatively O 0 1.3283314729051199e-05
spliced O 0 0.00013202587433625013
at O 0 8.233729749917984e-05
an O 0 1.5668318155803718e-05
activated O 0 0.0030619350727647543
cryptic O 0 0.0020392215810716152
5 O 0 0.00030639435863122344
splice O 0 0.0007168943993747234
site O 0 0.000507160322740674
88 O 0 0.0002539512061048299
bp O 0 0.0003187562106177211
upstream O 0 0.00018923214520327747
from O 0 9.104580385610461e-06
the O 0 1.801969119696878e-05
3 O 0 8.160377910826355e-05
end O 0 0.0003708373988047242
of O 0 0.00024416204541921616
exon O 0 0.0025571901351213455
6 O 0 0.00185842951759696
. O 0 0.00024275234318338335

Our O 0 0.00011834522592835128
data O 0 1.873164001153782e-05
suggest O 0 8.181811608665157e-06
that O 0 1.0785221320475102e-06
the O 0 1.703207271930296e-05
C O 0 0.00029737301520071924
to O 0 1.362882449029712e-05
A O 0 0.00023600301938131452
mutation O 0 5.566551408264786e-06
at O 0 5.251171751297079e-05
the O 0 2.3750970285618678e-05
penultimate O 0 0.0009509242372587323
nucleotide O 0 3.039450166397728e-05
of O 0 6.047911665518768e-05
exon O 0 0.00038253780803643167
6 O 0 0.0001681785361142829
of O 0 6.169093830976635e-05
the O 0 0.0003717288782354444
CYP27 O 1 0.9999736547470093
gene O 0 5.349111961550079e-05
not O 0 3.813460352830589e-06
only O 0 8.322917892655823e-06
causes O 0 0.00019125558901578188
the O 0 0.000746295612771064
deficiency B-Disease 1 0.9999998807907104
in I-Disease 0 0.00034793041413649917
the I-Disease 0 0.0005092832143418491
sterol I-Disease 0 0.002720901044085622
27 I-Disease 0 0.0017064298735931516
- I-Disease 0 0.000869797426275909
hydroxylase I-Disease 0 0.0004492102889344096
activity I-Disease 0 2.6540254111750983e-05
, O 0 3.0695998702867655e-06
but O 0 1.158338363893563e-06
also O 0 2.1107375687279273e-06
partially O 0 9.969018719857559e-05
leads O 0 1.1875653399329167e-05
to O 0 6.249924354051473e-06
alternative O 0 8.31029137771111e-06
pre O 0 0.0005990829085931182
- O 0 0.0002153276582248509
mRNA O 0 6.531404505949467e-05
splicing O 0 1.7036261851899326e-05
of O 0 1.4107878087088466e-05
the O 0 5.472573320730589e-05
gene O 0 0.00010147886496270075
. O 0 7.35826397431083e-05

To O 0 0.00012627105752471834
our O 0 5.709876859327778e-05
knowledge O 0 0.00011574505333555862
, O 0 5.401749149314128e-06
this O 0 1.6437038539152127e-06
is O 0 1.557782297822996e-06
the O 0 4.69297219751752e-06
first O 0 8.474712558381725e-06
report O 0 2.706003442654037e-06
regarding O 0 1.5730240193079226e-05
effects O 0 0.00023776627494953573
on O 0 0.0002866173454094678
pre O 0 0.0024577195290476084
- O 0 0.000370711408322677
mRNA O 0 7.146975985961035e-05
splicing O 0 2.253538514196407e-05
of O 0 5.534395768336253e-06
a O 0 1.0688340807973873e-05
mutation O 0 8.901191904442385e-06
at O 0 0.00010125316475750878
the O 0 5.5508768127765507e-05
- O 0 0.00016422176850028336
2 O 0 5.243246050667949e-05
position O 0 1.3740903341386002e-05
of O 0 2.136533657903783e-05
a O 0 5.94559678575024e-05
5 O 0 0.00039726062095724046
splice O 0 0.001696659834124148
site O 0 0.0017578513361513615
. O 0 0.00016065515228547156

ATM O 1 0.5910203456878662
germline O 0 0.011732066050171852
mutations O 0 0.0002541312132962048
in O 0 0.0003404346643947065
classical O 1 0.99997878074646
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.0005104403826408088
in O 0 5.7472207117825747e-05
the O 0 5.608587525784969e-05
Dutch O 0 0.00046523986384272575
population O 0 1.6373394828406163e-05
. O 0 3.950082100345753e-05

Germline O 0 0.04671879857778549
mutations O 0 0.00027121641323901713
in O 0 9.570569091010839e-05
the O 0 0.00021865777671337128
ATM O 0 0.004062081687152386
gene O 0 6.731288976880023e-06
are O 0 1.3027964484990662e-07
responsible O 0 1.568722041156434e-06
for O 0 2.7989312911813613e-06
the O 0 0.0015541028697043657
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.999988317489624
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.00013236897939350456
. O 0 5.694341234629974e-05

In O 0 0.0002772173029370606
our O 0 4.3073116103187203e-05
study O 0 5.5635318858549e-06
, O 0 1.2559249853438814e-06
we O 0 8.812596661300631e-07
have O 0 2.461315204982384e-07
determined O 0 5.600407348538283e-06
the O 0 2.6622134100762196e-05
ATM O 0 0.0016010940307751298
mutation O 0 6.1756381910527125e-06
spectrum O 0 4.623074710252695e-05
in O 0 3.724576527019963e-05
19 O 0 0.0007249932968989015
classical O 0 0.0045553394593298435
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999998807907104
patients O 0 8.49645075504668e-05
, O 0 3.4358538414380746e-06
including O 0 2.5829708647506777e-06
some O 0 6.197243692440679e-06
immigrant O 0 2.2483907741843723e-05
populations O 0 3.1098290946829366e-06
, O 0 9.025168310472509e-07
as O 0 2.2545159481524024e-06
well O 0 1.7241334262507735e-06
as O 0 6.6196034822496586e-06
12 O 0 3.25132641592063e-05
of O 0 2.4268929337267764e-05
Dutch O 0 0.00043597619514912367
ethnic O 0 0.00012742666876874864
origin O 0 0.00016998274077195674
. O 0 0.0003007946361321956

Both O 0 3.670521982712671e-05
the O 0 4.33111927122809e-05
protein O 0 2.5208923034369946e-05
truncation O 0 0.0002471774641890079
test O 0 5.7100780395558104e-05
( O 0 6.917195423739031e-05
PTT O 0 0.0011039653327316046
) O 0 5.249109563010279e-06
and O 0 7.121076350813382e-07
the O 0 4.726812221633736e-06
restriction O 0 1.4437900063057896e-05
endonuclease O 0 0.00011475278733996674
fingerprinting O 0 0.0003622713265940547
( O 0 0.00030164243071340024
REF O 1 0.547497570514679
) O 0 1.0315854524378665e-05
method O 0 1.3471883448801236e-06
were O 0 4.686281954491278e-06
used O 0 3.256248419347685e-06
and O 0 5.240201517153764e-06
compared O 0 1.961348607437685e-05
for O 0 4.800969236384844e-06
their O 0 1.086683914763853e-05
detection O 0 0.00015804707072675228
efficiency O 0 0.0001315270346822217
, O 0 3.977225333073875e-06
identifying O 0 2.7062718800152652e-05
76 O 0 0.00017663766629993916
% O 0 1.6249838154180907e-05
and O 0 8.908979907573666e-06
60 O 0 4.080163489561528e-05
% O 0 1.2610986232175492e-05
of O 0 7.177938095992431e-05
the O 0 0.00023143956786952913
mutations O 0 0.0001336336717940867
, O 0 4.0821054426487535e-05
respectively O 0 0.0004459515039343387
. O 0 0.00015312680625356734

Most O 0 0.00012972309195902199
patients O 0 4.52097192464862e-05
were O 0 2.50529501499841e-05
found O 0 9.20764978218358e-06
to O 0 1.5010082279331982e-05
be O 0 4.6124136133585125e-05
compound O 0 0.0016217351658269763
heterozygote O 0 0.005641827825456858
. O 0 0.00030396576039493084

Seventeen O 0 0.002015359466895461
mutations O 0 7.138442015275359e-05
were O 0 2.444767960696481e-05
distinct O 0 1.429813801223645e-05
, O 0 4.777220055984799e-06
of O 0 3.648584242910147e-05
which O 0 2.317633516213391e-05
10 O 0 6.915447011124343e-05
were O 0 1.9932345821871422e-05
not O 0 3.650734925031429e-06
reported O 0 2.9558981623267755e-05
previously O 0 0.00015942411846481264
. O 0 0.00014349720731843263

Mutations O 0 0.00034305526060052216
are O 0 8.442993021162692e-06
small O 0 1.6406735085183755e-05
deletions O 0 0.000335743126925081
or O 0 7.052914588712156e-05
point O 0 0.0009459704742766917
mutations O 0 0.00019974628230556846
frequently O 0 6.708923319820315e-05
affecting O 0 0.00011907977022929117
splice O 0 0.0010256300447508693
sites O 0 0.0003355504886712879
. O 0 0.0001566554856253788

Moreover O 0 0.001483152387663722
, O 0 2.9470629669958726e-05
a O 0 5.528204201254994e-05
16 O 0 0.0008881488465704024
. O 0 0.0002954902302008122

7 O 0 0.0032196000684052706
- O 0 0.0010072565637528896
kb O 0 0.0012739760568365455
genomic O 0 7.422146882163361e-05
deletion O 0 0.00013011392729822546
of O 0 0.0001049997445079498
the O 0 0.0002400624071015045
3 O 0 0.0003665563417598605
end O 0 0.0003307424776721746
of O 0 9.40321187954396e-05
the O 0 0.00011223110050195828
gene O 0 3.55149750248529e-05
, O 0 2.3942980078572873e-06
most O 0 1.872844450190314e-06
likely O 0 4.108118901058333e-06
a O 0 2.1976115931465756e-06
result O 0 3.926509180018911e-06
of O 0 3.2767606171546504e-05
recombination O 0 4.5021402911515906e-05
between O 0 0.00033714540768414736
two O 0 5.961106580798514e-05
LINE O 0 0.009428809396922588
elements O 0 0.00013072516594547778
, O 0 2.8866861612186767e-05
was O 0 0.0004759320872835815
identified O 0 8.956695819506422e-05
. O 0 0.00011311372509226203

The O 0 0.0003651933802757412
most O 0 3.952896440750919e-05
frequently O 0 2.616692472656723e-05
found O 0 9.953918379324023e-06
mutation O 0 5.29187309439294e-06
, O 0 2.102855432895012e-06
identified O 0 5.050027994002448e-06
in O 0 9.468906682741363e-06
three O 0 1.2879975656687748e-05
unrelated O 0 9.690948354545981e-05
Turkish O 0 0.0016632835613563657
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999319314956665
T I-Disease 1 0.9999873638153076
individuals O 0 1.060739941749489e-05
, O 0 1.0189325621468015e-05
was O 0 0.00012154616706538945
previously O 0 3.140083572361618e-05
described O 0 2.1893129087402485e-05
to O 0 3.126821638943511e-06
be O 0 2.182238404202508e-06
a O 0 8.50003107188968e-06
Turkish O 0 0.0007372666150331497
A B-Disease 1 0.9999877214431763
- I-Disease 1 0.9999665021896362
T I-Disease 1 0.9999998807907104
founder O 0 0.007412164472043514
mutation O 0 8.65595429786481e-05
. O 0 0.00010684669541660696

The O 0 0.00029833565349690616
presence O 0 7.777351856930181e-05
of O 0 0.00018791150068864226
a O 0 0.00037298936513252556
founder O 0 0.003038948867470026
mutation O 0 2.255060462630354e-05
among O 0 6.282001322688302e-06
relatively O 0 8.888112461136188e-06
small O 0 2.220833266619593e-06
ethnic O 0 1.972163317986997e-06
population O 0 1.0626906714605866e-06
groups O 0 2.5840083139883063e-07
in O 0 5.385895747167524e-06
Western O 0 6.575939187314361e-05
Europe O 0 8.502352284267545e-05
could O 0 6.095535354688764e-06
indicate O 0 1.1219498446735088e-05
a O 0 8.989281013782602e-06
high O 0 0.00012138263991801068
carrier O 0 2.5381374143762514e-05
frequency O 0 6.2479102780343965e-06
in O 0 4.71623116027331e-06
such O 0 1.96051496459404e-06
communities O 0 2.6159143089898862e-05
. O 0 0.0001030396088026464

In O 0 0.0003123474307358265
patients O 0 5.1898983656428754e-05
of O 0 8.916131628211588e-05
Dutch O 0 0.0012675569159910083
ethnic O 0 0.00023645258625037968
origin O 0 8.011213503777981e-05
, O 0 1.4261219803302083e-05
however O 0 8.714598152437247e-06
, O 0 3.1380632208311e-06
no O 0 6.0622237469942775e-06
significant O 0 9.447351476410404e-05
founder O 0 0.0019022757187485695
effect O 0 0.00011156262189615518
could O 0 1.2093479199393187e-05
be O 0 6.278336059040157e-06
identified O 0 2.8167085474706255e-05
. O 0 4.254258601577021e-05

The O 0 0.00036128112697042525
observed O 0 0.00014556232781615108
genetic O 0 0.00015590412658639252
heterogeneity O 0 0.0002756000030785799
including O 0 2.6772266210173257e-05
the O 0 0.00011285472282906994
relative O 0 0.00019351959053892642
high O 0 0.00023559450346510857
percentage O 0 4.932866067974828e-05
of O 0 0.00011582850856939331
splice O 0 0.005996076390147209
- O 0 0.0015682753873988986
site O 0 0.0005378169007599354
mutations O 0 6.934485281817615e-05
had O 0 8.459101081825793e-05
no O 0 4.0922666812548414e-05
reflection O 0 0.00016127536946441978
on O 0 0.00031206372659653425
the O 0 0.00030183515627868474
phenotype O 0 0.0005344513338059187
. O 0 0.00024789353483356535

All O 0 8.395824261242524e-05
patients O 0 8.965804590843618e-05
manifested O 0 0.0015054050600156188
classical O 0 0.009277637116611004
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9997825026512146
T I-Disease 1 0.9995617270469666
and O 0 9.564463653077837e-06
increased O 0 3.7644018448190764e-05
cellular O 0 0.0003850263892672956
radioresistant O 0 0.0051468550227582455
DNA O 0 0.0007391607505269349
synthesis O 0 0.0006455000257119536
. O 0 0.00025905994698405266

Determination O 0 0.00035162761923857033
of O 0 0.0001523690007161349
the O 0 7.747616473352537e-05
genomic O 0 6.18417325313203e-05
structure O 0 0.000259960099356249
of O 0 0.00016526071703992784
the O 0 0.0006122715421952307
COL4A4 O 1 0.9999951124191284
gene O 0 3.4544696973171085e-05
and O 0 1.1358093843227834e-06
of O 0 1.3344767467060592e-05
novel O 0 0.0002100324200000614
mutations O 0 0.0010721985017880797
causing O 1 0.9999786615371704
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999996423721313

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9662558436393738
a O 0 0.29866981506347656
progressive O 1 1.0
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999891519546509
by O 0 0.1204773336648941
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999064207077026
abnormalities I-Disease 1 0.9999600648880005
and O 0 9.109562233788893e-05
associated O 0 7.505893154302612e-05
with O 0 2.3673675968893804e-05
mutations O 0 0.0001337372959824279
in O 0 0.00017416513583157212
either O 0 0.00010071361612062901
the O 0 0.00039852410554885864
COL4A3 O 1 0.9999889135360718
or O 0 4.3352840293664485e-05
the O 0 0.0001136383943958208
COL4A4 O 1 0.9922950267791748
gene O 0 1.8415072190691717e-05
, O 0 8.766970154283626e-07
which O 0 5.475912416841311e-07
encode O 0 4.746584181702929e-06
the O 0 3.688185097416863e-05
alpha3 O 0 0.004680898040533066
and O 0 5.709909601137042e-05
alpha4 O 0 0.20907028019428253
type O 0 0.321664422750473
IV O 1 1.0
collagen O 1 1.0
chains O 0 0.013511541299521923
, O 0 0.00010628566087689251
respectively O 0 0.0006049990770407021
. O 0 0.00023234784021042287

To O 0 0.00019137781055178493
date O 0 0.0007941470830701292
, O 0 1.2182912541902624e-05
mutation O 0 2.3314607915381202e-06
screening O 0 5.761240572610404e-06
in O 0 5.983164101053262e-06
the O 0 1.4088676834944636e-05
two O 0 6.075442797737196e-06
genes O 0 8.70045641931938e-06
has O 0 5.3806543292012066e-06
been O 0 1.0331941666663624e-05
hampered O 0 0.00026618916308507323
by O 0 1.1818527809737134e-06
the O 0 7.653877219127025e-06
lack O 0 3.406364703550935e-05
of O 0 5.1563227316364646e-05
genomic O 0 0.00030079149291850626
structure O 0 0.0017650551162660122
information O 0 0.00018237147014588118
. O 0 0.0002585683832876384

We O 0 8.870354213286191e-05
report O 0 9.8844475360238e-06
here O 0 1.1975783309026156e-05
the O 0 3.820212441496551e-06
complete O 0 5.263650746201165e-05
characterization O 0 7.287185144377872e-05
of O 0 6.068420771043748e-05
the O 0 0.0001241333520738408
48 O 0 0.00015125625941436738
exons O 0 0.0003231196606066078
of O 0 0.00014464856940321624
the O 0 0.0004558345826808363
COL4A4 O 1 0.9999754428863525
gene O 0 5.630881787510589e-05
, O 0 2.900757181123481e-06
a O 0 6.927822141733486e-06
comprehensive O 0 0.00014691855176351964
gene O 0 4.021508357254788e-05
screen O 0 0.00015794509090483189
, O 0 5.170328222448006e-06
and O 0 1.3947287698101718e-06
the O 0 1.0059568921860773e-05
subsequent O 0 5.826736378367059e-05
detection O 0 7.710212230449542e-05
of O 0 5.510540722752921e-05
10 O 0 0.00010740158177213743
novel O 0 7.605321297887713e-05
mutations O 0 9.722151844471227e-06
in O 0 7.477880899386946e-06
eight O 0 0.0001263001759070903
patients O 0 0.0008685344364494085
diagnosed O 1 1.0
with O 0 0.025027627125382423
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 1.0

Furthermore O 0 0.000950232264585793
, O 0 1.3157450666767545e-05
we O 0 4.807975528819952e-06
identified O 0 1.0232658496533986e-05
a O 0 9.026821317092981e-06
glycine O 0 5.61245069548022e-05
to O 0 2.308413058926817e-05
alanine O 0 9.041650628205389e-05
substitution O 0 7.840894249966368e-05
in O 0 8.080757834250107e-05
the O 0 0.00022393011022359133
collagenous O 0 0.011659002862870693
domain O 0 0.00013411774125415832
that O 0 3.227532943128608e-06
is O 0 6.969975856918609e-06
apparently O 0 5.157513078302145e-05
silent O 0 0.00030113323009572923
in O 0 9.89114232652355e-06
the O 0 2.0760584447998554e-05
heterozygous O 0 5.9241601775283925e-06
carriers O 0 1.1815331163234077e-05
, O 0 2.834158067344106e-06
in O 0 2.2824602638138458e-05
11 O 0 0.0006868073833175004
. O 0 0.0002389986184425652

5 O 0 0.00035359716275706887
% O 0 2.821149246301502e-05
of O 0 4.2991694499505684e-05
all O 0 3.447151175350882e-05
control O 0 0.0002096650714520365
individuals O 0 8.804995559330564e-06
, O 0 1.4021537026565056e-05
and O 0 7.885230843385216e-06
in O 0 3.519632446113974e-05
one O 0 1.9419145246502012e-05
control O 0 3.695937994052656e-05
individual O 0 2.741713160503423e-06
homozygous O 0 9.253635653294623e-06
for O 0 3.80824894818943e-06
this O 0 6.9330039877968375e-06
glycine O 0 0.00021582918998319656
substitution O 0 0.0003200104692950845
. O 0 0.00033075068495236337

There O 0 0.00015818790416233242
has O 0 1.4507932064589113e-05
been O 0 8.940547559177503e-06
no O 0 3.463581151663675e-06
previous O 0 9.277883691538591e-06
finding O 0 1.5458863344974816e-05
of O 0 3.266704879933968e-05
a O 0 5.7016066421056166e-05
glycine O 0 0.00015381914272438735
substitution O 0 5.85390480409842e-05
that O 0 5.550262358156033e-06
is O 0 3.344692686368944e-06
not O 0 8.391357937398425e-07
associated O 0 3.590771484596189e-06
with O 0 1.5147738849918824e-06
any O 0 1.5244520000123885e-05
obvious O 0 0.00034174349275417626
phenotype O 0 0.00010506244871066883
in O 0 4.4793916458729655e-05
homozygous O 0 8.552980580134317e-05
individuals O 0 1.3709565791941714e-05
. O 0 0.0002649780653882772

Founder O 1 0.9716411828994751
BRCA1 O 0 0.008426791988313198
and O 0 0.00011120946146547794
BRCA2 O 0 0.0015648477710783482
mutations O 0 3.5404802474658936e-05
in O 0 2.7387357476982288e-05
French O 0 0.0008724935469217598
Canadian O 0 0.48974019289016724
breast B-Disease 1 1.0
and I-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.004902017768472433
. O 0 0.0011266296496614814

We O 0 4.2866504372796044e-05
have O 0 1.7272323020733893e-06
identified O 0 4.411740519572049e-06
four O 0 4.1736998355190735e-06
mutations O 0 4.425861789059127e-06
in O 0 2.9724246815021615e-06
each O 0 9.263138736059773e-07
of O 0 9.800300904316828e-05
the O 0 0.006135640665888786
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 0 0.2708689868450165
susceptibility O 0 0.0012221692595630884
genes O 0 0.00010964315151795745
, O 0 3.6787849239772186e-05
BRCA1 O 0 0.0006531382096000016
and O 0 3.157589890179224e-05
BRCA2 O 0 0.0005280352779664099
, O 0 2.784612661343999e-06
in O 0 3.3165158583869925e-06
French O 0 9.264101390726864e-05
Canadian O 0 0.002122176345437765
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999008178710938
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0003664696996565908
from O 0 0.0005255605210550129
Quebec O 0 0.006072713527828455
. O 0 0.0005174421239644289

To O 0 0.00024061050498858094
identify O 0 0.0007257750839926302
founder O 0 0.010434022173285484
effects O 0 0.002664893167093396
, O 0 4.169324165559374e-05
we O 0 7.822225597919896e-06
examined O 0 4.962028469890356e-05
independently O 0 8.779807103564963e-06
ascertained O 0 0.00021584505157079548
French O 0 0.0001591012696735561
Canadian O 0 0.00034621331724338233
cancer B-Disease 0 0.002446020720526576
families O 0 3.151369810439064e-06
for O 0 3.3701960546750342e-06
the O 0 2.1808213205076754e-05
distribution O 0 1.200071710627526e-05
of O 0 5.80233900109306e-05
these O 0 2.0545881852740422e-05
eight O 0 0.00030028121545910835
mutations O 0 0.00018117157742381096
. O 0 0.0001304483594140038

Mutations O 0 0.00030709823477081954
were O 0 7.4896561272908e-05
found O 0 1.3327013220987283e-05
in O 0 1.7954011127585545e-05
41 O 0 6.63260871078819e-05
of O 0 9.438319102628157e-05
97 O 0 0.0011273575946688652
families O 0 3.750352334463969e-05
. O 0 0.00011240728053962812

Six O 0 0.0002286561648361385
of O 0 0.00011364577221684158
eight O 0 0.00018859037663787603
mutations O 0 5.3183757700026035e-05
were O 0 3.450518852332607e-05
observed O 0 4.328063369030133e-05
at O 0 0.00015649663691874593
least O 0 2.6976194931194186e-05
twice O 0 0.0001647643221076578
. O 0 0.00010174947965424508

The O 0 0.003989889286458492
BRCA1 O 0 0.010859589092433453
C4446T O 0 0.004739462397992611
mutation O 0 4.626912050298415e-05
was O 0 0.00016850967949721962
the O 0 3.457643470028415e-05
most O 0 8.399498256039806e-06
common O 0 5.959127520327456e-06
mutation O 0 6.312906407401897e-06
found O 0 8.15504517959198e-06
, O 0 2.9218017516541295e-06
followed O 0 2.06601143872831e-05
by O 0 1.0552733328950126e-05
the O 0 0.00019218536908738315
BRCA2 O 0 0.004883476998656988
8765delAG O 0 0.009134311228990555
mutation O 0 0.00014331001148093492
. O 0 0.0001107675998355262

Together O 0 0.000302486791042611
, O 0 1.1234315934416372e-05
these O 0 2.6468430860404624e-06
mutations O 0 1.4533439752995037e-05
were O 0 2.3784288714523427e-05
found O 0 7.4042013693542685e-06
in O 0 1.1400709809095133e-05
28 O 0 0.000183779644430615
of O 0 8.092672214843333e-05
41 O 0 0.00012195715680718422
families O 0 3.3330197766190395e-06
identified O 0 6.531685812660726e-06
to O 0 4.829168574360665e-06
have O 0 3.141638217130094e-06
a O 0 4.157191142439842e-05
mutation O 0 3.871663284371607e-05
. O 0 0.00019315403187647462

The O 0 0.0003461466112639755
odds O 0 0.0005040370742790401
of O 0 5.047374725108966e-05
detection O 0 0.0001245706807821989
of O 0 5.759395207860507e-05
any O 0 2.7499423595145345e-05
of O 0 0.00013256882084533572
the O 0 0.0001766095228958875
four O 0 9.260055230697617e-05
BRCA1 O 0 0.0008236532448790967
mutations O 0 4.345959678175859e-05
was O 0 0.0005552054499275982
18 O 0 0.0008872104226611555
. O 0 0.0002472189662512392

7x O 0 0.09864449501037598
greater O 0 0.00032930588349699974
if O 0 2.126652361766901e-05
one O 0 4.320526386436541e-06
or O 0 1.6508029148099013e-06
more O 0 7.879673944444221e-07
cases O 0 4.041341890115291e-05
of O 1 0.994002640247345
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0021035249810665846
also O 0 2.7211370252189226e-05
present O 0 4.2346317059127614e-05
in O 0 2.7531961677595973e-05
the O 0 8.445641287835315e-05
family O 0 6.95078560966067e-05
. O 0 7.959737558849156e-05

The O 0 0.0005248333909548819
odds O 0 0.0004999712109565735
of O 0 8.67056951392442e-05
detection O 0 0.00023989671899471432
of O 0 0.0001043557349476032
any O 0 3.7067777157062665e-05
of O 0 0.00017115831724368036
the O 0 0.000192402076208964
four O 0 0.00017100512923207134
BRCA2 O 0 0.0016922091599553823
mutations O 0 6.284201663220301e-05
was O 0 0.0008720346377231181
5 O 0 0.000811382953543216
. O 0 0.00015026018081698567

3x O 0 0.02066490240395069
greater O 0 0.0002646503271535039
if O 0 1.4990112504165154e-05
there O 0 6.027818471920909e-06
were O 0 8.509910003340337e-06
at O 0 3.103167182416655e-05
least O 0 2.1484490844159154e-06
five O 0 5.832743681821739e-06
cases O 0 2.8506899980129674e-05
of O 0 0.0014072671765461564
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999960660934448
in O 0 0.0006847678450867534
the O 0 0.0007707859040237963
family O 0 0.00020257686264812946
. O 0 0.00015207332035060972

Interestingly O 0 0.0010351332603022456
, O 0 5.924855031480547e-06
the O 0 7.766278031340335e-06
presence O 0 2.6622437871992588e-05
of O 0 0.0002797905181068927
a O 0 0.003047097474336624
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999805688858032
case O 0 0.0006671176524832845
< O 0 0.003034913679584861
36 O 0 0.00015215991879813373
years O 0 9.034945833263919e-05
of O 0 8.992700168164447e-05
age O 0 0.0006699841469526291
was O 0 0.0005102771101519465
strongly O 0 1.0508656487218104e-05
predictive O 0 8.633597644802649e-06
of O 0 2.726402090047486e-05
the O 0 4.776720379595645e-05
presence O 0 1.976637213374488e-05
of O 0 3.281723547843285e-05
any O 0 1.2733089533867314e-05
of O 0 8.314873412018642e-05
the O 0 0.00018312965403310955
eight O 0 0.00029991011251695454
mutations O 0 8.577533299103379e-05
screened O 0 0.0005644073244184256
. O 0 0.00012607601820491254

Carriers O 0 0.00015578660531900823
of O 0 7.20721873221919e-05
the O 0 8.302560308948159e-05
same O 0 2.5155321054626256e-05
mutation O 0 7.010720764810685e-06
, O 0 2.620646000650595e-06
from O 0 3.7994880131009268e-06
different O 0 6.544665325236565e-07
families O 0 2.0755480818479555e-06
, O 0 2.4170128654077416e-06
shared O 0 9.477090316067915e-06
similar O 0 1.0721060789364856e-05
haplotypes O 0 0.0008931724005378783
, O 0 2.1477695554494858e-05
indicating O 0 0.00011726055527105927
that O 0 1.5468775700355764e-06
the O 0 1.3778444554191083e-05
mutant O 0 2.201915776822716e-05
alleles O 0 2.8204312911839224e-06
were O 0 5.710690402338514e-06
likely O 0 5.516416422324255e-06
to O 0 2.706759687498561e-06
be O 0 2.6274628908140585e-06
identical O 0 3.126102910755435e-06
by O 0 2.0309128103690455e-06
descent O 0 4.765300764120184e-05
for O 0 1.2194466762593947e-05
a O 0 4.2229366954416037e-05
mutation O 0 8.39339554659091e-06
in O 0 2.284642141603399e-05
the O 0 9.868128836387768e-05
founder O 0 0.0010215041693300009
population O 0 1.713897472654935e-05
. O 0 5.3979467338649556e-05

The O 0 8.211477688746527e-05
identification O 0 1.7188900528708473e-05
of O 0 0.00024330499581992626
common O 0 0.000576543330680579
BRCA1 O 0 0.016573255881667137
and O 0 0.0003460839798208326
BRCA2 O 0 0.0042826407589018345
mutations O 0 7.402928167721257e-05
will O 0 1.225276446348289e-05
facilitate O 0 6.19681813986972e-05
carrier O 0 2.366171611356549e-05
detection O 0 1.1365212230884936e-05
in O 0 4.293777692510048e-06
French O 0 0.000103675207355991
Canadian O 0 0.0030396815855056047
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9996600151062012
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0023644743487238884
. O 0 0.0008302131318487227

Are O 0 7.535541953984648e-05
Dp71 O 0 0.06436474621295929
and O 0 0.0001830734108807519
Dp140 O 0 0.1848251223564148
brain O 1 0.9721900820732117
dystrophin O 0 0.004068784881383181
isoforms O 0 6.0766433307435364e-05
related O 0 4.549793811747804e-05
to O 0 5.643509575747885e-05
cognitive B-Disease 1 0.9999889135360718
impairment I-Disease 1 1.0
in O 1 1.0
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999955892562866

Molecular O 0 0.0006417260156013072
study O 0 4.0609400457469746e-05
and O 0 1.1528947652550414e-05
neuropsychological O 0 0.0001440915948478505
analysis O 0 5.198558937991038e-06
were O 0 1.569032610859722e-05
performed O 0 7.146057760110125e-05
concurrently O 0 3.2536965591134503e-05
on O 0 2.9113216442056e-05
49 O 0 0.0001451296266168356
patients O 0 0.00029626849573105574
with O 0 0.06824444979429245
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.000446088844910264
in O 0 4.330285082687624e-05
order O 0 7.928905688459054e-06
to O 0 4.442676072358154e-06
find O 0 8.791872460278682e-06
a O 0 7.4187046266160905e-06
molecular O 0 2.421146200504154e-05
explanation O 0 4.74646185466554e-06
for O 0 3.2832772376423236e-06
the O 0 0.0001184487555292435
cognitive B-Disease 0 0.034043021500110626
impairment I-Disease 1 0.9999045133590698
observed O 0 0.002455726033076644
in O 0 0.0010143994586542249
most O 0 0.0021248820703476667
DMD B-Disease 1 1.0
patients O 0 0.003754486097022891
. O 0 0.0006479098810814321

Complete O 0 0.00025558765628375113
analysis O 0 6.679027137579396e-06
of O 0 9.567804227117449e-05
the O 0 0.0002902336127590388
dystrophin O 0 0.008214948698878288
gene O 0 9.391277126269415e-05
was O 0 0.0002579921274445951
performed O 0 8.582148439018056e-05
to O 0 9.029610737343319e-06
define O 0 6.781686533940956e-05
the O 0 9.189033880829811e-05
localization O 0 0.0013274020748212934
of O 0 0.00023720743774902076
deletions O 0 0.0005772829172201455
and O 0 5.2474973927019164e-05
duplications O 0 0.002041648840531707
in O 0 4.444034129846841e-05
relation O 0 5.853072798345238e-05
to O 0 2.4576971554779448e-05
the O 0 0.0001373729610349983
different O 0 0.00013466080417856574
DMD B-Disease 1 1.0
promoters O 1 0.9820778965950012
. O 0 0.0009796371450647712

Qualitative O 0 7.130583981052041e-05
analysis O 0 6.629300969507312e-06
of O 0 0.00012143288040533662
the O 0 0.0005516649107448757
Dp71 O 1 0.6739136576652527
transcript O 0 0.0017450549639761448
and O 0 3.975568233727245e-06
testing O 0 2.046388544840738e-06
for O 0 6.893169484101236e-07
the O 0 4.0398144847131334e-06
specific O 0 8.537528515262238e-07
first O 0 4.268795237294398e-05
exon O 0 0.00023980844707693905
of O 0 5.2052782848477364e-05
Dp140 O 0 0.0013910632114857435
were O 0 2.9784614525851794e-05
also O 0 6.915438461874146e-06
carried O 0 2.664453313627746e-05
out O 0 1.4194584764481988e-05
. O 0 6.585830124095082e-05

Neuropsychological O 0 0.0029397644102573395
analysis O 0 2.1880085114389658e-05
assessed O 0 0.00015630021516699344
verbal O 0 0.00029053568141534925
and O 0 0.00018274415924679488
visuospatial O 1 0.9060431718826294
intelligence O 0 0.0004849167598877102
, O 0 3.827361433650367e-05
verbal O 0 0.0004114819166716188
memory O 1 0.9999901056289673
, O 0 0.00019823978072963655
and O 0 5.061072442913428e-05
reading O 0 0.0013316276017576456
skills O 0 0.0031077477615326643
. O 0 0.0006021104636602104

Comparison O 0 0.00012302437971811742
of O 0 0.0002368124114582315
molecular O 0 0.00042024976573884487
and O 0 5.411099118646234e-05
psychometric O 0 0.001704353024251759
findings O 0 0.0001558317890157923
demonstrated O 0 0.000714354682713747
that O 0 2.5175433620461263e-05
deletions O 0 0.00054226687643677
and O 0 2.9489972803276032e-05
duplications O 0 0.00140297575853765
that O 0 7.781780368532054e-06
were O 0 3.11137227981817e-05
localized O 0 0.0003071439568884671
in O 0 7.346527127083391e-05
the O 0 0.00018501376325730234
distal O 0 0.002862050896510482
part O 0 0.0002162271412089467
of O 0 0.00032388820545747876
the O 0 0.0004720417782664299
gene O 0 7.302321319002658e-05
seemed O 0 5.637054709950462e-05
to O 0 1.7469739077569102e-06
be O 0 1.2919522305310238e-06
preferentially O 0 7.883028047217522e-06
associated O 0 9.94024048850406e-06
with O 0 9.151744961855002e-06
cognitive B-Disease 1 0.9794440269470215
impairment I-Disease 1 1.0
. O 1 0.9969508647918701

Two O 0 0.00021004023437853903
altered O 0 0.001079797511920333
Dp71 O 0 0.011377493850886822
transcripts O 0 0.0011269710958003998
and O 0 1.0775931514217518e-05
two O 0 6.856448180769803e-06
deleted O 0 0.0003893823886755854
Dp140 O 0 0.0006470478256233037
DNA O 0 2.737584145506844e-05
sequences O 0 6.8714780354639515e-06
were O 0 6.957583991606953e-06
found O 0 3.2588238809694303e-06
in O 0 7.487378752557561e-06
four O 0 1.822363083192613e-05
patients O 0 0.00010393207776360214
with O 0 0.00018836016533896327
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9999984502792358

These O 0 3.2902375096455216e-05
findings O 0 2.062654857581947e-05
suggest O 0 1.043969314196147e-05
that O 0 4.079962252490077e-07
some O 0 8.376742357540934e-07
sequences O 0 9.941549251379911e-06
located O 0 8.4959166997578e-05
in O 0 1.3683886209037155e-05
the O 0 3.96415707655251e-05
distal O 0 0.0012662488734349608
part O 0 0.0001375471765641123
of O 0 0.0002894689969252795
the O 0 0.00029821510543115437
gene O 0 7.808161899447441e-05
and O 0 9.796871381695382e-06
, O 0 3.999723048764281e-06
in O 0 8.039102795009967e-06
particular O 0 9.478880201641005e-06
, O 0 7.039328011160251e-06
some O 0 2.278336978633888e-05
DMD B-Disease 1 0.9999982118606567
isoforms O 0 0.00013601986574940383
expressed O 0 3.993091740994714e-05
in O 0 5.3109703003428876e-05
the O 0 0.0003004289756063372
brain O 0 0.10261281579732895
may O 0 8.694132702657953e-05
be O 0 5.941150448052213e-06
related O 0 5.187752776691923e-06
to O 0 7.360333711403655e-06
the O 0 8.815996261546388e-05
cognitive B-Disease 0 0.009467877447605133
impairment I-Disease 1 0.9999936819076538
associated O 1 0.7466036677360535
with O 0 0.03952067345380783
DMD B-Disease 1 1.0
. O 0 0.0012462587328627706
. O 0 0.00033230948611162603

I1307K O 0 0.05238226428627968
APC O 0 0.017774194478988647
and O 0 8.735809387871996e-05
hMLH1 O 0 0.00408907001838088
mutations O 0 8.485633588861674e-05
in O 0 3.4218723158119246e-05
a O 0 5.145074464962818e-05
non O 0 0.00033658536267466843
- O 0 0.0001968234428204596
Jewish O 0 1.447520662622992e-05
family O 0 3.8010643947927747e-06
with O 0 4.625725523510482e-06
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999960660934448

We O 0 4.012727731605992e-05
describe O 0 1.9913135474780574e-05
a O 0 5.970936854282627e-06
French O 0 5.003791375202127e-05
Canadian O 0 0.00027195204165764153
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 1.0
HNPCC B-Disease 1 1.0
) O 0 0.0018317210488021374
kindred O 0 0.0026420822832733393
which O 0 1.6893231077119708e-05
carries O 0 6.345202564261854e-05
a O 0 2.90844382107025e-05
novel O 0 0.00017340270278509706
truncating O 0 0.001215728116221726
mutation O 0 2.329604103579186e-05
in O 0 5.316981332725845e-05
hMLH1 O 0 0.009020778350532055
. O 0 0.0002646119974087924

Interestingly O 0 0.0020684474147856236
, O 0 3.3627500670263544e-05
the O 0 0.0001582384284120053
I1307K O 0 0.006727397441864014
APC O 0 0.005084688309580088
polymorphism O 0 7.371010724455118e-05
, O 0 4.819819878321141e-06
associated O 0 1.7904159221870941e-06
with O 0 8.064458256740181e-07
an O 0 3.066945964746992e-06
increased O 0 0.00016791734378784895
risk O 0 0.006138450000435114
of O 1 0.9999985694885254
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0007656074594706297
is O 0 2.049064278253354e-05
also O 0 3.860285687551368e-06
present O 0 1.1396186891943216e-05
in O 0 1.1650970009213779e-05
this O 0 8.545391210645903e-06
family O 0 3.668229692266323e-05
. O 0 6.180435593705624e-05

The O 0 0.0006544788484461606
I1307K O 0 0.0015480060828849673
polymorphism O 0 2.0641151422751136e-05
has O 0 2.96659368359542e-06
previously O 0 1.3280172424856573e-05
only O 0 1.3994974779052427e-06
been O 0 2.7107946607429767e-06
identified O 0 2.877038923543296e-06
in O 0 3.83234919354436e-06
individuals O 0 1.6611185174042475e-06
of O 0 0.0002222906332463026
self O 0 0.00364581192843616
- O 0 0.006026271730661392
reported O 0 0.0001425924856448546
Ashkenazi O 0 0.00022445489594247192
Jewish O 0 0.00017388536070939153
origins O 0 0.0015272231539711356
. O 0 0.00036551684024743736

In O 0 0.000173246517078951
addition O 0 4.112273018108681e-05
, O 0 9.4352735686698e-06
in O 0 1.1643461220955942e-05
this O 0 4.224625627102796e-06
family O 0 1.3240665794000961e-05
, O 0 3.3312783216388198e-06
there O 0 5.746172519138781e-06
appears O 0 2.849836710083764e-05
to O 0 3.0128426260489505e-06
be O 0 4.547509888652712e-06
no O 0 5.820252226840239e-06
relationship O 0 1.0616518011374865e-05
between O 0 7.224056025734171e-05
the O 0 0.00026154067018069327
I1307K O 0 0.002018431667238474
polymorphism O 0 3.777560414164327e-05
and O 0 5.0564999583002646e-06
the O 0 1.7327578461845405e-05
presence O 0 3.274255504948087e-05
or O 0 4.140854434808716e-05
absence O 0 0.000699923315551132
of O 0 0.0056588673032820225
cancer B-Disease 1 0.9999998807907104
. O 0 0.0005766573594883084
. O 0 0.0002791130100376904

Identification O 0 7.156252831919119e-05
of O 0 0.00012630282435566187
a O 0 9.62230988079682e-05
novel O 0 0.00018066578195430338
mutation O 0 1.1668573279166594e-05
of O 0 7.605785503983498e-05
the O 0 0.0006222851225174963
CPO O 0 0.08205335587263107
gene O 0 2.2000203898642212e-05
in O 0 1.0256282621412538e-05
a O 0 2.9097671358613297e-05
Japanese O 0 0.0013074070448055863
hereditary B-Disease 1 0.9999576807022095
coproporphyria I-Disease 1 0.9999597072601318
family O 0 0.0008595554972998798
. O 0 0.0005277736345306039

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 1 0.9999125003814697
HCP B-Disease 1 1.0
) O 0 0.00022378879657480866
is O 0 1.7441507225157693e-05
an O 0 3.790717528318055e-05
autosomal B-Disease 1 0.9999912977218628
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
characterized O 1 0.761958658695221
by O 0 0.00017226971976924688
a O 0 0.005152691155672073
deficiency B-Disease 1 1.0
of I-Disease 1 0.9999681711196899
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 0 0.0036888690665364265
( O 0 0.0005903496639803052
CPO O 1 0.718855619430542
) O 0 4.570332748699002e-05
caused O 0 8.305981464218348e-05
by O 0 2.2730389446223853e-06
a O 0 9.624036465538666e-06
mutation O 0 4.9483487600809895e-06
in O 0 2.171532469219528e-05
the O 0 0.0002467971353325993
CPO O 0 0.07357762008905411
gene O 0 0.00020535608928184956
. O 0 7.727112824795768e-05

Only O 0 7.133067265385762e-05
11 O 0 0.00016229583707172424
mutations O 0 2.1443271180032752e-05
of O 0 3.855334216495976e-05
the O 0 0.00014858719077892601
gene O 0 3.230788206565194e-05
have O 0 1.5913360584818292e-06
been O 0 1.249994329555193e-05
reported O 0 4.630469993571751e-05
in O 0 0.0002484103024471551
HCP B-Disease 1 1.0
patients O 0 0.0011944506550207734
. O 0 0.0005650026723742485

We O 0 9.354336361866444e-05
report O 0 1.2747889741149265e-05
another O 0 1.3426913028524723e-05
mutation O 0 3.5807177027891157e-06
in O 0 7.04471403878415e-06
a O 0 2.447546285111457e-05
Japanese O 0 0.0008130473433993757
family O 0 9.427921031601727e-05
. O 0 6.71748275635764e-05

Polymerase O 0 0.009319750592112541
chain O 0 0.0013736658729612827
reaction O 0 0.0002586029004305601
- O 0 0.001382680144160986
single O 0 4.002244531875476e-05
strand O 0 4.049852577736601e-05
conformational O 0 4.218152298562927e-06
polymorphism O 0 3.5697796647582436e-06
and O 0 9.390437867295987e-07
direct O 0 1.5592909221595619e-06
sequence O 0 1.0615728569973726e-05
analyses O 0 2.1005542294005863e-05
demonstrated O 0 9.366145968670025e-05
a O 0 2.972687070723623e-05
C O 0 0.000494274019729346
to O 0 4.264726157998666e-05
T O 0 0.0011750030098482966
substitution O 0 1.5681978766224347e-05
in O 0 2.0543764549074695e-05
exon O 0 7.960799848660827e-05
1 O 0 3.450522126513533e-05
of O 0 2.6182298825006e-05
the O 0 0.00012999946193303913
CPO O 0 0.0068676890805363655
gene O 0 1.3869846952729858e-05
at O 0 5.525415690499358e-05
nucleotide O 0 1.2739551493723411e-05
position O 0 1.4056749932933599e-05
85 O 0 4.5377262722468004e-05
, O 0 3.4312533898628317e-06
which O 0 5.0176004151580855e-06
lies O 0 0.0002082491118926555
in O 0 1.62599917530315e-05
the O 0 4.533379978965968e-05
putative O 0 0.00039491127245128155
presequence O 0 0.0009696762426756322
for O 0 5.146665444044629e-06
targeting O 0 1.3109056453686208e-05
to O 0 2.5779121642699465e-05
mitochondria O 0 0.00044643256114795804
. O 0 9.203486115438864e-05

This O 0 4.6815795940347016e-05
mutation O 0 5.1066908781649545e-06
changes O 0 4.066105702804634e-06
the O 0 2.573554593254812e-05
codon O 0 3.4495122235966846e-05
for O 0 7.270512469403911e-06
glutamine O 0 3.005539474543184e-05
to O 0 8.131809408951085e-06
a O 0 3.6154757253825665e-05
termination O 0 0.0003268237633164972
codon O 0 0.00025980468490161
at O 0 0.0008475710055790842
amino O 0 0.0001610164763405919
acid O 0 0.00020544520521070808
position O 0 0.00031590971047990024
29 O 0 0.0021718686912208796
. O 0 0.0003134376893285662

MaeI O 0 0.016089433804154396
restriction O 0 3.31795345118735e-05
analysis O 0 1.7656190038906061e-06
showed O 0 1.9642087863758206e-05
two O 0 2.219914449597127e-06
other O 0 1.4479585388471605e-06
carriers O 0 7.998305591172539e-06
in O 0 6.867783213237999e-06
the O 0 6.742621917510405e-05
family O 0 6.59227735013701e-05
. O 0 7.733186794212088e-05

The O 0 0.00212115072645247
C O 1 0.7773150205612183
- O 0 0.014226538129150867
T O 0 0.007041545584797859
mutation O 0 7.642513082828373e-06
is O 0 1.0720207228587242e-06
located O 0 6.8599147198256105e-06
within O 0 1.1600342304518563e-06
a O 0 2.4218768430728232e-06
recently O 0 1.0591458703856915e-05
proposed O 0 7.648798600712325e-06
putative O 0 6.445302278734744e-05
alternative O 0 1.0489411579328589e-05
translation O 0 0.00013240888074506074
initiation O 0 0.0008086917805485427
codon O 0 0.0003243362589273602
( O 0 0.00015997733862604946
TIC O 0 0.08027386665344238
- O 0 0.0004389252280816436
1 O 0 0.00015716043708380312
) O 0 7.014406037342269e-06
, O 0 1.9583173980208812e-06
supporting O 0 1.5988211089279503e-05
that O 0 2.1606916561722755e-05
TIC O 1 0.982296884059906
- O 0 0.0004608035378623754
1 O 0 0.00010036741150543094
is O 0 4.050137249578256e-06
the O 0 1.9412904293858446e-05
real O 0 0.00025194420595653355
TIC O 1 0.8282396197319031
rather O 0 4.247918332112022e-05
than O 0 4.424599319463596e-05
TIC O 1 0.9872380495071411
- O 0 0.0013024817453697324
2 O 0 0.0004088616115041077
. O 0 2.8349631975288503e-05
. O 0 5.8465349866310135e-05

Human B-Disease 0 7.162649126257747e-05
complement I-Disease 0 0.00030608984525315464
factor I-Disease 0 0.17592884600162506
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 0.4129297137260437
with O 1 0.9999998807907104
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 1.0

This O 0 1.0997753634001128e-05
study O 0 2.326323510715156e-06
reports O 0 3.3152289233839838e-06
on O 0 2.2899077521287836e-05
six O 0 2.6922993129119277e-05
cases O 0 3.500051752780564e-05
of O 0 0.0009965127101168036
deficiency B-Disease 1 1.0
in I-Disease 0 0.00045325030805543065
the I-Disease 0 0.00015416540554724634
human I-Disease 0 1.2572104424179997e-05
complement I-Disease 0 1.0321531590307131e-05
regulatory I-Disease 0 1.6783315004431643e-05
protein I-Disease 0 6.74929324304685e-05
Factor I-Disease 0 0.0003583679790608585
H I-Disease 1 0.9999955892562866
( O 0 0.00031459747697226703
FH O 0 0.03170891851186752
) O 0 6.178495368658332e-06
in O 0 1.4466831999015994e-06
the O 0 2.383837909292197e-06
context O 0 5.8391274251334835e-06
of O 0 4.448749314178713e-05
an O 0 0.0008229919476434588
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999998807907104

Five O 0 0.0001102859532693401
of O 0 5.740466804127209e-05
the O 0 6.67043641442433e-05
cases O 0 1.3169214980734978e-05
were O 0 1.3824722373101395e-05
observed O 0 1.08946278487565e-05
in O 0 2.704228563743527e-06
children O 0 1.5221520470731775e-06
presenting O 0 3.0174431230989285e-05
with O 0 0.0005113555816933513
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.999531626701355
. O 0 0.0014501232653856277

Two O 0 3.939116504625417e-05
of O 0 8.850204176269472e-05
the O 0 0.00015101284952834249
children O 0 5.683875860995613e-05
exhibited O 0 0.001964824041351676
a O 0 0.0014208724023774266
homozygous O 1 0.9559122323989868
deficiency O 1 1.0
characterized O 0 0.0023955428041517735
by O 0 4.7370333049912006e-05
the O 0 0.00014966675371397287
absence O 0 0.00023964481079019606
of O 0 0.0001705223403405398
the O 0 0.000260163884377107
150 O 0 0.0002782672527246177
- O 0 0.0005303897196426988
kD O 0 0.0030348156578838825
form O 0 8.772717592364643e-06
of O 0 0.00010274830128764734
Factor O 0 0.0008492277702316642
H O 1 0.998529314994812
and O 0 2.014303936448414e-05
the O 0 2.5758403353393078e-05
presence O 0 1.6405687347287312e-05
, O 0 3.5500684134603944e-06
upon O 0 3.744805871974677e-05
immunoblotting O 0 0.0018007768085226417
, O 0 4.197325779387029e-06
of O 0 2.4085906261461787e-05
the O 0 9.351098560728133e-05
42 O 0 0.0005476261721923947
- O 0 0.0006883128080517054
kD O 0 0.005934052634984255
Factor O 0 0.0002403276157565415
H O 0 0.028540760278701782
- O 0 0.00011860031372634694
like O 0 3.295046553830616e-06
protein O 0 9.189420779875945e-06
1 O 0 0.00012798194075003266
( O 0 7.285572792170569e-05
FHL O 0 0.05833747237920761
- O 0 0.00041670576320029795
1 O 0 0.00011588772758841515
) O 0 7.711331818427425e-06
and O 0 2.7852925086335745e-06
other O 0 6.775405836378923e-06
FH O 0 0.03894943371415138
- O 0 0.0004040059866383672
related O 0 8.408291614614427e-05
protein O 0 0.00016303584561683238
( O 0 0.0002024783898377791
FHR O 1 0.9997269511222839
) O 0 0.00019895042350981385
bands O 0 0.0007275794050656259
. O 0 0.0001605106081115082

Southern O 0 0.0013288200134411454
blot O 0 0.0006900783046148717
and O 0 7.471985554730054e-06
PCR O 0 3.0776071071159095e-05
analysis O 0 1.226019776368048e-06
of O 0 2.477095404174179e-05
DNA O 0 0.00019198533846065402
of O 0 9.828984912019223e-05
one O 0 5.415652776719071e-05
patient O 0 9.54444840317592e-05
with O 0 3.773765274672769e-05
homozygous O 0 0.008160346187651157
deficiency O 1 1.0
ruled O 0 0.0034565047826617956
out O 0 4.074832031619735e-05
the O 0 2.926478373410646e-05
presence O 0 2.030257019214332e-05
of O 0 4.426409941515885e-05
a O 0 2.95343816105742e-05
large O 0 4.8370267904829234e-05
deletion O 0 0.00018057123816106468
of O 0 0.00018175016157329082
the O 0 0.0007275735260918736
FH O 1 0.9963028430938721
gene O 0 3.146657400066033e-05
as O 0 1.2310601050558034e-05
the O 0 5.60002081329003e-05
underlying O 0 0.01103920117020607
defect O 1 0.6616700291633606
for O 0 0.0001996499195229262
the O 1 0.9996767044067383
deficiency O 1 1.0
. O 0 0.004179798066616058

The O 0 0.00015670133871026337
other O 0 5.496975063579157e-06
four O 0 1.0769736036309041e-05
children O 0 7.580269539175788e-06
presented O 0 0.00010468304390087724
with O 0 0.00010249552724417299
heterozygous O 0 0.004385891370475292
deficiency O 1 1.0
and O 0 0.0004285751492716372
exhibited O 0 0.4563429057598114
a O 0 0.0007976501947268844
normal O 0 0.0008080289699137211
immunoblotting O 0 0.0048124948516488075
pattern O 0 0.0001270490902243182
of O 0 0.00011768814147217199
proteins O 0 4.736748815048486e-05
of O 0 0.00018331201863475144
the O 0 0.0016820109449326992
FH O 1 0.9998664855957031
family O 0 0.00032053375616669655
. O 0 0.00010745698818936944

Factor B-Disease 1 0.9992239475250244
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.3985583286266774e-05
the O 0 4.6224133257055655e-05
only O 0 4.572886973619461e-05
complement B-Disease 1 0.9999970197677612
deficiency I-Disease 1 1.0
associated O 0 0.03531419113278389
with O 0 0.005289621651172638
HUS B-Disease 1 1.0
. O 0 0.014374111779034138

These O 0 1.996228820644319e-05
observations O 0 2.4152977857738733e-05
suggest O 0 1.5189912119240034e-05
a O 0 1.1589999303396326e-05
role O 0 0.00011305258522043005
for O 0 0.00016673987556714565
FH O 1 0.9999212026596069
and O 0 0.0003775185614358634
/ O 0 0.0029016437474638224
or O 0 0.0003922537434846163
FH O 1 0.9724425077438354
receptors O 0 9.982289338950068e-05
in O 0 2.192135616496671e-05
the O 0 0.00013305869651958346
pathogenesis O 1 0.999995231628418
of O 0 0.08472752571105957
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.021267838776111603
. O 0 0.0008621696615591645

Further O 0 6.765260332031175e-05
evidence O 0 2.041467269009445e-05
for O 0 2.5052927412616555e-06
a O 0 1.3798549844068475e-05
major O 0 0.00022658360830973834
ancient O 0 0.23513783514499664
mutation O 0 0.004780972842127085
underlying O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9999908208847046
linkage O 1 0.9999856948852539
disequilibrium O 1 0.9988248944282532
studies O 0 0.0001050021528499201
in O 0 2.5961859137169085e-05
the O 0 4.169646490481682e-05
Japanese O 0 0.0002643053885549307
population O 0 1.0180400749959517e-05
. O 0 3.8014910387573764e-05

The O 1 0.9993359446525574
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999858140945435
DM B-Disease 1 1.0
) O 0 0.000614559801761061
mutation O 0 1.9219869500375353e-05
is O 0 4.360363163868897e-06
an O 0 1.7795649910112843e-05
unstable O 0 0.011456570588052273
( O 0 0.0007162446854636073
CTG O 1 0.9996284246444702
) O 0 7.642799755558372e-05
n O 0 9.889550710795447e-05
repeat O 0 0.0003988471580669284
, O 0 4.363058451417601e-06
present O 0 1.6661475456203334e-05
at O 0 9.27821165532805e-05
a O 0 9.923276593326591e-06
copy O 0 3.60938829544466e-05
number O 0 6.3735446929058526e-06
of O 0 8.53206220199354e-05
5 O 0 0.0006392397917807102
- O 0 0.00048319390043616295
37 O 0 8.59843275975436e-05
repeats O 0 9.439129644306377e-05
on O 0 4.104409890715033e-05
normal O 0 5.374878310249187e-05
chromosomes O 0 1.3254057193989865e-05
but O 0 1.4020690741745057e-06
amplified O 0 1.2266946214367636e-05
to O 0 3.0265675832197303e-06
50 O 0 2.6245574190397747e-05
- O 0 7.959486538311467e-05
3000 O 0 0.00010337580897612497
copies O 0 4.1053182940231636e-05
on O 0 0.00042087017209269106
DM B-Disease 1 1.0
chromosomes O 0 0.0009346753358840942
. O 0 0.00012527633225545287

Previous O 0 0.0003169362898916006
findings O 0 6.588456017198041e-05
in O 0 3.7977621104801074e-05
Caucasian O 0 0.0004715881950687617
populations O 0 8.130151400109753e-06
of O 0 7.133291364880279e-05
a O 0 0.0015838841209188104
DM B-Disease 1 1.0
founder O 1 0.9997984766960144
chromosome O 0 0.0010207706363871694
raise O 0 7.46464284020476e-05
a O 0 1.1421124327171128e-05
question O 0 9.946594218490645e-06
about O 0 2.4755577214818913e-06
the O 0 8.060551408561878e-06
molecular O 0 1.8236791220260784e-05
events O 0 2.5449920940445736e-05
involved O 0 2.496885099390056e-05
in O 0 3.451443262747489e-05
the O 0 0.00011099979747086763
expansion O 0 0.0016643782146275043
mutation O 0 8.293492282973602e-05
. O 0 7.639513933099806e-05

To O 0 5.418503860710189e-05
investigate O 0 6.468762876465917e-05
whether O 0 8.516275556758046e-06
a O 0 3.669856960186735e-05
founder O 0 0.0010872926795855165
chromosome O 0 0.0001033090811688453
for O 0 3.124237628071569e-05
the O 0 0.0014069860335439444
DM B-Disease 1 1.0
mutation O 0 0.00020467370632104576
exists O 0 6.455624679801986e-05
in O 0 7.100087259459542e-06
the O 0 8.119937774608843e-06
Japanese O 0 0.0001776368881110102
population O 0 2.7532998956303345e-06
, O 0 1.6237610225289245e-06
we O 0 3.5585219393396983e-06
genotyped O 0 0.0004398385062813759
families O 0 2.0026511720061535e-06
using O 0 1.6280824866043986e-06
polymorphic O 0 8.246813376899809e-05
markers O 0 0.0010392696131020784
near O 0 0.004300751723349094
the O 0 0.0005797329940833151
( O 0 0.0006101487670093775
CTG O 1 0.950645387172699
) O 0 3.8361020415322855e-05
n O 0 8.376054756809026e-05
repeat O 0 0.0004190784238744527
region O 0 0.00023761170450598001
and O 0 2.6675017579691485e-05
constructed O 0 0.009411442093551159
haplotypes O 0 0.003686698153614998
. O 0 0.00040804955642670393

Six O 0 0.00012462578888516873
different O 0 2.710225999180693e-06
haplotypes O 0 0.00042764097452163696
were O 0 4.038020779262297e-05
found O 0 3.779188773478381e-05
and O 0 7.903750520199537e-05
DM B-Disease 1 1.0
alleles O 0 9.053254325408489e-05
were O 0 0.00011791717406595126
always O 0 8.837882342049852e-05
haplotype O 0 0.000678825716022402
A O 0 0.0022485970985144377
. O 0 0.0005181396845728159

To O 0 6.771302287233993e-05
find O 0 9.678136848378927e-06
an O 0 8.832520848045533e-07
origin O 0 2.5597732928872574e-06
of O 0 5.600159784080461e-05
the O 0 0.00035948105505667627
( O 0 0.0006906786584295332
CTG O 1 0.9977961778640747
) O 0 7.553058821940795e-05
n O 0 0.00015342861297540367
repeat O 0 0.0006367128225974739
mutation O 0 5.001724275643937e-06
and O 0 1.2225428918100079e-06
to O 0 3.0899598186806543e-06
investigate O 0 2.5102406652877107e-05
the O 0 3.859424396068789e-05
mechanism O 0 8.736076415516436e-05
of O 0 5.277347008814104e-05
the O 0 0.0001284935715375468
expansion O 0 0.000719296804163605
mutation O 0 6.569718607352115e-06
in O 0 4.8488923312106635e-06
the O 0 1.0716347787820268e-05
Japanese O 0 7.003907376201823e-05
population O 0 7.342270009758067e-07
we O 0 5.216837735133595e-07
have O 0 1.343381654805853e-07
studied O 0 2.196668356191367e-05
90 O 0 6.316982762655243e-05
Japanese O 0 0.0013965439284220338
DM B-Disease 1 0.9999978542327881
families O 0 1.2478383723646402e-05
comprising O 0 3.84504564863164e-05
190 O 0 7.272689254023135e-05
affected O 0 2.8355281756375916e-05
and O 0 1.2389523362799082e-05
130 O 0 0.00016679696273058653
unaffected O 0 0.0005883330595679581
members O 0 2.9806295060552657e-05
. O 0 9.984192001866177e-05

The O 0 0.00019725083257071674
results O 0 3.244153776904568e-05
suggest O 0 1.4542867575073615e-05
that O 0 1.5561415693809977e-06
a O 0 1.1980613635387272e-05
few O 0 2.8717191526084207e-05
common O 0 2.283953654114157e-05
ancestral O 0 0.001379805849865079
mutations O 0 0.00018957944121211767
in O 0 9.94418078335002e-05
both O 0 5.127989425091073e-05
Caucasian O 0 0.0019618491642177105
and O 0 3.0037714168429375e-05
Japanese O 0 0.00041408094693906605
populations O 0 4.684565737989033e-06
have O 0 6.085354584683955e-07
originated O 0 7.20967636880232e-06
by O 0 5.105578111397335e-07
expansion O 0 4.276732579455711e-05
of O 0 2.1610521798720583e-05
an O 0 1.0783590369101148e-05
ancestral O 0 0.0010696081444621086
n O 0 0.0003003894235007465
= O 0 0.0002447281440254301
5 O 0 5.837281423737295e-05
repeat O 0 0.00010432438284624368
to O 0 1.3186694559408352e-05
n O 0 8.484080171911046e-05
= O 0 0.00020333989232312888
19 O 0 0.0003662225790321827
- O 0 0.00022508922847919166
37 O 0 7.577370706712827e-05
copies O 0 0.00013400868920143694
. O 0 0.00012289528967812657

These O 0 1.073717612598557e-05
data O 0 1.1140174137835857e-05
support O 0 4.278702363080811e-06
multistep O 0 0.00021039441344328225
models O 0 4.3818450649268925e-05
of O 0 0.000488687539473176
triplet O 0 0.010259228758513927
repeat O 0 0.0030597085133194923
expansion O 0 0.0006996571901254356
that O 0 1.739894287311472e-06
have O 0 2.510540184630372e-07
been O 0 7.832250048522837e-07
proposed O 0 1.1238817023695447e-06
for O 0 2.021334466917324e-06
both O 0 4.6848446800140664e-05
DM B-Disease 1 1.0
and O 0 0.0013296162942424417
Friedreichs B-Disease 1 0.9999967813491821
ataxia I-Disease 1 0.9999414682388306
. O 0 0.0004910490824840963
. O 0 0.0003666790435090661

The O 0 5.7324141380377114e-05
molecular O 0 3.631879735621624e-05
basis O 0 0.00017886704881675541
of O 1 0.9999053478240967
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0013327833730727434
the O 0 0.00024011502682697028
western O 0 0.0001948844874277711
Cape O 0 0.0004467407998163253
, O 0 5.861673798790434e-06
South O 0 9.813720680540428e-05
Africa O 0 0.00015380654076579958
. O 0 5.70091578993015e-05

Deficiency B-Disease 1 1.0
of I-Disease 0 0.002163209021091461
the I-Disease 0 0.0005856677307747304
sixth I-Disease 0 0.0018880770076066256
component I-Disease 0 0.00011570685455808416
of I-Disease 0 8.72017044457607e-05
human I-Disease 0 0.00013429010869003832
complement I-Disease 0 0.0009966299403458834
( O 0 0.0014261119067668915
C6 O 1 0.9999985694885254
) O 0 3.364883377798833e-05
has O 0 2.8097838367102668e-06
been O 0 4.929330316372216e-06
reported O 0 5.403908289736137e-06
in O 0 2.0355507786007365e-06
a O 0 2.5178944724757457e-06
number O 0 2.2857950625621015e-06
of O 0 1.6572701497352682e-05
families O 0 2.598635774120339e-06
from O 0 1.621299634280149e-05
the O 0 7.161310350056738e-05
western O 0 0.0002154011745005846
Cape O 0 0.0009901653975248337
, O 0 1.424367383151548e-05
South O 0 0.00022076375898905098
Africa O 0 0.00023802848591003567
. O 0 4.528855424723588e-05

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.0003424907336011529
endemic O 0 0.0002764170931186527
in O 0 2.4055741960182786e-05
the O 0 5.72752978769131e-05
Cape O 0 0.00042150114313699305
and O 0 1.8348540606893948e-06
almost O 0 3.705354856720078e-06
all O 0 1.2590356845976203e-06
pedigrees O 0 8.64664907567203e-05
of O 0 0.0002262576308567077
total O 1 0.9999951124191284
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.995049774646759
C6Q0 O 1 0.9999998807907104
) O 0 5.017773582949303e-05
have O 0 1.7875631783681456e-06
been O 0 1.0442143320688047e-05
ascertained O 0 0.00020933269115630537
because O 0 7.569844456156716e-06
of O 0 0.00023215364490170032
recurrent O 1 1.0
disease O 1 1.0
. O 0 0.006623334251344204

We O 0 3.299956733826548e-05
have O 0 1.0221930324405548e-06
sequenced O 0 2.1404735889518633e-05
the O 0 4.287639967515133e-06
expressed O 0 6.273559847613797e-06
exons O 0 0.0001768304209690541
of O 0 0.00018801794794853777
the O 0 0.0013664360158145428
C6 O 1 0.9999977350234985
gene O 0 5.085605880594812e-05
from O 0 5.171472366782837e-06
selected O 0 6.616807240789058e-06
cases O 0 1.6694020814611576e-06
and O 0 8.351902920367138e-07
have O 0 5.658504846905998e-07
found O 0 2.182868911404512e-06
three O 0 1.5237179468385875e-05
molecular O 0 0.0007388262310996652
defects O 1 0.9999285936355591
leading O 0 0.0032648120541125536
to O 0 0.00039090917562134564
total O 1 0.9996459484100342
deficiency O 1 1.0
879delG O 1 0.9993698000907898
, O 0 4.4523396354634315e-05
which O 0 6.685227162961382e-06
is O 0 3.19590549224813e-06
the O 0 2.6261670427629724e-05
common O 0 6.242464587558061e-05
defect O 0 0.005939700175076723
in O 0 0.000151526925037615
the O 0 0.0002743688819464296
Cape O 0 0.0020014753099530935
and O 0 2.5609751901356503e-05
hitherto O 0 0.0008304702932946384
unreported O 0 0.0003949177043978125
, O 0 1.0691175702959299e-05
and O 0 8.438822987955064e-06
1195delC O 0 0.0020889611914753914
and O 0 4.853952850680798e-05
1936delG O 0 0.0017427363200113177
, O 0 5.103813691675896e-06
which O 0 8.039923500291479e-07
have O 0 1.6921197243391362e-07
been O 0 1.3954925179859856e-06
previously O 0 1.2043828064633999e-05
reported O 0 9.67762025538832e-06
in O 0 2.5592758902348578e-05
African O 0 0.00029491999885067344
- O 0 0.000800734618678689
Americans O 0 8.581984729971737e-05
. O 0 9.097730799112469e-05

We O 0 5.2842060540569946e-05
also O 0 3.7327997688407777e-06
show O 0 1.0974108590744436e-05
that O 0 1.1654310583253391e-06
the O 0 2.7748843422159553e-05
879delG O 0 0.003354607382789254
and O 0 0.00011300375626888126
1195delC O 1 0.9488184452056885
defects O 1 0.9791968464851379
are O 0 6.241180471988628e-06
associated O 0 4.203638673061505e-05
with O 0 6.31097427685745e-05
characteristic O 1 0.9999992847442627
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 0.007418026216328144
DNA O 0 0.0013964788522571325
marker O 0 0.0015983134508132935
haplotypes O 0 0.0006499375449493527
, O 0 9.574302566761617e-06
although O 0 4.0869044823921286e-06
small O 0 4.5594083530886564e-06
variations O 0 2.605390181997791e-05
were O 0 6.24302338110283e-05
observed O 0 0.0001264983438886702
. O 0 9.153928112937137e-05

The O 0 0.0024369806051254272
1936delG O 1 0.8595992922782898
defect O 0 0.13169999420642853
was O 0 0.0009889312786981463
observed O 0 3.7935962609481066e-05
only O 0 9.437208973395173e-06
once O 0 7.614929927513003e-05
in O 0 7.705200914642774e-06
the O 0 3.240943988203071e-05
Cape O 0 0.00043585608364082873
, O 0 2.5277176973759197e-06
but O 0 7.119630254237563e-07
its O 0 2.4409182515228167e-06
associated O 0 1.4042105249245651e-05
haplotype O 0 0.00028226326685398817
could O 0 4.3666026613209397e-05
be O 0 2.240285357402172e-05
deduced O 0 0.00045693721040152013
. O 0 0.00010716485121520236

The O 0 0.0001014742229017429
data O 0 1.9291468561277725e-05
from O 0 1.2809565305360593e-05
the O 0 4.022797293146141e-05
haplotypes O 0 0.0003196625330019742
indicate O 0 2.4674571250216104e-05
that O 0 4.497697148053703e-07
these O 0 1.182585606329667e-06
three O 0 1.2566207260533702e-05
molecular O 0 0.0005570905050262809
defects O 1 0.8872005343437195
account O 0 5.66408307349775e-05
for O 0 0.0001119986773119308
the O 0 0.0027218314353376627
defects O 1 0.9998940229415894
in O 0 0.00017361860955134034
all O 0 3.064071279368363e-05
the O 0 0.00014299986651167274
38 O 0 0.0004485273966565728
unrelated O 0 0.0008741985075175762
C6Q0 O 1 0.9941587448120117
individuals O 0 1.0346032468078192e-05
we O 0 9.970792234526016e-06
have O 0 2.1280388864397537e-06
studied O 0 0.00010429842950543389
from O 0 5.706234878743999e-05
the O 0 0.00023513111227657646
Cape O 0 0.003377723041921854
. O 0 0.00014278704475145787

We O 0 4.6348872274393216e-05
have O 0 1.6691886912667542e-06
also O 0 1.3880821825296152e-06
observed O 0 8.455055649392307e-06
the O 0 4.4214859372004867e-05
879delG O 0 0.004361599218100309
defect O 0 0.0037569766864180565
in O 0 0.00010362274042563513
two O 0 0.00016985635738819838
Dutch O 1 0.9999988079071045
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.0032844000961631536
, O 0 9.557625162415206e-06
but O 0 3.2682264645700343e-06
the O 0 6.752125773346052e-05
879delG O 0 0.012442344799637794
defect O 0 0.012313601560890675
in O 0 0.0001888761471491307
the O 0 0.00019727360631804913
Cape O 0 0.0015345411375164986
probably O 0 7.258928962983191e-05
did O 0 5.2485033847915474e-06
not O 0 5.306612251843035e-07
come O 0 1.387097654514946e-06
from O 0 2.0477434645727044e-06
The O 0 2.648382360348478e-05
Netherlands O 0 0.00037631180020980537
. O 0 3.447854396654293e-05
. O 0 5.63192370464094e-05

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.0005036509246565402
seven O 0 0.00016830768436193466
further O 0 0.00022165992413647473
molecular O 0 0.00486332643777132
defects O 1 0.9995741248130798
and O 0 5.820489241159521e-05
their O 0 5.204568151384592e-05
associated O 0 0.0003158699255436659
marker O 0 0.0067403363063931465
haplotypes O 0 0.00679665245115757
. O 0 0.0006092619732953608

Seven O 0 9.195160964736715e-05
further O 0 3.1452982511837035e-05
molecular O 0 0.00011906216968782246
bases O 0 0.0005415690829977393
of O 1 0.9999876022338867
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0005826373235322535
described O 0 0.0012607816606760025
. O 0 0.00029922922840341926

All O 0 2.5754963644430973e-05
these O 0 3.9363285395666026e-06
new O 0 2.3498998416471295e-05
molecular O 0 0.0011391431326046586
defects O 1 0.9976139068603516
involve O 0 0.0008894525817595422
single O 0 0.00060529779875651
- O 0 0.0020839888602495193
nucleotide O 0 7.552504393970594e-05
events O 0 6.495689740404487e-05
, O 0 1.3313636372913606e-05
deletions O 0 6.625527748838067e-05
and O 0 7.840904800104909e-06
substitutions O 0 7.143727270886302e-05
, O 0 4.586424893204821e-06
some O 0 1.2672076081798878e-06
of O 0 3.535247378749773e-05
which O 0 3.8980630051810294e-05
alter O 0 0.00027422659331932664
splice O 0 0.0005572264199145138
sites O 0 0.00010918784391833469
, O 0 9.641215910960454e-06
and O 0 9.958132977772038e-06
others O 0 4.4708991481456906e-05
codons O 0 0.00115650100633502
. O 0 0.00034280726686120033

They O 0 1.062632418324938e-05
are O 0 3.5076212157036935e-07
distributed O 0 1.1482514992167125e-06
along O 0 3.1666273571318015e-05
the O 0 0.00026632141089066863
C7 O 1 0.9999251365661621
gene O 0 9.894521645037457e-05
, O 0 3.0597971090173814e-06
but O 0 5.799822702101665e-07
predominantly O 0 1.8429703914080164e-06
towards O 0 1.7368243788951077e-05
the O 0 3.31945666403044e-05
3 O 0 0.00028751612990163267
end O 0 0.001440481748431921
. O 0 0.000149470244650729

All O 0 5.4612861276837066e-05
were O 0 4.1151055484078825e-05
found O 0 1.0691195711842738e-05
in O 0 3.310433748993091e-05
compound O 0 0.00046418842975981534
heterozygous O 0 2.9284659831319004e-05
individuals O 0 8.725434781808872e-06
. O 0 0.000186458884854801

The O 0 0.4620731770992279
C6 O 1 1.0
/ O 1 0.9999920129776001
C7 O 1 0.9999997615814209
marker O 0 0.003482924308627844
haplotypes O 0 0.0010609783930703998
associated O 0 8.694506686879322e-05
with O 0 0.00010083690722240135
most O 0 0.007363444659858942
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999997615814209
are O 0 5.9046491514891386e-05
tabulated O 0 0.0017171533545479178
. O 0 5.509163747774437e-05
. O 0 9.59301833063364e-05

A O 0 0.003167195012792945
genome O 0 0.0008647660142742097
- O 0 0.00019546921248547733
wide O 0 2.18416844290914e-05
search O 0 4.174161404080223e-06
for O 0 5.50910863239551e-06
chromosomal O 0 0.0025803884491324425
loci O 0 0.006784331984817982
linked O 1 0.9935123324394226
to O 0 0.0013399503659456968
mental O 1 1.0
health O 1 0.9939701557159424
wellness O 0 0.006537783890962601
in O 0 6.967335502849892e-05
relatives O 0 5.8630444982554764e-05
at O 0 0.0001886792160803452
high O 0 0.0003675883053801954
risk O 0 0.00010043548536486924
for O 0 0.0002186615311075002
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9999923706054688
the O 1 0.8942242860794067
Old O 0 0.2822715938091278
Order O 0 0.00022768613416701555
Amish O 0 0.0005597800482064486
. O 0 5.671217149938457e-05

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.0005484980647452176
is O 0 2.2122163500171155e-05
characterized O 0 4.391131369629875e-05
by O 0 7.08583547748276e-06
episodes O 0 0.00039749775896780193
of O 0 0.002025922294706106
mania B-Disease 1 1.0
and O 0 0.0013685235753655434
/ O 1 0.9950504899024963
or O 0 0.0013435793807730079
hypomania B-Disease 1 0.9999994039535522
interspersed O 0 0.0055205561220645905
with O 0 2.5914961952366866e-05
periods O 0 0.0009902908932417631
of O 0 0.002638744655996561
depression B-Disease 1 1.0
. O 0 0.003305487334728241

Compelling O 0 0.0004984724801033735
evidence O 0 6.85563645674847e-05
supports O 0 1.0885094525292516e-05
a O 0 3.325548959765001e-06
significant O 0 2.0133495127083734e-05
genetic O 0 5.791681178379804e-05
component O 0 0.00018296400958206505
in O 0 3.411797297303565e-05
the O 0 8.922858978621662e-05
susceptibility O 0 0.00031862829928286374
to O 0 0.0001794032141333446
develop O 0 0.07460788637399673
BPAD B-Disease 1 1.0
. O 0 0.0013335527619346976

To O 0 6.618651241296902e-05
date O 0 0.0003977543965447694
, O 0 6.735071110597346e-06
however O 0 6.152212790766498e-06
, O 0 4.408438599057263e-06
linkage O 0 0.00013861522893421352
studies O 0 9.770652468432672e-06
have O 0 1.6906628843571525e-06
attempted O 0 6.395745003828779e-05
only O 0 5.1489332690835e-06
to O 0 7.053036824800074e-06
identify O 0 5.689766112482175e-05
chromosomal O 0 0.0050222487188875675
loci O 0 0.001811451162211597
that O 0 4.355041528469883e-05
cause O 0 0.0010049538686871529
or O 0 6.675286567769945e-05
increase O 0 4.668797191698104e-05
the O 0 0.00018206705863121897
risk O 0 0.0001268329069716856
of O 0 0.0002808456774801016
developing O 0 0.008067423477768898
BPAD B-Disease 1 1.0
. O 0 0.0016667599556967616

To O 0 4.769820225192234e-05
determine O 0 3.17786616506055e-05
whether O 0 8.958028047345579e-06
there O 0 8.01105397840729e-06
could O 0 1.0386862413724884e-05
be O 0 8.349613381142262e-06
protective O 0 8.292084385175258e-05
alleles O 0 1.26894265122246e-05
that O 0 6.453884907386964e-06
prevent O 0 0.00034190239966847
or O 0 7.089287100825459e-05
reduce O 0 0.00014385163376573473
the O 0 0.00016155735647771508
risk O 0 0.0001312055828748271
of O 0 0.00033838581293821335
developing O 0 0.005011268425732851
BPAD B-Disease 1 1.0
, O 0 2.4112288883770816e-05
similar O 0 1.3470265685100458e-06
to O 0 3.7441018321260344e-06
what O 0 1.6413838466178277e-06
is O 0 8.74681916229747e-07
observed O 0 2.8849983664258616e-06
in O 0 6.6231523305759765e-06
other O 0 1.654864718148019e-05
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 0.008266378194093704
we O 0 0.00035725149791687727
used O 0 0.001640224363654852
mental O 1 1.0
health O 1 0.9998446702957153
wellness O 1 0.9979382157325745
( O 0 0.00014926343283150345
absence O 0 0.0003210543072782457
of O 0 0.00021701157675124705
any O 0 0.0005932578351348639
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.004317556973546743
as O 0 0.00029724996420554817
the O 0 0.00016741693252697587
phenotype O 0 4.9662645324133337e-05
in O 0 1.963568320206832e-05
our O 0 3.7028523365734145e-05
genome O 0 0.00030524065368808806
- O 0 0.0005583795718848705
wide O 0 0.00029865579563193023
linkage O 0 0.0011554951779544353
scan O 0 0.00022199112572707236
of O 0 9.947775106411427e-05
several O 0 6.086688154027797e-05
large O 0 0.0005144924507476389
multigeneration O 0 0.03039521723985672
Old O 0 0.0016033104620873928
Order O 0 0.00010773760732263327
Amish O 0 0.00044796933070756495
pedigrees O 0 0.00034690319444052875
exhibiting O 0 0.00032515364000573754
an O 0 3.524798376020044e-05
extremely O 0 0.00042194194975309074
high O 0 0.0016322147566825151
incidence O 0 0.011034286580979824
of O 0 0.01928509958088398
BPAD B-Disease 1 1.0
. O 0 0.003281391691416502

We O 0 8.412870374741033e-05
have O 0 2.4571620542701567e-06
found O 0 2.5910683234542375e-06
strong O 0 1.8831588022294454e-06
evidence O 0 1.0380089406680781e-05
for O 0 2.5146810003207065e-06
a O 0 2.323236367374193e-05
locus O 0 0.00014609684876631945
on O 0 0.0002768243139144033
chromosome O 0 0.0014070100151002407
4p O 0 0.12656138837337494
at O 0 0.0015871396753937006
D4S2949 O 0 0.002251335419714451
( O 0 4.96876600664109e-05
maximum O 0 0.00032264870242215693
GENEHUNTER O 1 0.9991375207901001
- O 0 0.0010218896204605699
PLUS O 0 0.000521258800290525
nonparametric O 0 0.00013039201439823955
linkage O 0 0.00015156420704443008
score O 0 2.942058927146718e-05
= O 0 7.819606980774552e-05
4 O 0 6.648920680163428e-05
. O 0 6.027105428074719e-06
05 O 0 0.0007904371013864875
, O 0 2.2078580514062196e-05
P O 0 0.0008491080370731652
= O 0 0.00013816144200973213
5 O 0 4.312547389417887e-05
. O 0 3.480783334453008e-06
22 O 0 4.5842745748814195e-05
x O 0 5.04734598507639e-05
10 O 0 6.567849050043151e-05
( O 0 2.9183847800595686e-05
- O 0 0.00015583369531668723
4 O 0 0.00010914776066783816
) O 0 1.0752710295491852e-05
; O 0 5.335900368663715e-06
SIBPAL O 0 0.02689117006957531
Pempirical O 0 0.0025809998624026775
value O 0 6.371717608999461e-05
< O 0 0.000288489245576784
3 O 0 6.684356776531786e-05
x O 0 4.42468372057192e-05
10 O 0 5.064239667262882e-05
( O 0 2.424089689156972e-05
- O 0 0.00016541853256057948
5 O 0 0.00011047824227716774
) O 0 2.3539887479273602e-05
) O 0 8.793071174295619e-06
and O 0 5.483137556439033e-06
suggestive O 0 0.00015428363985847682
evidence O 0 2.54421047429787e-05
for O 0 5.734927981393412e-06
a O 0 4.442165300133638e-05
locus O 0 0.0004969777655787766
on O 0 0.000968621694482863
chromosome O 0 0.004113742616027594
4q O 0 0.006694281008094549
at O 0 0.0008481595432385802
D4S397 O 0 0.002869239542633295
( O 0 4.9431644583819434e-05
maximum O 0 0.00021359122183639556
GENEHUNTER O 1 0.9996398687362671
- O 0 0.0015478101558983326
PLUS O 0 0.0007476815371774137
nonparametric O 0 0.00022552833252120763
linkage O 0 0.00020352630235720426
score O 0 4.280812936485745e-05
= O 0 7.571788592031226e-05
3 O 0 4.379046004032716e-05
. O 0 7.050225121929543e-06
29 O 0 0.00011942409764742479
, O 0 8.680466635269113e-06
P O 0 0.00048388479626737535
= O 0 7.777855353197083e-05
2 O 0 5.4244497732724994e-05
. O 0 3.5437765291135293e-06
57 O 0 2.2636962967226282e-05
x O 0 5.224658525548875e-05
10 O 0 8.332193101523444e-05
( O 0 2.2482492568087764e-05
- O 0 0.000161210642545484
3 O 0 6.954943091841415e-05
) O 0 1.0162968465010636e-05
; O 0 5.945543307461776e-06
SIBPAL O 0 0.02694561332464218
Pempirical O 0 0.00437083188444376
value O 0 5.1176724809920415e-05
< O 0 0.0003875629627145827
1 O 0 9.813571523409337e-05
x O 0 6.151113484520465e-05
10 O 0 7.040899799903855e-05
( O 0 2.452174339850899e-05
- O 0 0.00013903780200053006
3 O 0 6.261387170525268e-05
) O 0 3.5776663480646675e-06
) O 0 9.01504392913921e-07
that O 0 1.7062048129901086e-07
are O 0 5.698491918337822e-07
linked O 0 0.00018366928270552307
to O 0 0.00013601442333310843
mental O 1 1.0
health O 1 0.9982814788818359
wellness O 1 0.9943422079086304
. O 0 0.0007813359843567014

These O 0 5.138680717209354e-05
findings O 0 1.963323120435234e-05
are O 0 1.1389746532586287e-06
consistent O 0 9.971647159545682e-06
with O 0 1.6704181007298757e-06
the O 0 2.831779966072645e-05
hypothesis O 0 1.1551102033990901e-05
that O 0 6.288231588769122e-07
certain O 0 2.8118106456531677e-06
alleles O 0 1.3801786735712085e-05
could O 0 4.780466406373307e-05
prevent O 0 0.00028820527950301766
or O 0 2.4687566110515036e-05
modify O 0 3.366844975971617e-05
the O 0 3.743563138414174e-05
clinical O 0 0.00028785900212824345
manifestations O 0 0.007386752404272556
of O 1 0.8258660435676575
BPAD B-Disease 1 1.0
and O 0 0.00027208327082917094
perhaps O 0 0.00012175334995845333
other O 0 1.635872285987716e-05
related O 1 0.6680712103843689
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9999899864196777

Segregation O 1 0.9999974966049194
distortion O 1 0.9999998807907104
in O 1 0.9999977350234985
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.6296864151954651

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999995231628418
DM B-Disease 1 1.0
) O 0 0.0007493828888982534
is O 0 2.0440385924302973e-05
an O 0 1.7758202375262044e-05
autosomal B-Disease 1 0.9998041987419128
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
which O 0 0.00021808895689900964
, O 0 2.3864764443715103e-05
in O 0 3.109669705736451e-05
the O 0 7.383237243629992e-05
typical O 0 0.00014199494034983218
pedigree O 0 0.00019556278130039573
, O 0 2.172789663745789e-06
shows O 0 7.057995844661491e-06
a O 0 1.090800651581958e-05
three O 0 2.1655496311723255e-05
generation O 0 0.0007249520858749747
anticipation O 0 0.0016734478995203972
cascade O 0 0.01144771184772253
. O 0 0.00019426686048973352

This O 0 4.91326045448659e-06
results O 0 1.7150683561339974e-05
in O 0 0.00035582782584242523
infertility B-Disease 1 1.0
and O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 6.189371197251603e-05
with O 0 2.7049532036471646e-06
the O 0 4.247403921908699e-05
disappearance O 0 0.000550269556697458
of O 0 0.0007509136921726167
DM B-Disease 1 1.0
in O 0 0.00101561495102942
that O 0 5.4258569434750825e-05
pedigree O 0 0.0012400975683704019
. O 0 0.00013531367585528642

The O 0 0.0001225562737090513
concept O 0 0.00010489358101040125
of O 0 0.0004830721009057015
segregation O 1 0.9975008368492126
distortion O 0 0.4045904874801636
, O 0 4.436327799339779e-05
where O 0 2.9807431928929873e-05
there O 0 5.6335061344725545e-06
is O 0 2.1797507088194834e-06
preferential O 0 2.598891114757862e-05
transmission O 0 9.03679829207249e-05
of O 0 2.6296303985873237e-05
the O 0 3.810615453403443e-05
larger O 0 1.3273487638798542e-05
allele O 0 3.5904222386307083e-06
at O 0 0.00010080777428811416
the O 0 0.00019996387709397823
DM B-Disease 1 0.9999998807907104
locus O 0 0.0006426949403248727
, O 0 8.251788131019566e-06
has O 0 1.8247781099489657e-06
been O 0 5.192880507820519e-06
put O 0 1.3540339750761632e-05
forward O 0 1.907928890432231e-05
to O 0 1.2298244655539747e-05
explain O 0 9.648237755754963e-05
partially O 0 0.000537895830348134
the O 0 4.7570014430675656e-05
maintenance O 0 0.001150318537838757
of O 0 0.0010130361188203096
DM B-Disease 1 1.0
in O 0 0.0003803019935730845
the O 0 0.00014296006702352315
population O 0 1.650628291827161e-05
. O 0 4.726527913589962e-05

In O 0 8.46773837110959e-05
a O 0 1.4473135706793983e-05
survey O 0 1.3834270248480607e-05
of O 0 0.00019749606144614518
DM B-Disease 1 1.0
in O 0 0.0004359110025689006
Northern O 0 0.0002127659972757101
Ireland O 0 9.359324758406729e-05
, O 0 9.586269698047545e-06
59 O 0 0.00012643815716728568
pedigrees O 0 0.0006851376965641975
were O 0 0.00018045815522782505
ascertained O 0 0.0036176303401589394
. O 0 0.00020726914226543158

Sibships O 0 0.025724615901708603
where O 0 5.271738700685091e-05
the O 0 1.633546344237402e-05
status O 0 1.3423237760434859e-05
of O 0 2.8657334041781723e-05
all O 0 7.60982902647811e-06
the O 0 3.015967558894772e-05
members O 0 4.242600425641285e-06
had O 0 1.713387609925121e-05
been O 0 8.683711712365039e-06
identified O 0 6.283858510869322e-06
were O 0 5.500876795849763e-06
examined O 0 2.2020649339538068e-05
to O 0 4.500143859331729e-06
determine O 0 1.2108803275623359e-05
the O 0 4.35692272731103e-05
transmission O 0 0.00020114489598199725
of O 0 0.00011146160977659747
the O 0 0.0015208827098831534
DM B-Disease 1 1.0
expansion O 0 0.004639006685465574
from O 0 0.00016604574921075255
affected O 0 3.672962338896468e-05
parents O 0 2.122327487086295e-06
to O 0 4.063206233695382e-06
their O 0 1.9169603547197767e-05
offspring O 0 0.00040692457696422935
. O 0 8.977970719570294e-05

Where O 0 0.0002665185311343521
the O 0 0.00012924624024890363
transmitting O 0 0.0021700728684663773
parent O 0 5.137093103257939e-05
was O 0 0.0004063743108417839
male O 0 0.00010126744746230543
, O 0 1.4126872883934993e-05
58 O 0 0.00024224045046139508
. O 0 0.00023707267246209085

3 O 0 0.0005208500078879297
% O 0 3.914401531801559e-05
of O 0 0.0001121877648984082
the O 0 0.0004633529169950634
offspring O 0 0.0003024094912689179
were O 0 4.381635517347604e-05
affected O 0 3.9335009205387905e-05
, O 0 5.253060407994781e-06
and O 0 2.297042556165252e-06
in O 0 7.752454621368088e-06
the O 0 1.9982286175945774e-05
case O 0 1.7384185412083752e-05
of O 0 3.774031574721448e-05
a O 0 8.034655911615118e-05
female O 0 0.0003787471214309335
transmitting O 0 0.0059393406845629215
parent O 0 4.7424524382222444e-05
, O 0 2.0704414055217057e-05
68 O 0 0.00038146969745866954
. O 0 0.00019120547221973538

7 O 0 0.0016839418094605207
% O 0 0.00011077900853706524
were O 0 0.00017506987205706537
affected O 0 0.0004223580763209611
. O 0 0.00027732676244340837

Studies O 0 0.00015360221732407808
on O 0 0.0005979708512313664
meiotic O 0 0.020842185243964195
drive O 0 0.001674351398833096
in O 0 0.0003018454881384969
DM B-Disease 1 1.0
have O 0 7.403749350487487e-06
shown O 0 1.6971076547633857e-05
increased O 0 3.0024251827853732e-05
transmission O 0 9.085003694053739e-05
of O 0 1.3158793990442064e-05
the O 0 1.975397208298091e-05
larger O 0 1.1389418432372622e-05
allele O 0 2.830498033290496e-06
at O 0 5.314816371537745e-05
the O 0 8.00721172709018e-05
DM B-Disease 1 0.9999992847442627
locus O 0 0.0004720964643638581
in O 0 0.00015817899839021266
non O 0 0.0027025004383176565
- O 0 0.02311762608587742
DM O 1 1.0
heterozygotes O 0 0.005536144133657217
for O 0 9.289525769418105e-05
CTGn O 0 0.4938969910144806
. O 0 0.00023142897407524288

This O 0 1.7529167962493375e-05
study O 0 2.6091572635777993e-06
provides O 0 1.4992937167335185e-06
further O 0 4.0773002183414064e-06
evidence O 0 2.2569172870134935e-05
that O 0 5.923374828853412e-06
the O 0 0.00032600751728750765
DM B-Disease 1 1.0
expansion O 0 0.005556768737733364
tends O 0 0.00016191961185541004
to O 0 9.90169428405352e-06
be O 0 1.3888534340367187e-05
transmitted O 0 0.000137575640110299
preferentially O 0 4.843290662392974e-05
. O 0 3.7457593862200156e-05

Diagnosis O 1 0.9998445510864258
of O 1 0.9999281167984009
hemochromatosis B-Disease 1 1.0
. O 1 0.9992365837097168

If O 0 0.00575951999053359
untreated O 1 1.0
, O 1 0.8339844942092896
hemochromatosis B-Disease 1 1.0
can O 1 0.9982731342315674
cause O 1 0.9999998807907104
serious O 1 1.0
illness O 1 1.0
and O 0 0.000490608043037355
early B-Disease 0 0.0069831316359341145
death I-Disease 0 0.0033567508216947317
, O 0 1.367724598821951e-05
but O 0 4.070750037499238e-06
the O 0 5.665104617946781e-05
disease O 1 0.5316091775894165
is O 0 1.279995558434166e-05
still O 0 4.7496811021119356e-05
substantially O 0 0.00025547679979354143
under O 0 0.0006742193945683539
- O 0 0.2782178521156311
diagnosed O 1 0.9999963045120239
. O 0 0.0006555200670845807

The O 0 0.000780164438765496
cornerstone O 0 0.2116376757621765
of O 0 0.00023919351224321872
screening O 0 0.00012264170800335705
and O 0 1.8360939066042192e-05
case O 0 3.812622162513435e-05
detection O 0 5.873486225027591e-05
is O 0 3.611762394939433e-06
the O 0 1.4021469723957125e-05
measurement O 0 8.850607991917059e-05
of O 0 0.00019636773504316807
serum O 0 0.0037912088446319103
transferrin O 0 0.00736234663054347
saturation O 0 0.0005885187420062721
and O 0 1.3165597920306027e-05
the O 0 6.245882104849443e-05
serum O 0 0.0015776932705193758
ferritin O 0 0.006918988190591335
level O 0 0.0011770776472985744
. O 0 0.00016105594113469124

Once O 0 0.0015417838003486395
the O 0 0.000147859042044729
diagnosis O 0 0.0017327029490843415
is O 0 4.696367250289768e-05
suspected O 0 0.0003872996021527797
, O 0 1.8514561816118658e-05
physicians O 0 3.133911741315387e-05
must O 0 2.539914748922456e-05
use O 0 5.9825990319950506e-05
serum O 0 0.006093321368098259
ferritin O 0 0.3079906702041626
levels O 0 0.005924634635448456
and O 0 0.0003481013118289411
hepatic O 1 0.9999998807907104
iron O 1 1.0
stores O 0 0.0032275335397571325
on O 0 0.006302760448306799
liver O 1 0.9999891519546509
biopsy O 0 0.008393238298594952
specimens O 0 0.00026759682805277407
to O 0 3.37158671754878e-05
assess O 0 0.00019035724108107388
patients O 0 1.5063543287396897e-05
for O 0 3.8432413020927925e-06
the O 0 4.834135324927047e-05
presence O 0 0.00018270652799401432
of O 0 0.0059597971849143505
iron B-Disease 1 1.0
overload I-Disease 1 1.0
. O 0 0.0016460668994113803

Liver O 1 1.0
biopsy O 0 0.28988033533096313
is O 0 5.926983794779517e-05
also O 0 6.267053322517313e-06
used O 0 6.199270956130931e-06
to O 0 8.885011084203143e-06
establish O 0 7.989531877683476e-05
the O 0 5.8520290622254834e-05
presence O 0 4.525444455794059e-05
or O 0 2.341511208214797e-05
absence O 0 0.0005330411368049681
of O 0 0.002201516181230545
cirrhosis B-Disease 1 1.0
, O 0 0.00021821771224495023
which O 0 3.488844231469557e-05
can O 0 1.1289506801404059e-05
affect O 0 7.610312604811043e-05
prognosis O 1 0.6478132605552673
and O 0 6.187942926771939e-05
management O 0 0.0008622978930361569
. O 0 0.00040718226227909327

A O 0 0.002083349274471402
DNA O 0 0.0007356663700193167
- O 0 8.975984383141622e-05
based O 0 7.909940791250847e-07
test O 0 1.0045918088508188e-06
for O 0 2.0448414943530224e-06
the O 0 0.00012346578296273947
HFE O 1 0.9913886189460754
gene O 0 6.096389552112669e-05
is O 0 5.242880888545187e-06
commercially O 0 2.8688695238088258e-05
available O 0 1.1116327414129046e-06
, O 0 6.133352030701644e-07
but O 0 1.3771341400570236e-07
its O 0 7.688096843594394e-07
place O 0 5.512777079275111e-06
in O 0 6.169610514916712e-06
the O 0 5.221550600253977e-05
diagnosis O 0 0.00450475187972188
of O 0 0.006600293330848217
hemochromatosis B-Disease 1 1.0
is O 0 0.001268851920031011
still O 0 0.00016055224114097655
being O 0 4.821851325687021e-05
evaluated O 0 0.0001288632774958387
. O 0 6.217760528670624e-05

Currently O 0 0.00014817506598774344
, O 0 7.791828465997241e-06
the O 0 1.227499706146773e-05
most O 0 2.295060994583764e-06
useful O 0 4.3850245674548205e-06
role O 0 1.2074440746800974e-05
for O 0 1.6268284070974914e-06
this O 0 1.1311052503515384e-06
test O 0 3.4555043839645805e-06
is O 0 1.1860597624036018e-06
in O 0 1.8947420130643877e-06
the O 0 1.4026993994775694e-05
detection O 0 0.0002795068430714309
of O 0 0.001344797550700605
hemochromatosis B-Disease 1 1.0
in O 0 0.0012416962999850512
the O 0 0.0003691379970405251
family O 0 3.2908366847550496e-05
members O 0 4.2873866732406896e-06
of O 0 3.7973528378643095e-05
patients O 0 4.9220114306081086e-05
with O 0 9.668321581557393e-06
a O 0 0.00013230464537627995
proven O 0 0.004001469351351261
case O 0 8.231767424149439e-05
of O 0 0.00017617945559322834
the O 0 0.0017338497564196587
disease O 1 0.9999998807907104
. O 0 0.0007848296663723886

It O 0 9.351436347060371e-06
is O 0 2.79395203506283e-06
crucial O 0 9.919112926581874e-05
to O 0 0.00014859726070426404
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 1.0
because O 1 0.9120532274246216
phlebotomy O 1 1.0
therapy O 1 0.9996849298477173
can O 0 6.486689380835742e-05
avert O 1 0.9999991655349731
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 0.0011821069056168199
can O 0 4.235544474795461e-05
even O 0 2.9688453651033342e-05
lead O 0 7.712057413300499e-05
to O 0 3.442925662966445e-05
normal O 0 0.00024351570755243301
life O 0 0.0002121222496498376
expectancy O 0 0.0008398478967137635
. O 0 3.448890129220672e-05
. O 0 6.196309550432488e-05

Prevalence O 0 0.0048738447949290276
of O 0 0.0004882574430666864
the O 0 0.0009509645751677454
I1307K O 0 0.015520667657256126
APC B-Disease 0 0.0058573028072714806
gene O 0 3.592925349948928e-05
variant O 0 4.222312418278307e-05
in O 0 1.0535609362705145e-05
Israeli O 0 3.330256004119292e-05
Jews O 0 0.00011511764023452997
of O 0 2.878872874134686e-05
differing O 0 4.8517604227527045e-06
ethnic O 0 1.9381990568945184e-05
origin O 0 1.8357734006713144e-05
and O 0 2.1056863261037506e-05
risk O 0 0.00053263024892658
for O 1 0.9599665403366089
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9997512698173523

BACKGROUND O 0 0.014368721283972263
& O 0 0.004836102016270161
AIMS O 0 0.0022838155273348093
Israeli O 0 0.0001011282074614428
Jews O 0 0.00035927857970818877
of O 0 0.0001952315360540524
European O 0 0.0002646195935085416
birth O 0 0.0015815150691196322
, O 0 3.7961694033583626e-05
i O 0 0.00010011955600930378
. O 0 7.73677402321482e-06
e O 0 2.619618499011267e-05
. O 0 3.55156157638703e-06
, O 0 3.1975944239093224e-06
Ashkenazim O 0 0.00048445293214172125
, O 0 3.4073052574967733e-06
have O 0 1.2301659353397554e-06
the O 0 9.783054701983929e-05
highest O 1 0.9999990463256836
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999232292175293
of O 0 0.0014462671242654324
any O 0 7.526672561652958e-05
Israeli O 0 0.0001317425339948386
ethnic O 0 0.00018539077427703887
group O 0 6.420500722015277e-05
. O 0 0.00011075154907302931

The O 0 0.0010671206982806325
I1307K O 0 0.01587209291756153
APC B-Disease 0 0.005957318004220724
gene O 0 6.475762347690761e-05
variant O 0 0.0002843289403244853
was O 0 0.0004163273551966995
found O 0 2.337638034077827e-05
in O 0 4.6921497414587066e-05
6 O 0 0.0011950162006542087
. O 0 0.0001846299273893237

1 O 0 0.00045721742208115757
% O 0 2.388717075518798e-05
of O 0 4.634069773601368e-05
American O 0 6.0030011809431016e-05
Jews O 0 0.0004240714479237795
, O 0 1.1628215361270122e-05
28 O 0 9.257142664864659e-05
% O 0 1.119653825298883e-05
of O 0 8.283992065116763e-05
their O 0 0.0007601937977597117
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999619722366333
, O 0 0.0002052455092780292
but O 0 7.294960141734919e-06
not O 0 1.4100770613367786e-06
in O 0 1.3699920600629412e-05
non O 0 0.00032152971834875643
- O 0 0.0005785834509879351
Jews O 0 0.0009571808041073382
. O 0 0.00021131015091668814

We O 0 0.0001395349099766463
assessed O 0 0.00020564041915349662
the O 0 0.0001223959116032347
I1307K O 0 0.002056468278169632
prevalence O 0 0.00020105745352339
in O 0 7.370539151452249e-06
Israeli O 0 1.8567730876384303e-05
Jews O 0 8.21790163172409e-05
of O 0 1.824436003516894e-05
differing O 0 3.83179030905012e-06
ethnic O 0 1.6697169485269114e-05
origin O 0 1.4967057722969912e-05
and O 0 2.1583397028734908e-05
risk O 0 0.0006835035746917129
for O 1 0.9979773163795471
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.999811589717865

METHODS O 0 0.000790302234236151
DNA O 0 0.00019620172679424286
samples O 0 1.8095548512064852e-05
from O 0 1.6979351130430587e-05
500 O 0 8.398457430303097e-05
unrelated O 0 6.692233728244901e-05
Jews O 0 0.0002474203356541693
of O 0 0.00023157245595939457
European O 0 0.0002750380081124604
or O 0 0.00024200543703045696
non O 0 0.0012731216847896576
- O 0 0.0004206463636364788
European O 0 1.3348751053854357e-05
origin O 0 7.4917497840942815e-06
, O 0 3.3270366657234263e-06
with O 0 2.167840875699767e-06
or O 0 1.886381141957827e-05
without O 0 2.5591783924028277e-05
a O 0 5.7198987633455545e-05
personal O 0 0.0003588477848097682
and O 0 0.00020483222033362836
/ O 0 0.0022125723771750927
or O 0 0.00011237834405619651
family O 0 5.965224772808142e-05
history O 0 0.0007610799511894584
of O 0 0.0020268026273697615
neoplasia B-Disease 1 0.9999978542327881
, O 0 0.0001090555961127393
were O 0 4.4240503484616056e-05
examined O 0 8.908526069717482e-05
for O 0 8.997755685413722e-06
the O 0 8.557941328035668e-05
I1307K O 0 0.0011459907982498407
variant O 0 0.00011298500612610951
by O 0 4.929494934913237e-06
the O 0 2.0932171537424438e-05
allele O 0 1.6625972421024926e-05
- O 0 5.733748912462033e-05
specific O 0 2.773454980342649e-06
oligonucleotide O 0 0.0004805397184100002
( O 0 0.0004444305377546698
ASO O 1 0.9977163076400757
) O 0 5.580206197919324e-05
method O 0 2.0673991457442753e-05
. O 0 8.174896356649697e-05

RESULTS O 0 0.0005196252604946494
In O 0 3.7063535273773596e-05
persons O 0 1.418687043042155e-05
at O 0 0.00011566053581191227
average O 0 3.754850331461057e-05
risk O 0 0.00022016066941432655
for O 0 0.0016873785061761737
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.002294346457347274
I1307K O 0 0.007965551689267159
was O 0 0.0006195987807586789
found O 0 1.598612107045483e-05
in O 0 2.7092883101431653e-05
5 O 0 0.00025239671231247485
. O 0 8.910708129405975e-05

0 O 0 0.00010473994916537777
% O 0 2.254529499623459e-05
of O 0 7.964557880768552e-05
120 O 0 0.00015254518075380474
European O 0 5.724013681174256e-05
and O 0 3.6105109757045284e-05
1 O 0 0.0007536727352999151
. O 0 0.00020347838290035725

6 O 0 0.0010416583390906453
% O 0 2.9700968298129737e-05
of O 0 0.00010621464025462046
188 O 0 0.0002711750566959381
non O 0 0.000556024257093668
- O 0 0.00021078152349218726
European O 0 1.4545918929798063e-05
Jews O 0 0.0003712823672685772
( O 0 7.150282908696681e-05
P O 0 0.0019482853822410107
= O 0 0.00011158805136801675
0 O 0 2.3239301299327053e-05
. O 0 1.1439371519372799e-05
08 O 0 0.0006456018891185522
) O 0 3.923890835721977e-05
. O 0 5.4491185437655076e-05

It O 0 7.596537034260109e-05
occurred O 0 0.0005768382106907666
in O 0 5.948216494289227e-05
15 O 0 0.0002967134059872478
. O 0 0.00010029567056335509

4 O 0 0.0005029661115258932
% O 0 1.3996502275404055e-05
of O 0 4.9102956836577505e-05
52 O 0 0.0001265463506570086
Ashkenazi O 0 0.00011541375715751201
Israelis O 0 6.571476842509583e-05
with O 0 3.913707041647285e-05
familial O 1 0.9999957084655762
cancer B-Disease 1 1.0
( O 0 0.005236846394836903
P O 1 0.9566294550895691
= O 0 0.0005529069458134472
0 O 0 3.795836164499633e-05
. O 0 9.210302778228652e-06
02 O 0 0.0015031448565423489
) O 0 9.819403203437105e-06
and O 0 3.4315805805817945e-06
was O 0 0.00012977751612197608
not O 0 4.01712850361946e-06
detected O 0 9.418720583198592e-05
in O 0 1.8599614122649655e-05
51 O 0 0.00021452517830766737
non O 0 0.0003308011218905449
- O 0 0.00012549094390124083
European O 0 1.0280862625222653e-05
Jews O 0 0.0002754697052296251
at O 0 0.0005430587916634977
increased O 0 0.0009249089052900672
cancer B-Disease 1 0.9999591112136841
risk O 0 0.0016131334705278277
. O 0 0.0005437663057819009

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 1 0.9999810457229614
personally O 0 0.005579591728746891
or O 0 6.737653166055679e-05
in O 0 2.4700235371710733e-05
the O 0 2.2362744857673533e-05
families O 0 2.193378122683498e-06
of O 0 2.5751010980457067e-05
13 O 0 0.0002715729642659426
of O 0 0.00024175246653612703
20 O 0 0.000847195100504905
Ashkenazi O 0 0.0011451826430857182
I1307K O 0 0.003017150331288576
carriers O 0 5.781201980425976e-05
, O 0 7.010881290625548e-06
8 O 0 5.7932164054363966e-05
of O 0 5.146477997186594e-05
whom O 0 0.00016946000687312335
also O 0 4.14173882745672e-05
had O 0 0.00013351190136745572
a O 0 5.3452677093446255e-05
personal O 0 0.00019674611394293606
or O 0 7.333535904763266e-05
family O 0 4.903511216980405e-05
history O 0 0.0005373526946641505
of O 0 0.0030420320108532906
noncolonic O 1 0.9999997615814209
neoplasia B-Disease 1 0.9999998807907104
. O 0 0.004661158658564091

CONCLUSIONS O 0 0.0017477298388257623
The O 0 0.0008743268554098904
I1307K O 0 0.019734421744942665
APC O 0 0.010056065395474434
variant O 0 0.00026570132467895746
may O 0 3.4109383705072105e-05
represent O 0 7.3112018981191795e-06
a O 0 2.384469917160459e-05
susceptibility O 0 0.0003786339657381177
gene O 0 0.00011988836922682822
for O 0 0.00027631016564555466
colorectal B-Disease 1 1.0
, I-Disease 0 0.0007491101277992129
or I-Disease 0 0.0002087737520923838
other I-Disease 0 5.955680171609856e-05
, I-Disease 0 0.00015587233065161854
cancers I-Disease 1 0.9917995929718018
in O 0 0.00026575883384793997
Ashkenazi O 0 0.001572749693877995
Jews O 0 0.00515303760766983
, O 0 0.00011256367724854499
and O 0 4.5214717829367146e-05
partially O 0 0.0015964873600751162
explains O 0 4.4630185584537685e-05
the O 0 2.0333047359599732e-05
higher O 0 6.467214552685618e-05
incidence O 0 0.00700244540348649
of O 1 0.9997585415840149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.007911781780421734
European O 0 0.00037748386966995895
Israelis O 0 0.0007210386102087796
. O 0 0.00020577144459821284

Systematic O 0 8.08312397566624e-05
analysis O 0 1.0374972589488607e-05
of O 0 0.00040633848402649164
coproporphyrinogen O 1 0.999993085861206
oxidase O 0 0.007997067645192146
gene O 0 0.003146085189655423
defects O 1 0.9995735287666321
in O 0 0.0010417982703074813
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999997615814209
and O 0 0.0008705009240657091
mutation O 0 0.0001845264487201348
update O 0 0.0008817384368740022
. O 0 0.0003174936573486775

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 1 0.8240388035774231
HC B-Disease 1 1.0
) O 0 0.0016263097058981657
is O 0 6.46770786261186e-05
an O 0 0.00011577429540921003
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999995231628418
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 1.0
caused O 1 1.0
by O 0 0.0006663253880105913
deficient B-Disease 1 0.9704731702804565
activity I-Disease 0 8.170844375854358e-05
of I-Disease 0 0.0005281316698528826
coproporphyrinogen I-Disease 1 0.9998724460601807
III I-Disease 1 1.0
oxidase I-Disease 0 0.0020009204745292664
( O 0 0.0003184403758496046
CPO O 0 0.02254946157336235
) O 0 6.731109169777483e-05
. O 0 5.207149661146104e-05

Clinical O 0 0.00270555866882205
manifestations O 1 0.7395778894424438
of O 1 0.7597822546958923
the O 1 0.9999607801437378
disease O 1 1.0
are O 0 1.3419807146419771e-05
characterized O 0 0.0001104396942537278
by O 0 2.014427082031034e-05
acute O 1 0.9999997615814209
attacks O 0 0.0017597508849576116
of O 1 0.9999971389770508
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9998565912246704
precipitated O 1 0.9999998807907104
by O 0 0.0001426947710569948
drugs O 0 0.0006057575228624046
, O 0 3.8040114304749295e-05
fasting O 0 0.0008347473340108991
, O 0 7.097126945154741e-05
cyclical O 1 0.9964119791984558
hormonal O 1 0.9948042035102844
changes O 0 0.00015833850193303078
, O 0 0.00022084226657170802
or O 1 0.9791263341903687
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.0059633697383105755

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.0037048051599413157
also O 0 7.51427942304872e-05
be O 0 1.421767046849709e-05
present O 0 8.044920832617208e-05
. O 0 0.0001200186597998254

The O 0 0.0002212081162724644
seven O 0 0.00018967330106534064
exons O 0 0.0005762540968134999
, O 0 1.0680862033041194e-05
the O 0 5.739219341194257e-05
exon O 0 0.00181968929246068
/ O 0 0.0008965215529315174
intron O 0 0.0012488776119425893
boundaries O 0 5.224318556429353e-06
and O 0 3.7536763102252735e-06
part O 0 2.1187188394833356e-05
of O 0 0.00012427440378814936
3 O 0 0.0004430006956681609
noncoding O 0 0.0007273585652001202
sequence O 0 2.7239306291448884e-05
of O 0 6.255156768020242e-05
the O 0 0.00019595159392338246
CPO O 0 0.010492922738194466
gene O 0 1.0410523827886209e-05
were O 0 3.494896645861445e-06
systematically O 0 2.1130408640601672e-05
analyzed O 0 8.211814019887242e-06
by O 0 1.2217782341394923e-06
an O 0 5.714650797017384e-06
exon O 0 0.0007212290074676275
- O 0 0.00027358991792425513
by O 0 2.5305507733719423e-05
- O 0 0.0007752410601824522
exon O 0 0.0008089700131677091
denaturing O 0 0.002263307571411133
gradient O 0 0.002177977468818426
gel O 0 0.009340827353298664
electrophoresis O 0 0.0025313892401754856
( O 0 0.0008335637976415455
DGGE O 1 0.9996449947357178
) O 0 2.263361784571316e-05
strategy O 0 1.4899042980687227e-05
followed O 0 5.283991413307376e-06
by O 0 5.908639195695287e-07
direct O 0 3.941786417271942e-06
sequencing O 0 2.8381038646330126e-05
in O 0 1.6276466340059415e-05
seven O 0 0.00010657256643753499
unrelated O 0 0.00026622749282978475
heterozygous O 0 0.00020786999084521085
HC B-Disease 1 0.9999991655349731
patients O 0 0.0012157346354797482
from O 0 0.0004476302128750831
France O 0 0.0013803750043734908
, O 0 8.263321069534868e-05
Holland O 0 0.0007000585901550949
, O 0 2.0778610632987693e-05
and O 0 1.1796224498539232e-05
Czech O 0 0.0020989058539271355
Republic O 0 0.002389503177255392
. O 0 0.0003347776655573398

Seven O 0 0.0009087997023016214
novel O 0 0.0002977769763674587
mutations O 0 3.2156312954612076e-05
and O 0 5.141602287039859e-06
two O 0 4.0921113395597786e-06
new O 0 1.719872307148762e-05
polymorphisms O 0 0.0003134158905595541
were O 0 0.00017138529801741242
detected O 0 0.0016668169992044568
. O 0 0.0002648030349519104

Among O 0 6.790914630983025e-05
these O 0 7.71779832575703e-06
mutations O 0 7.877038115111645e-06
two O 0 5.482080723595573e-06
are O 0 2.509300429665018e-06
missense O 0 0.0003242874226998538
( O 0 0.00014480811660178006
G197W O 0 0.004576036240905523
, O 0 5.8946458011632785e-05
W427R O 0 0.0017789020203053951
) O 0 2.2017478841007687e-05
, O 0 2.229759274996468e-06
two O 0 2.449875637466903e-06
are O 0 2.1569710497715278e-06
nonsense O 0 0.0004362281470093876
( O 0 0.00012153504212619737
Q306X O 0 0.0035967607982456684
, O 0 4.6564804506488144e-05
Q385X O 0 0.0015058050630614161
) O 0 2.1052224838058464e-05
, O 0 2.21818731915846e-06
two O 0 8.632096069050021e-07
are O 0 5.734133878831926e-07
small O 0 1.1634604561550077e-05
deletions O 0 0.00023270478413905948
( O 0 0.00017400443903170526
662de14bp O 0 0.0041295262053608894
; O 0 5.2045088523300365e-05
1168del3bp O 0 0.00575458025559783
removing O 0 0.0008148335618898273
a O 0 7.280460704350844e-05
glycine O 0 0.0002189005899708718
at O 0 0.0003574398870114237
position O 0 0.0001703429443296045
390 O 0 0.00045068145846016705
) O 0 1.650354352022987e-05
, O 0 2.4010732886381447e-06
and O 0 1.3895935353502864e-06
one O 0 1.989933934964938e-06
is O 0 1.5558655377390096e-06
a O 0 7.424565410474315e-06
splicing O 0 0.00011015120981028304
mutation O 0 2.5795943656703457e-05
( O 0 0.00011643358448054641
IVS1 O 1 0.998646080493927
- O 0 0.0022324221208691597
15c O 0 0.003351286519318819
- O 0 0.0005751802236773074
- O 0 0.00023868320567999035
> O 0 0.0001235488016391173
g O 0 7.129720324883237e-05
) O 0 6.3569668782292865e-06
which O 0 1.788160034266184e-06
creates O 0 1.4267408914747648e-05
a O 0 6.730993845849298e-06
new O 0 5.684266852767905e-06
acceptor O 0 9.151902304438408e-06
splice O 0 0.001143899979069829
site O 0 0.0014941627159714699
. O 0 0.00016435554425697774

The O 0 0.0003714686317835003
pathological O 0 0.0026024472899734974
significance O 0 0.0006649870774708688
of O 0 0.0005571690853685141
the O 0 0.0004636971279978752
point O 0 0.0012690761359408498
mutations O 0 0.00026637219707481563
G197W O 0 0.001903132419101894
, O 0 1.8336177163291723e-05
W427R O 0 0.0009168246178887784
, O 0 1.035663444781676e-05
and O 0 4.0823624658514746e-06
the O 0 5.9461977798491716e-05
in O 0 0.00022279117547441274
- O 0 0.0015304578701034188
frame O 0 0.0008005773997865617
deletion O 0 0.0010510766878724098
390delGly O 0 0.002226043725386262
were O 0 3.663856114144437e-05
assessed O 0 4.900009298580699e-05
by O 0 2.8554634354804875e-06
their O 0 3.865030521410517e-06
respective O 0 2.9094120691297576e-05
expression O 0 1.372175756841898e-05
in O 0 1.0495325113879517e-05
a O 0 1.0491503417142667e-05
prokaryotic O 0 7.078221824485809e-05
system O 0 2.7392999982112087e-05
using O 0 5.792764568468556e-06
site O 0 0.00042590691009536386
- O 0 0.0001971107703866437
directed O 0 4.056667603435926e-05
mutagenesis O 0 0.0021196091547608376
. O 0 0.00023469951702281833

These O 0 7.724379247520119e-05
mutations O 0 0.00013439578469842672
resulted O 0 0.0004401034093461931
in O 0 0.00010539137292653322
the O 0 0.00016073667211458087
absence O 0 0.00048617104766890407
or O 0 1.810984394978732e-05
a O 0 2.0048786609550007e-05
dramatic O 0 0.0004457800241652876
decrease O 0 0.0014036026550456882
of O 0 0.002826292533427477
CPO O 1 0.9993946552276611
activity O 0 0.0007298766868188977
. O 0 0.00024771117023192346

The O 0 0.00035016308538615704
two O 0 3.2701831514714286e-05
polymorphisms O 0 0.00020527566084638238
were O 0 4.321666347095743e-05
localized O 0 0.0004309344512876123
in O 0 6.501650932477787e-05
noncoding O 0 0.0009651267901062965
part O 0 4.403804268804379e-05
of O 0 6.214786117197946e-05
the O 0 8.624710608273745e-05
gene O 0 1.715775033517275e-05
1 O 0 0.00010117769124917686
) O 0 7.357413778663613e-06
a O 0 2.249776298413053e-05
C O 0 0.0016557672061026096
/ O 0 0.0005051394109614193
G O 0 0.0007591198082081974
polymorphism O 0 1.4652678146376275e-05
in O 0 1.849777800089214e-05
the O 0 0.00011125231685582548
promotor O 0 0.014704897999763489
region O 0 0.000636158452834934
, O 0 2.7358642910257913e-05
142 O 0 0.00015332114708144218
bp O 0 0.00022510405688080937
upstream O 0 0.00013499558554030955
from O 0 3.439158263063291e-06
the O 0 6.822245268267579e-06
transcriptional O 0 8.227765647461638e-05
initiation O 0 0.0003268518194090575
site O 0 0.000524427043274045
( O 0 5.0442857173038647e-05
- O 0 0.0005103870644234121
142C O 0 0.002328542061150074
/ O 0 0.0009135850123129785
G O 0 0.001778591307811439
) O 0 2.056418998108711e-05
, O 0 3.935716449632309e-06
and O 0 3.2760651720309397e-06
2 O 0 9.453867096453905e-05
) O 0 9.581636732036714e-06
a O 0 2.415127346466761e-05
6 O 0 0.00039913132786750793
bp O 0 0.0003614947490859777
deletion O 0 0.0001431966375093907
polymorphism O 0 1.843921563704498e-05
in O 0 1.7926842701854184e-05
the O 0 4.2911986383842304e-05
3 O 0 0.00011750568955903873
noncoding O 0 0.0006499753217212856
part O 0 3.6779780202778056e-05
of O 0 0.00010832190309884027
the O 0 0.0006205104291439056
CPO O 0 0.11373576521873474
gene O 0 8.271109982160851e-05
, O 0 1.232104295922909e-05
574 O 0 0.0012605811934918165
bp O 0 0.0005069028702564538
downstream O 0 0.00025076590827666223
of O 0 2.0170547941233963e-05
the O 0 3.7173340388108045e-05
last O 0 3.340020339237526e-05
base O 0 1.7991083950619213e-05
of O 0 1.5012301446404308e-05
the O 0 5.011905523133464e-05
normal O 0 8.11649952083826e-05
termination O 0 0.00012532736582215875
codon O 0 0.00010981183004332706
( O 0 5.466355651151389e-05
+ O 0 0.0007999875815585256
574 O 0 0.005276998970657587
delATTCTT O 0 0.01887018047273159
) O 0 0.00011850988084916025
. O 0 7.977016502991319e-05

Five O 0 0.0013517707120627165
intragenic O 0 0.0755949467420578
dimorphisms O 0 0.01457933709025383
are O 0 8.031003744690679e-06
now O 0 2.7399559257901274e-05
well O 0 1.4158216799842194e-05
characterized O 0 9.066949132829905e-05
and O 0 1.2034756764478516e-05
the O 0 5.740986671298742e-05
high O 0 0.0002584190515335649
degree O 0 0.00013375247363001108
of O 0 0.0002964408486150205
allelic O 0 0.004317552782595158
heterogeneity O 0 0.004209842998534441
in O 0 0.0008286663796752691
HC B-Disease 1 0.9999997615814209
is O 0 0.00016179305384866893
demonstrated O 0 0.00019151801825501025
with O 0 2.798151854221942e-06
seven O 0 1.2411532225087285e-05
new O 0 2.793549811030971e-06
different O 0 5.165805418982927e-07
mutations O 0 5.327983217284782e-06
making O 0 3.176182644892833e-06
a O 0 3.210443082934944e-06
total O 0 1.9170884115737863e-05
of O 0 0.0002603030588943511
nineteen O 1 0.6040341854095459
CPO O 1 0.999993085861206
gene B-Disease 0 0.002925511682406068
defects I-Disease 1 0.9844218492507935
reported O 0 0.0002416257484583184
so O 0 2.8452199330786243e-05
far O 0 2.930262235167902e-05
. O 0 1.0718678822740912e-05
. O 0 4.6122160711092874e-05

Coincidence O 0 0.000969712738879025
of O 0 0.00011998728587059304
two O 0 3.260374069213867e-05
novel O 0 0.00028556419420056045
arylsulfatase O 0 0.005789787974208593
A O 0 0.0005093467771075666
alleles O 0 1.2606717973540071e-05
and O 0 1.0853385902009904e-05
mutation O 0 2.744299308687914e-05
459 O 0 0.0016180304810404778
+ O 0 0.005865173880010843
1G O 0 0.027216725051403046
> O 0 0.0002841972163878381
A O 0 8.988095942186192e-05
within O 0 6.43491239316063e-06
a O 0 1.0888894394156523e-05
family O 0 1.599679671926424e-05
with O 0 6.0746966482838616e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 0.00015466156764887273
molecular O 0 4.495611210586503e-05
basis O 0 2.0741585103678517e-05
of O 0 0.00013535340258385986
phenotypic O 0 0.004658978432416916
heterogeneity O 0 0.028894716873764992
. O 0 0.0019393175607547164

In O 0 0.00020785692322533578
a O 0 8.000747038749978e-05
family O 0 2.1199801267357543e-05
with O 0 5.908632374485023e-06
three O 0 4.8574212996754795e-05
siblings O 0 0.0002217474248027429
, O 0 4.275565515854396e-06
one O 0 3.141159140795935e-06
developed O 0 6.128273525973782e-05
classical O 0 0.001752155483700335
late O 1 0.9998883008956909
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9983046054840088
MLD B-Disease 1 1.0
) O 0 0.0007679976406507194
, O 0 5.166285336599685e-05
fatal O 0 0.0034600510261952877
at O 0 0.001008734107017517
age O 0 0.0009540843311697245
5 O 0 0.0003784041036851704
years O 0 0.00016247514577116817
, O 0 8.750266715651378e-06
with O 0 1.1563832231331617e-05
deficient O 1 0.7157686352729797
arylsulfatase O 0 0.0994565337896347
A O 0 0.006799167022109032
( O 0 0.0005921867559663951
ARSA O 1 0.999273955821991
) O 0 2.708513056859374e-05
activity O 0 6.7611276790557895e-06
and O 0 2.6403440642752685e-06
increased O 0 9.587933891452849e-05
galactosylsulfatide O 0 0.47101274132728577
( O 0 0.001053487416356802
GS O 1 0.9999985694885254
) O 0 0.0005431173485703766
excretion O 0 0.0023290631361305714
. O 0 0.0001773594703990966

The O 0 0.00023025806876830757
two O 0 1.6647625670884736e-05
other O 0 8.389811227971222e-06
siblings O 0 0.000197393266716972
, O 0 2.113567097694613e-05
apparently O 0 0.00012445931497495621
healthy O 0 0.00013354628754314035
at O 0 0.0001877703907666728
12 O 0 0.00012132083793403581
( O 0 2.8612303140107542e-05
1 O 0 0.0002964668383356184
/ O 0 0.00022620370145887136
2 O 0 0.00016554871399421245
) O 0 1.0621642104524653e-05
and O 0 3.5656628369906684e-06
15 O 0 5.00329042552039e-05
years O 0 0.000106264982605353
, O 0 9.67148480413016e-06
respectively O 0 5.056248846813105e-05
, O 0 8.204329787986353e-06
and O 0 5.006782885175198e-06
their O 0 1.8964443370350637e-05
father O 0 0.0005125758470967412
, O 0 3.654267129604705e-05
apparently O 0 0.00014227195060811937
healthy O 0 5.101771967019886e-05
as O 0 7.322506007767515e-06
well O 0 4.529746092885034e-06
, O 0 4.738411462312797e-06
presented O 0 0.0003767379093915224
ARSA O 1 0.9999983310699463
and O 0 0.00030354526825249195
GS O 1 0.9999088048934937
values O 0 4.774683020514203e-06
within O 0 5.230624992691446e-06
the O 0 1.2870472346548922e-05
range O 0 6.98717703926377e-05
of O 0 0.001531932852230966
MLD B-Disease 1 1.0
patients O 0 0.004016926512122154
. O 0 0.00047257167170755565

Mutation O 0 5.8258363424101844e-05
screening O 0 1.4034567357157357e-05
and O 0 2.0204422526148846e-06
sequence O 0 7.430890491377795e-06
analysis O 0 2.245756377305952e-06
disclosed O 0 0.00010106457193614915
the O 0 2.074720396194607e-05
involvement O 0 0.00011484475544421002
of O 0 0.00013260637933854014
three O 0 0.00016749727365095168
different O 0 5.0377573643345386e-05
ARSA O 1 0.9996090531349182
mutations O 0 0.00010792064131237566
being O 0 2.33947102969978e-05
the O 0 1.2594652616826352e-05
molecular O 0 1.7625066902837716e-05
basis O 0 1.650952617637813e-05
of O 0 0.00032280958839692175
intrafamilial O 0 0.07541342824697495
phenotypic O 0 0.00574085395783186
heterogeneity O 0 0.029334725812077522
. O 0 0.0017882226966321468

The O 0 0.0007696100510656834
late O 0 0.32292354106903076
infantile O 1 0.9999904632568359
patient O 0 0.0026593150105327368
inherited O 1 0.9999711513519287
from O 0 0.001075174892321229
his O 0 0.001120232162065804
mother O 0 0.00042357551865279675
the O 0 6.844218296464533e-05
frequent O 0 4.164615893387236e-05
0 O 0 0.00013105527614243329
- O 0 0.0001782541221473366
type O 0 5.250701724435203e-05
mutation O 0 1.2100064850528724e-05
459 O 0 0.0007471338612958789
+ O 0 0.0028541225474327803
1G O 0 0.017607828602194786
> O 0 0.00029803314828313887
A O 0 0.00030916405376046896
, O 0 1.0324958566343412e-05
and O 0 2.9880166039220057e-06
from O 0 1.4423367247218266e-05
his O 0 9.70572727965191e-05
father O 0 0.00027010703342966735
a O 0 3.1031966500449926e-05
novel O 0 0.00010551184095675126
, O 0 8.9849709183909e-06
single O 0 1.3363513971853536e-05
basepair O 0 0.003175262361764908
microdeletion O 0 0.0026066044811159372
of O 0 0.00021705256949644536
guanine O 0 0.00017878299695439637
at O 0 0.000320903433021158
nucleotide O 0 7.891798304626718e-05
7 O 0 0.00011598700803006068
in O 0 3.017014569195453e-05
exon O 0 0.00022712911595590413
1 O 0 0.00020338721515145153
( O 0 8.612834790255874e-05
7delG O 0 0.0041745733469724655
) O 0 7.818271842552349e-05
. O 0 6.428428605431691e-05

The O 0 0.0005239477613940835
two O 0 0.00015957423602230847
clinically O 0 0.02781597338616848
unaffected O 0 0.0026844863314181566
siblings O 0 0.00024115576525218785
carried O 0 2.7159880119143054e-05
the O 0 3.977429514634423e-05
maternal O 0 0.00031801225850358605
mutation O 0 3.7191315641393885e-05
459 O 0 0.0018300897208973765
+ O 0 0.0056318375281989574
1G O 0 0.03137630224227905
> O 0 0.0005106203607283533
A O 0 0.00034518438042141497
and O 0 1.7594349628780037e-05
, O 0 3.73096690964303e-06
on O 0 2.6498830266064033e-05
their O 0 9.402460818819236e-06
paternal O 0 0.00014183524763211608
allele O 0 1.4984037989052013e-05
, O 0 5.175576916371938e-06
a O 0 7.092495252436493e-06
novel O 0 4.111131784156896e-05
cytosine O 0 1.2065866030752659e-05
to O 0 6.358258360705804e-06
thymidine O 0 0.00010571537859505042
transition O 0 0.0006506118224933743
at O 0 0.0005504489527083933
nucleotide O 0 0.00035812563146464527
2435 O 0 0.016267860308289528
in O 0 0.0001194463184219785
exon O 0 0.00043710850877687335
8 O 0 0.0001335495908278972
, O 0 4.371480372356018e-06
resulting O 0 1.2211796274641529e-05
in O 0 7.753777936159167e-06
substitution O 0 2.233131272078026e-05
of O 0 0.00014440972881857306
alanine O 0 0.00021309976000338793
464 O 0 0.0015484720934182405
by O 0 8.884390263119712e-05
valine O 0 0.002338684629648924
( O 0 0.00024300592485815287
A464V O 0 0.0071689835749566555
) O 0 0.00014002995158080012
. O 0 0.0001392738486174494

The O 0 0.0006210715509951115
fathers O 0 0.0003318877425044775
genotype O 0 0.00010536494664847851
thus O 0 0.0001001441924017854
was O 0 0.001238295459188521
7delG O 0 0.01614963635802269
/ O 0 0.005445644725114107
A464V O 0 0.010617700405418873
. O 0 0.0003283685364294797

Mutation O 0 0.00046384811867028475
A464V O 0 0.0020582086872309446
was O 0 0.00019023565982934088
not O 0 2.737311206146842e-06
found O 0 3.766190047826967e-06
in O 0 2.629969094414264e-05
18 O 0 0.0010242594871670008
unrelated O 0 0.03078603371977806
MLD B-Disease 1 1.0
patients O 0 0.000737672031391412
and O 0 4.7055480536073446e-05
50 O 0 0.00027862220304086804
controls O 0 0.00038525366107933223
. O 0 0.00021375094365794212

A464V O 0 0.006140894256532192
, O 0 2.066961496893782e-05
although O 0 9.959254384739324e-06
clearly O 0 0.00011186738993274048
modifying O 0 0.001494245370849967
ARSA O 1 0.9999992847442627
and O 0 0.0012210033601149917
GS O 1 1.0
levels O 0 0.0021854806691408157
, O 0 2.9696664569200948e-05
apparently O 0 4.8061057896120474e-05
bears O 0 0.00013852803385816514
little O 0 6.395371656253701e-06
significance O 0 1.9955892639700323e-05
for O 0 3.3523153888381785e-06
clinical O 0 0.00037708590389229357
manifestation O 1 0.9958827495574951
of O 1 0.9998788833618164
MLD B-Disease 1 1.0
, O 0 0.0007028315449133515
mimicking O 0 0.0017002286622300744
the O 0 0.00021232986182440072
frequent O 0 0.0006384821608662605
ARSA O 1 0.9999732971191406
pseudodeficiency O 0 0.06292183697223663
allele O 0 0.00020384597883094102
. O 0 0.00013443797070067376

Our O 0 0.0001516272168373689
results O 0 8.095658813545015e-06
demonstrate O 0 2.8339927666820586e-05
that O 0 4.469191026146291e-07
in O 0 1.5989696748874849e-06
certain O 0 4.284835995349567e-06
genetic O 0 0.0003908528888132423
conditions O 1 0.9608312249183655
MLD B-Disease 1 1.0
- O 1 0.9995697140693665
like O 0 0.000999507843516767
ARSA O 1 0.9999974966049194
and O 0 0.0006487159989774227
GS O 1 0.9999690055847168
values O 0 1.2531214451882988e-05
need O 0 6.539626610901905e-06
not O 0 5.341377118384116e-07
be O 0 8.994416589303e-07
paralleled O 0 5.7488985476084054e-05
by O 0 6.146072792034829e-06
clinical O 0 0.0023890133015811443
disease O 1 0.9999985694885254
, O 0 6.064607805456035e-05
a O 0 5.075030276202597e-05
finding O 0 0.00013545101683121175
with O 0 2.714444781304337e-05
serious O 0 0.005006653256714344
diagnostic O 0 0.0029120896942913532
and O 0 0.0005135062383487821
prognostic O 1 0.999937891960144
implications O 0 0.10113974660634995
. O 0 0.0008778119808994234

Moreover O 0 0.0012139866594225168
, O 0 3.037838905584067e-05
further O 0 0.0001231888309121132
ARSA O 1 0.7651344537734985
alleles O 0 6.338863022392616e-05
functionally O 0 0.0002261515037389472
similar O 0 3.4724314446066273e-06
to O 0 3.666449629236013e-05
A464V O 0 0.002006193622946739
might O 0 1.729983887344133e-05
exist O 0 1.2249363862792961e-05
which O 0 2.1182006548770005e-06
, O 0 1.4011026223670342e-06
together O 0 3.0034129849809688e-06
with O 0 4.838111635763198e-06
0 O 0 0.00022964636445976794
- O 0 0.0005421211244538426
type O 0 0.00020111422054469585
mutations O 0 9.333210618933663e-05
, O 0 3.037937312910799e-05
may O 0 0.00027210713597014546
cause O 0 0.0036998558789491653
pathological O 1 0.9999998807907104
ARSA O 1 1.0
and O 0 0.01454127673059702
GS O 1 1.0
levels O 0 0.0012238678755238652
, O 0 3.897402166330721e-06
but O 0 4.0658312627783744e-07
not O 0 2.374964793716572e-07
clinical O 0 2.6660547518986277e-05
outbreak O 0 0.001018912997096777
of O 0 0.00040154167800210416
the O 0 0.006716967094689608
disease O 1 1.0
. O 0 0.00018248922424390912
. O 0 0.000160357027198188

Human O 1 0.9999985694885254
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999998807907104
to O 1 0.9930188059806824
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 0.022876204922795296
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9997382760047913
1 I-Disease 1 0.9993939399719238
. O 0 0.001340787741355598

Heterozygous O 0 0.003759654937312007
germ O 1 0.9999878406524658
- O 0 0.003299130592495203
line O 0 0.0003048186772502959
mutations O 0 9.816079909796827e-06
in O 0 6.8034546529816e-06
the O 0 3.059376103919931e-05
DNA O 0 0.000407242972869426
mismatch O 1 0.5221409797668457
repair O 0 0.15386426448822021
genes O 0 5.530355701921508e-05
lead O 0 0.00017008878057822585
to O 0 0.00017467168800067157
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999972581863403

The O 0 0.004339809995144606
disease O 1 0.9999994039535522
susceptibility O 0 0.002028870861977339
of O 0 0.0014713526470586658
individuals O 0 0.00016623520059511065
who O 0 0.000316046760417521
constitutionally O 0 0.0011352861765772104
lack O 0 0.000461312651168555
both O 0 4.373099000076763e-05
wild O 0 0.00030267774127423763
- O 0 0.00030276059987954795
type O 0 5.505319495568983e-05
alleles O 0 1.0083937013405375e-05
is O 0 1.1855434422614053e-05
unknown O 0 0.0002672566915862262
. O 0 8.220307063311338e-05

We O 0 4.503544550971128e-05
have O 0 1.595469370840874e-06
identified O 0 6.300822860794142e-06
three O 0 3.509950829538866e-06
offspring O 0 2.5491892301943153e-05
in O 0 7.891572749940678e-06
a O 0 0.00015586058725602925
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999992847442627
who O 0 0.00288948486559093
developed O 1 0.9999966621398926
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.011144748888909817
a O 0 9.396956738783047e-05
very O 0 2.3904349291115068e-05
early O 0 0.00017512598424218595
age O 0 0.00019962004444096237
, O 0 7.625462330906885e-06
and O 0 2.60084470937727e-06
at O 0 5.7448534789728e-05
least O 0 2.824134753609542e-06
two O 0 1.1113783102700836e-06
of O 0 1.3478229448082857e-05
them O 0 6.599074822588591e-06
displayed O 0 0.0007610109751112759
signs O 0 0.0015865858877077699
of O 0 0.0012181713245809078
neurofibromatosis B-Disease 1 0.9999998807907104
type I-Disease 0 0.1748584657907486
1 I-Disease 1 0.9659730792045593
( O 0 0.0018575548892840743
NF1 B-Disease 1 0.9999575614929199
) O 0 0.00030890473863109946
. O 0 0.00012758461525663733

DNA O 0 0.0002561304427217692
sequence O 0 3.312262560939416e-05
analysis O 0 6.927948106749682e-06
and O 0 7.2606871981406584e-06
allele O 0 1.9348493879078887e-05
- O 0 9.304018749389797e-05
specific O 0 4.473758963285945e-06
amplification O 0 0.0001401209010509774
in O 0 3.575595110305585e-05
two O 0 2.4749420845182613e-05
siblings O 0 0.00023152586072683334
revealed O 0 0.00038723571924492717
a O 0 8.074688230408356e-05
homozygous O 0 0.0011000989470630884
MLH1 O 1 0.9922975897789001
mutation O 0 0.00016849393432494253
( O 0 0.00018318186630494893
C676T O 0 0.006200125440955162
- O 0 0.0023239741567522287
- O 0 0.0008980120182968676
> O 0 0.0005550393252633512
Arg226Stop O 0 0.010781636461615562
) O 0 0.00010344423208152875
. O 0 9.255606710212305e-05

Thus O 0 0.00025417699362151325
, O 0 1.3995194422022905e-05
a O 0 4.839204120798968e-05
homozygous O 0 0.002309441100805998
germ O 1 1.0
- O 1 0.9925246834754944
line O 0 0.016014855355024338
MLH1 O 1 0.9999816417694092
mutation O 0 0.00013108865823596716
and O 0 8.370434807147831e-05
consequent O 1 0.9999978542327881
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.0031871171668171883
in O 0 0.00043594956514425576
a O 0 0.0001750989176798612
mutator O 0 0.03962729871273041
phenotype O 0 0.00011705086217261851
characterized O 0 0.00010876800661208108
by O 0 9.697677887743339e-05
leukemia B-Disease 1 1.0
and O 1 0.9972293972969055
/ O 1 1.0
or O 1 0.9999990463256836
lymphoma B-Disease 1 1.0
associated O 1 0.9997369647026062
with O 0 0.01787085272371769
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999610185623169
1 I-Disease 1 0.9975875616073608
. O 0 0.00019253090431448072
. O 0 9.855470852926373e-05

Missense O 0 0.007480010390281677
mutations O 0 0.00017412294982932508
in O 0 3.350324186612852e-05
the O 0 6.82003446854651e-05
most O 0 1.6639196473988704e-05
ancient O 0 0.0005851472378708422
residues O 0 0.00031902865157462656
of O 0 0.00013895441952627152
the O 0 0.0009261554223485291
PAX6 O 1 0.9999804496765137
paired O 0 0.0006135274306870997
domain O 0 0.00021483711316250265
underlie O 0 0.0012339754030108452
a O 0 5.136809340910986e-05
spectrum O 0 0.002284028334543109
of O 1 0.9999099969863892
human O 1 1.0
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9999964237213135

Mutations O 0 0.00010157121869269758
of O 0 4.1258481360273436e-05
the O 0 8.707880624569952e-05
human O 0 0.00023967542801983654
PAX6 O 1 0.9999998807907104
gene O 0 0.007853934541344643
underlie O 1 1.0
aniridia B-Disease 1 1.0
( O 1 0.9999997615814209
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999946355819702
of I-Disease 1 0.9999831914901733
the I-Disease 1 0.9999470710754395
iris I-Disease 1 0.9946001768112183
) O 0 0.0001287809864152223
, O 0 1.1782620276790112e-05
a O 0 4.289819844416343e-05
rare O 0 0.0010656355880200863
dominant O 1 0.9995086193084717
malformation B-Disease 1 1.0
of I-Disease 1 0.9993608593940735
the I-Disease 1 0.9999947547912598
eye I-Disease 1 0.9999996423721313
. O 0 0.0018190511036664248

The O 0 0.00032231418299488723
spectrum O 0 0.0005959782283753157
of O 0 0.0018054199172183871
PAX6 O 1 0.999998927116394
mutations O 0 0.001595736714079976
in O 0 0.0011271300027146935
aniridia B-Disease 1 1.0
patients O 0 0.0002111170324496925
is O 0 1.695900755294133e-05
highly O 0 5.359170609153807e-05
biased O 0 9.783612767932937e-06
, O 0 8.738205679037492e-07
with O 0 8.377733138331678e-07
92 O 0 0.0001465769746573642
% O 0 1.3966142432764173e-05
of O 0 5.421776222647168e-05
all O 0 4.021462518721819e-05
reported O 0 0.0001564369595143944
mutations O 0 5.187132774153724e-05
leading O 0 0.00019792963576037437
to O 0 4.9053345719585195e-05
premature O 0 0.000629693444352597
truncation O 0 0.0004256392421666533
of O 0 0.00026109718601219356
the O 0 0.0004456659662537277
protein O 0 0.00025202977121807635
( O 0 6.469243817264214e-05
nonsense O 0 0.0002895376819651574
, O 0 1.3266578207549173e-05
splicing O 0 6.185966049088165e-05
, O 0 9.445582691114396e-06
insertions O 0 0.00013512618897948414
and O 0 1.3816062164551113e-05
deletions O 0 0.00014807464322075248
) O 0 1.8911310689873062e-05
and O 0 4.431432898854837e-06
just O 0 3.789838956436142e-05
2 O 0 9.354585927212611e-05
% O 0 8.948626600613352e-06
leading O 0 3.130721233901568e-05
to O 0 5.758669885835843e-06
substitution O 0 2.382856109761633e-05
of O 0 0.00010109271534020081
one O 0 3.760075196623802e-05
amino O 0 4.928643465973437e-05
acid O 0 4.002156856586225e-05
by O 0 7.204459961940302e-06
another O 0 7.299056596821174e-05
( O 0 0.0001023400473059155
missense O 0 0.0012216496979817748
) O 0 0.00019337095727678388
. O 0 0.00020211921946611255

The O 0 0.00020847341511398554
extraordinary O 0 0.00019962860096711665
conservation O 0 2.5377235942869447e-05
of O 0 3.546282459865324e-05
the O 0 0.00013209563621785492
PAX6 O 1 0.6779581308364868
protein O 0 0.00014219626609701663
at O 0 0.00012382856220938265
the O 0 5.939975380897522e-05
amino O 0 7.945585821289569e-05
acid O 0 0.0001350085949525237
level O 0 0.0005477830418385565
amongst O 0 0.0009180580382235348
vertebrates O 0 0.0019614347256720066
predicts O 0 0.00026125856675207615
that O 0 7.80449317971943e-06
pathological O 0 0.0037461002357304096
missense O 0 0.0020494558848440647
mutations O 0 0.0002699932374525815
should O 0 5.0571939937071875e-05
in O 0 3.832288712146692e-05
fact O 0 4.526674820226617e-05
be O 0 9.70035125646973e-06
common O 0 5.072704425401753e-06
even O 0 6.376839792210376e-06
though O 0 3.6404644561116584e-06
they O 0 7.690927645853662e-07
are O 0 5.140583994034387e-07
hardly O 0 5.484479697770439e-05
ever O 0 3.968677265220322e-05
seen O 0 0.00010219338582828641
in O 0 0.0001845227525336668
aniridia B-Disease 1 0.9999998807907104
patients O 0 0.001057000015862286
. O 0 0.00039832203765399754

This O 0 2.9495879061869346e-05
indicates O 0 6.118568853707984e-05
that O 0 1.1138366744489758e-06
there O 0 3.625117187766591e-06
is O 0 3.3104456633736845e-06
a O 0 1.9546117982827127e-05
heavy O 0 0.0013317239936441183
ascertainment O 0 0.019923394545912743
bias O 0 0.0002130703069269657
in O 0 3.158309846185148e-05
the O 0 2.6599725970299914e-05
selection O 0 1.935096770466771e-05
of O 0 8.462167897960171e-05
patients O 0 0.0001094020190066658
for O 0 0.00010515947360545397
PAX6 O 1 0.9995056390762329
mutation O 0 2.6308369342586957e-05
analysis O 0 2.4279149783978937e-06
and O 0 2.3284742383111734e-06
that O 0 1.7352562053929432e-06
the O 0 8.759390766499564e-05
missing O 0 0.001792952767573297
PAX6 O 1 0.9998849630355835
missense O 0 0.002413329901173711
mutations O 0 0.0003007023478858173
frequently O 0 8.454489579889923e-05
may O 0 0.0003648464335128665
underlie O 0 0.012540941126644611
phenotypes O 0 0.000504580675624311
distinct O 0 0.00012112688273191452
from O 0 0.00048331415746361017
textbook O 1 0.875690758228302
aniridia B-Disease 1 1.0
. O 0 0.002018893836066127

Here O 0 0.00032124444260261953
we O 0 7.446362815244356e-06
present O 0 1.452277138014324e-05
four O 0 3.488458241918124e-05
novel O 0 0.0008933710632845759
PAX6 O 1 0.986862301826477
missense O 0 0.0030278924386948347
mutations O 0 9.153805876849219e-05
, O 0 1.8509301298763603e-05
two O 0 7.344619916693773e-06
in O 0 3.62284408765845e-05
association O 0 4.006216477137059e-05
with O 0 2.0372584913275205e-05
atypical O 0 0.03671878203749657
phenotypes O 0 0.008351854979991913
ectopia B-Disease 1 0.9998801946640015
pupillae I-Disease 1 0.9997839331626892
( O 0 0.0001612875348655507
displaced B-Disease 0 0.0009843469597399235
pupils I-Disease 0 0.0010599676752462983
) O 0 0.0004782427567988634
and O 0 0.0013657938688993454
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999996423721313
( O 0 0.04169423133134842
searching B-Disease 0 0.009499145671725273
gaze I-Disease 0 0.0179281048476696
) O 0 7.591721077915281e-05
, O 0 8.732326023164205e-06
and O 0 2.4913501874834765e-06
two O 0 2.6835655262402724e-06
in O 0 9.013505405164324e-06
association O 0 8.112398973025847e-06
with O 0 3.533059043547837e-06
more O 0 2.3703611077507958e-05
recognizable O 0 0.023825637996196747
aniridia B-Disease 1 1.0
phenotypes O 0 0.006246631965041161
. O 0 0.0005183251923881471

Strikingly O 0 0.0016874854918569326
, O 0 1.383485141559504e-05
all O 0 4.018572781205876e-06
four O 0 9.779974789125845e-06
mutations O 0 1.0325351468054578e-05
are O 0 9.72456973613589e-07
located O 0 8.076905942289159e-05
within O 0 3.353472493472509e-05
the O 0 0.0001941526134032756
PAX6 O 1 0.9590246677398682
paired O 0 0.0003104047500528395
domain O 0 8.203822653740644e-05
and O 0 1.4377881598193198e-05
affect O 0 6.446906627388671e-05
amino O 0 5.13938648509793e-05
acids O 0 1.48010994962533e-05
which O 0 1.853376147664676e-06
are O 0 4.1593889932300954e-07
highly O 0 2.572430639702361e-05
conserved O 0 6.89071457600221e-05
in O 0 8.201803211704828e-06
all O 0 5.806646640849067e-06
known O 0 5.6734679674264044e-05
paired O 0 8.023989357752725e-05
domain O 0 0.00020201248116791248
proteins O 0 8.307256939588115e-05
. O 0 8.880815585143864e-05

Our O 0 0.0001237117248820141
results O 0 9.790976946533192e-06
support O 0 4.613570581568638e-06
the O 0 2.2676547814626247e-05
hypothesis O 0 1.3070432032691315e-05
that O 0 4.5885323629590857e-07
the O 0 4.703116246673744e-06
under O 0 4.1238381527364254e-05
- O 0 5.5558131862198934e-05
representation O 0 5.476928436110029e-06
of O 0 0.000148249528137967
missense O 0 0.002826846204698086
mutations O 0 0.00037046990473754704
is O 0 7.913615263532847e-05
caused O 0 0.0010074551682919264
by O 0 6.604559894185513e-05
ascertainment O 0 0.049874719232320786
bias O 0 0.00031084276270121336
and O 0 1.5877081750659272e-05
suggest O 0 1.0785904123622458e-05
that O 0 7.24250128314452e-07
a O 0 4.9754203246266115e-06
substantial O 0 0.00012517817958723754
burden O 0 0.0009997431188821793
of O 0 0.0021554550621658564
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999532699584961
related I-Disease 0 0.08363203704357147
disease I-Disease 1 0.9999959468841553
remains O 0 0.0014283524360507727
to O 0 9.774044883670285e-06
be O 0 1.5088817235664465e-05
uncovered O 0 0.0014797223266214132
. O 0 3.7078632885823026e-05
. O 0 7.078971975715831e-05

The O 0 0.00022683781571686268
chromosomal O 0 0.00041389945545233786
order O 0 3.26505396515131e-05
of O 0 0.00016110215801745653
genes O 0 0.00011396622721804306
controlling O 0 0.000682569108903408
the O 0 0.00024083475000225008
major O 0 0.1671200394630432
histocompatibility O 1 1.0
complex O 1 0.9963687658309937
, O 0 4.732075467472896e-05
properdin O 0 0.002909767208620906
factor O 0 0.00011650511441985145
B O 0 0.002373645780608058
, O 0 1.821285877667833e-05
and O 0 3.761627522180788e-05
deficiency B-Disease 1 0.9999822378158569
of I-Disease 0 0.0006038607098162174
the I-Disease 0 0.0005441774846985936
second I-Disease 0 0.0004461249918676913
component I-Disease 0 0.00041580680408515036
of I-Disease 0 0.00023065337154548615
complement I-Disease 0 0.000862171349581331
. O 0 0.00039795140037313104

The O 0 0.0001976492058020085
relationship O 0 3.221997758373618e-05
of O 0 3.739880776265636e-05
the O 0 5.888494342798367e-05
genes O 0 2.0732846678583883e-05
coding O 0 0.0001301303127547726
for O 0 4.433101275935769e-05
HLA O 0 0.0510941743850708
to O 0 3.630678111221641e-05
those O 0 1.3488066542777233e-05
coding O 0 0.00012787434388883412
for O 0 3.3333250030409545e-05
properdin O 0 0.00870328489691019
Factor O 0 0.00047704941243864596
B O 0 0.003806508146226406
allotypes O 0 0.004487127531319857
and O 0 1.5114913367142435e-05
for O 0 6.75613118801266e-05
deficiency B-Disease 1 0.999997615814209
of I-Disease 0 0.0005854484625160694
the I-Disease 0 0.0002848762378562242
second I-Disease 0 0.00022246023581828922
component I-Disease 0 0.0001841682242229581
of I-Disease 0 0.00018164761422667652
complement I-Disease 0 0.001098710112273693
( O 0 0.0007117795757949352
C2 O 1 0.97097247838974
) O 0 4.3965192162431777e-05
was O 0 0.00010139015648746863
studied O 0 3.6673867725767195e-05
in O 0 3.44170462085458e-06
families O 0 8.019729875741177e-07
of O 0 2.2077001631259918e-05
patients O 0 0.0006594144506379962
with O 1 0.9777598977088928
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 1.0

Patients O 0 0.00046808685874566436
were O 0 5.164344111108221e-05
selected O 0 3.1584091630065814e-05
because O 0 3.2986499718390405e-06
they O 0 4.7171170081128366e-07
were O 0 4.073573109053541e-06
heterozygous O 0 2.605368081276538e-06
or O 0 1.738557875796687e-05
homozygous O 0 0.0006349518080241978
for O 0 0.1355780065059662
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9799112677574158

12 O 0 0.00027336148195900023
families O 0 4.272072601452237e-06
with O 0 3.203246933480841e-06
15 O 0 0.00025907400413416326
matings O 0 0.0024246510583907366
informative O 0 0.0018733543111011386
for O 0 0.005998515523970127
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.006975230760872364
found O 0 0.0003463267348706722
. O 0 0.0002001928078243509

Of O 0 0.0013386415084823966
57 O 0 0.001963577466085553
informative O 0 0.0009732089820317924
meioses O 0 0.005156950559467077
, O 0 6.651775947830174e-06
two O 0 1.3323176517587854e-06
crossovers O 0 5.135633728059474e-06
were O 0 4.57131136499811e-06
noted O 0 1.1230298696318641e-05
between O 0 0.0005680328467860818
the O 1 0.9928233623504639
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0008607660420238972
and O 0 5.3525614930549636e-05
the O 0 0.00040256063221022487
HLA O 1 0.9996098875999451
- O 0 0.0025547491386532784
B O 0 0.001020063878968358
gene O 0 5.162720754015027e-06
, O 0 4.2300217728552525e-07
with O 0 1.93341236354172e-07
a O 0 3.585987315091188e-06
recombinant O 0 2.218857298430521e-05
fraction O 0 2.207921352237463e-05
of O 0 0.00010940097126876935
0 O 0 0.0003558814059942961
. O 0 0.00014446098066400737

035 O 1 0.6279652118682861
. O 0 0.0008467794978059828

A O 0 0.0030441132839769125
lod O 0 0.0061096129938960075
score O 0 7.805279892636463e-05
of O 0 3.31945666403044e-05
13 O 0 5.163585956324823e-05
was O 0 2.7204418074688874e-05
calculated O 0 1.4933631291569327e-06
for O 0 7.2005309448286425e-06
linkage O 0 0.011977001093327999
between O 1 0.9999997615814209
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9089841842651367
HLA O 1 1.0
- O 0 0.009265439584851265
B O 0 0.0014015636406838894
at O 0 3.635487155406736e-05
a O 0 1.8852665562008042e-06
maximum O 0 3.0197347768989857e-06
likelihood O 0 3.50126538251061e-06
value O 0 1.4623911965827574e-06
of O 0 5.582740413956344e-06
the O 0 9.211084034177475e-06
recombinant O 0 1.9171890016878024e-05
fraction O 0 1.838255593611393e-05
of O 0 4.158011870458722e-05
0 O 0 0.00018464842287357897
. O 0 0.00011770408309530467

04 O 0 0.0943739116191864
. O 0 0.0011358807096257806

18 O 0 0.000569185649510473
families O 0 1.0330828445148654e-05
with O 0 8.585794603277463e-06
21 O 0 0.00047107780119404197
informative O 0 0.00014684040797874331
matings O 0 0.00025748962070792913
for O 0 8.442090802418534e-06
both O 0 2.2076790628489107e-05
properdin O 0 0.006460425443947315
Factor O 0 0.0003460486768744886
B O 0 0.0029162017162889242
allotype O 0 0.0038579574320465326
and O 0 5.255289943306707e-05
HLA O 1 0.9683828949928284
- O 0 0.0014499989338219166
B O 0 0.0011569749331101775
were O 0 3.560429468052462e-05
found O 0 2.132503141183406e-05
. O 0 4.316851482144557e-05

Of O 0 0.0018276263726875186
72 O 0 0.0030958077404648066
informative O 0 0.0016158836660906672
meioses O 0 0.008155053481459618
, O 0 1.758540929586161e-05
three O 0 1.4079638276598416e-05
recombinants O 0 0.003008113009855151
were O 0 3.9908645703690127e-05
found O 0 1.3163789844838902e-05
, O 0 2.6106583845830755e-06
giving O 0 2.287544020873611e-06
a O 0 8.43024918140145e-06
recombinant O 0 4.701076613855548e-05
fraction O 0 5.0164908316219226e-05
of O 0 0.0001358185982098803
0 O 0 0.0002948249748442322
. O 0 0.00014701441978104413

042 O 0 0.09924136102199554
. O 0 0.0007964691612869501

A O 0 0.002134096110239625
lod O 0 0.0036478026304394007
score O 0 5.102214709040709e-05
of O 0 7.666172314202413e-05
16 O 0 0.0004770657978951931
between O 0 0.0014525402802973986
HLA O 1 0.9999822378158569
- O 0 0.003847398329526186
B O 0 0.0008432029862888157
and O 0 6.163882062537596e-06
Factor O 0 4.988241198589094e-05
B O 0 0.0011320566991344094
allotypes O 0 0.0015150143299251795
was O 0 8.429140143562108e-05
calculated O 0 4.429493401403306e-06
at O 0 2.7743710234062746e-05
a O 0 2.942376568171312e-06
maximum O 0 3.625293629738735e-06
likelihood O 0 5.20873754794593e-06
value O 0 4.397428710944951e-06
of O 0 8.283989700430539e-06
the O 0 1.6481240891152993e-05
recombinant O 0 2.628574839036446e-05
fraction O 0 2.0033630789839663e-05
of O 0 5.8767531299963593e-05
0 O 0 0.0001846315135480836
. O 0 0.00010179374658036977

04 O 0 0.08226816356182098
. O 0 0.0015551568940281868

A O 0 0.0013303427258506417
crossover O 0 0.00026904966216534376
was O 0 0.00014588622434530407
shown O 0 1.1077879207732622e-05
to O 0 3.3319897738692816e-06
have O 0 1.149149738921551e-06
occurred O 0 7.29744861018844e-05
between O 0 1.7621234292164445e-05
genes O 0 3.380454700163682e-06
for O 0 2.4579026103310753e-06
Factor O 0 9.381627751281485e-05
B O 0 0.0012621994828805327
and O 0 4.212202475173399e-05
HLA O 0 0.4638558626174927
- O 0 0.0016740740975365043
D O 0 0.001511018956080079
, O 0 4.216274192003766e-06
in O 0 7.300395282072714e-06
which O 0 1.9031565898330882e-05
HLA O 0 0.4701163172721863
- O 0 0.0017820758512243629
D O 0 0.003594345413148403
segregared O 0 0.0038275185506790876
with O 0 5.043477358412929e-05
HLA O 1 0.9915380477905273
- O 0 0.0012971014948561788
A O 0 0.0007688594632782042
and O 0 7.32430416974239e-05
B O 0 0.004281393252313137
. O 0 0.00010507076513022184

These O 0 1.2888270248367917e-05
studies O 0 3.4924346437037457e-06
suggest O 0 2.5741233002918307e-06
that O 0 1.6603314634267008e-07
the O 0 2.8675226531049702e-06
genes O 0 8.752718940741033e-07
for O 0 2.2239828467718326e-06
Factor O 0 0.00041421683272346854
B O 1 0.9996657371520996
and O 0 0.005199622828513384
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.276479739928618e-05
located O 0 0.00018133439880330116
outside O 0 1.5232850273605436e-05
those O 0 2.706173745536944e-06
for O 0 2.590599251561798e-05
HLA O 1 0.9889673590660095
, O 0 1.4573453881894238e-05
that O 0 1.0912438028753968e-06
the O 0 4.487548267206876e-06
order O 0 5.851687092217617e-06
of O 0 4.923048982163891e-05
genese O 0 0.011222627945244312
is O 0 0.00011622326564975083
HLA O 0 0.14323672652244568
- O 0 0.0005172108067199588
A O 0 0.00037545934901572764
, O 0 1.281793538510101e-05
- O 0 8.90216397237964e-05
B O 0 0.00034546159440651536
, O 0 5.846120075148065e-06
- O 0 6.735546048730612e-05
D O 0 0.00022963782248552889
, O 0 1.5722312127763871e-06
Factor O 0 3.067814031965099e-05
B O 0 0.008303766138851643
allotype O 1 0.9999598264694214
, O 0 0.005126654170453548
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.086514309165068e-05
that O 0 6.325546451080299e-07
the O 0 6.524028322019149e-06
genes O 0 8.663949301990215e-06
coding O 0 0.00033670171978883445
for O 0 0.001226011081598699
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.0003668700810521841
Factor O 0 0.0004174470668658614
B O 0 0.0011485072318464518
allotypes O 0 0.0005920174298807979
are O 0 3.733080689016788e-07
approximately O 0 1.4860189367027488e-05
3 O 0 7.471956632798538e-05
- O 0 0.00015046377666294575
- O 0 8.009334123926237e-05
5 O 0 3.620087954914197e-05
centimorgans O 0 0.0007052234141156077
from O 0 2.153438254026696e-05
the O 0 9.81375778792426e-05
HLA O 0 0.1840435415506363
- O 0 0.000472305720904842
A O 0 0.0005370311555452645
and O 0 9.095543646253645e-05
HLA O 1 0.9990013241767883
- O 0 0.003201389452442527
B O 0 0.0027691409923136234
loci O 0 0.0001639370311750099
, O 0 3.7830009205208626e-06
and O 0 1.2943570482093492e-06
that O 0 8.16873068743007e-07
the O 0 1.7623789972276427e-05
apparent O 0 0.00020731581025756896
lack O 0 9.946590580511838e-05
of O 0 0.0001456678583053872
recombinants O 0 0.004146147519350052
between O 0 0.00011131566134281456
the O 0 4.922908192384057e-05
Factor O 0 0.00011679343151627108
B O 0 0.006418613716959953
gene O 0 0.0003865848993882537
and O 0 0.0018409490585327148
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0005555092939175665
suggests O 0 5.0193815695820376e-05
that O 0 1.1369701269359211e-06
these O 0 8.258458024101856e-07
two O 0 4.693263690569438e-06
genes O 0 3.66577114618849e-05
lie O 0 0.0003036659909412265
in O 0 3.6285498936194927e-05
close O 0 0.00012885589967481792
proximity O 0 0.00012953038094565272
to O 0 2.183335345762316e-05
one O 0 2.6408211851958185e-05
another O 0 5.893871275475249e-05
. O 0 0.00013558090722654015

Distribution O 0 0.00012882186274509877
of O 0 0.0009775831131264567
emerin O 1 0.9591100811958313
and O 0 0.00022668343444820493
lamins O 0 0.027739226818084717
in O 0 8.69870200403966e-05
the O 0 0.0002407509455224499
heart O 0 0.025854256004095078
and O 0 2.6002868253272027e-05
implications O 0 0.00023538211826235056
for O 0 0.000173410473507829
Emery B-Disease 1 0.9999955892562866
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.13981492817401886

Emerin O 0 0.03532762825489044
is O 0 3.426725379540585e-05
a O 0 4.2193903937004507e-05
nuclear O 0 0.0011956009548157454
membrane O 0 0.00011478529631858692
protein O 0 1.4251688298827503e-05
which O 0 2.840974730133894e-06
is O 0 4.893190180155216e-06
missing O 0 7.57806483306922e-05
or O 0 3.232708331779577e-05
defective O 0 0.0016991525189951062
in O 0 0.0005934903165325522
Emery B-Disease 1 0.9999839067459106
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999957084655762
EDMD B-Disease 1 1.0
) O 0 0.00233748322352767
. O 0 0.00031257528462447226

It O 0 4.4824260839959607e-05
is O 0 7.011703928583302e-06
one O 0 1.9894139313691994e-06
member O 0 6.581093657587189e-06
of O 0 2.8059817850589752e-05
a O 0 5.357015106710605e-05
family O 0 8.96165074664168e-05
of O 0 0.0008027798030525446
lamina O 1 0.9999325275421143
- O 0 0.002611360512673855
associated O 0 2.156987648049835e-05
proteins O 0 5.775862973678159e-06
which O 0 3.277112227806356e-06
includes O 0 2.893764030886814e-05
LAP1 O 1 0.9986770749092102
, O 0 9.540618339087814e-05
LAP2 O 1 0.9761142730712891
and O 0 7.019165786914527e-05
lamin O 0 0.002374928677454591
B O 0 0.003871448338031769
receptor O 0 0.0005446558934636414
( O 0 0.0003629033744800836
LBR O 1 0.9999115467071533
) O 0 0.00016582645184826106
. O 0 0.00012107467773603275

A O 0 0.0010605920106172562
panel O 0 6.699519144603983e-05
of O 0 7.432288839481771e-05
16 O 0 0.00048372289165854454
monoclonal O 0 0.00013588245201390237
antibodies O 0 7.667342288186774e-05
( O 0 0.00011141644063172862
mAbs O 0 0.0022648414596915245
) O 0 8.276606422441546e-06
has O 0 1.7103603795476374e-06
been O 0 2.739329829637427e-06
mapped O 0 9.446447620575782e-06
to O 0 1.9483140931697562e-06
six O 0 4.744823399960296e-06
specific O 0 5.460773309096112e-07
sites O 0 1.1292802810203284e-05
throughout O 0 1.2476562915253453e-05
the O 0 4.479929702938534e-05
emerin O 0 0.00330320093780756
molecule O 0 3.231882146792486e-05
using O 0 2.4191796910599805e-05
phage O 0 0.0009731894242577255
- O 0 0.00017756878514774144
displayed O 0 0.0001729141513351351
peptide O 0 0.00015675961913075298
libraries O 0 1.805567808332853e-05
and O 0 7.253505600601784e-07
has O 0 9.885530971587286e-07
been O 0 1.4136344361759257e-06
used O 0 3.043595597773674e-06
to O 0 2.3437181880581193e-05
localize O 0 0.00636470690369606
emerin O 0 0.0173953864723444
in O 0 0.00018616681336425245
human O 0 0.00019605063425842673
and O 0 0.00021012294746469706
rabbit O 0 0.008713294751942158
heart O 1 0.9964379072189331
. O 0 0.0009662951924838126

Several O 0 0.0003413893864490092
mAbs O 0 0.0034096096642315388
against O 0 8.525799785275012e-05
different O 0 1.3542896340368316e-05
emerin O 0 0.01660117879509926
epitopes O 0 0.0022542953956872225
did O 0 7.000556797720492e-05
not O 0 8.066303962550592e-06
recognize O 0 0.00020025504636578262
intercalated O 0 0.0178550835698843
discs O 0 0.03391651064157486
in O 0 0.0002093538350891322
the O 0 0.0005689773242920637
heart O 0 0.34630656242370605
, O 0 1.3596096323453821e-05
though O 0 4.7019411795190535e-06
they O 0 9.131773026638257e-07
recognized O 0 5.295819210004993e-05
cardiomyocyte O 0 0.005307637155056
nuclei O 0 0.0008486454025842249
strongly O 0 3.6194873246131465e-05
, O 0 5.446825980470749e-06
both O 0 6.641482286795508e-06
at O 0 0.0004822846094612032
the O 0 0.0003745471767615527
rim O 0 0.0028351678047329187
and O 0 1.6134687029989436e-05
in O 0 7.521513180108741e-05
intranuclear O 0 0.006831152364611626
spots O 0 0.00027758072246797383
or O 0 2.7910124117624946e-05
channels O 0 0.00020828879496548325
. O 0 9.667927952250466e-05

A O 0 0.011505534872412682
polyclonal O 0 0.018459811806678772
rabbit O 0 0.0022818855941295624
antiserum O 0 0.0012630352284759283
against O 0 0.0002655397402122617
emerin O 0 0.009813005104660988
did O 0 6.17430341662839e-05
recognize O 0 4.654074655263685e-05
both O 0 5.10051213495899e-05
nuclear O 0 0.006650259718298912
membrane O 0 0.0003551787813194096
and O 0 2.6974008505931124e-05
intercalated O 0 0.005735774990171194
discs O 0 0.004707956686615944
but O 0 5.741264885728015e-06
, O 0 1.6806429812277202e-06
after O 0 1.2047124073433224e-05
affinity O 0 1.3074084563413635e-05
purification O 0 0.000560845248401165
against O 0 0.00015778221131768078
a O 0 0.00019835699640680104
pure O 0 0.0042518870905041695
- O 0 0.00390642462298274
emerin O 0 0.010475913994014263
band O 0 0.0007700457936152816
on O 0 9.10820672288537e-05
a O 0 2.8210981326992624e-05
western O 0 0.0001161684122052975
blot O 0 0.0005305917584337294
, O 0 1.4602711416955572e-05
it O 0 9.601045348972548e-06
stained O 0 0.0013077335897833109
only O 0 1.0367959475843236e-05
the O 0 8.609468932263553e-05
nuclear O 0 0.005646808538585901
membrane O 0 0.0005589887732639909
. O 0 6.298186781350523e-05

These O 0 2.8859649319201708e-05
results O 0 1.7114507500082254e-05
would O 0 3.812976729022921e-06
not O 0 6.103127248024975e-07
be O 0 1.2918881111545488e-06
expected O 0 1.0241084964945912e-05
if O 0 5.919794148212532e-06
immunostaining O 0 0.0017287920927628875
at O 0 0.0006585483206436038
intercalated O 0 0.011500611901283264
discs O 0 0.004568066913634539
were O 0 4.4150314352009445e-05
due O 0 0.00010985130938934162
to O 0 7.275465122802416e-06
a O 0 6.0201555243111216e-06
product O 0 4.465997335501015e-06
of O 0 4.692883521784097e-05
the O 0 0.00027955934638157487
emerin O 0 0.023359820246696472
gene O 0 0.0001170304385595955
and O 0 1.5659281416446902e-05
, O 0 6.990212114033056e-06
therefore O 0 1.4235499293135945e-05
, O 0 3.1449985726794694e-06
cast O 0 9.047178537002765e-06
some O 0 2.218221197836101e-06
doubt O 0 3.893909160979092e-05
upon O 0 2.276058694405947e-05
the O 0 2.7448490072856657e-05
hypothesis O 0 9.969569509848952e-05
that O 0 3.9973092498257756e-05
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9920561909675598
EDMD B-Disease 1 1.0
are O 0 7.642836862942204e-05
caused O 0 0.0004921405925415456
by O 0 8.671546311234124e-06
absence O 0 0.00017503749404568225
of O 0 0.00044014910236001015
emerin O 1 0.9926857948303223
from O 0 0.001253430382348597
intercalated O 1 0.99054354429245
discs O 1 0.9956377148628235
. O 0 0.0006410320056602359

Although O 0 0.0007473374716937542
emerin O 0 0.014844628050923347
was O 0 0.0009152456186711788
abundant O 0 0.00014079069660510868
in O 0 1.2258701644896064e-05
the O 0 7.448821270372719e-05
membranes O 0 0.0002582702727522701
of O 0 0.0003476364945527166
cardiomyocyte O 1 0.9766098856925964
nuclei O 0 0.00347331864759326
, O 0 3.819540506810881e-05
it O 0 7.952563464641571e-06
was O 0 0.00021397077944129705
absent O 0 0.0001249451597686857
from O 0 1.6617348592262715e-05
many O 0 1.5299414371838793e-05
non O 0 0.0012575925793498755
- O 0 0.005741151049733162
myocyte O 1 0.5935243368148804
cells O 0 0.00018907993216998875
in O 0 3.0177110602380708e-05
the O 0 0.000203326519113034
heart O 0 0.40940165519714355
. O 0 0.000376617448637262

This O 0 1.1589843779802322e-05
distribution O 0 1.4088569514569826e-05
of O 0 0.00017865808331407607
emerin O 0 0.01482313871383667
was O 0 0.0003176946775056422
similar O 0 4.5837005018256605e-06
to O 0 9.150156984105706e-06
that O 0 3.2919276691245614e-06
of O 0 0.00012036339467158541
lamin O 0 0.0031285167206078768
A O 0 0.000550524506252259
, O 0 4.492472726269625e-06
a O 0 4.085618456883822e-06
candidate O 0 4.4866837924928404e-06
gene O 0 2.8069878226233413e-06
for O 0 1.2234140740474686e-06
an O 0 6.562573616974987e-06
autosomal O 0 0.0006258651264943182
form O 0 0.0006842113798484206
of O 1 0.9999982118606567
EDMD B-Disease 1 1.0
. O 1 0.7968641519546509

In O 0 0.0003374764637555927
contrast O 0 0.0002986264880746603
, O 0 0.00021315220510587096
lamin O 0 0.03211650997400284
B1 O 1 0.999977707862854
was O 0 0.0017849383875727654
absent O 0 0.0006838192930445075
from O 0 0.00018520948651712388
cardiomyocyte O 0 0.0485488586127758
nuclei O 0 0.002277355408295989
, O 0 2.2448257368523628e-05
showing O 0 0.00027320728986524045
that O 0 5.779151615570299e-05
lamin O 0 0.011542052030563354
B1 O 1 0.9961601495742798
is O 0 7.554527655884158e-06
not O 0 8.098462558336905e-07
essential O 0 8.245792741945479e-06
for O 0 3.873757123074029e-06
localization O 0 0.0004896684549748898
of O 0 0.00031929733813740313
emerin O 0 0.010961406864225864
to O 0 8.626553608337417e-05
the O 0 0.0004032406723126769
nuclear O 0 0.039432592689991
lamina O 1 0.5370534658432007
. O 0 0.00024700784706510603

Lamin O 1 0.9635440707206726
B1 O 1 0.9999557733535767
is O 0 3.266997737227939e-05
also O 0 5.495528512255987e-06
almost O 0 3.39121870638337e-05
completely O 0 0.0005000875098630786
absent O 0 0.0008574532112106681
from O 0 0.0006165656959638
skeletal O 1 0.9999991655349731
muscle O 1 0.9997145533561707
nuclei O 1 0.9979647397994995
. O 0 0.004311124794185162

In O 0 0.0028259565588086843
EDMD B-Disease 1 1.0
, O 0 1.6987480194075033e-05
the O 0 6.065873094485141e-06
additional O 0 4.399409135658061e-06
absence O 0 0.0002195370470872149
of O 0 0.0007731730584055185
lamin O 1 0.9945322275161743
B1 O 1 1.0
from O 0 0.00394052267074585
heart O 1 1.0
and O 0 0.004568101372569799
skeletal O 1 1.0
muscle O 1 0.9999990463256836
nuclei O 1 0.9995111227035522
which O 0 0.0003281263052485883
already O 0 0.00022143052774481475
lack O 0 0.0005034838104620576
emerin O 0 0.007368385326117277
may O 0 4.5211141696199775e-05
offer O 0 1.4419848639590782e-06
an O 0 1.5176875649558497e-06
alternative O 0 4.682801318267593e-06
explanation O 0 1.0670761184883304e-05
of O 0 6.870847573736683e-05
why O 0 0.00012907233031000942
these O 0 2.9878239729441702e-05
tissues O 0 0.0002767063560895622
are O 0 3.5249386201030575e-06
particularly O 0 4.339983206591569e-05
affected O 0 7.102359813870862e-05
. O 0 2.9818262191838585e-05
. O 0 8.254311251221225e-05

Genetic O 0 0.0003479484876152128
mapping O 0 0.0002754016895778477
of O 0 0.001430726028047502
the O 0 0.2197515219449997
copper B-Disease 1 1.0
toxicosis I-Disease 1 0.9999641180038452
locus O 0 0.0015050123911350965
in O 0 0.0003093270643148571
Bedlington O 0 0.012476521544158459
terriers O 0 0.002656984841451049
to O 0 6.309025047812611e-05
dog O 0 0.00042554817628115416
chromosome O 0 0.00021011695207562298
10 O 0 6.312924233498052e-05
, O 0 3.592579787436989e-06
in O 0 6.00853536525392e-06
a O 0 1.9107586922473274e-05
region O 0 0.0004048007249366492
syntenic O 0 0.002343015279620886
to O 0 2.6168645490542985e-05
human O 0 9.819205297389999e-05
chromosome O 0 0.000769676873460412
region O 0 0.0033267028629779816
2p13 O 0 0.025910401716828346
- O 0 0.00603895541280508
p16 O 0 0.0027981263119727373
. O 0 0.0001614256907487288

Abnormal O 1 0.9999998807907104
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999996423721313
is O 0 9.693157335277647e-05
recognized O 0 3.334221401019022e-05
as O 0 2.4145238057826646e-05
an O 0 6.411286449292675e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999977350234985
man O 1 0.999387264251709
, O 0 0.0002612984098959714
mouse O 0 0.0005308734253048897
, O 0 9.27217843127437e-05
rat O 0 0.003497621975839138
and O 0 5.767760376329534e-05
dog O 0 0.0011444188421592116
. O 0 0.00024014755035750568

The O 0 0.0006331685581244528
major O 0 0.0047385795041918755
cause O 0 0.0657690167427063
of O 1 0.9995490908622742
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 1.0
in O 0 0.002522155875340104
man O 0 0.0004116386699024588
is O 0 6.618523912038654e-06
a O 0 1.9171322492184117e-05
dysfunctional O 0 0.001512213726527989
ATP7B O 1 0.9998397827148438
gene O 0 0.0002218432491645217
, O 0 4.7103429096750915e-05
causing O 0 0.1012597307562828
Wilson B-Disease 1 0.9999935626983643
disease I-Disease 1 1.0
( O 0 0.004041991662234068
WD B-Disease 1 0.9999997615814209
) O 0 0.0005222544423304498
. O 0 0.00020519070676527917

Mutations O 0 0.00029810224077664316
in O 0 8.529555634595454e-05
the O 0 0.0002512838109396398
ATP7B O 1 0.9994438290596008
genes O 0 1.4593606465496123e-05
have O 0 4.814265821551089e-07
also O 0 1.1187656809852342e-06
been O 0 4.941944553138455e-06
demonstrated O 0 9.274867625208572e-05
in O 0 8.776473987381905e-05
mouse O 0 0.0003283594560343772
and O 0 7.207019370980561e-05
rat O 0 0.003933642990887165
. O 0 0.00011584044113988057

The O 0 0.001771922572515905
ATP7B O 1 0.99992835521698
gene O 0 0.00011839444050565362
has O 0 5.339413291949313e-06
been O 0 7.105939857865451e-06
excluded O 0 1.1196516425115988e-05
in O 0 3.39923690262367e-06
the O 0 1.2217283256177325e-05
much O 0 2.6153553335461766e-05
rarer O 0 0.0027531294617801905
human O 0 0.006844137329608202
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9927956461906433
- I-Disease 0 0.028877658769488335
Indian I-Disease 0 0.0002629162627272308
childhood I-Disease 1 0.9950820207595825
cirrhosis I-Disease 1 1.0
, O 0 0.00010245389421470463
indicating O 0 0.0009446158073842525
genetic O 0 0.0013867889065295458
heterogeneity O 0 0.008164022117853165
. O 0 0.0013535891193896532

By O 0 2.1462277800310403e-05
investigating O 0 4.3726860894821584e-05
the O 0 6.172978464746848e-05
common O 0 0.00030892304494045675
autosomal O 1 0.9999943971633911
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9980337023735046
CT B-Disease 1 0.9999984502792358
) O 0 0.0003035198024008423
in O 0 0.00019781435548793525
Bedlington O 0 0.02457207627594471
terriers O 0 0.0032218564301729202
, O 0 4.262980382918613e-06
we O 0 1.1383024229871808e-06
have O 0 2.026260688126058e-07
identified O 0 6.331914050861087e-07
a O 0 5.950814170319063e-07
new O 0 8.544264460397244e-07
locus O 0 2.7512433007359505e-05
involved O 0 3.350400584167801e-05
in O 0 0.0016652751946821809
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9983578324317932

We O 0 6.167924584588036e-05
examined O 0 0.0001113099351641722
whether O 0 8.341367902175989e-06
the O 0 0.00010923378431471065
WD B-Disease 1 0.9998706579208374
gene O 0 0.00039158741128630936
ATP7B O 1 0.9982118606567383
was O 0 0.0005533885559998453
also O 0 1.6146663256222382e-05
causative O 0 0.00017347134416922927
for O 0 2.0788065739907324e-05
CT B-Disease 0 0.0087801618501544
by O 0 9.679984032118227e-06
investigating O 0 3.3388925658073276e-05
the O 0 9.82102210400626e-05
chromosomal O 0 0.007764623966068029
co O 0 0.004846644587814808
- O 0 0.002708792220801115
localization O 0 0.0030359886586666107
of O 0 0.0009092828840948641
ATP7B O 1 0.999995231628418
and O 0 0.00015402463031932712
C04107 O 0 0.0012173603754490614
, O 0 3.331020934638218e-06
using O 0 1.8673691783988033e-06
fluorescence O 0 1.8962109606945887e-05
in O 0 7.964269752847031e-05
situ O 0 0.007599386852234602
hybridization O 0 0.00013665726874023676
( O 0 8.684711065143347e-05
FISH O 0 0.001035509048961103
) O 0 1.6447856978629716e-05
. O 0 3.223008752684109e-05

C04107 O 0 0.00860147550702095
is O 0 1.897730544442311e-05
an O 0 5.73242868995294e-06
anonymous O 0 5.627816426567733e-05
microsatellite O 0 0.0022197964135557413
marker O 0 0.0011448451550677419
closely O 0 0.00011866230488521978
linked O 0 0.0009935919661074877
to O 0 0.0005053612403571606
CT B-Disease 1 0.9997298121452332
. O 0 0.000887856527697295

However O 0 0.0005825203843414783
, O 0 0.00018669494602363557
BAC O 1 0.9838398098945618
clones O 0 0.0050061834044754505
containing O 0 0.0012088054791092873
ATP7B O 1 0.9988779425621033
and O 0 5.3690848289988935e-05
C04107 O 0 0.000892303476575762
mapped O 0 4.158503725193441e-05
to O 0 1.5454559616046026e-05
the O 0 0.00010973372991429642
canine O 0 0.0014501342084258795
chromosome O 0 0.0010653381468728185
regions O 0 0.0005493954522535205
CFA22q11 O 0 0.385339617729187
and O 0 0.00013362296158447862
CFA10q26 O 0 0.09753049165010452
, O 0 2.3774540750309825e-05
respectively O 0 5.6111341109499335e-05
, O 0 7.769915100652725e-06
demonstrating O 0 0.00015933963004499674
that O 0 1.592344960954506e-05
WD B-Disease 0 0.12379037588834763
cannot O 0 2.9855880711693317e-05
be O 0 4.9376626520825084e-06
homologous O 0 9.274177864426747e-05
to O 0 8.087742025963962e-05
CT B-Disease 1 0.8280893564224243
. O 0 0.0002989178756251931

The O 0 0.0015788535820320249
copper O 1 0.9958961009979248
transport O 0 0.0013663882855325937
genes O 0 0.0005333927692845464
CTR1 O 1 0.9999299049377441
and O 0 0.00016947327821981162
CTR2 O 1 0.9996121525764465
were O 0 9.74676659097895e-05
also O 0 1.0439433935971465e-05
excluded O 0 4.314612669986673e-05
as O 0 7.956121407914907e-06
candidate O 0 1.4202302736521233e-05
genes O 0 7.56356757847243e-06
for O 0 1.7510437828605063e-05
CT B-Disease 0 0.02148479036986828
since O 0 0.00011597284174058586
they O 0 1.4368233678396791e-06
both O 0 8.234110282501206e-07
mapped O 0 2.8121778086642735e-05
to O 0 3.2504151022294536e-05
canine O 0 0.001946743344888091
chromosome O 0 0.0025493598077446222
region O 0 0.005954138934612274
CFA11q22 O 1 0.9994514584541321
. O 0 0.0008484116988256574

2 O 0 0.0037683285772800446
- O 0 0.001709206961095333
22 O 0 0.0008628256036899984
. O 0 9.884507016977295e-05

5 O 0 0.004589447285979986
. O 0 0.0006443706224672496

A O 0 0.0014451341703534126
transcribed O 0 0.00039281827048398554
sequence O 0 3.04455024888739e-05
identified O 0 1.7040472812368535e-05
from O 0 1.5287718269973993e-05
the O 0 0.00011452224862296134
C04107 O 0 0.006821318529546261
- O 0 0.0017800903879106045
containing O 0 0.0009448656346648932
BAC O 0 0.06729928404092789
was O 0 0.00045674366992898285
found O 0 7.639189789188094e-06
to O 0 5.481469543155981e-06
be O 0 5.288871307129739e-06
homologous O 0 2.029267852776684e-05
to O 0 5.647820216836408e-06
a O 0 1.0554856999078766e-05
gene O 0 7.0452047111757565e-06
expressed O 0 7.248344445542898e-06
from O 0 5.1264349167468026e-05
human O 0 0.0001844071812229231
chromosome O 0 0.0034094913862645626
2p13 O 0 0.01565331406891346
- O 0 0.003154330188408494
p16 O 0 0.0008486235747113824
, O 0 6.513732841995079e-06
a O 0 1.5130662177398335e-05
region O 0 0.00030745682306587696
devoid O 0 0.0008730689878575504
of O 0 8.34531310829334e-05
any O 0 3.5953547921963036e-05
positional O 0 0.0010674180230125785
candidate O 0 0.0004839874163735658
genes O 0 0.00026584649458527565
. O 0 0.00019510852871462703

Molecular O 0 9.500308806309476e-05
analysis O 0 3.838593329419382e-06
of O 0 0.00010061935608973727
the O 0 0.0006272427854128182
APC B-Disease 0 0.006484671495854855
gene O 0 2.985001810884569e-05
in O 0 1.3397379916568752e-05
205 O 0 3.4381391742499545e-05
families O 0 1.719233864605485e-06
: O 0 3.746330548892729e-06
extended O 0 7.06985083525069e-05
genotype O 0 0.00033451226772740483
- O 0 0.0006478732102550566
phenotype O 0 3.823275983450003e-05
correlations O 0 0.00019638532830867916
in O 0 0.00020792946452274919
FAP B-Disease 0 0.02344534546136856
and O 0 8.239167073043063e-06
evidence O 0 1.3835920071869623e-05
for O 0 2.2941244424146134e-06
the O 0 1.8253706002724357e-05
role O 0 4.820481990464032e-05
of O 0 0.00028532062424346805
APC B-Disease 0 0.008053461089730263
amino O 0 8.140187128446996e-05
acid O 0 9.979081369237974e-05
changes O 0 6.364570435835049e-05
in O 1 0.9928706288337708
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 1 0.5898981094360352

BACKGROUND O 0 0.011277605779469013
/ O 0 0.002124372636899352
AIMS O 0 0.001420241896994412
The O 0 0.0001069792197085917
development O 0 0.0003995765291620046
of O 1 0.983027458190918
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0004373847914393991
a O 0 5.465824142447673e-05
variable O 0 7.882809768489096e-06
range O 0 2.396993659203872e-05
of O 0 0.00017486735305283219
extracolonic O 0 0.27225273847579956
manifestations O 0 0.00962500274181366
in O 0 0.0033449092879891396
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999971389770508
FAP B-Disease 1 0.9999997615814209
) O 0 0.00013376816059462726
is O 0 5.4014303714211565e-06
the O 0 4.517166871664813e-06
result O 0 4.079147856828058e-06
of O 0 2.1502655727090314e-05
the O 0 9.456410043640062e-05
dominant O 0 0.0005274482537060976
inheritance O 0 0.0004646176821552217
of O 0 0.007403970696032047
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.992634117603302
APC B-Disease 1 0.9970912933349609
) O 0 0.00028527877293527126
gene O 0 0.00011961761629208922
mutations O 0 0.00011377282498870045
. O 0 0.00020736598526127636

In O 0 0.00014676203136332333
this O 0 6.946120265638456e-06
study O 0 6.66197229293175e-06
, O 0 1.3841416830473463e-06
direct O 0 1.4519658861900098e-06
mutation O 0 1.3327255601325305e-06
analysis O 0 1.0270474604112678e-06
of O 0 3.9933354855747893e-05
the O 0 0.00042335817124694586
APC B-Disease 0 0.004588951822370291
gene O 0 3.159451807732694e-05
was O 0 9.215078898705542e-05
performed O 0 5.3779698646394536e-05
to O 0 6.220276191015728e-06
determine O 0 5.765797322965227e-05
genotype O 0 0.0002757314359769225
- O 0 0.00040095264557749033
phenotype O 0 2.6538684323895723e-05
correlations O 0 0.0001084105679183267
for O 0 3.86169231205713e-05
nine O 0 0.0012381537817418575
extracolonic O 0 0.263673335313797
manifestations O 0 0.0036185516510158777
and O 0 3.207576446584426e-05
to O 0 2.2245330910664052e-05
investigate O 0 7.63019488658756e-05
the O 0 7.549430301878601e-05
incidence O 0 0.0006878045969642699
of O 0 0.0005444057751446962
APC B-Disease 0 0.007243471220135689
mutations O 0 5.524020525626838e-05
in O 0 0.00015724843251518905
non O 1 0.9999184608459473
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.018565990030765533

METHODS O 0 0.0015222823712974787
The O 0 0.0008532517240382731
APC B-Disease 0 0.004905738867819309
gene O 0 3.0566643545171246e-05
was O 0 0.00011559249833226204
analysed O 0 9.241787483915687e-05
in O 0 1.7618731362745166e-05
190 O 0 0.00010069690324598923
unrelated O 0 0.00029721311875618994
FAP B-Disease 0 0.01568259857594967
and O 0 3.0114724722807296e-05
15 O 0 0.0009759798413142562
non O 1 0.9999865293502808
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.2654261589050293
using O 0 0.00030561976018361747
denaturing O 0 0.03215809538960457
gradient O 0 0.006762598175555468
gel O 0 0.01287507452070713
electrophoresis O 0 0.001068929792381823
, O 0 2.0276447685319e-05
the O 0 2.8622429454117082e-05
protein O 0 3.257403295719996e-05
truncation O 0 0.00025901771732605994
test O 0 1.4382106201082934e-05
, O 0 1.9290525870019337e-06
and O 0 1.1373139159331913e-06
direct O 0 7.407753855659394e-06
sequencing O 0 0.0002120846475008875
. O 0 9.843289444688708e-05

RESULTS O 0 0.004781185649335384
Chain O 0 0.0013143803225830197
terminating O 0 0.0006668687565252185
signals O 0 0.00019530805002432317
were O 0 2.1363808627938852e-05
only O 0 4.8224774218397215e-06
identified O 0 1.3182004295231309e-05
in O 0 1.7595155441085808e-05
patients O 0 3.549828034010716e-05
belonging O 0 6.587010284420103e-05
to O 0 4.515701948548667e-05
the O 0 0.0005078120157122612
FAP B-Disease 1 0.97529137134552
group O 0 3.080848910030909e-05
( O 0 3.882221790263429e-05
105 O 0 0.0005819269572384655
patients O 0 0.00020790885901078582
) O 0 9.657921327743679e-05
. O 0 0.00014965419541113079

Amino O 0 0.0014883361291140318
acid O 0 0.00014986655151005834
changes O 0 1.6391268218285404e-05
were O 0 3.463061875663698e-05
identified O 0 1.7805276002036408e-05
in O 0 1.3916895113652572e-05
four O 0 2.6639532734407112e-05
patients O 0 2.348291309317574e-05
, O 0 3.885466867359355e-06
three O 0 3.1475101422984153e-06
of O 0 4.073056697961874e-05
whom O 0 0.00017747789388522506
belonged O 0 0.0020111468620598316
to O 0 2.861213761207182e-05
the O 0 0.00012911063095089048
non O 0 0.0025656388606876135
- O 0 0.005835219752043486
FAP O 1 0.9921183586120605
group O 0 3.7740712286904454e-05
of O 1 0.9955036044120789
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.0037211747840046883

Genotype O 0 0.013713120482861996
- O 0 0.004662959836423397
phenotype O 0 0.00013823917834088206
correlations O 0 0.00021729442232754081
identified O 0 6.806065357523039e-05
significant O 0 5.823286483064294e-05
differences O 0 0.00019374613475520164
in O 0 5.599225187324919e-05
the O 0 5.790123395854607e-05
nature O 0 3.475365519989282e-05
of O 0 5.303642319631763e-05
certain O 0 0.0001438997860532254
extracolonic O 1 0.9998443126678467
manifestations O 1 0.9691817164421082
in O 0 0.0021336195059120655
FAP B-Disease 1 0.9998794794082642
patients O 0 0.00012178957695141435
belonging O 0 4.5000713726039976e-05
to O 0 1.8903629097621888e-05
three O 0 4.104237450519577e-05
mutation O 0 4.8315916501451284e-05
subgroups O 0 0.0005031686159782112
. O 0 0.00016661510744597763

CONCLUSIONS O 0 0.0014710990944877267
Extended O 0 0.0010914556914940476
genotype O 0 0.0011132366489619017
- O 0 0.0008071266347542405
phenotype O 0 3.3455664379289374e-05
correlations O 0 4.7698882553959265e-05
made O 0 2.6566642191028222e-05
in O 0 1.6544576283195056e-05
this O 0 4.084948159288615e-06
study O 0 1.2103400877094828e-05
may O 0 1.962336500582751e-05
have O 0 1.5187894177870476e-06
the O 0 9.494458026892971e-06
potential O 0 1.6049483747337945e-05
to O 0 3.313730530862813e-06
determine O 0 3.958158231398556e-06
the O 0 4.8238111958198715e-06
most O 0 1.4737146329935058e-06
appropriate O 0 3.0845867513562553e-06
surveillance O 0 4.38843562733382e-05
and O 0 1.3510724784282502e-05
prophylactic O 0 0.0023919197265058756
treatment O 0 0.0024423387367278337
regimens O 0 0.0026218669954687357
for O 0 2.9987393645569682e-05
those O 0 4.6818560804240406e-05
patients O 0 7.48757811379619e-05
with O 0 1.4244706108001992e-05
mutations O 0 0.00013862647756468505
associated O 0 0.0001354546402581036
with O 0 9.505801426712424e-05
life O 0 0.003942824900150299
threatening O 0 0.006607231218367815
conditions O 0 0.010793626308441162
. O 0 0.0009738239459693432

This O 0 1.6390957171097398e-05
study O 0 8.702473678567912e-06
also O 0 2.19481557905965e-06
provided O 0 4.515172349783825e-06
evidence O 0 2.2676547814626247e-05
for O 0 8.166204679582734e-06
the O 0 0.00011193430691491812
pathological O 0 0.006327614188194275
nature O 0 0.0005426660645753145
of O 0 0.0011619438882917166
amino O 0 0.0008456844952888787
acid O 0 0.00043283982085995376
changes O 0 4.750681546283886e-05
in O 0 0.00018340923998039216
APC O 0 0.0017807597760111094
associated O 0 6.690317150059855e-06
with O 0 1.9505971522448817e-06
both O 0 1.994436388486065e-05
FAP B-Disease 1 0.999881386756897
and O 0 0.00011766490206355229
non O 1 0.9999977350234985
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999704897403717
. O 0 0.00034848664654418826
. O 0 0.00017707135702949017

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999997615814209
cancer B-Disease 1 1.0
risk O 1 0.9027693867683411
of O 1 0.7401860356330872
the O 1 0.9939271807670593
APC O 1 0.9933218359947205
I1307K O 0 0.00700647896155715
polymorphism O 0 0.0001692163641564548
. O 0 0.00012740114470943809

Germ O 1 1.0
- O 0 0.010687191970646381
line O 0 0.0005111984792165458
and O 0 1.3788814612780698e-05
somatic O 0 0.00011493688361952081
truncating O 0 0.000983926933258772
mutations O 0 3.1905619835015386e-05
of O 0 0.00012794777285307646
the O 0 0.0007701001595705748
APC B-Disease 0 0.0058245244435966015
gene O 0 1.626067387405783e-05
are O 0 5.813279244648584e-07
thought O 0 8.492365850543138e-06
to O 0 1.5255034668371081e-05
initiate O 0 0.0022705381270498037
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.9999986886978149
in O 1 0.9999163150787354
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 1.0
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.0848473384976387
respectively O 0 0.0030367521103471518
. O 0 0.00026928342413157225

Recently O 0 0.0011023407569155097
, O 0 2.8925747756147757e-05
an O 0 3.857827323372476e-05
isoleucine O 0 0.012136010453104973
- O 0 0.0032095618080347776
- O 0 0.0016529905842617154
> O 0 0.0005000140517950058
lysine O 0 0.00024486795882694423
polymorphism O 0 1.5273042663466185e-05
at O 0 0.00032435604953207076
codon O 0 0.0002988346677739173
1307 O 0 0.007531951647251844
( O 0 7.174201164161786e-05
I1307K O 0 0.0008308030664920807
) O 0 7.275603365997085e-06
of O 0 2.77429680863861e-05
the O 0 0.00023787013196852058
APC B-Disease 0 0.004780178889632225
gene O 0 1.6290799976559356e-05
has O 0 1.7867007500171894e-06
been O 0 2.0615516405086964e-06
identified O 0 3.162008169965702e-06
in O 0 7.776097845635377e-06
6 O 0 0.00014946653391234577
% O 0 2.7557838620850816e-05
- O 0 0.0002806103730108589
7 O 0 0.00012488322681747377
% O 0 8.567162694816943e-06
of O 0 3.337300950079225e-05
the O 0 0.00010655519145075232
Ashkenazi O 0 0.00036029095645062625
Jewish O 0 0.00012229883577674627
population O 0 2.8577616831171326e-05
. O 0 7.414033461827785e-05

To O 0 6.700611993437633e-05
assess O 0 0.00015232700388878584
the O 0 9.177369793178514e-05
risk O 0 4.364912456367165e-05
of O 0 3.897602073266171e-05
this O 0 8.761839126236737e-06
common O 0 9.731452882988378e-05
APC B-Disease 0 0.005023203790187836
allelic O 0 0.002359357662498951
variant O 0 0.004652110859751701
in O 0 0.011083533987402916
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.0004035240854136646
we O 0 1.6446634617750533e-05
have O 0 1.5992641237971839e-06
analyzed O 0 1.3249179573904257e-05
a O 0 7.634813300683163e-06
large O 0 4.082922532688826e-05
cohort O 0 0.0003118951281066984
of O 0 7.624760473845527e-05
unselected O 0 0.022080572322010994
Ashkenazi O 0 0.0009227232658304274
Jewish O 0 0.00019543695088941604
subjects O 0 0.0008955657249316573
with O 0 0.0004659353871829808
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999972581863403
and O 0 0.0004875630547758192
. O 0 0.0016996662598103285
or O 1 0.9999986886978149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.0006331597687676549
for O 0 6.658806523773819e-05
the O 0 0.0011704536154866219
APC O 0 0.013931053690612316
I1307K O 0 0.003469716291874647
polymorphism O 0 0.0001452750148018822
. O 0 7.571080641355366e-05

The O 0 0.0028210452292114496
APC O 0 0.016002725809812546
I1307K O 0 0.002629182068631053
allele O 0 2.19989669858478e-05
was O 0 0.00011731849372154102
identified O 0 2.2773721866542473e-05
in O 0 1.7831103832577355e-05
48 O 0 6.447276246035472e-05
( O 0 1.7861601008917205e-05
10 O 0 3.5823493817588314e-05
. O 0 2.9055522645649035e-06
1 O 0 3.927046782337129e-05
% O 0 8.404113032156602e-06
) O 0 1.0170637324335985e-05
of O 0 7.587573782075197e-05
476 O 0 0.0062729427590966225
patients O 0 0.0007664483855478466
. O 0 0.00040751657797954977

Compared O 0 0.00028303073486313224
with O 0 8.69713767315261e-06
the O 0 5.7558321714168414e-05
frequency O 0 1.1916734365513548e-05
in O 0 5.7481788644508924e-06
two O 0 1.942621793205035e-06
separate O 0 2.2244280444283504e-06
population O 0 2.147338818758726e-06
control O 0 2.135950853698887e-05
groups O 0 1.515182816547167e-06
, O 0 6.484374353021849e-06
the O 0 0.00011425456614233553
APC O 0 0.008484512567520142
I1307K O 0 0.001765749417245388
allele O 0 6.767837021470768e-06
is O 0 1.3058793228992727e-06
associated O 0 1.353053335151344e-06
with O 0 4.5790159219905036e-07
an O 0 2.044882421614602e-06
estimated O 0 7.725668547209352e-05
relative O 0 0.00016297616821248084
risk O 0 0.00012057441199431196
of O 0 0.0003416049003135413
1 O 0 0.0057411398738622665
. O 0 0.0005378430942073464

5 O 0 0.002485178178176284
- O 0 0.0015247747069224715
1 O 0 0.0007445700466632843
. O 0 0.00012671167496591806

7 O 0 0.0030602554325014353
for O 0 0.000940559315495193
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 0.0019288465846329927
both O 0 0.0003686530399136245
P O 0 0.04825344309210777
= O 0 0.0008044162532314658
. O 0 3.949697929783724e-05
01 O 0 0.003352291649207473
) O 0 6.734608905389905e-05
. O 0 5.802537998533808e-05

Furthermore O 0 0.0005254095303826034
, O 0 1.3075755305180792e-05
compared O 0 5.5069576774258167e-05
with O 0 3.6789388104807585e-05
noncarriers O 1 0.7537919878959656
, O 0 0.0002810441656038165
APC O 0 0.007990503683686256
I1307K O 0 0.001453401055186987
carriers O 0 1.83654574357206e-05
had O 0 7.465874659828842e-06
increased O 0 6.148863576527219e-06
numbers O 0 1.3409932762442622e-05
of O 0 0.0005301528726704419
adenomas B-Disease 1 1.0
and O 1 0.7308168411254883
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.002166369231417775
patient O 0 0.001403910224325955
( O 0 0.00021903985179960728
P O 0 0.008450169116258621
= O 0 0.0004759742587339133
. O 0 3.0770377634325996e-05
03 O 0 0.0027578268200159073
) O 0 1.7167931218864396e-05
, O 0 2.2524613996210974e-06
as O 0 3.3619330679357518e-06
well O 0 2.3326083464780822e-06
as O 0 9.427367331227288e-06
a O 0 2.701839002838824e-05
younger O 0 0.0003253613831475377
age O 0 0.0006245232652872801
at O 0 0.0017377969343215227
diagnosis O 0 0.018478792160749435
. O 0 0.0009409401682205498

We O 0 7.801767787896097e-05
conclude O 0 0.00022364142932929099
that O 0 3.6973103760828963e-06
the O 0 9.209684503730386e-05
APC O 0 0.004661388695240021
I1307K O 0 0.001415338716469705
variant O 0 0.00014885139535181224
leads O 0 0.00014169575297273695
to O 0 9.170179691864178e-05
increased O 0 0.002351250033825636
adenoma B-Disease 1 1.0
formation O 0 0.12347244471311569
and O 0 6.621536886086687e-05
directly O 0 3.1400984880747274e-05
contributes O 0 2.549906275817193e-05
to O 0 1.0547290912654717e-05
3 O 0 6.924639455974102e-05
% O 0 1.3570512237492949e-05
- O 0 6.152140122139826e-05
4 O 0 2.0523322746157646e-05
% O 0 2.3358495582215255e-06
of O 0 5.731340934289619e-06
all O 0 1.4598534107790329e-05
Ashkenazi O 0 0.003745379624888301
Jewish O 1 0.9999942779541016
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9953343272209167

The O 0 0.00020879723888356239
estimated O 0 0.00016371237870771438
relative O 0 9.902913734549657e-05
risk O 0 5.147528281668201e-05
for O 0 2.0314268112997524e-05
carriers O 0 8.833265019347891e-05
may O 0 6.0251335526118055e-05
justify O 0 5.406606578617357e-05
specific O 0 1.466793719373527e-06
clinical O 0 2.4855786250554956e-05
screening O 0 1.7356238458887674e-05
for O 0 4.72498277304112e-06
the O 0 4.2401632526889443e-05
360 O 0 0.00012210880231577903
, O 0 4.795121640199795e-06
000 O 0 5.869270898983814e-05
Americans O 0 5.268272161629284e-06
expected O 0 1.0601968824630603e-05
to O 0 1.0193455636908766e-05
harbor O 0 0.0022723488509655
this O 0 4.632061063603032e-06
allele O 0 6.115903488534968e-06
, O 0 2.5577844553481555e-06
and O 0 2.069659785775002e-06
genetic O 0 3.737655788427219e-05
testing O 0 2.7957619749940932e-05
in O 0 2.5930214178515598e-05
the O 0 6.065099296392873e-05
setting O 0 8.716629236005247e-05
of O 0 0.00015976454596966505
long O 0 0.0008171070949174464
- O 0 0.0006400725687853992
term O 0 0.00017302185005974025
- O 0 7.289644418051466e-05
outcome O 0 6.559451321663801e-06
studies O 0 2.075223619613098e-06
may O 0 5.2953209888073616e-06
impact O 0 2.270444019814022e-05
significantly O 0 0.0003287355648353696
on O 0 0.46206289529800415
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9992656111717224
in O 0 6.972600385779515e-05
this O 0 4.2148426473431755e-06
population O 0 9.518900697003119e-06
. O 0 2.871127799153328e-05

Localization O 0 0.00982536468654871
of O 0 0.0011936402879655361
human O 0 0.0008681422332301736
BRCA1 O 0 0.002126730512827635
and O 0 9.138889254245441e-06
its O 0 1.7113365174736828e-05
loss O 0 0.0003074606356676668
in O 0 0.00010532526357565075
high O 0 0.0007055897731333971
- O 0 0.0005893090856261551
grade O 0 0.002986826468259096
, O 0 2.4157861844287254e-05
non B-Disease 0 0.002270602621138096
- I-Disease 1 0.9989297986030579
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.01912018470466137

Although O 0 4.209631879348308e-05
the O 0 2.3736434741294943e-05
link O 0 0.00018542824545875192
between O 0 0.00015588557289447635
the O 0 0.0006522191688418388
BRCA1 O 1 0.9998120665550232
tumour B-Disease 1 1.0
- O 1 0.9820927381515503
suppressor O 0 0.002650607842952013
gene O 0 6.955418939469382e-05
and O 0 6.430163921322674e-05
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.003112759906798601
established O 0 0.00056852848501876
, O 0 5.9093767958984245e-06
the O 0 9.884814971883316e-06
role O 0 6.153043796075508e-05
, O 0 3.6093110793444794e-06
if O 0 1.1425113370933104e-06
any O 0 1.3211654277256457e-06
, O 0 2.9231453027023235e-06
of O 0 6.094901618780568e-05
BRCA1 O 0 0.002317989245057106
in O 0 0.0003382395370863378
non B-Disease 1 0.9891546368598938
- I-Disease 1 0.999699592590332
familial I-Disease 1 0.9999698400497437
cancers I-Disease 1 0.9999998807907104
is O 0 0.00037442741449922323
unclear O 0 0.00045997934648767114
. O 0 0.00012822479766327888

BRCA1 O 0 0.010110663250088692
mutations O 0 0.0001170456234831363
are O 0 4.848082880926086e-06
rare O 0 0.0001537110802019015
in O 0 0.0002854275517165661
sporadic B-Disease 1 0.9089969992637634
cancers I-Disease 1 0.9999916553497314
, O 0 0.00012224439706187695
but O 0 1.4069140888750553e-05
loss O 0 0.0006501426105387509
of O 0 0.0011852820171043277
BRCA1 O 0 0.008718485943973064
resulting O 0 0.0007658179383724928
from O 0 0.00022874254500493407
reduced O 0 0.0004717055126093328
expression O 0 0.00011904843267984688
or O 0 5.120014975545928e-05
incorrect O 0 7.119027577573434e-05
subcellular O 0 0.0008865116396918893
localization O 0 0.0005007304134778678
is O 0 8.47154478833545e-06
postulated O 0 5.560403587878682e-05
to O 0 3.2391487820859766e-06
be O 0 1.8207365428679623e-06
important O 0 1.4561491298081819e-05
in O 0 2.3850612706155516e-05
non B-Disease 0 0.0016721149440854788
- I-Disease 1 0.8598724603652954
familial I-Disease 1 0.9999992847442627
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9999891519546509

Epigenetic O 0 0.14566105604171753
loss O 1 0.9017870426177979
, O 0 0.00011440621892688796
however O 0 3.97899275412783e-05
, O 0 3.3247210922127124e-06
has O 0 6.724313266204263e-07
not O 0 1.1991055259841232e-07
received O 0 2.062265593849588e-06
general O 0 9.47279932006495e-06
acceptance O 0 0.00011768061813199893
due O 0 0.0003663215902633965
to O 0 3.5691085940925404e-05
controversy O 0 0.00011087920574937016
regarding O 0 2.035279612755403e-05
the O 0 4.153058398514986e-05
subcellular O 0 0.0005411696620285511
localization O 0 0.0010144037660211325
of O 0 0.0003300155221950263
BRCA1 O 0 0.002417508512735367
proteins O 0 3.132208439637907e-05
, O 0 2.5650488169048913e-06
reports O 0 1.7576171558175702e-06
of O 0 7.4941649472748395e-06
which O 0 3.801158527494408e-06
have O 0 1.0700717893996625e-06
ranged O 0 0.00011652399552986026
from O 0 1.7375732568325475e-05
exclusively O 0 5.48974858247675e-05
nuclear O 0 0.000545675924513489
, O 0 3.708190206452855e-06
to O 0 5.4778633966634516e-06
conditionally O 0 0.000247333780862391
nuclear O 0 0.0002999530406668782
, O 0 2.114228891514358e-06
to O 0 3.7863210309296846e-06
the O 0 0.00016004386998247355
ER O 1 0.9999488592147827
/ O 0 0.0031225276179611683
golgi O 0 0.010152171365916729
, O 0 1.5224572052829899e-05
to O 0 2.2321219148579985e-05
cytoplasmic O 0 0.00024137107538990676
invaginations O 0 0.003246222622692585
into O 0 6.451494846260175e-05
the O 0 0.0002086217573378235
nucleus O 0 0.003795825643464923
. O 0 0.00023163670266512781

In O 0 0.00011869636364281178
an O 0 1.0737584489106666e-05
attempt O 0 9.04351327335462e-05
to O 0 2.0189734641462564e-05
resolve O 0 0.0003091478138230741
this O 0 4.501590410654899e-06
issue O 0 2.1853853468201123e-05
, O 0 1.564320882607717e-06
we O 0 1.1777212876040721e-06
have O 0 6.433719477172417e-07
comprehensively O 0 0.0008057894883677363
characterized O 0 0.0002170384832425043
19 O 0 0.0023103379644453526
anti O 0 0.007638774812221527
- O 0 0.012353849597275257
BRCA1 O 0 0.002716741757467389
antibodies O 0 0.00011831396113848314
. O 0 7.537468627560884e-05

These O 0 6.485069025075063e-05
reagents O 0 0.0003916732966899872
detect O 0 0.0006620496860705316
a O 0 0.0001096550768124871
220 O 0 0.0005140953580848873
- O 0 0.0008356394828297198
kD O 0 0.005815006326884031
protein O 0 2.848858457582537e-05
localized O 0 5.152784433448687e-05
in O 0 1.3262074389785994e-05
discrete O 0 3.375376763870008e-05
nuclear O 0 0.0010620730463415384
foci O 0 0.0013180432142689824
in O 0 4.167356382822618e-05
all O 0 4.223279393045232e-05
epithelial O 0 0.38284820318222046
cell O 0 0.0016357079148292542
lines O 0 0.00026338218594901264
, O 0 5.135084848006954e-06
including O 0 2.8738797936966876e-06
those O 0 9.869095265457872e-06
derived O 0 0.0001739391009323299
from O 0 0.0017456039786338806
breast B-Disease 1 0.9999966621398926
malignancies I-Disease 1 0.9999423027038574
. O 0 0.0014815883478149772

Immunohistochemical O 0 0.05061521381139755
staining O 0 0.005140252877026796
of O 0 0.0034037947189062834
human O 0 0.025882083922624588
breast O 1 0.9978200197219849
specimens O 0 0.0005817352794110775
also O 0 6.572730490006506e-05
revealed O 0 0.0021592704579234123
BRCA1 O 0 0.008357011713087559
nuclear O 0 0.022881321609020233
foci O 0 0.03971531242132187
in O 0 0.0014757349854335189
benign O 1 1.0
breast O 1 1.0
, O 0 0.31801989674568176
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.8244122266769409
low B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999998807907104
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.002047030720859766

Conversely O 0 0.0026518029626458883
, O 0 0.00011696171713992953
BRCA1 O 0 0.0009472484234720469
expression O 0 7.063031080178916e-05
was O 0 0.000726323458366096
reduced O 0 0.0001580127136548981
or O 0 4.566729694488458e-05
undetectable O 0 0.0013223986607044935
in O 0 9.613514521333855e-06
the O 0 7.578021268273005e-06
majority O 0 1.290110390073096e-06
of O 0 6.34036332485266e-05
high O 0 0.004417033866047859
- O 0 0.015067772939801216
grade O 1 0.9992411136627197
, O 0 0.0006850592908449471
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.00016900514310691506
suggesting O 0 0.0001085243493434973
that O 0 7.300987363123568e-06
absence O 0 0.0003726973372977227
of O 0 0.0007597777876071632
BRCA1 O 0 0.008386479690670967
may O 0 0.0002174229157390073
contribute O 0 0.00010176171053899452
to O 0 2.7837688321596943e-05
the O 0 0.00012150746624683961
pathogenesis O 0 0.014456938952207565
of O 0 7.317811105167493e-05
a O 0 1.715576945571229e-05
significant O 0 4.6889388613635674e-05
percentage O 0 0.00016227665764745325
of O 0 0.0006604710943065584
sporadic B-Disease 1 0.9999716281890869
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 0.00054813118185848
. O 0 0.000392666959669441

